Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.9083593852379027,1.9387848182546619,0.0,0.6393603049110247,0.33,2/35,1.31%,CPA1;PLA2G10
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8325716472866169,-1.9293133641649614,0.0,0.06668044062156785,0.07,2/41,1.18%,CD44;LCP1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.824337775736846,-1.8954881819959117,0.0,0.08096910646904666,0.15,2/41,1.18%,CD44;LCP1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.9561090151084517,-1.8835317283908748,0.0,0.06668044062156785,0.18,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.9071483260158346,-1.8803260004071753,0.0,0.05239177477408902,0.19,1/31,0.01%,CD44
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.9503300561419457,-1.8793986801512967,0.0,0.04381857526560172,0.2,1/18,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.9360334123438139,-1.8791379230984284,0.0,0.03651547938800143,0.2,2/19,0.52%,CD44;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8752014957496735,-1.867366695522925,0.0,0.03674228360780269,0.21,2/30,0.58%,CD44;CLDN4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9225936106794831,-1.8383072028018368,0.02,0.06548971846761127,0.32,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.896853391401081,-1.8297035853648165,0.0,0.07514779816081456,0.38,1/40,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7842187554963632,-1.8230879084520768,0.0,0.07811137329955091,0.39,2/59,0.85%,CD44;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8753340447399316,-1.8119312334959483,0.0,0.08919591407820114,0.44,2/26,1.74%,CD44;CLU
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8564241349367212,-1.7992205413396698,0.0,0.1024021052402649,0.49,1/37,0.01%,CD44
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8667789363488448,-1.797656132360432,0.0,0.09965428488498052,0.5,2/20,1.18%,CD44;LCP1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9920888140945641,1.7962252552855533,0.0,1.0,0.93,1/12,0.00%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.8637493711927144,-1.792484415885876,0.0,0.10614437486698555,0.55,1/32,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9138780181817722,1.786361276360215,0.0,1.0,0.96,3/24,1.78%,CPA1;ACE2;CEL
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.8117887093365841,-1.7804249154265877,0.0,0.12637531127325716,0.63,2/46,1.18%,CD44;LCP1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.7515607392632426,-1.7780840631633994,0.0,0.12443046508846142,0.64,4/79,4.20%,CD44;SIGLEC1;RAC1;ADAMTS12
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.711612412052571,-1.7750434019453034,0.0,0.12047306498854693,0.65,6/110,3.19%,CD44;SIGLEC1;CRH;RAC1;ABCF1;NLRP3
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.8627916716637322,-1.7629062550301655,0.0,0.1365361403203532,0.71,6/42,4.38%,CD44;HLA-DPB1;HCK;HLA-C;OAS3;B2M
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.8467139729216261,-1.7525667606313087,0.0,0.1534151490992463,0.77,2/39,1.05%,CD44;CCN3
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7392784366564701,-1.7340441575992722,0.0,0.19099183349463358,0.84,4/78,2.38%,CD44;DYSF;AOAH;HCK
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.799854173799772,-1.7274527562432165,0.0,0.20684544845874106,0.9,7/63,4.38%,CD44;HLA-DPB1;HCK;HLA-C;GBP6;OAS3;B2M
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.8672525252983576,1.726936240101949,0.0,1.0,1.0,3/19,3.03%,SEMA3C;SEMA5A;SEMA6D
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.894752760223857,-1.7099270729749265,0.0,0.25936093462544896,0.95,4/23,4.78%,CD44;SPRED3;CD74;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8788309316828318,-1.7060025091194282,0.0,0.26009513484686086,0.95,2/21,1.74%,CD44;CLU
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.7966884416028118,1.6955943158307252,0.0,1.0,1.0,6/29,7.24%,SEMA3C;SEMA5A;SEMA6D;ROBO1;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.9379386087472865,-1.6934992349808247,0.0,0.3028403344896206,0.98,1/14,0.01%,CD44
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9289922689683996,-1.6782161088460843,0.020833333333333332,0.3604554104457325,0.99,1/12,0.01%,CD44
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8872327528455947,-1.6781379992422776,0.0,0.34695811686057554,0.99,2/14,1.18%,CD44;LCP1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9303504301330997,-1.6754793361525984,0.0,0.34822007880152095,0.99,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.8638799603655378,1.6686104438884615,0.02127659574468085,1.0,1.0,7/16,9.31%,CEL;NLGN1;NRXN1;CNTN4;NRXN3;NCAM2;NLGN4X
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9263429559937322,-1.66731965700683,0.0,0.3803506766066982,1.0,1/14,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.8395312069445222,1.6636966179900328,0.0,1.0,1.0,5/23,5.96%,SEMA3C;SEMA5A;SEMA6D;DSCAM;NRP1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.8544651701757228,-1.6608045332403052,0.02,0.39581246772901113,1.0,1/13,0.22%,SELP
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6920669502019867,-1.6570352339556431,0.0,0.4010352214525723,1.0,2/78,0.85%,CD44;TERF2IP
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.6605360242528128,-1.6565604658105135,0.0,0.3911714327707644,1.0,30/174,13.83%,CD44;LDHC;DEPDC1;SLC25A10;HK2;AURKA;SPAG4;CASP6;SDHC;AGRN;GPC1;XYLT2;GPC3;STMN1;SDC2;RBCK1;IGFBP3;ANKZF1;RARS1;TXN;MPI;MET;GALK1;CYB5A;IL13RA1;AKR1A1;PGLS;ENO1;LDHA;PSMC4
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.6650432009896885,1.6544761459875683,0.0,1.0,1.0,13/162,6.18%,CPA1;MXRA5;ALDH1A1;HPGDS;LSAMP;LDB2;PCDH7;ROR1;POSTN;ADAMTS9;TCF7L1;GPM6A;HS2ST1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.7431827280514861,-1.6537483442697838,0.0,0.39442671349811337,1.0,9/47,4.95%,P2RY10;HLA-DPB1;CD5;SP140;SLA;AOAH;KLRB1;TRAF3IP3;CD4
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.7280465050997825,-1.6536847361683757,0.0,0.38247438884665536,1.0,4/53,3.40%,TLCD2;DYSF;AHNAK2;STX4
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9385254541145621,-1.6495393453961997,0.0,0.3667424234186231,1.0,1/9,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9385254541145621,-1.6495393453961997,0.0,0.3667424234186231,1.0,1/9,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9385254541145621,-1.6495393453961997,0.0,0.3667424234186231,1.0,1/9,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.7674619803331989,-1.647687696608867,0.0,0.368673324208823,1.0,8/63,8.50%,CD44;NLRP3;NODAL;PDCD5;IFI6;TRIAP1;BEX3;CARD9
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9838244323498827,1.6420718920583477,0.0,1.0,1.0,1/10,0.01%,CLEC2A
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9163168311349087,-1.6410915714673062,0.0,0.3847912644891227,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8449587617404554,-1.6333608806215834,0.019230769230769232,0.41937844889095965,1.0,1/21,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9453933771472293,-1.6320450918512763,0.0,0.4131805874229293,1.0,3/10,2.51%,CYP1A2;HSD11B1;CYP19A1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8084647783346995,-1.6291745516284468,0.038461538461538464,0.41866952613263153,1.0,3/25,3.80%,CYP1A2;CYP2E1;CYP2D6
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8865635030867688,1.6289575872155846,0.0,1.0,1.0,6/17,7.71%,IL1RAPL2;GPC6;IL1RAPL1;SNCA;PTPRD;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8865635030867688,1.6289575872155846,0.0,1.0,1.0,6/17,7.71%,IL1RAPL2;GPC6;IL1RAPL1;SNCA;PTPRD;LRFN5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.7366210622103597,1.6286089386710276,0.02,1.0,1.0,6/24,11.76%,MARVELD3;ADAMTS9;SLIT2;PTPRG;ADIPOR1;PTPRM
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8766543712917925,1.6242100019479038,0.02040816326530612,1.0,1.0,1/10,0.14%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8766543712917925,1.6242100019479038,0.02040816326530612,1.0,1.0,1/10,0.14%,ACE2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.7262576933924026,-1.6236230288036932,0.0,0.4413610117332348,1.0,5/67,3.80%,CYP1A2;ACOT1;CYP2E1;ACOT4;CYP2D6
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8051999541399305,1.6209981777527893,0.025,1.0,1.0,8/20,12.65%,NTF3;FGFR2;FGFR3;CCL5;ABL2;PDGFRB;FGFR1;GNA13
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.744820920057988,-1.6119510020090495,0.021739130434782608,0.5046446635745234,1.0,7/51,2.90%,CD44;P2RY10;CD5;SLA;AOAH;KLRB1;TRBC2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6691321731137534,-1.6063601565882095,0.0,0.5265156869858864,1.0,15/116,9.23%,CD44;INHA;NOG;PAPSS2;ARSL;RFLNA;DLX5;PRDX1;GNAS;RBP4;PHEX;NOTUM;DDRGK1;ALX4;BMP3
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.9228661120638506,1.6057268440055368,0.02,1.0,1.0,2/8,0.33%,ACE2;ENPEP
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.9228661120638506,1.6057268440055368,0.02,1.0,1.0,2/8,0.33%,ACE2;ENPEP
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.7473180471347954,1.6042273292358953,0.0,1.0,1.0,5/24,14.05%,PLA2G10;ABHD4;PLA2G15;NAPEPLD;SELENOI
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.7622540475725822,-1.602863755150663,0.0,0.5389473073730531,1.0,4/26,8.29%,NCKAP1L;RAC1;KIF17;PARVB
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6547381751365232,-1.602584227878233,0.0,0.5301302111528375,1.0,8/90,5.94%,PM20D1;ACOT1;CPXM2;DHFR2;ACOT11;ACOT4;ST6GAL1;PCCB
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7693648203362374,-1.6013474250549309,0.019230769230769232,0.5245257760748255,1.0,7/45,6.92%,CD44;GPC2;HGSNAT;AGRN;GPC1;GPC3;CEMIP
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.6909687712071719,-1.6010607437305957,0.0196078431372549,0.5149873315862159,1.0,15/106,7.74%,CD44;SELP;DYSF;SIGLEC1;HCK;RNASE1;HMGB3;ITGA6;MAFF;CPQ;SPI1;MYADM;IL3RA;ACE;SCARF1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7494271780599858,1.6007493913739814,0.0,1.0,1.0,7/32,12.59%,SEMA3C;ERBB4;SEMA5A;SEMA6D;NRP1;RADIL;NRTN
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6426361205262616,-1.5998471338834697,0.015873015873015872,0.5114759162546502,1.0,17/151,6.42%,CD44;SELP;SPRY4;ETV4;COL6A1;HK2;PLIN2;F2RL2;GPR83;PRKCH;SPRED2;CKAP4;ITGA6;MAFF;ADAM19;RGS16;AHNAK
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.9448087069777229,-1.5984859938362481,0.0,0.5000099146888994,1.0,2/6,3.08%,AZGP1;HLA-C
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.9448087069777229,-1.5984859938362481,0.0,0.5000099146888994,1.0,2/6,3.08%,AZGP1;HLA-C
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9704760844116305,-1.598401137065373,0.025,0.49094390347747746,1.0,1/6,0.04%,SLC28A2
prerank,PanglaoDB_Augmented_2021__MÃ¼ller Cells,-0.638421107010406,-1.5982034915134395,0.0,0.4822200058966753,1.0,4/125,1.74%,CD44;GSTM5;COL6A1;CLU
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6914879498701998,1.5972054523544872,0.02127659574468085,1.0,1.0,17/61,11.99%,LTK;NTF3;NLGN1;ZEB1;MOSMO;CNTN4;NEUROD2;HEY1;KCTD11;ECT2;BRINP3;NREP;TCF4;DISP3;DLL1;FGFR1;ZC4H2
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.9413557082180061,-1.5969051098372355,0.02,0.48193376660879195,1.0,3/7,3.46%,NCKAP1L;RAC1;BST1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.8314505117489641,-1.590725228147842,0.05555555555555555,0.5097156798682446,1.0,3/10,4.52%,PLK3;GOLGA2;PLK5
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.7608249983003977,1.5894787506946364,0.019230769230769232,1.0,1.0,3/29,3.03%,SEMA3C;SEMA5A;SEMA6D
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5928138014544324,-1.588417094225001,0.0,0.5154125894983432,1.0,16/167,5.73%,CD44;MMP26;COL6A1;HRNR;SERPINE1;ADAM12;COL4A3;COL6A2;COL9A1;ADAMTS12;MMP21;AGRN;ADAMTS15;LOXL1;ITGA6;ADAM19
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.8754794537146536,1.588077922472667,0.0,1.0,1.0,2/10,3.63%,SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.8754794537146536,1.588077922472667,0.0,1.0,1.0,2/10,3.63%,SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.885461290211347,1.586392487365273,0.0,1.0,1.0,4/9,3.60%,ACE2;ENPEP;OXTR;CORIN
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7930829482706083,-1.5850896946236266,0.017543859649122806,0.5289313147049178,1.0,5/31,4.45%,KRT16P6;CBLC;ENTPD2;FLG;DUOXA1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.7792509521034734,1.5839864515070667,0.018867924528301886,1.0,1.0,4/19,8.27%,SLC12A1;ATP6V0A4;SLC12A3;SCNN1B
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7857730962292703,1.5827162309618792,0.0392156862745098,1.0,1.0,3/20,2.12%,ACE2;OXTR;CHRM3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.6468560267517217,-1.5823694355453624,0.0,0.5368925132805549,1.0,7/105,4.17%,CYP1A2;ACOT1;LDHC;AOAH;ACOT11;ACOT4;MECR
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8709568841051538,-1.580186799367161,0.043478260869565216,0.541354763690356,1.0,2/10,3.39%,DDX11;NCL
prerank,PanglaoDB_Augmented_2021__Basophils,-0.6899406054275148,-1.5800386188678888,0.0,0.5326497102032384,1.0,5/81,2.38%,CD44;SIGLEC1;TEC;AOAH;HCK
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8278952060890098,-1.5728992302427278,0.0,0.5707658324867224,1.0,2/18,2.00%,CYP1A2;HSD11B1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7257572858197865,-1.5716438202178602,0.02040816326530612,0.5693956519436185,1.0,2/36,0.70%,EPN1;CBLC
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.8706353698123563,1.5700521775827907,0.02,1.0,1.0,4/14,7.71%,GPC6;LRRC4C;PTPRD;LRFN5
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.9554783838698726,-1.568847273810563,0.0,0.5812236139440063,1.0,1/8,0.65%,DDX11
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.937990738846328,-1.5679396105699268,0.019230769230769232,0.5769048835919575,1.0,2/8,2.00%,CYP1A2;HSD11B1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.6235146167197482,-1.567315956333947,0.0,0.5716931843181015,1.0,18/153,9.95%,CD44;PLK4;CD9;MYB;ASCL1;PAPSS2;ST6GALNAC2;FABP5;SORD;ETFB;CHST8;NMU;LLGL2;PRLR;IGFBP4;RAB31;BLVRB;CCND1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.802331921372948,-1.5650610353987087,0.0,0.5790517917180307,1.0,4/17,7.29%,SUN3;NEMP1;SPAG4;LEMD2
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.9515682778767193,1.563924849872703,0.02127659574468085,1.0,1.0,1/5,0.80%,EIF3E
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.7373832786348993,-1.563419448263392,0.06666666666666667,0.5829206962653052,1.0,2/28,3.19%,ACOT1;ACOT4
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6458717051908346,-1.5594313573135066,0.02127659574468085,0.6004041355126887,1.0,39/88,23.29%,SRP54;RPLP1;SEC62;RPL28;SRP14;SRP68;RPL37A;RPL34;RPS15;RPL4;RPS8;RPL12;RPL31;RPL8;RPL19;RPS27;RPL23;RPL7A;RPL29;RPS24;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;SRPRA;RPLP2;RPS4Y1;RPS20;RPS3;RPL35A;RPL11;RPL10A;RPL18;RPS14;RPS4X;RPS2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9326403490280968,-1.557446109735834,0.0,0.5961775721695688,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9326403490280968,-1.557446109735834,0.0,0.5961775721695688,1.0,1/10,0.01%,CD44
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7400724283895875,-1.5563153988546108,0.023809523809523808,0.595964823422544,1.0,2/57,0.69%,CD44;CD9
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.689626015160513,-1.5554208480566203,0.017543859649122806,0.5932442375934727,1.0,7/57,4.02%,CYP1A2;HSD11B1;CYP19A1;CYP2E1;HSD17B10;CYP2D6;DHRS11
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.9133863274522075,-1.5528259844964103,0.0,0.5993410249997282,1.0,3/6,4.52%,PLK3;GOLGA2;PLK5
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6995692032225684,-1.5525300675222473,0.06818181818181818,0.5935589029074311,1.0,4/60,4.07%,CYP1A2;CYP2E1;CYP2D6;DECR2
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.9545098287551023,-1.5522209698796008,0.0,0.5880579811006841,1.0,2/5,0.66%,SFRP1;INHA
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.8088652394236013,-1.5519728256964647,0.017857142857142856,0.5825764812200138,1.0,5/19,11.77%,SELP;SERPINE1;NOS2;HMGB2;AZU1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.8781537368776035,-1.5512886840290303,0.05454545454545454,0.58057756556033,1.0,1/10,0.14%,TLCD2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.8215077701224146,-1.5508164166499736,0.02,0.5765537732132267,1.0,4/16,2.41%,SELP;TXK;TEC;CELA2A
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8895933619160133,-1.5486544851528878,0.0,0.5801077754617774,1.0,4/14,3.80%,CYP1A2;CYP19A1;HSD17B10;CYP2D6
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.6910422664094822,1.5474874864060444,0.024390243902439025,1.0,1.0,5/40,3.03%,SEMA3C;NRG1;ERBB4;SEMA5A;SEMA6D
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.737322131447624,1.5452669162967425,0.04081632653061224,1.0,1.0,11/45,10.22%,IL1RAPL2;GPC6;IL1RAPL1;NLGN1;NRXN1;SNCA;GRID2;ROBO2;PTPRD;LRFN5;LHFPL4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6712866090264882,1.544447854556979,0.04,1.0,1.0,13/58,12.77%,SLC12A1;GABRR1;SLC26A7;GABRB1;SLC12A3;GABRG3;GLRA2;GABRB2;ANO7;GLRB;GABRA4;ANO5;SLC26A6
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6026464400440581,1.5422065707163584,0.0,1.0,1.0,35/127,15.13%,PMP2;CADM2;LRRC4C;LSAMP;LRRTM3;MAGI2;SLC39A12;NRXN1;ADGRB3;GFAP;EGFR;CDH20;ZEB2;GRM5;NRXN3;GRIA4;AMER2;CA10;SLC1A2;NPAS3;CTNNA2;DLG2;GPM6B;SYNPR;RBFOX1;SLC4A4;P2RX7;PPFIA2;AKAP6;RGS7BP;LRRC3B;P2RY1;GRIA2;GDF10;RFTN2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.7107381712862774,-1.541747121906393,0.08333333333333333,0.6161987146725242,1.0,6/28,7.43%,CLDN4;DUOX1;SERPINE1;VIL1;ADRA2A;CLDN1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.6431072764051855,-1.5414890580639025,0.0,0.6096497428257631,1.0,9/56,14.03%,BUD23;TRMO;HENMT1;CMTR1;TARBP1;METTL6;TRMT112;METTL3;TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.6806531713369146,-1.5412914742055972,0.0,0.6037251740597354,1.0,10/90,7.65%,CD44;TNFSF18;TEC;IL31RA;CD74;ENPP2;GHR;IL11;FGF7;ACE
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.623575643479728,1.5397021530748871,0.020833333333333332,1.0,1.0,10/195,5.34%,CPA1;ENPEP;PRSS57;KLKB1;KEL;CAPN13;HGFAC;ADGRV1;ATG4C;ADAMTS9
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5715768651248775,-1.5395735189748627,0.0,0.6104531216284326,1.0,15/167,5.73%,CD44;MMP26;COL6A1;SERPINE1;ADAM12;COL4A3;COL6A2;COL9A1;ADAMTS12;MMP21;AGRN;ADAMTS15;LOXL1;ITGA6;ADAM19
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.8166033069854987,-1.5387701989623368,0.0,0.6084023196168562,1.0,3/14,5.66%,TERF2IP;SLX4;ERCC1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7313029674520878,1.5364982658721618,0.022222222222222223,1.0,1.0,14/35,16.69%,GRM7;PLCB1;GRM5;GRID2;GRIA4;GRM8;GRIK2;GRM6;GNAQ;GRIK1;GRM1;GRIA2;CPEB4;CLN3
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7599467334641974,1.5345072574580898,0.045454545454545456,1.0,1.0,3/27,2.25%,ACE2;KCNJ3;NEDD4
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.8365953696874296,-1.5338618390160423,0.02040816326530612,0.6328478120840229,1.0,4/15,9.24%,STING1;CGAS;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.7931091714705629,1.5337616701818417,0.021739130434782608,1.0,1.0,3/26,2.58%,ACE2;KEL;KLF2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.8524790685680166,-1.5330584134647682,0.05263157894736842,0.6306950646166234,1.0,4/15,6.35%,C2ORF49;TRPT1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.9400500557589843,-1.5328009787517414,0.02,0.6255260382118507,1.0,1/9,0.65%,DDX11
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.650494280604708,-1.5321965391224046,0.041666666666666664,0.6225311915822024,1.0,40/87,23.29%,TMA7;RPLP1;RPL28;RWDD1;RPL37A;RPL34;RPS15;RPL4;RPS8;RPL12;RPL31;RPL8;RPL19;EIF4A2;RPS27;RPL23;DRG1;RPL7A;RPL29;EIF3I;EIF2B3;RPS24;ZC3H15;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPS20;RPL22L1;RPS3;RPL35A;RPL11;RPL10A;RPL18;RPS14;RPS4X;RPS2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.8385281838487939,-1.5309100985964554,0.0,0.6244200490950671,1.0,4/16,9.24%,STING1;CGAS;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6863848769173883,1.5263940044562825,0.04081632653061224,1.0,1.0,11/42,12.51%,SLC12A1;GABRR1;GABRB1;SLC12A3;GABRG3;GLRA2;GABRB2;ANO7;GLRB;GABRA4;ANO5
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.8591745547086166,-1.5260248949468231,0.0,0.6503989009833879,1.0,2/11,1.55%,TYMS;DHFR2
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.92023548964191,-1.524931396450312,0.038461538461538464,0.6489043193298258,1.0,1/7,0.65%,DDX11
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6878503139646417,-1.52469072775401,0.0,0.6430935041934128,1.0,1/67,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.6033074727560319,-1.5246022762914793,0.0,0.6369979419747012,1.0,5/111,5.30%,CD44;NTRK1;CD74;CD4;NODAL
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6591730593561151,-1.5243475522285241,0.0,0.6327548195153033,1.0,3/126,2.82%,CD44;CLU;CASP6
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.9410659770076282,-1.522628770413748,0.023255813953488372,0.6375251751457569,1.0,1/5,0.56%,SFRP1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6315649739664905,-1.5220727037010964,0.0,0.6359448570589707,1.0,42/97,23.29%,SRP54;RPLP1;SEC62;RPL28;SRP14;SRP68;RPL37A;RPL34;RPS15;RPL4;RPS8;RPL12;RPL31;RPL8;RPL19;SGTB;RPS27;RPL23;RPL7A;RPL29;RPS24;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;SRPRA;RPLP2;RPS4Y1;SPCS1;RPS20;RPS3;RPL35A;RPL11;RPL10A;SEC61G;RPL18;RPS14;RPS4X;RPS2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.8669324735228221,-1.5217723666510437,0.0196078431372549,0.6315492100696654,1.0,4/12,9.24%,STING1;CGAS;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6750761376857639,-1.521474422330373,0.0,0.6266600593108569,1.0,6/71,4.01%,CD44;SFRP1;TEC;BST1;CD74;ENPP2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.6241020093149089,1.5212842355549028,0.04,1.0,1.0,19/79,13.17%,MXRA5;SSC5D;FAT4;HMCN1;PRRX1;POSTN;SULF1;SLIT2;SYNPO2;NID2;ADAMTSL1;PRKG1;PDGFRB;ITGA11;FLNC;ACTA2;COL5A2;ABI3BP;CXCL12
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.903281766059228,1.5209197534606544,0.023255813953488372,1.0,1.0,3/9,3.80%,SULT2A1;ENPP1;SULT2B1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.5881016822514625,-1.5208879986425972,0.018867924528301886,0.6232167588829652,1.0,73/193,23.71%,NARS1;SARS1;ABCF1;WARS1;TMA7;MRPL23;RPLP1;MRPL16;RPL28;RWDD1;MRPS18B;RPL37A;RPL34;PPA1;RARS1;MRPL55;RPS15;RPL4;RPS8;CARS1;TRMT112;RPL12;RPL31;RPL8;RPL19;RPS27;MRPS18C;RPL23;MRPL9;IARS2;MRPS21;DRG1;MRPL27;RPL7A;MRPL51;RPL29;AIMP1;PABPC4;RPS24;ZC3H15;RPL5;GARS1;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;YARS1;RPS4Y1;MRPS33;EPRS1;RRBP1;RPS20;RPL22L1;RPS3;MRPL37;EIF4G1;RPL35A;RPL11;RPL10A;IARS1;MRPS11;RPL18;RPS14;GTPBP1;RPS4X;EEF1B2;IGHMBP2;RPS2;MARS1;EEF2
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7418636803159095,-1.519445844057243,0.058823529411764705,0.6269866573873708,1.0,3/27,4.37%,CYP1A2;ACOT4;ST6GAL1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5664991208796922,-1.5187151988623377,0.0,0.6249287122468296,1.0,33/286,10.05%,CD44;APIP;NCKAP1L;SFRP1;TNFSF18;SH3RF2;HMGN5;NUPR1;NTRK1;PLK3;HCK;ASCL1;IL31RA;CD74;ANXA5;ANKLE2;UBC;AHI1;HTATIP2;VIP;PTMA;BCL2L2;IFI6;CRYAB;PRLR;TAF9B;TRIAP1;DDRGK1;PA2G4;PLK2;PIDD1;FHL2;TCIM
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5868980009142656,-1.5168127715059916,0.0,0.6326236761491605,1.0,13/163,5.72%,CD44;GSTM5;TAGLN;ENTPD2;COL6A1;FBLN2;HCK;COL4A3;COL6A2;TNXB;CKAP4;ERCC1;SCARA5
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.8456120246625384,1.5160359988589034,0.05,1.0,1.0,3/10,11.81%,SGK2;SGK1;NR1H3
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9620251944196815,1.5157275903992593,0.0,1.0,1.0,1/9,0.01%,CLEC2A
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.869234257607827,-1.5156687744260309,0.0392156862745098,0.6347127101051596,1.0,3/11,3.80%,CYP1A2;CYP2E1;CYP2D6
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6345380755226706,-1.5149564724112259,0.0392156862745098,0.6330978098575233,1.0,37/85,23.29%,SRP54;RPLP1;RPL28;SRP14;SRP68;RPL37A;RPL34;RPS15;RPL4;RPS8;RPL12;RPL31;RPL8;RPL19;RPS27;RPL23;RPL7A;RPL29;RPS24;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;RPS4Y1;RPS20;RPS3;RPL35A;RPL11;RPL10A;RPL18;RPS14;RPS4X;RPS2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.8785224881427622,1.5145807720939999,0.04081632653061224,1.0,1.0,2/5,5.35%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.843251310094098,1.513752619224034,0.043478260869565216,1.0,1.0,6/11,11.27%,ROBO1;ADAMTS9;ROBO2;JAG1;PDGFRB;PDE2A
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.8333726096974505,-1.5117446645016517,0.041666666666666664,0.6472992433127708,1.0,1/14,0.85%,TERF2IP
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6591600150374347,-1.5116754219363975,0.03636363636363636,0.6417318416153853,1.0,1/70,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.8597319881706911,-1.511103338134192,0.07407407407407407,0.6397405157631328,1.0,5/12,7.09%,NCKAP1L;TNFSF18;RAC1;BST1;MADCAM1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.9298876817904322,1.51012454618983,0.0,1.0,1.0,2/9,3.23%,GALNT3;GALNT13
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.906172124867658,1.5094068853509115,0.06666666666666667,1.0,1.0,2/7,1.52%,ALDH1A1;SULT2A1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.8713176249420083,1.5063169708112227,0.0,1.0,1.0,4/11,7.46%,NOX5;LOXL2;SEMA5A;ERN1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.742311722029568,1.5060069615047935,0.09090909090909091,1.0,1.0,6/15,18.34%,TAFA1;CX3CR1;SMARCD3;CTNNB1;DISC1;VEGFA
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.8818313569112979,1.5059617395383695,0.0625,1.0,1.0,1/7,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.8433937146165688,1.5055094228516877,0.045454545454545456,1.0,1.0,9/17,11.70%,FZD1;CEL;IL1RAPL1;NLGN1;LRRTM3;WNT5A;PTPRD;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.7888187925519173,1.5047270120803233,0.09302325581395349,1.0,1.0,5/15,11.39%,NTF3;ABL2;PDGFRB;BICD1;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6607401499555852,-1.5040535783835753,0.019230769230769232,0.6802992572938529,1.0,8/47,7.04%,TERF2IP;H1-4;CGAS;POLR2I;PARPBP;H1-0;DAXX;POLR2J
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.8240633031910269,-1.5037806726777516,0.0425531914893617,0.6754562589306656,1.0,2/14,3.39%,DDX11;NCL
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.8817902112466158,-1.5029650027824615,0.04,0.6744250280010005,1.0,2/10,3.40%,STX1B;STX4
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6697602003170834,1.5017328674238375,0.0,1.0,1.0,9/35,6.79%,OR3A2;TRPV2;PTGES;PDYN;ADGRV1;PCDH15;USH2A;OPRK1;MYO7A
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.5805507535303104,-1.5012249462762959,0.019230769230769232,0.6799345315890373,1.0,13/159,5.46%,CD44;SFRP1;GEM;TAGLN;FBLN2;SERPINE1;ADAM12;COL6A2;TPM1;GADD45A;TPM4;LOXL1;GPC1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.8340861186631955,-1.5012190526206604,0.10416666666666667,0.6739487391394179,1.0,1/10,0.67%,BUD23
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7334913528934932,-1.5003482881863546,0.06976744186046512,0.6739698138678064,1.0,10/32,18.76%,TERF2IP;H1-4;RAD51AP1;H1-0;KPNA2;CHEK1;USP51;ZRANB3;H1-2;SUPT6H
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.8770986015886133,-1.4997594915681969,0.041666666666666664,0.6726535676737107,1.0,3/11,6.35%,FIP1L1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.6987448759285799,1.4990522479874067,0.02127659574468085,1.0,1.0,9/32,13.89%,LOXL2;TGFBR1;TWIST1;CRB2;JAG1;SMAD2;CTNNB1;MDK;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8286543734688089,-1.4978791539248926,0.0425531914893617,0.6810516556404109,1.0,2/11,3.93%,SELP;ETS1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.9190079731735324,1.495475142639672,0.0392156862745098,1.0,1.0,1/5,4.40%,SLC6A13
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.8906960421520641,-1.494023408083009,0.02040816326530612,0.7025260708343755,1.0,1/12,0.02%,CYP1A2
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.8707420609363778,-1.4922481738308988,0.018867924528301886,0.7100367798054861,1.0,3/10,3.80%,CYP1A2;CYP2E1;CYP2D6
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9751487913816679,-1.4911392873986684,0.0,0.6988745228955754,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9751487913816679,-1.4911392873986684,0.0,0.6988745228955754,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9751487913816679,-1.4911392873986684,0.0,0.6988745228955754,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7935153138305235,-1.488812287406163,0.0784313725490196,0.7091586884522822,1.0,4/18,6.19%,SLC28A2;AZGP1;B2M;PRDX1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.6407638683641831,1.4868535842358053,0.05555555555555555,1.0,1.0,27/90,11.58%,ACE2;ESRRG;TFCP2L1;ABO;FRK;LPP;SLC22A2;MUC20;SLC12A3;PPARGC1A;SLC8A1;CMYA5;PKHD1;SLC22A6;TMEM213;SLC5A8;GSTO2;BBOX1;EXPH5;COBL;PROM2;JAG1;PIK3C2G;COBLL1;SLC16A7;TRPM6;BAZ2B
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8052353669634886,1.4849442581175887,0.0975609756097561,1.0,1.0,7/17,9.45%,SEMA3C;ZFPM2;FGFR2;ROBO1;NRP1;ROBO2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.7056116856566997,1.4847281959002259,0.047619047619047616,1.0,1.0,12/33,15.46%,IRS1;KANK1;ENPP1;PIP4K2A;NCK1;ZBTB7B;SIRT1;SNX5;SORBS1;PID1;OGT;PRKCB
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.7808863727692531,-1.4827970802037016,0.08108108108108109,0.7467584708485654,1.0,4/19,9.01%,CSRP2;OBSCN;TPM1;SYNPO2L
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8774319268192051,1.482584785910165,0.04081632653061224,1.0,1.0,3/7,9.45%,NRG1;TGFBR1;BMPR1A
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.92826630676608,1.482298352236991,0.061224489795918366,1.0,1.0,1/8,0.73%,SSC5D
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8431827703457825,1.4799012826430897,0.06976744186046512,1.0,1.0,5/10,10.11%,ROBO1;SLIT2;HEY1;ROBO2;JAG1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5797434786132294,-1.4748056211569975,0.0196078431372549,0.8019465303557898,1.0,10/163,5.52%,CD44;APIP;DUSP4;NTRK1;SPRED3;CD74;SPRED2;CD4;NODAL;SPRY1
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8786871171556021,1.472608116435959,0.0392156862745098,1.0,1.0,3/6,9.90%,CX3CR1;ITGAM;C3
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.8829299672182701,-1.4706453741748708,0.0,0.8306631387569275,1.0,2/12,1.09%,DYSF;AHNAK2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.744342621617009,1.4691224332502593,0.061224489795918366,1.0,1.0,6/19,10.93%,ELAPOR2;SULF1;ACVR2A;BMPR1A;CRB2;SMAD2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.8624626394802043,1.4685545331467011,0.08,1.0,1.0,6/11,11.70%,CEL;NLGN1;NRXN1;WNT5A;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7385454658953405,-1.468460827796479,0.0425531914893617,0.8424597383673514,1.0,9/24,15.99%,XPC;ERCC1;UBC;RBX1;GTF2H2;CETN2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.8188004507974891,-1.4683015493561735,0.10204081632653061,0.8366051654402151,1.0,3/8,11.88%,HEBP2;PRELID1;PIP5KL1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7327887422563194,-1.4682785175878905,0.0784313725490196,0.8300177231926544,1.0,7/28,13.48%,STING1;OAS3;DHX58;POLR3A;OAS2;POLR3D;ISG15
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.9176924769824188,-1.467886906617281,0.0,0.8262867547112364,1.0,1/9,0.49%,NCKAP1L
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7402579398539707,-1.4670150807078488,0.07407407407407407,0.8263057924200932,1.0,8/20,15.99%,XPC;UBC;RBX1;GTF2H2;CETN2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6900460485730495,1.4666471858091192,0.07547169811320754,1.0,1.0,8/52,7.51%,VAPB;SPHK1;CERS3;PPM1L;ST8SIA6;ELOVL6;ACER1;PRKD1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.971329686718166,-1.4663634594085295,0.0,0.826177986822173,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.8357652303206585,-1.4661004157621518,0.09803921568627451,0.8216164651942148,1.0,2/9,7.43%,CLDN4;CLDN1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.7718902627435299,-1.4658321349203791,0.044444444444444446,0.8169075625932337,1.0,3/19,8.29%,NCKAP1L;RAC1;PARVB
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6738143106002755,-1.4650085632301562,0.07272727272727272,0.8172114151365082,1.0,4/39,5.52%,EPN1;CBLC;VPS25;SPRY1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7946310501423934,1.4649870943929952,0.02,1.0,1.0,6/16,11.27%,SMAD7;ROBO1;TGFBR1;NRP1;ROBO2;PDE2A
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8700003759388937,1.4649527710402845,0.10869565217391304,1.0,1.0,2/7,5.70%,PNP;HPRT1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.8082632220221939,1.464894858009495,0.07692307692307693,1.0,1.0,1/12,0.18%,SAMSN1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.839428748635364,1.4646161132369886,0.03773584905660377,1.0,1.0,3/9,8.71%,HDAC9;HDAC2;HDAC3
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.6957508607950397,-1.4645386825785565,0.037037037037037035,0.8157335353224852,1.0,7/50,10.86%,STING1;MAP1LC3B2;ATG14;WIPI1;NSFL1C;MAP1LC3A;WIPI2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.7672323517279867,1.4643141591364581,0.03636363636363636,1.0,1.0,2/14,8.72%,PLA2G10;PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.9065430325909442,1.463237422999292,0.0196078431372549,1.0,1.0,1/6,0.80%,EIF3E
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.913010502448897,-1.4626390656000448,0.019230769230769232,0.8247206243226295,1.0,2/7,2.38%,LCP1;HCK
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.8511317545384085,1.4614307482321307,0.1111111111111111,1.0,1.0,3/9,5.79%,ANTXR2;SLC22A2;RAB29
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7312390666284834,-1.4614179264757792,0.023255813953488372,0.8293029589909278,1.0,5/27,5.74%,HLA-DPB1;FGL1;TNFSF18;CD4;IL4I1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.8263260114463257,-1.4607967326991647,0.07317073170731707,0.8283949630504267,1.0,3/10,7.84%,SFRP1;NODAL;FOXP1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.8538325616561009,1.4596914441475863,0.046511627906976744,1.0,1.0,5/9,11.07%,PLA2G7;ADIPOR2;PPARGC1A;ACSM1;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.6866361605363682,-1.4589619810496255,0.06521739130434782,0.8358524383918892,1.0,4/39,4.65%,DDX11;TERF2IP;RAD51AP1;FOXM1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.8966418819961767,1.4586846745158537,0.044444444444444446,1.0,1.0,1/5,2.63%,ENPP1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.8966418819961767,1.4586846745158537,0.044444444444444446,1.0,1.0,1/5,2.63%,ENPP1
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.9207769643073813,-1.4584733967016739,0.08163265306122448,0.832854465440816,1.0,2/6,2.64%,CYP1A2;CYP2E1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.9081075466459956,-1.458164900201038,0.04081632653061224,0.8294230318131754,1.0,2/7,4.38%,HLA-C;B2M
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.8543174367390712,1.4577572467490763,0.043478260869565216,1.0,1.0,6/11,11.70%,CEL;IL1RAPL1;NLGN1;PTPRD;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.738512011844367,1.4574030772912128,0.09302325581395349,1.0,1.0,4/33,4.52%,ACE2;SYK;AKR1C1;ITGAM
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.9187788714108261,-1.4571894536130774,0.058823529411764705,0.8311071737857423,1.0,3/5,7.84%,FGF1;ADAMTS12;FOXP1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6829812510742237,-1.4570108289275967,0.09090909090909091,0.8266630480679884,1.0,7/43,6.63%,APIP;KIF25;UPB1;HSD17B10;GOLGA2;B2M;RYR1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6650327561552496,-1.4560614313284503,0.0784313725490196,0.8285427776733875,1.0,2/65,3.62%,SLC28A2;SLC1A7
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6364850385550361,-1.455900943371582,0.03333333333333333,0.8239135793071701,1.0,7/74,4.78%,CD44;SFRP1;FGF1;GTF2F1;SHCBP1;POLR2I;SPRED2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.5792082916313821,-1.455270784031335,0.0,0.8217789475223567,1.0,68/163,26.40%,RRP15;SBDS;UTP11;DDX27;PDCD11;EXOSC10;RPLP1;RSL1D1;NOP14;RPL28;NOP56;RPL37A;RPL34;LAS1L;NOLC1;RPS15;RPL4;RPL12;RPL31;RPL8;MRTO4;RPL19;RPS27;RPL23;EXOSC4;EIF6;NVL;RPL7A;RPL29;NOB1;POP5;NAT10;RPS24;EMG1;RPL5;MPHOSPH10;RRP1B;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;DDX54;NOL8;RPL35A;RPL11;RPL10A;FBL;NSA2;RPL18;RPS14;LYAR;WDR46;PELP1;RPS2;RRP1;UTP14A;KRR1;RPS6;DHX37;LSM6;NOP58;WDR75;TSR3;TBL3;RPL14
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.8679731958859642,1.4552439561204171,0.02,1.0,1.0,3/12,5.12%,SEMA5A;CNTN4;EPHA3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.8249822142162129,-1.4546422790260913,0.04,0.8215656637052665,1.0,1/11,0.29%,SLC19A3
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.9069062772306545,1.4545689972563745,0.061224489795918366,1.0,1.0,2/6,4.17%,DACH1;SMAD7
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.7360179518868384,1.4544872397515176,0.0784313725490196,1.0,1.0,3/19,9.93%,MED17;TWIST1;MITF
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.898759261181366,1.4543599043121491,0.044444444444444446,1.0,1.0,1/5,2.96%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.8364958270850795,1.4531460565421634,0.06666666666666667,1.0,1.0,3/9,13.71%,CX3CR1;CSF1;MTUS1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.6079256773868198,-1.4529032695579327,0.07407407407407407,0.8289370227707443,1.0,15/94,9.22%,LDHC;PARP2;RPL39L;GSTM3;AURKA;CCT6B;CDKN3;PEBP1;NCAPH;PCSK4;MEP1B;NPY5R;ACE;TULP2;SCG3
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.8887714566471498,-1.4521031287960975,0.0,0.8297080695488717,1.0,2/10,5.46%,CD9;GPC1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.8782204860135495,1.451759800327811,0.046511627906976744,1.0,1.0,4/8,11.49%,KEL;SLC8A1;EDN1;ACTA2
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7082087106948854,-1.4514170013489058,0.0625,0.8293819330619364,1.0,5/28,4.54%,P2RY10;CD5;KLRB1;TRBC2;TRAF3IP3
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.8994792208572056,-1.4507190155892937,0.019230769230769232,0.8291236502430378,1.0,1/6,2.02%,TESMIN
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8584285603466982,1.450400144957826,0.06521739130434782,1.0,1.0,6/10,11.70%,CEL;IL1RAPL1;NLGN1;PTPRD;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7210438502829372,1.449426370716876,0.07407407407407407,1.0,1.0,5/19,11.75%,RGPD3;RGPD5;RGPD4;RGPD2;CBLB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.5898429320570134,-1.4484364503216804,0.037037037037037035,0.8406025272302664,1.0,18/75,16.06%,PLK4;DDX11;AURKA;CXCR5;KIF20B;GIPC1;NUDT16;BTC;NSFL1C;DRD3;RANBP1;SOX15;WIZ;EREG;INO80;NPM2;KIF23;XRCC3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8658448278705602,1.447585219803173,0.10869565217391304,1.0,1.0,5/9,11.70%,CEL;NLGN1;NRXN1;NLGN4X;LRP4
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.768866163022933,-1.4474105150519898,0.018867924528301886,0.8425299283048479,1.0,2/17,1.18%,NCKAP1L;LCP1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.8805824291522188,1.4466460738600446,0.1,1.0,1.0,3/6,11.49%,SLC8A1;EDN1;ACTA2
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5758042170794919,-1.445851633996385,0.018518518518518517,0.8482299934904205,1.0,52/142,23.29%,SARS1;ABCF1;WARS1;MRPL23;RPLP1;RPL28;MRPS18B;RPL37A;RPL34;MRPL55;RPS15;RPL4;RPS8;RPL12;RPL31;RPL8;RPL19;RPS27;MRPS18C;RPL23;MRPL9;MRPS21;MRPL27;RPL7A;MRPL51;RPL29;PABPC4;RPS24;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;RPS4Y1;MRPS33;RRBP1;RPS20;RPS3;MRPL37;EIF4G1;RPL35A;RPL11;RPL10A;MRPS11;RPL18;RPS14;RPS4X;IGHMBP2;RPS2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.7180615773896507,-1.4456780473830038,0.0392156862745098,0.8447013888016053,1.0,9/33,18.88%,ENOSF1;HK2;MAN2B2;ENO1;LDHA;DERA;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.8069245948659118,1.4447060752236622,0.07894736842105263,1.0,1.0,5/21,10.15%,IGLL1;ARHGAP25;ITGAM;SNX18;GULP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.8830582345272956,-1.4441032553046385,0.05263157894736842,0.8446189145398593,1.0,1/7,2.48%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.8830582345272956,-1.4441032553046385,0.05263157894736842,0.8446189145398593,1.0,1/7,2.48%,APOD
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8941002155735145,-1.4439407029505644,0.05128205128205128,0.8402099560759523,1.0,1/6,0.56%,SFRP1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8401617313789898,1.4438834491337047,0.06,1.0,1.0,3/8,4.71%,PLA2G10;PLA2G7;CHPT1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.6594194357674958,-1.4430178480775935,0.04838709677419355,0.84146375203908,1.0,3/46,4.38%,STING1;DTX3L;B2M
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.784904580769705,-1.4425947828997818,0.10344827586206896,0.8386278596771848,1.0,4/11,16.24%,SPRED3;SPRED2;HIC1;SPRED1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.7530449921809376,1.4423045721367835,0.13043478260869565,1.0,1.0,5/22,9.73%,FGFR2;SSUH2;ROGDI;HDAC2;BCOR
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.7493718900211073,-1.4415372428319118,0.041666666666666664,0.8410665934472222,1.0,4/14,11.51%,ENTPD2;NUDT16;NUDT18;NUDT1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.7289588989509904,-1.4405288480842222,0.0784313725490196,0.8440666955699084,1.0,4/23,4.12%,P2RY10;RAC1;F2RL2;PRAG1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.7077601481107607,-1.4400908541115394,0.09090909090909091,0.8411496499925291,1.0,8/32,13.37%,STING1;PLK3;GOLGA2;PLK5;DDRGK1;MTIF3;UFC1;MCTS1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6593213727587057,1.4397692218796372,0.041666666666666664,1.0,1.0,12/37,11.62%,B4GALNT2;EFNA5;SMAD7;PKHD1;MEGF10;PTPRG;EPHA7;FUT9;JAG1;ZDHHC2;ADAM8;TENM3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.7387108522603482,-1.4388104319032868,0.09615384615384616,0.8390815724905654,1.0,2/17,1.79%,GSTM5;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.7387108522603482,-1.4388104319032868,0.09615384615384616,0.8390815724905654,1.0,2/17,1.79%,GSTM5;GSTM3
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.8431616810192548,-1.4388048436794088,0.05660377358490566,0.8339962296269862,1.0,3/9,3.89%,TNFSF18;LCP1;CD74
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.8601497592010918,-1.4386331407164212,0.05357142857142857,0.8306936819602548,1.0,3/6,12.13%,NOG;B2M;ATP2A3
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.5549473458544636,-1.4383711918150306,0.0,0.8275447669270369,1.0,71/181,26.40%,SURF6;SBDS;UTP11;DDX27;PDCD11;EXOSC10;RPF2;RPLP1;NOP14;RPL28;NOP56;RPL37A;RPL34;LAS1L;NOLC1;RPS15;RPL4;NOP16;RPL12;RPL31;RPL8;MRTO4;RPL19;RPS27;RPL23;EXOSC4;EIF6;NVL;RPL7A;RPL29;NOB1;POP5;RPS24;EMG1;RPL5;MPHOSPH10;RRP1B;PAK1IP1;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;NOM1;RBIS;RPLP2;DDX54;NOL8;RPL35A;RPL11;RPL10A;FBL;RPL18;RAN;RPS14;LYAR;WDR46;DHX29;PELP1;RPS2;RRP1;UTP14A;NPM1;KRR1;RPS6;DHX37;NOP58;WDR75;TBL3;RPL14
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8613448876486874,1.4380083933567087,0.06382978723404255,1.0,1.0,1/5,2.71%,PPARG
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7743191581845713,1.4378570772649193,0.07142857142857142,1.0,1.0,5/12,10.11%,ROBO1;SLIT2;HEY1;ROBO2;JAG1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7322001674900729,1.4374036749972032,0.038461538461538464,1.0,1.0,11/25,20.74%,NDNF;CSGALNACT1;CHSY3;CHSY1;CHST7;UGDH;CSGALNACT2;HEXB;CHST11;CHST15;VCAN
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7673775886440941,1.4369953174697174,0.041666666666666664,1.0,1.0,7/18,13.26%,HS6ST3;CSGALNACT1;HS3ST5;HS2ST1;HS3ST3B1;UGDH;EXT1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7570692697003225,1.4369403470957451,0.11320754716981132,1.0,1.0,9/17,21.32%,PARD3;DLG2;CRB2;LRRC7;PARD3B;ERBIN;MTCL1;OOEP;CRB1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.803226584535268,-1.436908253230137,0.08163265306122448,0.8331653014398962,1.0,3/13,0.66%,NCKAP1L;SFRP1;INHA
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.9135272298914154,1.436809546618049,0.03571428571428571,1.0,1.0,3/8,3.23%,GALNT3;GALNTL6;GALNT13
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.8613843624099484,1.4361669386518134,0.1,1.0,1.0,5/11,9.31%,FZD1;NLGN1;LRRTM3;WNT5A;NLGN4X
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.8948596059766256,-1.4344788795619114,0.02564102564102564,0.8440176820518654,1.0,1/5,1.82%,MRLN
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.809850431078407,1.4342595785132117,0.05,1.0,1.0,5/12,14.22%,PLA2G10;ABHD4;LPCAT3;PLBD1;PLA2G4C
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.6307332449276383,-1.4340642052492811,0.1,0.8414623334572138,1.0,7/58,6.63%,APIP;KIF25;UPB1;HSD17B10;GOLGA2;B2M;RYR1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.7207781900857256,1.4331793877774182,0.075,1.0,1.0,7/23,15.46%,IRS1;KANK1;ENPP1;PIP4K2A;NCK1;PID1;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.7226313940365859,1.4322047310532677,0.024390243902439025,1.0,1.0,7/22,15.46%,IRS1;KANK1;ENPP1;PIP4K2A;NCK1;PID1;PRKCB
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.877041209474721,1.431728843168207,0.022222222222222223,1.0,1.0,1/5,5.89%,AK3
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.8831975890548164,-1.4311020025742867,0.09433962264150944,0.8550492713923471,1.0,2/5,4.95%,CD74;CD4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.8831975890548164,-1.4311020025742867,0.09433962264150944,0.8550492713923471,1.0,2/5,4.95%,CD74;CD4
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6917363375115057,1.4304129189185464,0.08333333333333333,1.0,1.0,2/38,1.80%,ACE2;KCNJ3
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.7793911136782878,1.4303671229792159,0.0851063829787234,1.0,1.0,3/10,11.85%,KCNC2;PDE2A;PDE3A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.8332994135886934,-1.4302303997748074,0.12244897959183673,0.8571547639603192,1.0,3/7,11.88%,HEBP2;PRELID1;PIP5KL1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6328905866090524,1.429638902598577,0.041666666666666664,1.0,1.0,14/55,11.59%,SPHK1;NDNF;CHRM3;ACKR2;CX3CR1;ACKR3;MCTP1;MCU;EIF2AK3;LAT2;DDAH1;PLCE1;EDN1;DDAH2
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.9532280005277116,1.428717390592785,0.0,1.0,1.0,1/6,0.19%,VAPB
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.7008817568509168,1.4286080182001406,0.06382978723404255,1.0,1.0,9/28,18.24%,DOC2B;PPARGC1A;SORBS3;P2RX7;LIG4;STX18;TMED9;AKT2;ELAPOR1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8538214697986314,-1.428314338208994,0.024390243902439025,0.8670647114650176,1.0,2/8,5.78%,DUOX1;CPQ
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.9248978332468136,-1.428210269186807,0.0,0.8625999530857026,1.0,2/7,7.01%,CDHR5;CDHR2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7500266413721013,-1.4281205889658575,0.05660377358490566,0.8579153119257077,1.0,9/18,19.32%,SPRED3;SPRED2;EIF5A;RPS15;RPL23;HIC1;SPRED1;RPL37;RPS20
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.836692935088947,-1.4277916395714387,0.07142857142857142,0.855866866186274,1.0,2/8,7.18%,NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.638736682660968,1.4274730783964302,0.05660377358490566,1.0,1.0,15/65,16.27%,VAPB;SPHK1;CERS3;PPM1L;ELOVL6;TLCD3B;ACER1;PRKD1;ASAH2;HACD2;PLPP1;SMPD4;ALDH3A2;CERS5;SGMS1
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),0.8919666086950044,1.427466528979854,0.0784313725490196,1.0,1.0,1/5,1.32%,SPHK1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5438888521890477,-1.427100857686771,0.0,0.856196123197804,1.0,36/363,9.73%,CD44;DSC1;STING1;NCKAP1L;HEBP2;RNASET2;HRNR;RAC1;HLA-C;MGAM;BST1;HGSNAT;FABP5;FTH1;DNASE1L1;B2M;FLG2;CKAP4;PSMD7;PDAP1;APRT;CD63;PKP1;AGA;ACE;PSMC3;CARD9;SRP14;CRACR2A;ATP8B4;PA2G4;DBNL;ATP6V1D;RAB31;STK10;BRI3
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.8694756039753357,-1.4270621619964152,0.041666666666666664,0.8516789877953486,1.0,1/7,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.9400091275697451,1.426845100422986,0.02040816326530612,1.0,1.0,1/6,0.07%,TEX101
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6184711668350579,1.4260238895552297,0.07142857142857142,1.0,1.0,28/105,14.95%,RIT2;KCNC2;LSAMP;LRRTM3;OLFM3;MAGI2;NRXN1;NXPH1;KCTD16;GRM5;GRIA4;AMER2;CA10;SLC1A2;CTNNA2;DLG2;FUT9;NOL4;SYNPR;RBFOX1;MEIS2;ASIC2;GRM1;UNC79;PPFIA2;CNTNAP5;GRIA2;CSRNP3
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7407225340860438,1.4258499269944283,0.07272727272727272,1.0,1.0,6/17,16.34%,CDH8;GRID2;GRIK2;GRIK1;GRIA2;UNC13C
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7004015301184245,-1.4258110770284191,0.09090909090909091,0.8563144521409439,1.0,13/30,23.12%,NDUFC1;NDUFS5;NDUFA1;NDUFB9;NDUFA3;NDUFS6;NDUFAB1;NDUFB10;NDUFS2;NDUFA5;NDUFA10;NDUFA12;NDUFS8
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5843582655920609,-1.4255344497631026,0.061224489795918366,0.8533728055869949,1.0,1/75,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.7609657636474991,-1.4253360712124976,0.03773584905660377,0.8505681636900305,1.0,5/20,6.65%,SFRP1;ETS1;WARS1;HTATIP2;TSPAN12
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.648830248352928,-1.4244737695792067,0.07692307692307693,0.8525830889466508,1.0,5/51,4.12%,P2RY10;NTRK1;RAC1;F2RL2;PRAG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8446243386097476,-1.4240456286733363,0.08163265306122448,0.850693323209319,1.0,3/11,7.18%,AZGP1;B2M;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.8170387047468842,1.4233079411940555,0.10714285714285714,1.0,1.0,1/9,0.41%,STK26
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.8871723798873653,1.423271343538648,0.03773584905660377,1.0,1.0,1/7,5.23%,WNT5A
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.761266564430426,1.4225866182992544,0.13636363636363635,1.0,1.0,5/14,12.66%,GRM7;GRM5;GRM8;GRM6;GRM1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.9420451741053724,1.420954282440196,0.06,1.0,1.0,1/5,1.68%,CSGALNACT1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.8774954725604611,1.4208653352806955,0.061224489795918366,1.0,1.0,2/6,3.22%,NLGN1;PHACTR1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7942367436858254,-1.4205494132921412,0.07142857142857142,0.8705530575975656,1.0,4/10,11.11%,CYP19A1;TRIAP1;PRELID1;DBI
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.7962651710901351,-1.4205230352024982,0.043478260869565216,0.8659750925269514,1.0,2/9,4.84%,B3GNT9;B3GALT5
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8507077688972753,1.419840520071632,0.044444444444444446,1.0,1.0,2/8,5.61%,CHRM3;CHRM2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.9461415297468807,-1.418932301763797,0.0,0.8731113462594903,1.0,1/6,0.14%,TLCD2
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.8781998194870969,-1.41779695589124,0.0,0.8767768575346581,1.0,2/11,1.05%,SERPINB8;CCN3
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.583679327849912,-1.4173845185360765,0.020833333333333332,0.8748594771800261,1.0,6/148,2.62%,CD44;DUSP4;SERPINB8;GEM;MARCKS;SERPINE1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.8280110288173392,-1.4172036423104486,0.057692307692307696,0.8714080740176471,1.0,2/15,3.40%,STX1B;STX4
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5421127898587177,-1.4168893096188964,0.0,0.8692396406831009,1.0,34/358,9.73%,CD44;DSC1;STING1;NCKAP1L;HEBP2;RNASET2;HRNR;RAC1;HLA-C;MGAM;BST1;HGSNAT;FABP5;FTH1;DNASE1L1;B2M;FLG2;CKAP4;PSMD7;PDAP1;APRT;CD63;PKP1;AGA;PSMC3;SRP14;CRACR2A;ATP8B4;PA2G4;DBNL;ATP6V1D;RAB31;STK10;BRI3
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8660793244458918,1.4165694653877043,0.14,1.0,1.0,3/7,6.82%,ACE2;CHRM3;SNCA
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.8344891157851638,1.416208986894571,0.08163265306122448,1.0,1.0,3/9,8.57%,GLYAT;RIDA;SDS
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.8872815107303924,1.4161855758010082,0.1276595744680851,1.0,1.0,1/6,0.69%,IGLL1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6932035555903882,1.416123026215323,0.07547169811320754,1.0,1.0,8/27,17.02%,MAP3K11;PPEF2;DVL2;ZNF675;EDN1;SASH1;AIDA;MAP3K5
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.7279016125164238,1.4159706974937525,0.045454545454545456,1.0,1.0,4/22,10.19%,ZDHHC11;ZDHHC14;ZDHHC11B;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.7279016125164238,1.4159706974937525,0.045454545454545456,1.0,1.0,4/22,10.19%,ZDHHC11;ZDHHC14;ZDHHC11B;ZDHHC2
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5528011829484984,1.4158210049204962,0.08,1.0,1.0,25/113,16.14%,SLC12A1;KCND2;KCNE4;KCNJ3;KCNH7;KCNC2;KCNQ5;KCNS3;SLC12A3;HCN1;LRRC38;KCNK1;KCNG3;KCNJ6;ATP12A;KCNB2;SLC24A2;KCNN1;KCNV1;SLC9A1;KCNG1;KCNJ2;KCNA5;KCNK9;SLC12A2
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.8597000278977374,1.4157354515935086,0.06976744186046512,1.0,1.0,2/8,2.08%,PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6153802297251659,1.415243689756953,0.07692307692307693,1.0,1.0,14/51,12.46%,RALA;THSD7B;PHACTR1;CASS4;TNIK;NRP1;GAB1;MCU;AUTS2;FER;FGF10;THSD7A;RAP2A;BCAR1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.6584529259383542,1.4150268904580037,0.022222222222222223,1.0,1.0,11/41,10.45%,GALNT3;GALNT8;C1GALT1;MUC20;GALNT13;C1GALT1C1;GALNT7;GXYLT1;MUC16;GCNT3;MUC6
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.8773347727087644,-1.4150242446833643,0.0851063829787234,0.8779591348506433,1.0,3/10,4.05%,SIGIRR;APOD;OAS3
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.8687701422449923,-1.4149264495907292,0.02040816326530612,0.8699391505834443,1.0,1/8,1.32%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.8687701422449923,-1.4149264495907292,0.02040816326530612,0.8699391505834443,1.0,1/8,1.32%,NUPR1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8874833514246525,-1.4147213655255726,0.06451612903225806,0.8670411286389799,1.0,2/10,0.67%,APIP;NLRP1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5987012392743796,-1.4134925145459818,0.05357142857142857,0.8720946257386394,1.0,20/96,17.00%,STING1;DDX11;AURKA;GTF2F1;GOLGA2;DTX3L;B2M;IFIT1;PRKACA;HDAC5;LRPAP1;RACK1;TMC8;ACTB;PIN1;TTBK1;NVL;TAF1;IFIT2;TLE5
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.8592278472266259,1.4134449456175402,0.03571428571428571,1.0,1.0,4/8,12.87%,MYBPC3;PDE4B;PDE4D;ANK2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.8275625767707464,-1.412960628814645,0.058823529411764705,0.87206798158809,1.0,1/12,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.5757486070302136,-1.4128214979447689,0.022222222222222223,0.8684333576189908,1.0,63/150,26.40%,SBDS;UTP11;DDX27;PDCD11;EXOSC10;RPLP1;NOP14;RPL28;NOP56;RPL37A;RPL34;LAS1L;NOLC1;RPS15;RPL4;RPL12;RPL31;RPL8;MRTO4;RPL19;RPS27;RPL23;EXOSC4;DIS3L;NVL;RPL7A;RPL29;NOB1;POP5;RPS24;EMG1;RPL5;MPHOSPH10;RRP1B;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;DDX54;NOL8;RPL35A;RPL11;RPL10A;FBL;RPL18;RPS14;NIFK;LYAR;WDR46;PELP1;RPS2;RRP1;UTP14A;KRR1;RPS6;DHX37;NOP58;WDR75;TBL3;RPL14
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5464625031495289,-1.411053386510925,0.03508771929824561,0.8758928230390871,1.0,65/180,25.58%,HSD17B10;SDHC;ATP6V1E1;SLC25A3;ETFB;PDHX;VDAC2;NDUFC1;ATP6V1D;UQCRH;NDUFA1;ATP1B1;ISCU;HADHA;COX4I1;ATP5F1B;NDUFA3;UQCRC1;SLC25A5;COX6C;ATP5F1A;CYB5A;PDHA1;NDUFS6;NDUFAB1;ATP5F1D;TIMM17A;SUPV3L1;LDHA;PRDX3;COX6B1;NDUFS2;ETFDH;TIMM50;AFG3L2;GOT2;ATP6V1F;NDUFA5;COX7B;ATP5MC1;UQCR10;ATP5F1E;FH;COX5B;ATP5MC2;OAT;CYB5R3;COX7C;ATP5PD;MRPS22;TIMM13;SLC25A6;RETSAT;MRPS11;SLC25A11;IDH3G;NDUFS8;COX5A;SUCLA2;SLC25A4;GPX4;COX7A2;ATP5F1C;MGST3;VDAC3
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7359821916026059,1.4092130318556175,0.08771929824561403,1.0,1.0,11/28,14.13%,SPHK1;HSPB1;VEGFC;NRP1;GAB1;NUS1;ERN1;PRKD1;VEGFD;PIK3CA;RELA
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.8269530536897161,1.4091307186084046,0.08,1.0,1.0,2/8,6.82%,RAB29;SNCA
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6047677138386875,1.408849892665542,0.05660377358490566,1.0,1.0,44/110,17.25%,ESRRG;PDZRN4;GUCY1A2;PLCXD3;ERBB4;CXXC4;SEMA6D;PBX1;UNC5C;FLRT3;NRXN1;PPARGC1A;FGF12;TOX3;PCDH17;CNTN4;FGF14;MEIS1;PTPRD;CNTN3;HMGCLL1;PXK;PTGFR;LMO3;NOL4;CNTN1;NOVA1;THSD7A;ASXL3;ADGRL2;LIFR;ANK2;PPFIA2;RGS7BP;GRIA2;CSRNP3;PCLO;PPP1R9A;MAP2;MAPK4;NFIB;RNF180;PROX1;MAGI1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.6853547629228272,-1.408376865304569,0.04,0.8900886245256142,1.0,7/31,14.03%,TRMO;HSD17B10;TARBP1;METTL6;DALRD3;TRMT112;TRMT10C
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.6886501008387518,-1.4083032409813503,0.09836065573770492,0.8858972825436869,1.0,3/34,3.80%,CYP1A2;CYP2E1;CYP2D6
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7240079974042445,1.4077059805167471,0.08333333333333333,1.0,1.0,5/19,2.14%,TEX101;CYP4Z2P;GCNA;PRNT;ASB17
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.8061620180870729,1.4070166912882462,0.06,1.0,1.0,8/13,16.07%,ZFPM2;ERBB4;FGFR2;BMPR1A;EDN1;AKAP6;MEF2C;TGFBR3
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7306418629655447,1.406989940765067,0.0784313725490196,1.0,1.0,2/15,3.22%,FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7306418629655447,1.406989940765067,0.0784313725490196,1.0,1.0,2/15,3.22%,FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.8359593980700326,-1.406946651422774,0.14285714285714285,0.8912260589158492,1.0,1/9,0.98%,APOBEC3H
prerank,GO_Biological_Process_2021__negative regulation of SMAD protein signal transduction (GO:0060392),-0.9216882653775679,-1.4065243449429445,0.04081632653061224,0.8894635833791826,1.0,2/5,4.56%,CCN3;PBLD
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9540806385897167,-1.4064819710660361,0.061224489795918366,0.88547702766582,1.0,1/5,0.43%,APIP
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.8066693318067624,-1.4061453811322846,0.05660377358490566,0.8841779959213888,1.0,2/9,4.38%,CGAS;B2M
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.7393754445103294,-1.4060198710143175,0.06666666666666667,0.8809494273796733,1.0,2/19,4.00%,P2RY10;F2RL2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8163231626082319,-1.405815256422151,0.12195121951219512,0.8779361257268953,1.0,3/11,10.94%,DDX11;DTX3L;KDM4D
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.9035593703511062,1.4055515615751315,0.02,1.0,1.0,4/6,8.81%,HS6ST3;HS3ST5;HS2ST1;HS3ST3B1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8432482438709467,1.405527419985953,0.07692307692307693,1.0,1.0,2/8,6.82%,IL1RAPL1;SNCA
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8503077999920403,1.4052441340589323,0.0625,1.0,1.0,3/7,13.26%,CSGALNACT1;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7334776205259956,1.4051885872639538,0.10909090909090909,1.0,1.0,5/21,12.11%,ITGAX;JAM2;PARD3;EIF2AK3;TMEM98
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.8137028240664586,1.4051188941573138,0.12,1.0,1.0,3/13,6.82%,AP1AR;RAB29;SNCA
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6290160441271824,-1.4047796109105346,0.02631578947368421,0.8808596118923323,1.0,16/37,26.22%,RPS27L;SURF6;NOP14;RPS15;RPS27;NOB1;RPS24;EMG1;RPS25;NOM1;MRPS11;RPS14;NPM1;RPS6;LSM6;TSR3
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.7892340209755274,-1.4041697537945381,0.10638297872340426,0.8803823588832566,1.0,1/10,0.88%,PAH
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.6642489031751952,-1.4027576891005484,0.05660377358490566,0.8848086222886411,1.0,12/39,16.54%,NARS1;SARS1;TARS3;WARS1;PPA1;AARS2;RARS1;CARS1;PARS2;IARS2;AIMP1;GARS1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.9332485714856678,-1.402472871411211,0.0,0.8827370720876885,1.0,2/5,6.43%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.7963954859102041,1.4024647204646619,0.08695652173913043,1.0,1.0,5/12,10.18%,ADAMTS9;HEY1;BMPR1A;JAG1;PDGFRB
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6418509355711579,-1.4018454188291107,0.05357142857142857,0.8837854357045943,1.0,11/35,19.18%,NARS1;SARS1;WARS1;PPA1;RARS1;CARS1;IARS2;AIMP1;GARS1;YARS1;EPRS1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.5356329302841265,-1.4017813027935868,0.0,0.8798150961422563,1.0,34/360,9.73%,CD44;DSC1;STING1;NCKAP1L;HEBP2;RNASET2;HRNR;RAC1;HLA-C;MGAM;BST1;HGSNAT;FABP5;FTH1;DNASE1L1;B2M;FLG2;CKAP4;PSMD7;PDAP1;APRT;CD63;PKP1;AGA;PSMC3;SRP14;CRACR2A;ATP8B4;PA2G4;DBNL;ATP6V1D;RAB31;STK10;BRI3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.6470593649427496,-1.4017320107437496,0.020833333333333332,0.8758373495794184,1.0,2/36,2.38%,NCKAP1L;HCK
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7350220513695356,1.4014593259413726,0.08333333333333333,1.0,1.0,9/18,20.74%,CSGALNACT1;CHSY3;CHSY1;CHST7;UGDH;CSGALNACT2;CHST11;CHST15;VCAN
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8942883576039871,1.401091337233953,0.022222222222222223,1.0,1.0,2/5,3.11%,PLCB1;LHFPL2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7202470366012094,-1.400119256390545,0.1276595744680851,0.8831946201663344,1.0,8/23,15.57%,XPC;UBC;RBX1;COPS6;CETN2;DDB1;COPS7A;PARP1
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.8391044231294766,-1.3998960144495611,0.1346153846153846,0.8803846799790732,1.0,2/6,6.75%,CRH;ADRA2A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5667181866723747,-1.3998438207339337,0.06,0.8766787884485394,1.0,1/77,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.9405366699894651,-1.3996962111185223,0.05555555555555555,0.8736623393103718,1.0,1/5,2.94%,STX1B
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.6108089074778272,1.3995915139916666,0.058823529411764705,1.0,1.0,19/61,17.68%,PLA2G10;PLCB1;PLA2G7;ENPP6;PIGP;CSF1R;PLA2G15;GDPD3;PIGA;PDGFRB;LCAT;PRDX6;PIGV;PIGQ;PLA2G4C;SMPD4;CLN3;PIGW;GPCPD1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5702933569820926,-1.3984390336225947,0.03636363636363636,0.8777633997020475,1.0,6/116,4.20%,CD44;TAGLN;COL6A1;COL6A2;NLRP3;ADAMTS12
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.7044115508922169,-1.39829663406356,0.07547169811320754,0.8748127417650369,1.0,2/21,5.28%,SFRP1;LTBR
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.5753556811145673,1.3970856437104857,0.04081632653061224,1.0,1.0,37/124,17.09%,RUNX1;NEDD4;NLGN1;PBX1;HMGB1;GPRIN1;FLRT3;CNTN4;AGER;GPM6A;TENM2;PBX3;CNTNAP2;RYK;SH3GL2;MANF;GPM6B;RP1;TMEM108;EPHA8;NPY;TENM3;PTPRM;UGDH;NRTN;TENM1;ATXN10;BTG2;EPHA5;MEF2C;NCDN;LRP12;PPP1R9A;MAP2;ATP8A2;HDGFL3;TDP2
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5870576483561902,-1.3970443510946835,0.05454545454545454,0.879259410626608,1.0,13/105,8.37%,CYP1A2;PAH;FGL1;HSD11B1;AZGP1;CYP2E1;RND3;CYP2D6;GHR;GPC3;RBP4;AMBP;SDC2
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9421401064763015,1.3965426507339496,0.0,1.0,1.0,2/5,4.40%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.7866496516792405,-1.396321832913364,0.07272727272727272,0.8801045801730876,1.0,2/10,4.38%,CGAS;B2M
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.7419410695105021,1.3960738504006232,0.061224489795918366,1.0,1.0,6/18,13.64%,PLCB1;SYK;HMGB1;AGER;IL16;MDK
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7245391549537235,1.3958978343210473,0.10869565217391304,1.0,1.0,3/18,3.80%,SULT2A1;ENPP1;SULT2B1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.7773910893171709,-1.3955360568572983,0.04,0.8807713037643224,1.0,2/14,2.04%,SFRP1;NOG
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.6791242088337544,-1.3954626892630226,0.057692307692307696,0.8774346500923529,1.0,5/28,7.43%,CLDN4;DUOX1;SERPINE1;ADRA2A;CLDN1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.7920540002217028,1.395184834099482,0.12962962962962962,1.0,1.0,1/10,1.33%,FAS
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.7225068052451515,1.3939782607851319,0.11320754716981132,1.0,1.0,5/17,17.02%,MAP3K11;DVL2;EDN1;SASH1;MAP3K5
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6606931699463693,-1.3918498137748798,0.057692307692307696,0.8983442981263797,1.0,5/41,1.59%,DUSP4;SPDEF;CLDN4;CBLC;TMEM184A
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.900058635215101,-1.3918295151813886,0.10344827586206896,0.8944957717262406,1.0,1/5,6.26%,IL11
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7087385570432398,1.3906410025456273,0.10344827586206896,1.0,1.0,12/33,13.10%,CEL;NTF3;LRRC4C;NLGN1;CX3CR1;NRG3;GRID2;GRIK2;PXK;NLGN4X;GRIK1;BTBD9
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.731637212925967,-1.390336402000339,0.12,0.8999971113975869,1.0,3/23,7.84%,SFRP1;NODAL;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.8328862665172905,-1.390325718172873,0.0425531914893617,0.896049755645843,1.0,1/13,0.65%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.6518690659383496,-1.38990010321781,0.07547169811320754,0.8952566706533893,1.0,6/38,11.55%,DDX11;RAD51AP1;DTX3L;FOXM1;KDM4D;WRAP53
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5574172160833971,-1.3897593454124504,0.03773584905660377,0.8928966579878144,1.0,2/152,1.86%,CD44;MYB
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.8615692970273461,-1.3895294705934398,0.08,0.8901034698927285,1.0,1/7,1.74%,CLU
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8506168917521055,1.3892649868371372,0.061224489795918366,1.0,1.0,1/8,1.84%,SPX
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.7148001866971155,-1.3890901831548863,0.10869565217391304,0.8894283896209375,1.0,2/18,3.42%,EEF1AKMT2;KMT2B
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6875453575447426,-1.3881868216461748,0.046511627906976744,0.8916209255154954,1.0,2/20,5.46%,BUD23;GAR1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7226343232224898,-1.3877908798646,0.1346153846153846,0.8900495444138946,1.0,4/16,2.90%,P2RY10;CD5;KLRB1;TRBC2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7931768002680311,1.3877112408426107,0.1346153846153846,1.0,1.0,2/15,0.69%,SAMSN1;IGLL1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.7313290781556211,-1.387171485303849,0.0784313725490196,0.8906804387706444,1.0,3/14,2.15%,TXK;TEC;NTRK1
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9311508799698457,-1.3865344319869657,0.017543859649122806,0.891669257730663,1.0,2/5,3.80%,CYP1A2;CYP2D6
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.7971564167903017,1.386480613141863,0.043478260869565216,1.0,1.0,2/8,11.04%,CCNH;CDK12
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.8390799134673133,-1.385970815368164,0.13725490196078433,0.8918056760164842,1.0,1/8,0.98%,APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.8379785058956755,-1.3853615082963466,0.0847457627118644,0.8926213605895593,1.0,5/9,10.89%,NUPR1;IL10RB;ISCU;PRELID1;PINK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8229240376288863,1.3849259111422965,0.08695652173913043,1.0,1.0,1/11,0.19%,VAPB
prerank,GO_Biological_Process_2021__negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),-0.8767364478615922,-1.3844399223792563,0.07142857142857142,0.8961006255198505,1.0,1/5,1.86%,MYB
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.6231333892234191,1.3835347158439633,0.07142857142857142,1.0,1.0,20/75,17.27%,TBC1D3L;ARHGAP25;ARHGAP42;NTF3;TBC1D12;ECT2;TBC1D8B;CCDC125;RABGAP1L;RUNDC1;TIAM2;TBC1D1;GRTP1;ARHGAP24;SYDE2;EVI5;TBC1D4;USP6NL;TBC1D5;ABR
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.6658163364559283,-1.3834034386129588,0.058823529411764705,0.899669968791118,1.0,7/52,10.86%,STING1;MAP1LC3B2;ATG14;WIPI1;NSFL1C;MAP1LC3A;WIPI2
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8451303771109389,-1.383095787129594,0.06557377049180328,0.8978736746648104,1.0,4/8,12.62%,PDXDC1;ENPP2;CYP1B1;PPT1
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),0.8808306804779097,1.3826587531286791,0.09259259259259259,1.0,1.0,1/5,1.32%,SPHK1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.6720486377496921,1.3824399775744023,0.02631578947368421,1.0,1.0,8/31,13.69%,SEMA3C;SEMA6D;UNC5C;ROBO1;SLIT2;EPHA7;ITGAV;LRTM2
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.8341447294933972,1.3822568535236919,0.06382978723404255,1.0,1.0,3/10,8.55%,FGFR2;TGFBR1;TWIST1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.4955599260520971,-1.382209262253351,0.0,0.9003827619703322,1.0,17/232,5.73%,CD44;LOXL4;LCP1;MMP26;COL6A1;SERPINE1;ADAM12;COL4A3;COL6A2;COL9A1;ADAMTS12;MMP21;AGRN;ADAMTS15;LOXL1;ITGA6;ADAM19
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.8447149500267983,1.3820169230500636,0.041666666666666664,1.0,1.0,2/10,4.95%,SEMA5A;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8413313333595986,1.3817104181265276,0.07692307692307693,1.0,1.0,3/8,9.90%,PLA2G10;LPL;C3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.8112991164498424,-1.3812591921407444,0.07547169811320754,0.9036552129384962,1.0,1/7,2.28%,NMNAT3
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.772950230869148,-1.3810951976920867,0.07692307692307693,0.9016694710747839,1.0,1/10,0.66%,OR2M4
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8730354006630403,1.3799608244997241,0.10344827586206896,1.0,1.0,3/7,7.63%,CEL;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.6452684789163179,-1.3793842451014486,0.043478260869565216,0.9088757900698367,1.0,11/57,14.84%,EPN1;CBLC;WDR54;SPRY1;IFI6;BTC;BCAR3;DGKD;CEACAM1;EREG;SHKBP1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.6619498419358731,-1.3788152441658998,0.09615384615384616,0.9089372721893508,1.0,6/19,16.57%,NEMP1;DCTN1;NSFL1C;AKAP8L;EMD;CHMP2A
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.9244613447521844,1.3787659250244741,0.04838709677419355,1.0,1.0,2/5,5.98%,NUDT10;FHIT
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.8284823440669999,-1.3783128273901883,0.07692307692307693,0.9092296518762774,1.0,1/8,1.34%,ENTPD2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7564674539740589,1.3775033328726856,0.10638297872340426,1.0,1.0,2/21,2.91%,MARVELD3;NLGN1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.8822153561447144,-1.3772063982372298,0.11904761904761904,0.9128613777719938,1.0,1/5,0.22%,SELP
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8472556776274376,1.3769279040101734,0.08695652173913043,1.0,1.0,1/5,1.93%,GRM7
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9374284039944747,-1.3768498702763967,0.02702702702702703,0.9112228428945062,1.0,1/5,0.65%,DDX11
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8861917877123134,1.3767243954731812,0.03508771929824561,1.0,1.0,3/5,10.11%,ZFPM2;BMPR1A;JAG1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8917190864254594,-1.3752969277534095,0.07142857142857142,0.9175228629527735,1.0,2/7,3.80%,PM20D1;CYP2D6
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.78469547128473,-1.3752249055379206,0.12280701754385964,0.9147023220609153,1.0,1/10,2.04%,NOG
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7358054644530531,1.3751722827384565,0.08333333333333333,1.0,1.0,4/14,11.07%,PPARG;ADIPOR2;PRKAB2;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.9350514505485925,-1.37500429875917,0.02631578947368421,0.912546778370334,1.0,1/6,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.8064819393934685,-1.3749872398022782,0.11320754716981132,0.9089775254014065,1.0,2/8,5.74%,PAH;IL4I1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.7668673580299361,-1.374639981627194,0.1724137931034483,0.9077990695644944,1.0,2/15,7.84%,NCKAP1L;FOXP1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.8727562010032803,-1.374116136035599,0.047619047619047616,0.9081614520733533,1.0,1/8,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.7234143447324043,1.3739947590894248,0.13333333333333333,1.0,1.0,3/27,8.82%,VAPB;NR5A2;CCL5
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.7134063061077635,-1.3738407089568756,0.1590909090909091,0.9063628195648156,1.0,2/23,5.66%,TERF2IP;ERCC1
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9127989278203915,-1.3736050827764839,0.018867924528301886,0.9041334008237378,1.0,3/5,3.80%,CYP1A2;CYP2E1;CYP2D6
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8875328312893493,-1.3735817259949934,0.10344827586206896,0.9006659294144662,1.0,3/5,10.60%,OAS3;OAS2;HMGB2
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.9147313044589236,1.3732810582147394,0.0851063829787234,1.0,1.0,2/5,3.59%,CX3CR1;CSF1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.835483263511782,1.3731730155960782,0.09523809523809523,1.0,1.0,1/7,2.71%,PPARG
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7526448641158866,-1.3731198981694337,0.07142857142857142,0.9000572216718192,1.0,11/17,23.27%,RBM4;EIF2S2;EIF4A2;MCTS1;EIF3I;EIF2B3;EIF4G1;EIF4H;EIF2S3;EIF3A;DHX29
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.6537935726362304,-1.3730414549367107,0.08695652173913043,0.8971083895932472,1.0,5/23,5.11%,KRT16P6;NUPR1;ADIRF;DUOXA1;ANO1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.7681264525878224,1.372865121956152,0.16666666666666666,1.0,1.0,1/11,1.59%,RUNX1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.772508595938639,-1.3726263078880363,0.09090909090909091,0.8961895016215645,1.0,3/14,8.86%,AOAH;MGAM;CALM1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.9246095578002366,1.372553012448922,0.0425531914893617,1.0,1.0,1/5,0.45%,NOX5
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7534682169270441,-1.3720046552310223,0.12962962962962962,0.8965501555546572,1.0,3/13,9.09%,SFRP1;GPC3;RNF213
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.8089646819140618,1.3713662191651077,0.15384615384615385,1.0,1.0,2/10,12.56%,PLA2G10;LPCAT3
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8371482011044058,1.3710724021710732,0.08928571428571429,1.0,1.0,3/6,7.36%,RUNX1;HMGB1;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.904868306304509,-1.371000402547302,0.07692307692307693,0.8991536873603595,1.0,1/5,2.04%,FGF1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.8506057291989648,-1.370839916887091,0.04878048780487805,0.8965055344607548,1.0,2/10,5.03%,KIF25;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.8038918173165284,1.3707636155547953,0.19607843137254902,1.0,1.0,2/7,3.54%,PTPRK;FGFR2
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.9386171713410714,1.3706787036473609,0.0,1.0,1.0,3/5,3.80%,SULT2A1;HS3ST5;SULT2B1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.881152280771984,-1.3698540732938584,0.07407407407407407,0.9004195995308101,1.0,2/6,6.43%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.8488102035779085,-1.3696747079984324,0.08333333333333333,0.8979298432573535,1.0,2/6,5.74%,PAH;IL4I1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.6660293775114848,-1.3688736183641157,0.13725490196078433,0.9003108181301577,1.0,7/38,13.48%,STING1;OAS3;DHX58;POLR3A;OAS2;POLR3D;ISG15
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.8124795903146504,-1.3686824272175095,0.08888888888888889,0.8982665753668776,1.0,1/9,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.8066570318980787,1.3683410194382581,0.09433962264150944,1.0,1.0,5/11,16.34%,DOC2B;SYT1;RIMS2;SYT2;UNC13C
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8679243866157924,1.3680008813507127,0.09090909090909091,1.0,1.0,1/6,4.86%,H6PD
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6819128824681108,-1.3670079759241973,0.037037037037037035,0.9050196606295323,1.0,3/25,2.27%,P2RY10;TYMS;KLRB1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.8093583527969083,1.3659680689852018,0.14,1.0,1.0,3/7,14.77%,TGFBR1;JAG1;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8890382844939386,1.364574890105936,0.19298245614035087,1.0,1.0,3/5,5.96%,SEMA5A;DSCAM;NRP1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6880473854449765,1.3643941415533283,0.12727272727272726,1.0,1.0,5/18,9.57%,NLRP2B;SMAD7;DDIT4;PDE4D;NCK1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5611188164808872,1.364310281679924,0.06666666666666667,1.0,1.0,36/133,14.89%,NDNF;RCVRN;CADM2;LSAMP;VWC2L;OLFM3;MAGI2;NRXN1;ADGRB3;HCN1;CNTN4;NLK;CDH20;GRM5;PCDH15;CNTNAP2;GRIA4;AMER2;CA10;SLC1A2;GRM6;RAB3C;CTNNA2;PCSK2;SYNPR;PRKCA;RBFOX1;NCAM1;GRM1;UNC79;ZNF536;PPFIA2;SLC24A2;CNTNAP5;GRIA2;LIN7A
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5604278955993055,1.3631323534806343,0.09433962264150944,1.0,1.0,16/77,13.67%,VAPB;SLC39A12;SLC30A8;MT1M;SLC8A1;PKHD1;ATP2B4;SLC30A10;CCL5;SLC39A8;EDN1;TRDN;NPTN;ANK2;CXCL12;SLC24A2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6609575337153524,-1.3629395091349439,0.08333333333333333,0.9295747351836346,1.0,4/37,3.28%,STING1;SFRP1;CYP19A1;PAQR7
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.8789569640654744,-1.362794507394232,0.061224489795918366,0.9271287832548621,1.0,2/5,7.40%,SARDH;DMGDH
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.7563902364336058,-1.3627544024056617,0.09433962264150944,0.9239653702304751,1.0,1/16,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.6389632428387413,1.3624961107198605,0.09090909090909091,1.0,1.0,8/42,11.53%,PLCB1;ITPKB;INPP1;NUDT10;PLCE1;PLCB4;INPP4B;IP6K2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.707084090550504,1.3620991039773573,0.08333333333333333,1.0,1.0,4/14,15.65%,CEL;PLA2G15;FAAH;FAH
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5753970205152104,1.3613298890001593,0.06521739130434782,1.0,1.0,28/123,12.66%,KCND2;CADM2;OXTR;RIT2;KCNC2;LRRTM3;OLFM3;NGB;NRXN1;ADGRB3;GFAP;NXPH1;CDH20;AGER;GRM5;GRIA4;AMER2;CA10;ELAVL4;RAB3C;FEZF2;CTNNA2;SYNPR;KCNB2;RBFOX1;PDE2A;ASIC2;GRM1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7478009996476481,1.361267865942808,0.15517241379310345,1.0,1.0,5/15,10.85%,SPHK1;CHRM3;CHRM2;PLCE1;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.7541473192957496,-1.3612028281861506,0.11363636363636363,0.9301764448402697,1.0,1/15,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7166545479531995,1.3608945912314103,0.10204081632653061,1.0,1.0,4/12,12.69%,IRS1;IRS2;SOCS2;CRLF2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7166545479531995,1.3608945912314103,0.10204081632653061,1.0,1.0,4/12,12.69%,IRS1;IRS2;SOCS2;CRLF2
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.8032071667442534,-1.3602957253478618,0.06976744186046512,0.9336652311432878,1.0,1/9,0.85%,TYMS
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.641304373475589,1.3602868758964552,0.12,1.0,1.0,6/27,10.15%,IGLL1;ARHGAP25;ITGAM;XKR6;MEGF10;GULP1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6558364579267194,1.359921621322878,0.14285714285714285,1.0,1.0,3/28,2.80%,CD151;TRIP6;PTPRK
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.8762335695075696,-1.3599214790525371,0.06521739130434782,0.9326255497636844,1.0,3/5,7.18%,NCKAP1L;MYB;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.6884905690933127,1.3595250654635866,0.1346153846153846,1.0,1.0,10/29,17.41%,FAS;DAPK2;CX3CR1;TGFBR1;STYXL1;ASAH2;BCL2;SGMS1;CRADD;DEPTOR
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.8573359544398231,-1.3595197162335766,0.13333333333333333,0.9321111075914507,1.0,1/7,4.04%,GOLGA2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6845353561413365,1.3586799330806654,0.16,1.0,1.0,6/18,10.11%,ROBO1;SLIT2;HEY1;ROBO2;TWIST1;JAG1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6577163822356578,1.358167294515283,0.14,1.0,1.0,6/22,5.48%,MYBPC3;NRG1;ZFPM2;FGFR2;SMAD7;TGFBR1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8549596617989612,1.357679542902148,0.05454545454545454,1.0,1.0,2/5,9.92%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8549596617989612,1.357679542902148,0.05454545454545454,1.0,1.0,2/5,9.92%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.6583909899705787,-1.357365080685905,0.15555555555555556,0.9427424441462923,1.0,5/28,12.20%,TYMS;BACH1;CDK5;CCNE1;ORC1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6770170886430004,-1.3571360648483752,0.17647058823529413,0.9412701458758832,1.0,3/27,7.65%,HLA-C;B2M;ACE
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.7983396051892595,-1.3566040501286714,0.17777777777777778,0.9413106748267411,1.0,2/9,7.40%,SARDH;DMGDH
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.847705317074657,1.3549940588077856,0.1346153846153846,1.0,1.0,1/7,5.44%,PARD3
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.847705317074657,1.3549940588077856,0.1346153846153846,1.0,1.0,1/7,5.44%,PARD3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.8501745332856825,1.3548469805747092,0.07407407407407407,1.0,1.0,1/13,1.59%,RUNX1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.7387391546969246,-1.3546825772122575,0.043478260869565216,0.9505705058200139,1.0,4/12,10.53%,ADRA2A;DRD1;ADRA1D;DRD3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6737400389290066,-1.3544372260054198,0.07547169811320754,0.9486792734085288,1.0,2/36,0.66%,NCKAP1L;INHA
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7589615612629722,-1.3543095667081384,0.10714285714285714,0.9427490060216417,1.0,6/16,7.43%,CLDN4;HRNR;FLG;FLG2;STMN1;CLDN1
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7589615612629722,-1.3543095667081384,0.10714285714285714,0.9427490060216417,1.0,6/16,7.43%,CLDN4;HRNR;FLG;FLG2;STMN1;CLDN1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.8449413579579046,-1.353905118637738,0.08,0.9422134092054639,1.0,3/8,10.53%,ARR3;GTF2H2;DRD3
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.8444707639111719,1.353637456673677,0.1111111111111111,1.0,1.0,2/5,12.25%,AUTS2;SIRT1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8638870721089611,1.353085487264883,0.08333333333333333,1.0,1.0,3/5,5.73%,ZBTB1;HMGB1;AGER
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.6835765511656443,1.3527825008145788,0.18,1.0,1.0,7/19,23.17%,PLA2G10;PLA2G15;LPCAT3;ABHD12B;ABHD12;SERINC5;PLSCR1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.8018736828222095,-1.352439470613376,0.16363636363636364,0.948433174474992,1.0,2/9,8.72%,PARP2;PARP14
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.8863378482906983,-1.3523694427144446,0.11764705882352941,0.9456498851785984,1.0,1/5,0.22%,SELP
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.7251803322558108,1.352307125127883,0.11320754716981132,1.0,1.0,2/20,5.40%,NLRP2B;OTUD4
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5961429719609402,-1.3519739410373781,0.0,0.9450765884810963,1.0,12/58,11.64%,P2RY10;TRHR;F2RL2;ANO1;P2RY11;ADRA2A;VIP;DRD1;ADRA1D;HTR2A;DRD3;FPR3
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6993615056469829,1.3517902696046513,0.1016949152542373,1.0,1.0,1/23,0.37%,DACH1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6535485534271755,-1.351178538093292,0.14,0.9471202466262872,1.0,5/47,6.01%,P2RY10;CD9;SPAG4;CD74;CD37
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7342732581627162,-1.3510765339412911,0.08771929824561403,0.9442385479416974,1.0,4/12,16.79%,NFKBIB;TMSB4X;NFKBIA;PSMD10
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6416172657846969,-1.3509695977128047,0.11864406779661017,0.9417380456257882,1.0,13/47,16.88%,DDX11;XPC;UBC;RBX1;GTF2H2;CETN2;TWNK;DDB1;MCM2;SUPV3L1;PARP1;ERCC2;RECQL
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.867637654216067,1.3502267049208083,0.10714285714285714,1.0,1.0,3/8,7.63%,CEL;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.8808922858808808,-1.350104787508555,0.0625,0.9411924620219441,1.0,1/6,4.57%,ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.8808922858808808,-1.350104787508555,0.0625,0.9411924620219441,1.0,1/6,4.57%,ANAPC15
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.7137656315225226,1.3498594589737247,0.22916666666666666,1.0,1.0,2/13,2.19%,EIF3E;C8ORF88
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.9319419787621048,1.3497975848192543,0.0625,1.0,1.0,2/5,0.33%,ACE2;ENPEP
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.6343531300963045,1.3497751243842542,0.18181818181818182,1.0,1.0,3/23,9.19%,IFI16;HEY1;ZNF675
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.8613472432124767,-1.3496478252084163,0.1111111111111111,0.9409712300877806,1.0,1/6,2.90%,RAC1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8934310364552925,-1.3494552524309347,0.13725490196078433,0.9391962741969812,1.0,1/5,2.48%,APOD
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.6391208173308272,1.3492918594225733,0.10909090909090909,1.0,1.0,8/41,11.53%,PLCB1;ITPKB;INPP1;NUDT10;PLCE1;PLCB4;INPP4B;IP6K2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8632034761743652,1.3489939174926184,0.125,1.0,1.0,3/6,10.27%,NOX5;CYBRD1;SLC39A8
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.7162541644005938,-1.3488244729941732,0.14814814814814814,0.9397905781356467,1.0,1/16,0.85%,TYMS
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5885978271489055,1.3487564540638997,0.07407407407407407,1.0,1.0,13/55,18.12%,SULT2A1;CEL;HMGCS1;SULT2B1;FDFT1;HMGCR;MSMO1;LBR;LCAT;INSIG1;INSIG2;FDPS;PLPP6
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.8012801087156214,1.3486686618833297,0.17391304347826086,1.0,1.0,2/13,4.02%,P3H2;EGLN3
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6390765069148246,1.3479627024668503,0.08163265306122448,1.0,1.0,3/34,5.12%,SKA3;EFNA5;EPHA3
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.8748295786065822,-1.3476782425665623,0.1,0.9443392131270688,1.0,1/6,1.79%,GSTM3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8085787603496586,1.3475347923363024,0.1509433962264151,1.0,1.0,6/10,16.07%,ZFPM2;ERBB4;FGFR2;BMPR1A;MEF2C;TGFBR3
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.8517315875030684,-1.3473885688087193,0.025,0.9431160925816269,1.0,1/7,2.04%,NOG
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.7592157812504343,1.3460572318026645,0.0784313725490196,1.0,1.0,2/14,6.78%,DGAT2;AGMO
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.876510424698937,1.3455419099182302,0.09259259259259259,1.0,1.0,2/6,5.96%,PHACTR1;NRP1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.7492562532921134,-1.3449493265332602,0.16666666666666666,0.9561259153555685,1.0,2/14,9.10%,PLK4;PLK2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.7597921580316934,-1.3449192989968657,0.15384615384615385,0.9532786164732695,1.0,1/11,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8254198328174766,1.3446911038135534,0.09259259259259259,1.0,1.0,2/8,5.44%,ITGAX;PARD3
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6489100270126341,-1.3442195387944305,0.08888888888888889,0.9546416415654463,1.0,5/32,5.57%,H1-4;INCENP;NCAPH;SMC4;H1-0
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.771108576804501,-1.3441174980577102,0.09259259259259259,0.9521030166586941,1.0,2/8,6.38%,FGF1;PAX8
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.8010659743938189,1.3438636160084165,0.1282051282051282,1.0,1.0,2/7,10.95%,DOCK10;DLL1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7722073487592475,-1.3437897371398704,0.1568627450980392,0.9512844885079775,1.0,4/7,17.69%,ENPP2;VIL1;CORO1B;SRC
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.6907248523395335,1.3437084509869472,0.08333333333333333,1.0,1.0,6/20,15.99%,THRSP;PRKAB2;ACACA;SLC25A20;CPT2;ABCD3
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.7111590796230371,1.3436924640966714,0.1282051282051282,1.0,1.0,6/20,17.20%,KLRG1;CX3CR1;RELA;GNLY;VEZF1;C5AR1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.7758535210361008,1.3436279864980871,0.12280701754385964,1.0,1.0,3/6,17.04%,SCTR;CLN3;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.7237219392121311,1.3429359150782632,0.19148936170212766,1.0,1.0,5/11,18.34%,CX3CR1;SMARCD3;CTNNB1;DISC1;VEGFA
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.8836000372045081,-1.3424696278505726,0.05555555555555555,0.9566646902943468,1.0,3/5,11.47%,STMN1;PBXIP1;MET
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.7753427208857226,-1.3422794368190945,0.1724137931034483,0.9544891455702904,1.0,1/13,0.40%,STING1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6644368697706536,-1.3418684020698783,0.07547169811320754,0.9511768735723648,1.0,3/26,3.19%,ACOT1;ACOT11;ACOT4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6644368697706536,-1.3418684020698783,0.07547169811320754,0.9511768735723648,1.0,3/26,3.19%,ACOT1;ACOT11;ACOT4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.8224194290276233,1.3417441922690234,0.17307692307692307,1.0,1.0,3/8,9.04%,WNT5A;GRIP1;DVL2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.8546201687692949,-1.341567321370197,0.03508771929824561,0.9495058927224744,1.0,2/6,3.89%,LCP1;CD74
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.7793313490768696,-1.3413067479439291,0.14814814814814814,0.9475055560678814,1.0,1/8,0.65%,DDX11
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7368185273919936,1.3406788891992745,0.2127659574468085,1.0,1.0,1/12,1.68%,CSGALNACT1
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.7885605175682262,-1.339925015388666,0.14285714285714285,0.9529476562616297,1.0,6/9,18.80%,ACE;NOS2;DRD3;DRD4;ABCC4;LEP
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.533810372473101,1.3399242187267355,0.07142857142857142,1.0,1.0,36/131,16.07%,RUNX1;IRS1;PPARG;MAGI2;SMAD7;SYNJ2;NRP1;ATP2B4;SPOP;ACVR2A;CELF2;NR3C1;LDLR;ATXN1;PTGFR;NR1D2;TFPI;BMPR1A;MMP16;DDAH1;PDGFRB;IGF1R;TOGARAM1;PRKCA;DYRK1A;ADGRL2;PLCB4;INPP4B;PHF3;PTPRM;COL5A2;SMAD3;INSIG1;SCAF8;BCKDHB;TGFBR3
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5867325137870281,-1.3394934628914397,0.09302325581395349,0.9524855382243035,1.0,9/137,5.58%,CD44;SFRP1;NTRK1;ADAMTS12;PLK5;KNSTRN;DLX5;VIL1;PDCD5
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.7897998729570406,-1.3394042440521432,0.1,0.950127362462579,1.0,3/12,6.35%,FIP1L1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8540629608798467,-1.3391846588577268,0.15,0.9484254612950473,1.0,3/6,9.38%,CLDN4;DDRGK1;SVBP
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7691717459828936,1.3391638176631988,0.2,1.0,1.0,4/7,20.61%,NFATC2;NFATC3;PDGFB;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.8565071676451286,-1.339008083699129,0.07692307692307693,0.9463387955854186,1.0,2/9,4.50%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.773679926648422,1.3387848997350542,0.18518518518518517,1.0,1.0,3/14,8.11%,FLRT2;LAMB4;NID2
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7930180196869551,1.3371300864706952,0.15555555555555556,1.0,1.0,1/9,2.11%,RFWD3
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.6140078699164416,-1.3367914849477969,0.09090909090909091,0.9566428637672977,1.0,10/38,12.53%,GNAT3;AOAH;HCK;SPI1;CDHR2;CD24;RGS2;DRD3;PTPRC;IL13RA1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6767591177564015,-1.3365077687961213,0.14285714285714285,0.9552993738028699,1.0,12/25,21.40%,SPG7;MICOS13;ATP5F1B;DNAJC11;ATP5F1A;ATP5F1D;AFG3L2;ATP5MC1;ATP5F1E;APOO;ATP5MC2;ATP5PD
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.6764124913522789,-1.336283055079123,0.1276595744680851,0.9534820691049687,1.0,1/17,1.55%,DHFR2
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.828918598448859,1.3362372641804088,0.15217391304347827,1.0,1.0,3/7,11.81%,DISP3;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.743618405323017,1.3361226320321125,0.10416666666666667,1.0,1.0,2/9,1.68%,B4GALNT2;CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.7766673829460154,-1.3358771971133865,0.17543859649122806,0.9530885692628515,1.0,1/9,0.11%,EPN1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.7558839351220886,1.3357803351774549,0.16666666666666666,1.0,1.0,4/13,9.80%,PLA2G7;AGMO;TMEM86B;DHRS7B
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.8395827674964808,1.3357036058416998,0.15555555555555556,1.0,1.0,1/6,1.50%,ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5042089047307683,-1.3354454762251018,0.0,0.9529671417313287,1.0,34/358,9.10%,CD44;APIP;NCKAP1L;SFRP1;TNFSF18;SH3RF2;HMGN5;NUPR1;NTRK1;PLK3;HCK;ASCL1;IL31RA;CD74;ANXA5;PRKCH;ANKLE2;UBC;AHI1;HTATIP2;VIP;PTMA;BCL2L2;IFI6;FGF20;CRYAB;PRLR;TAF9B;TRIAP1;BEX3;DDRGK1;PA2G4;RNF213;PLK2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.6172239557585074,1.3345156048744669,0.08695652173913043,1.0,1.0,9/42,11.59%,LOXL2;SEMA5A;VEGFC;ROBO1;SLIT2;NRP1;DLL1;CDH13;VEGFD
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.7764504905155744,1.334393407568689,0.13636363636363635,1.0,1.0,4/12,9.45%,HEY1;SMAD5;SMAD1;BMPR1A
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6177512563556946,-1.3336010948890928,0.12727272727272726,0.9614166888723683,1.0,19/51,21.34%,SURF6;RRP15;RPF2;RSL1D1;TRAF7;LAS1L;NOP16;MRTO4;EIF6;NVL;RPL7A;RPL5;PAK1IP1;RPL6;RPL24;RPL35A;RPL11;RPL10A;NSA2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7155306373115771,-1.3333848128313692,0.14814814814814814,0.959811360250541,1.0,5/14,21.44%,DECR2;CRAT;ACOX3;ACOX2;ABCD1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.754546624870994,-1.3331828509182693,0.16666666666666666,0.95848311154251,1.0,1/10,0.67%,NLRP1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.711629538046632,-1.3331633130091296,0.1590909090909091,0.9555656222348106,1.0,1/11,1.56%,EEF1AKMT2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6964748331582484,-1.3328267314335427,0.1320754716981132,0.9547011162323725,1.0,3/16,11.95%,BUD23;NUDT16;TRMT112
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.7796530945555084,-1.332756582473639,0.10416666666666667,0.9521073144130745,1.0,2/9,5.74%,PAH;IL4I1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6148784768926678,1.3320185379673783,0.15789473684210525,1.0,1.0,12/42,12.28%,CADM2;CDH8;SMAD7;NECTIN3;CDH18;CDH20;CDH10;CDH2;CDH6;CADM1;CDH13;CTNNB1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6727445375719769,-1.331923497430959,0.1111111111111111,0.9536328861816842,1.0,2/28,2.04%,EPN1;FGF1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.8944362036616653,1.3316450041211199,0.05,1.0,1.0,2/5,5.25%,KANK1;ANLN
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.579192690720031,-1.3314792326196676,0.11538461538461539,0.9532497872030709,1.0,10/74,7.00%,DUSP4;CBLC;SPRY4;PEBP1;SPRED3;UCHL1;FOXM1;SPRED2;SPRY1;DUSP6
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7706477808803768,1.3313613746456998,0.10909090909090909,1.0,1.0,1/10,0.59%,NLRP2B
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6093750015940425,-1.331300902165256,0.0784313725490196,0.9515581445624786,1.0,13/58,13.78%,DDX11;AURKA;GTF2F1;GOLGA2;B2M;IFIT1;LRPAP1;RACK1;ATP2A3;TMC8;ACTB;PIN1;TTBK1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.8568064298726052,1.3312436772736167,0.17647058823529413,1.0,1.0,1/7,0.16%,CHIT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7491410555611625,1.33115829443668,0.17647058823529413,1.0,1.0,4/12,8.55%,IRS1;PPARGC1A;IRS2;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7162291102833155,-1.330883058798613,0.1590909090909091,0.9508352029399526,1.0,2/16,3.97%,SFRP1;FTH1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.662056092367878,-1.3308760254410756,0.13953488372093023,0.9479740800654592,1.0,1/19,0.67%,BUD23
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7687500951786483,1.3308755915777595,0.21153846153846154,1.0,1.0,6/8,20.51%,LEPROTL1;GPM6B;PICALM;COMMD1;NEDD4L;CAV3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7683209019124584,1.3307840705482101,0.2,1.0,1.0,5/11,18.84%,PPARG;RELA;NFATC3;NFIB;PDGFB
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.7581265161814636,1.3306999142989413,0.19148936170212766,1.0,1.0,5/16,12.28%,FZD1;FRAT2;DVL2;WNT8A;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8151681056378394,-1.3304797005837137,0.13636363636363635,0.9474973086417069,1.0,6/11,15.55%,NCKAP1L;TNFSF18;MADCAM1;ZP3;RSAD2;PIK3CB
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6422266428682812,1.3302157589218353,0.1276595744680851,1.0,1.0,11/24,20.39%,FAT4;TEAD2;LATS1;DVL2;SAV1;MOB1B;WWC1;AMOTL2;WWTR1;DCHS1;AMOT
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.7752316842837619,-1.329971005087718,0.18604651162790697,0.9474550997597135,1.0,1/8,0.56%,SFRP1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.8011378172116534,1.3299548157643288,0.22,1.0,1.0,2/6,6.88%,NRG1;HDAC9
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.8089943689613188,1.329794037689061,0.16,1.0,1.0,5/10,15.46%,THRSP;PRKAB2;ACACA;SLC25A20;CPT2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.9088396943463886,-1.3297384390776232,0.13333333333333333,0.9460072322434222,1.0,1/5,4.04%,GOLGA2
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7962868060072062,-1.3291393458280871,0.15217391304347827,0.9473428365784907,1.0,1/7,2.21%,AQP8
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.7070801415195427,-1.3288837162482217,0.14583333333333334,0.945961015627101,1.0,2/16,2.90%,SFRP1;RAC1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.6084732783920989,-1.3287367743883145,0.19148936170212766,0.944160917014302,1.0,14/52,13.62%,PLK4;HK2;MAP3K6;RABEPK;SORD;MCM5;PA2G4;NOP56;DDX18;LAS1L;NOLC1;NOP16;MRTO4;SUPV3L1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.6427815737916198,1.3280747414159442,0.1111111111111111,1.0,1.0,13/30,20.79%,SNCA;SERF1A;FBXL3;PLK1;PEX2;SIRT1;BTRC;RNF139;ISOC2;EP300;MDM2;DERL1;CUL3
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5678254099065507,1.328007952884335,0.07142857142857142,1.0,1.0,13/68,13.67%,VAPB;SLC8A1;PKHD1;ATP2B4;SNCA;TMTC2;CCL5;EDN1;TRDN;NPTN;ANK2;CXCL12;SLC24A2
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.8619315122876485,-1.3277748210424638,0.13636363636363635,0.9473045250548757,1.0,3/6,10.53%,ARR3;GTF2H2;DRD3
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7941651056760552,1.326950834650561,0.09259259259259259,1.0,1.0,2/7,5.96%,RIT2;NRP1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.7125572403260751,1.3263975981620024,0.17647058823529413,1.0,1.0,5/18,13.55%,SLC22A2;SLC15A2;ABCC2;ABCC11;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.6977338546209646,1.3262047599974303,0.10416666666666667,1.0,1.0,9/19,18.34%,CX3CR1;TOX;SMARCD3;DISP3;CTNNB1;MDK;DISC1;PROX1;VEGFA
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6668396206707871,1.3256397080923519,0.14893617021276595,1.0,1.0,6/23,9.31%,CEL;NLGN1;SYNJ2;SNCA;SYT1;NLGN4X
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.72442471287843,1.3256309456629882,0.13725490196078433,1.0,1.0,6/13,20.83%,LOXL2;BAHD1;SIRT1;MECOM;SETD7;HP1BP3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.6746062823751366,1.3252107034007679,0.10204081632653061,1.0,1.0,5/17,14.55%,PPARG;ZBTB20;DISP3;SORBS1;CREB1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6820258117260862,1.325091492609125,0.1509433962264151,1.0,1.0,9/19,19.96%,CSF1;CSF1R;CCL5;MSTN;MDK;MTUS1;C5;IL34;PTK2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.6440432025252086,1.3250815685033268,0.10256410256410256,1.0,1.0,3/35,3.79%,IFI16;PPARG;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.6809457839778491,-1.324987348383814,0.14,0.962612295619963,1.0,6/17,16.57%,CD74;CD4;KPNA2;DDB1;TYRO3;CHMP2A
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.8110097783676438,1.3247198315580981,0.12962962962962962,1.0,1.0,2/7,4.15%,SPHK1;DOC2B
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7235325228217129,1.3246680140200906,0.225,1.0,1.0,1/10,0.41%,STK26
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.788053868352715,1.3244588508582877,0.15555555555555556,1.0,1.0,1/10,1.84%,SPX
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.7514685396552514,1.3241456268636473,0.16666666666666666,1.0,1.0,1/11,1.16%,IFI16
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.6966574887111835,-1.3239846074618176,0.14814814814814814,0.9652599709588752,1.0,4/22,11.32%,STX4;RBP4;HMCES;PTPRC
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6510742369196285,-1.3239171895821655,0.2,0.9628621906188973,1.0,12/34,17.91%,CLU;CIDEB;PDCD5;TRIAP1;PRELID1;PINK1;DNM1L;BIK;PSMD10;GPX1;GHITM;HRK
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5451353014071872,1.3237620042628129,0.11320754716981132,1.0,1.0,32/100,17.17%,GUCY1A2;RGMA;LSAMP;MAGI2;NRXN1;ADGRB3;UNC5D;PCDH17;SLC35F1;GRID2;ROBO2;GRIA4;PTPRD;ADGRL3;RAB3C;CTNNA2;SH3GL2;GPM6B;CNTN1;NOVA1;RBFOX1;ASXL3;CPT1C;ANK2;GJC1;FAT3;GRIA2;RUNX1T1;CSRNP3;MAPK4;GABRB3;DCLK1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7939990180339253,-1.3237144516356802,0.1702127659574468,0.958555776911805,1.0,5/9,19.48%,MAP1LC3B2;MAP1LC3A;NPRL2;MAP1LC3B;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7939990180339253,-1.3237144516356802,0.1702127659574468,0.958555776911805,1.0,5/9,19.48%,MAP1LC3B2;MAP1LC3A;NPRL2;MAP1LC3B;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.45202544950803897,-1.323488423314718,0.0,0.9569785208336791,1.0,64/572,10.54%,CD44;APIP;NCKAP1L;SPDEF;SFRP1;TNFSF18;SH3RF2;HMGN5;NUPR1;USP27X;CLU;NTRK1;PLK3;HCK;OBSCN;ASCL1;CASP6;RASGRF2;IL31RA;CD74;UTP11;VAV3;ANXA5;PLK5;CDK5;BEX2;CIDEB;GADD45A;PRR7;ANKLE2;PDCD5;DNAJA3;ITGA6;UBC;AHI1;HTATIP2;PAX8;DAXX;DUSP6;VIP;PTMA;FGD3;BCL2L2;LATS2;RSL1D1;ANP32E;IFI6;CRYAB;PRLR;TAF9B;TRIAP1;ATF4;DDRGK1;PTPA;PA2G4;PLK2;PIDD1;IGFBP3;FHL2;TCIM;CYP1B1;PRELID1;LRP8;RFPL1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.7269307185172307,-1.3225620217485188,0.1951219512195122,0.9591041303064745,1.0,2/10,4.84%,B3GNT9;B3GALT5
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.8353315123616134,1.3224357808552971,0.16666666666666666,1.0,1.0,2/5,4.32%,SULT2B1;ELAPOR2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),0.8093198576383306,1.3219749499001903,0.15,1.0,1.0,1/5,4.17%,SMAD7
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.633695700307941,-1.321905780771708,0.0,0.9598328209405252,1.0,11/25,22.56%,RRP15;RPF2;RSL1D1;DDX18;LAS1L;EIF6;RPL7A;FTSJ3;RPL10A;NSA2;NIFK
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.7306266418043379,-1.32156935964636,0.12244897959183673,0.955881460933458,1.0,4/20,7.04%,TERF2IP;POLR2I;DAXX;POLR2J
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.7306266418043379,-1.32156935964636,0.12244897959183673,0.955881460933458,1.0,4/20,7.04%,TERF2IP;POLR2I;DAXX;POLR2J
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.6240789326922419,1.321520099658392,0.17073170731707318,1.0,1.0,15/63,16.14%,SLC12A1;KCNJ3;TRPV2;SLC12A3;SLC39A12;SLC8A1;ATP2B4;KCNJ6;SLC39A8;ATP12A;SLC24A2;SLC9A1;KCNJ2;KCNK9;SLC12A2
prerank,PanglaoDB_Augmented_2021__Macrophages,0.5583018762179321,1.3213336056696487,0.10204081632653061,1.0,1.0,15/97,5.99%,CHIT1;SAMSN1;PIK3R5;MARCHF1;PPARG;HPGDS;ITGAX;SYK;CX3CR1;EGLN3;ITGAM;LAIR1;TGFBR1;STAB1;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.8594042790968298,-1.3211540884722635,0.09523809523809523,0.9559817473056723,1.0,2/5,13.22%,STX1B;BAIAP3
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7038333404853274,-1.3208372304053502,0.1694915254237288,0.9547949299346913,1.0,3/15,11.52%,H1-4;H1-0;CHAF1A
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.8270267207305302,-1.3198163037886466,0.16,0.9583914496705327,1.0,2/6,14.03%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.8150703867679976,-1.319543881332195,0.15789473684210525,0.9575311273257142,1.0,2/6,6.04%,REC8;XRCC1
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.7865457764907378,-1.319428412510399,0.16981132075471697,0.9551830639465616,1.0,1/5,2.46%,CRH
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7407689704175675,-1.3193090608242108,0.11764705882352941,0.9530377749065563,1.0,2/15,7.18%,AZGP1;HLA-DRA
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.767413700297582,1.3191922945076184,0.14,1.0,1.0,3/8,10.21%,ZBTB1;TGFBR1;FGF10
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.6787618235536033,-1.3188367065296003,0.21739130434782608,0.952928530825344,1.0,1/17,1.31%,ATRAID
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.7552675928698931,-1.318752801773537,0.15789473684210525,0.9506402769486476,1.0,7/16,16.09%,CLDN4;DDRGK1;PRELID1;PINK1;PSME1;APH1B;CTSH
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8449015195498346,1.3184528190119609,0.18181818181818182,1.0,1.0,1/6,2.11%,RFWD3
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.9004213925164523,-1.3182175143353243,0.09803921568627451,0.9486978419894414,1.0,1/5,3.41%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.9004213925164523,-1.3182175143353243,0.09803921568627451,0.9486978419894414,1.0,1/5,3.41%,PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.7686274525917866,1.3178478829853641,0.09090909090909091,1.0,1.0,2/9,4.52%,SYK;ITGAM
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.8592618643313109,1.3176117325141425,0.14893617021276595,1.0,1.0,1/5,1.30%,TYR
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.8492927478987919,1.317488228324149,0.14893617021276595,1.0,1.0,3/6,10.13%,DGAT2;PLA2G15;PLCE1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.7807782055858428,-1.317264203634133,0.08,0.9517505548342149,1.0,2/10,5.57%,H1-4;H1-0
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.8207029104123049,1.3172110313057541,0.16981132075471697,1.0,1.0,2/5,11.07%,ADIPOR2;ADIPOR1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6997049000821618,1.3170792941510832,0.1568627450980392,1.0,1.0,3/23,8.75%,NLRP2B;OTUD4;MFHAS1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.549275508158357,-1.3163978667339291,0.0851063829787234,0.9536952724494152,1.0,8/65,9.46%,RPS27L;PLK3;AURKA;FOXM1;GADD45A;TRIAP1;PLK2;PIDD1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5343275303587884,1.3162361453721971,0.06521739130434782,1.0,1.0,35/109,17.17%,GUCY1A2;LRRC4C;NLGN1;SEMA6D;ADGRB3;GFAP;PCDH17;SLIT2;SLC35F1;PDZRN3;PTPRD;ADGRL3;MEGF10;NPAS3;GLI3;FBXL7;GPM6B;NOVA1;ASXL3;NOTCH3;LRP4;PDGFD;ANK2;ZNF536;PPFIA2;FAT3;RGS7BP;LRRC3B;GRIA2;RUNX1T1;CSRNP3;MAP2;TMEM178A;MAPK4;DCLK1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.684658466960975,-1.3162027831165481,0.17391304347826086,0.9521797101890019,1.0,5/19,7.74%,CLDN4;DUOX1;ADRA2A;CLDN1;SCARF1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6075646297149869,1.316188178341626,0.14285714285714285,1.0,1.0,11/60,12.62%,GALNT3;GALNTL6;GALNT13;NLK;TGFBR1;PRKD1;DYRK3;PRKCA;DYRK1A;DYRK2;ACVR1B
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5682075934592888,1.315476678589123,0.06976744186046512,1.0,1.0,21/82,15.31%,GALNT3;GALNT8;C1GALT1;GALNTL6;MUC20;GALNT13;ST8SIA6;C1GALT1C1;CRPPA;GALNT7;TMTC2;GXYLT1;MUC16;GCNT3;MUC6;B3GLCT;POMGNT2;GALNT12;B3GNT2;OGT;TET2
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8673805030776062,-1.314993810373627,0.022222222222222223,0.9570495463656696,1.0,2/6,6.38%,AMH;PAX8
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),-0.7984147332793357,-1.3149653578320957,0.2,0.9546095371454134,1.0,1/5,6.75%,ADRA2A
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7989552704117283,1.3145997597023873,0.11363636363636363,1.0,1.0,2/7,13.77%,LRRC38;AKAP6
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5890654722974913,1.3145725905089132,0.09803921568627451,1.0,1.0,19/64,13.40%,LTK;PIK3R5;PLCB1;IRS1;IRS2;CSF1R;NYAP2;PLCL1;PLCE1;PDGFRB;PIK3C2G;IGF1R;EDN1;PIK3C2B;FGFR1;PLCB4;PTAFR;PIK3CA;CD160
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.8306745057397205,-1.314301121036043,0.16326530612244897,0.9554986106589383,1.0,2/9,6.04%,TMSB4X;XRCC1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7137689788146575,1.3139345314072508,0.14583333333333334,1.0,1.0,2/15,7.93%,KCNC2;MAT2A
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7435434287151789,1.3137518465500837,0.1746031746031746,1.0,1.0,2/12,5.94%,INPP1;SYNJ2
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.8716867883928954,-1.313338229808841,0.11320754716981132,0.958377163298024,1.0,3/5,6.38%,FGF1;WNT7B;PAX8
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.692375281051918,-1.3130648165462953,0.14285714285714285,0.9578378364167993,1.0,3/21,8.60%,DDX11;NCL;ATF4
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5420863452484214,-1.31298725822108,0.09090909090909091,0.9557355835625972,1.0,16/96,12.09%,SELP;CD9;CLU;F5;SERPINE1;F8;TMSB4X;ANXA5;PCYOX1L;CD63;CALM1;SCG3;SPARC;CFD;MAGED2;SELENOP
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7161482472836321,1.312816334059457,0.14285714285714285,1.0,1.0,3/13,6.33%,TRPV2;SLC8A1;ATP2B4
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7161482472836321,1.312816334059457,0.14285714285714285,1.0,1.0,3/13,6.33%,TRPV2;SLC8A1;ATP2B4
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.8398131214734079,1.3127914265675942,0.1320754716981132,1.0,1.0,2/5,7.00%,AGMO;TMEM86B
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.8459341406562674,1.312511299364744,0.11538461538461539,1.0,1.0,1/5,2.91%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.8266527573064936,1.311710205478588,0.1568627450980392,1.0,1.0,2/8,1.84%,SPHK1;SPX
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8194415161942291,1.3111078331851744,0.17307692307692307,1.0,1.0,2/6,15.36%,KANK1;ARHGAP24
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5693698281449917,-1.310754249003842,0.11764705882352941,0.9665020150202662,1.0,5/54,5.03%,NCKAP1L;TPPP3;HCK;RAC1;DCTN1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.5950568169103094,1.310679265521955,0.05714285714285714,1.0,1.0,18/69,13.67%,SLC12A1;SLC5A12;SLC12A3;SLC6A13;HCN1;SLC8A1;SLC23A1;KCNK1;SLC5A8;SCNN1B;SLC5A4;SGK1;ASIC4;SLC4A4;ASIC2;FGF13;SCNN1D;SLC24A2
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.8598235250254223,1.3106777679305677,0.06666666666666667,1.0,1.0,2/6,2.08%,PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.6998063625294391,-1.310597026807679,0.14,0.9648548148016899,1.0,5/16,9.30%,SFRP1;CCN3;CRH;ADRA2A;MIDN
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.8830271485568919,-1.3102342381985468,0.14545454545454545,0.9645367152332534,1.0,1/5,1.02%,RTF1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.8287534989738476,1.309944597154174,0.14035087719298245,1.0,1.0,2/6,5.23%,ADGRV1;WNT5A
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7495547431562279,1.3091989766954262,0.16666666666666666,1.0,1.0,6/12,19.44%,STK26;TNIK;RAP2A;RAPGEF6;RAP1A;MAP4K4
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7495547431562279,1.3091989766954262,0.16666666666666666,1.0,1.0,6/12,19.44%,STK26;TNIK;RAP2A;RAPGEF6;RAP1A;MAP4K4
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.7524216369849963,1.3090823787526378,0.1774193548387097,1.0,1.0,2/11,5.94%,INPP1;SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7524216369849963,1.3090823787526378,0.1774193548387097,1.0,1.0,2/11,5.94%,INPP1;SYNJ2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.7725034654001331,1.3090434485277964,0.13953488372093023,1.0,1.0,1/7,2.71%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.583069190193917,-1.3090028307809747,0.10204081632653061,0.9688670603825251,1.0,4/69,4.58%,PM20D1;CCN3;CLU;CDK5
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6572722388590847,1.3087211444346214,0.13636363636363635,1.0,1.0,10/40,13.49%,IL1RAPL1;NLGN1;CX3CR1;NRXN1;GRID2;PTPRD;RGS14;FAIM;SERPINF1;LIG4
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7063446346914599,1.3086539942267894,0.1836734693877551,1.0,1.0,4/14,13.24%,ACKR3;CCL5;CXCL12;THPO
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.9326291476311439,-1.3085939294921831,0.05714285714285714,0.9686170723958482,1.0,1/5,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.8056643681019069,1.3082184341650616,0.1836734693877551,1.0,1.0,2/6,8.62%,PPARGC1A;ZNF516
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.789481814002093,1.308217157122829,0.23529411764705882,1.0,1.0,2/9,3.42%,MYRFL;HJV
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6045668831836399,1.3079660964629993,0.1509433962264151,1.0,1.0,11/53,11.03%,CD151;SPHK1;RIT2;EPHA3;CD22;SNCA;MCTP1;PRKD1;ABL2;DLL1;CDH13
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.49850205103334877,-1.3079026312854107,0.037037037037037035,0.9700887206638722,1.0,93/276,23.82%,INHA;TYMS;SARS1;ABCF1;NFKBIB;POLR2I;WARS1;PAX8;POLR2J;MRPL23;PTMA;RPLP1;RPL28;POLR3A;MCM5;MRPS18B;RPL37A;RPL34;ORC3;MRPL55;RPS15;RPL4;RPS8;RPL12;CHEK1;ORC1;RPL31;RPL8;RPL19;MCM2;TICRR;RPS27;HUS1;MRPS18C;RPL23;POLL;MRPL9;MRPS21;DRG1;TOP3A;MRPL27;RPL7A;POLR2G;MRPL51;DTX1;RPL29;POLR2C;NT5M;PABPC4;RPS24;RPL5;KIN;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;RPS4Y1;MRPS33;RRBP1;RPS20;POLE3;RPS3;POLR2L;RNPS1;MRPL37;CDC7;RBBP8;KAT5;EIF4G1;RPL35A;RPL11;RPL10A;RMI1;POLR2K;RPA3;PIF1;MRPS11;RPL18;RPS14;MCM4;GTPBP1;ORC2;RPS4X;EEF1B2;IGHMBP2;PTMS;RPS2;CDC6;EEF2;SET
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6875398783144759,1.3076913459844468,0.20408163265306123,1.0,1.0,4/14,20.37%,C3;PRKCB;BRAF;SLC2A1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.6308580437239376,-1.307570907267096,0.1836734693877551,0.9698623995936567,1.0,9/42,6.01%,P2RY10;NCKAP1L;CD5;SLA;AOAH;CXCR5;TRAF3IP3;CD4;CD37
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.8938626149271673,-1.30745153308971,0.07317073170731707,0.9679262274982928,1.0,1/5,0.60%,PLK4
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.7597042249274185,-1.3066741619017888,0.11320754716981132,0.9691586883465538,1.0,1/10,1.86%,MYB
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7755375562436532,1.3060143070749997,0.2,1.0,1.0,2/11,8.50%,ROGDI;HDAC2
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.8093250789910282,1.3057111541708342,0.20454545454545456,1.0,1.0,2/5,8.82%,HMGB1;CCL5
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7407469212287133,1.3048923467663778,0.1568627450980392,1.0,1.0,4/13,13.15%,DSCAM;CNTN4;NPTN;EMB
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8925986810212813,1.3048306035195325,0.10638297872340426,1.0,1.0,2/6,4.17%,NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.8218513620134624,-1.3038682757499982,0.06666666666666667,0.9834158393231913,1.0,1/5,4.13%,TNXB
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.7358714053191782,1.3038063662247268,0.18,1.0,1.0,1/10,2.58%,KLF2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.7328921097836016,1.3035770942983351,0.18181818181818182,1.0,1.0,4/12,12.25%,SLC30A10;CDK6;TWIST1;SIRT1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6863273400888259,1.3033251935993773,0.16981132075471697,1.0,1.0,3/23,7.29%,ACE2;AGER;CELF2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.6319851855822677,-1.3031796683807373,0.125,0.9844485416690285,1.0,4/29,12.93%,DYSF;NSFL1C;DNM1;DNM1L
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.8633067877496531,1.3031132354310406,0.10416666666666667,1.0,1.0,2/7,12.44%,CKM;CKMT1A
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7429410816892863,1.3031022095587275,0.1702127659574468,1.0,1.0,3/8,4.53%,APOLD1;ATOH8;ZEB1
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.785330879606523,1.3029877162051537,0.18181818181818182,1.0,1.0,2/6,5.70%,ITGAM;HPRT1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8185875291388067,-1.3022255534079406,0.17391304347826086,0.9873960813223296,1.0,1/8,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7684745122405898,1.3019458896660396,0.16666666666666666,1.0,1.0,4/10,16.07%,SMAD7;TGFBR1;ACVR1;TGFBR3
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.8536901210856283,-1.3014670443460652,0.16666666666666666,0.9884631908315862,1.0,3/5,12.91%,CD74;CARD9;ZP3
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.8556396901844535,1.3013682115419296,0.1346153846153846,1.0,1.0,1/5,3.59%,CSF1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.8199489865417313,-1.3013084754826463,0.19148936170212766,0.9868101996547292,1.0,4/8,15.57%,FBXO43;TOM1L1;CHEK1;BMP7
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7950734209340681,1.3007107483912492,0.15384615384615385,1.0,1.0,4/7,15.04%,HEY1;MRTFA;MRTFB;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.8478273473322954,-1.300277287266901,0.13953488372093023,0.9909816461097067,1.0,2/7,1.31%,SFRP1;ATRAID
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.722633729468444,-1.300266435735959,0.2127659574468085,0.988455650533815,1.0,1/8,6.45%,HENMT1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7927666101733056,1.3001935865715888,0.1836734693877551,1.0,1.0,1/9,2.25%,NEDD4
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5460159183186466,-1.2999540255154711,0.11764705882352941,0.9875388218007963,1.0,6/64,3.58%,SYTL1;PSD4;SIGIRR;B3GALT4;HLA-C;ST6GALNAC2
prerank,MSigDB_Hallmark_2020__Apical Surface,0.6190991037995093,1.299827941196479,0.10204081632653061,1.0,1.0,7/34,7.00%,EFNA5;ATP6V0A4;HSPB1;ADIPOR2;SHROOM2;PKHD1;B4GALT1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7182730839597862,1.299788422965876,0.17647058823529413,1.0,1.0,8/15,20.18%,ENPP6;GDPD3;PRDX6;PLA2G4C;SMPD4;GPCPD1;ABHD12;PNPLA6
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.7495438332172462,1.2995464145135516,0.14,1.0,1.0,2/10,4.52%,SYK;ITGAM
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7552956089950338,1.299321529066392,0.07547169811320754,1.0,1.0,1/10,5.96%,NRP1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.6170677749396697,-1.2988338278893337,0.15384615384615385,0.9917005628137912,1.0,4/32,15.39%,TERF2IP;LEMD2;TPP1;CTCF
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.8101573249131739,-1.2985764870233907,0.15517241379310345,0.9906808320918651,1.0,1/6,0.56%,SFRP1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.7282112673273435,-1.2984853495137858,0.18604651162790697,0.9887014498099632,1.0,4/14,13.97%,NUPR1;COX7A1;PINK1;UQCC2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.7786494908099928,1.298334776457003,0.1702127659574468,1.0,1.0,4/8,18.76%,PRELP;GLB1;HEXB;GNS
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.8374045538164665,-1.2982717778596082,0.18181818181818182,0.987497346954862,1.0,1/5,5.52%,SRP54
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8023112704628843,1.2980203086749722,0.16981132075471697,1.0,1.0,1/6,9.44%,MSTN
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8299053529450267,1.2979873781325288,0.0975609756097561,1.0,1.0,2/7,6.33%,CHRM3;ATP2B4
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.7020466739578197,1.297638753563354,0.20408163265306123,1.0,1.0,3/13,8.60%,CHMP6;CEP55;PDCD6IP
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.5510763727501872,-1.2972938485091037,0.05555555555555555,0.9909023617949267,1.0,37/96,25.41%,DDX11;NEMP1;DDX12P;INCENP;UCP3;ILF3;PDCD11;NOP14;DHX16;CHAF1A;GART;ORC1;DDB1;MCM2;NCAPD2;HNRNPL;PABPC4;NAT10;DHX38;GTF3C2;EFTUD2;DDX21;GLE1;FTSJ3;EIF4G1;NUP85;POLG;EIF3A;SNRNP200;TBRG4;ZDHHC5;SF3B3;USP19;BRPF1;HDGF;DHX37;YBX1
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.866432440793654,-1.297211017836725,0.10909090909090909,0.988864060145622,1.0,1/5,0.29%,SLC19A3
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.6739743582992263,1.2971737226024562,0.0851063829787234,1.0,1.0,9/35,12.28%,FZD1;HEY1;CUL1;HDAC2;DVL2;JAG1;DLL1;GNAI1;CTNNB1
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.8570290932037605,-1.2971331854224124,0.16666666666666666,0.9870076532107651,1.0,1/5,0.98%,APOBEC3H
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.8136027868781219,1.2967393613335987,0.16279069767441862,1.0,1.0,2/6,8.94%,PNP;GLI3
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.7284505413141485,1.2966306637982217,0.13333333333333333,1.0,1.0,2/9,4.04%,HPGDS;PTGES
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6043970403280959,-1.2965641692012038,0.12962962962962962,0.9875788482241219,1.0,9/53,8.37%,CYP1A2;GPC2;CYP2D6;RBP1;AGRN;GPC1;GPC3;RBP4;SDC2
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7669695701983944,1.2961428372257993,0.18867924528301888,1.0,1.0,3/9,14.22%,PLA2G10;PLBD1;PLA2G4C
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.8007021236993481,-1.2958821216335628,0.16,0.9895601524175529,1.0,2/7,13.37%,MTIF3;MCTS1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.6664556517841354,-1.2954422904371958,0.16666666666666666,0.9897574149112458,1.0,6/22,17.69%,ANKLE2;PTPA;CALM1;PIN1;CALM3;SRC
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.7972301227993873,1.2953424103637758,0.16279069767441862,1.0,1.0,8/12,14.77%,HJV;TGFBR1;ACVR2A;SMAD2;ACVR1B;INHBB;SMAD3;ACVR1
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.7371646758493114,-1.2951580773618339,0.22727272727272727,0.9891295604816213,1.0,4/13,12.57%,NCKAP1L;IL4I1;PRELID1;METTL3
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8478097370046671,1.2949555597882942,0.13043478260869565,1.0,1.0,2/5,5.73%,HMGB1;AGER
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.800098741474354,-1.2944596703887414,0.1,0.9905841236935742,1.0,2/6,5.47%,PLEKHH2;VIL1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8414623780083118,1.2943805546806995,0.11627906976744186,1.0,1.0,5/6,15.87%,SLIT2;NRP1;ROBO2;PTPRM;ALCAM
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7936084590990904,1.2941751242260902,0.20833333333333334,1.0,1.0,3/6,17.08%,GLI3;CHD7;PROX1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6025273115978039,1.2940623758983665,0.12,1.0,1.0,8/28,15.99%,SPX;PPARG;THRSP;PRKAB2;ACACA;SLC25A20;CPT2;ABCD3
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.6578591796695104,-1.2933914885056161,0.1590909090909091,0.9937194344493036,1.0,3/27,5.30%,RTF1;COL6A1;NODAL
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8447289410808565,1.2933686534670006,0.17307692307692307,1.0,1.0,2/6,9.65%,MFHAS1;TLR1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.631160712673209,1.2932386758980152,0.20408163265306123,1.0,1.0,8/34,16.14%,SLC12A1;KCNJ3;SLC12A3;KCNJ6;ATP12A;KCNJ2;KCNK9;SLC12A2
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.8193197647115666,1.2927508991887875,0.21428571428571427,1.0,1.0,2/5,10.95%,DOCK10;DLL1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5892483276607866,-1.2927390649720258,0.2,0.9944093560082948,1.0,23/52,23.12%,SDHC;NDUFC1;NDUFS5;UQCRH;NDUFA1;NDUFB9;COX4I1;NDUFA3;UQCRC1;COX6C;NDUFS6;NDUFAB1;NDUFB10;COX6B1;NDUFS2;NDUFA5;COX7B;UQCR10;NDUFA10;COX5B;COX7C;NDUFA12;NDUFS8
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6531603192607388,-1.2924390382533102,0.1509433962264151,0.9933921994147283,1.0,6/24,18.88%,HK2;ENO1;LDHA;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.8731151855339578,1.292427133043282,0.11764705882352941,1.0,1.0,1/5,5.23%,WNT5A
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.7737270835610335,1.2922211174952258,0.16981132075471697,1.0,1.0,1/9,3.50%,REP15
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.78509284792692,-1.292204054040518,0.3076923076923077,0.9921408130243545,1.0,1/6,4.27%,DTX3L
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.7445345634303451,-1.2920887348956251,0.14583333333333334,0.9903943425510634,1.0,1/13,0.73%,PARP2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8060348236397925,1.2916049737839266,0.13333333333333333,1.0,1.0,2/8,9.88%,LOXL2;SOX5
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4732613156702423,-1.291593174565104,0.057692307692307696,0.9907284609780234,1.0,34/286,11.90%,CD44;INHA;TERF2IP;TEC;FGF1;NTRK1;RAC1;CD74;ENPP2;ATG14;CD4;NODAL;GHR;IL11;DAXX;CEMIP;FGF7;FGF20;RBPMS;DDRGK1;CALM1;BMP3;CCND1;LRP8;BCAR3;PINK1;TOM1L1;TXN;PTPRC;FGF18;NIBAN1;AZU1;CENPE;RACK1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6144089718253201,-1.2912700418281773,0.1836734693877551,0.9901344658167327,1.0,3/26,11.55%,TERF2IP;GAR1;WRAP53
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4911485947704739,1.290737593743187,0.10416666666666667,1.0,1.0,43/218,13.82%,SEMA3C;PLA2G10;EFNA5;GFRA1;SEMA5A;SEMA6D;FGFR2;UNC5C;NRXN1;DSCAM;UNC5D;ROBO1;CNTN4;EPHA3;WNT5A;SLIT2;PARD3;IRS2;NRP1;NRXN3;GAB1;ROBO2;RYK;DOK6;FRS2;CTNNA2;EPHA7;AUTS2;PRKCA;NCAM1;NOTCH3;EPHA8;PSPN;NPTN;NRTN;PIK3CA;SLITRK5;EMB;CXCL12;EFNB1;ENAH;LRTM2;ANK3
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7988279195356764,-1.2906909993672127,0.13157894736842105,0.9886953102867563,1.0,2/8,5.34%,CHTF18;DSCC1
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7988279195356764,-1.2906909993672127,0.13157894736842105,0.9886953102867563,1.0,2/8,5.34%,CHTF18;DSCC1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.6740891490560866,-1.2905846206034335,0.16363636363636364,0.9868846683931125,1.0,2/21,2.90%,SFRP1;RAC1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7448844475984864,1.289911410320492,0.11363636363636363,1.0,1.0,4/14,14.78%,LOXL2;SOX5;MDK;SCX
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8193774939444298,1.2897258666473836,0.1320754716981132,1.0,1.0,3/6,14.08%,UHRF2;HELLS;ZNF445
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.7660992627597712,1.288924751915375,0.16666666666666666,1.0,1.0,3/6,12.82%,HMGB1;BATF3;CAMK4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.7843929295935447,-1.2887879437964254,0.14285714285714285,0.994585224734962,1.0,2/9,4.65%,RPS27L;FOXM1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.751440170869893,-1.2885424148573306,0.22641509433962265,0.9936136452789502,1.0,4/16,6.35%,C2ORF49;TRPT1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6421112055083043,1.2884792751959635,0.16326530612244897,1.0,1.0,8/22,24.27%,SPHK1;PRKCA;MEIS2;PPP1R10;MDM2;CUL3;LGMN;RPS6KB1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6553800971119313,-1.2881909112626013,0.14893617021276595,0.9933489859110503,1.0,3/27,5.30%,DUSP4;COL6A1;NODAL
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8484546396509949,1.288134463454621,0.17777777777777778,1.0,1.0,2/7,5.70%,PNP;HPRT1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.7386002243423064,1.2880843481496747,0.17777777777777778,1.0,1.0,3/14,6.27%,CALCR;ADGRV1;FSHR
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.6869733555143498,1.2880687355818325,0.17777777777777778,1.0,1.0,3/17,10.62%,PLA2G10;SLC15A2;SLC29A2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.7954761158439257,1.2878607379220335,0.18867924528301888,1.0,1.0,1/6,2.85%,SYK
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7030430369917332,-1.287800985356093,0.1956521739130435,0.9927821064812002,1.0,3/14,5.29%,TYMS;DUOX1;TRPC3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.8118668027220195,1.2874946337643258,0.17777777777777778,1.0,1.0,2/5,7.24%,ROBO1;ROBO2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7187313965034023,-1.2873586993967154,0.15217391304347827,0.992707097664368,1.0,1/10,1.74%,CLU
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5997422658167637,-1.2871158345500173,0.16,0.9917031106240425,1.0,4/31,13.86%,TERF2IP;GAR1;WRAP53;STN1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6772492568358187,-1.2870469046550028,0.18518518518518517,0.989707395002499,1.0,8/14,25.32%,ATP5F1B;ATP5F1A;ATP5F1D;ATP5MC1;ATP5F1E;ATP5MC2;ATP5PD;ATP5F1C
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7631237238844664,1.286725679147583,0.1702127659574468,1.0,1.0,3/12,5.82%,IRS1;PPARG;IRS2
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.8455664207404993,1.2865354507359277,0.10869565217391304,1.0,1.0,1/5,4.23%,S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.8455664207404993,1.2865354507359277,0.10869565217391304,1.0,1.0,1/5,4.23%,S100A13
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.7090293508155274,-1.2861643417385378,0.14583333333333334,0.9915594231957554,1.0,5/21,8.85%,SH3RF2;PPP1R17;ZCCHC9;PPP1R35;PTPA
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.7341949490252226,-1.2861343523663107,0.22950819672131148,0.9893200067730574,1.0,2/9,11.06%,CCN3;HDAC5
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.826188123116203,-1.2861096332069102,0.10256410256410256,0.9870453905396884,1.0,3/8,10.94%,DDX11;DTX3L;KDM4D
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.6576766708472948,1.2860186359693655,0.2222222222222222,1.0,1.0,2/18,2.80%,TRIP6;PTPRK
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.7928490459961745,-1.2856367403124025,0.12962962962962962,0.9876050389616445,1.0,4/7,16.79%,NFKBIB;TMSB4X;NFKBIA;PSMD10
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.8583113899095743,-1.2855085030928786,0.13043478260869565,0.9860095374878816,1.0,1/6,1.32%,NUPR1
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.8693785579143699,1.2854561567861584,0.12195121951219512,1.0,1.0,2/5,12.12%,SLC22A2;SLC7A2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8113264253652098,1.285073229423827,0.09090909090909091,1.0,1.0,4/7,13.17%,CALCR;GRM6;PDGFRB;CXCL12
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.7037313860198957,1.2848916285178773,0.16,1.0,1.0,2/18,3.63%,SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.5043448789408088,1.2844786524617537,0.09615384615384616,1.0,1.0,20/102,15.52%,KCND2;KCNJ3;KCNH7;KCNC2;KCNQ5;KCNS3;HCN1;LRRC38;KCNK1;KCNG3;KCNJ6;KCNB2;SLC24A2;KCNN1;KCNV1;SLC9A1;KCNG1;KCNJ2;KCNA5;KCNK9
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.8639837493036766,1.2842979758335231,0.18,1.0,1.0,2/5,9.65%,MFHAS1;TLR1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7540260275937101,1.2842923386260934,0.28846153846153844,1.0,1.0,5/8,22.57%,NEDD4;NEDD4L;HECW2;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.549723175426499,1.2842181373080495,0.16666666666666666,1.0,1.0,12/64,14.53%,SGK2;CD151;DOC2B;SNCA;ZNF205;SGK1;RAB27A;DLL1;NR1H3;IL15RA;BOK;TUB
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4914181113735,-1.2840427587031116,0.10416666666666667,0.9919372295684618,1.0,19/190,11.38%,CD44;FGF1;NTRK1;CD74;CD4;NODAL;IL11;ADRA2A;GPR37;CARD9;TRAF7;CD24;ADRA1D;ALKAL1;HTR2A;BCAR3;PTPRC;NDRG4;FGF18
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.8137095735803249,1.284021353668,0.25,1.0,1.0,2/6,12.01%,ABHD4;NAPEPLD
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5861283914488512,-1.2839032253410978,0.2,0.9904301537436637,1.0,23/53,23.12%,SDHC;NDUFC1;NDUFS5;UQCRH;NDUFA1;NDUFB9;COX4I1;NDUFA3;UQCRC1;COX6C;NDUFS6;NDUFAB1;NDUFB10;COX6B1;NDUFS2;NDUFA5;COX7B;UQCR10;NDUFA10;COX5B;COX7C;NDUFA12;NDUFS8
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.7811406936230214,1.2834837195301452,0.17857142857142858,1.0,1.0,4/8,14.98%,TGFBR1;RORA;SMAD2;INSIG1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6137006527641791,-1.2832563996419977,0.16326530612244897,0.9914992759590237,1.0,3/27,11.55%,TERF2IP;GAR1;WRAP53
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.6414131255133501,1.282909701129442,0.19047619047619047,1.0,1.0,14/26,17.08%,ZFPM2;SMAD7;ROBO1;SLIT2;TGFBR1;HEY1;ROBO2;BMPR1A;PDE2A;ACVR1;TGFBR3;SALL1;SOX11;PROX1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.8093392401990338,1.282879198911651,0.15,1.0,1.0,3/8,7.51%,HSPB1;GAB1;PRKD1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7185957458019052,-1.2827413029352575,0.16,0.991746811924931,1.0,4/11,22.03%,CDC37;IFNGR2;STAT1;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.798719793050547,1.2826672294863346,0.2,1.0,1.0,2/8,11.81%,PPARG;NR1H3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.7304216501403675,-1.2824421468055607,0.11764705882352941,0.991223869273717,1.0,8/13,24.38%,SAP18;C1QBP;SRSF7;RBMX;SRSF10;RNPS1;SFSWAP;PCBP4
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5415145991049816,1.2821479046021536,0.16666666666666666,1.0,1.0,27/100,13.98%,CEL;NTF3;GRM7;LRRC4C;NLGN1;CX3CR1;NRG3;AGER;GRM5;GRID2;MCTP1;SYT1;GRM8;GRIK2;GRM6;PXK;CHRNB4;NLGN4X;CDH2;TMEM108;RIMS2;GRIK1;GRM1;DLGAP1;BTBD9;SNCAIP;SYN3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.64864188740431,1.2816318811826373,0.21818181818181817,1.0,1.0,10/30,13.40%,LTK;PIK3R5;IRS1;NYAP2;PIK3C2G;IGF1R;EDN1;PIK3C2B;PIK3CA;CD160
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.8101740768697036,-1.2807235178076068,0.24,0.9984007747772328,1.0,1/7,1.02%,RTF1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7843102046933828,-1.2800850502255523,0.10204081632653061,0.9999588940763587,1.0,2/10,4.65%,RPS27L;FOXM1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.7492603400111577,-1.279975870818598,0.2545454545454545,0.9982070947631001,1.0,1/10,2.48%,APOD
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.8381065814508699,1.2797013254971892,0.17307692307692307,1.0,1.0,2/5,8.59%,OTUD4;TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.8381065814508699,1.2797013254971892,0.17307692307692307,1.0,1.0,2/5,8.59%,OTUD4;TOX
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.8437608767407613,-1.2795901302388042,0.1774193548387097,0.9980324907553522,1.0,3/5,14.03%,HSD17B10;SUPV3L1;TRMT10C
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8503298607407309,-1.2795353418959652,0.11627906976744186,0.9958909402960319,1.0,1/6,3.42%,KMT2B
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7275229810393148,1.2795321027728956,0.24444444444444444,1.0,1.0,8/14,17.04%,SLC12A1;SLC12A3;SLC8A1;SCNN1B;ATP12A;SLC9A1;SLC12A2;NEDD4L
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.528547205828958,-1.2794950992516698,0.10526315789473684,0.9937148032944523,1.0,34/72,26.38%,AURKA;PSMA7;ECRG4;ANAPC15;PSMD7;UBC;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;ANAPC2;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;FZR1;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;PSMA5;UBE2S;UBB;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4;PTTG1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.8185877500614364,-1.2793559537997237,0.16666666666666666,0.9898370569524645,1.0,1/7,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.8185877500614364,-1.2793559537997237,0.16666666666666666,0.9898370569524645,1.0,1/7,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.6609287540041692,-1.2792111253588092,0.1836734693877551,0.9881553934769619,1.0,1/27,0.07%,PM20D1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.7892267790816575,-1.279015017803768,0.2,0.9866362445433907,1.0,1/7,4.43%,MAN2B2
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6998772823431657,-1.2789192935991895,0.1702127659574468,0.9848374733733746,1.0,4/13,17.33%,PRPF6;PRPF19;USP4;SRSF10
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.8482070309563375,1.2781624847512754,0.16666666666666666,1.0,1.0,1/5,1.59%,RUNX1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.8545120385959217,-1.2774934863403815,0.20408163265306123,0.9900648464972085,1.0,1/6,1.27%,SIGLEC1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5061797156760264,1.2771263641002473,0.10638297872340426,1.0,1.0,45/165,18.36%,ENPEP;DACH1;LRIG3;LOXL2;FAT4;KANK1;MAGI2;EGFR;SULF1;CCN2;SH2D4A;AIF1L;SNX7;RASAL2;PTPRG;MYO1D;CRB2;DDAH1;PLCE1;THSD7A;CDH13;ADGRL2;PARD3B;LIFR;BCAR1;SH3BP4;EFNB1;ENAH;PRICKLE2;AMOTL2;THSD4;ARHGAP24;TDRD5;ADAMTS13;NEBL;GPRC5A;NFIB;QKI;MAGI1;LGR4;MID1;WWTR1;PROS1;VEGFA;DST
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6466692846744588,1.2771003009540627,0.17391304347826086,1.0,1.0,9/24,16.95%,RALA;NLGN1;GPM6A;NRP1;TENM2;TENM1;FNBP1L;PIK3R1;PLPPR5
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8278250738325178,1.277053743846654,0.13953488372093023,1.0,1.0,2/6,12.12%,SLC22A2;SLC7A2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7145054058335142,-1.2768169090752395,0.1509433962264151,0.9912515007739457,1.0,6/14,24.93%,ENTPD2;AK8;ENTPD5;AK7;ENTPD1;AK1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8598465240849638,-1.2765936079551896,0.19607843137254902,0.9854928801899582,1.0,4/5,12.97%,SORD;CRYL1;XYLB;AKR1A1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8598465240849638,-1.2765936079551896,0.19607843137254902,0.9854928801899582,1.0,4/5,12.97%,SORD;CRYL1;XYLB;AKR1A1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8598465240849638,-1.2765936079551896,0.19607843137254902,0.9854928801899582,1.0,4/5,12.97%,SORD;CRYL1;XYLB;AKR1A1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.732428362692533,-1.2759827504365633,0.20689655172413793,0.9867661291199531,1.0,2/11,12.17%,SERPINE1;CHEK1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.70894961191698,1.2757545001016921,0.1951219512195122,1.0,1.0,3/9,10.00%,SPX;SLC2A5;DDAH1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6902319321099458,1.2757410825420943,0.12244897959183673,1.0,1.0,7/14,22.49%,FGFR2;GLI3;RARB;SALL1;SOX11;PKDCC;NIPBL
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.816113597560522,-1.2755794799670996,0.25,0.986818444057163,1.0,1/6,0.88%,PAH
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7004865391943127,1.2754203096744445,0.22641509433962265,1.0,1.0,4/11,19.56%,CIDEA;BOK;TP53BP2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.8009955218831686,1.2752372442210875,0.18867924528301888,1.0,1.0,2/8,7.61%,ENPP1;ERRFI1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.6332359839527577,1.2748814020383206,0.19047619047619047,1.0,1.0,12/22,17.08%,ZFPM2;SMAD7;ROBO1;SLIT2;TGFBR1;HEY1;ROBO2;BMPR1A;ACVR1;TGFBR3;SOX11;PROX1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7713516430747547,1.2748118720285326,0.29310344827586204,1.0,1.0,6/11,12.80%,VEGFC;NRP1;GAB1;NUS1;VEGFD;PIK3CA
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6435133837538074,-1.2743245283552374,0.1509433962264151,0.990962275510073,1.0,5/25,4.54%,P2RY10;CD5;KLRB1;TRBC2;TRAF3IP3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.5196511086379044,-1.2741212928640975,0.08163265306122448,0.9899464184277467,1.0,15/119,10.51%,AARD;INHA;AMH;TMEM184A;COL6A1;CLU;EPAS1;SELENBP1;DOCK6;RBP4;CRYAB;PRLR;COL18A1;VWA1;BCAR3
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.6612962110438195,1.2730762806997304,0.17777777777777778,1.0,1.0,7/18,20.37%,THRSP;PRKAB2;ACACA;SLC25A20;CPT2;ABCD3;SLC2A1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.7719631522654408,1.2730458650663694,0.20689655172413793,1.0,1.0,3/8,15.67%,SYK;CCL5;PREX1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6251002863070427,1.2723820557495797,0.12962962962962962,1.0,1.0,1/24,0.37%,DACH1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.5469877869495805,1.2722181610028251,0.13333333333333333,1.0,1.0,23/79,15.07%,ESRRG;ATP6V0A4;FRK;ERBB4;ATP6V0D2;CYP4Z1;MUC20;HYDIN;SLC22A6;TMEM213;SLC5A8;BBOX1;SCNN1B;EXPH5;RP1;PROM2;JAG1;PPIL6;ITGB8;DCDC1;PACRG;TMEM150C;AVPR1A
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7996639828198887,-1.2721001503945077,0.1836734693877551,0.9975988739275222,1.0,2/9,2.51%,NMB;CYP19A1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7316917222336746,1.2719090179683614,0.16666666666666666,1.0,1.0,3/11,10.11%,CD8A;KLRD1;JAG1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5636254244048018,1.2716057349265075,0.1276595744680851,1.0,1.0,3/49,4.45%,VAPB;IFI16;NR5A2
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.7130856232033831,-1.270920923781873,0.29508196721311475,1.0,1.0,3/10,10.53%,PAH;DRD1;DRD3
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.6162112089614091,-1.27077459608667,0.17647058823529413,1.0,1.0,3/31,6.35%,FIP1L1;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.6308698928446244,-1.2706297880173136,0.13043478260869565,0.9985583287688271,1.0,9/26,17.82%,CLU;TRIAP1;PRELID1;PINK1;ADCK1;SLC25A5;PSMD10;GPX1;GHITM
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.7238196174822638,-1.270457788959533,0.21428571428571427,0.9972164550355549,1.0,3/18,6.23%,SFRP1;TTC23;TXNDC15
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.7072054346222599,-1.2703628623096996,0.16981132075471697,0.995624859648338,1.0,1/11,1.18%,LCP1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5708860200790185,-1.2693469622692615,0.14,0.9987182066310719,1.0,13/67,7.46%,CLDN4;CD9;CBLC;HEBP2;SH3RF2;ADIRF;EPAS1;DNPH1;DUOXA1;LTBR;GYPC;CLDN1;PKP1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7131642974386724,1.2690217782732096,0.20754716981132076,1.0,1.0,8/14,19.34%,IRS1;FOXO3;SCD;LPL;FOXO1;PID1;GLDC;PDK4
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.8046920129095249,-1.268732024440757,0.19607843137254902,0.9977722440309842,1.0,3/6,15.66%,ACE;DRD3;DRD4
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.8046920129095249,-1.268732024440757,0.19607843137254902,0.9977722440309842,1.0,3/6,15.66%,ACE;DRD3;DRD4
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.7862200562041872,1.2684976536932149,0.22727272727272727,1.0,1.0,3/9,9.43%,SPX;RNLS;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6787761116454775,1.2680753211221616,0.19642857142857142,1.0,1.0,4/14,15.64%,PPARG;ITGAV;NR1H3;ABHD5
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.6412985610850541,1.2678524441278882,0.21739130434782608,1.0,1.0,6/21,10.11%,ROBO1;SLIT2;HEY1;ROBO2;TWIST1;JAG1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6440926827593595,1.2678080347432459,0.13725490196078433,1.0,1.0,5/27,7.37%,IL1RAPL1;NLGN1;NRXN1;GRID2;PTPRD
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.6006278776447238,1.267651364724642,0.08333333333333333,1.0,1.0,9/29,14.55%,ADIPOR2;THRSP;ZBTB20;C3;PRKAB2;ASXL3;ADIPOR1;SORBS1;CREB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7531846865363332,1.2676248071656744,0.21153846153846154,1.0,1.0,1/9,2.85%,SYK
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.7624490801879368,1.2675419854900527,0.22916666666666666,1.0,1.0,1/9,1.29%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.7013216844131527,-1.2672576351009346,0.20754716981132076,1.0,1.0,3/19,8.85%,NCKAP1L;PPP1R15A;PTPA
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5898756337502395,1.2668788505131663,0.16666666666666666,1.0,1.0,8/45,7.37%,ACE2;IL1RAPL1;NLGN1;NRXN1;NRP1;GRID2;CNTNAP2;PTPRD
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.7069387133826127,1.266308518268777,0.23076923076923078,1.0,1.0,4/13,11.59%,NDNF;KCNC2;DDAH1;DDAH2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6817567996766773,1.2661475646350258,0.19230769230769232,1.0,1.0,5/15,16.29%,IRS1;IRS2;TWIST1;ABHD5;AKT2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.629057268431872,-1.265631413870744,0.19230769230769232,1.0,1.0,7/17,21.34%,RRP15;EXOSC10;LAS1L;EXOSC4;EIF6;FTSJ3;NSA2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.6794034773688851,-1.2649907235789177,0.1956521739130435,1.0,1.0,2/11,11.39%,CLU;LRPAP1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.8698057888701031,1.2649699207542464,0.11764705882352941,1.0,1.0,2/5,8.94%,FAS;GLI3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6966054361320602,1.2643339228704886,0.22641509433962265,1.0,1.0,3/17,2.25%,NRG1;OXTR;ERBB4
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7222862607872884,-1.26353395930606,0.2222222222222222,1.0,1.0,1/7,2.21%,AQP8
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7808720945092272,-1.2630636666166206,0.2037037037037037,1.0,1.0,4/8,20.08%,WIZ;INO80;NUGGC;CDC7
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.787898584762079,-1.2627021531677003,0.17857142857142858,1.0,1.0,5/9,20.95%,SIGIRR;PTPRC;APOA1;TLE5;MAPK7
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6311098993213284,1.262572400713782,0.2553191489361702,1.0,1.0,8/28,17.04%,KCNJ3;CHRM3;NEDD4;KCNJ6;P2RX7;AKAP6;KCNJ2;NEDD4L
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6286507447804598,1.2625454796328137,0.1702127659574468,1.0,1.0,4/23,7.54%,CCDC63;PLD6;JAM2;SYCP3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5610108270054776,-1.2623956887623118,0.16666666666666666,1.0,1.0,4/42,4.50%,TERF2IP;CGAS;RAD51AP1;PARPBP
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5550411682905931,-1.2622179846777684,0.14035087719298245,1.0,1.0,5/60,2.84%,EPN1;ISM1;SARS1;SERPINE1;COL4A3
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6064455513335545,1.2621129757452776,0.15217391304347827,1.0,1.0,6/32,8.68%,SLC12A1;SLC12A3;SLC8A1;SNCA;SCNN1B;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.650799640810594,1.2620935412814,0.23404255319148937,1.0,1.0,5/18,13.37%,HMGB1;MFHAS1;TLR1;NR1H3;IFI35
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6174365997441142,1.2618184038851141,0.2,1.0,1.0,7/24,16.63%,ESAM;JAM2;MBP;CLDN12;SLC12A2;DMD;TJP3
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.8421562699374733,-1.261462840515523,0.14583333333333334,1.0,1.0,3/5,14.41%,SBDS;C1QBP;EIF6
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.5897589119595861,1.2609531727271919,0.16666666666666666,1.0,1.0,9/32,17.05%,RUNX1;ZBTB20;HDAC2;CCL5;RAB27A;SORBS1;CREB1;SCX;VIM
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.7800601755587717,1.2602982046620923,0.17307692307692307,1.0,1.0,3/5,21.88%,TWSG1;CD274;CD55
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8079289548911474,-1.2601809156290555,0.15789473684210525,1.0,1.0,4/6,18.58%,HK2;PINK1;TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6820427946032914,-1.2598849343608927,0.22448979591836735,1.0,1.0,3/14,6.63%,DUOX1;TRPC3;RYR1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6595238548863541,1.2592094348402074,0.1509433962264151,1.0,1.0,5/19,18.42%,KANK1;NLGN1;PLEKHM1;ARHGAP24;EPS8
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6808549211897994,-1.2589412172003345,0.1956521739130435,1.0,1.0,1/14,0.56%,SFRP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.627578066740088,1.2589070300956693,0.1956521739130435,1.0,1.0,7/30,13.82%,NKAIN2;NEDD4;FGF12;ATP2B4;P2RX7;NKAIN3;ANK3
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.7307738084003061,1.2583900794854568,0.23255813953488372,1.0,1.0,1/8,4.73%,ROBO1
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.7885590509749052,1.258188295549467,0.2692307692307692,1.0,1.0,3/5,19.96%,CSF1R;IL34;PTK2
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.7885590509749052,1.258188295549467,0.2692307692307692,1.0,1.0,3/5,19.96%,CSF1R;IL34;PTK2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6670968701308823,-1.2578335653199482,0.2222222222222222,1.0,1.0,11/15,31.73%,ATP5F1B;ATP5F1A;ATP5F1D;ATP5MC1;ATP5F1E;ATP5MC2;ATP5PD;ATP5F1C;ATP5PB;VPS9D1;ATP5MC3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.7366943329034039,1.2573843046327693,0.24489795918367346,1.0,1.0,3/12,9.22%,SPHK1;ACER1;ASAH2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.7366943329034039,1.2573843046327693,0.24489795918367346,1.0,1.0,3/12,9.22%,SPHK1;ACER1;ASAH2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.6932489811824183,-1.2572542018523118,0.23404255319148937,1.0,1.0,4/12,18.76%,PTCD2;SAFB;CDK11B;SUPT6H
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.48844156131669214,1.2572203190642102,0.14285714285714285,1.0,1.0,39/182,13.69%,SEMA3C;PLA2G10;EFNA5;GFRA1;SEMA5A;SEMA6D;UNC5C;NRXN1;DSCAM;UNC5D;ROBO1;CNTN4;EPHA3;WNT5A;SLIT2;IRS2;NRP1;NRXN3;GAB1;ROBO2;RYK;DOK6;FRS2;EPHA7;LAMC2;PRKCA;NCAM1;NOTCH3;EPHA8;PTPRM;PSPN;NPTN;NRTN;PIK3CA;EMB;CXCL12;EFNB1;ENAH;LRTM2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.5789670410816024,1.2571888439124297,0.11475409836065574,1.0,1.0,24/57,21.81%,SEMA5A;VEGFC;HMGB1;WNT5A;TGFBR1;NRP1;PRKD1;HIF1A;PRKCA;CDH13;FGFR1;VEGFD;SIRT1;MDK;PROX1;THBS4;PDCL3;VEGFA;ECM1;PDGFB;ARNT;VASH2;AKT3;F3
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.6310142035643531,-1.2568505653954,0.2037037037037037,1.0,1.0,5/22,18.88%,HK2;ENO1;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5495283956946015,1.2561826760983836,0.1590909090909091,1.0,1.0,10/63,15.05%,VAPB;EIF2AK3;REEP1;TOR1AIP2;TRDN;TRAM1L1;LPCAT3;STX18;SMPD4;ALDH3A2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7863428869878045,1.2561442605418205,0.16923076923076924,1.0,1.0,4/6,21.14%,SLC30A10;RELA;ROCK2;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7624610644448341,-1.2560434419738948,0.2127659574468085,1.0,1.0,4/9,13.68%,NLRP3;CD74;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.86847381886239,-1.2550078383507375,0.15384615384615385,1.0,1.0,2/5,7.92%,GHR;PRLR
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.5936346548926419,1.2549066029770615,0.13636363636363635,1.0,1.0,14/80,11.81%,ACE2;PLA2G10;NTF3;PPARG;CSF1;MAGI2;AKR1C1;RAB29;SNCA;CCL5;PDGFRB;ACACA;STARD4;NR1H3
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6415799498263309,1.2547358696753306,0.25,1.0,1.0,8/27,16.69%,SHISA9;MCTP1;GRIK2;ZDHHC2;PPFIA3;NETO1;NCDN;CLN3
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.701352819479175,-1.2539595853786372,0.21153846153846154,1.0,1.0,2/10,5.69%,CACNG5;NPTXR
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.7158411345897769,1.2537340398773216,0.23076923076923078,1.0,1.0,4/12,5.34%,MYBPC3;FGFR2;SMAD7;ADAMTS9
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8251502677302834,-1.2536992297816716,0.20408163265306123,1.0,1.0,2/7,5.93%,B2M;UBC
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8251502677302834,-1.2536992297816716,0.20408163265306123,1.0,1.0,2/7,5.93%,B2M;UBC
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7733271404954833,-1.2536079869526757,0.2653061224489796,1.0,1.0,1/7,2.84%,COL4A3
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7038018502198929,1.2532429397858087,0.20833333333333334,1.0,1.0,8/14,24.99%,ZFP36;ZFP36L2;CPEB3;NANOS1;TNRC6C;ZFP36L1;CNOT7;TOB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7038018502198929,1.2532429397858087,0.20833333333333334,1.0,1.0,8/14,24.99%,ZFP36;ZFP36L2;CPEB3;NANOS1;TNRC6C;ZFP36L1;CNOT7;TOB1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7727861105257663,1.2532402726090468,0.21428571428571427,1.0,1.0,2/8,5.19%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.528344952868079,1.2530724834256604,0.17307692307692307,1.0,1.0,17/120,11.03%,SGK3;SGK2;SPHK1;RIT2;NEDD4;NRG3;GFAP;CHPT1;WNT5A;MLLT3;CD22;LATS1;ABL2;SGK1;SOCS2;PLCE1;CDH13
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.7759502262138748,-1.2529027361167993,0.18,1.0,1.0,2/6,4.37%,ST6GALNAC2;ST6GAL1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6586848950428208,-1.2528840141772508,0.12195121951219512,1.0,1.0,7/21,16.53%,PARP2;TERF2IP;NTHL1;SMUG1;EXOSC4;PARP1;MBD4
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.8039162496388201,-1.2524159350250452,0.2549019607843137,1.0,1.0,2/5,16.02%,SLX4;MUS81
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8100658923192031,1.252348001185847,0.21951219512195122,1.0,1.0,1/5,1.68%,CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7642316633317141,1.2522740750575725,0.2,1.0,1.0,3/9,8.55%,IRS1;IRS2;TWIST1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6241350482712835,1.2520862610554557,0.16666666666666666,1.0,1.0,12/29,18.64%,PARD3;SYNE4;PDCD6IP;DLG2;CRB2;LRRC7;RAP2A;PARD3B;ERBIN;LIN7A;MTCL1;WDR1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7415031058283001,-1.2519059802698538,0.19607843137254902,1.0,1.0,1/8,1.74%,CLU
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.8233658559147875,-1.2517844445472952,0.13333333333333333,1.0,1.0,5/6,17.64%,SPRED3;SPRED2;SPRY1;SPRED1;SPRY2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7214254951816788,-1.2517714716389623,0.22916666666666666,1.0,1.0,3/11,10.86%,PORCN;WIPI1;WIPI2
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8238665016274698,-1.2517576533752421,0.15555555555555556,1.0,1.0,5/5,17.64%,SPRED3;SPRED2;SPRY1;SPRED1;SPRY2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.7756475988697616,-1.2516745308473398,0.2127659574468085,1.0,1.0,3/6,12.01%,DHX58;UFD1;C1QBP
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.7713233658511371,-1.2513969861817127,0.22,1.0,1.0,2/6,10.10%,RAB17;NOS2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7085635609522565,1.2512128215299074,0.16666666666666666,1.0,1.0,9/13,22.05%,SLC8A1;CDH2;CTNNB1;PIK3CA;SLC9A1;DMD;PTK2;CAV3;TCAP
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6078491121765367,1.2512058022495327,0.20408163265306123,1.0,1.0,10/23,20.37%,CX3CR1;RFX3;RGS14;FAIM;PDE3A;SERPINF1;LIG4;SOX11;BAD;TRIM32
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.8347402791587906,1.2506190397730244,0.2222222222222222,1.0,1.0,2/6,8.81%,PTPRD;FRS2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6110294052688083,-1.250500027369388,0.10204081632653061,1.0,1.0,2/27,1.79%,SFRP1;GSTM3
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.8020725552167581,-1.2504960015228634,0.10526315789473684,1.0,1.0,2/8,6.38%,NOG;PAX8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.8020725552167581,-1.2504960015228634,0.10526315789473684,1.0,1.0,2/8,6.38%,NOG;PAX8
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6953329734643545,1.2499137304293215,0.2558139534883721,1.0,1.0,3/11,7.84%,B4GALNT2;CSGALNACT1;GMDS
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6739076602415845,-1.2497337220014655,0.11627906976744186,1.0,1.0,6/18,15.99%,ERCC1;RBX1;GTF2H2;DDB1;PARP1;ERCC2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6739076602415845,-1.2497337220014655,0.11627906976744186,1.0,1.0,6/18,15.99%,ERCC1;RBX1;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6578789973461042,1.2496100418108051,0.2127659574468085,1.0,1.0,6/21,18.61%,LEPR;PPARGC1A;ACSM1;ACADVL;PID1;COX10
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8230227689643914,1.2494932274430295,0.21739130434782608,1.0,1.0,3/5,16.29%,DOC2B;SNCA;AKT2
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.689292604947246,1.2493189310530275,0.21428571428571427,1.0,1.0,2/16,6.67%,IFI16;XAF1
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5217452816313719,1.2487060034655189,0.10638297872340426,1.0,1.0,10/93,6.25%,TEX101;SPAG6;GCNA;PRNT;ASB17;CREB5;EGFR;DMC1;FAM229A;UBE3D
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.69753789314425,1.2486120101877582,0.2653061224489796,1.0,1.0,2/12,12.25%,ATP2B4;SIRT1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.7112192575793497,-1.2485387750614911,0.16666666666666666,1.0,1.0,2/13,1.31%,SFRP1;ATRAID
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.5462241103063112,-1.2482631668926216,0.12244897959183673,1.0,1.0,13/66,13.51%,PLK4;PLK3;AURKA;CXCR5;PLK5;KIF20B;GIPC1;CALM1;PLK2;CETN2;DRD3;ANKRD53;PIN1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.7029885703627419,-1.2477388588914997,0.21568627450980393,1.0,1.0,2/14,6.81%,NUPR1;PGP
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5919842705455666,1.2476647563949113,0.2,1.0,1.0,6/39,8.60%,MARVELD3;ESAM;FRMPD2;PARD3;ECT2;PDCD6IP
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.8199559157755049,1.2476226487866386,0.13043478260869565,1.0,1.0,1/6,4.23%,S100A13
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.8203969773438256,-1.246076441421183,0.2608695652173913,1.0,1.0,1/5,3.93%,ETS1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7646517865927156,1.2459830617620542,0.25,1.0,1.0,2/8,4.17%,KLF2;SMAD7
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.8745415886490473,1.2454080690480718,0.12244897959183673,1.0,1.0,1/5,4.57%,DSCAM
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.5659637866004129,-1.2453124323943998,0.1875,1.0,1.0,2/40,1.18%,PLK4;LCP1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5749448893283948,-1.2446437919377982,0.2413793103448276,1.0,1.0,12/62,15.60%,GOLGA8B;ABRAXAS1;GOLGA2;HAUS8;TUBGCP5;TUBGCP2;GOLGA8A;WRAP73;TOGARAM2;GOLGA8N;INO80;GOLGA8M
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8697975490254419,-1.2445307377485897,0.2222222222222222,1.0,1.0,1/5,0.69%,CD9
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6773336930945403,-1.2443722252546483,0.1836734693877551,1.0,1.0,6/14,17.82%,CLU;TRIAP1;PRELID1;PSMD10;GPX1;GHITM
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.7751732557306102,1.2439630799944925,0.23529411764705882,1.0,1.0,1/6,9.96%,CDO1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6342166099753482,-1.24391538795773,0.2222222222222222,1.0,1.0,10/25,21.49%,GTF2F1;POLR2I;POLR2J;SUPT5H;CCNT1;POLR2G;POLR2C;NELFA;POLR2L;POLR2K
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.7745845853782082,1.2437524297632168,0.15555555555555556,1.0,1.0,1/8,2.85%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.7745845853782082,1.2437524297632168,0.15555555555555556,1.0,1.0,1/8,2.85%,SYK
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.7758709349398898,-1.243160623702725,0.18,1.0,1.0,1/5,2.90%,RAC1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5614829744700223,1.2423493831343595,0.15555555555555556,1.0,1.0,16/46,16.09%,PLCB1;IRS1;IRS2;CSF1R;PLCL1;PLCE1;PDGFRB;PIK3C2G;IGF1R;PIK3C2B;FGFR1;PLCB4;PTAFR;PIK3CA;OGT;PIK3R1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5619749736599984,-1.2423390958006255,0.12280701754385964,1.0,1.0,17/44,21.60%,SPG7;MICOS13;MTX1;ATP5F1B;DNAJC11;ATP5F1A;ATP5F1D;TMEM11;AFG3L2;TIMM29;GHITM;ATP5MC1;ATP5F1E;APOO;ATP5MC2;ATP5PD;TIMM13
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.53643083437284,1.2422162541159587,0.14583333333333334,1.0,1.0,20/64,18.96%,IL1RAPL1;CX3CR1;ROBO1;SLIT2;ROBO2;PTPRD;RGS14;SMARCD3;FAIM;NPTN;CTNNB1;SERPINF1;LIG4;TIAM2;CAPRIN1;DISC1;SOX11;CUL7;VEGFA;PLXNB2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.8079079792882229,1.2418682711729518,0.21428571428571427,1.0,1.0,3/6,15.93%,PPP3CA;MSTN;EYS
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7564895199922518,-1.2416637789384866,0.1896551724137931,1.0,1.0,1/11,0.69%,CD9
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6277085524702224,1.2416347834820571,0.1956521739130435,1.0,1.0,9/24,20.74%,CSGALNACT1;CHSY3;CHSY1;CHST7;UGDH;CSGALNACT2;CHST11;CHST15;VCAN
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6410556596829425,1.241597290624115,0.21739130434782608,1.0,1.0,8/23,12.40%,ENPP1;MOSMO;GLIS2;KCTD21;TULP3;GLI3;BTRC;KCTD6
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.558429924653534,1.241551052184836,0.12244897959183673,1.0,1.0,21/67,16.86%,MARVELD3;CADM2;CDH8;NECTIN3;CDH18;CDH20;PKHD1;CSF1R;CDH10;NLGN4X;CDH2;CDH6;CADM1;CDH13;GJC1;SMAD3;CTNND2;MARVELD2;PARD6B;TJP3;AFDN
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7093314119724721,1.241314700096149,0.2682926829268293,1.0,1.0,3/14,3.80%,SULT2A1;ENPP1;SULT2B1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.6274041794821938,-1.2410130206774233,0.16666666666666666,1.0,1.0,4/39,5.52%,CBLC;SPRY4;UCHL1;SPRY1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6514025255700893,-1.2409719687342378,0.23684210526315788,1.0,1.0,2/19,1.07%,NCKAP1L;TNFSF18
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.6288593221833769,1.2405953903271858,0.18518518518518517,1.0,1.0,4/19,15.05%,SLC22A2;SLC6A13;SH3BP4;SLC25A38
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.8255364602122093,1.24046408807364,0.2727272727272727,1.0,1.0,2/6,9.12%,SPX;RNLS
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.7912398586019772,-1.2404305218485803,0.2553191489361702,1.0,1.0,1/6,0.84%,DYSF
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7677037459336618,1.2401630603662668,0.24074074074074073,1.0,1.0,4/8,17.97%,PPP3CA;NFATC2;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7677037459336618,1.2401630603662668,0.24074074074074073,1.0,1.0,4/8,17.97%,PPP3CA;NFATC2;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6222386018538593,1.2399154129279502,0.21428571428571427,1.0,1.0,3/46,2.85%,NLRP2B;SPHK1;SYK
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5730440073166805,-1.239706959277727,0.14583333333333334,1.0,1.0,10/56,8.84%,SPDEF;CLDN4;CD9;CBLC;TMEM184A;CD74;CEBPD;CLDN1;BTC;BTG1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.7573257925019277,-1.2394714683937098,0.15789473684210525,1.0,1.0,1/9,0.69%,CD9
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5067548763714702,1.2393791548703543,0.11627906976744186,1.0,1.0,31/114,10.88%,NDNF;PDZRN4;CADM2;LSAMP;SEMA6D;OLFM3;MAGI2;NRXN1;ADGRB3;UNC5D;CNTN4;SULF1;KCTD16;ZNF385D;GMPPA;FGF14;PDZRN3;ROBO2;GRIA4;PTPRD;HFM1;NREP;RAB3C;PRKG1;PCSK2;RSPO2;FGF10;RAB27A;NOVA1;RBFOX1;ASXL3
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.758360110671324,1.2390047658229657,0.2037037037037037,1.0,1.0,4/9,15.00%,SYK;ADAM8;PRKCA;PLEKHM1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6628743464623841,1.2389046000961577,0.22413793103448276,1.0,1.0,2/22,1.67%,NOX5;ATP6V0A4
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.807153887486084,1.2386538666965055,0.17142857142857143,1.0,1.0,2/5,10.95%,CDK6;DLL1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.7872389922894067,-1.2386288233107696,0.2826086956521739,1.0,1.0,1/6,2.94%,STX1B
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),0.8263332074760744,1.2385598153612662,0.2033898305084746,1.0,1.0,1/5,5.20%,SULF1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.6730386778503028,1.2383731047826352,0.18,1.0,1.0,1/13,1.32%,SPHK1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.6579323856855416,1.238233338741783,0.23076923076923078,1.0,1.0,5/16,19.14%,CHMP6;CEP55;PDCD6IP;CHMP1A;CNTROB
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5872763741891324,1.237875105754989,0.24324324324324326,1.0,1.0,6/23,11.29%,SLC8A1;CACNB2;MICU1;MCU;TRPC4;MAIP1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.6025884340754493,1.2378175868156054,0.16666666666666666,1.0,1.0,4/32,5.96%,SEMA3C;SEMA5A;SEMA6D;NRP1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7804470688596842,1.2376878948352905,0.22916666666666666,1.0,1.0,4/9,18.04%,HEY1;PDE2A;SALL1;TMEM65
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.543408092299555,-1.2373996465627926,0.18181818181818182,1.0,1.0,8/68,9.29%,CBLC;SPRY4;UCHL1;GADD45A;SPRY1;LATS2;INCA1;RGS2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.4715312501303365,-1.2371297175923401,0.12244897959183673,1.0,1.0,54/233,18.58%,SNRNP27;FIP1L1;DDX41;ZCRB1;GTF2F1;RBM4;RBM8A;POLR2I;CWC25;UPF3B;CPSF1;RNF113A;PRPF6;SYF2;CPSF4;POLR2J;LSM7;DNAJC8;SF3A2;PDCD7;DHX16;WBP4;PRPF19;NONO;SF3B2;MFAP1;RBM19;SF3A1;RNPC3;ZRSR2;METTL3;GPATCH1;PRPF4;CPSF3;SNIP1;SNW1;RBM22;POLR2G;HNRNPL;POLR2C;SRSF7;DHX8;RBM4B;RBMX2;SF3B6;PRCC;DHX38;RBMX;SRSF10;HNRNPH2;EFTUD2;IK;HNRNPM;PPIL3
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.5570310237629837,-1.2370782387128667,0.19298245614035087,1.0,1.0,9/71,11.47%,STING1;DDX11;DTX3L;B2M;STMN1;HMGB2;KDM4D;TXN;MET
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.6377146455727647,1.2369480151998025,0.20454545454545456,1.0,1.0,4/20,11.08%,TGFBR1;HEY1;SMAD2;WNT8A
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7039233753183789,-1.236610944134793,0.2,1.0,1.0,5/7,28.40%,PIK3CB;SPRY2;IL12A;DAB2IP;CADM4
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6776517185218459,1.2366022536252663,0.18867924528301888,1.0,1.0,3/13,13.40%,KLRD1;CADM1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6776517185218459,1.2366022536252663,0.18867924528301888,1.0,1.0,3/13,13.40%,KLRD1;CADM1;CD160
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5164947454042159,1.2363003193945155,0.14,1.0,1.0,26/109,11.98%,LTK;FZD1;NDNF;RIT2;IL1RAPL1;MAGI2;ROBO1;ROR1;EPHA3;WNT5A;SLIT2;ZNF804A;GRIP1;ROBO2;PTPRD;PRKD1;STYXL1;TOX;DVL2;ABL2;FUT9;RETREG3;PROM2;LRRC7;TENM3;NPTN
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7142171281357172,1.2359940654190888,0.2545454545454545,1.0,1.0,2/8,3.04%,NDNF;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7026563821272998,1.2359173650884259,0.20689655172413793,1.0,1.0,3/15,9.04%,WNT5A;GRIP1;DVL2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5484321409640148,-1.2357910348024346,0.15,1.0,1.0,25/52,21.32%,AURKA;PSMA7;PSMD7;SKP1;PSMB4;RBX1;PSMC3;RFPL1;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;MACROH2A1;GPR132;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.6429692844957101,1.2356518999501123,0.20754716981132076,1.0,1.0,11/26,18.21%,ZFPM2;ENPP1;WNT5A;RORA;FOXO1;ZFP36L2;SIRT1;SMAD3;RUNX1T1;ASXL1;WWTR1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7226265791889351,1.2354396401459224,0.25862068965517243,1.0,1.0,4/9,11.08%,NRP1;ZSWIM6;ZSWIM5;ZSWIM8
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.7548204170362283,1.2350945498361108,0.2926829268292683,1.0,1.0,3/7,13.17%,JAM2;CCL5;CXCL12
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.5993204860513529,-1.2347921247222977,0.17307692307692307,1.0,1.0,8/35,11.46%,NCKAP1L;LCP1;RAC1;RND3;LLGL2;RND2;RHOBTB1;RHOBTB2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.7077259079784592,1.2346319066451037,0.25,1.0,1.0,3/11,20.79%,ESPL1;NSMCE2;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.7077259079784592,1.2346319066451037,0.25,1.0,1.0,3/11,20.79%,ESPL1;NSMCE2;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.7077259079784592,1.2346319066451037,0.25,1.0,1.0,3/11,20.79%,ESPL1;NSMCE2;CUL3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.6573327142620315,-1.2341705681948651,0.24074074074074073,1.0,1.0,4/12,20.64%,OAS2;STAT1;CANX;STAT3
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7986853310541635,-1.2340239828258905,0.21951219512195122,1.0,1.0,3/6,16.04%,LDB1;NUP133;NUP155
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.7434803576587501,-1.2336577205868382,0.2857142857142857,1.0,1.0,4/10,22.03%,STX4;RANGRF;MAP1A;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.5953681709460762,-1.233416338286427,0.21818181818181817,1.0,1.0,9/34,7.44%,CBLC;DUOX1;AZGP1;CYP2B7P;DUOXA1;SCGB1A1;ZBTB7C;MYH14;C11ORF97
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.6992009439828156,1.2330501749930791,0.2,1.0,1.0,4/13,17.47%,HS3ST5;TRIM22;TRIML2;TRIM5
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7783167423613138,-1.2330441923168889,0.23255813953488372,1.0,1.0,5/9,18.05%,H1-4;H1-0;CTCF;SMARCA5;H1-2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.7826585964773034,-1.2329829727532822,0.2549019607843137,1.0,1.0,1/6,9.09%,RNF213
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.6094715136434583,-1.2328754695680886,0.22448979591836735,1.0,1.0,1/44,0.07%,PM20D1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.6436637382830845,-1.2327613378444895,0.23529411764705882,1.0,1.0,5/21,18.88%,HK2;ENO1;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.6436637382830845,-1.2327613378444895,0.23529411764705882,1.0,1.0,5/21,18.88%,HK2;ENO1;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6731747703887629,-1.2324265265946845,0.1282051282051282,1.0,1.0,3/12,6.19%,NUPR1;CLU;MBTPS2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.5646265534377505,1.2320221645308962,0.15555555555555556,1.0,1.0,5/41,7.68%,PRSS57;HEMGN;TOR2A;B9D2;FAM117A
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.73288432952938,1.2317488746601732,0.16666666666666666,1.0,1.0,4/15,12.56%,KLKB1;BAG2;ADAM8;LPCAT3
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.6107434417518322,1.231711733869798,0.17647058823529413,1.0,1.0,4/30,15.02%,SULT2A1;SULT2B1;LCAT;IDH1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6934786435476075,-1.231550783814544,0.19298245614035087,1.0,1.0,1/13,2.48%,APOD
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5706586541580231,1.2311110608223494,0.13333333333333333,1.0,1.0,8/40,12.87%,ACE2;CORIN;SLC8A1;ATP2B4;NPR2;ITPR1;TRDN;ANK2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.7144110994335924,1.2309247850179414,0.25,1.0,1.0,2/13,9.19%,NLRP2B;ZNF675
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.7486779656573016,-1.2306133370698946,0.3114754098360656,1.0,1.0,2/6,10.53%,NOG;DRD3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6519649062923228,1.2301775353682751,0.1836734693877551,1.0,1.0,3/21,5.96%,SEMA5A;DSCAM;NRP1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.8040697725575202,-1.2294666067573632,0.25,1.0,1.0,3/7,15.57%,TOM1L1;CHEK1;BMP7
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.8221377979832799,1.229194057792772,0.26666666666666666,1.0,1.0,1/5,4.17%,SMAD7
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5354715952956154,1.2288496386373238,0.14583333333333334,1.0,1.0,30/109,16.57%,SEMA3C;HS6ST3;CADM2;NKAIN2;KCNC2;LRRTM3;OLFM3;ADGRB3;GFAP;NXPH1;KCTD16;GRM5;CA10;LRFN5;HMGCLL1;SH3GL2;SYNPR;RBFOX1;ASIC2;ANK2;ZNF536;PPFIA2;RGS7BP;LRRC3B;GRIA2;CTNND2;PVALB;GADD45B;MAP2;MAPK4
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5582259351058194,1.228795029995211,0.22916666666666666,1.0,1.0,28/91,17.42%,GPC6;FIGN;PRTG;SERTAD4;CNN3;SLIT2;PTPRG;GLI3;CDR2L;GLRB;CDH2;DDAH1;IL17RD;FLNC;ZFHX4;ADGRL2;TENM3;LRP4;TRAM1L1;LIFR;BCAR1;TUSC3;ENAH;AMOTL2;MEIS3;SALL1;MAGI1;MID1
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.7852819645616563,-1.2286940260050774,0.2923076923076923,1.0,1.0,1/7,0.51%,DUSP4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6027851760097266,1.2284969281472253,0.19230769230769232,1.0,1.0,1/25,0.43%,SKA3
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5703609175581903,-1.2284171116317142,0.18,1.0,1.0,9/33,16.94%,ENTPD2;RNASET2;DNASE1L1;NUDT16;NUDT18;NUDT1;SUPV3L1;PABPC4;ENTPD5
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6160196509736102,1.2283964917231964,0.2916666666666667,1.0,1.0,7/27,16.29%,IRS1;ENPP1;IRS2;SORBS1;PID1;PIK3R1;AKT2
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.730346666456798,-1.2280347316119382,0.28846153846153844,1.0,1.0,2/7,6.56%,PLK5;SPI1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.8032597290572081,1.227954675916231,0.24,1.0,1.0,3/6,12.30%,PARD3;PKHD1;PARD3B
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7687221472006005,1.227946397744489,0.2549019607843137,1.0,1.0,1/5,5.61%,RPS6KA4
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.5870328616707255,1.227814786509885,0.14814814814814814,1.0,1.0,8/25,22.49%,FGFR2;GLI3;COBL;NPY;RARB;SALL1;PKDCC;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.5634610509584141,-1.2277909852235234,0.1896551724137931,1.0,1.0,5/32,10.53%,SFRP1;CCN3;ADRA2A;MIDN;DRD3
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.732500385279655,-1.2276884813386837,0.2391304347826087,1.0,1.0,1/9,1.93%,HK2
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5466446119042605,1.2276532472834583,0.1590909090909091,1.0,1.0,11/56,10.95%,SLC12A1;GABRR1;GABRB1;SLC12A3;GABRG3;GLRA2;GABRB2;ANO7;GLRB;SLC37A4;GABRA4
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.8034664654530435,1.2271151114506815,0.22,1.0,1.0,2/6,9.01%,SULF1;EIF2AK3
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6924643507252589,1.227077155661707,0.22916666666666666,1.0,1.0,4/15,13.99%,SPHK1;ACER1;ASAH2;QDPR
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.6806755172416814,-1.226630550996341,0.28205128205128205,1.0,1.0,4/24,8.80%,NCKAP1L;FGL1;IL4I1;GLMN
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.8195666286717335,1.2265016487245666,0.16,1.0,1.0,1/5,4.20%,IMMP2L
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.6320423911342364,1.22622943623555,0.2549019607843137,1.0,1.0,3/13,11.39%,NR5A2;SCEL;FGFR1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.6093534668446207,1.2261863076197543,0.26,1.0,1.0,2/15,8.44%,CHRNA10;CHRNB4
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8016579105801974,1.2258305112102774,0.22448979591836735,1.0,1.0,2/5,11.39%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7545453932430819,1.2256695743436465,0.27450980392156865,1.0,1.0,5/8,22.57%,NEDD4;COMMD1;NEDD4L;HECW2;CAMK2D
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.6878965943604358,1.2256224244332905,0.21052631578947367,1.0,1.0,4/18,5.99%,IFI16;PPARG;BATF3;CSF1R
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5737511630274377,-1.2256199490712172,0.23255813953488372,1.0,1.0,3/26,7.84%,SFRP1;NODAL;FOXP1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.4634446718552977,-1.2250304645358925,0.08695652173913043,1.0,1.0,12/204,7.42%,EPN1;TLCD2;RTP5;SUN3;DYSF;NEMP1;SPAG4;M6PR;CD4;UBC;LEMD2;MYADM
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7545194550036889,1.2249476061563278,0.2916666666666667,1.0,1.0,3/8,8.59%,NFIL3;PBX1;TOX
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.5972865894767527,-1.2246537833449855,0.24444444444444444,1.0,1.0,1/37,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.763233740105663,-1.2246532897607303,0.2727272727272727,1.0,1.0,1/5,11.39%,LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.7973162724824525,1.2242383968013153,0.24074074074074073,1.0,1.0,3/6,18.34%,PRKD1;MAPK8;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7515177685618495,-1.224191679720065,0.16666666666666666,1.0,1.0,5/9,21.02%,TRIAP1;PRELID1;DBI;APOA1;ABCB4
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.8130271272234657,-1.2238843835688296,0.32653061224489793,1.0,1.0,1/5,6.05%,BEX4
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.8266761927904756,-1.223734845305257,0.21739130434782608,1.0,1.0,1/5,3.79%,FABP5
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.6768751805340615,-1.223598178757971,0.3181818181818182,1.0,1.0,2/17,6.78%,DDX11;DAXX
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7678723144410071,1.2233167675218861,0.22641509433962265,1.0,1.0,5/7,18.34%,NRP1;RYK;NCAM1;NFIB;VEGFA
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.7906061271385049,-1.2233065116871058,0.1875,1.0,1.0,1/7,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6735879944412313,-1.2232894281299216,0.23529411764705882,1.0,1.0,6/18,18.28%,INHA;ANKLE2;CDKN2B;PRKRIP1;BMP7;CDKN1C
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.7331839293473056,-1.2230622523082473,0.25925925925925924,1.0,1.0,4/7,25.37%,SECISBP2;SEPSECS;EEFSEC;DIO2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.7331839293473056,-1.2230622523082473,0.25925925925925924,1.0,1.0,4/7,25.37%,SECISBP2;SEPSECS;EEFSEC;DIO2
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.7541653370054482,-1.2226638866363575,0.2692307692307692,1.0,1.0,4/9,21.91%,WIZ;INO80;CDC7;E2F7
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.785798335950303,1.2226471250980722,0.24074074074074073,1.0,1.0,1/7,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.4759293477154512,1.2222654474528005,0.22727272727272727,1.0,1.0,42/218,16.14%,SLC12A1;NOX5;KCND2;ATP6V0A4;KCNH7;KCNC2;TRPV2;KCNQ5;KCNS3;SLC12A3;SLC30A8;SLC6A13;HCN1;SLC8A1;LRRC38;ATP2B4;KCNK1;KCNG3;SLC30A10;SCNN1B;SLC39A8;TRPC4;ATP12A;KCNB2;ITGAV;ASIC4;TRPM6;SLC4A4;P2RX7;ASIC2;SLC40A1;SCNN1D;SLC24A2;KCNN1;KCNV1;SLC9A1;KCNG1;KCNJ2;KCNA5;KCNK9;SLC6A4;SLC12A2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6538511576939613,1.2221331479252902,0.30434782608695654,1.0,1.0,8/16,18.84%,NRP1;RGS14;FER;PDGFRB;PDGFD;BCAR1;PLAT;PDGFB
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.758976731337769,1.2218890713449602,0.2037037037037037,1.0,1.0,1/5,12.87%,DCP1B
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7596295391558645,1.2217943203975914,0.21666666666666667,1.0,1.0,2/5,13.82%,CNTNAP2;ANK3
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.7710409938878398,-1.2217923287268067,0.23076923076923078,1.0,1.0,1/6,0.67%,NLRP1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6415413368993695,1.2212130851013323,0.20454545454545456,1.0,1.0,4/18,10.99%,PLCB1;CHRM3;CHRM2;GNAQ
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.8445150770735285,-1.2211465270336535,0.21153846153846154,1.0,1.0,1/5,0.56%,SFRP1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6857684951856803,-1.2209479976143933,0.23076923076923078,1.0,1.0,4/12,14.15%,AHI1;TRAF3IP1;ACTB;FUZ
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.4945919323772589,-1.2208711610606386,0.1875,1.0,1.0,4/71,6.78%,PM20D1;CLU;CDK5;DAXX
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.6645315244657969,1.2204573920271267,0.32,1.0,1.0,3/12,14.20%,NR3C2;NR3C1;PLPP1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.5667700324643447,-1.220415450759572,0.2549019607843137,1.0,1.0,12/40,15.57%,AURKA;ANAPC15;KIF20B;FBXO43;BTC;DRD3;TOM1L1;CHEK1;PIN1;EREG;CUL9;BMP7
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.46313324415110596,-1.220183875380866,0.08888888888888889,1.0,1.0,56/256,18.61%,SNRNP27;FIP1L1;DDX41;ZCRB1;GTF2F1;RBM4;RBM8A;POLR2I;CWC25;UPF3B;CPSF1;RNF113A;PRPF6;SYF2;CPSF4;POLR2J;LSM7;DNAJC8;SF3A2;PDCD7;DHX16;WBP4;PRPF19;NONO;SF3B2;MFAP1;RBM19;SF3A1;RNPC3;ZRSR2;METTL3;GPATCH1;PRPF4;CPSF3;SNIP1;SNW1;GEMIN4;RBM22;POLR2G;HNRNPL;POLR2C;SRSF7;DHX8;RBM4B;RBMX2;SF3B6;PRCC;DHX38;RBMX;SRSF10;HNRNPH2;EFTUD2;IK;HNRNPM;PPIL3;PRMT7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6314662194469557,-1.2199385510150378,0.2692307692307692,1.0,1.0,2/19,0.52%,NCKAP1L;HLA-DPB1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6492838401106,1.2199153951625228,0.2641509433962264,1.0,1.0,2/13,3.69%,BCO1;AKR1C1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.54065113707906,1.2199080722804043,0.1702127659574468,1.0,1.0,19/124,8.46%,LTK;HEMGN;RUNX1;NTF3;NLGN1;FGFR2;CSF1;SMAD7;MOSMO;TRPS1;EPHA3;CCN2;TGFBR1;RUNX2;HEY1;MEGF10;NREP;CDK6;NR1D2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.6576070341625532,-1.2195507905092038,0.23809523809523808,1.0,1.0,1/14,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.7835851383878276,-1.2195099153464393,0.2,1.0,1.0,1/5,7.86%,KCNE3
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.4711345747347782,-1.219400331090226,0.11538461538461539,1.0,1.0,59/189,23.29%,SARS1;TRPT1;SBDS;UTP11;INTS5;DDX27;PDCD11;EXOSC10;RPLP1;NOP14;RPL28;NOP56;RPL37A;RPL34;LAS1L;NOLC1;RPS15;RPL4;POP7;RPL12;RPL31;RPL8;METTL3;MRTO4;POP1;RPL19;RPS27;RPL23;EXOSC4;NVL;RPL7A;RPL29;NOB1;POP5;RPS24;EMG1;RPL5;MPHOSPH10;RRP1B;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;DDX54;DGCR8;NOL8;RPL35A;RPL11;RPL10A;FBL;RPL18;RPS14;LYAR;WDR46;PELP1;RPS2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.628311746109273,1.218708394795441,0.2222222222222222,1.0,1.0,5/24,10.21%,PLCB1;UBE2E2;EGFR;ANKRD17;FGF10
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5310401759676621,1.2186482734728252,0.14,1.0,1.0,16/69,17.27%,MARVELD3;PKHD1;GRM5;SNCA;FBLIM1;CBLN1;NLGN4X;FLNC;LRP4;PPFIA3;PPFIA2;SMAD3;CTNND2;MARVELD2;TJP3;VMP1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7256377636758602,1.2179746079850329,0.23255813953488372,1.0,1.0,5/8,21.96%,CASS4;MCU;BCAR1;DMTN;EFS
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7911808981364851,-1.2179461615376488,0.28846153846153844,1.0,1.0,2/5,10.95%,SF3A2;SF3A1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6261022837611266,1.2179199415627198,0.22,1.0,1.0,7/19,26.06%,AHCY;MSRA;CDO1;MPST;SMS;ADI1;GCLC
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.6237189669055623,1.2178921147535144,0.17777777777777778,1.0,1.0,9/27,22.28%,PRELP;B4GALT1;CHST6;GLB1;B3GNT2;HEXB;GNS;ST3GAL6;ST3GAL4
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.8073299285532562,-1.2177225648421584,0.3220338983050847,1.0,1.0,4/5,19.08%,SERPINE1;SERPINF2;THBS1;USF1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.7142202043727626,-1.2176472768071125,0.20833333333333334,1.0,1.0,2/12,6.78%,TERF2IP;DAXX
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8074782181684594,1.2176013908763332,0.28888888888888886,1.0,1.0,2/5,10.27%,SLC39A12;SLC39A8
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.7073466389441477,1.2174012188065575,0.22807017543859648,1.0,1.0,3/13,11.81%,PPARG;LPL;NR1H3
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.6769459104899134,-1.217173697695226,0.2391304347826087,1.0,1.0,6/15,17.26%,NCL;RBM3;CELF3;CIRBP;SNW1;RBMX
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.8097025071934169,-1.2168974006045712,0.18181818181818182,1.0,1.0,1/5,2.62%,SERPINE1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.8003360475208411,-1.2168546306299988,0.23404255319148937,1.0,1.0,2/5,6.83%,WNT7B;DACT2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7124290028044454,1.216551006339072,0.3181818181818182,1.0,1.0,4/8,23.27%,GRIA2;CPEB4;CLN3;GRIN3A
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),-0.7597287278164451,-1.2164230670193783,0.2962962962962963,1.0,1.0,3/6,17.05%,KIF4A;KIF23;KIF4B
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),-0.7597287278164451,-1.2164230670193783,0.2962962962962963,1.0,1.0,3/6,17.05%,KIF4A;KIF23;KIF4B
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5052714300929305,-1.2163606592045104,0.24074074074074073,1.0,1.0,22/98,15.99%,UVSSA;XPC;POLR2I;SLX4;ERCC1;UBC;XRCC1;FANCC;POLR2J;RBX1;GTF2H2;COPS6;PRPF19;CETN2;DDB1;HUS1;POLL;COPS7A;POLR2G;POLR2C;PARP1;ERCC2
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.7138696351019005,1.2163503385278591,0.32,1.0,1.0,2/8,15.75%,SNCA;VAMP8
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.7889888506136477,-1.2161567382113039,0.2807017543859649,1.0,1.0,2/6,17.64%,CD4;CTSL
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.7889888506136477,-1.2161567382113039,0.2807017543859649,1.0,1.0,2/6,17.64%,CD4;CTSL
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7414046879069565,1.2160805077048766,0.2558139534883721,1.0,1.0,1/6,2.71%,PPARG
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.8037147232364853,-1.2158187379026877,0.29310344827586204,1.0,1.0,2/5,8.93%,KIF17;KIF5A
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.8037147232364853,-1.2158187379026877,0.29310344827586204,1.0,1.0,2/5,8.93%,KIF17;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6460819294432538,1.2156739030292325,0.1836734693877551,1.0,1.0,7/17,19.96%,CSF1;CSF1R;CCL5;MSTN;MDK;IL34;PTK2
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.66033463790628,-1.2154139265436323,0.23529411764705882,1.0,1.0,1/11,0.98%,APOBEC3H
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.8406744802543128,1.2150554109372047,0.1836734693877551,1.0,1.0,4/5,12.08%,RUNX1;HMGB1;GLI3;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5713607693748266,-1.2148789974302525,0.23076923076923078,1.0,1.0,7/26,17.71%,HPS4;PDCD5;ARIH2;PINK1;TOMM7;VPS11;FZD5
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.6049242207140307,-1.2143237622172374,0.21818181818181817,1.0,1.0,7/31,15.12%,NCKAP1L;C2;RAB31;PTPRC;AZU1;APOA1;MYO18A
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7617370228371361,-1.2143141793086185,0.27450980392156865,1.0,1.0,1/6,0.67%,BUD23
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5727177918617861,-1.2142218348785696,0.2,1.0,1.0,10/58,11.24%,SYTL1;PSD4;TMEM184A;UPK1B;TMCO4;LLGL2;SLC14A1;TNK1;RASSF7;EPHA1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.8198051004079803,-1.213414081403999,0.2807017543859649,1.0,1.0,2/5,16.39%,POLR3H;BRF1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6792775319779959,1.2133955188388232,0.25,1.0,1.0,6/15,16.14%,SLC23A1;ABCC2;SLC1A2;SLC26A6;ABCG2;SLC12A2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.7681677551004299,-1.213390573476619,0.2553191489361702,1.0,1.0,1/7,0.88%,PAH
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6635768358291637,1.2132467742691149,0.17543859649122806,1.0,1.0,1/15,1.59%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.7505426604841536,1.2132422547068804,0.28,1.0,1.0,3/7,19.38%,CCL5;ANK3;DMTN
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7648396277839957,1.2131572558414725,0.23076923076923078,1.0,1.0,4/7,14.78%,CRB2;SMAD2;TBX19;SCX
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.6966983852104406,1.2129123223869978,0.20408163265306123,1.0,1.0,7/10,25.41%,GABRG3;GABRB2;GABRA4;GABRA2;GABRG1;GABRA5;GABRG2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.7482857623882857,-1.212892962270614,0.21568627450980393,1.0,1.0,3/8,14.63%,SERPINE1;CYP1B1;SNAI2
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.7913867061067219,-1.2124837690787749,0.2909090909090909,1.0,1.0,3/5,11.11%,TRIAP1;PRELID1;DBI
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.633380398091523,1.212431205583531,0.21739130434782608,1.0,1.0,7/23,17.21%,IRS1;IRS2;C3;SORBS1;PIK3R1;AKT2;BRAF
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6416613093336433,1.21232045452883,0.19230769230769232,1.0,1.0,6/17,18.03%,DGAT2;SCD;ACSL4;ACACA;FASN;SLC25A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.6895328940607114,1.212079971562641,0.288135593220339,1.0,1.0,1/11,0.73%,SSC5D
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7953790380077326,1.21175278799587,0.2727272727272727,1.0,1.0,2/5,14.77%,TGFBR1;ACVR1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7039011920774866,-1.211551228976052,0.25806451612903225,1.0,1.0,2/11,5.93%,TNFSF18;BTN3A1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8135811556490236,1.2114803639515281,0.24390243902439024,1.0,1.0,3/6,11.39%,FGFR2;FGFR3;FGFR1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5805178031774721,1.2114357090235583,0.2807017543859649,1.0,1.0,6/35,4.79%,ACE2;SLC26A3;BCO1;GOLT1A;HNF4G;TOX3
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.6566214135331137,-1.2109366729617217,0.26666666666666666,1.0,1.0,5/18,20.79%,CYP19A1;CYP21A2;TSPO;SRD5A1;HSD17B14
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.6175647071964213,1.2102226728301855,0.2857142857142857,1.0,1.0,10/30,18.25%,NEDD4;IL1RAPL1;ADGRB3;TNIK;PTPRD;RAP2A;CAPRIN1;NEDD4L;CUL7;HECW2
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.7543129992088466,1.210210651856543,0.26785714285714285,1.0,1.0,1/7,1.84%,SPX
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.5873979645182511,-1.2096388205644097,0.20833333333333334,1.0,1.0,3/26,8.72%,PARP2;ART4;PARP14
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.6386771790983833,-1.2095967622048263,0.24,1.0,1.0,1/16,0.98%,APOBEC3H
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.5805096148796669,-1.2094417526265493,0.24,1.0,1.0,2/26,2.62%,NCKAP1L;SERPINE1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5494150997447391,1.2092367641556219,0.22,1.0,1.0,16/55,16.56%,PLA2G10;AKR1C1;CYP39A1;DGAT2;HDAC9;LDLR;ACSM1;RORA;LPL;DISP3;NR1H3;SIRT1;LCAT;INSIG1;TMEM97;CYP7B1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5927374649944259,1.2092177520004328,0.20833333333333334,1.0,1.0,6/29,9.31%,CEL;NLGN1;SYNJ2;SNCA;SYT1;NLGN4X
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6748661261430684,-1.2091699153207947,0.20833333333333334,1.0,1.0,5/17,13.09%,SELP;PRKACA;PTPRC;AZU1;FIS1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.789382474272418,1.2090011203318698,0.21428571428571427,1.0,1.0,4/5,18.38%,CDK6;CDH2;DLL1;BMP6
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6953491066655114,1.208993606144684,0.22,1.0,1.0,6/15,14.73%,PLA2G10;LPL;C3;ITGAV;SIRT1;FTO
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.7331841816557404,1.2089061869233366,0.17391304347826086,1.0,1.0,5/12,15.39%,KCNJ3;CACNB2;ANK2;GJC1;KCNA5
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.7340274840955601,1.2084216111339061,0.22916666666666666,1.0,1.0,5/9,14.27%,IRS1;ZBTB7B;SIRT1;SNX5;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7340274840955601,1.2084216111339061,0.22916666666666666,1.0,1.0,5/9,14.27%,IRS1;ZBTB7B;SIRT1;SNX5;SORBS1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.5470331923742998,-1.2079227542895097,0.25,1.0,1.0,9/55,4.95%,P2RY10;CD5;ARHGAP15;SLA;KLRB1;TRBC2;EPSTI1;TRAF3IP3;CD4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.7218658044918431,1.207786465039973,0.32608695652173914,1.0,1.0,1/7,4.86%,H6PD
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6900835275371905,1.207748746351717,0.22,1.0,1.0,3/13,16.49%,ITPKB;IP6K2;IPPK
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6497390825571377,1.2077366400177145,0.2826086956521739,1.0,1.0,4/14,14.42%,HORMAD1;KIF2C;RAD18;SMC5
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.7609327091344977,1.207654044216891,0.29545454545454547,1.0,1.0,4/5,22.83%,SH3GL2;TMEM108;WASF1;NTRK2
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.7624335803932701,1.207433603275965,0.2727272727272727,1.0,1.0,1/6,7.83%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.7624335803932701,1.207433603275965,0.2727272727272727,1.0,1.0,1/6,7.83%,GLA
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4849955578288774,1.2071866678577003,0.16666666666666666,1.0,1.0,43/162,17.17%,DACH1;NRG1;NDNF;CADM2;KCNH7;NLGN1;GALNT13;OLFM3;FLRT3;ADGRB3;SLC35F1;GRID2;CNTNAP2;SYT1;ADGRL3;MEGF10;HMGCLL1;FAM171B;SH3GL2;EPHA7;SMAD1;FUT9;GPM6B;NOL4;NOVA1;LINGO2;TMEM170B;ANK2;SLITRK5;GNL3L;ZNF536;PPFIA2;FAT3;INSYN2A;ERC2;GRIA2;CSRNP3;MAPK8;MAP2;MAPK4;PLPPR5;ATRNL1;DCLK1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.638519690532526,-1.2071464863648835,0.22,1.0,1.0,2/24,4.66%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.638519690532526,-1.2071464863648835,0.22,1.0,1.0,2/24,4.66%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.5353933448151278,-1.2067030444711664,0.20454545454545456,1.0,1.0,5/43,10.60%,SELP;FOXP1;CD24;NOS2;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8120891742903398,-1.2066106509234773,0.17391304347826086,1.0,1.0,1/5,1.74%,CLU
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7488004128946053,1.206608159372986,0.24,1.0,1.0,2/6,12.97%,SNCA;NDFIP2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7748128310214435,1.206298931668969,0.3050847457627119,1.0,1.0,2/6,6.82%,SLC22A2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5380351109496293,-1.206166131064492,0.20754716981132076,1.0,1.0,11/65,13.48%,STING1;DDX41;CGAS;OAS3;DHX58;POLR3A;OAS2;POLR3E;POLR3D;POLR3H;ISG15
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6915391829645874,1.2059821362914898,0.2549019607843137,1.0,1.0,4/11,10.27%,PLCB1;IRS1;EIF2AK3;IGF1R
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7530545851511327,-1.2059206816167474,0.20512820512820512,1.0,1.0,3/6,14.27%,SPI1;METTL3;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6172991131142705,-1.2057999012253315,0.19230769230769232,1.0,1.0,6/21,17.91%,CIDEB;PDCD5;PINK1;DNM1L;BIK;HRK
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7163731160671511,1.2053136147275259,0.25,1.0,1.0,2/9,5.99%,CSF1;CSF1R
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5837629901121028,1.2050982825299947,0.26,1.0,1.0,7/24,10.33%,CERS3;WNT5A;ACER1;SCEL;EXPH5;JAG1;ST14
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.46327307143279317,-1.2050833847431761,0.15254237288135594,1.0,1.0,38/358,12.05%,TEKT3;GOLGA8B;STING1;PLK4;MAP1LC3B2;RILP;GOLGA2;HAUS8;TEKT5;HPS4;RAB17;TUBGCP5;ATG14;CFAP221;UBXN10;VPS25;AHI1;TXNDC15;WIPI1;TRAPPC6A;LIMD1;TUBGCP2;DBNL;GOLGA8A;ATP6V1D;CFAP52;CIRBP;NSFL1C;MAP1LC3A;WIPI2;PATL2;TRAPPC14;DZIP1L;TCTN1;TRAF3IP1;B9D1;CENPE;EHD4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.5905805650582175,1.204836820903958,0.23076923076923078,1.0,1.0,8/22,21.14%,ZBTB20;HIF1A;SLC4A4;P2RX7;PDGFB;ARNT;INSR;NFKB1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6068340861910911,1.204756049798319,0.22033898305084745,1.0,1.0,11/31,18.46%,SOCS6;ITPKB;PIP4K2A;SOCS2;PIK3C2G;PIK3C2B;IP6K2;PIK3CA;PIK3R1;SOCS4;SMG1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5996422013345684,-1.2046496980463213,0.22,1.0,1.0,9/29,19.30%,TTF1;TCEA2;TAF6;TBPL2;TAF7;SMARCA5;BRF1;TAF10;BRF2
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6650753594528134,1.2045686692809257,0.21428571428571427,1.0,1.0,6/19,14.22%,PLA2G10;TMEM86B;NR1H3;LPCAT3;PLBD1;PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.7123533496152865,1.2036558054920612,0.2653061224489796,1.0,1.0,1/5,12.69%,CRLF2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5190971357996843,-1.2036460248483758,0.1568627450980392,1.0,1.0,18/88,13.62%,SFRP1;PLK4;PLK3;AURKA;PLK5;KIF20B;KNSTRN;ANKK1;FBXO43;NUDT16;CALM1;IHO1;PLK2;CETN2;CDKN2B;CHEK1;PIN1;USP51
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5430079018201701,-1.2033073969635975,0.22033898305084745,1.0,1.0,7/49,9.99%,HSD17B10;DECR2;MECR;ETFB;CRAT;ECHDC2;HADHA
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.857013441953194,-1.2031797505294137,0.25,1.0,1.0,1/5,3.19%,ACOT4
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6960629972204386,-1.2030119188982888,0.23214285714285715,1.0,1.0,2/10,5.66%,SLX4;ERCC1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6960629972204386,-1.2030119188982888,0.23214285714285715,1.0,1.0,2/10,5.66%,SLX4;ERCC1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6960629972204386,-1.2030119188982888,0.23214285714285715,1.0,1.0,2/10,5.66%,SLX4;ERCC1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.7942713289913272,-1.2023419043610089,0.2682926829268293,1.0,1.0,1/7,3.42%,KMT2B
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5706760818976693,-1.2021109630612923,0.24074074074074073,1.0,1.0,10/46,18.88%,LDHC;HK2;PDHX;PDHA1;SLC16A8;ENO1;LDHA;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.7787120087558512,1.2019884496730056,0.27450980392156865,1.0,1.0,3/5,17.08%,GRID2;CBLN1;PROX1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8101653833570823,1.2013501621900184,0.20454545454545456,1.0,1.0,3/6,17.22%,MEGF10;MSTN;THBS4
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.6384818014273655,-1.2013466621679882,0.23529411764705882,1.0,1.0,6/20,17.26%,NCL;RBM3;CELF3;CIRBP;SNW1;RBMX
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5614747762631611,1.2010355170563496,0.18518518518518517,1.0,1.0,8/35,12.80%,LOXL2;KANK1;ZEB2;ANLN;NRP1;PRSS3;CDH13;PIK3CA
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.7446158644950314,-1.201001465787342,0.30612244897959184,1.0,1.0,1/6,6.02%,AHI1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7453327621539994,-1.2007112005316944,0.25,1.0,1.0,3/9,17.94%,PGP;GK5;TKFC
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5102310351437838,1.2006897046191791,0.14285714285714285,1.0,1.0,56/150,21.46%,EFNA5;CADM2;TAFA1;GUCY1A2;LRRC4C;LSAMP;TSHZ1;OLFM3;NRXN1;ADGRB3;PCDH17;KCTD16;CYB561;CA10;ADGRL3;HMGCLL1;ELAVL4;TOX;FILIP1;FBXO7;PLCE1;ZDHHC2;CNTN1;NOVA1;RBFOX1;ASXL3;ASIC2;PIK3CA;ANK2;ZNF536;PLEKHA5;PPFIA2;AKAP6;RGS7BP;GRIA2;TUB;CSRNP3;PCLO;MAP2;HIVEP3;MAPK4;ATRNL1;DCLK1;FSTL5;ST8SIA3;SLC10A4;GFRA2;BRINP1;TMEM59L;ADGRA1;PAK5;SLC7A14;MAPK10;STXBP5;CPE;LRCH2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6031344206942532,1.1998631813512908,0.18867924528301888,1.0,1.0,5/21,12.77%,SLC2A5;ERN1;ZBTB20;IGF1R;SLC26A6
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6595118271110558,-1.1995570647235712,0.29545454545454547,1.0,1.0,4/17,6.56%,CCN3;NLRP3;TMSB4X;SPI1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.6634208867592027,1.1990379469019108,0.2962962962962963,1.0,1.0,3/15,11.50%,TEX14;BUB1B;PLK1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.6634208867592027,1.1990379469019108,0.2962962962962963,1.0,1.0,3/15,11.50%,TEX14;BUB1B;PLK1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.6634208867592027,1.1990379469019108,0.2962962962962963,1.0,1.0,3/15,11.50%,TEX14;BUB1B;PLK1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.6104721799699259,1.1988923653770018,0.26,1.0,1.0,8/22,18.16%,HORMAD1;DMC1;FSHR;M1AP;MDK;MEI4;NANOS1;DIAPH2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.8077336697900996,1.1988806452946665,0.23636363636363636,1.0,1.0,3/5,17.74%,TWSG1;GLI3;CD274
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7424319073819886,-1.198810227006483,0.2,1.0,1.0,5/9,23.27%,EIF2S2;MCTS1;EIF4H;EIF2S3;DHX29
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6326733003967143,1.198780480590906,0.20930232558139536,1.0,1.0,6/19,11.70%,CEL;NLGN1;NRXN1;NLGN4X;LHFPL4;LRP4
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7256258365458903,1.198563163855519,0.30434782608695654,1.0,1.0,2/7,11.99%,MDGA2;ZC4H2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5584004112483368,1.1983793970713768,0.16,1.0,1.0,5/30,12.12%,ZDHHC11;ZDHHC14;ZDHHC11B;ZDHHC2;HHAT
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7057805180776916,1.19825564164066,0.23529411764705882,1.0,1.0,3/11,10.93%,CXXC4;COBL;SMAD2
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.7692764890687205,1.1981065288145298,0.2982456140350877,1.0,1.0,1/6,10.56%,EDN1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7207531801288344,1.1979284508256371,0.2553191489361702,1.0,1.0,2/7,7.48%,MICU1;MCU
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.6763440605952279,1.1977404145165398,0.23636363636363636,1.0,1.0,3/11,4.04%,HPGDS;AKR1C1;PTGES
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5424643008742628,1.197674930590434,0.24,1.0,1.0,16/56,16.56%,PLA2G10;AKR1C1;CYP39A1;DGAT2;HDAC9;LDLR;ACSM1;RORA;LPL;DISP3;NR1H3;SIRT1;LCAT;INSIG1;TMEM97;CYP7B1
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.8105592594160813,-1.1975300093901147,0.23404255319148937,1.0,1.0,1/5,2.51%,CYP19A1
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.7841306513022073,-1.1972598690562373,0.22916666666666666,1.0,1.0,2/5,11.11%,NOP14;NOP9
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.7841306513022073,-1.1972598690562373,0.22916666666666666,1.0,1.0,2/5,11.11%,NOP14;NOP9
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.7841306513022073,-1.1972598690562373,0.22916666666666666,1.0,1.0,2/5,11.11%,NOP14;NOP9
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6807194378379458,1.1972094094571237,0.21153846153846154,1.0,1.0,6/15,17.97%,PPP3CA;NFATC2;PLCE1;EDN1;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6607117194590082,-1.196937430426698,0.15217391304347827,1.0,1.0,1/19,0.22%,SELP
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7543207700721103,-1.1965009529484403,0.20833333333333334,1.0,1.0,1/9,1.31%,ATRAID
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.7657288525517434,1.196373866536173,0.25862068965517243,1.0,1.0,3/5,22.14%,HTR1E;HTR1F;HTR5A
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.5640249701901779,1.196308295609402,0.19148936170212766,1.0,1.0,9/51,15.27%,PLCB1;UBE2E2;EGFR;RAD51B;ANKRD17;FGF10;ESPL1;NSMCE2;DTL
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.7854297172750854,-1.1962353224920061,0.21052631578947367,1.0,1.0,4/5,20.95%,CALM1;RACK1;CALM3;MAPK7
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.689384021756291,1.1960718161216866,0.35714285714285715,1.0,1.0,6/11,21.35%,MYO7A;CRB2;RP1;BBS4;VEGFA;RPGRIP1L
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.7682270110188711,-1.1957834220721646,0.23214285714285715,1.0,1.0,2/5,21.15%,PNPO;NNMT
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.6051615037979482,-1.195662309380981,0.21568627450980393,1.0,1.0,10/28,20.38%,TPPP3;GOLGA2;TUBGCP5;TUBGCP2;PIN1;TRPV4;TUBG1;CKAP5;TPX2;TUBG2
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7590060227084259,1.1956145237686426,0.2833333333333333,1.0,1.0,3/6,7.83%,ATP2B4;SNCA;GLA
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.6152675952054364,1.1952875860518337,0.2037037037037037,1.0,1.0,12/24,19.91%,PLA2G10;PLCB1;LHFPL2;PDE3A;SMURF2;ACVR1B;INHBB;TACR1;TACR3;VEGFA;RNASE10;CACNA1H
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.6984539370968852,-1.1952728206595797,0.24074074074074073,1.0,1.0,3/9,7.87%,ACOT4;PCCB;CRAT
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6644923999850038,1.1952665877376691,0.20833333333333334,1.0,1.0,4/13,19.03%,NAA50;EP300;KAT2B;NAA30
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.570133589374805,-1.1951237647778963,0.20408163265306123,1.0,1.0,3/50,0.98%,HLA-DPB1;INHA;TXK
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6634087252286742,1.1950893165154668,0.3018867924528302,1.0,1.0,3/16,11.50%,TEX14;BUB1B;PLK1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6035099078247695,1.195085228547492,0.25,1.0,1.0,6/33,8.60%,MARVELD3;ESAM;FRMPD2;PARD3;ECT2;PDCD6IP
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.8034495149458629,-1.19504581318139,0.27450980392156865,1.0,1.0,2/5,15.47%,CEMIP;HAS3
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5433052589488737,-1.1949859154102722,0.2641509433962264,1.0,1.0,35/57,26.05%,PSMA7;PSMD7;UBC;PSMB4;PSMC3;MCM5;ORC3;PSMD8;ORC1;PSME1;MCM2;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;MCM4;ORC2;CDC6;PSMA5;UBB;PSMB1;PSMB6;ORC6;PSMD3;PSMD11;PSMA4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.7378983927396336,1.1949848515638142,0.30357142857142855,1.0,1.0,3/7,22.38%,ZFP36;DCP1B;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6732171461175428,1.1947390636301138,0.25,1.0,1.0,7/14,19.96%,CSF1;CSF1R;CCL5;MSTN;MDK;IL34;PTK2
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.7670371175023449,-1.1945526483575049,0.32558139534883723,1.0,1.0,1/5,3.76%,PDZD7
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.8065385995582793,1.1942409274128745,0.23404255319148937,1.0,1.0,2/6,7.07%,ERBB4;LATS1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6799869524173427,1.1942365233927663,0.2857142857142857,1.0,1.0,1/9,0.64%,CD151
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4860307694558448,1.194051160928067,0.17391304347826086,1.0,1.0,32/122,14.95%,CADM2;RIT2;LRRC4C;KCNC2;LSAMP;GABRB1;LRRTM3;NEGR1;OLFM3;NRXN1;ADGRB3;GFAP;NXPH1;GRM5;GRIA4;AMER2;CA10;ATXN1;ELAVL4;RAB3C;SH3GL2;SYNPR;RBFOX1;MRTFB;NPY;ASIC2;ZNF536;PPFIA2;RGS7BP;LRRC3B;GRIA2;CSRNP3
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.7980894756960524,-1.1939435376911258,0.29411764705882354,1.0,1.0,2/6,4.46%,TEKT3;TEKT5
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.7007474990674217,1.1935047482521697,0.3137254901960784,1.0,1.0,7/11,27.84%,DGAT2;ZNF516;ARID5B;NAMPT;LRP5;PGRMC2;SH3PXD2B
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.6911563129896446,-1.1933716738847233,0.3114754098360656,1.0,1.0,3/10,18.79%,COLEC12;SCARA3;RFTN1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.7967799186892927,1.1929728759371412,0.2777777777777778,1.0,1.0,4/6,16.69%,SLC26A3;SLC26A6;BCL2;CLN3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5028217892135876,1.1927041482797183,0.10638297872340426,1.0,1.0,28/119,14.19%,PIK3R5;CALCR;NRG1;ERBB4;SEMA5A;IRS1;CX3CR1;FGFR2;CASS4;EGFR;TGFBR1;IRS2;GAB1;FGFR3;FGF5;MFHAS1;FRS2;FGF17;MYORG;PDGFRB;FGF10;IGF1R;ADAM8;FGFR1;PIK3CA;THPO;HGF;NRG2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7352081579369634,1.1925891690831245,0.32786885245901637,1.0,1.0,3/5,21.68%,HIF1A;VEGFA;NFE2L2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5588039716581116,1.1925712636131562,0.15555555555555556,1.0,1.0,6/30,13.88%,RUNX1;H3-3A;LATS1;NCOA2;KCTD6;EP300
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.7167984232731539,-1.1924431717872772,0.20454545454545456,1.0,1.0,2/7,13.87%,HTR2A;NR1H4
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.6681503950964844,-1.1921457528666206,0.2708333333333333,1.0,1.0,2/12,7.46%,TCHH;PKP1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6709380304658678,-1.19161966209581,0.18518518518518517,1.0,1.0,1/14,0.69%,CD9
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.5911215497301776,1.1915735297975003,0.3111111111111111,1.0,1.0,2/19,4.17%,MYBPC3;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5381791289355438,-1.191547289123111,0.2,1.0,1.0,25/57,21.32%,AURKA;PSMA7;PSMD7;SKP1;PSMB4;RBX1;PSMC3;RFPL1;PSMD8;CHEK1;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;GPR132;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.6225970576238716,1.1912729876111154,0.2037037037037037,1.0,1.0,10/24,17.08%,MYBPC3;FGFR2;SMAD7;HEY1;BMPR1A;JAG1;MEF2C;TGFBR3;SOX11;PROX1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.7504406780013022,1.1912220983835013,0.27450980392156865,1.0,1.0,2/6,12.25%,BAHD1;SIRT1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.6096243322494095,-1.1909902697497525,0.2830188679245283,1.0,1.0,4/19,7.74%,CCN3;PBLD;NODAL;RBPMS
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5647873576066302,-1.190950545901953,0.24489795918367346,1.0,1.0,11/40,17.64%,DUSP4;SPRED3;SPRED2;SPRY1;DUSP6;PTPRC;PIN1;CAMK2N1;SPRED1;GSTP1;SPRY2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7020051863673149,1.190434543827332,0.32,1.0,1.0,2/7,18.16%,ADIPOR1;VHL
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6779893734577513,-1.1903880521256405,0.25,1.0,1.0,5/9,21.93%,DHX58;UFD1;C1QBP;TKFC;NPLOC4
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6348321782085156,1.1903043811947842,0.23529411764705882,1.0,1.0,4/14,11.37%,VEGFC;NRP1;ITGA11;EPHA8
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7412188953473837,1.1901691972377317,0.28846153846153844,1.0,1.0,3/6,18.38%,PRKCA;SASH1;BMP6
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.5733030840540521,-1.189952865281748,0.2127659574468085,1.0,1.0,1/40,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6639096752425143,1.1899421202148341,0.27906976744186046,1.0,1.0,5/11,22.38%,NR3C1;ZFP36;ZFP36L2;HNRNPU;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6845434336499722,1.1896004900709085,0.22033898305084745,1.0,1.0,3/12,13.64%,HMGB1;FGFR1;MDK
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.6926753450291248,-1.18920596647648,0.2777777777777778,1.0,1.0,2/7,20.85%,SEC62;SEC61G
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.7552025095146851,1.1888877121853274,0.2653061224489796,1.0,1.0,3/8,12.77%,SLC2A5;SLC23A1;SLC26A6
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-0.7388273644603214,-1.188872068365663,0.3018867924528302,1.0,1.0,3/6,10.53%,GNAS;DRD1;DRD3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5969732546690962,1.1888042990864802,0.20833333333333334,1.0,1.0,7/32,13.65%,PLCB1;GNAT2;NLK;WNT5A;PPP3CA;CTNNB1;PDE6A
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7690543096081568,1.188705696462178,0.21739130434782608,1.0,1.0,3/8,12.00%,PTAR1;RCE1;PGGT1B
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),-0.7894359063947715,-1.1886274420365315,0.3695652173913043,1.0,1.0,1/5,1.86%,MYB
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.4812876767657859,1.18860049611129,0.19047619047619047,1.0,1.0,34/149,15.60%,CADM2;RIT2;TSHZ1;LRRTM3;OLFM3;NRXN1;ADGRB3;HCN1;NXPH1;GRM5;HIVEP2;PPM1E;GRID2;CNTNAP2;GRIA4;AMER2;CA10;ELAVL4;RAB3C;CBLN1;CTNNA2;PRKG1;SYNPR;PRKCA;RBFOX1;PDE1A;ASIC2;DLGAP1;SLC24A2;LRRC3B;GRIA2;CTNND2;SYT2;PVALB
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.75769379277938,1.1884036480964868,0.3076923076923077,1.0,1.0,1/5,2.63%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.75769379277938,1.1884036480964868,0.3076923076923077,1.0,1.0,1/5,2.63%,ENPP1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.6731320075164092,1.188120185036083,0.2926829268292683,1.0,1.0,5/16,11.40%,CALCR;SLIT2;NR3C1;ZFP36;ZFP36L2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5602540565246024,-1.1880687093241138,0.25,1.0,1.0,5/32,9.01%,CSRP2;OBSCN;TPM1;ACTC1;SYNPO2L
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.5820414334924295,1.1878984366499175,0.20408163265306123,1.0,1.0,9/27,18.12%,HMGCS1;FDFT1;HMGCR;MSMO1;LBR;INSIG1;INSIG2;FDPS;PLPP6
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.7042161655250333,-1.1877519715121874,0.2830188679245283,1.0,1.0,3/7,19.35%,IFIT1;DDB1;STAT1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5099868117021248,-1.1877341489908415,0.17307692307692307,1.0,1.0,17/77,13.88%,STING1;NLRP1;APOBEC3H;CGAS;RNASE1;OAS3;IFI6;IFIT1;IFI27;OAS2;PTPRC;AZU1;STAT2;NLRP9;ISG15;RSAD2;EXOSC4
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6662322276287438,-1.1871429144488972,0.30357142857142855,1.0,1.0,2/13,8.86%,MGAM;CALM1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.7839411244660561,-1.186972125360473,0.20833333333333334,1.0,1.0,2/8,5.57%,H1-4;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.7839411244660561,-1.186972125360473,0.20833333333333334,1.0,1.0,2/8,5.57%,H1-4;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.7839411244660561,-1.186972125360473,0.20833333333333334,1.0,1.0,2/8,5.57%,H1-4;H1-0
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6655203565913836,-1.1861683490302557,0.225,1.0,1.0,4/16,11.78%,HEBP2;SPG7;BAK1;SLC25A5
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7659063980313773,1.18615309553945,0.17391304347826086,1.0,1.0,3/6,7.24%,FGFR2;WNT5A;ROBO2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5789150570014878,-1.1857581686870726,0.21951219512195122,1.0,1.0,8/34,15.99%,ERCC1;UBC;NTHL1;RBX1;GTF2H2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.7052902290304106,-1.1856269107125523,0.3157894736842105,1.0,1.0,2/14,5.74%,FGL1;IL4I1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.552906359002743,-1.1855556944897097,0.16,1.0,1.0,14/47,14.80%,CLDN4;CBLC;PAH;FGL1;FOXM1;RAB17;CLDN1;AMBP;TOM1L1;MET;A1CF;HNF4A;NR1H4;EFNA1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.6209592235533825,1.1850348406783042,0.26,1.0,1.0,6/16,13.98%,CALCR;SNCA;CACNB2;ANK2;AKAP6;NPSR1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.7800573040018828,-1.184967343259029,0.2692307692307692,1.0,1.0,1/5,0.85%,TYMS
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.6113849088314824,1.1847543531941351,0.17777777777777778,1.0,1.0,3/15,12.06%,PTGES;OPRK1;P2RX7
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.6790971659458763,-1.1846763510894018,0.2765957446808511,1.0,1.0,6/13,15.93%,HSD17B10;RPP25;POP7;POP1;TRMT10C;POP5
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6188707986478384,1.1846350147977651,0.2916666666666667,1.0,1.0,3/20,6.92%,SLC8A1;ATP2B4;JPH1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.7384393656106878,1.184479981295461,0.2708333333333333,1.0,1.0,1/7,6.33%,ATP2B4
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7327273455664549,1.1843092197090201,0.3333333333333333,1.0,1.0,3/8,7.24%,FGFR2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.748230858600859,-1.183983913971366,0.21052631578947367,1.0,1.0,3/7,15.75%,PINK1;TOMM7;HDAC6
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.67545655218969,-1.1839038453122608,0.3137254901960784,1.0,1.0,4/11,18.52%,CLU;LIPC;APOA1;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.6412017741448981,1.1834674016222058,0.24528301886792453,1.0,1.0,4/13,17.05%,RUNX1;HDAC2;SCX;VIM
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.6412017741448981,1.1834674016222058,0.24528301886792453,1.0,1.0,4/13,17.05%,RUNX1;HDAC2;SCX;VIM
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5782081929606865,1.1831285192316532,0.20833333333333334,1.0,1.0,8/21,20.48%,SPHK1;AGMO;ACER1;ST6GALNAC4;TECR;ST3GAL6;TEX2;GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.6647800295602717,1.1830162006648848,0.23076923076923078,1.0,1.0,5/12,24.40%,ZFP36;UBP1;MID2;TRIM32;IFITM3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.7175505655745856,1.1829508391325814,0.2777777777777778,1.0,1.0,7/11,26.27%,ELOVL6;HACD2;TECR;ELOVL7;HACD4;ELOVL2;ELOVL5
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5786110134919172,-1.1823967467180656,0.23333333333333334,1.0,1.0,4/55,8.82%,STING1;ATG14;UBC;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8124026557781308,1.1820134476133977,0.2826086956521739,1.0,1.0,2/5,15.64%,PPARG;ABHD5
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.7670179400707087,1.1816193694992656,0.2978723404255319,1.0,1.0,3/6,13.55%,SLC22A2;ABCC2;ABCG2
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.568374184965235,1.1809938258104553,0.2641509433962264,1.0,1.0,5/18,14.43%,SLC8A1;SNCA;TMTC2;ANK3;CNNM2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5908264633625732,-1.1809787774840184,0.23076923076923078,1.0,1.0,3/31,3.19%,ACOT1;ACOT11;ACOT4
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.7445516274248427,-1.180765979922294,0.3111111111111111,1.0,1.0,2/5,21.33%,TRMT112;FBL
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6869774547589182,1.1806310607954684,0.3111111111111111,1.0,1.0,5/10,23.46%,JAG1;ZFP36L2;N4BP2L2;HNRNPU;NELFB
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7843827529278039,1.1805197162438354,0.26,1.0,1.0,3/7,13.63%,NRP1;BCAR1;HGF
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7843827529278039,1.1805197162438354,0.26,1.0,1.0,3/7,13.63%,NRP1;BCAR1;HGF
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5370326837673579,-1.1802581202782996,0.20689655172413793,1.0,1.0,27/45,26.05%,PSMA7;PSMD7;BCKDK;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;PSMA5;AZIN1;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.669034716024439,-1.180170230171469,0.30612244897959184,1.0,1.0,3/11,18.59%,FOLH1;AGBL1;GPLD1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6339284553153276,1.1800094385578692,0.2653061224489796,1.0,1.0,6/13,14.77%,MAGI2;SMAD7;ACVR2A;ACVR1B;FST;ACVR1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7184945957347442,1.1799955920118308,0.37209302325581395,1.0,1.0,5/6,25.49%,KCNJ2;DMD;CAV3;C12ORF57;SLC8A3
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.7169632635325534,1.179590428321852,0.3137254901960784,1.0,1.0,2/6,9.92%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.7328720978875299,-1.1794145398698048,0.26785714285714285,1.0,1.0,2/7,7.84%,PRKCH;FOXP1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7721851653642755,-1.1793216730063831,0.28846153846153844,1.0,1.0,1/5,13.86%,RAP1GAP
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.6664930416300305,1.17920886566743,0.3050847457627119,1.0,1.0,6/14,13.17%,NTF3;VEGFC;CDH13;VEGFD;IL16;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7020521804559011,1.1789881423820103,0.2857142857142857,1.0,1.0,4/8,21.30%,DNAJB2;HSPA1A;SACS;DNAJB1
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7362103086067021,1.1789606206060836,0.32,1.0,1.0,4/6,26.27%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7362103086067021,1.1789606206060836,0.32,1.0,1.0,4/6,26.27%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7362103086067021,1.1789606206060836,0.32,1.0,1.0,4/6,26.27%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7362103086067021,1.1789606206060836,0.32,1.0,1.0,4/6,26.27%,ELOVL6;ELOVL7;ELOVL2;ELOVL5
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.7211431330532881,1.1789376799919318,0.288135593220339,1.0,1.0,5/9,13.17%,NTF3;VEGFC;VEGFD;IL16;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.7120548948002972,-1.1785547938628393,0.34782608695652173,1.0,1.0,6/10,22.68%,STX4;ANO1;BAIAP3;GPLD1;TRPM4;CFTR
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.4757383536965253,-1.1781119048601132,0.2391304347826087,1.0,1.0,27/178,13.30%,PLK4;DEPDC1;AURKA;CDKN3;RAD51AP1;HMGB3;GINS3;SMC4;DSCC1;ILF3;KIF4A;STMN1;ANP32E;MCM5;PA2G4;NOP56;KPNA2;NOLC1;CCNE1;HMGB2;SPC25;POP7;RANBP1;CENPE;CHEK1;MCM2;HUS1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.6505116432803321,1.1780993357844096,0.2549019607843137,1.0,1.0,5/11,22.38%,NR3C1;ZFP36;ZFP36L2;HNRNPU;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.8295353057265017,1.1779862199337576,0.2641509433962264,1.0,1.0,1/5,5.40%,OTUD4
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.7335153140143843,1.1777133326616778,0.35185185185185186,1.0,1.0,3/6,21.09%,HEY1;DCHS1;SMAD4
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6170977091253248,1.1773657675670404,0.2777777777777778,1.0,1.0,9/21,24.43%,PNLDC1;ZFP36;CNOT4;PAN3;CNOT2;CNOT6L;TUT7;CNOT8;CNOT7
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.6630613765907162,-1.177354056617506,0.2545454545454545,1.0,1.0,4/15,9.30%,SFRP1;CCN3;ADRA2A;MIDN
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.6915318732544607,-1.1773048835834214,0.32075471698113206,1.0,1.0,1/11,1.21%,CSRP2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.7099974194338065,1.1769850961934942,0.2391304347826087,1.0,1.0,6/11,21.09%,WNT5A;SMAD2;WNT8A;CHD7;TGFBR3;SMAD4
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6578482652978271,1.1766972603948616,0.3181818181818182,1.0,1.0,4/8,20.29%,PPARG;PRKCB;VMP1;ZDHHC17
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.6102181110531489,-1.1765225925801919,0.25862068965517243,1.0,1.0,3/18,7.05%,B2M;RFLNA;PAX6
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.7367655568448562,1.1763095299675153,0.3584905660377358,1.0,1.0,2/5,15.78%,QDPR;MTHFS
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.7503921527443976,-1.1760824363289568,0.2653061224489796,1.0,1.0,1/6,1.05%,CCN3
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6013199642598871,1.1760297888644606,0.32,1.0,1.0,6/19,13.64%,CSF1;SLIT2;CSF1R;CCL5;MSTN;MDK
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.7236235989738826,-1.1760020603904215,0.32653061224489793,1.0,1.0,5/9,16.42%,CALM1;DRD3;GNB5;DRD4;CALM3
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.6633541985238256,-1.1759478409767636,0.3,1.0,1.0,3/15,13.25%,RPS27L;RPS15;RPS27
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.756698785836452,1.175926425394399,0.3170731707317073,1.0,1.0,2/6,15.75%,SYK;VAMP8
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5927408951254841,-1.1756873659402003,0.24,1.0,1.0,1/19,0.35%,NOSTRIN
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.6617022571006945,-1.17565732183394,0.3191489361702128,1.0,1.0,4/17,10.89%,HK2;SKP1;CHCHD10;PINK1
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.7760168054752525,-1.175447539421626,0.2641509433962264,1.0,1.0,3/5,18.15%,PKP1;NEFL;PKP2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6963942475286266,-1.1749821842435484,0.2692307692307692,1.0,1.0,1/12,0.73%,PARP2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.4654413205326205,-1.1748861408612739,0.14814814814814814,1.0,1.0,15/169,10.37%,TLCD2;GOLGA8B;SUN3;DYSF;SPAG4;GOLGA2;ZFP69B;LEMD2;PLEKHF1;TANGO2;REEP6;ATP8B4;GOLGA8A;NSFL1C;GAK
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6454935625109931,-1.1745638467157036,0.23255813953488372,1.0,1.0,1/18,0.85%,TERF2IP
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6072100287170035,1.174375076531906,0.20689655172413793,1.0,1.0,12/20,20.18%,PLA2G10;PLA2G7;ENPP6;PLA2G15;GDPD3;PRDX6;PLA2G4C;SMPD4;GPCPD1;ABHD12B;ABHD12;PNPLA6
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6864443296609046,-1.1743112468153816,0.3333333333333333,1.0,1.0,3/8,12.28%,TPM1;MYL5;PVALEF
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.683673717751474,1.174166248896579,0.3488372093023256,1.0,1.0,3/10,5.99%,IFI16;PPARG;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.6378119713293329,-1.1737001988965443,0.27586206896551724,1.0,1.0,6/17,17.54%,MYB;DHX58;HLA-DRA;PTPRC;MYO18A;DDX60
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.7987079385693401,-1.1730681202368674,0.27450980392156865,1.0,1.0,3/5,13.68%,NLRP3;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.7987079385693401,-1.1730681202368674,0.27450980392156865,1.0,1.0,3/5,13.68%,NLRP3;PRKCZ;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.6299038393537029,1.1729124245124207,0.2692307692307692,1.0,1.0,7/15,17.26%,PBX1;MAML2;MAML3;NOTCH3;WWC1;EP300;KAT2B
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.6838028640526481,1.1727192540698503,0.3090909090909091,1.0,1.0,2/9,1.84%,NRG1;SPX
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6062916574780979,-1.172652834373348,0.23076923076923078,1.0,1.0,10/29,19.81%,MAP1LC3B2;ATG14;CALM1;MAP1LC3A;WIPI2;VPS16;MAP1LC3B;VIPAS39;GABARAPL2;RUBCNL
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6824637620878846,1.1724236318194083,0.3469387755102041,1.0,1.0,6/10,25.97%,SLC8A1;JAG1;VEGFA;ALPK2;TCAP;CXADR
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5742569696479694,-1.1719271373005105,0.23255813953488372,1.0,1.0,8/36,15.99%,ERCC1;UBC;NTHL1;RBX1;GTF2H2;DDB1;PARP1;ERCC2
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.5718542011857528,-1.171921197462335,0.3148148148148148,1.0,1.0,11/33,14.54%,PAH;FGL1;SARDH;CDHR2;RBP4;AMBP;PROC;TTBK1;NR1H4;APOA1;ACOT12
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.7281176811725849,1.1718304708983396,0.2708333333333333,1.0,1.0,2/9,10.51%,CEP120;PCM1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.7470327544731636,-1.1717649163707176,0.35555555555555557,1.0,1.0,1/5,0.84%,HEBP2
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7808249024591035,-1.17175604618798,0.27450980392156865,1.0,1.0,3/5,17.66%,SERPINE1;SERPINF2;THBS1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6522735181036495,-1.1717235450809902,0.33962264150943394,1.0,1.0,2/10,7.92%,GHR;PRLR
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.628237552602861,1.1717027091321344,0.2553191489361702,1.0,1.0,4/15,8.59%,NFIL3;PBX1;IL21R;TOX
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.5783464264296792,-1.171684652263221,0.21818181818181817,1.0,1.0,6/31,14.27%,FGF1;ANO1;DAXX;PRKACA;TCIM;TRPV4
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6943419633468098,1.171649695525569,0.33962264150943394,1.0,1.0,4/13,16.70%,ACER1;GLA;ASAH2;HEXB
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.6678964476067839,-1.1716473955191173,0.32608695652173914,1.0,1.0,1/7,0.56%,SFRP1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.568680469398618,1.1716387176899332,0.24489795918367346,1.0,1.0,9/28,18.12%,HMGCS1;FDFT1;HMGCR;MSMO1;LBR;INSIG1;INSIG2;FDPS;PLPP6
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.7595904583111721,-1.171365025664089,0.25,1.0,1.0,2/7,5.66%,TERF2IP;ERCC1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.5999925198489262,-1.1712835626438793,0.24444444444444444,1.0,1.0,1/18,1.55%,DHFR2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.7359563995053512,-1.171095036391467,0.2830188679245283,1.0,1.0,1/7,9.09%,RNF213
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.6288282198338664,1.1709012859106078,0.23809523809523808,1.0,1.0,3/13,13.34%,RNF128;KPTN;SH3BP4
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4674488976541205,1.170759964958504,0.19230769230769232,1.0,1.0,23/112,11.88%,MARVELD3;DACH1;STK26;KANK1;PTPRK;MAGI2;SMAD7;ROBO1;NAV3;SULF1;SLIT2;RHOB;FOXO3;MCTP1;PTPRG;BMPR1A;MITF;JAG1;SRGAP2B;ADIPOR1;TMEFF2;TP53INP1;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.6402426668518831,-1.1707498661820868,0.32558139534883723,1.0,1.0,3/13,4.80%,WNT9A;ADAMTS12;RFLNA
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.574643145721748,-1.1706761899515794,0.2857142857142857,1.0,1.0,4/28,9.14%,LCP1;PLK3;KIF20B;IFI27
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7521173200839517,1.1706282751600763,0.26666666666666666,1.0,1.0,2/6,10.87%,NTF3;TMEM108
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.5247659717866461,1.1705079045347357,0.2702702702702703,1.0,1.0,18/69,18.03%,SLC12A1;SLC12A3;SLC6A13;HCN1;SLC8A1;KCNK1;SCNN1B;ATP12A;ASIC4;SLC4A4;ASIC2;SCNN1D;SLC24A2;SLC9A1;SLC6A4;SLC12A2;SLC9A2;SLC24A4
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.7765657889928346,-1.1704916708063355,0.28846153846153844,1.0,1.0,3/6,20.08%,WIZ;INO80;CDC7
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.660105034036256,1.170017554441638,0.3023255813953488,1.0,1.0,2/11,8.19%,KLF2;CTBP2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6082108170340716,-1.169979865076375,0.2708333333333333,1.0,1.0,2/22,1.88%,HSF2BP;BRME1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.6722635012842959,-1.169953686611282,0.27450980392156865,1.0,1.0,2/12,7.78%,CLU;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6435776424434098,-1.1699113184180583,0.3488372093023256,1.0,1.0,3/7,14.13%,ADRA2A;BTC;EREG
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.5491955313787701,1.1698222728047971,0.26666666666666666,1.0,1.0,10/29,23.16%,PLCB1;TDG;CRB2;RPS6KA6;CLASP1;INSR;CLASP2;PHLDB1;NIPBL;DAG1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7398636926812387,-1.169790765593745,0.3111111111111111,1.0,1.0,1/8,0.56%,SFRP1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.642559906905466,1.1697610387760244,0.325,1.0,1.0,4/18,14.20%,SPHK1;ACER1;ASAH2;PLPP1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.618669803114625,1.1697569412340854,0.36,1.0,1.0,5/17,15.63%,HPRT1;AK3;PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.7008447370339063,-1.1695593798537711,0.2765957446808511,1.0,1.0,3/8,17.06%,PHAX;PKP1;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.7099649579356809,1.1695065095127257,0.2807017543859649,1.0,1.0,3/9,18.02%,CSF1;PRKCA;IL34
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5549935035342763,1.169409823429794,0.24489795918367346,1.0,1.0,15/42,19.03%,LOXL2;FGFR2;WNT5A;TGFBR1;RANBP3L;HIF1A;FGFR1;CTNNB1;HGF;MEF2C;TGFBR3;FBXL17;CUL7;LIMS1;ROCK2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7282903966346379,-1.168758241120471,0.2857142857142857,1.0,1.0,2/8,8.84%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5675339495163912,-1.168606173761895,0.3157894736842105,1.0,1.0,12/38,20.68%,MAP1LC3B2;ATG14;WIPI1;MAP1LC3A;WIPI2;PINK1;FIS1;CISD2;MAP1LC3B;SPATA18;GABARAPL2;FUNDC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6430505493829854,1.168546113138031,0.3076923076923077,1.0,1.0,6/15,9.45%,ZFPM2;RUNX1;ERBB4;FGFR2;TGFBR1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.5845482534686681,-1.1684055401388893,0.2413793103448276,1.0,1.0,3/28,5.50%,APOD;SERPINE1;PLET1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.663687543720013,1.1684002930268103,0.3181818181818182,1.0,1.0,5/10,11.85%,SLIT2;SH3GL2;DDAH1;PDE2A;PDE3A
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.5382427631797645,1.1682318040664432,0.27906976744186046,1.0,1.0,4/37,6.83%,STK26;RHOB;CAT;ECT2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6008406140194391,-1.1680848094453817,0.27941176470588236,1.0,1.0,13/18,26.92%,PSMA7;PSMB4;PSMB2;PSMB8;PSMB5;PSMA1;PSMB7;PSMB3;PSMA5;PSMB1;PSMB6;PSMA4;PSMA8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6305154816345462,1.1678732580510633,0.21428571428571427,1.0,1.0,2/15,2.96%,NLRP2B;CX3CR1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.7346520295673896,1.1676405966252237,0.36363636363636365,1.0,1.0,1/7,1.59%,RUNX1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5532448912075292,1.167397385691191,0.15,1.0,1.0,9/31,16.00%,SEMA5A;FLRT3;NRP1;SH3GL2;AUTS2;TMEM108;CTNNB1;ALCAM;LLPH
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6033616350008089,1.1672816070994951,0.22916666666666666,1.0,1.0,6/18,13.64%,PTPRK;FGFR2;PRKD1;ZFP36;FGF10;MDK
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7029894729555831,1.1672801149641348,0.25,1.0,1.0,4/7,23.17%,ITGAM;SETMAR;HNRNPU;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.663218216741066,-1.167276577799865,0.36666666666666664,1.0,1.0,3/8,12.52%,GPR37;TXN;PDE8A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7509721315875246,-1.1669691084198517,0.37037037037037035,1.0,1.0,1/7,4.38%,B2M
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.6036319132659052,1.1669323618042236,0.17391304347826086,1.0,1.0,9/26,11.23%,FZD1;WNT5A;CUL1;DTX4;MAML2;JAG1;PRKCA;DLL1;NOTCH3
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7229795757280206,-1.166903952650414,0.34615384615384615,1.0,1.0,3/7,21.29%,HSD17B10;TRMT10C;TRMT10B
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.8026769503739463,-1.1666628249720237,0.2909090909090909,1.0,1.0,1/5,4.05%,OAS3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4411261957525288,-1.1666100780760489,0.15217391304347827,1.0,1.0,43/394,10.58%,CD44;HLA-DPB1;TNFSF18;DUOX1;LCP1;TEC;SLA;HCK;HLA-C;PSMA7;STX4;IL31RA;CEBPD;TMSB4X;OAS3;B2M;CD4;LTBR;PSMD7;SKP1;UBC;GHR;EIF5A;IL11;SPI1;PSMB4;HLA-DRA;RBX1;IFI6;IL3RA;PSMC3;PRLR;IFIT1;ARF1;IL10RB;IFI27;OAS2;PRKACA;IFNGR2;CCND1;NOS2;LRP8;NDN
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6326937868897309,1.1664313315624504,0.2909090909090909,1.0,1.0,11/24,20.74%,POSTN;NRP1;LPL;JAG1;ITGAV;FGFR1;COL5A2;TIMP1;VEGFA;PTK2;VCAN
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6453246416512641,-1.166272123321361,0.2909090909090909,1.0,1.0,1/10,0.58%,CLDN4
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.5805310990275425,-1.1662627771798983,0.29411764705882354,1.0,1.0,4/18,3.89%,NCKAP1L;RAC1;BST1;CD74
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.7571199125165005,1.1651193978271948,0.40384615384615385,1.0,1.0,1/5,5.61%,RPS6KA4
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6830207712412307,-1.1650942800318673,0.36363636363636365,1.0,1.0,9/9,31.73%,ATP5F1A;ATP5F1D;ATP5MC1;ATP5MC2;ATP5PD;ATP5F1C;ATP5PB;VPS9D1;ATP5MC3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.48634569494309343,-1.1647215018708648,0.25,1.0,1.0,18/146,11.14%,SELP;CD9;CLU;F5;SERPINE1;F8;SYT6;TMSB4X;ANXA5;CDK5;PCYOX1L;CD63;CALM1;SCG3;RAB31;SPARC;CFD;MAGED2
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.730606478320443,-1.1643915813518746,0.3333333333333333,1.0,1.0,3/5,20.73%,COLEC12;APOA1;FLOT1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.5683310167090347,1.1641653459038286,0.23529411764705882,1.0,1.0,14/30,26.22%,GABRG3;GRID2;GABRA4;INSYN2A;MEF2C;GABRA2;GABRG1;GABRA5;MPP2;LRRK2;GRIN2A;GABRG2;GRIN2B;ARRB2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.5038716513919481,-1.164037718479541,0.18181818181818182,1.0,1.0,16/85,21.88%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;TRMT112;MRPS18C;MRPL9;MRPL19;MRPS21;MRPL27;MRPL51;MRPS33;MRPL37;MRPS22;MRPS11
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5583353862199498,1.1639828283577178,0.24489795918367346,1.0,1.0,5/23,13.64%,RUNX1;ZBTB1;NFATC2;CAMK4;MDK
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.7735035727776077,1.1639321001994596,0.26666666666666666,1.0,1.0,1/5,2.63%,ENPP1
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.7914543517292979,-1.1638870689757599,0.28846153846153844,1.0,1.0,1/5,5.11%,ANO1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6188393936350136,1.1627954833866072,0.3829787234042553,1.0,1.0,4/17,16.14%,ACKR3;CCL5;CXCL12;SLC12A2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.6768102904770834,-1.1627569950008252,0.30612244897959184,1.0,1.0,3/11,20.85%,SEC62;SGTB;SEC61G
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.5834394796883561,1.1627476402929393,0.2857142857142857,1.0,1.0,6/36,8.60%,MARVELD3;ESAM;FRMPD2;PARD3;ECT2;PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.8137363293260967,-1.1622962613023695,0.29545454545454547,1.0,1.0,2/5,7.78%,MRLN;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5762135478626361,1.1622276157995732,0.26,1.0,1.0,6/19,20.80%,ZBTB20;HIF1A;SLC4A4;P2RX7;ARNT;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5762135478626361,1.1622276157995732,0.26,1.0,1.0,6/19,20.80%,ZBTB20;HIF1A;SLC4A4;P2RX7;ARNT;INSR
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.5644364365217761,1.1622177379722833,0.21568627450980393,1.0,1.0,9/28,9.55%,SYK;HMGB1;WNT5A;AGER;CSF1R;TWIST1;HIF1A;LPL;MBP
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.7838417082478877,-1.162028377281929,0.3469387755102041,1.0,1.0,3/5,18.77%,HPGD;PTGR1;LTC4S
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.6582660760359931,1.1620106565902109,0.2608695652173913,1.0,1.0,4/16,10.27%,SLC39A12;SLC30A8;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.6819842264467716,-1.161795591387733,0.3617021276595745,1.0,1.0,2/16,2.51%,INHA;CYP19A1
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.7643537827177109,1.1617634323772144,0.2777777777777778,1.0,1.0,2/5,16.69%,MICU1;CLN3
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7226809604149929,1.1616691785806583,0.38461538461538464,1.0,1.0,2/7,9.71%,SYK;FER
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.7214979487035551,1.1616587694238258,0.35714285714285715,1.0,1.0,2/7,16.70%,GLA;HEXB
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.7163367272780314,-1.1612978048889406,0.3333333333333333,1.0,1.0,1/7,5.94%,PCCB
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5392545920968849,-1.161247114629711,0.22033898305084745,1.0,1.0,12/55,11.19%,CLDN4;CBLC;SH3RF2;TMEM184A;ANO1;BTN3A1;GPR39;CLDN1;PRLR;BTC;BTN2A2;ATP2C2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.47705673952142524,1.160978305625354,0.16071428571428573,1.0,1.0,20/75,19.35%,VAPB;SLC8A1;PKHD1;ATP2B4;CCL5;EDN1;ATP12A;TRDN;NPTN;ANK2;CXCL12;SLC24A2;SLC9A1;KCNJ2;TMEM203;SLC12A2;NEDD4L;SLC24A4;STIM1;ATP1A2
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6366422136068801,1.1608023389436093,0.21951219512195122,1.0,1.0,4/18,10.99%,PLCB1;CHRM3;CHRM2;GNAQ
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7257596357152625,1.1607958034664025,0.3793103448275862,1.0,1.0,2/6,9.71%,SYK;FER
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6084702327825215,1.1604878013123032,0.2127659574468085,1.0,1.0,7/21,13.26%,HS6ST3;HS3ST5;SULF1;HS2ST1;HS3ST3B1;UGDH;EXT1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6414221375078483,-1.160415628405584,0.3829787234042553,1.0,1.0,7/15,30.91%,WBP4;RBM22;SNRNP200;DCPS;SFSWAP;SNRPC;CACTIN
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.7381114904154535,1.1603541646349824,0.32,1.0,1.0,2/5,6.33%,EGFR;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.7613875822267284,1.1599632697096198,0.2727272727272727,1.0,1.0,2/5,7.63%,RNF128;LDLR
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6787436615716993,1.1599596391271632,0.34615384615384615,1.0,1.0,3/9,18.34%,SHROOM2;TENM3;VEGFA
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.5502294184434461,1.1599434353168518,0.20754716981132076,1.0,1.0,7/32,9.45%,NRG1;ADAMTS9;HEY1;SGCZ;SMAD5;SMAD1;BMPR1A
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.6546576331803621,-1.1598323191090785,0.2909090909090909,1.0,1.0,2/13,3.30%,CYP19A1;HSD17B10
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.4717393541166422,1.1597426209796071,0.17857142857142858,1.0,1.0,23/163,9.65%,SGK3;SGK2;PMP2;CREB5;LRRTM3;FGFR2;ENPP6;SLC39A12;PEX5L;NRXN1;GFAP;KIF6;ANLN;GRM5;TMEM63A;AMER2;CA10;SLC1A2;DLG2;MBP;MYO1D;GPM6B;TSPAN15
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5765044671425554,1.1597332188166616,0.2391304347826087,1.0,1.0,9/32,12.28%,CERS3;WNT5A;USH2A;ACER1;SCEL;HDAC2;JAG1;ST14;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.7051335464438573,1.159628472253336,0.32727272727272727,1.0,1.0,2/9,10.34%,BAG2;ADAM8
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6122836625993233,1.1594680277631166,0.22448979591836735,1.0,1.0,3/19,4.90%,AEN;IFI16;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.610963988352336,-1.1593010705950144,0.34545454545454546,1.0,1.0,4/21,5.52%,SFRP1;SPRED3;SPRED2;SPRY1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4837619931818367,1.1592636968281191,0.1320754716981132,1.0,1.0,35/135,14.95%,CADM2;NKAIN2;GDAP1;LSAMP;LRRTM3;OLFM3;MAGI2;NRXN1;ADGRB3;KCTD16;GRM5;GRIA4;PTPRD;AMER2;CA10;LRFN5;ELAVL4;RAB3C;SH3GL2;DLG2;ZDHHC2;NOVA1;CLGN;SYNPR;RBFOX1;ASXL3;ASIC2;ANK2;ZNF536;PPFIA2;FGF13;RGS7BP;ERC2;GRIA2;CSRNP3
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7489104063895571,-1.1592177784459834,0.30357142857142855,1.0,1.0,4/7,22.14%,SUPV3L1;TRMT10C;TRMT10B;TBRG4
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7205972908390281,1.1588348905706543,0.3409090909090909,1.0,1.0,3/9,6.82%,IRS1;IRS2;SNCA
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.7168829992959026,-1.1587762270045097,0.33962264150943394,1.0,1.0,2/5,9.30%,AGBL3;AGBL1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.6389433955740111,1.1584100815509217,0.30434782608695654,1.0,1.0,4/14,17.05%,RUNX1;HDAC2;SCX;VIM
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.4875532067942569,1.1583999582415263,0.23529411764705882,1.0,1.0,18/52,21.22%,IRS1;PPARG;ADIPOR2;LEPR;SLC30A8;MCU;IGF1R;ADIPOR1;KLF7;CRY1;BAD;MBD5;PDK4;PDK2;PYGL;CAV3;INSR;TENT4B
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.5958583925179814,-1.1583572431883795,0.23636363636363636,1.0,1.0,4/30,8.11%,GSTM5;GSTM3;CHAC1;GSTK1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6685055830142705,1.1581957423639224,0.3,1.0,1.0,4/11,20.37%,TRIM8;MID2;TRIM5;TRIM32
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7493448038105087,1.158148514355631,0.32653061224489793,1.0,1.0,1/5,1.50%,ALDH1A1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5866911228488841,1.157871749114037,0.2653061224489796,1.0,1.0,6/27,13.88%,TCF7L1;TLE3;TLE1;RBBP5;CTNNB1;EP300
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.5605384159603577,1.157512336223795,0.28,1.0,1.0,9/33,15.33%,CEL;NLGN1;SYNJ2;SNCA;SYT1;NLGN4X;DNAJC6;SYT2;PICALM
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7092321525774257,-1.157377723052167,0.36585365853658536,1.0,1.0,4/6,19.71%,RAD51AP1;NPM2;PRDM7;MEIOSIN
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.7345638673402182,-1.1569683565408568,0.29411764705882354,1.0,1.0,3/7,9.30%,FOLH1;AGBL3;AGBL1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7558596464026787,1.1568648545308577,0.3,1.0,1.0,4/7,14.82%,ANO7;PLSCR2;P2RX7;PLSCR5
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7463001322419062,-1.1566767918107972,0.37037037037037035,1.0,1.0,1/7,1.56%,SIGIRR
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.48982309993077283,1.1566146137444362,0.18604651162790697,1.0,1.0,46/126,17.17%,CADM2;LRRC4C;LSAMP;LRRTM3;OLFM3;NRXN1;ADGRB3;ROBO1;NXPH1;EPHA3;HIVEP2;SLC35F1;ROBO2;GRIA4;AMER2;ADGRL3;ELAVL4;RAB3C;NPAS3;FEZF2;CTNNA2;EPHA7;FUT9;GPM6B;SOX5;NOL4;NOVA1;SYNPR;RBFOX1;NOTCH3;UNC79;ANK2;ZNF536;PPFIA2;FAT3;ERC2;BCL2;GRIA2;CREB1;CSRNP3;CTNND2;PCLO;MAPK4;ATRNL1;PROX1;DCLK1
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.7381806708527401,-1.1563881514282524,0.3728813559322034,1.0,1.0,2/6,10.53%,DRD1;DRD3
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.7132546413803982,-1.156337043191218,0.3137254901960784,1.0,1.0,1/6,0.84%,HEBP2
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.7608933085957472,1.156319504611135,0.3877551020408163,1.0,1.0,1/5,0.98%,HORMAD1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5067746697267844,1.1560895649599199,0.22916666666666666,1.0,1.0,11/64,12.87%,ACE2;CORIN;SMAD7;SLC8A1;ATP2B4;CELF2;NPR2;PDE4D;ITPR1;TRDN;ANK2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5203284830006422,-1.1558801631059108,0.2826086956521739,1.0,1.0,7/48,6.56%,SIGLEC1;AOAH;HCK;NLRP3;KLHDC4;PLET1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.620161397993643,-1.1558728521658397,0.2413793103448276,1.0,1.0,1/17,1.74%,CLU
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6648950584163931,1.1546707852778066,0.3333333333333333,1.0,1.0,3/9,14.22%,CHPT1;DHRS7B;PLA2G4C
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7673103424110301,1.1542958034495268,0.34210526315789475,1.0,1.0,1/6,5.98%,FHIT
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7673676757682324,1.1542732441311108,0.37037037037037035,1.0,1.0,2/8,9.92%,FAS;FOXO1
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.7087100877518038,-1.1535223947823703,0.32075471698113206,1.0,1.0,2/9,13.48%,IFIT1;ISG15
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.595578433519991,1.1531289380023357,0.27419354838709675,1.0,1.0,4/26,6.62%,CALCR;RXFP2;FSHR;LGR5
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.7452091816911564,1.1527543531606428,0.3584905660377358,1.0,1.0,2/5,14.78%,CDO1;MPST
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.7048019895986524,-1.1526971403113058,0.30357142857142855,1.0,1.0,3/6,23.14%,FUZ;BRSK2;CELSR1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.7022541640225993,1.1526604301025631,0.35294117647058826,1.0,1.0,2/6,6.54%,GABRB1;GABRB2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.6441790172870183,-1.1521726772074763,0.2711864406779661,1.0,1.0,2/12,7.65%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6281491940783925,1.1521725117420627,0.3333333333333333,1.0,1.0,6/12,32.77%,REEP1;RAB10;TMEM33;ATL1;ATL2;REEP2
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.6495813929252704,1.1518326992407408,0.3673469387755102,1.0,1.0,1/8,3.63%,IDO1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.6987016285696865,-1.1517268713624194,0.32608695652173914,1.0,1.0,2/6,17.22%,SLC6A20;SLC6A7
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5779080145942658,1.15157082890398,0.3,1.0,1.0,6/21,19.03%,ENPP1;HEY1;TWIST1;ECM1;ANKH;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.7348953264752414,-1.151454306226197,0.30612244897959184,1.0,1.0,3/7,17.00%,IL4I1;HLA-DRA;CR1
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),-0.7653512488110374,-1.1513744289142844,0.35714285714285715,1.0,1.0,1/5,3.76%,PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),-0.7653512488110374,-1.1513744289142844,0.35714285714285715,1.0,1.0,1/5,3.76%,PDZD7
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5763062849082605,-1.151039799572015,0.36538461538461536,1.0,1.0,5/27,8.82%,NUPR1;CLU;PSMC3;KCNE2;DDRGK1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.6260110777530936,-1.150963316738909,0.2857142857142857,1.0,1.0,2/12,16.06%,ANAPC15;XRCC3
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7003952402095327,1.1508995197087841,0.35294117647058826,1.0,1.0,6/9,23.87%,DNAJB2;SNCAIP;HSPA1A;SACS;DNAJB1;BAG5
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.665470316621389,1.1507639297647887,0.39285714285714285,1.0,1.0,3/8,10.87%,NLGN1;NRXN1;TMEM108
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7535034223261033,-1.150517293102401,0.32142857142857145,1.0,1.0,2/5,14.70%,VPS25;VPS28
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.7535034223261033,-1.150517293102401,0.32142857142857145,1.0,1.0,2/5,14.70%,VPS25;VPS28
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.5167409936734039,1.1504588013439223,0.25862068965517243,1.0,1.0,11/80,6.92%,ENPEP;SGK2;COL22A1;CALCR;CORIN;PPARGC1A;OIT3;CYP3A4;OPRK1;C6;RNF128
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.718244306363138,-1.1500196120075508,0.3090909090909091,1.0,1.0,4/8,12.17%,KIF25;NSFL1C;RANBP1;CHEK1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.568163484820585,1.1500135830395832,0.19148936170212766,1.0,1.0,11/31,14.69%,AEN;IFI16;DDIT4;FHIT;ZNF385B;DYRK2;PPP1R13B;SIRT1;EP300;BOK;TP53BP2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.4809572300178456,-1.1497770806745564,0.2413793103448276,1.0,1.0,18/93,15.99%,TPPP3;LCP1;TRABD2A;CLU;WARS1;ERCC1;RBX1;GTF2H2;PSMC3;BAK1;RACK1;DDB1;ISG15;TTBK1;PSMC4;BIK;PARP1;ERCC2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.5869135778537806,1.1497397358759456,0.2553191489361702,1.0,1.0,6/28,18.34%,KLF2;GLRA2;SH3BP4;CPEB4;CPEB3;VEGFA
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.6056360292860214,1.1495922075812366,0.2641509433962264,1.0,1.0,4/27,9.54%,SLC26A3;SLC26A7;SLC22A6;ABCC11
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7180639583035439,1.1495729223718447,0.3673469387755102,1.0,1.0,2/7,14.69%,BOK;TP53BP2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.7054827832240628,1.1488664938637811,0.3076923076923077,1.0,1.0,3/9,16.49%,ITPKB;IP6K2;IPPK
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7063324941208897,1.1488093774158032,0.24074074074074073,1.0,1.0,2/10,5.23%,FGFR2;WNT5A
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6441477088603115,1.148774642197676,0.3023255813953488,1.0,1.0,4/9,20.29%,PPARG;PRKCB;VMP1;ZDHHC17
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.542271897610166,-1.1487046765871292,0.2413793103448276,1.0,1.0,4/32,6.56%,NCKAP1L;LDB1;ETS1;SPI1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6601565146649068,-1.1486226225492264,0.3695652173913043,1.0,1.0,5/10,29.31%,WRAP53;CCT2;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.5972875664779611,-1.14853014989412,0.3404255319148936,1.0,1.0,4/15,10.53%,ADRA2A;DRD1;ADRA1D;DRD3
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5747279542812797,-1.1485292205376727,0.2545454545454545,1.0,1.0,1/24,0.41%,RTP5
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.6051080294289454,1.1484121657638293,0.2978723404255319,1.0,1.0,4/23,14.80%,PRELP;B4GALT1;CHST6;B3GNT2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.6115010662024472,1.1481930562728568,0.30434782608695654,1.0,1.0,2/17,8.60%,CHMP6;PDCD6IP
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.8027560705322027,-1.1481317135951699,0.40350877192982454,1.0,1.0,2/5,12.80%,PDHX;PDHA1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.68745533740238,1.1481248635729904,0.3148148148148148,1.0,1.0,2/7,10.11%,HEY1;JAG1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7170480683979212,1.1480809951756552,0.32653061224489793,1.0,1.0,3/8,15.63%,HPRT1;DPYD;GMPS
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.6717786183567261,1.1480668371155933,0.3673469387755102,1.0,1.0,2/9,12.25%,DGAT2;SIRT1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.4994843176153681,-1.148023522801214,0.2545454545454545,1.0,1.0,15/79,21.88%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS18C;MRPL9;MRPL19;MRPS21;MRPL27;MRPL51;MRPS33;MRPL37;MRPS22;MRPS11
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.7206311647517079,1.1476808162326635,0.36363636363636365,1.0,1.0,2/7,8.82%,HMGB1;CCL5
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7253385031786961,1.1476502675485871,0.3541666666666667,1.0,1.0,3/7,17.04%,NEDD4;COMMD1;NEDD4L
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5421443125363256,-1.1476484966844507,0.23404255319148937,1.0,1.0,9/52,7.43%,NCKAP1L;HLA-DPB1;SIGLEC1;AOAH;HCK;CD74;SPI1;HLA-DRA;CLDN1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7048362001684056,1.1475739340560138,0.34545454545454546,1.0,1.0,2/9,5.19%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.5922817092587056,1.1475461385867056,0.30612244897959184,1.0,1.0,1/20,0.33%,ENPEP
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7124216870189819,-1.1475242507359427,0.2765957446808511,1.0,1.0,3/8,2.42%,RTP5;GNAT3;AZGP1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5378007534947596,1.1474658427315747,0.2608695652173913,1.0,1.0,2/36,0.76%,ACE2;UTS2R
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6689282682381509,1.1474582820311527,0.2857142857142857,1.0,1.0,1/10,2.24%,PLD6
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.668495726851228,-1.1473134097029616,0.3333333333333333,1.0,1.0,4/12,17.66%,SERPINE1;CHAC1;SERPINF2;THBS1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.738161733038883,1.147286726188473,0.24489795918367346,1.0,1.0,2/7,3.03%,CX3CR1;KLRD1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6655809421274359,1.1472764284395254,0.3508771929824561,1.0,1.0,3/10,18.38%,EPCAM;VEGFA;BMP6
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4987718387967811,1.1472042337065465,0.22916666666666666,1.0,1.0,21/72,18.42%,RALA;NLGN1;ANLN;GPM6A;NRP1;TENM2;MSTN;AUTS2;CEP120;PLCE1;WASF2;P2RX7;PIK3CA;TENM1;FNBP1L;PLEKHM1;ACTR3;PIK3R1;PLPPR5;BBS4;EPS8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.6029064598339362,1.14715450381807,0.2727272727272727,1.0,1.0,2/18,2.96%,NLRP2B;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.7091425819443483,1.1468712570984883,0.38461538461538464,1.0,1.0,3/6,11.81%,PPARG;ARG1;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.7091425819443483,1.1468712570984883,0.38461538461538464,1.0,1.0,3/6,11.81%,PPARG;ARG1;NR1H3
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.7432351098397932,1.146097966727482,0.32608695652173914,1.0,1.0,3/6,10.21%,OPRK1;SGK1;FGF10
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.7633184957496149,1.1460970834597952,0.32653061224489793,1.0,1.0,4/5,16.00%,SH3GL2;AUTS2;TMEM108;LLPH
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5172775360348185,-1.1458324148622814,0.2830188679245283,1.0,1.0,10/73,5.67%,P2RY10;CD5;TXK;GEM;MYB;KLRB1;TRBC2;TRAF3IP3;CD4;MAFF
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5046810491034008,-1.1454031261701023,0.21568627450980393,1.0,1.0,14/74,13.51%,STING1;DDX41;CGAS;DHX58;UBE2L6;POLR3A;NLRX1;POLR3E;UFD1;POLR3D;TRAF3IP1;POLR3H;ISG15;PIN1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.5555015583814109,-1.1454026866905616,0.32653061224489793,1.0,1.0,1/17,0.75%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.7971046595376903,-1.1451331389392965,0.36363636363636365,1.0,1.0,1/5,4.27%,DTX3L
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5655105984317376,1.145080113785176,0.2608695652173913,1.0,1.0,9/30,18.12%,HMGCS1;FDFT1;HMGCR;MSMO1;LBR;INSIG1;INSIG2;FDPS;PLPP6
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.5991627519501688,1.1449592945404579,0.32,1.0,1.0,5/15,17.46%,PIGP;PIGA;PIGV;PIGQ;PIGW
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.678075445068794,1.1449488586297245,0.3541666666666667,1.0,1.0,3/8,22.49%,FGFR2;SOX11;NIPBL
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.6789187435857204,1.1449028405511201,0.2830188679245283,1.0,1.0,3/11,3.10%,OXTR;ERBB4;SLC22A2
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.7311800539888622,-1.1448532180987667,0.3617021276595745,1.0,1.0,2/6,8.50%,CD74;CARD9
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5964544280131506,1.1447391883683533,0.36363636363636365,1.0,1.0,1/13,0.18%,SAMSN1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6049498871622956,-1.144648769867169,0.23636363636363636,1.0,1.0,6/15,26.62%,EMC8;CAMLG;EMC4;EMC1;EMC3;BAG6
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7345062451430177,-1.1446036641577184,0.40816326530612246,1.0,1.0,3/5,22.42%,RPF2;NOL8;RAN
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.7682025548140703,-1.1446025556315063,0.34,1.0,1.0,3/7,7.65%,SFRP1;MEOX1;ACE
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5021233744311976,-1.1445904621951413,0.26229508196721313,1.0,1.0,6/50,7.43%,DYSF;AHNAK2;FGF1;NOG;TPM1;CLDN1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6778525216888803,-1.1444205355902126,0.391304347826087,1.0,1.0,1/7,0.65%,DDX11
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.6945863796506714,-1.1441422053931143,0.3181818181818182,1.0,1.0,3/8,18.22%,ST6GAL1;PARP1;ST3GAL1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6928113779060229,-1.1440412278850904,0.35294117647058826,1.0,1.0,2/8,19.97%,ZRANB3;ZNF830
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5812185122273249,-1.1440091203803062,0.32653061224489793,1.0,1.0,1/17,1.05%,CCN3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6713854346313872,1.143501639537814,0.3673469387755102,1.0,1.0,1/10,3.01%,ZBTB1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4962512809522335,1.143117065522694,0.19230769230769232,1.0,1.0,17/69,16.07%,PTPRK;SMAD7;NLK;PARD3;TGFBR1;TWSG1;SMAD5;SMAD1;BMPR1A;SMAD2;SMAD9;SIRT1;SMAD3;SMURF1;ACVR1;GDF10;TGFBR3
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5494322570839849,-1.1429150352249438,0.2127659574468085,1.0,1.0,15/38,20.69%,HLA-C;OAS3;IFI6;IFIT1;IFI27;OAS2;STAT2;ISG15;RSAD2;PSMB8;IFIT5;IFIT2;IRAK1;STAT1;IRF1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5494322570839849,-1.1429150352249438,0.2127659574468085,1.0,1.0,15/38,20.69%,HLA-C;OAS3;IFI6;IFIT1;IFI27;OAS2;STAT2;ISG15;RSAD2;PSMB8;IFIT5;IFIT2;IRAK1;STAT1;IRF1
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),0.7482047890733277,1.1428553797632903,0.37037037037037035,1.0,1.0,2/5,3.04%,NDNF;ADIPOR2
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.7437904729693785,1.142760456715932,0.3076923076923077,1.0,1.0,1/5,13.24%,THPO
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.7193143500938304,-1.1426835968508207,0.3191489361702128,1.0,1.0,2/9,6.78%,TERF2IP;DAXX
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.7193143500938304,-1.1426835968508207,0.3191489361702128,1.0,1.0,2/9,6.78%,TERF2IP;DAXX
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5802139784739291,1.1425849394064962,0.2727272727272727,1.0,1.0,4/28,5.73%,PLCB1;SYK;HMGB1;AGER
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.7257158966361238,-1.1425531042821222,0.37209302325581395,1.0,1.0,1/5,13.68%,RSAD2
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4947156719466402,1.1424363243107698,0.24444444444444444,1.0,1.0,13/49,22.83%,LRRC4C;ROBO1;SLIT2;ROBO2;CDH2;LRP4;TIAM2;SIPA1L1;PLXNB2;EPHA4;PAK3;PLXNB1;NTRK2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.7881678726969253,1.1424173556382273,0.3050847457627119,1.0,1.0,2/5,7.51%,HSPB1;PRKD1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.7350576914826192,1.1423958282065956,0.38,1.0,1.0,3/7,22.57%,PRKD1;VEGFA;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.7413672158537006,1.1423345658890098,0.32608695652173914,1.0,1.0,4/6,19.91%,DLG2;CRHBP;SLC12A2;CACNA1H
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.7413672158537006,1.1423345658890098,0.32608695652173914,1.0,1.0,4/6,19.91%,DLG2;CRHBP;SLC12A2;CACNA1H
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.7568553364104279,-1.1422759134987663,0.33962264150943394,1.0,1.0,1/5,7.85%,PSMC3
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6661599517511942,1.1418054927485835,0.35714285714285715,1.0,1.0,3/9,20.01%,GBE1;UGP2;PYGL
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.6335703787049556,-1.1417676239743684,0.3469387755102041,1.0,1.0,1/12,0.84%,HEBP2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.5087958826192815,-1.1416683133982195,0.3111111111111111,1.0,1.0,6/48,9.46%,PLK3;AURKA;GADD45A;TRIAP1;PLK2;PIDD1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.660091231524281,1.141575944086274,0.36363636363636365,1.0,1.0,3/8,6.79%,NRXN1;PCDH15;MYO7A
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.6418757454724272,1.1415710428683785,0.30357142857142855,1.0,1.0,3/9,15.46%,ENPP1;PID1;PRKCB
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5464205221741086,-1.1415128275751036,0.32075471698113206,1.0,1.0,10/64,8.57%,SELP;CD9;AOAH;PLK3;HCK;TSPAN32;MAFG;SPI1;PRAM1;PDE6B
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5935312911860061,-1.1414515722131002,0.2549019607843137,1.0,1.0,2/24,3.36%,DDX11;HMGB3
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6786949817866792,1.1411747599313367,0.4166666666666667,1.0,1.0,3/9,24.68%,RNF139;STX18;LRRK2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.7080561879881939,1.141087849579396,0.3508771929824561,1.0,1.0,5/9,21.14%,SELPLG;RELA;PID1;ST3GAL6;NFKB1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.7289786596066836,-1.140905449978355,0.37254901960784315,1.0,1.0,1/7,4.44%,SLX4
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7337053023100022,1.1408714060848844,0.3181818181818182,1.0,1.0,3/6,18.34%,SH3GL2;TJP3;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6377811156600026,1.1408608442578225,0.3148148148148148,1.0,1.0,2/12,3.79%,SYK;HMGB1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6463000465050881,1.1406907916696956,0.3333333333333333,1.0,1.0,4/14,12.25%,HDAC9;HDAC2;HDAC3;SIRT1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7130835465113193,-1.1406162643073232,0.40816326530612246,1.0,1.0,2/5,13.18%,DBI;SVIP
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.7323423935550755,-1.140525196132681,0.32653061224489793,1.0,1.0,2/8,11.87%,SPI1;TAF7
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.5271336798230779,1.1403208598746446,0.24444444444444444,1.0,1.0,5/28,11.29%,SLC8A1;JPH1;MICU1;MCU;MAIP1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.5878451059172539,-1.1399858716938251,0.3018867924528302,1.0,1.0,5/25,9.85%,KIF25;DCTN1;SPDL1;LLGL2;NSFL1C
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.749013718045109,1.139940726843251,0.3673469387755102,1.0,1.0,1/5,0.91%,COL22A1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.7386945858210127,-1.139895537842277,0.34782608695652173,1.0,1.0,3/6,21.87%,CEACAM1;IL12A;PVR
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5824507839912549,-1.1396217213078845,0.2641509433962264,1.0,1.0,5/19,5.52%,SPRY4;NOG;LRIT3;GPC1;SPRY1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.6501038584995124,1.1394078143078188,0.3898305084745763,1.0,1.0,2/9,9.54%,ABCC2;ABCC11
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5876996198043665,-1.1393297653687595,0.2641509433962264,1.0,1.0,3/33,5.93%,HLA-DPB1;TXK;BTN3A1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.6088277609702691,1.139152204140745,0.25,1.0,1.0,4/18,10.13%,DGAT2;AGMO;PLA2G15;PLCE1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6400591521305463,1.1391224574512486,0.375,1.0,1.0,3/14,11.81%,PPARG;PPARGC1A;NR1H3
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5506088745084704,1.1388750330669688,0.3018867924528302,1.0,1.0,11/28,19.27%,NRG1;ERBB4;EGFR;GAB1;PRKCA;PIK3CA;ERBIN;NRG2;PIK3R1;PTPN12;SOS1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.6302856521245587,1.1388398159931696,0.3023255813953488,1.0,1.0,3/16,10.22%,NLGN1;DOC2B;RAB27A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6166216308050728,1.1387930962573256,0.28888888888888886,1.0,1.0,5/16,20.01%,LEPR;GBE1;PID1;UGP2;PYGL
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4900026997924025,-1.1387259521455013,0.23333333333333334,1.0,1.0,23/61,21.32%,MYB;LDB1;PSMA7;PSMD7;SPI1;PSMB4;PSMC3;PSMD8;PSME1;METTL3;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7040034580811063,1.1387039242398207,0.36363636363636365,1.0,1.0,3/7,18.82%,RFX3;FOXO1;BAD
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.6392625411405639,-1.1386850021640689,0.390625,1.0,1.0,2/17,6.19%,FGF1;MBTPS2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.4901794689441772,-1.138629695153673,0.26785714285714285,1.0,1.0,17/93,15.75%,SELP;TRABD2A;CLU;HCK;STX1B;WARS1;CRYAB;PINK1;BAK1;TRAF3IP1;RACK1;TMC8;SVIP;PRKCZ;BIK;KIF9;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6175590463799994,1.1385967803370824,0.37209302325581395,1.0,1.0,5/18,16.29%,IRS1;IRS2;SORBS1;PIK3R1;AKT2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.6522291736343222,1.1383935104120257,0.2708333333333333,1.0,1.0,3/13,13.71%,SLIT2;MDK;MTUS1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.7525301074832502,-1.138293337033693,0.2982456140350877,1.0,1.0,4/7,14.43%,METAP2;FKBP10;METAP1D;APOA1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.6454091426325362,1.1382668668959766,0.3333333333333333,1.0,1.0,3/13,10.84%,CD8A;JAG1;CADM1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.6980621637827802,1.1380284143858144,0.36363636363636365,1.0,1.0,2/9,6.82%,THRSP;SNCA
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6374248763922448,1.1378441398456045,0.35714285714285715,1.0,1.0,2/12,11.88%,SYNE4;RAP2A
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5933668611318172,-1.137270283217897,0.35185185185185186,1.0,1.0,2/14,7.81%,KIF25;LLGL2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5274625751834566,-1.1372627701431723,0.22641509433962265,1.0,1.0,10/60,15.93%,SARS1;C2ORF49;TRPT1;CPSF1;CPSF4;AARS2;POP7;POP1;TRMT10C;POP5
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5684386868553808,1.1370569381614457,0.2926829268292683,1.0,1.0,6/30,9.43%,RUNX1;PNP;NAV3;PDE4B;ZFP36;PDE4D
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5746298653995515,1.1366815215133728,0.3387096774193548,1.0,1.0,7/18,23.18%,DXO;RIDA;FTO;MEX3D;ROCK2;PUM1;YTHDF3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.5159605435569307,1.1366685708048978,0.30612244897959184,1.0,1.0,8/34,19.96%,B4GALNT2;EPCAM;MBP;JAG1;ADTRP;VEGFA;BMP6;PTK2
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.7043220830892801,1.1366233502164125,0.375,1.0,1.0,1/5,3.47%,JAM2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.6908558050073247,1.1363701179909875,0.3148148148148148,1.0,1.0,3/8,22.49%,GLI3;COL5A2;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.6265335480700005,-1.136168656339435,0.2903225806451613,1.0,1.0,1/12,1.05%,CCN3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6398533462230778,-1.135997998618099,0.3617021276595745,1.0,1.0,7/11,24.38%,COX4I1;COX6C;COX6B1;COX7B;COX5B;COX7C;COX5A
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.7118168083455796,1.1358466503423474,0.391304347826087,1.0,1.0,1/7,5.92%,MLLT3
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5231773789169953,-1.1358365205509926,0.288135593220339,1.0,1.0,26/43,26.05%,PSMA7;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;PSMA5;AZIN1;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.49765551780898476,-1.1357182237479746,0.28,1.0,1.0,4/59,4.39%,NCKAP1L;HCK;RAC1;VAV3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.49765551780898476,-1.1357182237479746,0.28,1.0,1.0,4/59,4.39%,NCKAP1L;HCK;RAC1;VAV3
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.7403306227617623,1.1356594579876782,0.42857142857142855,1.0,1.0,1/6,1.19%,CALCR
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.7222731416817154,1.135542504233061,0.32608695652173914,1.0,1.0,3/8,10.77%,PGM5;TMOD1;TMOD4
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5618311524142912,1.135011133549622,0.38095238095238093,1.0,1.0,5/29,10.21%,PLCB1;UBE2E2;EGFR;ANKRD17;FGF10
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.6809846666563102,-1.1348389233925935,0.3548387096774194,1.0,1.0,3/8,8.82%,TMSB4X;ZNF593;DDRGK1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.4907159894820097,-1.1347238924348146,0.29411764705882354,1.0,1.0,26/77,19.69%,HLA-C;CD74;DHX58;EPSTI1;B2M;UBE2L6;WARS1;IFI44;CMTR1;PARP14;IFI27;STAT2;PSME1;TMEM140;GMPR;ISG15;LAMP3;RSAD2;PSMB8;PROCR;IFIT2;DDX60;LY6E;TRIM25;PSME2;OGFR
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.5951903897144657,-1.1346741087174197,0.3170731707317073,1.0,1.0,2/11,8.54%,ADRA2A;PACSIN3
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.6756594837914519,1.1345592498198263,0.325,1.0,1.0,2/7,13.55%,PNP;ABCG2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7002871400269626,-1.1344443158797184,0.40425531914893614,1.0,1.0,2/6,21.19%,LLGL2;SLC7A5
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.7217557374494268,-1.1343359587861828,0.3333333333333333,1.0,1.0,2/6,13.88%,EXOSC10;EXOSC4
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5674408181221915,-1.1342502644981363,0.3137254901960784,1.0,1.0,4/42,4.58%,DDX11;NTRK1;CACNB1;CDK5
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.6636095698737564,1.1340819342174844,0.3469387755102041,1.0,1.0,3/12,8.94%,PNP;SYK;GLI3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.7137551237902046,-1.1340445848862368,0.30952380952380953,1.0,1.0,4/5,28.64%,RFPL1;RPS3;RFFL;RNF34
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.6137560556371404,1.134036545728277,0.32727272727272727,1.0,1.0,5/18,10.27%,SLC39A12;SLC30A8;MT1M;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.6349555510114208,-1.1334022072584464,0.32075471698113206,1.0,1.0,3/19,6.99%,TEKT3;TEKT5;DNAH2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6223220305859022,1.1331770879828222,0.37777777777777777,1.0,1.0,2/15,12.25%,HSPB1;SIRT1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6174196871329228,1.133154996221442,0.39285714285714285,1.0,1.0,4/18,19.12%,NEDD4;HIF1A;PRKCB;ARNT
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.7528847236650236,-1.1330066108706183,0.37254901960784315,1.0,1.0,2/5,13.40%,SLC25A10;SLC13A3
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.7528847236650236,-1.1330066108706183,0.37254901960784315,1.0,1.0,2/5,13.40%,SLC25A10;SLC13A3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6305785064209161,-1.1329595931757435,0.32,1.0,1.0,4/10,23.97%,EMC8;EMC4;EMC1;EMC3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6438791239582125,1.132933743193582,0.32142857142857145,1.0,1.0,2/14,3.20%,RUNX1;LEPR
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6667107705461355,1.1328236767995037,0.3076923076923077,1.0,1.0,4/11,9.34%,IRS1;AKR1C1;DGAT2;LPL
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.7699088904572761,-1.1326556142884683,0.40350877192982454,1.0,1.0,1/5,4.50%,PRKCH
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6577349632375564,1.1325835353558182,0.375,1.0,1.0,4/13,16.69%,SHISA9;GRIK2;PPFIA3;CLN3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7292839753607592,-1.1325809611494733,0.3617021276595745,1.0,1.0,2/7,8.84%,SFRP1;BTG1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5490727704966184,-1.1325125037930979,0.30952380952380953,1.0,1.0,8/45,6.01%,P2RY10;NCKAP1L;CD5;SLA;AOAH;TRAF3IP3;CD4;CD37
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.6264615915770593,-1.1323669327611263,0.3392857142857143,1.0,1.0,5/12,12.52%,GPR37;TXN;MET;RACK1;PDE8A
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.710219852419213,1.132073681305138,0.4222222222222222,1.0,1.0,1/6,9.49%,AUTS2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.6442721305314173,-1.1313681606223416,0.3409090909090909,1.0,1.0,3/14,15.57%,NUPR1;FIS1;PARP1
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.7492320691426245,1.1308409503801096,0.4074074074074074,1.0,1.0,1/5,3.10%,SLC22A2
prerank,GO_Biological_Process_2021__norepinephrine transport (GO:0015874),0.7492320691426245,1.1308409503801096,0.4074074074074074,1.0,1.0,1/5,3.10%,SLC22A2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6537848575485712,-1.1307843145518834,0.3333333333333333,1.0,1.0,2/9,4.93%,TK2;PUDP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6537848575485712,-1.1307843145518834,0.3333333333333333,1.0,1.0,2/9,4.93%,TK2;PUDP
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.511470143149133,-1.130253807707188,0.30434782608695654,1.0,1.0,16/78,15.57%,INHA;TERF2IP;NUPR1;WARS1;ATG14;ANKLE2;MYADM;IGFBP3;NIBAN1;TRAF3IP1;PIP5KL1;CDKN2B;PRKRIP1;NPRL2;PRDX3;BMP7
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7307752206321161,-1.1294261619266255,0.39344262295081966,1.0,1.0,1/5,6.39%,D2HGDH
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.504469672728447,-1.1292007362965413,0.2830188679245283,1.0,1.0,18/50,24.69%,NDUFC1;NDUFS5;NDUFA1;NDUFB9;NDUFAF3;NDUFA3;NDUFS6;NDUFAB1;NDUFB10;TMEM126B;NDUFS2;NDUFA5;NDUFA10;NDUFAF5;NDUFA12;NDUFS8;NUBPL;TMEM126A
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.504469672728447,-1.1292007362965413,0.2830188679245283,1.0,1.0,18/50,24.69%,NDUFC1;NDUFS5;NDUFA1;NDUFB9;NDUFAF3;NDUFA3;NDUFS6;NDUFAB1;NDUFB10;TMEM126B;NDUFS2;NDUFA5;NDUFA10;NDUFAF5;NDUFA12;NDUFS8;NUBPL;TMEM126A
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.6585468783240362,-1.1288532583888484,0.3389830508474576,1.0,1.0,3/10,6.87%,ACOT4;IL4I1;BCKDK
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7187304056142013,1.1284824384858405,0.3695652173913043,1.0,1.0,3/6,21.14%,ZSWIM8;RELA;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.5739639859145554,-1.1281371242659066,0.23076923076923078,1.0,1.0,4/16,5.24%,NCKAP1L;RAC1;CD74;XG
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5129822822477863,-1.1280682438721281,0.2830188679245283,1.0,1.0,4/59,4.12%,P2RY10;RAC1;F2RL2;PRAG1
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7181007170159267,-1.1279828375469911,0.425531914893617,1.0,1.0,2/5,13.50%,KCNE1;GDI1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.5384950105183939,-1.1278062598404521,0.2459016393442623,1.0,1.0,2/24,7.81%,LCP1;LLGL2
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6751376504507045,-1.1277232072457575,0.3225806451612903,1.0,1.0,3/11,6.38%,TMIE;NOG;PAX8
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7074363865108902,1.1273846887302208,0.32142857142857145,1.0,1.0,3/7,25.17%,LIG4;MSH2;MSH6
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.506660270289342,1.1273258859500257,0.26666666666666666,1.0,1.0,15/47,21.06%,PPARG;PPARGC1A;STEAP4;CTBP2;ZNF516;FOXO1;BBS9;SIRT1;INHBB;EP300;PID1;AKT2;BBS4;TRIM32;WNT5B
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.7147963601803861,-1.1271637102016878,0.375,1.0,1.0,1/11,0.66%,INHA
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.7246234831117127,-1.1266228830827998,0.3191489361702128,1.0,1.0,3/6,18.61%,DIRAS3;CTCF;PRMT7
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7518876184423218,1.126285520078184,0.38,1.0,1.0,1/5,6.69%,OPRK1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5254582386784687,1.1262753797920544,0.28846153846153844,1.0,1.0,12/56,13.52%,MAP3K11;PIK3R5;ROBO1;EGFR;DVL2;PDGFRB;ADAM8;EDN1;FGFR1;PDGFD;TENM1;SASH1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.6241043953029218,1.126227284154141,0.391304347826087,1.0,1.0,4/10,27.26%,TRDN;ANK2;RYR2;DIAPH1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.5119621673286439,1.1260684964458278,0.32142857142857145,1.0,1.0,7/36,12.29%,MYBPC3;FLRT2;TGFBR1;HEY1;BMPR1A;CHD7;TBX19
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7518214773915184,-1.1258858856014078,0.35294117647058826,1.0,1.0,2/5,13.39%,NLRP3;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.7518214773915184,-1.1258858856014078,0.35294117647058826,1.0,1.0,2/5,13.39%,NLRP3;PRKCZ
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.523639418629142,1.1258349053445977,0.2826086956521739,1.0,1.0,11/42,17.08%,NRG1;ZBTB1;FGFR2;TGFBR1;COBL;FGF10;ARID5B;MDK;TGFBR3;SALL1;PROX1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.44787327301719393,-1.1255922994802245,0.21568627450980393,1.0,1.0,7/160,3.41%,CYP1A2;HSD11B1;UPB1;SERPINE1;CYP2E1;CASP6;PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.625684432133896,1.1253546266680974,0.3448275862068966,1.0,1.0,5/14,19.58%,ITGAX;PARD3;RIMS2;ATPSCKMT;MYRF
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.5267709201000956,-1.1251030718067498,0.3157894736842105,1.0,1.0,14/33,28.55%,NGDN;NOP14;RPS8;TSR2;NOB1;NAT10;MRPS11;RPS14;WDR46;DHX37;LSM6;TSR3;SNU13;RPS16
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.5657367245528226,-1.124983814503657,0.3829787234042553,1.0,1.0,6/24,14.84%,ADRA2A;BTC;BCAR3;DGKD;EREG;SHKBP1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.5206574100613589,-1.1249179827130236,0.28846153846153844,1.0,1.0,5/45,6.04%,DDX11;ABRAXAS1;FOXM1;RNF8;XRCC1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6820361279651532,1.124884409928206,0.2682926829268293,1.0,1.0,2/8,8.33%,FGFR2;FGFR3
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.6750991417487978,1.124850025419987,0.3469387755102041,1.0,1.0,2/5,12.77%,SLC2A5;SLC26A6
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.4822133569374796,1.1248117191998062,0.2545454545454545,1.0,1.0,21/68,19.12%,SEMA5A;ATOH8;VEGFC;SULF1;WNT5A;TGFBR1;NRP1;PRKD1;HIF1A;PRKCA;CDH13;VEGFD;PTPRM;SIRT1;PROX1;THBS4;PDCL3;VEGFA;ECM1;PDGFB;ARNT
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.6915710255953711,-1.1238320854643853,0.4107142857142857,1.0,1.0,2/6,10.53%,RYR1;DRD3
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.68025050685908,-1.123804531452481,0.375,1.0,1.0,2/7,10.38%,SLC6A9;SLC6A20
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.4720379862202842,1.1236150459269458,0.23255813953488372,1.0,1.0,34/155,12.15%,MARVELD3;LOXL2;ALDH1A1;SPX;HS3ST5;ZNF706;SMAD7;ELAPOR2;ROBO1;EGFR;RPS6KA4;AGER;HEY1;ATP2B4;CIDEA;ARRDC3;PLCL1;HDAC9;TWSG1;CHSY1;TLE3;IL18R1;PTPRG;HMGCR;IL17RD;NOVA1;CRHBP;ADIPOR1;WWC1;LRP4;NR1H3;USF3;NPTN;MAP2K6
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.7534106401653351,1.1235789104370209,0.38,1.0,1.0,1/6,3.54%,FGFR2
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6815651487141701,-1.1233055957968856,0.41304347826086957,1.0,1.0,1/7,3.25%,DIRAS3
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.6821917667585269,-1.1232946557677432,0.30612244897959184,1.0,1.0,2/9,7.78%,CLU;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7274819533925301,1.1228754554670868,0.37037037037037035,1.0,1.0,1/5,9.44%,LMO3
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.6897173790726238,-1.1227889341436939,0.4,1.0,1.0,4/8,13.14%,APOBEC3H;NUDT16;METTL3;A1CF
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.6416325031515715,1.122609258569544,0.36538461538461536,1.0,1.0,5/19,17.08%,NRG1;EDN1;AKAP6;MEF2C;PROX1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.7168776480189145,1.1225477909807078,0.29411764705882354,1.0,1.0,3/6,22.49%,FGFR2;SOX11;NIPBL
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.734318912369637,-1.122541102956881,0.4230769230769231,1.0,1.0,3/6,23.54%,CORO1B;SYAP1;MARS1
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.7376153607628158,-1.122382978147778,0.37735849056603776,1.0,1.0,2/5,21.30%,STK11;MME
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6838138352881553,1.1222167972028996,0.38636363636363635,1.0,1.0,1/8,12.25%,SIRT1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6049243253678487,1.122101914535546,0.2857142857142857,1.0,1.0,4/16,14.78%,TRPS1;SOX5;MDK;SCX
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6073397979444418,1.121963616966722,0.33962264150943394,1.0,1.0,7/15,26.22%,GRID2;MEF2C;MPP2;LRRK2;GRIN2A;GRIN2B;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.5976915407999204,-1.1219509014973224,0.3829787234042553,1.0,1.0,8/18,24.38%,SAP18;C1QBP;SRSF7;RBMX;SRSF10;RNPS1;SFSWAP;PCBP4
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.495164181075326,1.1218730356559325,0.2692307692307692,1.0,1.0,14/88,12.48%,MARVELD3;MAP3K11;PLCB1;HMGB1;EGFR;CCN2;AGER;HDAC3;MFHAS1;ZNF675;IGF1R;PHLPP1;RAP2A;GADD45G
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.7021151383604872,-1.1218419478424297,0.38,1.0,1.0,2/8,14.03%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6590882045276489,1.1218219796593045,0.34,1.0,1.0,4/10,22.07%,SLC1A2;PRAF2;SLC25A12;SLC1A3
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4968140126391152,-1.1217415429688395,0.2916666666666667,1.0,1.0,4/61,4.39%,NCKAP1L;HCK;RAC1;VAV3
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.7002834862041212,1.1216903845103678,0.35714285714285715,1.0,1.0,2/5,10.95%,CDK6;DLL1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.7514464114415462,1.12164338363703,0.3333333333333333,1.0,1.0,2/5,24.15%,MSTN;MYOCD
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.6704073521493866,-1.1216287492246009,0.3333333333333333,1.0,1.0,1/5,7.60%,BCAT2
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.6515794723555854,-1.1210542875166671,0.35135135135135137,1.0,1.0,6/16,12.17%,PLK3;ZWILCH;PLK5;PLK2;WEE2;CHEK1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.5757824052497239,1.1209576893901385,0.2826086956521739,1.0,1.0,8/25,15.04%,SLIT2;RHOB;PKHD1;CSF1R;FGF10;CTNNB1;ACVR1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.7390596799477713,-1.1209385165421788,0.41818181818181815,1.0,1.0,4/6,25.84%,ABCB11;GPLD1;SCIN;ALOX12B
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5019364314252492,1.1207280312799957,0.2765957446808511,1.0,1.0,22/85,18.21%,IRS1;ENPP1;PPARG;CYSLTR2;IRS2;HDAC9;SLC30A10;PRKACB;FER;FOXO1;CRHBP;INHBB;RELA;SORBS1;INSIG1;INSIG2;PIK3R1;AKT2;CPEB2;TBC1D4;KAT2B;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.6359630406277125,1.120185144507579,0.375,1.0,1.0,1/6,12.82%,CAMK4
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4727366834522552,1.1201460848262887,0.22,1.0,1.0,22/88,11.88%,DACH1;STK26;KANK1;PTPRK;MAGI2;SMAD7;ROBO1;NAV3;SULF1;SLIT2;FRMD5;RHOB;FOXO3;MCTP1;SPOCK3;MITF;JAG1;SRGAP2B;TMEFF2;CCDC125;TP53INP1;RAP2A
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5609741376903341,-1.1195436146850852,0.2857142857142857,1.0,1.0,3/38,1.07%,NCKAP1L;HLA-DPB1;TNFSF18
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6401661176059382,1.119192003383799,0.32653061224489793,1.0,1.0,4/9,24.74%,SHQ1;RUVBL2;NAF1;RUVBL1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6767518756990727,1.1191811998483778,0.3191489361702128,1.0,1.0,3/11,20.43%,BATF3;CAMK4;BATF2
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.753813145996917,-1.119103338019354,0.3103448275862069,1.0,1.0,4/5,19.20%,DSC2;CTNNA3;PKP2;JUP
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.753813145996917,-1.119103338019354,0.3103448275862069,1.0,1.0,4/5,19.20%,DSC2;CTNNA3;PKP2;JUP
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.523761382355487,1.1190951011189256,0.3333333333333333,1.0,1.0,6/39,15.07%,SLC22A2;SLC6A13;SLC38A11;SLC7A13;SLC38A2;SLC25A12
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.46363202866275643,1.1184338333146455,0.24074074074074073,1.0,1.0,28/111,20.18%,MYBPC3;FLRT2;ZFPM2;ERBB4;FLRT3;FGF12;TGFBR1;SGCZ;HDAC9;DVL2;BCOR;TAB2;PLCE1;CHD7;TBX19;SGCG;MEF2A;ACVR1;MEF2C;TGFBR3;SALL1;KAT2B;VEGFA;PDGFB;PDLIM1;KDM6A;PTK2;ALPK2
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.7342713645408068,1.117951974627621,0.39215686274509803,1.0,1.0,2/7,2.25%,OXTR;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.7298248629268302,1.1178845971216462,0.4,1.0,1.0,2/5,14.76%,TIMP3;TIMP1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6874608020898649,1.1176635989367896,0.375,1.0,1.0,4/10,16.56%,CCL5;ADAM8;SLC12A2;CYP7B1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6147711131197613,1.1175855392896061,0.36,1.0,1.0,3/11,11.83%,FRMD5;SPOCK3;CCDC125
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.45509483570530757,1.1173256182845255,0.2608695652173913,1.0,1.0,11/91,8.06%,ALDH1A1;TFCP2L1;NEDD4;NR3C2;SULT2B1;PEX11A;CYP39A1;SLC23A1;CAT;BBOX1;ATXN1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5901877611208067,1.1172742960161592,0.35294117647058826,1.0,1.0,5/16,11.03%,RIT2;NEUROD2;CD22;ITPR1;CDH13
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.604331611503487,-1.1170201947315408,0.3157894736842105,1.0,1.0,5/13,11.98%,CD9;ADAM12;ADAMTS15;ERVW-1;ADAMTS5
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6385628116199559,1.1168906302466983,0.40425531914893614,1.0,1.0,4/10,21.30%,NCK1;HSPA1A;VHL;DNAJB1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.5000319824504167,-1.1168637553944203,0.3333333333333333,1.0,1.0,4/50,2.90%,SFRP1;LDB1;APOD;RAC1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5137565298164707,-1.1166240657656727,0.2692307692307692,1.0,1.0,21/60,21.32%,HLA-C;PSMA7;B2M;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4894882172736672,1.1164538748715924,0.27450980392156865,1.0,1.0,5/39,5.97%,RALA;NLGN1;GPM6A;NRP1;TENM2
prerank,MSigDB_Hallmark_2020__Coagulation,-0.49776083696991874,-1.1163597161890308,0.24561403508771928,1.0,1.0,16/89,10.39%,CD9;CLU;C2;SERPINE1;F8;RAC1;F2RL2;MAFF;CPQ;SH2B2;DUSP6;CTSO;SPARC;ISCU;USP11;CFD
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5455818153969447,1.1163497678188576,0.28,1.0,1.0,4/36,10.00%,MAP3K11;TAB3;DUSP9;TAB2
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.4119564968089434,-1.1163187187231733,0.2545454545454545,1.0,1.0,87/322,20.61%,FIP1L1;SARS1;TSPAN32;ABCF1;LMF2;RBM4;RBM8A;NFKBIB;POLR2I;UPF3B;WARS1;CPSF1;RBM3;RBMS2;CPSF4;PAX8;POLR2J;MRPL23;PTMA;RPLP1;RBPMS;RPL28;POLR3A;MRPS18B;RPL37A;RPL34;MRPL55;RPS15;RPL4;RPS8;NUP133;LMF1;NUP43;RPL12;RPL31;RPL8;RPL19;RPS27;MRPS18C;RPL23;MRPL9;PRPF4;MRPS21;CPSF3;DRG1;MRPL27;RPL7A;POLR2G;MRPL51;DTX1;HNRNPL;RPL29;POLR2C;SRSF7;DHX8;PABPC4;NUP155;RPS24;RPL5;CHTOP;MPHOSPH10;GALNT2;DHX38;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;ALKBH5;RPS4Y1;DDX54;MRPS33;NXT1;RRBP1;RPS20;GLE1;RPS3;POLR2L;RNPS1;MRPL37;EIF4G1;NUP85;RPL35A;RPL11;RPL10A
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.5464000087752217,1.1162114004270445,0.2727272727272727,1.0,1.0,5/33,9.24%,ESAM;NTF3;NRP1;CSF1R;ABL2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.4991388444656337,-1.1158217114253772,0.26,1.0,1.0,12/95,7.18%,P2RY10;HLA-DPB1;SLA;AOAH;HCK;HLA-C;CD74;PPP1R14A;ADAM19;SPI1;RYR1;HLA-DRA
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.7191944978121658,-1.1155082477667444,0.3333333333333333,1.0,1.0,3/7,2.42%,RTP5;GNAT3;AZGP1
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7191944978121658,-1.1155082477667444,0.3333333333333333,1.0,1.0,3/7,2.42%,RTP5;GNAT3;AZGP1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.6770821654093911,-1.115439531546748,0.41304347826086957,1.0,1.0,2/12,10.89%,NUPR1;PINK1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7178593767599042,-1.1151184457055134,0.2978723404255319,1.0,1.0,4/10,18.88%,B2M;UBC;ENO1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.6731948951392799,-1.1149542466505322,0.3404255319148936,1.0,1.0,3/9,10.87%,DBNL;LRP8;CUX2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.5966663622324052,-1.1144923812795675,0.3275862068965517,1.0,1.0,4/19,17.06%,WTIP;LIMD1;EIF6;NRDE2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6821453102826065,1.1144693580469758,0.43636363636363634,1.0,1.0,2/10,6.79%,DSCAM;MYO7A
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7557908622497099,-1.1143887650550393,0.49056603773584906,1.0,1.0,2/5,19.40%,TAF7;NLRC5
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.5254033206523904,1.1140566722238119,0.3111111111111111,1.0,1.0,3/25,14.84%,UBE2E2;UBE2E3;UBE2D3
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6949776022130969,1.1136734669459032,0.38596491228070173,1.0,1.0,3/8,16.75%,LMO3;SIRT1;ASXL1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4428691394274999,-1.1136199163450933,0.24444444444444444,1.0,1.0,34/120,23.86%,RPS27L;EIF2S2;PRPF6;CELF3;RPF2;SF3A2;TRAF7;PRPF19;RPS15;ZRSR2;RPS27;MCTS1;EIF6;GEMIN4;RPL5;RPL6;RPL24;SRSF10;RPL38;PRMT7;SNRPD2;EIF4H;EIF2S3;RPL11;WDR77;EIF3A;MRPS11;HSP90AB1;SNRNP200;RPS14;DHX29;COIL;SNRPD1;KHDC4
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.6529513467564332,1.113566512233308,0.3695652173913043,1.0,1.0,3/12,6.82%,LOXL2;MT1M;SNCA
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6624454675675358,1.1134909438431804,0.30952380952380953,1.0,1.0,3/7,23.02%,AGER;EPHA4;ABL1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.583491862435913,1.1133107414101862,0.35294117647058826,1.0,1.0,6/17,25.38%,HELLS;TEX15;ATF7IP;PPM1D;KMT2E;GATAD2A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.583491862435913,1.1133107414101862,0.35294117647058826,1.0,1.0,6/17,25.38%,HELLS;TEX15;ATF7IP;PPM1D;KMT2E;GATAD2A
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.6966171551794934,-1.1132726517475011,0.3877551020408163,1.0,1.0,2/7,13.67%,SERPINE1;SERPINF2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.46453996028381206,1.1130275128973708,0.2391304347826087,1.0,1.0,22/107,14.81%,LRIG3;CALCR;RUNX1;KCNS3;EGFR;SNX7;ERRFI1;NFATC2;MSTN;DDAH1;FLNC;NCAM1;NOTCH3;TIMP3;PARD3B;LIFR;BCAR1;COL5A2;SH3BP4;ENAH;CDCP1;AMOTL2
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.4843324604620292,1.1127871169204253,0.24489795918367346,1.0,1.0,9/62,9.57%,EIF3E;HSPB1;C8ORF88;PPP1R15B;DNAJC3;CCL5;EIF3H;EIF2AK3;NCK1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.7066950285893698,1.1126967963398604,0.38636363636363635,1.0,1.0,4/9,11.39%,FGFR2;SNCA;FGFR3;FGFR1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.5004256540354003,-1.1121656001222449,0.3191489361702128,1.0,1.0,21/48,24.47%,NUPR1;PSMC3;KCNE2;GLMN;DDRGK1;PRKACA;PINK1;PSME1;LAMP3;ARAF;GPX1;DESI1;GABARAPL2;PSME2;PSMC6;HSP90AB1;UFL1;NUDT15;UBB;DAB2IP;USP19
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.7475790225347679,-1.112039930103365,0.41509433962264153,1.0,1.0,1/5,7.09%,VIP
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.6512802022709635,1.1120089524405572,0.3090909090909091,1.0,1.0,1/8,1.78%,CEL
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.6512802022709635,1.1120089524405572,0.3090909090909091,1.0,1.0,1/8,1.78%,CEL
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.6512802022709635,1.1120089524405572,0.3090909090909091,1.0,1.0,1/8,1.78%,CEL
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.7229031696655303,1.1120066522895244,0.35555555555555557,1.0,1.0,1/5,5.70%,HPRT1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.48642334620878075,-1.1119682961123176,0.32075471698113206,1.0,1.0,11/67,12.04%,SELP;NLRP1;SERPINE1;GBP6;OAS3;OAS2;COLEC12;NOS2;HMGB2;AZU1;DEFB109B
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.6578726123059391,-1.1118247453670311,0.37209302325581395,1.0,1.0,2/8,7.26%,SARDH;CHAC1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.7192338476069705,-1.1118096565003779,0.4,1.0,1.0,2/5,11.38%,FGF1;FGF18
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5541972556811068,1.1118039526671017,0.3023255813953488,1.0,1.0,5/25,6.33%,PPARG;HMGB1;ADAMTS9;SLIT2;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.694424844442792,1.111521203563805,0.3888888888888889,1.0,1.0,1/8,3.03%,KLRD1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.46592657121153147,1.111499987897514,0.24074074074074073,1.0,1.0,22/125,11.81%,MED17;ESRRG;CCNH;PPARG;HNF4G;NR3C2;PPARGC1A;NR5A2;CCN2;NR2E1;TEAD2;HDAC9;NR3C1;MAML2;TBL1XR1;NR1D2;HDAC3;MAML3;RORA;TAF3;NOTCH3;NR1H3
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5767339779278194,1.111419351538104,0.3,1.0,1.0,6/19,25.38%,HELLS;TEX15;ATF7IP;PPM1D;KMT2E;GATAD2A
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.6916069528992466,-1.1112980932313903,0.3404255319148936,1.0,1.0,1/9,1.74%,CLU
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.660898744978976,1.1112568220248134,0.40816326530612246,1.0,1.0,1/8,7.83%,GLA
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.7651026034977506,1.1107355707485638,0.37254901960784315,1.0,1.0,1/5,8.82%,CCL5
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5877405628651826,-1.1104305746417003,0.3125,1.0,1.0,4/19,10.74%,HSD17B10;BCKDK;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5877405628651826,-1.1104305746417003,0.3125,1.0,1.0,4/19,10.74%,HSD17B10;BCKDK;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.671030956312053,-1.1103404159806003,0.34782608695652173,1.0,1.0,4/6,29.97%,TSR3;RPUSD2;DKC1;RPUSD3
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.681317471655412,1.11013453807183,0.34,1.0,1.0,4/7,15.93%,GNAT2;GRM6;CNGB1;EYS
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.681317471655412,1.11013453807183,0.34,1.0,1.0,4/7,15.93%,GNAT2;GRM6;CNGB1;EYS
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6947922737680423,1.110073073402281,0.38181818181818183,1.0,1.0,1/7,8.19%,UBR5
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7322911788572101,-1.1100504601114571,0.35294117647058826,1.0,1.0,1/5,3.40%,STX4
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.6739587685283458,-1.109945411977195,0.3877551020408163,1.0,1.0,2/10,16.28%,ATF4;KDR
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4907282298721989,-1.1098307531786713,0.34782608695652173,1.0,1.0,5/64,9.08%,SLC19A3;DHFR2;PCCB;PNPO;PDZD11
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.7379737520070393,1.1098056822547193,0.4423076923076923,1.0,1.0,3/5,19.65%,FAAH;ABHD12B;ABHD12
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6086248632877866,1.1095038215781226,0.2830188679245283,1.0,1.0,11/22,25.60%,PDE4D;PDE2A;RIMS2;PDE3A;AKAP6;EPHA5;CAP1;ADCY2;PDE7B;RAPGEF2;CAP2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5956014073684881,1.1090172515141041,0.29310344827586204,1.0,1.0,2/16,13.38%,SLC22A2;SLC25A26
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.7001799246312523,-1.108944146050716,0.3673469387755102,1.0,1.0,4/6,27.50%,SETDB1;BEND3;PRDM5;SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.5964030249002088,-1.1088237636341993,0.3148148148148148,1.0,1.0,3/13,3.89%,NCKAP1L;RAC1;CD74
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.5964030249002088,-1.1088237636341993,0.3148148148148148,1.0,1.0,3/13,3.89%,NCKAP1L;RAC1;CD74
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.7140212393643455,-1.1087888841249707,0.37777777777777777,1.0,1.0,1/7,5.66%,ERCC1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6266180839431317,1.1087455480999815,0.2549019607843137,1.0,1.0,3/13,7.07%,ERBB4;CSF1R;LATS1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.5619570852775977,1.108660357333108,0.3148148148148148,1.0,1.0,5/22,11.27%,PNP;HPRT1;NUDT10;PDE4D;PDE2A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.4419958747680435,1.1086353323294547,0.3333333333333333,1.0,1.0,24/120,11.70%,CX3CR1;PBX1;KLHL17;SHROOM2;AFF2;DDIT4;CNTN4;ROGDI;SYNJ2;MEIS1;SLC23A1;PBX3;CNTNAP2;ROBO2;SCTR;CA10;ADGRL3;ATXN1;CTNNA2;EPHA7;CDH2;SHROOM4;ADGRL2;MEIS2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.5957598481538319,1.1086034958463222,0.35294117647058826,1.0,1.0,6/18,18.65%,RUNX1;BAG2;ADAM8;RNF139;CLN3;NLRP7
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5351796758340264,1.1084598615123926,0.37037037037037035,1.0,1.0,3/26,6.27%,LHFPL2;WNT5A;FSHR
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.670642982312142,-1.108400612166456,0.38181818181818183,1.0,1.0,2/6,25.47%,SVIP;UBXN1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.4838863037905617,1.1082292265693965,0.18421052631578946,1.0,1.0,7/55,10.34%,SLC30A8;DOC2B;IRS2;MCU;EXPH5;ACSL4;ADAM8
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6154859554796487,1.1080410976370245,0.3076923076923077,1.0,1.0,7/17,22.05%,NRG1;SLC8A1;ACVR1;MEF2C;VEGFA;ALPK2;TCAP
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.49953616315880395,-1.107923082875902,0.2653061224489796,1.0,1.0,9/81,8.93%,HLA-DPB1;RILP;CD74;DCTN1;KIF4A;HLA-DRA;AP1S1;ARF1;KIF5A
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6339707087797913,-1.1078978774499608,0.34,1.0,1.0,4/10,21.97%,ART4;PRMT7;NDUFAF5;PADI4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.45377435039386754,-1.1077355287183563,0.30612244897959184,1.0,1.0,6/73,5.47%,NCKAP1L;CLU;HCK;RAC1;DCTN1;VIL1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.49133379870328814,-1.1076258751942498,0.2978723404255319,1.0,1.0,8/56,9.95%,RPS27L;PLK3;AURKA;GADD45A;TRIAP1;PLK2;PIDD1;CCND1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.6817798583740204,-1.1074912744515202,0.33962264150943394,1.0,1.0,1/8,3.61%,CACNG5
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.6817798583740204,-1.1074912744515202,0.33962264150943394,1.0,1.0,1/8,3.61%,CACNG5
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.691378045051545,1.1073822488006664,0.34615384615384615,1.0,1.0,2/9,8.82%,WNT5A;CCL5
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.4703554871416151,-1.1072700783176277,0.26229508196721313,1.0,1.0,36/80,26.37%,AURKA;PSMA7;PSMD7;SKP1;PSMB4;RBX1;PSMC3;RFPL1;PSMD8;CDKN2B;PSME1;PSMB2;BRD7;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;GPR132;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;E2F7;CDKN2D;PSMA5;GPNMB;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4;FAM107A
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.7541506221139828,-1.1070538759320232,0.47058823529411764,1.0,1.0,1/5,7.88%,LAGE3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.5128472951461812,-1.1070527179578378,0.29411764705882354,1.0,1.0,9/46,19.21%,DHFR2;ACOT4;D2HGDH;MDH1B;NIT2;GOT2;ASS1;L2HGDH;FH
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),-0.7114705609783155,-1.106833957409074,0.47058823529411764,1.0,1.0,2/5,6.38%,FGF1;PAX8
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.6941244618678526,-1.1063681987008769,0.4,1.0,1.0,3/6,26.03%,IRF1;MAPK8IP1;PTPN22
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.678962057178486,-1.1060940891160076,0.4339622641509434,1.0,1.0,4/6,29.27%,CDHR2;PTPRJ;YAP1;SMO
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5060656036515818,-1.1058465624751728,0.29411764705882354,1.0,1.0,21/62,21.32%,HLA-C;PSMA7;B2M;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6568185521494563,-1.1056918063270902,0.3673469387755102,1.0,1.0,1/14,1.56%,SIGIRR
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5674789527084827,-1.1056089650207175,0.2692307692307692,1.0,1.0,3/20,7.29%,RYR1;MYH14;LEMD2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6974425061482246,-1.1054872251086967,0.34545454545454546,1.0,1.0,2/5,19.58%,NUCKS1;PPIB
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.7319539509783748,1.10530618471565,0.3695652173913043,1.0,1.0,2/5,14.41%,CASP9;BOK
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6898760545522657,-1.1048839767530867,0.3617021276595745,1.0,1.0,4/8,22.27%,DNAH1;CCDC39;CFAP100;CCDC40
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.569830550493008,1.104784906410782,0.38461538461538464,1.0,1.0,6/12,21.09%,HIF1A;ITGAV;ITGB8;SMAD3;PTGS2;SMAD4
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.6652002708093123,-1.1046764767959252,0.32608695652173914,1.0,1.0,1/10,1.26%,SPA17
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.6226093888897866,1.104352116011233,0.2894736842105263,1.0,1.0,5/16,16.50%,CSF1;ZNF675;CAMK4;GPR137B;TMEM178A
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.732383576130788,-1.1040815816522875,0.375,1.0,1.0,3/6,23.16%,PINK1;SYAP1;PRR5L
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.5111649144001006,-1.1040491663679077,0.3404255319148936,1.0,1.0,14/39,24.99%,TERF2IP;KPNA2;TOM1L1;TICRR;NUCKS1;USP1;PDGFA;SUB1;MPV17;PIF1;PARG;ALYREF;SMG6;THOC1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4970276510824809,-1.1039961643497567,0.3269230769230769,1.0,1.0,11/68,15.31%,GTF2F1;POLR2I;INTS5;PHAX;POLR2J;TAF6;TAF11;SNAPC5;CCNT1;POLR2G;POLR2C
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.489037700359909,1.1039803373288843,0.2903225806451613,1.0,1.0,21/77,15.01%,HMGCS1;PPARG;THRSP;FDFT1;IRS2;ELOVL6;NCOA2;TBL1XR1;SCD;NR1D2;HDAC3;RORA;SMARCD3;HMGCR;DISP3;ACACA;ADIPOR1;PLPP1;CCDC3;FASN;NFYC
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6777868609002793,1.1037571252821476,0.36538461538461536,1.0,1.0,3/9,11.81%,PPARG;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.503671538869719,-1.1035618575824317,0.28,1.0,1.0,9/77,8.93%,HLA-DPB1;RILP;CD74;DCTN1;KIF4A;HLA-DRA;AP1S1;ARF1;KIF5A
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.44656807276055355,-1.1028617943239556,0.2037037037037037,1.0,1.0,35/166,16.79%,PLK4;AURKA;XPC;PSMA7;HAUS8;PLK5;ANAPC15;DCTN1;PSMD7;SKP1;UBC;PSMB4;SSNA1;PSMC3;CETN2;PRKACA;TUBB4B;CENPE;PSMD8;PSME1;ODF2;DDB1;PSMB2;PSMC4;PSMB8;ANAPC2;PSMC1;PSMB5;PSMD2;INO80;NPM2;PSMA1;ERCC2;TUBG1;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.7092297335797189,1.1028273175948033,0.36363636363636365,1.0,1.0,1/5,9.44%,LMO3
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6852040196925648,1.1028272893564781,0.4375,1.0,1.0,5/7,22.05%,CDH2;CTNNB1;PTK2;CAV3;TCAP
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.5580026592748591,-1.1026904316123411,0.37735849056603776,1.0,1.0,5/24,13.99%,LDB1;TCEA2;SUPT5H;SUPT16H;CCNT1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5764469446709948,-1.1023001651661337,0.34615384615384615,1.0,1.0,5/22,11.32%,SFRP1;SBDS;MEOX1;ACE;PTPRC
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.4619873142993561,1.1020883755336177,0.2222222222222222,1.0,1.0,18/90,13.61%,LRIG3;FIGN;EGFR;WNT5A;SLIT2;SNX7;ERRFI1;PTPRG;CDR2L;DDAH1;FLNC;ADGRL2;TENM3;LRP4;LIFR;BCAR1;ABCG2;ENAH
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.4165871090800631,-1.1020762416344925,0.22448979591836735,1.0,1.0,63/276,18.58%,SNRNP27;FIP1L1;DDX41;ZCRB1;GTF2F1;RBM4;RBM8A;POLR2I;CWC25;UPF3B;CPSF1;RNF113A;PRPF6;SYF2;CPSF4;POLR2J;GTF2H2;LSM7;CMTR1;DNAJC8;SF3A2;PDCD7;DHX16;WBP4;PRPF19;NONO;PRKACA;SF3B2;MFAP1;RBM19;SF3A1;AKAP8L;SUPT5H;RNPC3;ZRSR2;METTL3;GPATCH1;PRPF4;CPSF3;SNIP1;SNW1;RBM22;POLR2G;HNRNPL;POLR2C;SRSF7;DHX8;RBM4B;RBMX2;ERCC2;SF3B6;CHTOP;PRCC;DHX38;KIN;RBMX;SRSF10;HNRNPH2;EFTUD2;IK;ALKBH5;HNRNPM;PPIL3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.6556040869344613,1.1015476652242144,0.4074074074074074,1.0,1.0,2/8,12.25%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4318183195234797,1.1014244064103123,0.2978723404255319,1.0,1.0,22/118,9.42%,GPC6;LRRC4C;PCDHB3;NEDD4;NLGN1;CX3CR1;FLRT3;NRXN1;DSCAM;RAB29;GPM6A;GRM5;PDZRN3;SNCA;CACNB2;PTPRD;LRFN5;ADGRL3;RYK;CBLN1;NLGN4X;CDH2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.46262781739443565,1.1013116082860637,0.25925925925925924,1.0,1.0,17/76,12.47%,SLC26A3;SEMA5A;LSAMP;SEMA6D;PPARGC1A;AFP;CNTN4;FGF14;GIPC2;SLC38A11;PTPRD;CNTN3;NXPE1;FREM1;SLC4A4;PDE3A;ANXA13
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6999712882168282,1.1011299666364913,0.4642857142857143,1.0,1.0,3/6,28.09%,CNOT2;CNOT6L;CNOT6
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7288179851695493,1.1010191282453228,0.41818181818181815,1.0,1.0,2/5,21.22%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5263858786296239,1.1009792370911804,0.29411764705882354,1.0,1.0,10/30,16.14%,PBX1;ITGAM;MEIS1;PBX3;CPAMD8;C3;ATF6;MEIS2;MEIS3;SCO2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.5269012663121693,1.100896417886609,0.34146341463414637,1.0,1.0,12/39,19.03%,LOXL2;WNT5A;TGFBR1;HEY1;HIF1A;FGFR1;CTNNB1;HGF;TGFBR3;CUL7;LIMS1;ROCK2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.6374867384421616,-1.1008445346803615,0.38461538461538464,1.0,1.0,2/14,6.38%,TMIE;PAX8
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.476640008844694,-1.100712825800424,0.33962264150943394,1.0,1.0,8/57,12.68%,F5;F8;GOLGA2;TRAPPC2L;TRAPPC6A;TRAPPC4;CNIH3;TRAPPC1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.476640008844694,-1.100712825800424,0.33962264150943394,1.0,1.0,8/57,12.68%,F5;F8;GOLGA2;TRAPPC2L;TRAPPC6A;TRAPPC4;CNIH3;TRAPPC1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.476640008844694,-1.100712825800424,0.33962264150943394,1.0,1.0,8/57,12.68%,F5;F8;GOLGA2;TRAPPC2L;TRAPPC6A;TRAPPC4;CNIH3;TRAPPC1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.7131405664552257,-1.100644287986985,0.45652173913043476,1.0,1.0,3/6,15.62%,FBXO43;WEE2;NPM2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.47470674712051225,-1.0998755070060178,0.2641509433962264,1.0,1.0,9/88,7.18%,P2RY10;NCKAP1L;CD5;SP140;BST1;CD74;TRAF3IP3;CD37;HLA-DRA
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),0.7414952695935206,1.0998684146171036,0.43636363636363634,1.0,1.0,1/5,1.80%,KCNJ3
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),0.7414952695935206,1.0998684146171036,0.43636363636363634,1.0,1.0,1/5,1.80%,KCNJ3
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.7657335583062593,-1.0997782207896565,0.4,1.0,1.0,3/5,18.80%,NOS2;ABCC4;LEP
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.474020982380362,-1.099700698019991,0.2826086956521739,1.0,1.0,4/58,4.04%,KIF25;ATRAID;NUPR1;GOLGA2
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.563685426886865,-1.0996017032386598,0.3333333333333333,1.0,1.0,7/29,12.62%,CLU;SERPINE1;RAC1;B2M;ARF1;LRPAP1;PPT1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5145603959828395,-1.0995944967925209,0.3,1.0,1.0,10/43,14.13%,MYB;NLRP3;STX4;CD74;HLA-DRA;POLR3D;PTPRC;ZP3;RSAD2;EREG
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.6566939393048281,-1.0995569202180857,0.3877551020408163,1.0,1.0,4/6,31.68%,TAMM41;SLC27A1;CDS2;PLA2G6
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.5768570056197189,-1.0995364780381496,0.35714285714285715,1.0,1.0,5/24,8.85%,SH3RF2;ZCCHC9;PPP1R35;PPP1R15A;PTPA
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7556323541445661,1.099355439186835,0.35185185185185186,1.0,1.0,2/5,21.22%,ELAVL4;TENT4B
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.659150196655963,1.0991531661923495,0.38181818181818183,1.0,1.0,2/9,6.49%,CYP2C8;CYP3A4
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.46291073596834886,-1.0986299938723936,0.3076923076923077,1.0,1.0,11/101,5.47%,SLC28A2;CDHR5;GSTM3;AQP8;CASP6;PLIN2;BEST4;TREH;SLC51A;FABP6;VIL1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6413512126743219,1.0982521308267363,0.3958333333333333,1.0,1.0,3/7,16.29%,IRS2;PRKCB;AKT2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.5743693966133133,1.0982000466194624,0.36363636363636365,1.0,1.0,5/20,10.27%,SLC39A12;SLC30A8;MT1M;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5574628468947556,-1.0977031437754232,0.3103448275862069,1.0,1.0,2/23,3.93%,NCKAP1L;ETS1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.6830739662552062,1.0975672720898246,0.38181818181818183,1.0,1.0,2/6,16.49%,GRM5;TCAF2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.6781460641679666,-1.097529370060486,0.4782608695652174,1.0,1.0,2/11,8.68%,ATOX1;ARF1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.5936532724703603,1.097373111038676,0.32142857142857145,1.0,1.0,5/13,18.89%,C3;P2RX7;SLC26A6;BRAF;CA2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.49689729905584384,-1.097312171055569,0.35294117647058826,1.0,1.0,11/69,15.31%,GTF2F1;POLR2I;INTS5;PHAX;POLR2J;TAF6;TAF11;SNAPC5;CCNT1;POLR2G;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.5755206983899503,-1.0973003348186638,0.35714285714285715,1.0,1.0,7/21,16.42%,SLC6A9;KCNE3;CALM1;DRD3;GNB5;DRD4;CALM3
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.45087738182935067,1.0972090156162364,0.25,1.0,1.0,21/97,13.17%,MXRA5;FAT4;GUCY1A2;GFRA1;SEMA6D;PRRX1;POSTN;SULF1;ADAMTS9;SLIT2;PDZRN3;FBXL7;PRKG1;ADGRL2;LRP4;TIMP3;PARD3B;LIFR;COL5A2;ANK2;CXCL12
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4817765163500054,1.0970526002860002,0.24561403508771928,1.0,1.0,20/98,16.99%,VAPB;SPHK1;CERS3;PPM1L;ELOVL6;ACER1;PRKD1;GLA;PLA2G15;ASAH2;GLB1;HACD2;PLPP1;SMPD4;ALDH3A2;ESYT3;CERS5;SGMS1;HEXB;TECR
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.5079716626813933,-1.0967902663531464,0.35555555555555557,1.0,1.0,3/40,4.87%,GUCY2C;PAPSS2;DCAKD
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.599174531169813,-1.0962830924298526,0.34782608695652173,1.0,1.0,1/12,2.38%,HCK
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.5947377009588851,-1.0962015424430194,0.37254901960784315,1.0,1.0,1/11,1.18%,LCP1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.538164632139918,1.096163442619147,0.3269230769230769,1.0,1.0,7/25,11.70%,NLGN1;MAGI2;NRXN1;DLG2;SAV1;LRRC7;LRP4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.5753301124859993,-1.0951996612761572,0.37777777777777777,1.0,1.0,2/27,5.66%,SLX4;ERCC1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6576212001784173,-1.0950235705991875,0.42,1.0,1.0,1/6,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.532715787153429,-1.0950123930941604,0.3125,1.0,1.0,10/36,15.31%,NFKBIB;POLR2I;PAX8;POLR2J;PTMA;POLR3A;DRG1;POLR2G;DTX1;POLR2C
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.6849252976158424,1.094996325214642,0.4117647058823529,1.0,1.0,1/7,5.17%,THOC6
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.6849252976158424,1.094996325214642,0.4117647058823529,1.0,1.0,1/7,5.17%,THOC6
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5480229425340011,-1.0949100285414068,0.34,1.0,1.0,6/46,5.28%,P2RY10;CD5;KLRB1;TRAF3IP3;CD4;LTBR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.5655804390244743,1.094875637318641,0.4666666666666667,1.0,1.0,4/18,9.43%,RUNX1;PNP;PDE4B;PDE4D
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.5026662343656708,1.0948345092854603,0.2765957446808511,1.0,1.0,11/40,14.14%,UTS2R;CYSLTR2;PDYN;GLRA2;OPRK1;GLRB;NXPH4;NPY;MCHR2;SORT1;GPR149
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.48142207125138436,1.094757289251784,0.2549019607843137,1.0,1.0,13/60,15.17%,NLGN1;ITPKB;ADGRV1;NEUROD2;WNT5A;ECT2;SYT1;ACER1;CRHBP;SYT15;MEF2A;MEF2C;SYT2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6843676119191096,-1.0943722422103914,0.4,1.0,1.0,2/7,16.54%,AARS2;GARS1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5226978987113146,1.0943264392700085,0.3269230769230769,1.0,1.0,5/34,9.01%,IFI16;NUAK2;FOXO3;KPTN;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7190446690367803,1.0940888204119348,0.43548387096774194,1.0,1.0,4/5,23.16%,CLASP1;CLASP2;PHLDB1;DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7190446690367803,1.0940888204119348,0.43548387096774194,1.0,1.0,4/5,23.16%,CLASP1;CLASP2;PHLDB1;DAG1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.7088615767266335,-1.093998574298737,0.44,1.0,1.0,2/5,23.16%,KYNU;CDKN2D
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.6929805776839765,1.0939400768455634,0.5111111111111111,1.0,1.0,3/6,24.81%,PIK3R1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.6929805776839765,1.0939400768455634,0.5111111111111111,1.0,1.0,3/6,24.81%,PIK3R1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.7068400181527651,-1.0938591768403503,0.41818181818181815,1.0,1.0,3/6,20.35%,PRDX1;SOD1;NOS3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4761626302874617,-1.0938300928723508,0.27450980392156865,1.0,1.0,40/104,23.29%,RBM8A;UPF3B;UPF3A;RPLP1;RPL28;RPL37A;RPL34;RPS15;RPL4;RPS8;RPL12;RPL31;RPL8;RPL19;RPS27;RPL23;RPL7A;RPL29;RPS24;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;RPS4Y1;RPS20;RPS3;RNPS1;EIF4G1;RPL35A;RPL11;RPL10A;MAGOHB;RPL18;RPS14;RPS4X;RPS2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6239944295173779,-1.0933917069374095,0.4,1.0,1.0,1/14,3.55%,PPP1R17
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.7281594964498355,1.0928780889210306,0.40425531914893614,1.0,1.0,4/5,26.15%,MAPK8;CAP1;CAP2;MAPK14
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6114242518073492,1.0923312586927985,0.42857142857142855,1.0,1.0,3/13,9.57%,PPP1R15B;PPP3CA;NCK1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.44811321978164115,1.0922892051428024,0.2553191489361702,1.0,1.0,20/99,12.95%,MYBPC3;ZFPM2;RRAD;ADIPOR2;CKM;ADPRHL1;CMYA5;CCN2;SYNPO2;FILIP1;PRKG1;XIRP2;PDE4D;MITF;ADIPOR1;FLNC;PDE1A;TRDN;CTNNB1;SGCG
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.5440787536544767,-1.0922119518347284,0.3392857142857143,1.0,1.0,2/40,0.52%,NCKAP1L;HLA-DPB1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.48582681868434785,-1.09215462608989,0.3148148148148148,1.0,1.0,5/43,6.26%,TEKT3;SPA17;CFAP61;TEKT5;ODAD1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.6806620230818157,-1.091993515443976,0.36363636363636365,1.0,1.0,1/8,1.05%,CCN3
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7012554268561911,-1.0919104445072898,0.43103448275862066,1.0,1.0,3/7,20.90%,PSMC3;PSMC4;PSMC6
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5288740287748969,1.0918285141407493,0.4,1.0,1.0,4/27,12.25%,PLA2G10;PPARG;NR1H3;SIRT1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.5703419445236617,1.0917573172924182,0.38095238095238093,1.0,1.0,3/13,21.48%,ELP4;MOCS3;DPH3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.6082240372080369,1.091708103558363,0.40816326530612246,1.0,1.0,3/13,19.03%,SLC8A1;ACTA2;ROCK2
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.6943195928866239,-1.0916529421642298,0.42592592592592593,1.0,1.0,3/7,20.35%,PRDX1;SOD1;NOS3
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.7102825198892818,-1.0915970555725398,0.45098039215686275,1.0,1.0,3/6,25.41%,MAP1S;UBB;UXT
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5090890146404339,-1.091428177591368,0.32,1.0,1.0,11/42,17.14%,RPS27L;SBDS;RPF2;TRAF7;RPS15;C1QBP;RPS27;EIF6;RPL5;RPL6;RPL24
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.596965346759074,-1.091232287271046,0.37777777777777777,1.0,1.0,7/10,29.97%,GAR1;TSR3;RPUSD2;NHP2;DKC1;NOP10;RPUSD3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6418985656756444,1.0910612304343599,0.375,1.0,1.0,6/10,23.92%,KLF2;HDAC3;MEF2C;NFE2L2;SREBF2;PKD2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4729903687186177,1.0909395511895306,0.2727272727272727,1.0,1.0,12/68,10.56%,CALCR;PLCB1;KCTD8;GUCY2F;CAMKMT;RGS6;TULP3;RGS14;CCL5;C3;PLCE1;EDN1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.4645594695759851,1.0908425632886996,0.2727272727272727,1.0,1.0,6/64,10.86%,U2AF1;THOC6;NXF1;ZFP36;NXF5;RBFOX1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.48655453492592715,1.0908019073595547,0.3220338983050847,1.0,1.0,13/54,21.83%,MED17;RUNX2;CSF1R;TWIST1;MITF;CTNNB1;RELA;ZNF45;CBFB;MECP2;TNRC6C;NFKB1;MED24
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5626370101795992,-1.0905257680744918,0.36538461538461536,1.0,1.0,3/31,3.40%,SFRP1;SERPINE1;STX4
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6614316937678272,1.090380372308396,0.39655172413793105,1.0,1.0,4/6,22.81%,ATP2B4;GLA;ROCK2;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6614316937678272,1.090380372308396,0.39655172413793105,1.0,1.0,4/6,22.81%,ATP2B4;GLA;ROCK2;SIRPA
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4433953480243952,1.0900705588870097,0.32075471698113206,1.0,1.0,30/113,17.17%,GUCY1A2;GFRA1;SEMA6D;PBX1;LDB2;CCN2;SLIT2;PDZRN3;PTPRD;LRFN5;ADGRL3;MEGF10;FBXL7;PRKG1;CDO1;ASXL3;ADGRL2;LRP4;LIFR;PRDX6;ANK2;RGS7BP;PRICKLE2;CCDC3;RUNX1T1;CSRNP3;MAP2;TMEM178A;MAPK4;DCLK1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.7106685446632808,-1.0899845533324108,0.42857142857142855,1.0,1.0,2/6,20.65%,PRPSAP1;PRPSAP2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.5102964697189109,1.0899466799923627,0.2909090909090909,1.0,1.0,13/53,15.73%,PLA2G10;PLA2G7;ABHD4;CHPT1;TMEM86B;PLA2G15;SLC44A5;NR1H3;LCAT;LPCAT3;PLBD1;PLA2G4C;PCYT1B
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.6389318042433405,-1.0899443118648913,0.40425531914893614,1.0,1.0,1/8,1.05%,CCN3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.6180683885075247,1.0897486705422177,0.375,1.0,1.0,2/7,12.28%,RHOB;CTNNB1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6764267076434219,1.0896339043208587,0.4727272727272727,1.0,1.0,2/8,9.71%,SYK;FER
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.4622754416113395,-1.0894820032595323,0.28888888888888886,1.0,1.0,7/59,5.30%,NCKAP1L;TNFSF18;FBLN2;RAC1;STX4;TPM1;NODAL
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5808978860769836,1.089356472203835,0.34,1.0,1.0,7/15,29.70%,NEDD1;PCM1;BBS4;KIAA0753;CCDC14;CEP192;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.5732632167169875,-1.0891909624139442,0.37254901960784315,1.0,1.0,5/18,8.85%,SH3RF2;ZCCHC9;PPP1R35;PPP1R15A;PTPA
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.45051657144329954,-1.0891216684534766,0.3333333333333333,1.0,1.0,30/124,15.98%,HLA-DPB1;TXK;BTNL2;TEC;PSMA7;CD4;PSMD7;SKP1;BTN3A1;PSMB4;HLA-DRA;PRAM1;PSMC3;RBCK1;BTN2A1;BTN2A2;PTPRC;PSMD8;PSME1;EIF2B4;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;THEMIS;PSMD2;PIK3CB;EIF2B3;PSMA1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.49120819067946586,-1.088867272313472,0.28888888888888886,1.0,1.0,3/40,7.29%,SUN3;SPAG4;LEMD2
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6993364557964498,-1.0887061984293727,0.42857142857142855,1.0,1.0,2/7,6.26%,NMB;IL11
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6017698038956626,-1.0886360147355811,0.38333333333333336,1.0,1.0,1/16,0.66%,INHA
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4444030821287933,1.088540686844487,0.23529411764705882,1.0,1.0,26/107,14.95%,GPC6;FIGN;GFRA1;SEMA6D;PBX1;PCDH7;SLIT2;PDZRN3;ADGRL3;PTPRG;FBXL7;GULP1;IL17RD;ADGRL2;TENM3;LRP4;TMEM98;LIFR;TUSC3;ANK2;ENAH;PRICKLE2;AMOTL2;MEIS3;RUNX1T1;CSRNP3
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5973472494308012,1.088017675589871,0.32,1.0,1.0,5/12,27.66%,DLL1;SOX11;VIT;PKD2;PKD1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6285849676161317,1.0879863262165257,0.4583333333333333,1.0,1.0,3/16,5.96%,ROBO1;SLIT2;NRP1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.42466596585054606,1.0878072092419135,0.28125,1.0,1.0,80/394,16.30%,MYRFL;FZD1;MED17;ESRRG;RUNX1;NFIL3;PLCB1;ERBB4;KLF2;PPARG;RFPL2;ATOH8;CREB5;FANK1;TFEB;PPARGC1A;NR5A2;EGFR;ARID1A;WNT5A;GLIS2;TGFBR1;RUNX2;TP63;ARID1B;RFX3;HEY1;MLLT3;FOXO3;TEAD2;SP3;SMAD5;PSRC1;TBL1XR1;SPIN1;TCF4;NR1D2;NPAS3;HDAC2;HINFP;ZNF516;SUPT3H;RORA;GLI3;HIF1A;NFATC2;MSTN;SMARCD3;FOXO1;MITF;FLI1;DYRK1A;SMAD2;ACTA2;NR1H3;TP53INP1;CTNNB1;ING1;BTRC;RYBP;CAMK4;SNX5;PPM1A;EPC1;EP300;SMAD3;YAF2;RELA;CD38;CREB1;ACVR1;SCX;MEF2C;PICALM;ELF1;HNRNPD;ZXDC;HIVEP3;TRERF1;SALL1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.5250393278536698,-1.0874542139965757,0.37254901960784315,1.0,1.0,4/28,8.55%,NKX2-2;SST;PAX6;SRP14
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5689242178833671,1.0871328397418136,0.4098360655737705,1.0,1.0,4/18,17.75%,PARD3;SYNE4;RAP2A;CLASP1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.6167642530270369,1.0871280911477543,0.4222222222222222,1.0,1.0,4/8,10.56%,ROBO1;SLIT2;HIF1A;EDN1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.6378073861638229,-1.0870488789243393,0.4222222222222222,1.0,1.0,1/7,11.56%,ADCK1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5971543723245342,1.0868720999929407,0.3170731707317073,1.0,1.0,5/19,7.61%,ACE2;CALCR;PPARG;CHMP6;ERRFI1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6306277845282794,1.086699708610525,0.43137254901960786,1.0,1.0,1/7,2.96%,CX3CR1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4526251126383089,1.0865067190107793,0.28846153846153844,1.0,1.0,18/81,14.80%,GPC6;GPC5;CSGALNACT1;CHSY3;HS3ST5;PRELP;HS2ST1;B4GALT1;CHSY1;HS3ST3B1;CHST6;CHST7;HS3ST1;UGDH;EXT1;HS3ST3A1;CSGALNACT2;B3GNT2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.5395030808300613,-1.0864644486872823,0.37037037037037035,1.0,1.0,10/34,20.68%,MAP1LC3B2;WIPI1;MAP1LC3A;WIPI2;PINK1;FIS1;CISD2;MAP1LC3B;GABARAPL2;FUNDC1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.5468305963187878,-1.0863592222897394,0.3050847457627119,1.0,1.0,2/22,6.53%,USP27X;USP20
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.730262498288883,-1.0862468726449541,0.3877551020408163,1.0,1.0,1/5,10.38%,SLC6A20
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7297860987738901,-1.0862189489422487,0.4032258064516129,1.0,1.0,2/5,18.58%,PINK1;ATP5IF1
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.7133603127889052,1.0862098645719727,0.49056603773584906,1.0,1.0,1/5,3.79%,HMGB1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.556151295747604,-1.0858235558255316,0.4,1.0,1.0,6/21,14.13%,CBLC;VPS25;ADRA2A;BTC;SNX6;EREG
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7365877904992941,1.0857908394783127,0.3541666666666667,1.0,1.0,1/5,12.00%,PGGT1B
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7003175695431562,1.0857085144605159,0.4166666666666667,1.0,1.0,1/6,9.54%,ABCC11
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5458640733971333,1.0856823795061212,0.32727272727272727,1.0,1.0,6/22,15.04%,NRG1;CTNNA2;CDH2;CTNNB1;MEF2A;MEF2C
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.5705045786725738,-1.085383915719231,0.36538461538461536,1.0,1.0,2/14,6.19%,DUOX1;PRDX1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.5616604784834108,-1.0853558547971363,0.3584905660377358,1.0,1.0,4/21,15.21%,APOD;KCNE1;GDI1;BAG4
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5009079216314773,-1.0853306958901303,0.35714285714285715,1.0,1.0,8/33,18.58%,HPS4;ARIH2;PINK1;TOMM7;BAG4;VPS11;FZD5;ATP5IF1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4940073789722763,1.085237550810931,0.3877551020408163,1.0,1.0,6/47,5.99%,IFI16;RUNX1;PPARG;CSF1;BATF3;CSF1R
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.7051104572176841,1.0849667866966417,0.4,1.0,1.0,2/6,15.10%,TRDN;SLC9A1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.46237124716278655,-1.0848529981611632,0.2909090909090909,1.0,1.0,53/134,26.05%,PLK4;AURKA;PSMA7;HAUS8;DCTN1;PSMD7;SKP1;PSMB4;SSNA1;RBX1;PSMC3;CETN2;PRKACA;CCND1;RFPL1;TUBB4B;PSMD8;PSME1;ODF2;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;TUBG1;PSMD10;GPR132;RAB11A;CKAP5;PSME2;PSMD12;TPX2;CDC7;HAUS5;PSMC6;PSMB7;PSMB3;PAFAH1B1;DYNLL1;CENPF;PCNT;TUBB4A;PSMA5;PSMB1;PSMB6;PSMD3;DCTN2;DCTN3;CEP164;PSMD11;PSMA4
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5902052284784863,1.08482242265071,0.40384615384615385,1.0,1.0,3/16,13.40%,KLRD1;CADM1;CD160
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7225632602666145,1.0844580357201667,0.3888888888888889,1.0,1.0,2/6,19.35%,TSHZ3;ATP1A2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4994139764800953,1.0844321495304936,0.32653061224489793,1.0,1.0,10/27,16.65%,SMAD7;LATS1;TWSG1;NREP;SMAD2;SMURF2;SMAD3;FST;TGFBR3;SOX11
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.4580299531940507,-1.0842777458566042,0.30952380952380953,1.0,1.0,15/103,16.28%,STING1;ATP6V1E2;UCHL1;CDK5;ATP6V1E1;ATP6V1D;PRKACA;PINK1;SUPT5H;LAMTOR2;SNX6;ATP6V0A2;CAPNS1;HDAC6;KDR
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.7294385813845827,1.0839982352349213,0.375,1.0,1.0,3/5,25.36%,MDK;IL34;PTPRZ1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.6667949689713712,-1.083886894357842,0.46,1.0,1.0,1/7,2.04%,NOG
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.46420497301017766,1.083822673201408,0.24,1.0,1.0,34/155,14.19%,PIK3R5;CALCR;NRG1;ERBB4;SEMA5A;IRS1;CX3CR1;FGFR2;MAGI2;CASS4;EGFR;TGFBR1;IRS2;PKHD1;GAB1;FGFR3;FGF5;MFHAS1;FRS2;FGF17;MYORG;MSTN;PDGFRB;FGF10;IGF1R;ADAM8;PHLPP2;PHLPP1;FGFR1;SIRT1;PIK3CA;THPO;HGF;NRG2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5468362376615264,1.0837741678436845,0.35185185185185186,1.0,1.0,4/27,10.27%,AGER;ERN1;ZBTB20;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.5144806433807442,-1.082858663702471,0.34782608695652173,1.0,1.0,1/48,0.40%,STING1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.42500815241798834,-1.0827957432131654,0.2641509433962264,1.0,1.0,21/199,12.98%,TEKT3;PLK4;RILP;CATIP;CFAP61;TEKT5;RAB17;CFAP221;UBXN10;AHI1;TXNDC15;ATP6V1D;CFAP52;TRAPPC14;DZIP1L;TCTN1;TRAF3IP1;B9D1;EHD4;ODF2;UNC119B
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5176704628746123,1.082579578446083,0.2978723404255319,1.0,1.0,6/23,22.57%,SLC30A8;SLC4A4;SLC4A7;NEDD4L;KLHL3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.6196785274839333,1.0825472912889076,0.3442622950819672,1.0,1.0,6/19,11.81%,PLA2G10;PPARG;CSF1;LPL;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.648154220111294,-1.0824280636558863,0.44,1.0,1.0,2/9,9.08%,PCCB;PDZD11
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.7080946010736053,-1.0820347558295185,0.4166666666666667,1.0,1.0,2/6,8.50%,ACE;CARD9
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.46354119947384753,1.081817018544176,0.3389830508474576,1.0,1.0,24/84,15.46%,ESRRG;OXTR;TRPV2;SYK;ADIPOR2;LEPR;PPARGC1A;ELOVL6;SCD;ZNF516;HDAC3;PIGA;PRKAB2;DISP3;IGF1R;ACACA;ADIPOR1;ZBTB7B;GADD45G;PLAC8;FASN;IL4R;OGT;CPT2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.6192595408966626,1.0817650780510557,0.45614035087719296,1.0,1.0,4/8,24.60%,ANK3;AKT2;BAD;GLRX
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.47382122624889395,-1.081652863144368,0.3181818181818182,1.0,1.0,15/70,15.99%,UVSSA;POLR2I;ERCC1;UBC;XRCC1;POLR2J;RBX1;GTF2H2;COPS6;PRPF19;DDB1;COPS7A;POLR2G;POLR2C;ERCC2
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6525488002649478,-1.0815026612975431,0.4444444444444444,1.0,1.0,1/11,0.66%,INHA
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.6164890288772555,1.0814886990982993,0.40816326530612246,1.0,1.0,3/18,5.96%,ROBO1;SLIT2;NRP1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6701845416626125,1.0808526944882346,0.391304347826087,1.0,1.0,1/8,4.80%,EGFR
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.6804726592842459,-1.0808195506338334,0.3953488372093023,1.0,1.0,2/6,14.72%,PNPO;PSAT1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.45002839459822996,1.0806666236486255,0.35,1.0,1.0,44/202,12.98%,GABRR1;KCND2;CEL;RIT2;GRM7;PCDHB3;CHRM3;NLGN1;GABRB1;CHRNA10;GPR176;PTCHD1;NRXN1;GABRG3;PDYN;CHRM2;GRM5;GLRA2;GABRB2;OPRK1;SNCA;CACNB2;GRIA4;SYT1;SYPL1;GRIK2;SLC1A2;CHRNB4;CBLN1;ZACN;DLG2;NLGN4X;GLRB;PRKACB;MBP;APBA1;NOVA1;GABRA4;NPY;GRIK1;ASIC2;GRM1;CAMK4;DLGAP1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5828292989766516,1.0797123618031212,0.4107142857142857,1.0,1.0,4/16,18.34%,RPS6KA4;PRKD1;EPHA5;VEGFA
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6486309206693788,1.0796413937689455,0.3888888888888889,1.0,1.0,7/12,26.27%,ELOVL6;HACD2;TECR;ELOVL7;HACD4;ELOVL2;ELOVL5
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.48502953208505284,1.0795874650923762,0.2916666666666667,1.0,1.0,5/46,11.07%,MARVELD3;PTPRG;HIF1A;FGF10;ADIPOR1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4965479040286445,-1.0795684875774174,0.32075471698113206,1.0,1.0,12/40,22.04%,TOMM40;TIMM17B;SRP54;SEC62;TOMM20;TIMM17A;PEX1;TIMM50;TIMM44;TOMM40L;SEC61G;HSPD1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.47537063870333557,-1.0794926083585012,0.2553191489361702,1.0,1.0,5/62,5.47%,NCKAP1L;PLK4;HCK;CDK5;VIL1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.6913419941684795,1.0793427292682505,0.32432432432432434,1.0,1.0,3/6,12.25%,PPARG;CTBP2;SIRT1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.5940264924032187,-1.0790715582972465,0.37735849056603776,1.0,1.0,4/13,15.72%,CD9;AZU1;METTL3;NDUFS2
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.6730059741658754,1.0789120214889787,0.4098360655737705,1.0,1.0,3/6,25.21%,CCL5;PREX1;KMT2E
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7030211542073999,1.0786609686304791,0.3584905660377358,1.0,1.0,2/5,12.01%,GDPD3;NAPEPLD
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7030211542073999,1.0786609686304791,0.3584905660377358,1.0,1.0,2/5,12.01%,GDPD3;NAPEPLD
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.6706305574213958,1.0785973484933367,0.5357142857142857,1.0,1.0,2/7,9.54%,ABCC2;ABCC11
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4533691115329736,1.0785200345983283,0.3148148148148148,1.0,1.0,21/87,19.20%,ZFPM2;ERBB4;FLRT3;FGF12;TGFBR1;HEY1;HDAC9;DVL2;BCOR;CRB2;TAB2;PLCE1;PIK3CA;MEF2A;ACVR1;MEF2C;SALL1;KAT2B;PDGFB;PDLIM1;KDM6A
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.7156592007329272,1.0780579139844173,0.3448275862068966,1.0,1.0,2/6,2.66%,PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.49156853890300267,1.0777845866138058,0.3269230769230769,1.0,1.0,10/39,16.14%,PBX1;SHROOM2;MEIS1;PBX3;CPAMD8;ATF6;MEIS2;COL5A2;MEIS3;SCO2
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.4748208598636211,1.077738863950706,0.2711864406779661,1.0,1.0,15/66,14.27%,CADM2;RGMA;LRP1B;PTCHD1;CMYA5;SLC35F1;CACNB2;HFM1;FILIP1;RBFOX1;TRDN;ANO5;FGF13;KBTBD12;SORBS1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.6319877200990323,-1.0776672387824067,0.42592592592592593,1.0,1.0,5/15,19.40%,OAS3;STAT2;METTL3;ISG15;NLRC5
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5528243725531694,1.0776595530508593,0.4230769230769231,1.0,1.0,4/20,12.12%,SLC22A2;SLC6A13;SLC1A2;SLC7A2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.515877572128076,1.0776202843856986,0.4117647058823529,1.0,1.0,4/24,9.49%,SEMA5A;SLIT2;NRP1;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.6116638580065943,1.076740596463661,0.3877551020408163,1.0,1.0,2/13,9.12%,NUS1;HIF1A
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5954139217229919,-1.0765394600089113,0.375,1.0,1.0,4/11,15.36%,XPC;ERCC1;DDB1;INO80
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.7439610691588435,-1.0762382617002726,0.5102040816326531,1.0,1.0,1/5,1.32%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6251954996852704,-1.0762332716016458,0.4166666666666667,1.0,1.0,1/9,1.32%,NUPR1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6518274544708659,1.076042454291595,0.3958333333333333,1.0,1.0,1/9,2.25%,ERBB4
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.6191080442060776,-1.0760048134948301,0.43636363636363634,1.0,1.0,1/11,1.26%,SPA17
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.7048295000100284,1.075756184020768,0.43478260869565216,1.0,1.0,2/5,13.88%,PPARG;EP300
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.7048295000100284,1.075756184020768,0.43478260869565216,1.0,1.0,2/5,13.88%,PPARG;EP300
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.6768075753014146,-1.0757214427135553,0.4444444444444444,1.0,1.0,2/8,6.63%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.7449359017288253,1.0756718510808687,0.41509433962264153,1.0,1.0,4/5,24.68%,FGF13;PEX13;EFHC1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5414248284194143,1.075495146537743,0.3269230769230769,1.0,1.0,10/35,13.64%,PLA2G7;VEGFC;CSF1;HMGB1;CSF1R;CCL5;MSTN;VEGFD;CXCL12;MDK
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6516520007173132,1.0750678384381451,0.37209302325581395,1.0,1.0,1/6,4.73%,ROBO1
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),0.6967456334536967,1.0750448804892683,0.4423076923076923,1.0,1.0,3/5,25.78%,WWC1;SLC6A4;PTEN
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.6528558131072953,1.0750112592373755,0.4,1.0,1.0,2/9,11.88%,SYNE4;RAP2A
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5732956834832597,-1.0745321972478605,0.41935483870967744,1.0,1.0,1/15,0.56%,SFRP1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.515867231399876,1.0743016535484633,0.40816326530612246,1.0,1.0,2/23,4.84%,MYBPC3;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.4564869540417197,1.0742957836612885,0.3157894736842105,1.0,1.0,29/102,19.91%,NLGN1;ITPKB;MT1M;ADGRV1;EGFR;NEUROD2;WNT5A;GLRA2;SNCA;ECT2;SYT1;ACER1;DLG2;CRHBP;SYT15;MEF2A;ANK3;TF;FBP1;MEF2C;SYT2;MAPK8;SLC12A2;BRAF;BMP6;ZNF658;DMTN;SYT17;CACNA1H
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.673815571195672,-1.0742557924312015,0.4482758620689655,1.0,1.0,1/10,5.89%,GNB3
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.6958991731804538,1.0734004568176232,0.4117647058823529,1.0,1.0,2/8,8.82%,WNT5A;CCL5
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.6958991731804538,1.0734004568176232,0.4117647058823529,1.0,1.0,2/8,8.82%,WNT5A;CCL5
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6475534028628239,1.0730589418996073,0.391304347826087,1.0,1.0,8/11,34.44%,PICALM;ROCK2;PRNP;FLOT2;ABCA2;CHRNA7;APOE;RANBP9
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.6756961902327074,-1.0728556058450605,0.4489795918367347,1.0,1.0,1/6,6.56%,SPI1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5209509616579574,1.0728179319218516,0.3888888888888889,1.0,1.0,5/32,10.22%,RAB9A;SNCA;PDCD6IP;EXPH5;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5001325639055089,1.0726579182398848,0.3333333333333333,1.0,1.0,9/43,12.78%,SYK;HMGB1;WNT5A;AGER;TWIST1;LPL;MBP;TLR1;IL16
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6732618338382194,1.0726293520729155,0.47058823529411764,1.0,1.0,2/6,11.15%,WNT5A;CHD7
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6621504368150746,1.072534996372544,0.4230769230769231,1.0,1.0,3/7,12.80%,PIK3C2G;PIK3C2B;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.46984092546977885,1.072265494654758,0.3137254901960784,1.0,1.0,19/80,11.98%,LTK;FZD1;NDNF;RIT2;MAGI2;ROR1;EPHA3;WNT5A;ZNF804A;PRKD1;STYXL1;TOX;ABL2;FUT9;COBL;RETREG3;LRRC7;TENM3;NPTN
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.45509153266683017,-1.0721994797779528,0.3508771929824561,1.0,1.0,22/93,25.25%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;RACK1;MRPS18C;MRPL9;MRPL19;MRPS21;MRPL27;MRPL51;MRPS33;MRPL37;MRPS22;MRPS11;GTPBP1;EEF1B2;EEF2;MRPS23;EEF2K;EEFSEC
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6713248527759949,1.0721586438738202,0.4482758620689655,1.0,1.0,3/6,21.35%,RP1;BBS4;RPGRIP1L
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.52564178761209,-1.0721417524164951,0.25,1.0,1.0,5/30,14.41%,RBM4;WTIP;LIMD1;SNIP1;EIF6
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5922327731739434,1.0720885309813823,0.3333333333333333,1.0,1.0,1/21,1.00%,MED17
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.6701594421895386,1.0720281929737696,0.4888888888888889,1.0,1.0,2/5,11.85%,PDE2A;PDE3A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.6701594421895386,1.0720281929737696,0.4888888888888889,1.0,1.0,2/5,11.85%,PDE2A;PDE3A
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6202025849728054,-1.0717053644982313,0.3673469387755102,1.0,1.0,2/7,12.60%,RAB3B;RIN3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.49626674586141073,-1.071364010371215,0.30612244897959184,1.0,1.0,6/33,13.92%,DUSP4;PGP;DUSP6;PTPN9;DUSP5;PTPRB
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.42881932626238417,1.071277274591782,0.30612244897959184,1.0,1.0,30/139,14.04%,FZD1;NDNF;RUNX1;TAFA1;IL1RAPL1;CX3CR1;ATOH8;DDIT4;NEUROD2;WNT5A;RUNX2;GPM6A;HEY1;NRP1;PTPRD;ADGRL3;RYK;CDK6;NLGN4X;AUTS2;FUT9;ACSL4;DLL1;WNT8A;FGFR1;CTNNB1;POMGNT2;FGF13;PEX13;ADNP2
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6399498527815448,1.0712114772673993,0.36363636363636365,1.0,1.0,3/8,15.87%,SLIT2;NRP1;ALCAM
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6399498527815448,1.0712114772673993,0.36363636363636365,1.0,1.0,3/8,15.87%,SLIT2;NRP1;ALCAM
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.6420519698647151,1.071162931902742,0.43137254901960786,1.0,1.0,1/7,2.63%,ENPP1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.6790950602736112,1.0710857554701405,0.3877551020408163,1.0,1.0,2/9,7.63%,SPHK1;LDLR
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.42451255412925726,-1.0710477895537622,0.3488372093023256,1.0,1.0,8/131,7.74%,SLC28A2;SERPINE1;ADRM1;NLRP3;RGS16;GPC3;VIP;SCARF1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.6071685407887577,-1.070898108562033,0.4117647058823529,1.0,1.0,8/14,24.38%,SAP18;C1QBP;SRSF7;RBMX;SRSF10;RNPS1;SFSWAP;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.5233922712216419,-1.0705365932636821,0.3269230769230769,1.0,1.0,4/18,12.60%,RAC1;WDR54;LRPAP1;RIN3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.4412378446137648,-1.070299105867346,0.3333333333333333,1.0,1.0,13/95,10.41%,CPXM2;TAGLN;COL6A1;GSTM3;FBLN2;RNASE1;TPM1;TPM4;CALD1;CRYAB;COX7A1;CYP1B1;ADAM33
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.7130632216500512,-1.0699780945768924,0.4,1.0,1.0,4/7,19.51%,WARS1;XRCC1;PUM3;HPF1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5362402773484435,1.0697040230213797,0.4074074074074074,1.0,1.0,3/19,10.22%,SNCA;SLC30A10;RAB27A
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.5376616755281972,1.0695946038672046,0.32558139534883723,1.0,1.0,2/24,7.07%,ESAM;LATS1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6485946259180553,1.0689895612112008,0.46808510638297873,1.0,1.0,5/10,19.39%,RUNX1;ELF1;PAX5;ELF2;CBFB
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.4630038126986827,1.068929889989317,0.2982456140350877,1.0,1.0,13/73,11.81%,HSPB1;SYK;CX3CR1;HMGB1;WNT5A;AGER;CIDEA;ZFP36;TWIST1;LPL;TLR1;PTPN6;NLRC3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.47801635191789815,1.0688332559098985,0.3508771929824561,1.0,1.0,16/55,25.78%,MED17;RUNX2;CSF1R;CTNNB1;RELA;ZNF45;ATF7IP;CBFB;MECP2;TNRC6C;NFKB1;MED24;PPM1D;LEF1;MED25;PTEN
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.4274768143096268,-1.068728474190248,0.2962962962962963,1.0,1.0,11/98,10.51%,ACOT1;AOAH;ACOT11;ACOT4;MECR;CRAT;ACSBG2;ABCB11;PER2;LIPC;LIPI
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7190750638556747,1.068439612216716,0.4107142857142857,1.0,1.0,2/6,21.22%,ELAVL4;TENT4B
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5704952969678947,1.068365912985854,0.3181818181818182,1.0,1.0,7/18,13.60%,PLA2G10;SPHK1;WNT5A;LRFN5;MFHAS1;NR1H3;GPR137B
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.4362973679233206,1.0681788004980541,0.275,1.0,1.0,54/255,14.89%,GABRR1;KCND2;CEL;RIT2;GRM7;PCDHB3;CHRM3;NLGN1;GABRB1;CHRNA10;GPR176;PTCHD1;CDH8;NRXN1;GABRG3;PDYN;CHRM2;GRM5;GLRA2;GABRB2;OPRK1;SNCA;GRID2;CACNB2;GRIA4;SYT1;SYPL1;GRIK2;SLC1A2;CHRNB4;CBLN1;ZACN;DLG2;NLGN4X;GLRB;PRKACB;MBP;APBA1;NOVA1;CRHBP;GABRA4;NPY;GRIK1;ASIC2;GRM1;CAMK4;PPFIA3;DLGAP1;SYN3;ERC2;HTR1E;GRIA2;KCNN1;LIN7A
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4644445535604309,-1.0679294059083817,0.35294117647058826,1.0,1.0,10/61,11.90%,PLK4;FGF1;PLK3;AURKA;PLK5;CALM1;PLK2;CETN2;RFPL1;RACK1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.603631098784541,-1.0679152915133223,0.39655172413793105,1.0,1.0,4/16,19.93%,TSPYL5;CRYAB;XRCC6;TMEM109
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.6063516072329947,-1.0678594163534494,0.43137254901960786,1.0,1.0,5/15,15.93%,SARS1;TRPT1;POP7;POP1;POP5
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.4226333436339293,1.0676122131326413,0.22916666666666666,1.0,1.0,34/150,17.17%,NTF3;GRM7;NEDD4;NLGN1;HMGB1;GPRIN1;FLRT3;ADGRV1;CNTN4;AGER;TNIK;GPM6A;NYAP2;CNTNAP2;RYK;SH3GL2;SGK1;MANF;GPM6B;DOCK10;TMEM108;EPHA8;NPY;PTPRM;NRTN;ATXN10;BTG2;CTNND2;NCDN;LRP12;PPP1R9A;MAP2;HDGFL3;DCLK1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.7148203649902418,-1.0671457985563688,0.4489795918367347,1.0,1.0,2/7,9.72%,LCP1;PRKACA
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.6297721925651371,-1.0670730031253464,0.3888888888888889,1.0,1.0,4/11,9.95%,RPS27L;PLK3;PLK5;CCND1
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.673048883300501,1.067014072760724,0.42857142857142855,1.0,1.0,3/6,27.92%,CRLF2;PLSCR1;CD300LF
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.42149807282480023,-1.0669456188527122,0.2708333333333333,1.0,1.0,52/196,20.01%,RTF1;HSF2BP;GTF2F1;NFKBIB;POLR2I;CEBPD;DRAP1;TTF1;TCEA2;PAX8;POLR2J;PTMA;GTF2H2;TAF9B;POLR3A;ATF4;NFX1;TWNK;THRA;TAF6;ELOB;TBPL2;MNT;SUPT5H;TAF11;TAF7;POLR3H;SUPT16H;MED16;BTF3;CCNT1;EREG;DRG1;POLR2G;DTX1;POLR2C;PARP1;POLRMT;TAF1;ERCC2;SMARCA5;BRF1;TAF10;RBMX;GTF3C2;DDX21;SUPT6H;NELFA;ETV7;BRF2;POLR2L;RNPS1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5161153849121944,-1.0664396530819447,0.3958333333333333,1.0,1.0,4/22,7.73%,FGF1;WNT7B;FGF7;RBP4
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.47405942052251915,-1.0663797297214836,0.36,1.0,1.0,8/45,10.85%,HSD11B1;CYP19A1;HSD17B10;DHRS11;PRLR;ABCB11;TM7SF2;CYP21A2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.6876069064752269,1.0660334578545838,0.42857142857142855,1.0,1.0,3/8,16.69%,PIP4K2A;PLEKHM1;CLN3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7045669022991639,1.065641072212301,0.5,1.0,1.0,2/9,4.02%,P3H2;EGLN3
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5496237754865745,1.0656286162898718,0.43137254901960786,1.0,1.0,3/13,21.48%,ELP4;MOCS3;DPH3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6583145266454383,1.0656272923308576,0.48,1.0,1.0,1/6,11.06%,BICD1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.453655414826506,1.0655098663255431,0.21153846153846154,1.0,1.0,18/81,11.39%,LTK;ERBB4;FGFR2;LDB2;ROR1;EGFR;EPHA3;IRS2;CSF1R;ECT2;RYK;FGFR3;EPHA7;PLCE1;PDGFRB;IGF1R;EPHA8;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.661530747487951,1.0655018195261532,0.4375,1.0,1.0,1/5,2.96%,CX3CR1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6423810716786409,-1.0654604300657908,0.5,1.0,1.0,2/8,8.43%,SLC3A1;SLC7A7
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.561399509061038,-1.0651803003521332,0.40350877192982454,1.0,1.0,1/19,1.74%,CLU
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.4509016246516839,1.0651438769059653,0.32558139534883723,1.0,1.0,22/65,20.80%,IRS1;PPARG;ADIPOR2;LEPR;SLC30A8;PPARGC1A;MCU;HIF1A;FOXO1;IGF1R;ADIPOR1;SIRT1;KLF7;PIK3R1;CRY1;BAD;MBD5;PDK4;PDK2;PYGL;CAV3;INSR
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6658292815692187,1.0647849932870626,0.45652173913043476,1.0,1.0,1/7,2.30%,HS3ST5
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5070412033019012,-1.0646776144745567,0.35714285714285715,1.0,1.0,15/36,29.56%,PRPF6;PRPF19;GEMIN4;USP4;SRSF10;PRMT7;SNRPD2;WDR77;COIL;SNRPD1;LSM4;PRPF3;LSM2;SNRPC;SNRPB
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5833396372634078,1.0642080789945987,0.3125,1.0,1.0,3/16,10.27%,SLC30A8;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.6509501250468575,-1.0641975422410772,0.46938775510204084,1.0,1.0,2/9,6.63%,BDH1;HMGCL
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.48134204166424277,1.064087298880328,0.36,1.0,1.0,6/47,5.73%,NLRP2B;IFI16;HSPB1;CX3CR1;WNT5A;AGER
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.5868819873303787,-1.0640415339755056,0.4339622641509434,1.0,1.0,1/12,1.72%,SLC25A10
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5882423410711485,-1.063823605282169,0.36065573770491804,1.0,1.0,2/11,5.10%,CBLC;VPS25
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7087029017915794,-1.0634125809944486,0.46296296296296297,1.0,1.0,1/7,8.72%,PARP14
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.5288021004987364,-1.0631842486464158,0.3469387755102041,1.0,1.0,9/36,19.52%,HEBP2;PRELID1;PINK1;BAK1;PIP5KL1;PRDX3;TUSC2;ATP5IF1;SOD1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.7034128966194694,1.0631255954720273,0.43478260869565216,1.0,1.0,1/6,12.06%,P2RX7
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5423726628859316,-1.063059177526426,0.4,1.0,1.0,9/37,6.01%,P2RY10;CD5;SLA;AOAH;KLRB1;TRBC2;TRAF3IP3;CD4;CD37
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.47455759246707835,-1.0629998515236345,0.3333333333333333,1.0,1.0,15/79,21.88%,MRPS25;MRPL23;MRPL16;MRPS18B;MRPL55;MRPS18C;MRPL9;MRPL19;MRPS21;MRPL27;MRPL51;MRPS33;MRPL37;MRPS22;MRPS11
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.6331642250161829,-1.062965092863011,0.391304347826087,1.0,1.0,1/7,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.6421059104903757,-1.062906028722826,0.36,1.0,1.0,3/6,23.17%,STAT1;STAT3;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.6421059104903757,-1.062906028722826,0.36,1.0,1.0,3/6,23.17%,STAT1;STAT3;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.6962708967975836,1.0627411781867757,0.4339622641509434,1.0,1.0,1/6,2.27%,NFKBIZ
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.6736835632204564,1.0626752899022613,0.4791666666666667,1.0,1.0,2/6,17.68%,TMED9;TMED2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.6736835632204564,1.0626752899022613,0.4791666666666667,1.0,1.0,2/6,17.68%,TMED9;TMED2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.6736835632204564,1.0626752899022613,0.4791666666666667,1.0,1.0,2/6,17.68%,TMED9;TMED2
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.6853038197698266,-1.0624498360093586,0.43478260869565216,1.0,1.0,2/5,18.16%,WRAP53;CCT2
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.6853038197698266,-1.0624498360093586,0.43478260869565216,1.0,1.0,2/5,18.16%,WRAP53;CCT2
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5814445154177879,1.0624053194888632,0.38181818181818183,1.0,1.0,3/14,17.07%,HMGCS1;ACACA;ACSS1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5419480779124759,1.062391941610336,0.37037037037037035,1.0,1.0,11/30,25.60%,PDE4D;PDE2A;RIMS2;PDE3A;AKAP6;EPHA5;CAP1;ADCY2;PDE7B;RAPGEF2;CAP2
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.6021438192364732,1.0622045709646188,0.4,1.0,1.0,6/12,15.93%,GNAT2;GRM6;RP1;GNAQ;CNGB1;EYS
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6117437830519019,1.0620325246617173,0.4666666666666667,1.0,1.0,5/14,17.98%,IRS1;IRS2;TWIST1;AKT2;TYSND1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.46513439095889364,1.062023746209634,0.3333333333333333,1.0,1.0,35/117,12.62%,LTK;NTF3;FRK;ERBB4;CD8A;SYK;FGFR2;CSF1;CASS4;GUCY2F;ROR1;EGFR;EPHA3;CSF1R;CNKSR1;GP6;ACVR2A;PTPRD;RYK;FGFR3;BLNK;PTPRG;FRS2;NPR2;EPHA7;FER;CLNK;PDGFRB;IGF1R;EPHA8;FGFR1;LIFR;YES1;BCAR1;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5403910962078449,1.0618872450034127,0.3617021276595745,1.0,1.0,7/24,14.13%,PPARG;ATOH8;FOXO3;NR3C1;HIF1A;SMAD3;RELA
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5796347961501627,-1.0615704698944373,0.42857142857142855,1.0,1.0,7/12,26.79%,RPS15;NOP9;EIF6;NMD3;RAN;NPM1;SDAD1
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.7033360672687088,-1.0614406475373854,0.5,1.0,1.0,1/5,1.05%,CCN3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5278073868033819,-1.060959018283267,0.38,1.0,1.0,8/20,18.61%,TPPP3;STMN1;PIN1;TRPV4;STMN3;STMN2;KATNB1;CKAP5
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5609833394508169,1.060707919307085,0.43137254901960786,1.0,1.0,2/17,14.22%,CIDEA;PLA2G4C
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.47036301985468487,1.0606270973597334,0.3191489361702128,1.0,1.0,5/51,7.63%,PLA2G10;PRELID2;ATP10A;ATP8B3;LDLR
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6819110052002355,1.0604947271366079,0.4583333333333333,1.0,1.0,1/5,3.79%,HMGB1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6774257573230703,-1.0604791111083225,0.46153846153846156,1.0,1.0,3/8,24.93%,AK8;AK7;AK1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6131558686794214,1.0602022906487316,0.4067796610169492,1.0,1.0,5/7,29.09%,HMGCR;MVD;PDSS2;MVK;IDI2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.7186244919881055,1.0601582793585003,0.42857142857142855,1.0,1.0,2/5,15.46%,CPT1C;CPT2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.46371279704763946,-1.06003817063223,0.34615384615384615,1.0,1.0,11/75,10.42%,TYMS;BACH1;PLK3;CDKN3;CDK5;ZNF324;LATS2;MAX;PLK2;CCND1;CCNE1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5787032265446572,1.0597197944728511,0.4418604651162791,1.0,1.0,7/15,20.73%,NAPEPLD;ZBTB7B;SIRT1;FTO;PTGS2;PIM1;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.5358283995100221,-1.0594747648841278,0.34782608695652173,1.0,1.0,5/16,16.40%,TAF11;CCNT1;SNW1;NUCKS1;RRP1B
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.48338909544518993,1.059405214378651,0.28846153846153844,1.0,1.0,7/56,12.37%,MAP3K11;TAB3;CUL1;DUSP9;ZFP36;TAB2;BTRC
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6562594670187971,-1.059344570391237,0.40816326530612246,1.0,1.0,1/5,6.77%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6562594670187971,-1.059344570391237,0.40816326530612246,1.0,1.0,1/5,6.77%,EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6562594670187971,-1.059344570391237,0.40816326530612246,1.0,1.0,1/5,6.77%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6562594670187971,-1.059344570391237,0.40816326530612246,1.0,1.0,1/5,6.77%,EXOSC10
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6062551395356981,1.0592603006586683,0.4772727272727273,1.0,1.0,3/9,7.24%,FGFR2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5390015501317044,-1.059201801172026,0.3541666666666667,1.0,1.0,6/23,16.16%,RAC1;VIL1;SHANK3;SYNPO2L;ASAP3;SHANK1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5252655963297281,1.0591778431298762,0.425531914893617,1.0,1.0,8/25,12.25%,CX3CR1;ADIPOR2;CCL5;C3;MITF;PRKAB2;ADIPOR1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5319092861572053,1.0590822262408177,0.40425531914893614,1.0,1.0,3/17,12.25%,HSPB1;HIF1A;SIRT1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5459390128014745,-1.05873555379254,0.3958333333333333,1.0,1.0,1/25,0.85%,TYMS
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.6986448929546467,1.0586479512326716,0.5116279069767442,1.0,1.0,1/6,2.58%,KLF2
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.6084139537599258,-1.0582175398736353,0.4,1.0,1.0,4/9,16.41%,ZWILCH;PLK2;WEE2;PRCC
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6096902350216298,1.0581503130383674,0.3617021276595745,1.0,1.0,2/11,4.40%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6337590221779401,1.0579356249854495,0.5,1.0,1.0,2/7,13.37%,NR1H3;IFI35
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6739283074870709,1.057849892049444,0.48,1.0,1.0,3/5,29.83%,SETMAR;SETD3;ASH1L
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.6881369879150098,1.0578390954120869,0.40816326530612246,1.0,1.0,2/7,8.55%,UBR5;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.743847166387418,-1.057445820532945,0.5,1.0,1.0,1/5,0.49%,NCKAP1L
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.5915529068566556,1.0574355607001285,0.4186046511627907,1.0,1.0,3/11,16.69%,NLGN1;SYN3;CLN3
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4111606165949276,1.0572987945979677,0.3958333333333333,1.0,1.0,61/321,13.64%,DACH1;STK26;SGK3;CD151;SEMA3C;FAM83H;SPHK1;NTF3;ERBB4;SEMA5A;TRIP6;KANK1;ITGAX;PTPRK;SEMA6D;PHACTR1;CSF1;MAGI2;LDB2;CASS4;SMAD7;ROBO1;ARHGEF39;EGFR;NAV3;SULF1;SLIT2;TGFBR1;FRMD5;RHOB;CSF1R;FOXO3;PPP3CA;MCTP1;FGF5;CCL5;FGF17;CTNNA2;SGK1;FER;MITF;LAMC2;JAG1;PDGFRB;FGF10;IGF1R;DOCK10;EDN1;PRKCA;CDH13;SRGAP2B;TMEFF2;TP53INP1;RAP2A;PDGFD;BCAR1;CXCL12;ARID2;SASH1;HGF;MDK
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5945941448292429,1.0568832883011057,0.46296296296296297,1.0,1.0,3/11,18.42%,NLGN1;PLEKHM1;EPS8
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6463657422598309,1.0563938740642238,0.4888888888888889,1.0,1.0,2/6,24.68%,ARFIP1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.7134734009669078,1.0562738556481421,0.4807692307692308,1.0,1.0,1/5,11.98%,NPTN
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.730096256227444,1.0560756083729288,0.4230769230769231,1.0,1.0,2/5,9.43%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.5553915629168,1.0560470378355673,0.39215686274509803,1.0,1.0,5/17,8.82%,PLA2G7;JAM2;HMGB1;AGER;CCL5
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.46762606162694154,-1.055972932813951,0.4,1.0,1.0,13/74,11.90%,SH3RF2;NUPR1;CLU;TRIB2;ARIH2;DDA1;RBX1;PSMC3;KCNE2;DDRGK1;ELOB;RFPL1;RACK1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.6140444163056538,1.0557470096715162,0.4262295081967213,1.0,1.0,4/7,20.61%,NFATC2;NFATC3;PDGFB;PDCD4
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.42402410423940573,-1.0556855064518202,0.2826086956521739,1.0,1.0,21/151,10.34%,NOSTRIN;CD9;EMCN;ADIRF;F8;EPAS1;RNASE1;ETS1;ARAP3;PRKCH;CYYR1;MEOX1;MADCAM1;MCAM;SCARF1;COX7A1;IFI27;SPARC;FHL2;VWA1;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.7134246465043477,-1.0556777217253792,0.40816326530612246,1.0,1.0,1/5,6.75%,ADRA2A
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5259031346122207,-1.0555925356458284,0.37254901960784315,1.0,1.0,2/21,5.52%,NCKAP1L;SRP54
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6229079143735645,1.0554022689553488,0.3877551020408163,1.0,1.0,3/15,15.04%,NRG1;SORT1;MEF2C
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.6156507374471627,-1.055306190391138,0.4230769230769231,1.0,1.0,3/11,12.73%,SLC25A10;SLC25A3;SLC37A1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6156507374471627,-1.055306190391138,0.4230769230769231,1.0,1.0,3/11,12.73%,SLC25A10;SLC25A3;SLC37A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.427063819133343,-1.0537836872704809,0.34,1.0,1.0,22/120,14.43%,NCKAP1L;INHA;SIGIRR;SARS1;APOD;RAC1;TMSB4X;DHX58;UBE2L6;TRIB2;NLRX1;UFD1;BTN2A2;PTPRC;TRAF3IP1;C1QBP;CEACAM1;ISG15;PIN1;SELENOS;NR1H4;APOA1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.6147524566706504,-1.0535241510686628,0.38461538461538464,1.0,1.0,2/6,10.09%,TPM1;ADRA1D
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4789724653774174,-1.0534929415913186,0.4074074074074074,1.0,1.0,8/42,14.41%,FOXM1;GNB3;ARF1;ABCB11;CYP1B1;BTN2A2;PINK1;EIF6
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.523868528448289,-1.053137610898145,0.35714285714285715,1.0,1.0,3/29,6.53%,USP27X;ABRAXAS1;USP20
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5793650646085963,-1.053030661562804,0.44680851063829785,1.0,1.0,6/15,19.89%,SVBP;PINK1;CSTB;PSMB8;CTSH;CST3
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5774527284267376,1.0529807946420147,0.3953488372093023,1.0,1.0,4/14,10.11%,NRG1;MBNL1;HINFP;JAG1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.5665385956319382,1.052938729864718,0.4166666666666667,1.0,1.0,4/17,21.18%,NEDD1;PCM1;BBS4;KIAA0753
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.6457007804069544,1.0522296065339618,0.4666666666666667,1.0,1.0,1/9,5.89%,AK3
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6394852810000221,1.0521605368606644,0.4634146341463415,1.0,1.0,5/12,16.29%,IRS1;PPARGC1A;IRS2;SIRT1;AKT2
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.6451355415949664,-1.051943093681991,0.4489795918367347,1.0,1.0,1/7,0.75%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.5044988520110599,1.0516236703279027,0.34782608695652173,1.0,1.0,3/46,6.82%,ACE2;AKR1C1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7267318815987742,-1.0515691407137526,0.4807692307692308,1.0,1.0,2/5,23.46%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.7164007374334276,-1.0512825605231524,0.4827586206896552,1.0,1.0,3/5,27.39%,ATP5F1D;ATPAF1;OXA1L
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4722305339439945,-1.0510836070150327,0.3888888888888889,1.0,1.0,22/58,21.32%,MYB;LDB1;PSMA7;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;METTL3;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.6222632130339593,-1.0509084238219983,0.3469387755102041,1.0,1.0,1/7,4.85%,ACTC1
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.6853436917807598,-1.050840167850535,0.4423076923076923,1.0,1.0,3/6,25.84%,ALOXE3;GSTP1;ALOX12B
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.6853436917807598,-1.050840167850535,0.4423076923076923,1.0,1.0,3/6,25.84%,ALOXE3;GSTP1;ALOX12B
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.625849482311759,-1.0507610122245625,0.35555555555555557,1.0,1.0,2/12,4.93%,TK2;PUDP
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.6025865806432916,-1.0505622759470528,0.37209302325581395,1.0,1.0,2/11,4.20%,WNT9A;ADAMTS12
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6101426700013823,1.0505467928849326,0.46511627906976744,1.0,1.0,7/12,24.77%,SAXO2;PCM1;BICD1;CLASP1;CLASP2;DAG1;BCCIP
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5519800467184085,-1.0501959899478708,0.4339622641509434,1.0,1.0,5/17,20.85%,SRP54;SRP14;SRPRA;SPCS1;SEC61G
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.4898158402204982,-1.0492314326905892,0.4,1.0,1.0,3/23,12.12%,ECRG4;SPI1;CDKN2B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.49593105266313836,-1.0490960580583897,0.3684210526315789,1.0,1.0,5/46,4.39%,NCKAP1L;HLA-DPB1;BST1;CD74;VAV3
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.5587082255645247,-1.0489980406092272,0.3617021276595745,1.0,1.0,7/16,19.85%,TOMM40;TIMM17B;TOMM20;TIMM17A;TIMM50;TIMM44;TOMM40L
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.6983707622732362,-1.0487816519962119,0.48,1.0,1.0,2/5,20.78%,CD63;RAB32
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.6983707622732362,-1.0487816519962119,0.48,1.0,1.0,2/5,20.78%,CD63;RAB32
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.47132455584384786,-1.0487187905750988,0.42592592592592593,1.0,1.0,6/63,8.11%,GSTM5;CPXM2;GSTM3;CPQ;ACE;GSTK1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.4292262282006182,-1.048353477489018,0.35294117647058826,1.0,1.0,47/117,26.10%,PSMA7;GINS3;PSMD7;UBC;PSMB4;PSMC3;MCM5;TWNK;ORC3;PSMD8;ORC1;PSME1;MCM2;PSMB2;PSMC4;PSMB8;RPAIN;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;RECQL;DDX21;POLE3;PSME2;PSMD12;CDC7;PSMC6;POLG;PSMB7;PSMB3;RPA3;POLE4;MCM4;ORC2;CDC6;PSMA5;UBB;PSMB1;WDHD1;PSMB6;ORC6;PSMD3;PSMD11;PSMA4;RFC2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.5340504393667935,-1.0482781792029898,0.4423076923076923,1.0,1.0,2/19,5.52%,NCKAP1L;SRP54
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6257626240960596,1.048199156126555,0.42592592592592593,1.0,1.0,5/10,19.05%,RUNX1;WNT5A;ETV6;MECOM;YJEFN3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6792384493552505,1.047926105301526,0.4186046511627907,1.0,1.0,4/6,21.09%,HIF1A;BMPR1A;SMAD3;SMAD4
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.47870459233851087,-1.0476160353062742,0.38461538461538464,1.0,1.0,13/51,17.00%,AOAH;HCK;NLRP3;BST1;OAS3;SPI1;PRAM1;CD24;AZU1;CEACAM1;PILRA;DOCK8;CR1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.5906909869032746,1.0474674221778248,0.3958333333333333,1.0,1.0,2/9,12.28%,SMAD7;CTNNB1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7010914738519601,1.0474568600379066,0.5,1.0,1.0,2/5,22.24%,GLA;GALC
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4684568469820747,-1.047186771842515,0.3829787234042553,1.0,1.0,5/46,7.95%,TPPP3;RAC1;CATIP;VIL1;WASHC3
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5891597924062552,-1.0469310201010908,0.42857142857142855,1.0,1.0,6/19,20.38%,GOLGA2;TUBGCP5;TUBGCP2;TUBG1;TPX2;TUBG2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.6370188458576109,1.0467359322131224,0.4423076923076923,1.0,1.0,4/7,28.24%,NLRC3;RELB;SIRPA;REL
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.5630055667244953,-1.0465177131954477,0.4,1.0,1.0,2/13,5.34%,REC8;DSCC1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.6063196051944709,1.046473616291325,0.42,1.0,1.0,5/10,31.75%,BMPR1A;ACVR1;SLIT3;TGFB2;BMPR2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6229038857831926,1.0462297318386937,0.4222222222222222,1.0,1.0,1/6,2.96%,CX3CR1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.6717864451075017,1.0461067881053407,0.4897959183673469,1.0,1.0,2/7,16.79%,KIF26A;PHACTR4
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.4417237747872284,-1.0458906190655255,0.34545454545454546,1.0,1.0,22/105,17.31%,SFRP1;NTRK1;AGRN;ITGA6;RGS16;CALM1;BCAR3;HMGB2;PINK1;RACK1;GNB5;PIN1;RAP1GAP;APOA1;ASAP3;RGS8;RTN4R;CTSH;ZC3H15;CALM3;DOCK8;RASGRP2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.4605754626708633,1.0458528901244633,0.3695652173913043,1.0,1.0,21/98,17.02%,SGK2;FGFR2;CAPN13;TOX3;ABLIM1;FGFR3;ZSWIM5;COBL;ZDHHC11B;PIK3C2B;PPP1R13B;MTUS1;ANK3;SORBS1;FAAH;PPP1R9A;MYO5C;NEBL;MAPK4;HLF;SLC22A23
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.6511316698175148,1.0457612794443394,0.5217391304347826,1.0,1.0,1/7,2.91%,NLGN1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.6645293472278259,-1.0454138644467215,0.5098039215686274,1.0,1.0,2/7,9.32%,GNAT3;ASIC3
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.5440064244894751,1.0452866656046014,0.475,1.0,1.0,7/20,16.29%,IRS1;ENPP1;IRS2;PPP1R3B;DYRK2;SORBS1;AKT2
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.6505236966694903,1.0449178454257426,0.4482758620689655,1.0,1.0,3/8,8.72%,PLA2G10;PLA2G7;PLA2G15
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.6039873999146884,-1.0442630984267534,0.39622641509433965,1.0,1.0,2/12,2.74%,NTRK1;ASCL1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.5328567181921201,1.044168823735717,0.4,1.0,1.0,7/20,10.18%,SMAD7;ADAMTS9;TGFBR1;NRP1;BMPR1A;JAG1;PDGFRB
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.6750980121517896,-1.0440257250316836,0.5,1.0,1.0,1/5,3.58%,ST6GALNAC2
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.6056833329798672,1.0440137920217936,0.45454545454545453,1.0,1.0,2/13,5.98%,COL22A1;PKHD1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.5820695950962771,1.0439775246428813,0.38461538461538464,1.0,1.0,3/16,9.73%,ENPP1;HEY1;BCOR
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.450360187100679,-1.0439002241695905,0.3829787234042553,1.0,1.0,9/79,10.60%,SELP;WNT9B;CYP19A1;ASCL1;PAQR7;RBP4;FOXP1;NOS2;HMGB2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6236344968313705,1.043548087301917,0.43103448275862066,1.0,1.0,4/10,13.89%,PUS10;SMAD1;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6773610707465765,1.0434217689788088,0.4807692307692308,1.0,1.0,3/8,6.82%,NLGN1;WNT5A;GRID2
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.5778806814941151,-1.0433903376745388,0.4782608695652174,1.0,1.0,1/16,0.66%,INHA
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.42390519662330656,-1.0431204535364975,0.3469387755102041,1.0,1.0,22/153,9.49%,ETV5;LCP1;ETV4;HSD11B1;APOD;PTCD2;RBM4;ETS1;ST6GAL1;ANO1;TRIB2;RGS16;CD37;GYPC;TMEM158;DUSP6;ACE;RBP4;BTC;PPP1R15A;SCG3;IGFBP3
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.6440863255812885,1.042719804856697,0.5384615384615384,1.0,1.0,3/8,22.15%,RNF2;BMI1;PCGF5
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.4154264187267023,1.0427101136236188,0.32558139534883723,1.0,1.0,28/151,11.98%,LTK;FZD1;NDNF;RIT2;LRRC4C;KANK1;IL1RAPL1;MAGI2;ROR1;EPHA3;WNT5A;ZNF804A;RAB29;CSMD3;PRKD1;MINAR1;STYXL1;HDAC2;TOX;CTNNA2;FBXO7;ABL2;CDH2;FUT9;RETREG3;LRRC7;TENM3;NPTN
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.48117345751498086,-1.0426650615564748,0.29411764705882354,1.0,1.0,17/57,20.59%,SURF6;RPF2;NOP14;RPS15;NOP16;MRTO4;NVL;RPS24;EMG1;RPL5;PAK1IP1;RPL38;RPS25;NOM1;RBIS;RPL35A;RPL11
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5384980947251661,-1.0426342286193961,0.42592592592592593,1.0,1.0,6/29,6.62%,SELP;PCDHB6;PCDHB10;PCDHB9;CDH24;PCDHB4
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6435551307857592,1.0425376448491082,0.43137254901960786,1.0,1.0,1/9,1.49%,DAPK2
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.5337220547423129,1.042483592374586,0.35185185185185186,1.0,1.0,4/14,15.65%,IDO1;HPD;QDPR;FAH
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6426544789123484,1.0423428007831939,0.42857142857142855,1.0,1.0,5/8,23.16%,SMAD3;CLASP1;CLASP2;PHLDB1;DAG1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.614799411881594,1.0422710592954427,0.49056603773584906,1.0,1.0,3/10,14.08%,PCBP2;NOVA1;ZNF445
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.45471719736183047,-1.0418209437101928,0.3103448275862069,1.0,1.0,9/75,12.40%,PLK4;AURKA;HAUS8;DCTN1;SSNA1;CETN2;PRKACA;TUBB4B;ODF2
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5837132214135261,1.0417084623270194,0.41304347826086957,1.0,1.0,2/18,2.24%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.4742652461330886,1.04167935121321,0.42105263157894735,1.0,1.0,10/45,11.29%,RALA;IL1RAPL1;RAB9A;CHMP6;SNCA;SYT1;RAB3C;EXPH5;RAB27A;RIMS2
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.5647891232602795,1.0415444115565964,0.39473684210526316,1.0,1.0,3/12,14.20%,SPHK1;ASAH2;PLPP1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.4960161207714163,-1.0415129761907322,0.4339622641509434,1.0,1.0,13/71,14.36%,DDX11;AURKA;GTF2F1;CYP2D6;GOLGA2;IFIT1;LRPAP1;RACK1;TMC8;ACTB;PIN1;TTBK1;NFKBIA
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.7060952776009881,1.0411941616822948,0.48,1.0,1.0,1/6,7.42%,DENND4A
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.5125052356201742,-1.0411339072084433,0.4634146341463415,1.0,1.0,6/27,16.31%,RAD51AP1;HMCES;WRAP53;PARP1;ERCC2;PRDM7
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.5091438420823488,1.041122743838006,0.4,1.0,1.0,11/25,22.40%,ELOVL6;SCD;ACSL4;ACACA;HACD2;FASN;TECR;SLC25A1;ELOVL7;ACSBG1;ELOVL2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.4556623679936607,1.040724330751958,0.2553191489361702,1.0,1.0,21/72,21.84%,GRM7;SEMA5A;FGFR2;CNTN4;PARD3;RYK;NREP;CTNNA2;SLITRK5;ANK3;PARD6B;KLF7;BAIAP2;VASH2;ZDHHC17;RAB10;RTN4RL1;LLGL1;NTNG1;PLP1;PAK3
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7041909108697442,1.0404925691580256,0.5128205128205128,1.0,1.0,2/7,10.95%,ALDH1A1;NPL
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.5242997024799064,1.0404789183658232,0.4375,1.0,1.0,5/17,9.59%,B4GALNT2;ABO;ST8SIA6;B4GALT1;FUT9
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3918745095572268,-1.0403933038623823,0.32142857142857145,1.0,1.0,59/306,19.73%,DDX11;PARP2;BACH1;PLK3;CGAS;CBX1;XPC;RAD51AP1;REXO4;DTX3L;VAV3;SLX4;PLK5;CIDEB;GADD45A;ERCC1;RNF8;PWWP3A;FANCC;BCL2L2;FOXP1;PPP1R15A;HMCES;PIDD1;CCND1;STK11;BAK1;XRCC2;NUDT1;CHEK1;METTL3;DDB1;TICRR;FANCG;HUS1;RPAIN;INO80;HIC1;PARP1;MORC2;TAF1;MUS81;XRCC3;MBD4;KIN;RECQL;FBXO6;NRDE2;USP10;CBX5;APEX1;ZRANB3;XIAP;SPATA18;CIB1;HPF1;POLE3;POLQ;RPS3
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.6832301353512732,1.0402776167352563,0.5,1.0,1.0,1/5,5.23%,WNT5A
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.42395498498173784,-1.0401288098093577,0.3333333333333333,1.0,1.0,27/136,15.99%,TYMS;GTF2F1;XPC;ADRM1;TK2;POLR2I;UPF3B;ERCC1;APRT;POLR2J;RBX1;ITPA;CETN2;NFX1;USP11;TAF6;SUPT5H;EIF1B;DDB1;SNAPC5;POLL;NME4;ZNF707;VPS28;POLR2G;POLR2C;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.6680210202091401,-1.0397884611364034,0.4583333333333333,1.0,1.0,1/7,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.6166202076280632,1.0394348018529511,0.4358974358974359,1.0,1.0,6/10,26.34%,ZNF675;GPR137B;TMEM178A;GPR137;FBXW7;FBN1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.45123466518287436,1.0391791050917847,0.29411764705882354,1.0,1.0,16/93,11.39%,LTK;ERBB4;FGFR2;CSF1;ROR1;EGFR;EPHA3;CSF1R;RYK;FGFR3;EPHA7;TAB2;PDGFRB;IGF1R;EPHA8;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.6290517229849624,-1.0390165250614423,0.525,1.0,1.0,2/5,19.88%,GSTP1;GREM1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.6532634524426726,1.0389608608205128,0.5370370370370371,1.0,1.0,2/6,29.63%,RIF1;EZH2
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.49084111647554524,-1.038845020663119,0.37254901960784315,1.0,1.0,7/46,18.81%,TERF2IP;HUS1;STN1;PARP1;XRCC3;APEX1;XRCC6
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5670233200692228,-1.0387597088168625,0.43636363636363634,1.0,1.0,1/12,0.22%,SELP
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.7007359046640175,1.038438332136678,0.5,1.0,1.0,1/5,3.10%,SLC22A2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.49122539515493835,1.0380628580298175,0.36363636363636365,1.0,1.0,5/34,8.19%,NEDD4;NR3C2;ARID1A;NR3C1;UBR5
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.6303459449326588,1.0380171614452345,0.5094339622641509,1.0,1.0,3/7,17.12%,COL4A6;ITGA11;ITGA2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.6429009264213883,-1.0378193852554247,0.43478260869565216,1.0,1.0,2/6,27.68%,CPTP;TTPA
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6051526448533456,1.0375584868463192,0.425531914893617,1.0,1.0,1/11,4.80%,EGFR
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.7133302771662203,-1.0375047310518168,0.4915254237288136,1.0,1.0,2/5,11.32%,SBDS;PTPRC
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.625257031157996,1.0374706374855365,0.42592592592592593,1.0,1.0,2/7,8.82%,IDO1;CCL5
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.5839804496939158,-1.037399816982008,0.35555555555555557,1.0,1.0,1/14,0.65%,DDX11
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6180962562672689,1.0373065306746314,0.42,1.0,1.0,2/17,3.14%,ATP6V0A4;ATP6V0D2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.667877394730727,-1.0372630914742949,0.4727272727272727,1.0,1.0,2/6,22.28%,NDUFS2;NDUFA12
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.5985997791059285,-1.0371852553004464,0.41818181818181815,1.0,1.0,2/18,2.41%,CD9;CELA2A
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.519189730169571,-1.037041585226193,0.41304347826086957,1.0,1.0,2/17,14.28%,HENMT1;SNIP1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.6130914890138385,-1.036847190224926,0.54,1.0,1.0,6/11,23.90%,VIL1;ARF1;CORO1B;SCIN;ARFIP2;WHAMM
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.43232974363339166,-1.0367010722377934,0.3584905660377358,1.0,1.0,13/89,13.24%,DYSF;SIGLEC1;HCK;RNASE1;CEBPD;RASSF4;RAB3B;SLC7A7;THRA;FPR3;IL13RA1;NRP2;IL1R1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5661454799466811,1.0366628140962102,0.4782608695652174,1.0,1.0,3/25,4.58%,IFI16;KLKB1;HGFAC
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.6064192277170023,-1.0363025366445586,0.4791666666666667,1.0,1.0,5/13,24.92%,COX7A1;PINK1;UQCC2;ABCD1;COX7A2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.49181502098881746,-1.036061043297572,0.4230769230769231,1.0,1.0,1/42,0.56%,SFRP1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5156568572677592,-1.0359332463823396,0.41304347826086957,1.0,1.0,11/31,18.98%,SPG7;MICOS13;MTX1;RCC1L;BAK1;SLC25A5;DNAJC11;TMEM11;TIMM50;GHITM;APOO
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.7064448046321388,-1.0358801488827407,0.46,1.0,1.0,1/5,4.77%,ATG14
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.693376094353683,-1.0356698790001087,0.5106382978723404,1.0,1.0,2/6,12.38%,SHANK3;NECAB2
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6394753219247107,-1.0355072598847483,0.5306122448979592,1.0,1.0,2/7,16.33%,GTF2H2;CHTOP
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5753969103172154,1.0350121309918558,0.5111111111111111,1.0,1.0,10/19,21.45%,FGFR2;TGFBR1;MBNL1;HINFP;CHD7;LIG4;FUT8;VEGFA;ZNF568;ADAM10
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.6721988714467168,1.0349934797902143,0.425531914893617,1.0,1.0,1/5,9.65%,TLR1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5775491635649862,-1.034553315587228,0.4339622641509434,1.0,1.0,9/13,32.60%,DDRGK1;BAK1;UFL1;DAB2IP;BCL2L11;BAX;PTPN1;COPS5;FICD
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.4945581748510962,1.0341723553042206,0.35714285714285715,1.0,1.0,12/24,24.58%,SGCZ;MRTFA;MEGF10;RORA;MRTFB;MEF2C;DMD;NEBL;SYNE1;WNT5B;MYOCD;SEMA4C
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5470196540921294,1.0341132798831427,0.4642857142857143,1.0,1.0,4/23,9.14%,IL1RAPL1;ZNF804A;CTNNA2;FBXO7
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5426184437014093,-1.0339056302323295,0.4318181818181818,1.0,1.0,2/18,4.58%,NLRP1;CDK5
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.45534783473293067,1.0337716172680136,0.32558139534883723,1.0,1.0,14/62,18.00%,B4GALNT2;UBE2J1;MGAT4C;OSTC;B4GALT1;SLC39A8;TUSC3;ALG13;MOGS;UGGT1;MGAT3;FUT8;ALG10;DPM1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5487945868998357,-1.0335419478292052,0.4666666666666667,1.0,1.0,1/10,6.48%,XYLT2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.42382295674205395,1.0334800997818716,0.3968253968253968,1.0,1.0,20/87,13.64%,SPHK1;RUNX1;HSPB1;SEMA5A;ITGAX;VEGFC;WNT5A;RHOB;GAB1;PRKD1;TWIST1;HIF1A;SMAD1;PRKCA;DLL1;VEGFD;SIRT1;ITGB8;SASH1;MDK
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4376736206840121,-1.0332152805053096,0.3958333333333333,1.0,1.0,3/77,4.58%,PM20D1;NTRK1;CDK5
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.46986587105368405,1.0329175927099898,0.35,1.0,1.0,3/32,4.63%,CHRM3;NEDD4;FGF12
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.6707261027101796,1.0328736678922923,0.5098039215686274,1.0,1.0,2/5,10.18%,FLRT3;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.6723283032721894,-1.0325713587852603,0.5531914893617021,1.0,1.0,1/5,2.07%,LDB1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.47563774264930186,1.0325345473878593,0.33962264150943394,1.0,1.0,9/48,10.34%,HSPB1;SYK;HMGB1;WNT5A;AGER;TWIST1;LPL;TLR1;ADAM8
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.7134556277852664,-1.0323409510468031,0.5490196078431373,1.0,1.0,3/6,22.03%,CD24;CDH3;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.5829560002662924,-1.032225133551215,0.44642857142857145,1.0,1.0,3/14,10.48%,IL10RB;NOS2;PRELID1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.43011139877509735,1.031759587377248,0.36363636363636365,1.0,1.0,28/107,16.97%,NEDD4;NLGN1;HMGB1;GPRIN1;FLRT3;CNTN4;AGER;GPM6A;CSF1R;CNTNAP2;RYK;SH3GL2;MANF;GPM6B;TMEM108;EPHA8;NPY;PTPRM;NRTN;ATXN10;BTG2;TTC29;NCDN;LRP12;PPP1R9A;MAP2;ROPN1B;HDGFL3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6782610855702782,1.0316806503731377,0.4375,1.0,1.0,1/8,4.29%,LAMB4
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5460109232065122,1.0316563400601253,0.4791666666666667,1.0,1.0,6/25,17.26%,SPHK1;FOXO1;NAA50;SIRT1;EP300;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5452877654409918,1.0316429365249487,0.36,1.0,1.0,10/23,22.38%,IRS1;PRKD1;FGFR3;PDGFRB;EPHA8;DGKZ;PDGFB;PTK2;TNFAIP8L3;AMBRA1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5556775042214112,1.0316060710905082,0.48214285714285715,1.0,1.0,4/16,10.85%,MYBPC3;CHRM2;PLCE1;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5449859734526454,-1.031401915993025,0.4339622641509434,1.0,1.0,5/19,13.94%,CBLC;VPS25;SH3BP5;PTPRC;SNX6
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.6476985772928185,1.0310393558958733,0.41509433962264153,1.0,1.0,2/6,21.42%,SLC38A2;SLC38A3
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.636470580597862,-1.0309189635422882,0.5476190476190477,1.0,1.0,4/8,22.27%,SRP54;MET;CCDC39;CCDC40
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5862544873127209,1.0307796870585426,0.46511627906976744,1.0,1.0,5/12,20.73%,NAPEPLD;ZBTB7B;PTGS2;PIM1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6086278345218495,1.0306671910753948,0.47619047619047616,1.0,1.0,1/9,1.33%,FAS
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.6737476647194455,1.03059868805366,0.52,1.0,1.0,1/7,1.32%,SPHK1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.44451296329157564,-1.0305589300504425,0.4,1.0,1.0,13/94,15.09%,MRPS25;MRPL23;MRPL16;MRPS18B;MTIF3;MRPL55;MRPS18C;MRPL9;IARS2;MRPL19;MRPS21;MRPL27;MRPL51
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4803092393876138,1.0302409547817148,0.3673469387755102,1.0,1.0,11/42,12.66%,GRM7;NLGN1;NRXN1;TSHZ3;GRM5;SYT1;GRM8;GRM6;CDH2;GRIK1;GRM1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.47151897889034416,1.0294992400004126,0.2909090909090909,1.0,1.0,8/46,9.65%,HSPB1;SYK;HMGB1;WNT5A;AGER;TWIST1;LPL;TLR1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.4765258005605527,-1.0293612518189994,0.40384615384615385,1.0,1.0,1/30,0.35%,NOSTRIN
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.6982914539769746,-1.0293276395285904,0.5,1.0,1.0,2/5,21.87%,IL12A;PVR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.6982914539769746,-1.0293276395285904,0.5,1.0,1.0,2/5,21.87%,IL12A;PVR
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4301373817918036,1.0290614426483855,0.4117647058823529,1.0,1.0,22/121,13.34%,IRS1;HMGB1;TFEB;IRS2;FOXO3;DXO;SNCA;PRKD1;TRIM22;ZBTB20;TWIST1;HIF1A;FOXO1;TRIM8;ADAM8;ATF6;ZSWIM8;SLC4A4;TP53INP1;TRIML2;P2RX7;SH3BP4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.604227247165706,-1.0289357330396327,0.36363636363636365,1.0,1.0,1/9,1.05%,CCN3
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6778968125586702,1.028901873692876,0.45098039215686275,1.0,1.0,3/7,17.81%,CPEB4;CPEB2;CPEB3
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.581311016171842,1.0288190177676315,0.4897959183673469,1.0,1.0,6/16,16.84%,NRG1;CDH2;WNT8A;MEF2C;SOX11;FBXL17
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5641552870456397,1.0287882031616686,0.41025641025641024,1.0,1.0,3/18,12.25%,PPARG;NR1H3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5716280865235905,-1.0284725198474822,0.47368421052631576,1.0,1.0,6/17,17.71%,NLRP3;B2M;IL1R1;PRKCZ;RSAD2;FZD5
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.4090335451529812,1.0281567657362873,0.36585365853658536,1.0,1.0,25/129,13.74%,MXRA5;FAS;RRAD;LDB2;PRRX1;ACKR3;POSTN;SULF1;LMO7;SLC38A11;SYNPO2;NID2;ADAMTSL1;FBXL7;PRKG1;PDGFRB;NOTCH3;ACTA2;PDGFD;TIMP3;COL5A2;CXCL12;GJC1;SPON2;ZBTB44
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6340420554957938,1.0281372839982585,0.4166666666666667,1.0,1.0,4/7,21.14%,SLC30A10;RELA;CA2;NFKB1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5097208455206256,-1.0278429555292803,0.4489795918367347,1.0,1.0,2/21,5.52%,NCKAP1L;SRP54
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.6731852381519441,1.027807204954159,0.49122807017543857,1.0,1.0,1/7,3.54%,FGFR2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.519166831148043,-1.0276113295931535,0.4375,1.0,1.0,4/26,10.53%,CXCR5;KIF20B;GIPC1;DRD3
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5477608718670666,-1.0275766435643752,0.38596491228070173,1.0,1.0,1/13,0.22%,SELP
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.6569623610831006,1.02743517474697,0.5423728813559322,1.0,1.0,2/7,10.34%,CCL5;ADAM8
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.6836156811098938,-1.0268071621977533,0.5,1.0,1.0,2/5,16.27%,OPALIN;SLC45A3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.6554328281617147,-1.0265511805849874,0.5625,1.0,1.0,1/5,2.74%,ASCL1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.6384110500197429,1.0265137081270326,0.5,1.0,1.0,1/7,5.96%,NRP1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5895604298818315,1.026468930578563,0.52,1.0,1.0,3/10,11.37%,ADGRB3;C3;EPHA8
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.48963838013164296,-1.0263896813576157,0.42857142857142855,1.0,1.0,6/40,18.81%,TERF2IP;HUS1;STN1;PARP1;APEX1;XRCC6
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.6406502486841137,1.026350753140724,0.5476190476190477,1.0,1.0,1/5,6.05%,SLC15A2
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5940280938208652,1.0259610853678178,0.48148148148148145,1.0,1.0,1/11,5.44%,PARD3
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.6115635858514151,-1.0258167399944493,0.48,1.0,1.0,4/10,12.92%,DYSF;FOXP1;AZU1;MT1G
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.5540948261182574,1.025549886532212,0.4528301886792453,1.0,1.0,3/10,15.46%,PRKCA;PLK1;PRKCB
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4082637512989173,1.0255479785845008,0.3611111111111111,1.0,1.0,12/77,14.35%,ESAM;EFNA5;EPHA3;RHOB;CSF1R;ABL2;GPM6B;PDGFRB;PIK3CA;RHOBTB3;MDK;EPHA5
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.6382287543369112,-1.025516095081181,0.4772727272727273,1.0,1.0,2/7,8.60%,WNT7B;ATF4
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.6135734004871192,1.0254528231859463,0.4838709677419355,1.0,1.0,3/7,32.49%,LPCAT3;SOAT1;MTTP
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.6399395674190926,-1.0254201409374522,0.5192307692307693,1.0,1.0,3/5,30.08%,RNF20;CTR9;CDK9
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.5680738240577563,-1.0243435283536104,0.47058823529411764,1.0,1.0,4/14,21.44%,DCTN1;ARF1;MAP1A;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.4448261282250556,-1.0242437225622403,0.43137254901960786,1.0,1.0,18/83,14.95%,CCN3;MMP26;SIGIRR;AOAH;SERPINE1;NLRP3;DHX58;DRD1;DRD3;CERS2;TRAF3IP1;C1QBP;PROC;TYRO3;SELENOS;NR1H4;APOA1;TNFRSF1A
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4307432206079869,1.0242319681147065,0.38636363636363635,1.0,1.0,24/101,15.03%,RGMA;PTPRK;HJV;SMAD7;NLK;PARD3;TGFBR1;RUNX2;ACVR2A;TWSG1;SMAD5;SMAD1;BMPR1A;SMAD2;SMAD9;SMURF2;SIRT1;ACVR1B;INHBB;SMAD3;SMURF1;ACVR1;SCX;GDF10
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5431149220080992,1.024156861262963,0.4375,1.0,1.0,5/14,18.03%,SCD;ACACA;FASN;ACSS1;SLC25A1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.5945638064143661,1.0238452453130176,0.5,1.0,1.0,1/8,5.13%,CYP2C8
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.5265773347542997,1.023765122387613,0.4423076923076923,1.0,1.0,3/25,1.35%,CHIT1;GPC6;GPC5
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5224270974085571,-1.0237105209783752,0.4107142857142857,1.0,1.0,1/13,0.69%,CD9
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.6344727848118646,-1.0236515072954353,0.4523809523809524,1.0,1.0,2/10,6.01%,DTX3L;RNF8
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5940325490017341,1.0234490879983338,0.5102040816326531,1.0,1.0,3/13,13.17%,WNT5A;CCL5;CXCL12
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5495525237514436,-1.023367520292929,0.5333333333333333,1.0,1.0,4/22,10.85%,CYP19A1;DHRS11;PRLR;CYP21A2
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4976727180626673,-1.0230433207519274,0.40425531914893614,1.0,1.0,11/27,26.35%,NGDN;NOP14;RPS8;NOP9;KRI1;TSR2;MRPS11;RPS14;WDR46;DHX37;TBL3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.41908226082232336,1.0230392692161614,0.4,1.0,1.0,31/153,16.02%,MED17;ESRRG;CCNH;PPARG;HNF4G;NR3C2;PPARGC1A;NR5A2;CAVIN1;CCN2;NR2E1;TEAD2;HDAC9;NR3C1;MAML2;TBL1XR1;NR1D2;HDAC3;MAML3;RORA;TAF3;NOTCH3;NR1H3;TAF1A;TFB2M;MNAT1;GTF2F2;RARB;TAF2;TAF1B;TAF4B
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5619294701087907,1.0230363369248408,0.41818181818181815,1.0,1.0,7/17,24.32%,CYSLTR2;PRKACB;CREB1;CRY1;ADCY2;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.4388796442295074,1.0228459750775598,0.35294117647058826,1.0,1.0,11/53,17.26%,RUNX1;MEIS1;H3-3A;CDK6;CNOT4;RBBP5;MEIS2;EP300;MEF2C;PRKCB;KAT2B
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4142606701762505,1.0226499705169094,0.423728813559322,1.0,1.0,32/115,17.09%,FZD1;RUNX1;IL1RAPL1;ATOH8;PBX1;DDIT4;NEUROD2;WNT5A;TGFBR1;RUNX2;TENM2;USH2A;MYO7A;PBX3;PTPRD;RYK;NLGN4X;MANF;FUT9;ACSL4;WNT8A;TENM3;CTNNB1;UGDH;TENM1;ADNP2;EPHA5;MEF2C;ATP8A2;SOX11;OLIG1;TDP2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.5879112306247676,1.0226496522192337,0.37777777777777777,1.0,1.0,6/12,23.21%,SLC2A5;SLC2A14;SORT1;SLC2A11;SLC2A1;SLC2A9
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.4651343043957768,-1.0225125441492893,0.42857142857142855,1.0,1.0,27/53,26.05%,PSMA7;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;NR1H4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;PSMA5;AZIN1;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6478358100941187,-1.0223404936819294,0.5714285714285714,1.0,1.0,2/8,16.06%,SLX4;XRCC3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.45230443329000936,-1.0222537744303024,0.3888888888888889,1.0,1.0,2/53,3.95%,TLCD2;RBP1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7035680425209961,-1.022246528227759,0.5660377358490566,1.0,1.0,3/5,27.14%,SLC25A5;SLC25A4;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.6117018539708275,1.0222439352562758,0.4897959183673469,1.0,1.0,3/9,15.07%,OXTR;TBXA2R;AVPR1A
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.6733023818137136,-1.0222018659398733,0.5535714285714286,1.0,1.0,4/6,19.20%,DSC2;CTNNA3;PKP2;JUP
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.520203532127492,-1.0219889113387495,0.44,1.0,1.0,1/23,1.56%,EEF1AKMT2
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.5450540675123274,-1.0215915991582272,0.4782608695652174,1.0,1.0,2/13,7.26%,RAB17;FGD3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4490941469423046,1.0211974850667416,0.40350877192982454,1.0,1.0,20/74,15.46%,ESRRG;OXTR;TRPV2;SYK;ADIPOR2;LEPR;PPARGC1A;ELOVL6;SCD;ZNF516;HDAC3;PRKAB2;IGF1R;ADIPOR1;ZBTB7B;GADD45G;PLAC8;IL4R;OGT;CPT2
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.558837041620781,-1.0211321568462979,0.49019607843137253,1.0,1.0,4/20,4.39%,NCKAP1L;BST1;CD74;VAV3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6091398956171076,1.021118265445086,0.46808510638297873,1.0,1.0,1/10,1.68%,CSGALNACT1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.6996229505170588,-1.0209569366223723,0.5087719298245614,1.0,1.0,3/6,27.39%,ATP5F1D;ATPAF1;OXA1L
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5196465673304799,1.0208581060341524,0.3902439024390244,1.0,1.0,4/24,12.56%,PPARG;NR1H3;SIRT1;LPCAT3
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.6553403152071252,1.0208564763516175,0.43636363636363634,1.0,1.0,1/7,5.63%,ARG1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5304612717794606,1.0207086408310588,0.43137254901960786,1.0,1.0,6/19,13.95%,NTF3;MAGI2;DDIT4;FRS2;BCAR1;SORT1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.46040493271415384,1.0206154716969666,0.3620689655172414,1.0,1.0,12/53,16.95%,PLA2G10;PIP4K2A;FDFT1;PLA2G15;LPL;LCAT;AGPAT5;PLBD1;PLPP1;PLA2G4C;PLBD2;PLPPR5
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6130214224385735,-1.0204601320581976,0.5370370370370371,1.0,1.0,3/10,26.06%,TIMM29;TIMM13;TIMM8A
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.37794584038999834,1.0203441569322889,0.32608695652173914,1.0,1.0,59/367,14.44%,DACH1;LOXL2;IFI16;NRG1;ZFPM2;NAB1;NFIL3;PLCB1;PPARG;PTPRK;ATOH8;ZNF706;MTERF3;ZEB1;BAHD1;WNT5A;GLIS2;TSHZ3;RUNX2;TP63;RFX3;HEY1;SP3;HDAC9;FOXP2;KCTD1;NR3C1;ATXN1;CTBP2;NR1D2;HDAC2;TWIST1;HINFP;HDAC3;GLI3;SOX7;PHC2;BCOR;TLE1;FOXO1;SPINDOC;SMAD2;ARID5B;POU2F1;SMURF2;SIRT1;CTNNB1;BTRC;PRICKLE1;NPAS1;ID3;EPC1;HIC2;FOXN3;YAF2;DPF3;RELA;NACC2;CD38
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.6316288996400978,1.0195545613665031,0.45652173913043476,1.0,1.0,3/10,12.55%,MSTN;DLL1;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.5915034028096622,-1.0194618224665657,0.4528301886792453,1.0,1.0,2/10,7.48%,FOXM1;RSL1D1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.629727184766883,-1.0193936230736516,0.5434782608695652,1.0,1.0,4/10,28.56%,COPS6;COPS7A;COPS7B;GPS1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5555034140599275,1.019342954768687,0.40384615384615385,1.0,1.0,7/18,19.56%,FAS;ITGAV;CASP9;BCL2;BOK;CASP2;BCL2L1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5229358151690562,-1.0192314222688699,0.4888888888888889,1.0,1.0,3/15,14.03%,CMTR1;METTL3;TRMT10C
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5250214337161678,1.0188162487605714,0.4339622641509434,1.0,1.0,8/27,15.04%,FGFR2;HDAC9;MEGF10;CTNNA2;CDH2;CTNNB1;MEF2A;MEF2C
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6314698505293638,1.018803891625416,0.5434782608695652,1.0,1.0,2/6,11.68%,PLK1;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.6537350706782865,1.018743992963218,0.5,1.0,1.0,1/7,6.77%,NUDT16L1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5148299357322808,1.0187060046529433,0.3793103448275862,1.0,1.0,4/20,12.25%,BAHD1;H3-3A;HELLS;SIRT1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4000734037293189,1.018600756576204,0.34615384615384615,1.0,1.0,20/158,13.02%,GALNT3;SGK3;SGK2;NDNF;GALNT13;TGFBR1;RPS6KA4;CLSPN;LATS1;PRKD1;DYRK3;EIF2AK3;SGK1;PRKCA;DYRK1A;PLK1;DYRK2;RPS6KA6;CAMK4;DCLK3
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.44470025318389794,1.018516342213743,0.3469387755102041,1.0,1.0,15/71,13.17%,MXRA5;SSC5D;FAT4;LDB2;PRRX1;POSTN;NID2;CYBRD1;ADAMTSL1;PRKG1;PDGFRB;ITGA11;ACTA2;COL5A2;CXCL12
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.42219503948178444,1.0185066278561519,0.4807692307692308,1.0,1.0,34/128,11.98%,GPC6;FAT4;LRRC4C;PCDHB3;IL1RAPL1;NLGN1;HMCN1;CDH8;FLRT3;ITGAM;DSCAM;UNC5D;NECTIN3;ROBO1;CDH18;CNTN4;CDH20;TENM2;GRID2;ROBO2;PTPRD;LRFN5;ADGRL3;CBLN1;CDH10;CDH2;CRB2;CDH6;CADM1;CDH13;TENM3;PTPRM;CLDN12;NPTN
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.5432498160241926,-1.0183922874611482,0.4528301886792453,1.0,1.0,2/19,3.69%,NUPR1;CDC37
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5642718694721911,1.0181196915325466,0.4186046511627907,1.0,1.0,7/15,20.85%,ERN1;NCK1;BOK;RNFT1;PIK3R1;USP13;RNF185
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5687440895759658,1.0180802715476052,0.4878048780487805,1.0,1.0,5/10,28.28%,NDFIP2;TERF1;WWP2;SNX3;CORO2B
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5310518876915338,1.0180406042541255,0.47058823529411764,1.0,1.0,5/14,17.12%,CRB2;SMAD2;TBX19;SCX;ITGA2
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6648967506754188,1.0180297670745495,0.5319148936170213,1.0,1.0,3/7,25.78%,MSRA;SMS;ADI1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.431271100802715,1.0180232798653976,0.36538461538461536,1.0,1.0,18/85,13.17%,MXRA5;SSC5D;TNC;LDB2;PRRX1;POSTN;SULF1;CYBRD1;ADAMTSL1;TLR1;LAMC2;PDGFRB;ITGAV;ACTA2;TIMP3;COL5A2;ABI3BP;CXCL12
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.38516189017417696,-1.0179042601164348,0.40384615384615385,1.0,1.0,22/231,10.35%,STING1;NCKAP1L;F5;F8;HGSNAT;CD74;GOLGA2;SPG7;VIL1;SKP1;TRAPPC2L;FANCC;RBX1;CLDN1;TRAPPC6A;TRAPPC4;CHCHD10;PDZD11;TUBGCP2;DBNL;RSPH4A;ELOB
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.5705241379747918,-1.017680157166544,0.44680851063829785,1.0,1.0,3/12,17.06%,ACOT4;ACSF3;GOT2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.6194173106905287,-1.0176657078514157,0.5,1.0,1.0,2/9,13.48%,UBC;ISG15
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5359778935053855,1.0176639382157966,0.34,1.0,1.0,2/24,1.91%,SAMSN1;NTF3
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.44442462524569154,-1.0175743055111743,0.3541666666666667,1.0,1.0,16/60,21.03%,KIF25;ABRAXAS1;GOLGA2;KNSTRN;SMC4;WRAP73;TOGARAM2;INO80;TUBG1;CHMP2A;RAB11A;TPX2;SGO2;TUBG2;KIF11;PPP2R2D
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.489560072143219,1.017527701195691,0.43478260869565216,1.0,1.0,4/25,8.26%,PPARG;HMGB1;ATP2B4;TBXA2R
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.6313107147805196,-1.0175123655010938,0.4489795918367347,1.0,1.0,2/6,12.82%,GINS3;MCM2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.6313107147805196,-1.0175123655010938,0.4489795918367347,1.0,1.0,2/6,12.82%,GINS3;MCM2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.5933082210030223,1.0173814432483732,0.5,1.0,1.0,3/11,13.93%,PEX5L;PEX2;PEX13
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.699903347146198,-1.0170661726593744,0.48,1.0,1.0,2/5,14.03%,RGS2;KCNQ1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.40474337931108884,-1.0170400726059539,0.3559322033898305,1.0,1.0,12/81,12.91%,PLK4;HK2;NCL;FANCI;KNOP1;ERCC6L;CHAF1A;CENPH;CHEK1;ORC1;SUPT16H;TICRR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6073613107155782,-1.0169298447102348,0.4897959183673469,1.0,1.0,4/13,14.03%,RCC1L;C1QBP;UQCC2;TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.59136459157546,-1.0168732183569258,0.45454545454545453,1.0,1.0,4/12,19.08%,SERPINE1;SERPINF2;THBS1;USF1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.6583636036667484,-1.0168295402586836,0.46938775510204084,1.0,1.0,1/6,6.58%,PCARE
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5717365163943681,1.0167530356808876,0.48,1.0,1.0,2/12,11.29%,SLC30A8;RIMS2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6215711604624201,1.0166166098302727,0.47058823529411764,1.0,1.0,2/8,9.25%,HSPB1;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6215711604624201,1.0166166098302727,0.47058823529411764,1.0,1.0,2/8,9.25%,HSPB1;DLG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6215711604624201,1.0166166098302727,0.47058823529411764,1.0,1.0,2/8,9.25%,HSPB1;DLG2
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.6592099668901608,1.0164715782933884,0.52,1.0,1.0,3/7,10.34%,IDO1;CCL5;ADAM8
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.43139234473266524,1.016365521441027,0.43478260869565216,1.0,1.0,8/98,7.51%,GRAP2;RRAD;RIT2;RALA;CCNA2;ARHGAP30;CNKSR1;PRKD1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5038332300105675,1.0161481343188035,0.35555555555555557,1.0,1.0,6/24,14.76%,PTPRK;FGF10;CTNNB1;ANK2;SMURF1;PIGU
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.6863581718862897,-1.0160584716601087,0.5434782608695652,1.0,1.0,1/5,6.56%,SPI1
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.6635978455974729,1.0158871038346802,0.46875,1.0,1.0,2/5,8.86%,HORMAD1;BUB1B
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.6079078244961732,-1.0157839272839353,0.45652173913043476,1.0,1.0,4/7,29.27%,NOS2;PRDX3;PARK7;NOS1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5189467418960737,-1.0156705717318846,0.3958333333333333,1.0,1.0,2/20,9.74%,EEF1AKMT2;METTL22
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.5689506082322789,-1.0156520117399475,0.49056603773584906,1.0,1.0,5/13,23.17%,GHR;SOD1;PPIB;GHRHR;STAT5A
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.4908531253119114,-1.0156507512836976,0.4318181818181818,1.0,1.0,1/33,0.56%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.5966207895628187,1.015286275088702,0.5,1.0,1.0,6/14,18.84%,NRP1;CCL5;PDGFRB;DOCK4;MDK;PDGFB
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4662885734280516,1.0152661123781053,0.3617021276595745,1.0,1.0,9/67,7.49%,LRIG3;MXRA5;SPHK1;TNC;EGFR;POSTN;TP63;FAM114A1;FBLIM1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.52409581573756,-1.0151717436408796,0.49056603773584906,1.0,1.0,4/28,4.39%,NCKAP1L;BST1;CD74;VAV3
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.6123395053455587,-1.0149232228758354,0.5283018867924528,1.0,1.0,1/9,0.88%,PAH
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.6077187469587972,-1.0148998532114202,0.5,1.0,1.0,1/11,2.04%,NOG
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.41524347071798184,-1.014800797060477,0.39215686274509803,1.0,1.0,17/114,11.50%,CNGA3;GNAT3;NKX2-2;TMEM179;KIF1A;FABP5;ENPP2;GFRA3;VWA5B2;SST;CELF3;PAX6;SCG3;CHGB;TCEAL5;LRRTM1;TAGLN3
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.421780997352531,1.0147647920224558,0.3728813559322034,1.0,1.0,21/104,17.82%,GPC6;FLRT3;SHROOM2;TOX3;EGFR;PDZRN3;RNF128;FGFR3;COBL;DDAH1;NOTCH3;ADGRL2;TMEM98;PARD3B;BCAR1;PRICKLE2;AMOTL2;TMEM178A;MAGI1;LGR4;SLC31A1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.49217969998947647,1.0147552056375755,0.4489795918367347,1.0,1.0,3/27,5.23%,NRG1;NTF3;WNT5A
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.5916585759044335,-1.0147160737935914,0.49056603773584906,1.0,1.0,2/11,3.08%,RAC1;NTN5
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.41208874656345856,1.0146316408399048,0.375,1.0,1.0,37/105,21.11%,PMP2;KCNC2;NRXN1;HCN1;TAS1R1;CACNB2;GRIA4;NR3C1;AMER2;SLC1A2;ZNF493;CTNNA2;PCSK2;KCNJ6;SYNPR;ST18;P2RX7;FGF13;RUNDC3A;SLC24A2;CNTNAP5;GRIA2;C4ORF50;PRKCB;UNC13C;PROX1;MOBP;SLC24A4;ADCY2;TNR;SEZ6L;ST8SIA3;GNG7;CATSPER2;SLC7A14;GRM4;CACNB4
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.39610353958209604,-1.0143157960192895,0.37735849056603776,1.0,1.0,44/246,16.96%,PARP2;TYMS;TERF2IP;BACH1;XPC;RAD51AP1;HMGB3;REXO4;DNASE1L1;SLX4;GADD45A;ERCC1;UBC;XRCC1;NTHL1;PWWP3A;FANCC;MCM5;KPNA2;ORC3;HMGB2;XRCC2;NUDT1;CHEK1;ORC1;DDB1;MCM2;TICRR;SMUG1;FANCG;HUS1;SUPV3L1;POLL;STN1;TOP3A;RPAIN;GLRX2;INO80;PARP1;MUS81;XRCC3;MBD4;RECQL;FBXO6
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.46595740877558983,1.0142194798108675,0.38636363636363635,1.0,1.0,14/56,16.69%,NDNF;NTF3;CX3CR1;PPARGC1A;TOX3;SLC30A10;HIF1A;ADAM8;LIG4;MDK;BCL2;MEF2C;CPEB4;CLN3
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.6790884130653191,1.0141791198824612,0.5,1.0,1.0,1/5,12.12%,SLC7A2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.46317827608778717,-1.0140893328813934,0.3333333333333333,1.0,1.0,4/30,9.71%,DND1;PHAX;VIP;CIRBP
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.40868930852990293,-1.0137833452610896,0.42857142857142855,1.0,1.0,36/126,21.32%,SFRP1;TNFSF18;PSMA7;TMSB4X;ADAMTS12;LTBR;PSMD7;EIF5A;PSMB4;PSMC3;YBX3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;NFKBIA;TNFRSF1A;PSMC1;PSMB5;BAG4;PSMD2;LTB;PSMA1;PSMD10;ASAH1;CIB1;STAT1;PSME2;RPS3;PSMD12;CD58;TNFSF9;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4571859906653695,-1.0132810178844849,0.4,1.0,1.0,7/49,6.78%,HEBP2;CLU;NTRK1;CIDEB;PRR7;HTATIP2;DAXX
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5820819830171884,-1.012925638774883,0.4782608695652174,1.0,1.0,1/14,1.56%,SIGIRR
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.49555156607494855,-1.0129052802700864,0.425,1.0,1.0,9/30,19.47%,RAC1;VAV3;RAB3B;PPP1R15A;PEX11B;RIN3;PEX11G;PPP1CA;MTPN
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),0.679258205462363,1.0127959601588048,0.5185185185185185,1.0,1.0,2/6,8.26%,SPX;TBXA2R
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.6331824845748575,-1.012743285234587,0.55,1.0,1.0,2/8,15.59%,DRD3;RGS8
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.48241048107557033,1.0124825720889883,0.40425531914893614,1.0,1.0,8/44,9.66%,FGFR2;PBX1;HEY1;TEAD2;PBX3;GLI3;BMPR1A;COBL
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3784067595952236,1.0121495928586979,0.38596491228070173,1.0,1.0,51/243,15.75%,NOX5;LOXL2;IFI16;ESRRG;OXTR;PLCB1;TRPV2;ITGAX;SYK;NLGN1;ADIPOR2;LEPR;S100A13;PPARGC1A;WNT5A;TGFBR1;RFX3;ELOVL6;TBXA2R;SCD;TWIST1;ZNF516;HDAC3;BMPR1A;CRB2;SOX5;PRKAB2;IGF1R;CADM1;SMAD2;CCDC88B;ADIPOR1;SMURF2;ZBTB7B;SIRT1;CTNNB1;GADD45G;ACVR1B;SHLD1;MDK;INHBB;SMAD3;FST;PLAC8;ACVR1;SCX;AVPR1A;IL4R;OGT;CPT2;VAMP8
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.491055036552864,1.0120093034342954,0.3888888888888889,1.0,1.0,1/30,0.25%,MARVELD3
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6500943745125881,1.011883614134976,0.5,1.0,1.0,3/8,28.71%,TSFM;NSUN3;SHMT2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6192867408593328,1.011723964453228,0.5084745762711864,1.0,1.0,3/8,19.12%,HIF1A;PRKCB;ARNT
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.5687325893022774,-1.011615961278665,0.5121951219512195,1.0,1.0,2/15,6.34%,TERF2IP;NTHL1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.6601907328095232,-1.01135670012959,0.5263157894736842,1.0,1.0,2/6,5.17%,CGAS;PDE11A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.618696177577028,1.0111217270881794,0.4791666666666667,1.0,1.0,1/8,3.79%,HMGB1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.4239908576622169,1.010954924656728,0.38,1.0,1.0,28/119,11.55%,EFNA5;CADM2;LRRC4C;CXXC4;LSAMP;SLC30A8;NRXN1;ADGRB3;FGF12;UNC5D;PCDH17;CNTN4;ROBO2;GRIA4;CA10;HMGCLL1;ELAVL4;RAB3C;SH3GL2;PCSK2;NOL4;CNTN1;NOVA1;KCNB2;RBFOX1;ASXL3;SMAD9;NPY
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.460476481890759,1.0108802599788602,0.3541666666666667,1.0,1.0,16/62,9.42%,FZD1;PCDHB3;NLGN1;LRRTM3;FLRT3;NRXN1;DSCAM;WNT5A;RAB29;GPM6A;GABRB2;GRID2;ADGRL3;RYK;NLGN4X;CDH2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5356441001596598,-1.0108507377112597,0.38095238095238093,1.0,1.0,3/14,15.57%,RAD51AP1;WRAP53;PARP1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4477051433963091,-1.010631195842429,0.40350877192982454,1.0,1.0,28/81,21.32%,PSMA7;FBXO48;PSMD7;SKP1;PSMB4;RBX1;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;FBXL13;PSMA1;PSMD10;FBXO6;FBXO2;PSME2;PSMD12;FBXL16;FBXL12;FBXL18;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.6643590828145098,-1.010588555206539,0.5454545454545454,1.0,1.0,1/7,2.62%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.6643590828145098,-1.010588555206539,0.5454545454545454,1.0,1.0,1/7,2.62%,SERPINE1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.5138742303694278,-1.0099310511003485,0.44642857142857145,1.0,1.0,3/21,5.46%,GSTM3;GFRA3;GPC1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.5669310206443349,-1.0099092197777686,0.48,1.0,1.0,4/11,12.60%,WDR54;LRPAP1;NECAB2;RIN3
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.42685256254184883,-1.0096809662528912,0.44,1.0,1.0,28/82,21.32%,XPC;PSMA7;ANAPC15;PSMD7;SKP1;PSMB4;PSMC3;TCIM;PSMD8;PSME1;DDB1;PSMB2;PSMC4;PSMB8;ANAPC2;PSMC1;PSMB5;PSMD2;TAF1;PSMA1;ERCC2;PSMD10;FZR1;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5071578337663544,1.0096694021594494,0.4117647058823529,1.0,1.0,8/19,24.68%,EIF2AK3;NCK1;HSPA1A;BOK;SYVN1;BCL2L1;CREB3;LRRK2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.5165622045824716,-1.0096287827899375,0.5087719298245614,1.0,1.0,7/29,10.53%,KCNE1;ADRA2A;VIP;CD63;DRD1;KCNE2;DRD3
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.45293222100675146,-1.0095647393377774,0.48,1.0,1.0,11/66,11.90%,SH3RF2;CLU;PLK3;TRIB2;ARIH2;DDA1;RBX1;DDRGK1;ELOB;RFPL1;RACK1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6435137444178571,-1.009412817938868,0.5245901639344263,1.0,1.0,3/8,23.18%,ATG14;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.5978478717029231,-1.0090991715247963,0.5098039215686274,1.0,1.0,1/5,9.99%,HADHA
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.4371702173135825,1.0089045903791436,0.4523809523809524,1.0,1.0,22/103,16.11%,LRIG3;MXRA5;FZD1;ACKR3;EGFR;POSTN;SULF1;IL17RE;FAM114A1;TWSG1;MUC16;COBLL1;FLNC;TIMP3;PARD3B;COL5A2;CXCL12;LURAP1L;PRICKLE2;AMOTL2;FRAS1;PTGS2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5280384312153762,1.0086937407303445,0.4074074074074074,1.0,1.0,12/21,26.27%,ELOVL6;DGAT2;ACSL4;HACD2;TECR;ELOVL7;ACSBG1;ELOVL2;FAR2;ACOT7;ACSL5;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5082285705364568,1.0086457708437182,0.425,1.0,1.0,14/36,20.37%,ZEB1;NEUROD2;KCTD11;ECT2;BRINP3;TCF4;FGFR1;ZC4H2;MEF2C;SOX11;PROX1;VWC2;BRINP1;TRIM32
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5179386818929783,1.0085805060763096,0.35,1.0,1.0,3/25,12.40%,RUNX1;LATS1;KCTD6
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6308722028043572,1.0084913700325948,0.5272727272727272,1.0,1.0,4/8,18.34%,TGFBR1;NRP1;TGFBR3;VEGFA
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5592025437134535,1.0083795733776566,0.46808510638297873,1.0,1.0,3/21,14.51%,NEDD4;ZNRF3;SMURF1
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6289430119687938,1.0082496074105933,0.5476190476190477,1.0,1.0,2/6,11.59%,DDAH1;DDAH2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5587944952480777,1.0081056845075942,0.5348837209302325,1.0,1.0,3/10,11.29%,MICU1;MCU;MAIP1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.4649223178590129,1.0079691588631148,0.40384615384615385,1.0,1.0,7/68,12.55%,RGPD3;RGPD5;SYK;RGPD4;RGPD2;CBLB;PRICKLE1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5868039624692551,1.0078305212841046,0.52,1.0,1.0,2/10,5.48%,FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.5806003837601161,1.0074252833150577,0.44,1.0,1.0,1/6,4.49%,MTERF3
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4216050868288106,-1.0068522857634998,0.5283018867924528,1.0,1.0,10/97,9.09%,APIP;KIF25;UPB1;HSD17B10;GOLGA2;B2M;SCARA5;RYR1;CARD9;RNF213
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.6459581410255828,-1.006797619916917,0.5510204081632653,1.0,1.0,1/5,11.90%,RACK1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.5545115240067354,-1.0065068910786454,0.509090909090909,1.0,1.0,2/15,2.74%,NTRK1;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.6128788609731459,1.0064957013754008,0.48214285714285715,1.0,1.0,1/9,4.17%,SMAD7
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5203154063885661,1.0064034357487444,0.37735849056603776,1.0,1.0,8/29,16.03%,SPHK1;AGER;RELL1;MFHAS1;PHLPP1;GADD45G;SASH1;GADD45B
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.45900982980277144,-1.0062654186153008,0.46808510638297873,1.0,1.0,5/39,8.43%,SIGLEC1;AOAH;HCK;SPI1;SLC7A7
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5759252085382742,-1.0059614293163075,0.49056603773584906,1.0,1.0,4/11,8.41%,DCTN1;MYADM;CLDN1;CHCHD10
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.5955637667146697,-1.0058377735067645,0.42857142857142855,1.0,1.0,4/11,14.59%,HIRIP3;CHAF1A;SUPT16H;MTA2
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.6332828798706531,-1.005745449358405,0.5,1.0,1.0,1/5,5.30%,NODAL
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.5965352500172723,-1.0056294313788743,0.5227272727272727,1.0,1.0,2/9,6.64%,STX1B;GRIPAP1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.4082631759862476,-1.0051760251496664,0.4339622641509434,1.0,1.0,33/142,15.98%,NCKAP1L;HLA-DPB1;TXK;BTNL2;TEC;PSMA7;VAV3;CD4;PSMD7;SKP1;BTN3A1;SH2B2;PSMB4;HLA-DRA;PRAM1;PSMC3;RBCK1;BTN2A1;BTN2A2;PTPRC;PSMD8;PSME1;EIF2B4;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;THEMIS;PSMD2;PIK3CB;EIF2B3;PSMA1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.4353126280429493,-1.0051692357021282,0.3181818181818182,1.0,1.0,8/47,14.42%,SLC25A10;SLC1A7;SLC6A9;LLGL2;SLC6A20;SLC16A8;SLC13A3;SLC16A12
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.40528404879165664,1.0048814872051601,0.3673469387755102,1.0,1.0,12/95,9.34%,SLC12A1;SLC26A3;SLC26A7;GABRB1;SLC5A12;SLC12A3;SLC8A1;SLC15A2;SLC5A8;SLC1A2;CHRNB4;GLRB
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4501184068206867,-1.0048779274179342,0.42857142857142855,1.0,1.0,28/63,26.05%,PSMA7;PSMD7;SKP1;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;IRAK1;CARD10;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;PSMA5;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.525117763421477,1.0048696117053804,0.42857142857142855,1.0,1.0,6/15,25.57%,SLC8A1;SLC9A1;SLC12A2;SLC9A2;SLC9A7;SLC9A5
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.496627511936897,-1.0047634626711779,0.5116279069767442,1.0,1.0,7/25,20.69%,DHX58;FOXP1;LRP8;HERC5;TKFC;XIAP;IRF1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.5798150364950393,-1.0042962173794139,0.44,1.0,1.0,3/7,19.21%,ARF1;PLK2;PRRT1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.576185843200489,-1.0041561903889775,0.46808510638297873,1.0,1.0,2/8,4.78%,SPRED3;SPRED2
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.6664532105456815,1.0039772138962968,0.5416666666666666,1.0,1.0,1/5,12.12%,SLC7A2
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5992724465701648,1.0035987662172159,0.509090909090909,1.0,1.0,4/8,12.28%,FZD1;WNT5A;RYK;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.5915419800196209,-1.0034101334085896,0.44642857142857145,1.0,1.0,2/11,6.87%,PGP;BCKDK
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.5724416009679529,1.0034053661366817,0.5555555555555556,1.0,1.0,3/13,11.81%,LDLR;C3;NR1H3
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.45375250455799415,-1.0031616653217685,0.5,1.0,1.0,7/77,5.92%,CAMK1G;GEM;KIF1A;UCHL1;SEZ6L2;SPRED2;SST
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.546172295027121,-1.0031525794217433,0.46,1.0,1.0,8/20,23.11%,RPF2;TRAF7;DDX28;RPL5;RPL6;RPL24;RPL11;DHX30
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.45552900258253115,1.0031393044294974,0.4186046511627907,1.0,1.0,15/65,15.39%,NKAIN2;KCNJ3;NEDD4;SNCA;SYT1;PXK;KCNJ6;SYT15;P2RX7;NKAIN3;ANK3;TF;SYT2;KCNJ2;KCNA5
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.6913383801441074,1.002989334697621,0.5681818181818182,1.0,1.0,2/5,20.48%,GLA;GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.5690515917704679,-1.002947785282229,0.5111111111111111,1.0,1.0,4/7,24.84%,RFPL1;E2F7;TXNIP;ORC6
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.42780446133951483,-1.0028698211574645,0.34,1.0,1.0,13/75,11.88%,TERF2IP;WARS1;ATG14;XRCC1;BEX4;MYADM;PPP1R15A;PTPA;IGFBP3;DBI;NIBAN1;TRAF3IP1;PIP5KL1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.5673394596303036,-1.00283168558688,0.5333333333333333,1.0,1.0,2/10,5.87%,GOLGA2;SKP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.6520426894522675,-1.0018749737271295,0.5614035087719298,1.0,1.0,2/7,18.58%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5988697666543807,-1.0014821488423507,0.5102040816326531,1.0,1.0,1/8,4.27%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5988697666543807,-1.0014821488423507,0.5102040816326531,1.0,1.0,1/8,4.27%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5988697666543807,-1.0014821488423507,0.5102040816326531,1.0,1.0,1/8,4.27%,DTX3L
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5998358007598235,-1.000920305863223,0.5357142857142857,1.0,1.0,5/10,19.42%,DSC2;CTNNA3;PKP2;JUP;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.5509460534852907,1.0007574266863295,0.5555555555555556,1.0,1.0,5/11,18.38%,PDE2A;PDE3A;TJP3;VEGFA;BMP6
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4547817321530102,-1.0006630291452958,0.4897959183673469,1.0,1.0,15/64,15.99%,RTF1;GTF2F1;ADRM1;POLR2I;TCEA2;POLR2J;GTF2H2;ELOF1;ELOB;SUPT5H;SUPT16H;CCNT1;POLR2G;POLR2C;ERCC2
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.5138574522100231,1.0005181045863265,0.5,1.0,1.0,4/20,9.24%,SLC30A8;MT1M;GLRA2;ZACN
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.4884460302237803,1.000427881709823,0.4426229508196721,1.0,1.0,5/25,15.04%,PLCB1;RANBP3L;MSTN;DLL1;MEF2C
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.4491698016001118,0.999803887817822,0.4418604651162791,1.0,1.0,6/40,15.34%,INF2;PPARGC1A;PDE2A;EP300;PID1;MARCHF5
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.5689620624283938,0.9997950552561139,0.5416666666666666,1.0,1.0,2/12,9.42%,NRG1;CDH2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4839809578882619,0.9995399090089293,0.41379310344827586,1.0,1.0,7/43,11.88%,FAS;EGFR;AGER;FOXO1;IGF1R;PHLPP1;RAP2A
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4691220401565222,-0.9994152769731108,0.42592592592592593,1.0,1.0,7/64,2.27%,P2RY10;CD5;TXK;SLA;HSD11B1;AOAH;KLRB1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.5737004884035475,0.9991910084392387,0.5319148936170213,1.0,1.0,1/9,1.67%,ATP6V0A4
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),-0.6811824627456273,-0.9990825429014906,0.4772727272727273,1.0,1.0,3/5,11.73%,AHI1;PCARE;CDHR1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.6159358968625146,-0.9986497059330335,0.4782608695652174,1.0,1.0,1/6,5.50%,PLET1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.5964606967394306,-0.9985198233024125,0.4791666666666667,1.0,1.0,4/11,13.62%,MYH14;DNM1L;FIS1;SUPV3L1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5918239303326508,0.9984917296010851,0.48,1.0,1.0,1/9,4.68%,PIP4K2A
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.5182880489064761,-0.9983185487791572,0.45901639344262296,1.0,1.0,4/20,13.04%,DUSP4;DUSP6;PPM1G;DUSP5
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.40450923333673733,-0.9982690891078589,0.41509433962264153,1.0,1.0,11/116,7.88%,DDX24;RNASET2;GTF2F1;RNASE1;RBM4;POLR2I;RBM3;RBMS2;POLR2J;RBPMS;LAGE3
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5393794714545577,0.9982394847332193,0.4117647058823529,1.0,1.0,2/15,8.94%,MBNL1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5811945697788234,0.9981745242966531,0.43636363636363634,1.0,1.0,2/8,19.03%,HEY1;ROCK2
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.5702964170559325,-0.998155364079779,0.49019607843137253,1.0,1.0,1/11,0.84%,DYSF
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.6231482232181569,-0.9981076887095585,0.47058823529411764,1.0,1.0,1/5,4.85%,ACTC1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.6627228767359397,-0.9980469068663254,0.5510204081632653,1.0,1.0,3/5,23.17%,LRP8;PAFAH1B1;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.5372711110285855,0.9980212628930435,0.5238095238095238,1.0,1.0,7/11,20.99%,IRS1;IRS2;DYRK2;SORBS1;AKT2;INSR;EPM2AIP1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6493013897571447,0.9979694429893071,0.52,1.0,1.0,3/9,16.27%,SMPDL3A;SMPD4;SGMS1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.43426982540558656,-0.9978598119507252,0.3877551020408163,1.0,1.0,9/82,9.02%,SFRP1;WNT9A;WNT9B;PORCN;WNT7B;SKP1;UBC;RBX1;CD24
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5594210350113726,-0.9977683657967645,0.5,1.0,1.0,4/14,15.07%,KIF20B;FBXO43;PIN1;CUL9
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.5715013682661044,0.9976100811556332,0.5348837209302325,1.0,1.0,2/11,5.70%,PNP;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6572006415549122,0.9974816652689582,0.5102040816326531,1.0,1.0,4/5,33.45%,SOX11;RNF10;SKI;DICER1
prerank,PanglaoDB_Augmented_2021__Interneurons,0.38608968596550103,0.9974807295696169,0.43478260869565216,1.0,1.0,68/274,17.41%,NDNF;CADM2;RIT2;KCNC2;RGMA;KCNQ5;SHISA9;LRRTM3;OLFM3;NRXN1;ADGRB3;FGF12;NXPH1;NCALD;CCN2;GRM5;HIVEP2;SLC35F1;TRIM9;GRIA4;RPRML;SYT1;AMER2;CA10;ELAVL4;RAB3C;RORA;CTNNA2;SH3GL2;LMO3;SPOCK3;CALN1;PCSK2;ACSL4;NOL4;SPTY2D1;SYNPR;RBFOX1;GABRA4;PDE1A;ADGRL2;PLCB4;NXPH4;NPY;VEGFD;DNAJC6;GRM1;TMEM132D;CAMK4;DLGAP1;PPFIA2;PCF11;RGS7BP;FBXO11;ERC2;GRIA2;CSRNP3;CTNND2;PRKCB;KCNK9;PVALB;OXR1;MAP2;MAPK4;HLF;PLPPR5;ABR;DEPTOR
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.4516652884572024,-0.9973256126910731,0.48148148148148145,1.0,1.0,3/57,3.19%,ACOT1;ACOT11;ACOT4
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5171254727170811,0.9972113270037952,0.5333333333333333,1.0,1.0,7/37,19.75%,RFWD3;NSMCE1;RADX;CASP9;CRY1;SMG1;ANKLE1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.5719494406137765,0.9971886901823249,0.49056603773584906,1.0,1.0,4/16,9.90%,PLA2G10;CIDEA;LPL;C3
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.5733959764151016,0.9970291583895183,0.5185185185185185,1.0,1.0,4/14,15.57%,CCDC63;DNAH5;DNAI2;ODAD2
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.6853949573462625,-0.9969632817860414,0.5283018867924528,1.0,1.0,1/6,8.42%,COX7A1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6778876035061988,0.9969364309758331,0.5686274509803921,1.0,1.0,5/7,28.35%,IGF1R;INSR;FYN;PRNP;MTMR2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.6429004749878142,-0.996915027540991,0.5416666666666666,1.0,1.0,2/5,6.64%,CDK5;GRIPAP1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.6739555670719002,0.9968199481171607,0.5102040816326531,1.0,1.0,2/5,15.46%,PRKCA;PRKCB
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.6494685785877042,-0.9967421697528908,0.5434782608695652,1.0,1.0,1/6,17.03%,VPS11
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.5296316416375395,-0.996649316813355,0.5,1.0,1.0,2/15,6.46%,OR2M4;GNAS
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.605958457205714,0.996641307610954,0.49019607843137253,1.0,1.0,1/6,5.19%,NEUROD2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.6436867413876024,0.9966214646821071,0.5853658536585366,1.0,1.0,2/6,16.30%,MDK;SALL1
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.6376525324298177,0.9965789990950772,0.5106382978723404,1.0,1.0,3/5,29.09%,MVD;MVK;IDI2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6080650995871046,0.9958793704879578,0.5357142857142857,1.0,1.0,3/8,8.73%,AGER;GRID2;CBLN1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6236152974757401,0.9957498122626448,0.49056603773584906,1.0,1.0,1/6,14.11%,SLC38A2
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.5088163171113458,0.9956998805731309,0.45652173913043476,1.0,1.0,4/15,6.82%,CX3CR1;ITGAM;AGER;SNCA
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.4314032159543769,0.9955149352824073,0.4666666666666667,1.0,1.0,11/62,16.12%,IFI16;DAPK2;HSPB1;PIP4K2A;ABL2;ITPR1;GPR137B;EP300;BOK;FBXL2;DEPP1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.6157476895989,0.9954028860584768,0.5471698113207547,1.0,1.0,4/13,11.44%,ENPP1;AK3;DCTPP1;SMPDL3A
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6049419268250532,0.9953874117405773,0.5490196078431373,1.0,1.0,4/11,19.01%,HMGB1;LIG4;RAG2;RAG1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.5920577115021736,-0.995347560990498,0.5344827586206896,1.0,1.0,2/8,8.60%,DRD1;ATF4
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.5920577115021736,-0.995347560990498,0.5344827586206896,1.0,1.0,2/8,8.60%,DRD1;ATF4
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.4619374297596553,-0.9952832547315764,0.47058823529411764,1.0,1.0,9/51,7.43%,CLDN4;HRNR;FLG;FLG2;ITGA6;RYR1;DACT2;STMN1;CLDN1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.41384526985884307,0.995055090488834,0.4791666666666667,1.0,1.0,31/140,17.05%,PMP2;CADM2;PLA2G7;RLBP1;LRRTM3;SLC39A12;NRXN1;ADGRB3;GFAP;CDH20;GRM5;AMER2;CA10;SLC1A2;FGFR3;LUZP2;GPM6B;SYNPR;RBFOX1;SLC4A4;LCAT;SRR;RGS7BP;LRRC3B;SORBS1;GRIA2;NFATC3;TMEM178A;MAPK4;BYSL;VIM
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.6753943134075662,-0.9950361081105629,0.4883720930232558,1.0,1.0,1/6,5.60%,WNT7B
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5495186454599879,-0.9948537264765754,0.46774193548387094,1.0,1.0,1/11,2.17%,UPB1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.6418531776115585,0.9947392486199663,0.5,1.0,1.0,1/5,8.60%,PDCD6IP
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.49064140099984255,0.9946577672676008,0.4827586206896552,1.0,1.0,5/35,5.44%,SPHK1;PPEF2;SMAD7;DDIT4;PARD3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.47130238501760136,0.9944778526943269,0.4489795918367347,1.0,1.0,4/25,11.50%,DCUN1D1;SMAD7;ARRDC3;PLK1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5186985443476517,0.9944336515522407,0.4772727272727273,1.0,1.0,10/32,18.84%,PPARG;ATOH8;FOXO3;NR3C1;HIF1A;SMAD3;RELA;NFATC3;NFIB;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5453496096527611,0.9941769892608381,0.47368421052631576,1.0,1.0,1/11,4.68%,PIP4K2A
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.48113992744935974,0.9941683385133042,0.38636363636363635,1.0,1.0,4/18,18.88%,ADGRV1;GNAI3;CAP1;STIM1
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.6238111487113529,0.9940270829642531,0.5510204081632653,1.0,1.0,2/7,16.11%,ADAM8;PTGS2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.5411148324096046,-0.993922695626339,0.46296296296296297,1.0,1.0,3/16,7.73%,WNT9A;NOG;RBP4
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.49341006413906474,0.9935659145646223,0.4375,1.0,1.0,6/24,13.55%,SLC26A7;SLC6A13;SLC19A2;SLC26A6;SLC25A26;ABCG2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5356258772618594,-0.9931373106832624,0.5,1.0,1.0,3/21,6.57%,NMNAT3;NUDT12;NAXE
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.4658323840727633,-0.9930151835757863,0.4489795918367347,1.0,1.0,13/49,18.88%,SLC25A10;APOD;SORD;G6PC3;RBP4;ATF4;PER2;AKR1A1;ENO1;GOT2;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.4964328414545662,0.9929357098027718,0.5172413793103449,1.0,1.0,5/20,17.96%,DGAT2;PLA2G15;PLCE1;DGKB;DGKZ
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.4165182025159034,-0.9928183689110133,0.5,1.0,1.0,17/83,14.89%,TAGLN;CASP6;DNPH1;UPK1B;VIL1;WNT7B;AHI1;PAX8;MEOX1;CDHR2;GSTK1;PTER;NDRG4;AKR1C2;TPP1;SNAI2;ANXA7
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.542702213432189,0.9927483801392238,0.5283018867924528,1.0,1.0,4/16,15.07%,SLC6A13;SLC1A2;PRAF2;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.5037869491317999,0.992742999144336,0.4727272727272727,1.0,1.0,9/16,33.94%,PID1;PICALM;BCL2L1;PPP2R5A;LZTFL1;RHOQ;MRAP;TMBIM1;TMEM59
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.5467738649504676,0.99265494330855,0.4482758620689655,1.0,1.0,8/18,18.34%,SPHK1;AGER;RELL1;MFHAS1;GADD45G;SASH1;GADD45B;VEGFA
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.5518411080565353,0.9925990055754188,0.5121951219512195,1.0,1.0,5/15,25.05%,HEY1;BMPR1A;ACVR1;SMAD4;SLIT3
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.5592145281709066,-0.9925866979731021,0.5111111111111111,1.0,1.0,1/12,2.90%,RAC1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.6073009641150181,0.9925652188046327,0.47540983606557374,1.0,1.0,3/9,10.34%,KLKB1;PTGES;ADAM8
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.49040086907409586,-0.992503350907616,0.5208333333333334,1.0,1.0,4/25,7.95%,RAC1;CATIP;VIL1;WASHC3
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5829894054394884,-0.9924996902575453,0.5102040816326531,1.0,1.0,5/9,21.44%,IFI6;RACK1;KDR;SRC;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.5502179350703842,-0.9924992382748137,0.54,1.0,1.0,2/10,17.69%,CDH17;SRC
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6211315362109951,-0.992462654739913,0.5227272727272727,1.0,1.0,4/7,24.49%,RPS15;NOP9;RAN;NPM1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5862322289244264,0.9924149849465791,0.4888888888888889,1.0,1.0,2/12,7.38%,DOC2B;SYT1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6046751256557644,-0.9923945119330223,0.5370370370370371,1.0,1.0,2/11,4.50%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.4981669847245533,-0.992315231635783,0.4418604651162791,1.0,1.0,5/31,10.53%,FGF1;CXCR5;KIF20B;GIPC1;DRD3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.530360573848014,0.9922767328471056,0.44,1.0,1.0,7/18,26.34%,SHROOM2;TENM3;COL5A2;VEGFA;NIPBL;C12ORF57;FBN1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.47167783076761244,-0.9922205117181995,0.46153846153846156,1.0,1.0,7/30,17.26%,ADAM19;MBTPS2;APH1B;HM13;CTSH;AFG3L2;RBMX
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.5403288973120622,0.9920718956945781,0.45454545454545453,1.0,1.0,3/10,13.60%,PLA2G10;MFHAS1;GPR137B
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.4422225226378417,0.9918315570320186,0.4791666666666667,1.0,1.0,13/71,10.07%,ACE2;FZD1;PHACTR1;CAPN13;NR3C2;TMEM229A;PTGES;PELI2;SCNN1B;EPCAM;COBL;CDO1;PROM2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.49786469714606807,-0.9918233629687285,0.46296296296296297,1.0,1.0,6/22,26.10%,UBC;UFD1;RPA3;NPLOC4;UBB;RFC2
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.43677900292711014,0.99167410780974,0.39215686274509803,1.0,1.0,11/56,14.77%,MAP3K11;CCNH;CCNA2;CUL1;LATS1;CDK6;HINFP;CCNE2;ACVR1B;MNAT1;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.397148026829447,-0.9916425901353517,0.48214285714285715,1.0,1.0,29/134,17.00%,SFRP1;NOG;PSMA7;PSMD7;PSMB4;LATS2;RBX1;LIMD1;PSMC3;IGFBP2;NOTUM;IGFBP4;STK11;TLE2;PSMD8;PSME1;PSMB2;EMD;PSMC4;FUZ;SFRP4;PSMB8;SNAI2;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;TLE5
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.574132013576839,-0.9915430550081876,0.5283018867924528,1.0,1.0,2/11,13.55%,NECAB2;ITM2C
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.6494463230207105,0.9915088668889769,0.56,1.0,1.0,4/5,34.62%,ATP8A2;ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6240225981274504,0.9914948279419271,0.58,1.0,1.0,1/5,3.01%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.583926754551389,-0.9914739570104855,0.54,1.0,1.0,2/8,14.95%,RACK1;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.583926754551389,-0.9914739570104855,0.54,1.0,1.0,2/8,14.95%,RACK1;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3495176490401228,-0.9914477300799193,0.4716981132075472,1.0,1.0,54/433,14.43%,SFRP1;INHA;CD9;DYSF;APOBEC3H;CCN3;SINHCAF;NUPR1;CLU;WNT9A;NTRK1;AZGP1;COL4A3;CDKN3;ETS1;FTH1;WARS1;TSPYL2;FOXM1;TPTE2;FABP6;TCHP;PDCD5;DNAJA3;SST;ZBTB7C;DACT2;INCA1;CRYAB;COL18A1;GLMN;BTG1;IGFBP3;TAF6;CYP1B1;RFPL1;STK11;BTN2A2;MNT;LRPAP1;RACK1;CDKN2B;PDE8A;PPT1;HPGD;PLXND1;ZP3;BRD7;ENO1;HNF4A;EREG;FUZ;SFRP4;APOA1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.4621765247275804,-0.9913769140251302,0.41509433962264153,1.0,1.0,8/45,14.30%,SERPINB8;SERPINE1;PRELID1;PSME1;TIMP4;SERPINF2;APH1B;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.4978098479950218,0.9911770046384432,0.48214285714285715,1.0,1.0,9/39,12.15%,ALDH1A1;CIDEA;ARRDC3;PLCL1;TLE3;IL18R1;NOVA1;NR1H3;MAP2K6
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.6510441833978797,0.9911703529724821,0.5434782608695652,1.0,1.0,3/5,23.17%,SETMAR;HNRNPU;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.6510441833978797,0.9911703529724821,0.5434782608695652,1.0,1.0,3/5,23.17%,SETMAR;HNRNPU;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.36857055034261277,0.9910058507905973,0.41379310344827586,1.0,1.0,77/419,14.41%,PIK3R5;CALCR;NRG1;SPHK1;RIT2;NTF3;ERBB4;NEDD4;SEMA5A;TRIP6;IRS1;NLGN1;CX3CR1;LITAF;FGFR2;NR3C2;HMGB1;CASS4;S100A13;TAB3;IQCJ-SCHIP1;ADGRV1;ROR1;EGFR;NEUROD2;WNT5A;TGFBR1;AGER;PELI1;IRS2;PELI2;FSHR;GAB1;ECT2;PRKD1;SCTR;TRIM22;RYK;STYXL1;FGFR3;FGF5;HDAC3;MFHAS1;FRS2;CCL5;FGF17;MYORG;ANKRD17;LRRC19;TAB2;TRIM8;PDGFRB;FGF10;IGF1R;ADAM8;PTPN6;ITGAV;CDH13;EPHA8;FGFR1;WWC1;TRIML2;SIRT1;PDGFD;PIK3CA;NDFIP2;PPM1A;THPO;IFI35;SASH1;RUNDC3A;HGF;EP300;RELA;NRG2;BCL2;BOK
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.5492938846967511,-0.990984480963962,0.5178571428571429,1.0,1.0,7/11,33.07%,AKAP8L;HPF1;NNMT;PARG;PARK7;CDK9;MTHFR
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.5755063119682075,-0.9907701273005346,0.5306122448979592,1.0,1.0,2/11,8.93%,CDK5;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.5019333934695641,-0.9907277422376349,0.4827586206896552,1.0,1.0,2/30,3.93%,NCKAP1L;ETS1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.5562295973646676,-0.9905409853815577,0.5,1.0,1.0,3/12,18.76%,AKAP8L;NRDE2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.49151867069411315,-0.9901900166131858,0.4727272727272727,1.0,1.0,3/23,4.27%,STING1;CGAS;DTX3L
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6002086722494058,-0.9901040787016848,0.5526315789473685,1.0,1.0,3/9,15.88%,TAF11;TAF7;TAF1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.4065001366126789,0.9899850884654542,0.425531914893617,1.0,1.0,14/90,11.70%,CD151;NRG1;RUNX1;SYK;NRXN1;NEUROD2;ATP10A;TGFBR1;FRMPD4;SNCA;PROM2;IGF1R;DLL1;LRP4
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.5690550460531412,0.9896507388741276,0.46808510638297873,1.0,1.0,2/9,20.74%,HEXB;VCAN
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.6079498526845541,0.9893476758734991,0.5384615384615384,1.0,1.0,3/9,18.20%,LEPR;SIRT1;BBS4
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.3947167418260665,-0.9891088635250774,0.48333333333333334,1.0,1.0,11/111,10.37%,GOLGA8B;PLK3;STX16;GOLGA2;PLK5;ZFP69B;TANGO2;ATP8B4;GOLGA8A;NSFL1C;GAK
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.6450489267345556,-0.9890292552766203,0.5111111111111111,1.0,1.0,1/6,11.95%,TRMT112
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6618297480487315,-0.9890145895067047,0.559322033898305,1.0,1.0,3/5,23.46%,DDRGK1;UFC1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6618297480487315,-0.9890145895067047,0.559322033898305,1.0,1.0,3/5,23.46%,DDRGK1;UFC1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6618297480487315,-0.9890145895067047,0.559322033898305,1.0,1.0,3/5,23.46%,DDRGK1;UFC1;UFL1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.5035734544196391,0.9890128315632692,0.49019607843137253,1.0,1.0,4/19,9.34%,SLC30A8;SLC2A5;IRS2;LPL
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.5372128236700117,0.9888419015226836,0.5434782608695652,1.0,1.0,7/12,20.99%,IRS1;IRS2;DYRK2;SORBS1;AKT2;INSR;EPM2AIP1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3624309127346474,0.9888056275583778,0.4166666666666667,1.0,1.0,58/424,13.05%,STK26;SGK3;SGK2;MAP3K11;LTK;NUAK2;DAPK2;CCNH;FRK;ERBB4;CCNA2;SYK;FGFR2;SMAD7;EGFR;NLK;EPHA3;TGFBR1;RPS6KA4;TNIK;CLSPN;CSF1R;ACVR2A;LATS1;ERN1;PRKD1;LIMK2;DYRK3;RYK;FGFR3;CDK6;PXK;EIF2AK3;PRKG1;ABL2;SGK1;BMPR1A;PRKACB;FER;PDGFRB;IGF1R;PTPN6;PRKCA;DYRK1A;STK36;SMAD2;CDK12;EPHA8;FGFR1;PLK1;DYRK2;MAP2K6;ACVR1B;NIM1K;RPS6KA6;CAMK4;DCLK3;STK33
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.5120494825881707,0.988588781176188,0.509090909090909,1.0,1.0,4/19,10.95%,SYK;HMGB1;AGER;DLL1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.45130240276467326,-0.9883326355957707,0.4716981132075472,1.0,1.0,6/40,5.28%,CLDN4;CBLC;CRH;ST6GALNAC2;CEBPD;LTBR
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.603869613954295,-0.9882617264784771,0.5319148936170213,1.0,1.0,2/7,18.85%,LGSN;ASS1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.48137787890176736,0.9881030783723492,0.4444444444444444,1.0,1.0,6/26,15.07%,SLC22A2;SLC1A2;PRAF2;SLC7A2;SLC25A38;SLC25A12
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.4123213495779815,0.9875972288158336,0.37777777777777777,1.0,1.0,16/88,15.17%,NEDD4;NLGN1;ITPKB;ADGRV1;NEUROD2;WNT5A;ECT2;PPP3CA;SYT1;ACER1;CRHBP;SYT15;MEF2A;MEF2C;SLC25A12;SYT2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5001668231526271,0.9875608597093992,0.4716981132075472,1.0,1.0,8/21,16.65%,SMAD7;LATS1;NREP;SMAD2;SMURF2;SMAD3;TGFBR3;SOX11
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.4336051836480805,0.9874941450574688,0.425531914893617,1.0,1.0,24/135,10.99%,SAMSN1;NLRP2B;HSPB1;PPEF2;NTF3;ENPP1;SMAD7;DDIT4;SLIT2;PPP1R15B;PARD3;PPM1E;SNCA;PTPN13;ERRFI1;DNAJC3;TWIST1;FKBP8;SH3GL2;PDE4D;CEP85;NCK1;PTPN6;GNAQ
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.570640595931391,0.9873391660070212,0.49056603773584906,1.0,1.0,4/7,37.24%,CXCL12;FERMT2;FN1;ITGB1BP1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.39385698471689234,-0.9873292655703785,0.425531914893617,1.0,1.0,12/98,11.46%,RAC1;RND3;WTIP;ARAP3;TPM1;FGD3;LIMD1;PAK6;PACSIN3;RND2;RHOBTB1;RHOBTB2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.5543793447818474,0.9870443677480643,0.4528301886792453,1.0,1.0,1/13,0.98%,HORMAD1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.559207736485988,0.9870211147200237,0.48148148148148145,1.0,1.0,2/10,4.52%,SYK;ITGAM
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.43654268863911067,0.9870009300816597,0.43478260869565216,1.0,1.0,16/97,16.09%,PIK3R5;PLA2G10;PLCB1;PIP4K2A;SYNJ2;CSF1R;PTPN13;PDGFRB;PIK3C2G;PIK3C2B;INPP4B;PIK3CA;PLBD1;PLA2G4C;MTMR12;PIK3R1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.6174438448390659,-0.9868579831645995,0.5918367346938775,1.0,1.0,3/8,24.93%,AK8;AK7;AK1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.4810729130835901,-0.9868412997554467,0.3953488372093023,1.0,1.0,12/33,21.93%,DHX58;UBE2L6;NLRX1;UFD1;TRAF3IP1;ISG15;PIN1;HERC5;TRIM25;NLRC5;OTUD5;NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.47144142226141406,0.9866741421101761,0.45652173913043476,1.0,1.0,4/27,9.99%,GRM7;IL1RAPL1;SNCA;HMGCR
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.41396488661524483,0.9866698425828158,0.4,1.0,1.0,18/67,12.87%,SPHK1;CHRM3;ACKR2;CX3CR1;ACKR3;EGFR;SLC8A1;GRM5;PPP3CA;MCTP1;MCU;PTGFR;EIF2AK3;LAT2;PLCE1;EDN1;P2RX7;ANK2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40475360888485734,0.9865598504761418,0.4897959183673469,1.0,1.0,57/331,11.59%,GALNT3;LTK;FLRT2;NRG1;EFNA5;ATP6V0A4;NTF3;PLCB1;FRK;ERBB4;HNRNPH1;IRS1;CD8A;SYK;VEGFC;ATP6V0D2;MUC20;FGFR2;CSF1;CASS4;FLRT3;ROR1;EGFR;DDIT4;EPHA3;SULF1;IRS2;NRP1;CSF1R;CNKSR1;GAB1;NUS1;PRKD1;RYK;FGFR3;FGF5;BLNK;RGS14;PTPRG;COL4A6;FRS2;FGF17;EIF2AK3;EPHA7;NCK1;FER;CLNK;FOXO1;SOCS2;PDGFRB;FGF10;IGF1R;ITGAV;EPHA8;FGFR1;WASF2;VEGFD
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4750894625199067,-0.9863977809115629,0.509090909090909,1.0,1.0,2/37,0.52%,NCKAP1L;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6923716716422892,0.9861794652931158,0.6274509803921569,1.0,1.0,2/5,16.96%,LMO3;CRY1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6166409972211826,0.9860953537926326,0.5769230769230769,1.0,1.0,1/7,14.78%,MPST
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.583056201565419,0.9859488811538517,0.5,1.0,1.0,2/7,15.05%,PEX13;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.42166754572748977,0.985913707864042,0.4,1.0,1.0,13/84,11.29%,SPHK1;RIT2;RALA;SYK;SLC30A8;NRP1;CD22;SYT1;RAB3C;ABL2;ITGAV;CDH13;RIMS2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.39738595250339576,-0.9859010126176991,0.48,1.0,1.0,28/124,17.18%,PLEKHH2;ASCL1;KIF1A;PPP1R17;RND3;DLX5;RBM3;CELF3;ID4;IFI44;IFIT1;IGFBP3;RND2;TMTC4;ZIC1;TAGLN3;CCDC177;MAGEL2;ISG15;PCDH19;PCDH8;TUBB2B;S100B;RGS8;BRSK2;HOPX;FABP7;CACNG4
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.482218543279888,-0.985807285511413,0.40384615384615385,1.0,1.0,2/34,3.40%,TLCD2;STX4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.4156996062442393,-0.9856890976705658,0.4166666666666667,1.0,1.0,14/79,16.09%,HLA-C;FABP5;CEBPD;OAS3;DTX3L;ANXA5;LTBR;MARCKSL1;EHD4;IL13RA1;IL1R1;NFKBIA;TNFRSF1A;CTSH
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6215863973777495,0.9855846787774001,0.45,1.0,1.0,3/8,21.35%,RP1;BBS4;RPGRIP1L
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.5113189656722499,0.9855369207219338,0.5192307692307693,1.0,1.0,2/17,9.12%,NUS1;HIF1A
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.38238073430342573,-0.9854955737248426,0.46,1.0,1.0,24/174,13.30%,PLK4;AURKA;MARCKS;INCENP;CBX1;CDKN3;HMGB3;NCL;KIF20B;SMC4;ILF3;KIF4A;FANCC;STMN1;MCM5;KPNA2;CCND1;NOLC1;CHAF1A;CENPE;CHEK1;ODF2;MCM2;HUS1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.6446287994719934,0.9854713989936245,0.54,1.0,1.0,2/6,12.28%,USH2A;CTNNB1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.4550462810317498,0.9854552407133902,0.4117647058823529,1.0,1.0,9/44,16.27%,CERS3;TLCD3B;ACER1;PLA2G15;ASAH2;PLPP1;SMPD4;CERS5;SGMS1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5002696968006478,-0.985224625180049,0.5,1.0,1.0,3/19,11.32%,RYR1;HTR2A;PTPRC
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3973735582753756,0.9851071761085931,0.4634146341463415,1.0,1.0,75/371,14.32%,IL1RAPL2;NRG1;FAT4;NAB1;EFNA5;NTF3;PCDHB3;CHRM3;ERBB4;GFRA1;SEMA5A;LSAMP;NLGN1;LDB2;SNTG2;FLRT3;NRXN1;DSCAM;FGF12;ADGRV1;ROBO1;CNTN4;NAV3;IRF2BPL;THOC6;NEUROD2;ZEB2;GLIS2;BTBD3;ROGDI;NR2E1;TGFBR1;CHRM2;RAB29;GPM6A;ECT2;ROBO2;POU6F2;ADGRL3;ATXN1;RYK;FGF5;MBNL1;CBLN1;FGF17;SH3GL2;GLRB;CDH2;MBP;GPM6B;HMGCR;APBA1;SERF1A;JAG1;DYRK1A;RBFOX1;CHD7;PSPN;ZC4H2;ADORA1;GRIK1;PCDHA1;ASIC2;NPAS1;NRTN;ACVR1B;RPS6KA6;TENM1;ATXN10;FGF13;LIG4;MDK;EP300;DPF3;TBX6
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.4724938755336979,0.9850769827241037,0.5192307692307693,1.0,1.0,10/36,18.34%,SYK;SMAD7;TGFBR1;NRP1;CDH2;ITGB8;TGFBR3;PROX1;CUL7;VEGFA
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.5982414722349707,0.9848021667381275,0.5769230769230769,1.0,1.0,4/9,20.10%,AGER;PICALM;ROCK2;EPHA4
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5456973086538655,-0.9847724185670652,0.5166666666666667,1.0,1.0,4/12,19.04%,UPB1;DERA;NT5M;UPP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.5791121978159647,-0.9847135386914587,0.5714285714285714,1.0,1.0,2/6,17.66%,C1QBP;THBS1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5665614423388754,-0.9846927927706217,0.49019607843137253,1.0,1.0,3/12,12.21%,NOP14;NOP9;KRI1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.36888162252723106,-0.9846604568506521,0.44,1.0,1.0,34/284,10.82%,SFRP1;CCN3;ATRAID;NUPR1;WNT9A;NOG;NTRK1;AZGP1;APOD;COL4A3;CDKN3;ETS1;FTH1;B2M;WARS1;TPTE2;FABP6;NODAL;PDCD5;DNAJA3;SST;ZBTB7C;VIP;INCA1;RBP4;COL18A1;GLMN;BTG1;IGFBP3;PER2;CYP1B1;RFPL1;STK11;MNT
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.405533120349892,0.9844736022813834,0.425531914893617,1.0,1.0,10/95,11.55%,SEMA3C;ALDH1A1;CEL;SULT2B1;PEX11A;CAT;ATXN1;ACSL4;CADM1;PEX2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.565982952111072,0.9843873924593479,0.5348837209302325,1.0,1.0,2/11,6.02%,MT1M;GLRA2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.603454509408921,-0.9842288698164019,0.5384615384615384,1.0,1.0,4/6,17.94%,DHX58;C1QBP;DDX60;TKFC
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5238100727499662,-0.984018238366291,0.5,1.0,1.0,1/15,1.16%,HSF2BP
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.5574902077537536,0.9839049627295061,0.509090909090909,1.0,1.0,5/16,15.83%,PLD6;TDRD9;TEX15;TDRD1;FKBP6
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.6526265169329971,-0.9839042706461272,0.5094339622641509,1.0,1.0,3/5,32.00%,YBX3;PKM;CNBP
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.5805852990518682,-0.9835812761596077,0.6170212765957447,1.0,1.0,1/13,0.84%,DYSF
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4459031652359986,-0.9835157880380743,0.5102040816326531,1.0,1.0,14/62,15.99%,RTF1;GTF2F1;ADRM1;POLR2I;POLR2J;GTF2H2;ELOF1;ELOB;SUPT5H;SUPT16H;CCNT1;POLR2G;POLR2C;ERCC2
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.6833776868180667,0.9834793446377462,0.5714285714285714,1.0,1.0,1/6,5.98%,PKHD1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.623653081438445,0.9833140113252091,0.6071428571428571,1.0,1.0,4/7,20.10%,AGER;PICALM;ROCK2;EPHA4
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.6011363263299083,-0.983077997615828,0.5,1.0,1.0,1/9,0.75%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5508738579197039,0.9829861082147893,0.4583333333333333,1.0,1.0,7/15,24.99%,ZFP36;BTG2;CPEB3;TNRC6C;TENT4B;CNOT7;TOB1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5044912851364759,0.982896372111527,0.5192307692307693,1.0,1.0,3/22,7.77%,KANK1;SLIT2;LIMK2
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.4308613466811899,0.9827912311240173,0.42857142857142855,1.0,1.0,12/99,9.71%,SAMSN1;IFI16;CALCR;RXFP2;SYK;CYSLTR2;GPR176;FSHR;SCTR;PCBP2;PRKACB;FER
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.661053063503811,0.9827175718021833,0.5576923076923077,1.0,1.0,2/5,21.84%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.661053063503811,0.9827175718021833,0.5576923076923077,1.0,1.0,2/5,21.84%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5068795337132327,-0.9826449125330708,0.49122807017543857,1.0,1.0,2/24,2.51%,SFRP1;CYP19A1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4795488619766439,0.9825563532376805,0.4074074074074074,1.0,1.0,7/33,11.03%,HSPB1;SEMA5A;DSCAM;NRP1;PRKD1;PDGFRB;CDH13
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.6216167435209572,-0.9823723296884589,0.6,1.0,1.0,3/5,37.53%,SSU72;CTDP1;RPAP2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.4564566859852437,-0.9823655428098917,0.4489795918367347,1.0,1.0,14/50,17.75%,RAD51AP1;FANCI;SLX4;ERCC1;UBC;RNF8;FANCC;CENPX;FANCG;NUCKS1;MUS81;XRCC3;USP1;FANCM
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4067818054037931,0.9823436715997191,0.41509433962264153,1.0,1.0,46/206,14.35%,LTK;FAS;EFNA5;ERBB4;VEGFC;LEPR;FGFR2;DSCAM;ROR1;EGFR;EPHA3;AGER;PELI2;TNIK;NRP1;CSF1R;ACVR2A;LIMK2;ZBTB20;RYK;FGFR3;FGF5;HDAC3;CCL5;FGF17;DVL2;HIF1A;EPHA7;C3;PROM2;PDGFRB;FGF10;IGF1R;EPHA8;FGFR1;VEGFD;SLC4A4;RAP2A;NPTN;P2RX7;SIRT1;THPO;HGF;BTBD10;P2RY1;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.4256693976085436,-0.9823056165893643,0.4339622641509434,1.0,1.0,10/81,12.33%,TYMS;ATRAID;NCL;RBM4;CDK5;ILF3;ZNF540;PATL2;RACK1;CSTB
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6312957865674022,0.9822906376239229,0.6071428571428571,1.0,1.0,4/9,27.34%,CCL5;ADA;DPP4;WNK1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.5344338464590793,-0.9821493187300816,0.46,1.0,1.0,6/15,25.84%,ALOXE3;GSTP1;ABCD1;CYP2J2;FADS1;ALOX12B
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6362255435735705,0.9820402259053853,0.574468085106383,1.0,1.0,3/5,34.36%,PIGU;GPAA1;PIGK
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.6638220308070152,-0.9820344760141638,0.5,1.0,1.0,3/5,30.31%,NLRP9;GBP5;TLR2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.46912931655536777,0.9819103012470185,0.4897959183673469,1.0,1.0,3/33,5.61%,CHRM3;CNR2;CHRM2
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5995128731156817,0.9816061505938377,0.5918367346938775,1.0,1.0,1/6,15.97%,KIF13A
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.6734479795546744,-0.9815543322772279,0.5869565217391305,1.0,1.0,2/5,25.03%,TMEM9;ALDOB
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.632729393718186,0.9815003330127215,0.5714285714285714,1.0,1.0,1/5,15.97%,KIF13A
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6307871884809951,-0.9814480830417657,0.5777777777777777,1.0,1.0,4/7,26.03%,DCAF15;LEP;IL12A;PTPN22
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.41677921542254304,-0.9813736269354385,0.5,1.0,1.0,29/89,21.32%,TNFSF18;PSMA7;TMSB4X;LTBR;PSMD7;EIF5A;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;NFKBIA;TNFRSF1A;PSMC1;PSMB5;BAG4;PSMD2;LTB;PSMA1;PSMD10;STAT1;PSME2;PSMD12;TNFSF9;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.4334007409367115,-0.981335920110667,0.4897959183673469,1.0,1.0,10/68,11.33%,B3GALT4;ST6GALNAC2;GOLGA2;B3GNT9;B3GALT5;CHST8;ST8SIA2;ALG1L2;MPI;CHST10
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.6077088948022404,0.9811582567789607,0.5892857142857143,1.0,1.0,4/9,24.32%,ADCY10;ADCY2;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.6185647192835688,0.9811395818837232,0.5714285714285714,1.0,1.0,1/6,5.20%,PUS10
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.4916999365385105,-0.981011015810374,0.5581395348837209,1.0,1.0,3/20,11.32%,RYR1;HTR2A;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5417226839829912,-0.9809442253494269,0.4583333333333333,1.0,1.0,3/15,11.55%,DTX3L;KDM4D;WRAP53
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5581168780739922,-0.9808630457804485,0.4642857142857143,1.0,1.0,1/12,1.07%,TNFSF18
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.4548964267967044,-0.9808601905394506,0.45454545454545453,1.0,1.0,10/33,18.88%,SLC25A10;G6PC3;RBP4;ATF4;PER2;ENO1;GOT2;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.45278325835030253,0.9807033893576792,0.39215686274509803,1.0,1.0,5/66,6.83%,AEN;IFI16;RFWD3;RHOB;ECT2
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),0.5940723751820248,0.9806719966769626,0.5471698113207547,1.0,1.0,1/5,7.20%,CACNB2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5291828660320144,-0.9801729767747864,0.5111111111111111,1.0,1.0,1/19,1.74%,CLU
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.44172837562125405,0.9799507621528,0.45454545454545453,1.0,1.0,10/60,7.69%,TYR;GNAT2;GUCY2F;ADGRV1;PCDH15;ABLIM1;USH2A;MYO7A;POU6F2;GRM8
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.6445341771588899,0.9798603280570453,0.56,1.0,1.0,1/5,2.96%,CX3CR1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.4963291622594824,0.9797015063041906,0.5,1.0,1.0,7/29,16.52%,ATP10A;ATP8B3;PLSCR2;P2RX7;ATP11C;PLSCR5;ATP8A2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6056841420930599,-0.9796881278424437,0.5454545454545454,1.0,1.0,3/7,33.17%,CTPS2;UMPS;CTPS1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.44257399678027526,0.9795241941013,0.45098039215686275,1.0,1.0,11/46,16.56%,SULT2A1;SULT2B1;CYP39A1;HMGCR;MSMO1;LBR;LCAT;CYP4V2;INSIG1;INSIG2;CYP7B1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.6260024953650676,0.9794505249153103,0.5416666666666666,1.0,1.0,1/7,1.33%,FAS
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.4432110840455636,0.9794350225244911,0.4583333333333333,1.0,1.0,13/41,10.33%,ALDH1A1;TFCP2L1;LEPR;MUC20;CAPN13;SFTPC;ERN1;STEAP4;SCEL;SCNN1B;MUC16;PROM2;ST14
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5980649898033575,0.9794170782007702,0.5178571428571429,1.0,1.0,4/8,12.28%,FZD1;WNT5A;RYK;CTNNB1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.42384033050548814,-0.9792339786557608,0.44,1.0,1.0,8/72,6.01%,P2RY10;NCKAP1L;SP140;CD74;CXCR5;TRAF3IP3;PSG2;CD37
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.5440896675634888,0.9789099220764731,0.5098039215686274,1.0,1.0,3/12,5.77%,ATOH8;SULT2B1;RFX3
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.6644066706838295,-0.9788298604991013,0.5454545454545454,1.0,1.0,1/5,2.56%,AMDHD1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.6644066706838295,-0.9788298604991013,0.5454545454545454,1.0,1.0,1/5,2.56%,AMDHD1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6123904411329205,0.9787905848425432,0.6111111111111112,1.0,1.0,3/6,30.40%,SIRT1;MAPK14;TP53
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5681310922604879,0.978535553369459,0.5208333333333334,1.0,1.0,7/13,24.44%,COMMD1;NEDD4L;ATP1A2;SLC43A1;CAV3;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5847045162846062,0.9784467050783391,0.5283018867924528,1.0,1.0,1/8,1.69%,DCUN1D1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.3833557746304388,0.9782263961155891,0.45454545454545453,1.0,1.0,20/108,16.72%,VAPB;SLC8A1;PKHD1;ATP2B4;MICU1;MCU;CCL5;EDN1;TRPC4;MAIP1;TRDN;NPTN;ANK2;CXCL12;SLC24A2;BCL2;TMEM203;TMEM178A;CLN3;PDZD8
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.4986062615630098,-0.9781263317354176,0.4909090909090909,1.0,1.0,6/19,28.73%,BCAR3;DGKD;SHKBP1;HAP1;AGT;AKT1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.5933241180899419,-0.9778804825922717,0.5098039215686274,1.0,1.0,2/7,5.60%,ASCL1;WNT7B
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.4993035338044695,0.9778426950837308,0.41304347826086957,1.0,1.0,10/28,17.08%,MDGA2;GRID2;RYK;TOX;CBLN1;NPY;ZC4H2;CTNNB1;MAP2;PROX1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.45761327085805703,0.9776522651007619,0.4772727272727273,1.0,1.0,9/34,16.11%,PHACTR1;BTBD3;CTNNA2;DOCK10;LRP4;MEF2A;CTNND2;KLF7;MAP2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5051499767150855,-0.9775495750021265,0.49122807017543857,1.0,1.0,2/19,5.69%,CACNG5;NPTXR
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.554463294257916,0.9773584019106597,0.5217391304347826,1.0,1.0,2/14,11.41%,LDLR;STARD4
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5892533923204821,0.9772438379271254,0.5636363636363636,1.0,1.0,2/7,8.19%,NEDD4;UBR5
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.4236901576932437,-0.9770437692440452,0.4576271186440678,1.0,1.0,7/69,6.01%,P2RY10;NCKAP1L;SP140;CXCR5;TRAF3IP3;ZBTB32;CD37
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.556162783949773,-0.9769860921590844,0.5416666666666666,1.0,1.0,2/10,7.65%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.49318429741094183,0.9768623252454182,0.5263157894736842,1.0,1.0,7/22,22.39%,SLC2A14;SLC19A2;SLC23A1;ABCG2;CBLIF;TCN2;CUBN
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.46102718822706124,-0.9767945296061591,0.4915254237288136,1.0,1.0,4/37,6.61%,CLDN4;TMEM184A;WNT7B;GPR39
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.4127994028090614,0.9766727010558948,0.5161290322580645,1.0,1.0,16/76,12.49%,SPHK1;RUNX1;HSPB1;SEMA5A;ITGAX;VEGFC;WNT5A;RHOB;GAB1;PRKD1;TWIST1;HIF1A;PRKCA;VEGFD;SIRT1;ITGB8
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.47419911263186876,-0.9765621199289605,0.5294117647058824,1.0,1.0,11/36,18.88%,SLC25A10;SORD;G6PC3;RBP4;ATF4;PER2;ENO1;GOT2;GAPDHS;ENO2;PGK1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5180025884922541,0.976497567614078,0.48936170212765956,1.0,1.0,2/14,10.11%,CD8A;JAG1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.49158148907930554,-0.9764286382309664,0.46511627906976744,1.0,1.0,2/43,1.62%,SFRP1;ADIRF
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.47009524754624643,0.9764081611543131,0.4583333333333333,1.0,1.0,4/21,10.87%,NTF3;MAGI2;SH3GL2;TMEM108
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5674602265122966,0.9761114312159148,0.5409836065573771,1.0,1.0,5/11,24.32%,PDE4D;ADCY10;ADCY2;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5053717880596114,-0.9758281894755652,0.5476190476190477,1.0,1.0,4/18,17.22%,SELENOK;BAK1;FIS1;TMCO1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3921246858126119,0.9757183078587129,0.4032258064516129,1.0,1.0,27/149,16.00%,PLCB1;RALA;PLD6;NLGN1;ELAPOR2;NRXN1;NEUROD2;WNT5A;CCN2;GRIP1;MCU;DVL2;FOXO6;BMPR1A;COBL;SOX5;FGFR1;SMURF2;SIRT1;ACVR1B;SHLD1;MDK;FST;ACVR1;SCX;MARCHF5;LLPH
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.5022069507914095,0.9752663898514351,0.5294117647058824,1.0,1.0,3/21,8.35%,SPHK1;WNT5A;CDK6
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.4955840255133135,-0.9750845939183782,0.5116279069767442,1.0,1.0,5/26,19.18%,LDB1;RNF8;SUPT16H;SUPT6H;NELFA
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5678760416620467,0.9749924393540763,0.5652173913043478,1.0,1.0,2/10,11.81%,LDLR;NR1H3
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.49657905459721274,0.9747715312477853,0.5510204081632653,1.0,1.0,6/20,14.80%,CSGALNACT1;HS2ST1;FUT9;EXT1;CSGALNACT2;B3GNT2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.37692313183820836,-0.9744912615371367,0.5416666666666666,1.0,1.0,79/186,25.21%,TYMS;PSMA7;EIF2S2;HDDC2;SLC25A3;PSMD7;MRPL23;RSL1D1;LSM7;MCM5;PA2G4;NOP56;MRPS18B;KPNA2;RPL34;DDX18;NOLC1;SF3A1;PPM1G;RANBP1;NOP16;RACK1;C1QBP;PSMD8;MCM2;NDUFAB1;PSMB2;LDHA;MRPL9;PSMC4;XPOT;PRDX3;SRSF7;PABPC4;PSMA1;USP1;RPL6;GOT2;ACP1;APEX1;CCT2;DDX21;XRCC6;PGK1;SNRPD2;EPRS1;IMPDH2;EIF3J;POLE3;RPS3;RNPS1;CANX;SERBP1;EIF4H;PSMC6;PCBP1;IARS1;PSMB3;FBL;DEK;HSP90AB1;HSPD1;RPL18;RAN;MCM4;ORC2;SNRPA1;EEF1B2;RPS2;SF3B3;SNRPD1;SET;TARDBP;COX5A;NPM1;HDGF;TFDP1;PSMD3;RPS6
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6618260387785422,0.9743765487389654,0.68,1.0,1.0,3/5,25.78%,DEPTOR;CAV3;PTEN
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.4175941791657264,0.9742506139821062,0.3902439024390244,1.0,1.0,15/75,13.61%,LRIG3;PPARG;PRRX1;EGFR;SLIT2;TCF7L1;STAB1;TEAD2;TWIST1;GLI3;FGF10;NOTCH3;TIMP3;COL5A2;ENAH
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.39953666528397297,-0.9739941309138078,0.5306122448979592,1.0,1.0,32/137,20.83%,TCHH;PARP2;NPTXR;PDAP1;MRPL23;PSMC3;IGFBP2;BTG1;PRKACA;CCNE1;BAK1;YKT6;FGF18;CDKN2B;WIZ;GGH;PPT1;TYRO3;NFKBIA;RXRB;SIGMAR1;CLTB;RPN1;ATP6V1F;DDX21;CDKN1C;ENO2;NPTX2;POLE3;EIF2S3;IRF1;EPHX1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5057617135901878,0.973877602892099,0.48333333333333334,1.0,1.0,5/19,20.85%,KLHL15;UGGT1;DERL1;CUL3;RNF185
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.5752887003053303,-0.9738452940505371,0.5217391304347826,1.0,1.0,4/11,15.93%,RPP25;POP7;POP1;POP5
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.5070532992828927,-0.9737564955643949,0.5294117647058824,1.0,1.0,5/28,11.72%,GPC2;EVC2;DISP2;IFT27;B9D1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.45228191234732573,0.9735000374101097,0.4186046511627907,1.0,1.0,1/49,0.56%,SNX31
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.5465813836799518,0.9732366522005801,0.49122807017543857,1.0,1.0,11/18,20.18%,ENPP6;GDPD3;SMPDL3A;PRDX6;PLBD1;PLA2G4C;SMPD4;PLBD2;GPCPD1;ABHD12;PNPLA6
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.5598048007997523,0.9731884327120371,0.5106382978723404,1.0,1.0,2/9,3.67%,NTF3;MAGI2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.4307286217745776,0.9726996222669269,0.4,1.0,1.0,7/52,9.24%,LOXL2;NEDD4;SLC30A8;SNCA;PPP3CA;HIF1A;ZACN
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5305375181303658,0.972586045974278,0.5,1.0,1.0,2/10,6.93%,HPRT1;PPAT
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.5608350133992118,-0.972329749388136,0.5,1.0,1.0,6/10,25.84%,HPGD;ALOXE3;GPX1;LTC4S;GPX4;ALOX12B
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.5859706719666956,-0.9722841912664621,0.49056603773584906,1.0,1.0,2/11,12.17%,HDAC5;CHEK1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5847964170364424,0.9722382236279151,0.5789473684210527,1.0,1.0,3/12,15.80%,CHST6;CHST7;MGAT3
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.41386503998992985,0.9720440713748328,0.4716981132075472,1.0,1.0,9/91,7.36%,ACE2;NOX5;IFI16;S100A13;RPS6KA4;CIDEA;DTX4;HDAC9;TWSG1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.58742515532363,-0.9720435101735153,0.5254237288135594,1.0,1.0,1/7,9.09%,RNF213
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.4496403841473171,0.9718627483141538,0.5,1.0,1.0,17/57,14.84%,PPARG;VWC2L;SMAD7;ELAPOR2;SULF1;ACVR2A;TWSG1;SMAD5;SMAD1;BMPR1A;CRB2;SMAD2;SMAD9;SMURF2;FST;SMURF1;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.5776022253926505,0.9711810247499286,0.56,1.0,1.0,2/6,5.35%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.46435962321792784,-0.9711630441200733,0.5555555555555556,1.0,1.0,2/34,2.90%,SFRP1;RAC1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4570546570651447,-0.9706009986936178,0.4642857142857143,1.0,1.0,8/41,14.43%,SFRP1;RAC1;TPM1;VIL1;SYNPO2L;EPHA1;SERPINF2;APOA1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.39775215782912887,-0.970505639396169,0.4807692307692308,1.0,1.0,21/86,16.04%,GEM;LDB1;XPC;UBC;PWWP3A;RBX1;COPS6;CETN2;SAFB;HMGB2;HDAC5;GATAD1;NUP133;CENPH;SOX15;DDB1;COPS7A;NUCKS1;FAM50A;PARP1;NUP155
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.41056234789834,0.969939755805358,0.42857142857142855,1.0,1.0,8/39,16.69%,KCND2;KCNE4;GNAQ;AKAP6;ANK3;KCNJ2;DMD;CLN3
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.6119127794591455,-0.9694451217561338,0.6078431372549019,1.0,1.0,3/9,14.43%,METAP2;METAP1D;APOA1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.533892192266506,0.9692193672774182,0.4528301886792453,1.0,1.0,4/12,21.68%,RNFT1;USP13;RNF185;NFE2L2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.458797311484799,0.9690662296980009,0.5208333333333334,1.0,1.0,11/28,19.38%,SLIT2;MSTN;AUTS2;FER;PLCE1;WASF2;PIK3CA;ACTR3;PIK3R1;TWF1;DMTN
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.5024797731834342,-0.9686719444877365,0.45454545454545453,1.0,1.0,2/15,17.06%,HENMT1;NRDE2
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),-0.6365909174015091,-0.9682798452209065,0.6274509803921569,1.0,1.0,1/5,8.17%,DRD1
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),-0.6365909174015091,-0.9682798452209065,0.6274509803921569,1.0,1.0,1/5,8.17%,DRD1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.4257942283737107,0.9681805644853886,0.5106382978723404,1.0,1.0,9/62,11.78%,ZDHHC11;NECTIN3;EGFR;ZDHHC14;PARD3;ZDHHC11B;ZDHHC2;REEP1;VPS37D
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5480757842987752,-0.9678729484807496,0.5510204081632653,1.0,1.0,4/20,11.32%,STX4;RBP4;LACC1;PTPRC
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.4044622056766565,0.9677702914213867,0.5121951219512195,1.0,1.0,18/70,21.43%,LOXL2;CHRM3;MSRA;ABL2;YES1;FBXO11;UBE2D3;PLAT;PHKA2;ST8SIA4;FBXL2;AKT2;STK38;CSNK1G3;QPCT;ST3GAL6;CPE;GNMT
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.6716671601909312,0.9674135837600211,0.6274509803921569,1.0,1.0,2/5,13.64%,GLI3;MDK
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5409725678694767,0.9672542481896558,0.5098039215686274,1.0,1.0,6/13,24.99%,ZFP36;BTG2;CPEB3;TNRC6C;CNOT7;TOB1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.6156180963499505,-0.9672387167556755,0.5555555555555556,1.0,1.0,3/7,12.21%,NOP14;NOP9;KRI1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5953076985662042,0.9669494569713185,0.5,1.0,1.0,3/8,6.82%,ATP2B4;PDE4B;SNCA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5953076985662042,0.9669494569713185,0.5,1.0,1.0,3/8,6.82%,ATP2B4;PDE4B;SNCA
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.6842026823262066,0.966895790702654,0.5849056603773585,1.0,1.0,3/5,11.44%,ENPP1;DCTPP1;SMPDL3A
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.615498884260248,0.9667780949043597,0.5614035087719298,1.0,1.0,3/10,9.34%,PLA2G10;CSF1;LPL
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.43566777644541155,0.9659094783383788,0.5490196078431373,1.0,1.0,4/47,3.03%,SEMA3C;ERBB4;SEMA5A;SEMA6D
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.47507769868874666,-0.9656382017677566,0.4888888888888889,1.0,1.0,12/37,28.51%,PHAX;NUP133;NUP43;XPOT;NUP155;NUP85;RAN;NUP214;NPM1;SEC13;NUP50;TPR
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.5201678252048092,-0.9655945741721751,0.5094339622641509,1.0,1.0,1/22,0.98%,TXK
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.4337409103061352,-0.965509912702459,0.4727272727272727,1.0,1.0,11/87,12.40%,PLK4;HAUS8;DCTN1;AHI1;SSNA1;CETN2;PRKACA;TUBB4B;TCTN1;B9D1;ODF2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.4531530698058209,0.9652731763848486,0.43137254901960786,1.0,1.0,5/33,14.60%,CENPI;KNL1;H3-3A;ASF1A;CENPO
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.37773865033209625,0.9649382866765625,0.48148148148148145,1.0,1.0,20/112,10.96%,LOXL2;TYR;HSPB1;TNC;ENPP1;PPARG;BNC2;HMCN1;PRRX1;EGFR;POSTN;TP63;MLANA;FAM114A1;RASAL2;GLI3;MITF;PTPN14;PRKCA;ITGAV
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.5836946164811145,0.964897271558074,0.543859649122807,1.0,1.0,3/7,23.43%,PIK3CA;CXCL12;WAS
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6237127801130407,0.9646732263338571,0.5576923076923077,1.0,1.0,3/6,9.92%,DNAJC3;EIF2AK3;FOXO1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.5671310336524071,0.9644805739225877,0.5087719298245614,1.0,1.0,2/9,6.94%,SLC23A1;GSTO2
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.6361344152569568,-0.964429582466793,0.6190476190476191,1.0,1.0,5/5,36.41%,SLC11A1;EIF4G1;EIF4G2;COL5A1;RPS23
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.673942617645723,0.9643347608545717,0.5306122448979592,1.0,1.0,1/6,5.47%,ATP10A
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.5505381026881706,0.9642607419207438,0.5416666666666666,1.0,1.0,2/7,8.84%,SULF1;TBC1D8B
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4537333609436982,0.9640663943693927,0.5306122448979592,1.0,1.0,6/44,11.81%,PLA2G10;CSF1;FOXO3;GRM5;EDN1;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.5476241689457669,0.9639417630891401,0.5581395348837209,1.0,1.0,2/11,16.03%,ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.5476241689457669,0.9639417630891401,0.5581395348837209,1.0,1.0,2/11,16.03%,ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5617365279621673,-0.9639288830169053,0.5740740740740741,1.0,1.0,5/14,18.76%,STX4;RBP4;PTPRC;CR1;SUPT6H
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.4823441797090392,0.9638068858893164,0.5416666666666666,1.0,1.0,4/16,9.59%,B4GALNT2;ABO;B4GALT1;FUT9
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.5235071985157214,0.9637143262015114,0.48936170212765956,1.0,1.0,3/17,14.18%,IFI16;EPHA7;AIM2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.5587186172262618,-0.9636105270004552,0.5686274509803921,1.0,1.0,3/8,5.52%,SPRED3;SPRED2;SPRY1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.402472610366918,0.9635727770038969,0.46,1.0,1.0,28/106,17.08%,SEMA6D;LEPR;NRXN1;PPARGC1A;UNC5D;TOX3;PCDH17;CNTN4;LCORL;PTPRD;HMGCLL1;ELAVL4;RAB3C;CBLN1;PCSK2;NOL4;CNTN1;KCNB2;ASXL3;ASIC2;RGS7BP;SORBS1;GRIA2;CSRNP3;BCHE;MAPK4;GABRB3;PROX1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4022567117723292,0.963536774836658,0.47368421052631576,1.0,1.0,13/105,10.79%,SLC12A1;DACH1;MXRA5;PLA2G7;SLC12A3;LDB2;POSTN;FAM114A1;SMARCD3;C3;JAG1;CDH6;SHROOM4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4655815808287667,0.9633797883170595,0.5,1.0,1.0,9/42,14.41%,AEN;IFI16;DDIT4;CASP9;DYRK2;SIRT1;EP300;BCL2;BOK
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.5800288478518221,-0.9631470320192252,0.6363636363636364,1.0,1.0,3/8,21.44%,DCTN1;MAP1A;ABCD1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.4509721335206669,0.9630204057436678,0.4,1.0,1.0,13/47,16.42%,NDNF;DDIT4;GPM6A;NRP1;ADGRL3;AUTS2;FGFR1;POMGNT2;FGF13;PEX13;MEF2C;LRP12;DISC1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5442100412077628,0.9629572663873688,0.6037735849056604,1.0,1.0,6/12,27.88%,RORA;INSIG1;INSIG2;GRAMD1C;GRAMD1A;LRP6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.4205670274995962,0.9627727413705998,0.46808510638297873,1.0,1.0,7/57,5.20%,MARVELD3;PTPRK;ATOH8;FGFR2;ROBO1;MAGED1;SULF1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3881058413270781,0.962679836522615,0.4,1.0,1.0,21/98,17.17%,PMP2;ALDH1A1;NRXN1;GFAP;PCDH17;INTS6;PTPRD;ADGRL3;MEGF10;GPM6B;FREM1;CNTN1;CRTAC1;ANK2;ZNF536;RGS7BP;SORBS1;CCDC3;CHL1;MAPK4;DCLK1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3971759425741611,0.9626182297541616,0.46938775510204084,1.0,1.0,31/170,13.64%,CD151;SEMA3C;FAM83H;SPHK1;NTF3;SEMA5A;TRIP6;ITGAX;SEMA6D;CSF1;CASS4;CAVIN1;ARHGEF39;EGFR;TGFBR1;CSF1R;PPP3CA;TWIST1;CCL5;FER;LAMC2;PDGFRB;IGF1R;EDN1;PRKCA;CDH13;PDGFD;BCAR1;CXCL12;HGF;MDK
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5217274322200867,-0.9625811653898074,0.5686274509803921,1.0,1.0,1/14,2.38%,HCK
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6237165423097768,0.9624304490941215,0.6170212765957447,1.0,1.0,1/5,15.00%,PLEKHM1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.4368910554224296,0.9622435095142526,0.5333333333333333,1.0,1.0,3/29,6.30%,B4GALNT2;UBE2J1;OSTC
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.46882780501082316,-0.9622422342181866,0.5283018867924528,1.0,1.0,7/36,14.43%,SFRP1;RAC1;TPM1;SYNPO2L;EPHA1;SERPINF2;APOA1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6078912201532096,0.9622145289952898,0.5818181818181818,1.0,1.0,2/6,12.25%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5106944910664923,0.9620350296708315,0.46,1.0,1.0,5/21,11.37%,IRS1;PRKD1;FGFR3;PDGFRB;EPHA8
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4597587754234497,0.9618000207460755,0.5094339622641509,1.0,1.0,3/25,7.48%,INF2;RALA;MCU
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.48547286573097737,0.9617689974762362,0.5,1.0,1.0,6/27,14.69%,IFI16;FHIT;ZNF385B;PPP1R13B;BOK;TP53BP2
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.4337139843962322,0.9616519293003769,0.5185185185185185,1.0,1.0,8/61,13.34%,DDIT4;PKHD1;MINAR1;DYRK3;HDAC3;SIRT1;PIK3CA;SH3BP4
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.38767738911764393,0.9614047506582226,0.42592592592592593,1.0,1.0,24/111,22.39%,LRP1B;SLC22A2;SLC6A13;SLC25A48;SLC19A2;SLC15A2;SLC23A1;ARRDC3;ABCC2;EDN1;SLC7A2;ABCG2;SLC38A2;SLC6A4;SLC12A2;CBLIF;CHMP1A;SLC16A10;SLC43A1;SLC7A9;SLC7A14;SLC38A3;TCN2;CUBN
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.44341008967034135,-0.9612770173309163,0.5333333333333333,1.0,1.0,3/22,14.03%,CMTR1;METTL3;TRMT10C
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.4041668222809311,0.96103667184406,0.5384615384615384,1.0,1.0,24/92,15.04%,PTPRK;SMAD7;NLK;WNT5A;WWOX;PARD3;TGFBR1;TWSG1;NR3C1;SMAD5;SMAD1;BMPR1A;SOX5;SMAD2;PDE2A;SMAD9;ZFP36L2;PDE3A;SIRT1;SMAD3;SMURF1;ACVR1;GDF10;MEF2C
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.4634302118194386,0.960854553135186,0.5,1.0,1.0,9/26,16.83%,RUNX1;SULF1;RUNX2;FGFR3;EIF2AK3;SOX5;SCX;MEF2C;NFIB
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.42799472803175503,0.9608317786223073,0.46153846153846156,1.0,1.0,17/69,16.10%,IFI16;RUNX1;SELPLG;FGFR2;WNT5A;RUNX2;CSF1R;MEIS1;TOX;JAG1;DLL1;ZFP36L2;FST;ETV6;TET2;TGFBR3;MELK
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.5555675810821076,0.9606882097018952,0.5111111111111111,1.0,1.0,1/14,1.16%,IFI16
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.5141071541377533,0.9606110501931874,0.5,1.0,1.0,3/15,19.20%,TGFBR1;SMAD2;GRAMD1C
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.41239301154254676,0.9602778481777834,0.49056603773584906,1.0,1.0,11/85,13.78%,U2AF1;PPARGC1A;DXO;NUDT16L1;ERN1;ZFP36;RIDA;PCBP2;ZFP36L2;PCF11;HSPA1A
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.5723339643336399,0.9601218324462378,0.5660377358490566,1.0,1.0,5/12,28.58%,SYNE4;RAP2A;RAB10;CAMSAP3;OPHN1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.632648412205577,0.9600186812930943,0.6086956521739131,1.0,1.0,3/5,33.88%,PROX1;BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.6094525943956643,-0.9599593218909389,0.5185185185185185,1.0,1.0,1/8,2.04%,FGF1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.5052064540985932,-0.9591710081418634,0.5319148936170213,1.0,1.0,4/18,9.92%,TXK;CDC37;PARP14;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4949418939065125,-0.9589991436783102,0.5121951219512195,1.0,1.0,4/23,5.66%,TERF2IP;H1-4;H1-0;ERCC1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5796332657735416,0.9589091997447889,0.5434782608695652,1.0,1.0,2/12,8.10%,B4GALNT2;UAP1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4719937349789909,0.9588432828142656,0.5333333333333333,1.0,1.0,8/23,23.28%,ADIPOR2;PRKAB2;ADIPOR1;NR1H3;ACADVL;PDK4;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.47883685130148457,-0.9587857738677147,0.4642857142857143,1.0,1.0,6/23,18.86%,AZGP1;B2M;HLA-DRA;ZP3;FZD5;IL12A
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.5348730058499299,0.9587793683985932,0.5348837209302325,1.0,1.0,2/10,10.48%,H3-3A;ASF1A
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.47010067078760986,0.958558402272463,0.43137254901960786,1.0,1.0,5/23,8.91%,NEDD4;IL1RAPL1;ABHD17B;WNT5A;CTNNA2
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.46353708172404595,-0.9583843221413454,0.4423076923076923,1.0,1.0,7/34,16.42%,ANKLE2;PPP1R15A;PTPA;CALM1;PIN1;YWHAB;CALM3
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.46722728645414613,-0.9581890798467597,0.54,1.0,1.0,11/28,24.97%,TOMM40;TIMM17B;TOMM20;TIMM17A;PEX1;TIMM50;TIMM44;TOMM40L;HSPD1;PEX10;PEX7
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4566301555613484,0.9580261248263494,0.4782608695652174,1.0,1.0,13/48,13.15%,HMCN1;DSCAM;NECTIN3;ROBO1;CNTN4;ROBO2;CDH2;CADM1;CDH13;TENM3;PTPRM;NPTN;EMB
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.6487778257660581,-0.9580146131151825,0.6458333333333334,1.0,1.0,2/6,12.93%,RFT1;CPTP
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.5737529971904578,-0.9576951097444235,0.5319148936170213,1.0,1.0,2/7,12.13%,B2M;ATP2A3
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.45313902635743036,-0.9575257071628438,0.5652173913043478,1.0,1.0,2/44,4.20%,SFRP1;ADAMTS12
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.4072927001374201,0.9574332297373718,0.525,1.0,1.0,15/76,13.17%,MXRA5;LDB2;PRRX1;GFAP;POSTN;SULF1;ADAMTSL1;FBXL7;PRKG1;PDGFRB;FLNC;ACTA2;TIMP3;COL5A2;CXCL12
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.38565924730612117,-0.9573856630470439,0.5098039215686274,1.0,1.0,34/135,20.59%,AURKA;INCENP;ABRAXAS1;SBDS;GOLGA2;ZWILCH;ERCC6L;KIF4A;SPDL1;STMN1;PTPA;PLK2;WRAP73;SPC25;NUP133;NUP43;CENPH;CENPE;TOGARAM2;ITGB3BP;RPS27;EFHC2;KIF23;TUBG1;KIF4B;RAB11A;CKAP5;NUDC;GPSM2;TPX2;SGO2;TUBG2;NUP85;KIF11
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.4494108597862458,0.9572857335318569,0.5306122448979592,1.0,1.0,6/36,11.88%,NEDD4;ADGRB3;TNIK;CSMD3;COBL;RAP2A
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.43924129930120964,-0.9571010339411054,0.4716981132075472,1.0,1.0,20/78,25.28%,ARF3;COPE;KIF4A;KDELR1;KIF5A;COPG2;CENPE;ARF5;KIF23;KIF4B;RER1;KDELR3;KIF11;ATP9B;KLC1;COG4;USE1;KIF1C;RAB1B;ARCN1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.513449980355805,-0.9569253824121124,0.5344827586206896,1.0,1.0,3/16,16.08%,SERPINE1;CERS2;RTN4R
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.45921790634074355,-0.9566632548528358,0.5581395348837209,1.0,1.0,11/39,20.95%,SH3RF2;GMIP;ZCCHC9;PPP1R35;CSTB;RRP1B;CAMK2A;ATP5IF1;GCHFR;CST3;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.47830790305360793,0.9565649682086583,0.6046511627906976,1.0,1.0,3/22,8.55%,PPARG;HMGB1;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.42390567798526413,0.9564448296593353,0.46511627906976744,1.0,1.0,15/57,21.12%,HMGB1;EGFR;OTUD4;TOX;PDGFRB;FGF10;SIRT1;HGF;PPP1R10;PDGFB;EYA2;MECP2;EYA3;BABAM2;TMEM161A
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.49928273740997753,-0.9559189757591278,0.5957446808510638,1.0,1.0,1/25,1.32%,NUPR1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.6025773461777667,0.9553678815223521,0.5769230769230769,1.0,1.0,3/9,12.82%,TOX;ADAM8;CAMK4
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),-0.6120888739742951,-0.955090150373793,0.627906976744186,1.0,1.0,3/5,34.74%,EREG;FOXO4;ID2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5038324475001663,0.9549355811537406,0.5892857142857143,1.0,1.0,4/16,5.44%,PPEF2;SMAD7;DDIT4;PARD3
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.5478385014560705,-0.9548249044747056,0.5227272727272727,1.0,1.0,6/15,16.80%,FABP5;FABP6;LIPC;LIPI;PNPLA1;FABP7
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3652276525518848,-0.9545053801540726,0.5,1.0,1.0,46/266,18.01%,PARP2;BACH1;XPC;RAD51AP1;ABRAXAS1;FANCI;REXO4;DTX3L;SLX4;ALKBH2;GADD45A;ERCC1;UBC;RNF8;XRCC1;PWWP3A;FANCC;GTF2H2;CENPX;CETN2;KPNA2;MDC1;XRCC2;NUDT1;CHEK1;DDB1;TICRR;SMUG1;FANCG;HUS1;POLL;NUCKS1;RPAIN;INO80;PARP1;ERCC2;MUS81;XRCC3;SMARCA5;USP1;MBD4;RECQL;FBXO6;FANCM;APEX1;ZRANB3
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5553194811400279,0.9541843562343543,0.5517241379310345,1.0,1.0,2/9,8.55%,RPS6KA4;TWIST1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.4519274843867054,0.9539272208961639,0.5283018867924528,1.0,1.0,6/37,10.27%,SLC30A8;IRS2;ERN1;ZBTB20;LPL;IGF1R
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5907591664630915,-0.9538832663980052,0.5555555555555556,1.0,1.0,3/8,21.10%,NR1H4;PRMT7;COPRS
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.393875079616794,-0.9536630273491512,0.4642857142857143,1.0,1.0,50/110,25.23%,XPC;PSMA7;PSMD7;UBC;DAXX;PSMB4;RBX1;GTF2H2;PSMC3;MCM5;CETN2;ORC3;HMGB2;CHAF1A;PSMD8;ORC1;PSME1;DDB1;MCM2;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PARP1;PSMA1;ERCC2;SMARCA5;PSMD10;MACROH2A1;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;RPA3;PADI4;MCM4;ORC2;CDC6;PSMA5;UBB;NPM1;PSMB1;PSMB6;ORC6;CHAF1B;PSMD3;DDB2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6490128164742395,-0.953618984874922,0.6862745098039216,1.0,1.0,4/5,29.05%,CPSF3;SLBP;CPSF2;LSM11
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.5965963424460051,0.9534344680908557,0.5106382978723404,1.0,1.0,1/7,5.79%,RAB29
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.5589145990150518,-0.9533964413898147,0.5849056603773585,1.0,1.0,1/9,6.19%,MBTPS2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.36958996354243406,-0.953327944699399,0.5882352941176471,1.0,1.0,33/275,13.66%,TEKT3;PLK4;RILP;HAUS8;TEKT5;KIF17;RAB17;CFAP221;UBXN10;DCTN1;AHI1;TXNDC15;SSNA1;ATP6V1D;CETN2;CFAP52;PRKACA;RSPH4A;CFAP46;TUBB4B;IFT27;BBOF1;TRAPPC14;DZIP1L;TCTN1;TRAF3IP1;B9D1;EHD4;TBC1D32;ODF2;UNC119B;IFT22;DYNLRB1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.4486851595716664,0.9530684365369042,0.5166666666666667,1.0,1.0,6/35,13.88%,SPHK1;ZDHHC14;FOXO1;ZDHHC2;HHAT;EP300
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.451674209792312,0.952840020876251,0.46,1.0,1.0,3/39,3.19%,PLA2G10;PLD6;ABHD4
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.5936598252652951,0.9527587923680415,0.6346153846153846,1.0,1.0,4/5,28.66%,CHD7;SALL1;ERBB3;CHRNB2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.4951546365867395,-0.9525388339894836,0.5581395348837209,1.0,1.0,4/25,9.59%,KIF25;KNSTRN;SMC4;WRAP73
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5015612158484845,0.9525151153624696,0.5471698113207547,1.0,1.0,3/13,15.04%,PLCB1;RANBP3L;MEF2C
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4120528020845367,0.9524586081070654,0.5434782608695652,1.0,1.0,2/64,2.83%,VAPB;BET1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.3965674490420661,0.9523888530638369,0.5476190476190477,1.0,1.0,24/142,13.87%,STK26;MAP3K11;DAPK2;ERBB4;FGFR2;EGFR;TNIK;CSF1R;ERN1;PRKD1;FGFR3;EIF2AK3;FER;PDGFRB;IGF1R;DYRK1A;CDK12;EPHA8;FGFR1;ACVR1B;CAMK4;STK33;PIM3;MEX3B
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.6029959043763341,0.9521354961871676,0.5909090909090909,1.0,1.0,1/6,7.03%,NUS1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.6029959043763341,0.9521354961871676,0.5909090909090909,1.0,1.0,1/6,7.03%,NUS1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.5106658682500135,-0.9520761803023197,0.5416666666666666,1.0,1.0,5/17,17.13%,DTX3L;SKP1;RNF8;DDB1;RING1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.5884354000004777,-0.9517868930009098,0.5454545454545454,1.0,1.0,2/7,19.21%,MDH1B;FH
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.6470113805676198,-0.951429413034926,0.6666666666666666,1.0,1.0,1/6,0.75%,GUCY2C
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.5227130950976444,0.9512401982663133,0.5535714285714286,1.0,1.0,2/21,4.78%,GDAP1;PEX11A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.5508361801024586,-0.9510841203335036,0.5094339622641509,1.0,1.0,1/14,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.5238234637251314,0.9505041522047853,0.5531914893617021,1.0,1.0,4/17,15.89%,RUNX1;WNT5A;LIFR;ELF1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.6126373852478874,-0.9502059508875119,0.5098039215686274,1.0,1.0,1/5,24.49%,NPM1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.5176434714621088,-0.9501766997118685,0.4909090909090909,1.0,1.0,6/16,16.44%,CLU;IFI6;BAK1;DNM1L;FIS1;TIMM50
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.473138696356592,0.950103047403227,0.5,1.0,1.0,6/33,12.25%,MAGI2;PKHD1;MSTN;PHLPP2;PHLPP1;SIRT1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5995014985316813,0.9498705835456316,0.6326530612244898,1.0,1.0,6/10,21.43%,SDHAF3;FBP1;OGT;ZNF692;PDK2;GNMT
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.5344796655420998,-0.9494627337289064,0.5178571428571429,1.0,1.0,6/11,28.98%,D2HGDH;GOT2;L2HGDH;GPT2;AADAT;PHYH
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.45013667859018347,0.9492579142463081,0.45098039215686275,1.0,1.0,8/39,10.95%,CERS3;FGFR2;CCN2;ACER1;SCEL;HDAC2;LAMC2;DLL1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4731308283921468,0.9489593814882812,0.5208333333333334,1.0,1.0,5/35,11.52%,MYBPC3;FGF10;SETMAR;TOR1AIP2;DNAJB2
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.5432559789581433,0.9489019681184808,0.6153846153846154,1.0,1.0,2/8,8.84%,SULF1;TBC1D8B
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5143359232015741,0.9485167871119741,0.5555555555555556,1.0,1.0,5/17,19.35%,SLC8A1;CACNB2;ANK2;KCNJ2;ATP1A2
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.6150537673849716,-0.9484841816644815,0.6545454545454545,1.0,1.0,2/5,10.53%,SLC51A;DRD3
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4516978392486897,0.948414031862994,0.5416666666666666,1.0,1.0,5/35,13.67%,TRPV2;SLC8A1;ATP2B4;ITPR1;SLC24A2
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5099834135569804,0.9483799593941026,0.5434782608695652,1.0,1.0,5/17,17.08%,TAFA1;TOX;DISP3;MDK;PROX1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.5569943019481466,-0.948202807875539,0.58,1.0,1.0,4/9,19.72%,DCTN1;RANGRF;CKAP5;EML2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.571378828216575,-0.9480820775450058,0.56,1.0,1.0,4/13,13.62%,MYH14;DNM1L;FIS1;SUPV3L1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.5022721655105271,0.9480744204089574,0.5106382978723404,1.0,1.0,4/11,26.66%,SLCO4A1;SLCO2B1;SLCO1C1;SLCO6A1
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.6549058048223276,0.9476961889392693,0.6666666666666666,1.0,1.0,3/5,18.34%,VEGFC;VEGFD;VEGFA
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.4405437183876486,0.9475831670259416,0.5333333333333333,1.0,1.0,3/28,6.30%,B4GALNT2;UBE2J1;OSTC
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4458710285396229,-0.9475087682529679,0.49056603773584906,1.0,1.0,2/53,3.95%,TLCD2;RBP1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.44690247781988046,-0.947178145231138,0.4583333333333333,1.0,1.0,11/41,19.52%,TXNRD2;ATOX1;PRDX1;PTPA;TXN;SELENOS;GLRX2;NDUFS2;ERCC2;SBNO2;SOD1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6092586629635963,-0.9470346982150504,0.5319148936170213,1.0,1.0,2/7,8.86%,ATG14;CALM1
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.6305719547087706,0.9470240727742543,0.6166666666666667,1.0,1.0,2/5,18.34%,TGFBR1;VEGFA
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.5794070914196859,0.9469176056957298,0.66,1.0,1.0,3/8,19.95%,HDAC9;SIRT1;HDAC10
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5071527443041683,0.9468327737531972,0.56,1.0,1.0,3/17,4.17%,MYBPC3;FGFR2;SMAD7
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.40038661985140145,-0.9467937008546486,0.5384615384615384,1.0,1.0,17/84,13.88%,STING1;NLRP1;APOBEC3H;CGAS;RNASE1;OAS3;IFI6;IFIT1;IFI27;OAS2;PTPRC;AZU1;STAT2;NLRP9;ISG15;RSAD2;EXOSC4
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.46841680551367504,-0.9467721541561628,0.5490196078431373,1.0,1.0,1/20,3.00%,RILP
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.3758526156381323,-0.946698674360239,0.5106382978723404,1.0,1.0,17/109,14.41%,NCKAP1L;INHA;LDB1;ATG14;ANKLE2;ITGA6;GLMN;CD24;KDM4D;NUP133;NUP43;STAT2;CDKN2B;PRKRIP1;PIN1;EREG;EIF6
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.44726993803320236,-0.9465738317041961,0.5660377358490566,1.0,1.0,12/50,8.38%,CLDN4;CBLC;TMEM184A;AZGP1;RAB17;ANO1;GPR39;MYH14;CLDN1;SLC3A1;AMBP;BTC
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5344063585091556,0.9465528634971558,0.54,1.0,1.0,3/14,9.45%,NXF1;NXF5;C12ORF50
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.5413155039227454,0.946536292696066,0.6170212765957447,1.0,1.0,1/10,9.88%,SOX5
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4508696386741361,-0.9463344692113339,0.5106382978723404,1.0,1.0,12/35,28.51%,TOMM20;NUP133;NUP43;XPOT;NUP155;NUP85;RAN;NUP214;YBX1;SEC13;NUP50;TPR
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.48028539531043724,-0.9462963035675545,0.4888888888888889,1.0,1.0,2/17,4.50%,CGAS;PARPBP
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.4239539131799157,0.9462768566958426,0.4,1.0,1.0,14/41,18.72%,ENPP1;ADGRV1;SLC8A1;ACVR2A;TWIST1;BMPR1A;GPM6B;BCOR;P2RX7;ACVR1;MEF2C;BMP6;ECM1;ANKH
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5107347601584458,0.9462766928814975,0.58,1.0,1.0,2/18,3.96%,LOXL2;ZNF706
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.4000839029936925,0.9462175881551206,0.5283018867924528,1.0,1.0,34/117,16.57%,GUCY1A2;LSAMP;SEMA6D;DOC2B;NRXN1;ADGRB3;UNC5D;PCDH17;KCTD16;GRIA4;PTPRD;FAM171B;ELAVL4;RAB3C;CNTN1;SYNPR;RBFOX1;ASXL3;NPY;LRP4;LIFR;ASIC2;TTLL7;ANK2;RGS7BP;P2RY1;ERC2;GRIA2;CSRNP3;PLAT;PCLO;MAP2;SLC12A2;MAPK4
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.3520996598610965,0.946001846252915,0.5849056603773585,1.0,1.0,41/347,12.82%,STK26;SGK3;SGK2;MAP3K11;LTK;SPHK1;NUAK2;DAPK2;FRK;SYK;NLK;TGFBR1;RPS6KA4;TNIK;ACVR2A;LATS1;ERN1;PRKD1;LIMK2;DYRK3;RYK;CDK6;PXK;EIF2AK3;EPHA7;PRKG1;SGK1;BMPR1A;PRKACB;FER;PRKCA;DYRK1A;STK36;CDK12;FGFR1;PLK1;DYRK2;ACVR1B;NIM1K;PIK3CA;CAMK4
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5006429251293217,-0.9459098165654041,0.6595744680851063,1.0,1.0,4/30,13.48%,PLK3;PLK5;CDKN2B;BRD7
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.4701256118601539,0.9458208943463007,0.5116279069767442,1.0,1.0,7/16,23.92%,COBL;ARID5B;TGFBR3;PROX1;NIPBL;CEBPG;PKD2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.5678662797981223,-0.9456840018206628,0.6,1.0,1.0,1/11,4.58%,TSPYL2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.5412314237240452,0.9455951275628025,0.5555555555555556,1.0,1.0,2/9,6.54%,GABRB1;GABRB2
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.5880043680726251,0.9455263376776929,0.5217391304347826,1.0,1.0,3/6,28.24%,SOX5;SOX6;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.5343935175569602,0.9453458633092063,0.5178571428571429,1.0,1.0,4/14,11.39%,HSPB1;SEMA5A;PRKD1;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4042360808437137,-0.945322661540366,0.5737704918032787,1.0,1.0,9/80,13.51%,TYMS;CLU;NCL;RBM4;ILF3;ZNF540;PATL2;RACK1;PIN1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.4437873120649165,-0.9450410800384493,0.52,1.0,1.0,10/38,21.49%,GTF2F1;POLR2I;POLR2J;SUPT5H;CCNT1;POLR2G;POLR2C;NELFA;POLR2L;POLR2K
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4596489808619842,0.9445692335193597,0.48214285714285715,1.0,1.0,10/22,21.43%,PPARGC1A;SDHAF3;SIRT1;EP300;FBP1;OGT;CRY1;ZNF692;PDK2;GNMT
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.4048874488280755,-0.9441758190224098,0.5849056603773585,1.0,1.0,12/97,13.68%,SFRP1;CCN3;OSTN;TSPYL2;TCHP;CDHR2;BTG1;STK11;RACK1;PPT1;ENO1;HNF4A
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.3900238461824802,0.9441275123750599,0.5531914893617021,1.0,1.0,12/74,7.78%,ENPEP;SGK2;GLYAT;SLC5A12;PKHD1;SLC22A6;OIT3;CYP3A4;C6;SLC5A8;ABCC2;SLC7A13
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.5488076738597734,-0.9438596831676882,0.5294117647058824,1.0,1.0,5/10,20.35%,CALM1;PRKG2;PTS;GCHFR;NOS3
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.40372350833041815,0.9436710856062971,0.5217391304347826,1.0,1.0,19/102,14.00%,CALCR;ACKR2;CX3CR1;CHRNA10;HMGB1;ACKR3;SLC8A1;WNT5A;ATP2B4;TBXA2R;PTGFR;ABL2;PLCE1;EDN1;TRPC4;NPTN;KNG1;SMAD3;P2RY1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.48686563173600206,-0.9435930664985726,0.6181818181818182,1.0,1.0,6/18,26.60%,ADAM19;HM13;RBMX;NCSTN;ADAM17;ADAM9
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.6110588630407989,0.9434614895114602,0.6190476190476191,1.0,1.0,2/6,10.11%,MAGI2;JAG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6110588630407989,0.9434614895114602,0.6190476190476191,1.0,1.0,2/6,10.11%,MAGI2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.459151691787478,0.9434082610290822,0.44680851063829785,1.0,1.0,6/41,16.09%,NEDD4;ECT2;UBR5;HDAC3;SMAD3;PIK3R1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.6118049478331419,-0.9429163852664503,0.6458333333333334,1.0,1.0,2/5,28.59%,SFSWAP;SNRPC
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.5909991609081068,0.9429095263877477,0.5227272727272727,1.0,1.0,1/5,5.06%,DMC1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4869331102988184,0.9425570074437236,0.45454545454545453,1.0,1.0,11/21,22.06%,RUNX2;SMAD5;HIF1A;SMAD1;SMAD9;EP300;RELA;VEGFA;SMAD4;NFE2L2;CREB3
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5307018697631529,0.9425537206647873,0.5510204081632653,1.0,1.0,7/18,15.04%,PDE4B;PPM1E;CRHBP;RAP2A;AIM2;FBP1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.45586727048071846,0.9420010337473903,0.5102040816326531,1.0,1.0,10/35,14.18%,IFI16;HSPB1;HMGB1;S100A13;WNT5A;AGER;LPL;P2RX7;IL16;AIM2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.5525720524974196,0.9416028565690644,0.6,1.0,1.0,3/10,21.93%,RAB34;CLN3;PIKFYVE
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5147096414270985,0.9415903219321411,0.5102040816326531,1.0,1.0,3/10,14.98%,UBE2J1;YOD1;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.4684504956210318,-0.941407353143595,0.5813953488372093,1.0,1.0,4/25,9.71%,DND1;VIP;PKP1;CIRBP
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5112899215854672,0.9413305657258924,0.5490196078431373,1.0,1.0,7/15,24.44%,NEDD4;TCAF2;NEDD4L;HECW2;CAV3;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.35800310841906624,-0.9411258168697788,0.5636363636363636,1.0,1.0,96/338,22.77%,SARS1;F5;ABCF1;SPG7;UBE2L6;WARS1;PAPPA;CKAP4;TTF1;D2HGDH;GPC3;ST8SIA2;MRPL23;RPLP1;RPL28;PHEX;IGFBP2;MXRA8;NOTUM;SDC2;IGFBP4;SCG3;IGFBP3;UBE2M;MRPS18B;CHGB;RPL37A;RPL34;VWA1;MRPL55;RPS15;RPL4;NUCB1;RPS8;RPL12;RPL31;RPL8;CALU;RPL19;VGF;PROC;RPS27;MRPS18C;RPL23;MRPL9;MRPS21;PRSS23;APH1B;APOA1;MRPL27;RPL7A;MRPL51;RPL29;ARAF;HM13;PABPC4;CTSH;RPS24;RPL5;RPN1;AFG3L2;RPL13;RPL6;RPL37;RPL24;RPL38;RAB12;RPS25;FBXO2;RPLP2;ST3GAL1;RPS4Y1;L2HGDH;SPCS1;MRPS33;RRBP1;RPS20;RPS3;CST3;MRPL37;EIF4G1;RPL35A;RPL11;RPL10A;SCG2;LTBP1;MSRB2;UBL5;MRPS11;PADI4;PCMT1;RPL18;RPS14;SEC11C;APLP2;RPS4X
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.45784342796320543,0.9410410371717667,0.5254237288135594,1.0,1.0,13/30,12.84%,FAT4;IL1RAPL1;NLGN1;HMCN1;NECTIN3;TENM2;GRID2;PTPRD;CBLN1;CRB2;CADM1;TENM3;TENM1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5540788246376434,-0.9409751176309463,0.6190476190476191,1.0,1.0,6/11,29.31%,EXOSC10;EXOSC4;FBL;LARP7;EXOSC6;DKC1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.5354660375285829,-0.9409576781561548,0.5714285714285714,1.0,1.0,1/13,2.04%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.5542494125814493,0.9409402852822961,0.6304347826086957,1.0,1.0,2/10,12.69%,WNT5A;CRLF2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.5225625624229687,-0.9405062977780748,0.5714285714285714,1.0,1.0,5/13,22.31%,AASS;CHTOP;NNMT;CTR9;PAF1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.4618443928102471,-0.9403545917262873,0.54,1.0,1.0,4/44,6.74%,GPC2;LCP1;GPC1;GPC3
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.5515692415716262,0.9401959694689018,0.5961538461538461,1.0,1.0,1/9,0.45%,NOX5
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.4427904584046544,0.9399425807062698,0.5185185185185185,1.0,1.0,5/39,10.82%,NEDD4;UBE2E2;PELI1;RNF135;UBE2E3
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.5670640842709284,0.9396379080665272,0.6326530612244898,1.0,1.0,2/7,15.39%,ANK2;KCNA5
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5896959777073651,-0.9394498153487598,0.5964912280701754,1.0,1.0,1/8,4.67%,KIF20B
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3429013405734172,0.9394383370277862,0.6136363636363636,1.0,1.0,65/436,14.44%,DACH1;LOXL2;IFI16;NRG1;ZFPM2;NAB1;NFIL3;PLCB1;ENPP1;PPARG;PTPRK;ATOH8;ZNF706;MTERF3;ZEB1;BAHD1;WNT5A;GLIS2;TSHZ3;RUNX2;TP63;RFX3;HEY1;SP3;HDAC9;FOXP2;KCTD1;NR3C1;SYNCRIP;ATXN1;CTBP2;RIDA;NR1D2;HDAC2;TWIST1;HINFP;HDAC3;GLI3;EIF2AK3;SOX7;PHC2;BCOR;TLE1;FOXO1;SPINDOC;SMAD2;ARID5B;POU2F1;SMURF2;SIRT1;CTNNB1;BTRC;PRICKLE1;NPAS1;RNF139;ID3;EPC1;HIC2;BTG2;FOXN3;YAF2;DPF3;RELA;NACC2;CD38
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.41685849675215836,-0.9391493497660036,0.5357142857142857,1.0,1.0,7/50,5.73%,CLDN4;TMEM184A;SERPINE1;CD4;LTBR;MAFF;ADAM19
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.46283455639733967,0.9390584529258839,0.5490196078431373,1.0,1.0,8/48,11.15%,NFIL3;LEPR;PBX1;HDAC9;BLNK;TOX;TPD52;CHD7
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.5414636772788487,-0.9390538712078295,0.5471698113207547,1.0,1.0,3/9,13.18%,PBLD;RBP4;VSIG1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4810419150121604,-0.9389318036224131,0.5306122448979592,1.0,1.0,6/23,17.69%,SLX4;EXOSC10;STN1;PARP1;NAT10;SRC
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.612500460976867,0.9388086653190487,0.6538461538461539,1.0,1.0,1/6,14.78%,MPST
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.3814418578557764,-0.9387360672332902,0.5576923076923077,1.0,1.0,15/125,11.37%,TAGLN;FGF1;NTRK1;APOD;GFRA3;MPZ;PCDHB4;ID4;CMTM5;STMN1;CRYAB;NRN1;TCEAL6;SCN4B;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5187479326944121,0.9387184244086632,0.5344827586206896,1.0,1.0,9/17,27.49%,SYT1;RIMS2;SMURF1;SYT2;NEDD4L;SYT17;SYT4;RASAL1;ITSN2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3968123812345232,0.9387060870652503,0.4473684210526316,1.0,1.0,26/122,21.03%,GRAP2;RIT2;RALA;CCNA2;RHOB;CNKSR1;PRKD1;PLCE1;CDH13;RAP2A;GNA13;RASSF1;ARHGAP5;ADGRG1;ROPN1B;PHACTR4;RAPGEF6;RGL2;EPS8;RAP1A;ROCK2;SOS1;ARHGEF3;RIT1;RRAS2;WASF1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5053567323233477,-0.9384863867642079,0.5490196078431373,1.0,1.0,4/20,14.91%,HK2;G6PC3;PGLS;DERA
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.582426874901554,0.9380756434859068,0.6206896551724138,1.0,1.0,4/8,20.10%,AGER;PICALM;ROCK2;EPHA4
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5302619547869074,-0.9376397781101703,0.5454545454545454,1.0,1.0,1/11,2.48%,APOD
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.6585497221486252,0.9375497314954738,0.58,1.0,1.0,1/5,3.10%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.6585497221486252,0.9375497314954738,0.58,1.0,1.0,1/5,3.10%,SLC22A2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5075449310074264,-0.9373967181584985,0.5106382978723404,1.0,1.0,2/20,3.92%,CLU;M6PR
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.5750251570254133,-0.9373725401892888,0.5961538461538461,1.0,1.0,1/6,2.04%,NOG
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.5505922038117149,0.937286562302608,0.5416666666666666,1.0,1.0,2/7,8.82%,IRS2;CCL5
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.38988985640934337,0.9372312287808588,0.5423728813559322,1.0,1.0,35/170,16.09%,SGK3;SGK2;SPHK1;ENPP1;NRG3;CHPT1;EGFR;SLIT2;TGFBR1;KIF26A;H3-3A;MINAR1;PSRC1;CDKN2AIP;SERTAD2;SGK1;SOCS2;PLCE1;DNAJB2;IP6K2;SIRT1;ING1;BCAR1;ACVR1B;SH3BP4;AKAP6;HSPA1A;SMAD3;ADNP2;BCL2;FBP1;OSGIN2;TMEM97;URI1;DACT3
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5330377588347001,0.9372280445017065,0.5384615384615384,1.0,1.0,1/15,1.87%,GDAP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.42598022057413304,-0.9371205660308755,0.58,1.0,1.0,9/79,8.93%,HLA-DPB1;RILP;CD74;DCTN1;KIF4A;HLA-DRA;AP1S1;ARF1;KIF5A
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.38970748979850445,-0.9369743873076899,0.5483870967741935,1.0,1.0,21/97,13.24%,CLDN4;CBLC;TMEM184A;F5;INCENP;EMILIN2;ST6GAL1;KIF20B;SCGB1A1;DLX5;SELENBP1;CLDN1;CKAP2;HIRIP3;CD24;STAP2;CRYBA1;ATP2C2;CEACAM1;NRP2;IL1R1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.5724428117287831,-0.9363701895666252,0.5686274509803921,1.0,1.0,6/8,41.45%,RIOX1;KDM5C;KDM5D;KDM1A;KDM1B;RIOX2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.5360794889750637,-0.9363473750625455,0.5283018867924528,1.0,1.0,1/13,1.86%,MYB
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4502754158763061,0.9362808455326029,0.5238095238095238,1.0,1.0,7/29,17.72%,CSGALNACT1;HS3ST3B1;UGDH;EXT1;CSGALNACT2;GAL3ST3;CHST11
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.39861765944424316,0.9360469912003305,0.5636363636363636,1.0,1.0,32/135,13.89%,LRIG3;FZD1;ARHGAP42;PRTG;L1TD1;ROR1;PARD3;TEAD2;FBLIM1;SMAD5;PTPRG;COL4A6;EPCAM;SMAD1;GULP1;PTPN14;IL17RD;CD59;SMAD2;SMAD9;ADGRL2;TENM3;LRP4;CTNNB1;LIFR;YES1;GJC1;SH3BP4;ABCG2;ENAH;FNBP1L;SMAD3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.5143964915832181,-0.9359902820670607,0.5306122448979592,1.0,1.0,3/15,12.36%,JADE2;KANSL1;MEAF6
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.5143964915832181,-0.9359902820670607,0.5306122448979592,1.0,1.0,3/15,12.36%,JADE2;KANSL1;MEAF6
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.36710883440347725,0.935758675535257,0.5306122448979592,1.0,1.0,34/198,11.23%,NLRP2B;SHISA2;NEDD4;IRS1;KANK1;CXXC4;ENPP1;CX3CR1;MOSMO;PIP4K2A;EGFR;DDIT4;NLK;SULF1;GLIS2;WWOX;OTUD4;KIF26A;HEY1;SNCA;KCTD21;TULP3;RGS14;CBLN1;CCL5;GLI3;ASAH2;NLGN4X;NCK1;TSPAN15;TLE1;CRHBP;DLL1;NOTCH3
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.4687839043647299,-0.9355331936425353,0.46,1.0,1.0,2/27,2.44%,CLU;C2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.46368803457770824,0.9355195762389276,0.5813953488372093,1.0,1.0,11/38,20.90%,KLF2;CHMP6;SPOP;LDLR;ODC1;ZDHHC2;MAPK8;NEDD4L;ROCK2;MDM2;SPOPL
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4912708553448709,0.9353287460944721,0.5576923076923077,1.0,1.0,4/11,16.09%,ERN1;ATF6;BOK;PIK3R1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.48826693992657694,0.935261894722764,0.5,1.0,1.0,5/15,24.68%,SMAD7;NEDD4L;CAV3;CAMK2D;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5610024906044148,0.9352152115968129,0.5925925925925926,1.0,1.0,2/9,20.80%,IGF1R;INSR
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.47706760677182886,-0.9351665786855156,0.6046511627906976,1.0,1.0,5/22,14.95%,NCAPH;SMC4;AKAP8L;NCAPD3;NCAPD2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.5496157988471078,-0.934546886431233,0.5833333333333334,1.0,1.0,2/9,13.42%,LGSN;NIT2
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.49404103423928813,-0.934361604735537,0.49056603773584906,1.0,1.0,3/18,4.27%,STING1;CGAS;DTX3L
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.6057077732293671,-0.9342887063533208,0.5714285714285714,1.0,1.0,2/5,29.44%,HDAC6;TRIM37
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.5688608135347375,0.9342664053853346,0.5813953488372093,1.0,1.0,1/7,6.05%,SLC15A2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.34066122195883325,-0.9342173223019054,0.6274509803921569,1.0,1.0,32/282,10.34%,TCHH;LOXL4;TPPP3;MYO15A;COL6A1;PLK3;MARCKS;COL4A3;RAC1;COL6A2;RND3;TNXB;COL9A1;TPM1;B2M;UBE2L6;TUBGCP5;ACTC1;DCTN1;TPM4;LOXL1;ITGA6;UBC;STMN1;ERMN;COL18A1;TUBGCP2;MYO7B;COL28A1;RND2;RHOBTB1;CYP1B1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.5618281302705099,0.934157547374967,0.6538461538461539,1.0,1.0,4/7,34.74%,RUVBL2;RUVBL1;NUFIP1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.5794340442608952,-0.9338320849079751,0.6086956521739131,1.0,1.0,3/7,20.73%,ADAM19;SERPINF2;FLOT1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.39104954124762803,0.9334483735823644,0.5365853658536586,1.0,1.0,12/50,15.99%,ADIPOR2;PPARGC1A;ACSM1;ADIPOR1;PEX2;ECHDC1;PEX13;CYP4V2;ACADVL;ALDH3A2;CPT2;ABCD3
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.41845496559034945,0.9332093660152019,0.4782608695652174,1.0,1.0,7/59,10.49%,PLCB1;UBE2E2;EGFR;CDK6;ANKRD17;FGF10;PTPN6
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.44509638225845677,0.9328722601361099,0.6136363636363636,1.0,1.0,6/44,5.63%,NLRP2B;PPARG;ROBO1;SLIT2;OTUD4;ARG1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.44950201044215143,0.9327040202230571,0.5681818181818182,1.0,1.0,9/31,22.18%,NECTIN3;ANK3;BLZF1;RAB34;KIF13A;AFDN;SPTBN1;RAB10;GGA1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.4961993659443372,-0.9323875450441927,0.575,1.0,1.0,3/21,6.01%,ATXN7L3;DTX3L;RNF8
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5902175984403306,0.9323660234267748,0.5952380952380952,1.0,1.0,2/7,13.49%,SIRT1;LIG4
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.5414314188284526,-0.9321604248004572,0.5454545454545454,1.0,1.0,4/7,26.86%,POLL;POLQ;PMS2;MCM3AP
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.41982299102187765,0.9320792608505906,0.6153846153846154,1.0,1.0,10/40,13.63%,SEMA5A;ACKR2;CX3CR1;ACKR3;NRP1;PDGFRB;DOCK4;BCAR1;CXCL12;HGF
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.5753737008064344,-0.9320661664699192,0.6274509803921569,1.0,1.0,3/7,19.80%,KDELR1;RER1;KDELR3
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.6239255766173563,-0.932009521317031,0.5869565217391305,1.0,1.0,2/5,17.11%,MIDN;GCKR
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.43697131233494857,0.9319632956092105,0.5660377358490566,1.0,1.0,7/30,17.82%,DDIT4;KPTN;MINAR1;SIRT1;SH3BP4;DEPTOR;SESN1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.46225825677384613,-0.9318859927291113,0.5,1.0,1.0,3/28,7.18%,CLU;C2;HLA-DRA
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.5978552428740518,0.9317988577821175,0.6538461538461539,1.0,1.0,2/6,3.32%,BCO1;RLBP1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.5658026726630135,-0.931738101707278,0.5789473684210527,1.0,1.0,3/8,20.27%,TMSB4X;TMSB10;SCIN
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.4529018890079286,0.9316305514442981,0.5925925925925926,1.0,1.0,16/42,24.99%,ZFP36;RIDA;ZFP36L2;BTG2;FTO;CPEB3;MEX3D;NANOS1;ROCK2;TNRC6C;PUM1;ZFP36L1;YTHDF3;CNOT8;CNOT7;TOB1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5159213534025602,0.931389823510588,0.6041666666666666,1.0,1.0,2/18,5.61%,PPARGC1A;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5916916350920904,-0.931207251721772,0.6274509803921569,1.0,1.0,2/5,11.87%,SPI1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3791889256713792,0.9308572474730582,0.6444444444444445,1.0,1.0,33/149,18.98%,TBC1D3L;ARHGAP25;ARHGAP42;NTF3;RGS6;TBC1D12;ECT2;CCL5;TBC1D8B;SNX18;ARHGAP27;DOCK10;CCDC125;RGS7;RABGAP1L;RUNDC1;TIAM2;TBC1D1;GRTP1;PICALM;ARHGAP24;SYDE2;EVI5;TBC1D4;USP6NL;TBC1D5;AFDN;ABR;RAPGEF6;SIPA1L1;LIMS1;RSU1;RAP1A
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.5362436775027559,0.9306438426326686,0.5476190476190477,1.0,1.0,3/15,10.21%,SEMA5A;NRP1;FGF10
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6503810194539592,-0.9303560842852732,0.6585365853658537,1.0,1.0,3/5,30.54%,ATP6V0A2;ATP6AP1;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.4954660029060481,0.9299307644953829,0.5576923076923077,1.0,1.0,11/18,22.38%,RUNX1;SULT2B1;ERRFI1;ZFP36;DLL1;KLF7;ROCK2;CBFB;CTSV;CTSK;ZFP36L1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.47691440098272875,0.9298960969097905,0.4772727272727273,1.0,1.0,3/28,7.51%,NEDD4;RNF128;KPTN
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4602995312988448,0.9298203764192263,0.5454545454545454,1.0,1.0,5/29,9.74%,SLC30A8;DOC2B;IRS2;MCU;ACSL4
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.5066495466902673,-0.9296815565662577,0.5849056603773585,1.0,1.0,6/19,21.65%,CDK5;EIF2B4;EIF2B3;EIF2B2;SHH;EIF2B1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.6047794797825626,-0.9295401552802571,0.62,1.0,1.0,1/6,2.37%,CGAS
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.6155977387397024,0.9293960444626483,0.6538461538461539,1.0,1.0,2/5,7.02%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.6155977387397024,0.9293960444626483,0.6538461538461539,1.0,1.0,2/5,7.02%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),0.5554141857328636,0.9292857563158726,0.5490196078431373,1.0,1.0,2/8,8.37%,ARG1;ODC1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.3940141950128152,-0.9290403316335203,0.5416666666666666,1.0,1.0,9/38,22.40%,CALM1;ACTB;TTBK1;COX6B1;CALM3;FGF9;SEC16A;DYNLL1;INA
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4662603418043344,0.9286914656235399,0.6949152542372882,1.0,1.0,8/27,24.04%,PUS10;SMAD1;SMAD2;SMAD3;HNRNPA2B1;PUM1;TUT7;PRKRA
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.45015376745886676,-0.9284377564468262,0.5294117647058824,1.0,1.0,2/36,2.62%,SERPINB8;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.4445815988605635,-0.9282183262455006,0.46153846153846156,1.0,1.0,9/35,15.73%,APOBEC3H;OAS3;ILF3;IFIT1;OAS2;ISG15;RSAD2;MORC2;IFIT5
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.6164338516329185,0.9279354274156334,0.5769230769230769,1.0,1.0,2/5,12.25%,DGAT2;SIRT1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.4761537263755995,0.9276977853620523,0.5918367346938775,1.0,1.0,3/22,6.93%,PNP;HPRT1;PPAT
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.42565412533776004,0.927631936024956,0.5510204081632653,1.0,1.0,8/77,8.75%,MAP3K11;SPHK1;PLCB1;HMGB1;CCN2;AGER;RELL1;MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.372342659355437,0.9275954647394598,0.5416666666666666,1.0,1.0,38/190,15.04%,LOXL2;PLA2G10;PLCB1;PPARG;CSF1;ZEB1;NEUROD2;CCN2;TGFBR1;RUNX2;TP63;KCTD11;ECT2;ACVR2A;BRINP3;PRKD1;ZFP36;TCF4;TWIST1;RANBP3L;CTNNA2;LPL;CDH2;LMO3;BMPR1A;CRB2;SOX5;SMAD2;FGFR1;ZC4H2;CTNNB1;HGF;MDK;MEF2A;SMAD3;CREB1;ACVR1;MEF2C
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.42709642724560576,0.9273978675308996,0.6,1.0,1.0,6/29,12.95%,MYBPC3;SLC8A1;SGCZ;TRDN;PIK3CA;SGCG
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.5235333800269757,0.9272265725466473,0.5853658536585366,1.0,1.0,9/17,26.03%,GRM6;PDGFRB;CTNNB1;CXCL12;PDGFB;CAV3;FYN;PKD2;PRNP
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.47507445758286515,0.9267039578528349,0.5652173913043478,1.0,1.0,2/16,6.93%,PPARG;SLC5A8
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.5910628744204924,-0.9265531140962221,0.7027027027027027,1.0,1.0,1/6,13.78%,TTBK1
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.6021707921067216,-0.926525768435681,0.6511627906976745,1.0,1.0,3/5,7.28%,ADAMTS12;TSPAN12;CD63
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.5751450634555806,0.9264984018378357,0.625,1.0,1.0,2/7,19.56%,CIDEA;BCL2L1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.5491109197884844,-0.926361837593536,0.6,1.0,1.0,2/14,8.68%,ATOX1;ARF1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.41261281446356346,-0.9262304398153303,0.6326530612244898,1.0,1.0,13/61,14.95%,CCN3;MMP26;AOAH;NLRP3;DHX58;TRAF3IP1;C1QBP;PROC;TYRO3;SELENOS;NR1H4;APOA1;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.4441403547933494,0.9261606219362734,0.5208333333333334,1.0,1.0,4/27,10.95%,PLCB1;LATS1;FGFR3;DLL1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4520321708401225,0.9260466320359806,0.6326530612244898,1.0,1.0,5/32,3.62%,ACE2;SLC26A3;PLA2G10;REP15;CAPN13
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.5885281660520065,-0.9256619416927866,0.5892857142857143,1.0,1.0,3/6,30.25%,ATP1B1;ATP1B2;WNK3
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.40129564237129367,-0.9254590696616842,0.5294117647058824,1.0,1.0,4/74,5.52%,SPRY4;NTRK1;FOXM1;SPRY1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.5277674529954606,0.925368743585222,0.5416666666666666,1.0,1.0,2/9,7.20%,PDE4B;CACNB2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.42617553171632055,-0.9252918005791467,0.5660377358490566,1.0,1.0,7/51,4.83%,ETV5;SIGLEC1;C2;RNASE1;CEBPD;DUOXA1;SCGB1A1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.45861417047184,0.92524514316629,0.5740740740740741,1.0,1.0,4/34,9.92%,MARVELD3;HDAC3;ZNF675;FOXO1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.4602064087139849,-0.9250979409608662,0.6086956521739131,1.0,1.0,1/21,2.90%,RAC1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.49771608133933476,0.9249209451356909,0.5777777777777777,1.0,1.0,3/21,5.73%,IDO1;HMGB1;AGER
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5070870272504968,-0.9245511842643167,0.5384615384615384,1.0,1.0,4/16,17.93%,AOAH;DERA;FBXO6;FBXO2
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.6192333720124283,-0.9244471207308935,0.6382978723404256,1.0,1.0,1/5,16.97%,GK5
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.4979851324603156,0.9244107538759373,0.5714285714285714,1.0,1.0,4/16,15.48%,KANK1;ABL2;CCDC125;KCTD10
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.40422376766464624,0.9243175320265814,0.5666666666666667,1.0,1.0,10/48,11.08%,NRG1;ERBB4;EGFR;TGFBR1;PKHD1;ZSWIM6;CDK6;ZSWIM5;ABL2;ZSWIM8
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.5771490004144935,-0.924102323915398,0.5892857142857143,1.0,1.0,3/7,29.52%,MAP1LC3B;SQSTM1;PEX5
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.47444378178261093,0.9238146819374251,0.5849056603773585,1.0,1.0,8/21,26.22%,GRID2;INSYN2A;MEF2C;MPP2;LRRK2;GRIN2A;GRIN2B;ARRB2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.515450920404305,-0.9237859654583541,0.5555555555555556,1.0,1.0,7/23,25.21%,RHEBL1;PINK1;MEAK7;SYAP1;PRR5L;MTOR;RPS6
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.45368269529805716,0.9237639514440142,0.4888888888888889,1.0,1.0,3/38,3.19%,PLA2G10;PLD6;ABHD4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.43963203073041723,0.9237337038574077,0.5813953488372093,1.0,1.0,7/19,19.35%,SLC8A1;PDE4D;TRDN;ANK2;AKAP6;DMD;ATP1A2
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.617325718083275,0.9236442940742474,0.6739130434782609,1.0,1.0,3/5,20.51%,EDN1;PROX1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5090361663218099,-0.9235813860045272,0.6111111111111112,1.0,1.0,3/13,8.82%,H1-0;PAX6;DDRGK1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.5677845141784283,-0.923244486634267,0.6101694915254238,1.0,1.0,2/9,12.12%,IL11;CDKN2B
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.485787488714218,0.9231738054658043,0.5333333333333333,1.0,1.0,2/19,5.61%,PPARGC1A;RPS6KA4
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3950503103404784,-0.9231334344881061,0.6136363636363636,1.0,1.0,14/79,17.33%,NCL;RBM4;RBM8A;RBM3;CELF3;RBM11;CIRBP;SAP18;C1QBP;SNW1;HNRNPL;SRSF7;RBMX;SRSF10
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.36187034908012927,-0.9230478191071138,0.5490196078431373,1.0,1.0,4/136,1.79%,GSTM5;INHA;PAH;GSTM3
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.5815511776664128,-0.9230323864522619,0.5849056603773585,1.0,1.0,1/7,6.05%,BEX4
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.5073717198682903,-0.9224975601775773,0.6086956521739131,1.0,1.0,1/15,0.49%,NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.5611921747594025,0.922399650228532,0.6111111111111112,1.0,1.0,1/10,1.32%,SPHK1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.48031068119414444,-0.922161739508284,0.5178571428571429,1.0,1.0,6/22,16.42%,ADRA2A;CALM1;DRD3;GNB5;DRD4;CALM3
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.36344706485570816,-0.9218330780310625,0.6379310344827587,1.0,1.0,34/153,17.00%,SFRP1;TRABD2A;NOG;PSMA7;HMGXB4;PSMD7;PSMB4;LATS2;RBX1;LIMD1;PSMC3;IGFBP2;NOTUM;RNF213;IGFBP4;STK11;TLE2;RACK1;PSMD8;PSME1;PSMB2;EMD;PSMC4;FUZ;SFRP4;PSMB8;SNAI2;PSMC1;PSMB5;PSMD2;HIC1;PSMA1;PSMD10;TLE5
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.539098714416818,-0.9217188396624263,0.56,1.0,1.0,4/12,20.31%,BRD8;CTSH;CTSL;CTSB
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.4470145527241867,-0.9214239895060782,0.5686274509803921,1.0,1.0,2/27,3.81%,PIGO;PGAP2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.4943021646454842,0.9213395675810477,0.5208333333333334,1.0,1.0,5/12,18.70%,PAM16;PXK;SIRT1;VCPKMT;THADA
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.5674801419870249,0.9212733338772572,0.6,1.0,1.0,4/8,13.82%,SLC8A1;PDE4D;TRDN;ANK3
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.42969583466312755,0.9210558833868305,0.5609756097560976,1.0,1.0,6/41,3.69%,GPC6;GPC5;ALDH1A1;BCO1;RLBP1;AKR1C1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.5058880402891992,-0.9209263391316718,0.5454545454545454,1.0,1.0,4/10,20.64%,IL12A;STAT1;CANX;STAT3
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.5096291649047879,-0.920849853754368,0.5641025641025641,1.0,1.0,3/13,14.26%,EXOSC10;EXOSC4;DIS3L
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.5166336508259946,-0.9207222007983594,0.5555555555555556,1.0,1.0,1/9,2.04%,NOG
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.43466804406804493,-0.9204381890045245,0.625,1.0,1.0,11/72,7.57%,P2RY10;NCKAP1L;SLA;AOAH;HCK;TRAF3IP3;CD4;CD37;SPI1;HLA-DRA;IL3RA
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4796692815376282,0.9204227321511421,0.5254237288135594,1.0,1.0,9/16,26.27%,ELOVL6;ACSL4;HACD2;TECR;ELOVL7;ACSBG1;ELOVL2;ACSL5;ELOVL5
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5577975369484206,-0.920334141936625,0.5283018867924528,1.0,1.0,3/8,13.18%,PBLD;RBP4;VSIG1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.5871967937995771,-0.9201102571063091,0.58,1.0,1.0,2/5,24.73%,COMT;MOXD1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.4892447851506005,-0.9200156396113043,0.5849056603773585,1.0,1.0,2/16,6.95%,B3GALT4;ST8SIA2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.5974095362444599,0.9199901320015114,0.6415094339622641,1.0,1.0,4/5,40.17%,ZNF274;PIH1D1;ZNF304;ATRX
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.4648517378130766,-0.9199443332103577,0.47368421052631576,1.0,1.0,6/23,21.19%,SLC6A9;LLGL2;SLC6A20;SLC6A7;CTNS;SLC7A5
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.49266379836736873,0.9199308864679651,0.5882352941176471,1.0,1.0,2/18,3.67%,NTF3;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.5668180105531408,0.9198600933075533,0.5957446808510638,1.0,1.0,2/7,4.17%,KLRD1;SMAD7
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5402460082022065,0.9197273151863492,0.6046511627906976,1.0,1.0,5/13,17.81%,LDLR;RGS14;SGK1;CAMK4;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.40661081436928465,-0.9197069570685351,0.5869565217391305,1.0,1.0,13/54,21.91%,KIF25;FBXO43;MAX;TOM1L1;CHEK1;BMP7;CHMP2A;RING1;CBX5;CDC7;RBBP8;L3MBTL2;E2F7
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.5929248160405943,0.919265719630242,0.6274509803921569,1.0,1.0,1/5,4.63%,FGF12
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4058919079651612,0.9191186040625493,0.5192307692307693,1.0,1.0,5/57,5.73%,MAP3K11;PLCB1;HMGB1;CCN2;AGER
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.4111607055858902,-0.9188744247333618,0.6491228070175439,1.0,1.0,17/71,16.79%,MYB;LDB1;PSMA7;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;METTL3;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5576615814537027,-0.9187068839269427,0.5178571428571429,1.0,1.0,2/10,8.14%,CACNB1;CACNG1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.4800385454267269,0.9186845364607931,0.5111111111111111,1.0,1.0,4/20,6.93%,PNP;HPRT1;FHIT;PPAT
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.49437881735137984,-0.9185934902630579,0.509090909090909,1.0,1.0,4/13,27.53%,CPTP;ABCB4;PLTP;ABCB1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.43458190087007476,0.9185773664233742,0.5192307692307693,1.0,1.0,5/40,8.60%,KIF2C;CHMP6;CEP55;PSRC1;PDCD6IP
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.5537524713668898,0.9185726711761607,0.6041666666666666,1.0,1.0,1/8,3.47%,JAM2
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.42895240233444104,0.9182788690108126,0.5531914893617021,1.0,1.0,11/43,22.92%,HSPB1;ERN1;DNAJB2;PACRG;HSPA1A;DNAJB4;DERL1;DNAJB1;HSPA1L;RHBDD1;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.6069020462233715,-0.9182435479029357,0.6078431372549019,1.0,1.0,3/5,30.08%,RNF20;CTR9;CDK9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.5272563730438157,0.9179602945639175,0.6037735849056604,1.0,1.0,5/15,24.32%,CYSLTR2;PRKACB;ADCY2;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.5593945014397173,-0.9179360742092086,0.5932203389830508,1.0,1.0,1/8,2.04%,NOG
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5734083309752922,0.9176157191391572,0.6226415094339622,1.0,1.0,2/6,7.36%,AGER;TWSG1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.42483834214368926,0.9174589817170719,0.5319148936170213,1.0,1.0,5/35,8.35%,FAT4;BTBD3;ROGDI;RYK;CDK6
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5527604371325601,0.9170465491247491,0.5925925925925926,1.0,1.0,1/10,2.71%,PPARG
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5032508396214608,0.9166558180943281,0.5434782608695652,1.0,1.0,4/14,9.45%,NRG1;TGFBR1;HEY1;BMPR1A
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.3995810947166586,-0.916614020295093,0.5576923076923077,1.0,1.0,7/76,8.26%,CPXM2;TSPAN32;LMF2;PCSK4;METAP2;ADAM19;PHEX
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6275679043059076,0.9165951065209039,0.6666666666666666,1.0,1.0,5/6,34.14%,FYN;PRNP;GRIN2B;APOE;HOMER1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.5389277737263285,-0.9165890894025691,0.5614035087719298,1.0,1.0,3/8,32.04%,VPS11;SAMD9;VPS41
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.4922271260622596,0.9156832319826869,0.4791666666666667,1.0,1.0,2/14,9.42%,NRG1;CDH2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.39099618706120803,-0.9150411931651526,0.6065573770491803,1.0,1.0,11/80,9.00%,HLA-DPB1;LDHC;C2;TMEM220;CD74;RASSF4;KCNE1;HLA-DRA;C11ORF97;KCNE3;CCDC170
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.4011003445979169,-0.9149692894616351,0.6470588235294118,1.0,1.0,6/66,7.54%,FIP1L1;POLR1G;CPSF1;TTF1;CPSF4;GTF2H2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.5495139607675493,0.9149406952061407,0.5306122448979592,1.0,1.0,2/10,10.56%,ABL2;EDN1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.39539819156572026,0.9149187378571397,0.5490196078431373,1.0,1.0,17/64,19.37%,NOX5;ANLN;RHOB;CEP55;ECT2;SEPTIN11;PDCD6IP;SNX18;PLK1;ESPL1;ANK3;ROPN1B;SPAST;CUL7;BBS4;ROCK2;SPTBN1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.4982025755093784,0.9149163703449135,0.5178571428571429,1.0,1.0,4/13,10.21%,NRG1;OPRK1;SGK1;FGF10
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.40219876815974664,-0.914750669550465,0.58,1.0,1.0,7/59,9.19%,NCKAP1L;HCK;KANK3;VIL1;MYADM;ABITRAM;DBNL
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.5540670919686356,-0.914526807457093,0.6,1.0,1.0,4/11,20.31%,BRD8;CTSH;CTSL;CTSB
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.4111725626797318,0.9144128172043658,0.46153846153846156,1.0,1.0,2/59,4.45%,VAPB;NR5A2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4446969055833404,-0.9143001097968005,0.5098039215686274,1.0,1.0,2/29,2.44%,CLU;C2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5358552457191236,-0.9140535698327152,0.6304347826086957,1.0,1.0,3/9,24.04%,HADHA;TAMM41;SLC27A1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.482779628236408,0.9138340058964043,0.5882352941176471,1.0,1.0,3/15,13.37%,MFHAS1;NR1H3;IFI35
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.6030365580904025,-0.9137092234642751,0.6333333333333333,1.0,1.0,2/7,8.93%,KIF1A;KIF5A
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4597374047946047,-0.9136907124089966,0.5925925925925926,1.0,1.0,6/21,15.05%,FLG2;AHI1;TRAF3IP1;ACTB;PRKX;ARHGAP12
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4034482409681726,0.913670432736037,0.6341463414634146,1.0,1.0,21/104,12.65%,CALCR;GNAT2;CNR2;RXFP2;ADGRB3;CHRM2;FSHR;LGR5;OPRK1;SCTR;GRM8;ADGRL3;TBXA2R;PTGFR;PRKACB;GNAQ;PDE2A;ADGRL2;WASF2;GNAI1;GNA13
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.521231089113937,-0.9134792917930469,0.6,1.0,1.0,1/15,2.48%,APOD
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.521231089113937,-0.9134792917930469,0.6,1.0,1.0,1/15,2.48%,APOD
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.3911888857495765,0.9132546081031939,0.6,1.0,1.0,27/79,15.40%,EFNA5;TNC;VEGFC;SERTAD4;P3H2;CNN3;ROR1;WNT5A;SLIT2;TCF7L1;SNX7;FBLIM1;COL4A6;GLI3;CDR2L;FBXL7;PTPN14;IL17RD;FLNC;NOTCH3;ADGRL2;TENM3;ENAH;MDK;FST;AMOTL2;PLAT
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.39805665067431883,-0.91318635161365,0.5384615384615384,1.0,1.0,17/61,19.61%,H1-4;H1-0;RNF8;DAXX;SMARCD1;ANP32E;HMGB2;CHAF1A;SUPT16H;INO80;CTCF;ZNHIT1;SMARCA5;MACROH2A1;H1-2;SUPT6H;POLE3
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.5236759478038333,0.9131193334927439,0.5740740740740741,1.0,1.0,2/12,14.13%,RAB29;RELA
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.47716549110812817,0.9129872691064164,0.5686274509803921,1.0,1.0,3/16,6.93%,PNP;HPRT1;PPAT
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.5496524026110517,-0.9127619664970793,0.6071428571428571,1.0,1.0,1/8,6.14%,EIF5A
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.4576748354234922,0.9127496718786186,0.5918367346938775,1.0,1.0,3/15,10.56%,HPGDS;PTGES;EDN1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.41315745100526924,-0.9127349102094053,0.6111111111111112,1.0,1.0,4/59,9.45%,RAC1;RAB17;ABITRAM;TBC1D24
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.4497918724345943,0.9124004477077531,0.5625,1.0,1.0,7/33,22.61%,GLRA2;SH3BP4;CPEB4;CPEB3;SESN1;FYN;IPO5
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.5376809232595,-0.9122799675826282,0.5192307692307693,1.0,1.0,6/8,30.89%,SUPT5H;CCNT1;RNF20;CTR9;CDK9;NELFE
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.42422989665613425,-0.9122419900082798,0.6363636363636364,1.0,1.0,3/38,3.97%,SFRP1;CD74;FTH1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.5449189365053181,0.9120950054400893,0.6470588235294118,1.0,1.0,1/7,7.20%,CACNB2
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.4045957372616589,-0.9120582799554037,0.6440677966101694,1.0,1.0,5/50,5.30%,SFRP1;AMH;ADAMTS12;DLX5;NODAL
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.5599631297056709,0.9117845570109859,0.5490196078431373,1.0,1.0,2/7,12.37%,RFX3;CFAP53
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.32689079514040575,-0.9117551269306936,0.7358490566037735,1.0,1.0,34/253,12.99%,SPDEF;SFRP1;NUPR1;USP27X;CLU;OBSCN;RASGRF2;UTP11;VAV3;CDK5;GADD45A;PRR7;PDCD5;ITGA6;UBC;DUSP6;FGD3;LATS2;TRAF7;ATF4;BTG1;PTPA;PIDD1;IGFBP3;CYP1B1;RFPL1;BAK1;SAP18;PIP5KL1;RACK1;C1QBP;ITGB3BP;DNM1L;TNFAIP8
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.41698859794378357,0.9114704187296572,0.5625,1.0,1.0,23/65,17.99%,ANTXR2;NFIL3;HMGCS1;PPARG;FDFT1;ERRFI1;LDLR;SCD;LPL;HMGCR;JAG1;STARD4;GNAI1;TP53INP1;CTNNB1;ANXA13;FASN;AVPR1A;TMEM97;ALCAM;CPEB2;GLDC;FDPS
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.6368862095633662,-0.9112965377104295,0.6274509803921569,1.0,1.0,3/5,33.17%,CTPS2;UMPS;CTPS1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.5178076792163248,-0.9100606243962074,0.5925925925925926,1.0,1.0,1/15,2.17%,UPB1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.47225041536458856,0.9100021130141849,0.6041666666666666,1.0,1.0,7/17,23.92%,CDH2;CTNNB1;PTK2;CAV3;TCAP;PKD1L3;PKD2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5886675393192071,0.9099580972546144,0.7111111111111111,1.0,1.0,2/5,26.84%,PTPN12;HIP1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5523389360086952,-0.9099250093448924,0.6222222222222222,1.0,1.0,5/11,29.31%,CCT2;CCT6A;LARP7;CCT8;DKC1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5523389360086952,-0.9099250093448924,0.6222222222222222,1.0,1.0,5/11,29.31%,CCT2;CCT6A;LARP7;CCT8;DKC1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.578893155713658,0.9090175509964408,0.5454545454545454,1.0,1.0,3/6,32.79%,MSH2;MSH6;RMI2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.41719062893391484,-0.9088014418579033,0.55,1.0,1.0,11/49,22.42%,ANKLE2;LEMD2;NSFL1C;NUP133;NUP43;EMD;NUP155;CHMP2A;NUP85;VRK1;RAN
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.5523310731642266,0.9087271055697448,0.6122448979591837,1.0,1.0,2/8,10.73%,ERN1;DYRK1A
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.37062831540588853,-0.9086744300412135,0.62,1.0,1.0,32/110,23.26%,AURKA;INCENP;SBDS;ZWILCH;ERCC6L;KIF4A;SPDL1;STMN1;PTPA;PLK2;SPC25;NUP133;NUP43;CENPH;CENPE;ITGB3BP;RPS27;EFHC2;TUBG1;KIF4B;CKAP5;NUDC;GPSM2;SGO2;TUBG2;NUP85;KIF11;PAFAH1B1;DYNLL1;RAN;CENPF;PCNT
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.5737271766651298,-0.908439327198625,0.6,1.0,1.0,1/8,2.48%,APOD
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4759000315710119,0.908193002864643,0.6086956521739131,1.0,1.0,6/16,19.35%,NR3C1;TFPI;URI1;TRERF1;ADTRP;ATP1A2
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.5025720861936415,0.9080100760301663,0.64,1.0,1.0,1/9,2.72%,UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.5531711492216654,0.9075196729559022,0.5272727272727272,1.0,1.0,2/5,19.49%,TCAF2;SLC43A1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.45602543211525626,0.9073786351920345,0.6666666666666666,1.0,1.0,5/18,19.91%,CHMP6;ODC1;ZDHHC2;NEDD4L;MDM2
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.40633686723886797,0.9073622397327433,0.5531914893617021,1.0,1.0,6/73,10.39%,U2AF1;THOC6;NXF1;ATXN1;RANBP3L;WASHC4
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.5901663711739966,0.907200231880918,0.6153846153846154,1.0,1.0,2/5,11.81%,ITGAV;NR1H3
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3825229043695745,0.9070644442217793,0.6222222222222222,1.0,1.0,26/79,21.28%,L1TD1;FGFR2;UNC5D;TOX3;GRID2;CNTNAP2;CBLN1;EPCAM;EPHA7;NLGN4X;IL17RD;EPHA8;ADAMTS20;CXCL12;FRAS1;NANOG;SOX11;GABRB3;IGDCC3;GAL3ST3;DPYSL5;BCL11A;VASH2;CRABP1;GRM4;ADAMTS19
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.5727851363166206,-0.9068632062827752,0.58,1.0,1.0,4/7,39.52%,VIPAS39;P3H4;PLOD1;PLOD3
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.4984198548800879,0.9062625720968905,0.5849056603773585,1.0,1.0,2/11,5.23%,ADGRV1;WNT5A
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.44217287083353135,-0.905919890388406,0.58,1.0,1.0,10/37,20.59%,ABRAXAS1;GOLGA2;KIF4A;WRAP73;TOGARAM2;KIF23;KIF4B;RAB11A;TPX2;KIF11
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.37466390845655445,0.9055996174671646,0.5357142857142857,1.0,1.0,7/77,5.65%,CD151;LOXL2;COL22A1;TLL1;P3H2;TGFBR1;COL8A1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.576460681158181,0.9053170836142523,0.62,1.0,1.0,2/6,18.82%,AKT2;BAD
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.5604998977754125,0.9053116596109179,0.6923076923076923,1.0,1.0,2/8,8.04%,CX3CR1;ZFP36
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.4620667144657647,-0.9052245071164062,0.6046511627906976,1.0,1.0,4/25,7.73%,FGF1;WNT7B;FGF7;RBP4
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5631891123579339,0.9052024650142279,0.6415094339622641,1.0,1.0,1/8,2.08%,PLCB1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.5788930180897534,0.9050331123959732,0.627906976744186,1.0,1.0,2/6,16.29%,IRS2;AKT2
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.5313254301875161,-0.904892986271136,0.6153846153846154,1.0,1.0,6/11,29.27%,ISCU;NOS2;NOS3;ORAI1;PARK7;NOS1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.5242253656979569,-0.9048899659152202,0.5102040816326531,1.0,1.0,2/12,6.56%,SRP54;SPI1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.5462755365238642,0.9048612044369646,0.6363636363636364,1.0,1.0,3/8,14.41%,PPP1R15B;NCK1;BOK
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.4532649920876655,-0.9047060693282217,0.559322033898305,1.0,1.0,4/23,7.42%,KANK3;TMSB4X;VIL1;MYADM
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.6301724998656351,0.9045427204618356,0.6666666666666666,1.0,1.0,2/5,12.11%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.5511168816266543,0.904481960796533,0.5652173913043478,1.0,1.0,1/6,0.41%,STK26
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.43009586929651966,0.9041364523598302,0.5957446808510638,1.0,1.0,10/33,25.68%,GFAP;LATS1;SPTY2D1;SNCAIP;RAP1A;ROCK2;HSPA8;RAPGEF2;BAG5;BBS10
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.33993518003987,0.9038024624513924,0.6610169491525424,1.0,1.0,64/306,16.14%,PTPN20;GRAP2;IL20RB;IFI16;SELPLG;SOCS6;IL1RAPL1;ITGAX;SYK;LEPR;GBP4;CSF1;ITGAM;ZEB1;WNT5A;CSF1R;FOXO3;PTPN13;SYNCRIP;IL18R1;ZFP36;TWIST1;GREM2;CCL5;RORA;NPR2;HIF1A;ZNF675;ASAH2;ABL2;FER;FOXO1;SOCS2;PTPN14;PTPN6;CRHBP;PDE2A;ZFP36L2;CSF2RA;PTAFR;POU2F1;SIRT1;LIFR;CRLF2;SLC26A6;IL16;PIK3CA;CXCL12;ERBIN;HGF;AKAP6;SMAD3;RELA;AIM2;BCL2;SMPD4;TIMP1;PID1;IL4R;ICAM1;MAPK8;PIK3R1;PTGS2;SLC12A2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5476435102273004,0.9036007344288479,0.6222222222222222,1.0,1.0,6/10,19.35%,SLC8A1;ATP12A;SLC9A1;SLC12A2;NEDD4L;ATP1A2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.512180304024373,-0.9035489122317186,0.5660377358490566,1.0,1.0,5/14,20.73%,NAXE;MYADM;PPT1;RFTN1;FLOT1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.44220512161949227,0.9035455239296083,0.54,1.0,1.0,6/34,12.26%,ENPP1;ERRFI1;EPHA7;MOB1B;RAP2A;PDGFD
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.47465344201066473,0.9033900108441681,0.5769230769230769,1.0,1.0,3/16,13.84%,CSF1;CSF1R;OSTM1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.5191538069296046,0.903371217792473,0.5714285714285714,1.0,1.0,1/11,0.28%,ZDHHC11
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.3332252604041725,-0.9033543733079448,0.6808510638297872,1.0,1.0,50/360,15.63%,GOLGA8B;GEM;KIF25;CATIP;HPS6;HSD17B10;PTCD2;STX4;CFAP61;WTIP;GOLGA2;ARAP3;TPM1;ZFP69B;DNAJA3;KIF4A;FGD3;LIMD1;MTX1;PAK6;PLEKHF1;CHCHD10;TANGO2;PACSIN3;REEP6;ATP8B4;GOLGA8A;RAB31;NSFL1C;TWNK;GAK;ATP5F1B;PINK1;ADCK1;PEX11B;ODF2;DOP1B;DNM1L;FANCG;CHCHD2;ZMYM6;PEX1;GOLGA8N;MYO18A;PRDX3;KIF9;TMEM11;PARP1;GOLGA8M;POLRMT
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.4428584636278602,-0.9032076283183282,0.603448275862069,1.0,1.0,2/24,3.81%,PIGO;PGAP2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.39196531848072796,0.9028108781054295,0.5526315789473685,1.0,1.0,16/52,23.92%,PTPRK;EGFR;RHOB;ECT2;FER;SIRT1;AGAP3;RELA;MAPK8;MAP3K5;PDK2;PLEKHA1;NFE2L2;SIRPA;ABL1;PKD2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4995717950147655,-0.9027339017954562,0.5192307692307693,1.0,1.0,8/15,24.27%,NLRP3;TXN;ENTPD5;HSP90AB1;TXNIP;IL18;ENTPD1;P2RX4
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.49346572681687045,0.9026777972687773,0.5227272727272727,1.0,1.0,1/13,4.52%,ITGAM
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.5637313937687884,0.9026748128001283,0.6140350877192983,1.0,1.0,4/6,29.81%,CXCL12;EPS8;WAS;ARHGAP35
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5680200624825609,0.9025957229630076,0.6363636363636364,1.0,1.0,2/6,10.22%,NLGN1;LHFPL4
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5105073061950292,0.9025304791808382,0.5882352941176471,1.0,1.0,6/14,22.57%,EDN1;PRKCA;MEF2A;SLC9A1;ROCK2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.5722239495809671,-0.9024476784951098,0.6923076923076923,1.0,1.0,2/6,18.76%,AKAP8L;SUPT6H
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.5722239495809671,-0.9024476784951098,0.6923076923076923,1.0,1.0,2/6,18.76%,AKAP8L;SUPT6H
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.4427662389055908,-0.9019328787902164,0.6041666666666666,1.0,1.0,3/26,7.48%,CGAS;B2M;RSL1D1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3847962980388144,0.9018190653013983,0.5581395348837209,1.0,1.0,11/70,13.55%,CA9;SLC26A7;SLC2A14;SLC22A6;SLC23A1;ABCC11;SLC39A8;SLC25A41;SLC4A4;SLC26A6;ABCG2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.45362081490353945,-0.9015326123994155,0.64,1.0,1.0,3/32,6.41%,KIF1A;DCTN1;KIF4A
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.35625133927217323,-0.9014498257824178,0.6666666666666666,1.0,1.0,25/143,17.31%,SFRP1;ARHGAP15;NTRK1;VAV3;AGRN;ITGA6;RGS16;GMIP;FGD3;BCAR3;EPHA1;RACK1;PLXND1;GNB5;PIN1;RAP1GAP;STMN3;ARHGAP12;ASAP3;RGS8;RTN4R;ZC3H15;RRP1B;DOCK8;RASGRP2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.5407680429664659,0.901446668648357,0.6086956521739131,1.0,1.0,3/8,25.81%,FGF13;SEMA4D;DCC
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.5093922445506411,-0.9013551315604557,0.6521739130434783,1.0,1.0,3/25,4.58%,NTRK1;CACNB1;CDK5
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.4491984849233574,0.9013184398364017,0.5869565217391305,1.0,1.0,5/28,14.55%,LDLR;ZBTB20;NR1H3;SORBS1;CREB1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.5545921493820589,-0.9011191719250533,0.6896551724137931,1.0,1.0,1/10,4.79%,ALKBH2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.5545921493820589,-0.9011191719250533,0.6896551724137931,1.0,1.0,1/10,4.79%,ALKBH2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5187993946971527,0.9011131757441029,0.6140350877192983,1.0,1.0,2/15,4.39%,CORO7;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.5289407878389907,-0.9010497686271615,0.6470588235294118,1.0,1.0,1/8,6.75%,ADRA2A
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.4690905016169852,0.9009454635419676,0.5581395348837209,1.0,1.0,7/22,16.65%,FGFR2;WWOX;TGFBR1;FGFR3;FGFR1;SPEF2;SOX11
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4280498008459331,0.9008570662544281,0.6415094339622641,1.0,1.0,7/31,15.57%,DNAH5;RFX3;DLL1;CFAP53;DNAI2;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.42151807981266415,0.9007984365616021,0.6739130434782609,1.0,1.0,17/52,25.76%,KCNJ3;NEDD4;KCNIP4;KCNJ6;DPP10;AKAP6;KCNN1;KCNJ2;NEDD4L;GNG2;CAV3;KCNJ16;KCNN4;CAB39;KCNMB3;KCNJ9;WWP2
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.5954363424279291,0.9006344161866153,0.5909090909090909,1.0,1.0,2/5,9.57%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4708712585329189,-0.9005767974047905,0.625,1.0,1.0,1/16,1.26%,SPA17
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5206519328252247,0.9004889251086554,0.6,1.0,1.0,4/12,26.07%,AK3;GNAI3;LRRK2;RHOQ
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4479926943208911,0.9003633023234143,0.543859649122807,1.0,1.0,2/24,3.93%,MSH4;TDG
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3258973150294176,-0.9001734937151079,0.66,1.0,1.0,33/235,12.99%,SPDEF;SFRP1;USP27X;CLU;NTRK1;OBSCN;RASGRF2;UTP11;VAV3;GADD45A;PRR7;PDCD5;ITGA6;UBC;HTATIP2;DUSP6;FGD3;LATS2;ATF4;PTPA;PIDD1;IGFBP3;NOS2;CYP1B1;RFPL1;BAK1;SAP18;PIP5KL1;RACK1;C1QBP;ITGB3BP;DNM1L;TNFAIP8
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4126347952921867,-0.8999816372901385,0.6481481481481481,1.0,1.0,5/56,5.60%,SFRP1;WNT9A;WNT9B;PORCN;WNT7B
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.6017621969248943,0.8994342788282513,0.6808510638297872,1.0,1.0,1/5,15.16%,SLC25A20
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.42025739331291745,0.8992752720402547,0.5531914893617021,1.0,1.0,20/72,17.26%,IRS1;ENPP1;PPARG;IRS2;HDAC9;FER;FOXO1;ZBTB7B;SIRT1;INHBB;SORT1;SORBS1;INSIG1;OGT;INSIG2;PIK3R1;AKT2;CPEB2;TBC1D4;KAT2B
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.602271284672895,0.8990331004579355,0.74,1.0,1.0,2/6,15.80%,LDLR;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.46728764662614275,-0.8990319101567511,0.5490196078431373,1.0,1.0,5/17,15.62%,AURKA;BTC;DRD3;EREG;NPM2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.5453063417994606,0.8989292786932336,0.6727272727272727,1.0,1.0,2/7,9.40%,KLKB1;TFPI
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4411903081131693,-0.8987239722034905,0.6511627906976745,1.0,1.0,11/26,29.56%,EXOSC10;EXOSC4;CPSF3;LSM10;SLBP;MTPAP;CPSF2;DCP2;LSM1;LSM11;SNRPB
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4924855681182013,-0.8987016736413423,0.6078431372549019,1.0,1.0,5/16,27.68%,APOA1;ABCG4;ABCA5;ABCG5;NPC1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.36936703862281656,-0.8985937073391128,0.5833333333333334,1.0,1.0,20/66,16.79%,BACH1;EPAS1;PSMA7;PSMD7;UBC;PSMB4;RBX1;LIMD1;PSMC3;ELOB;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.5033143390842993,-0.898467446537119,0.5434782608695652,1.0,1.0,1/10,0.88%,PAH
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.5285597118134866,0.8984367676541776,0.5789473684210527,1.0,1.0,2/8,22.24%,GAL3ST1;GALC
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.5331783267196238,-0.8983024456740905,0.5918367346938775,1.0,1.0,1/8,7.38%,NPY5R
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3904676611691611,0.8982719597711926,0.5636363636363636,1.0,1.0,21/89,13.63%,PIK3R5;NTF3;NEDD4;PIP4K2A;ROR1;EGFR;IRS2;FSHR;GAB1;PTPN13;TWIST1;CCL5;PDGFRB;IGF1R;PTPN6;FGFR1;NLRC3;SIRT1;PDGFD;PIK3CA;HGF
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5155061505341164,0.8981733194643255,0.6216216216216216,1.0,1.0,3/14,16.03%,AK3;IMPDH1;GNAI3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.43127080128791406,0.89815477495124,0.6181818181818182,1.0,1.0,13/49,11.39%,ERBB4;SYK;FGFR2;EGFR;EPHA3;CSF1R;FGFR3;ABL2;FER;PDGFRB;PTPN6;DYRK1A;FGFR1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3581274131211564,-0.8980713959097917,0.6153846153846154,1.0,1.0,9/77,12.93%,STING1;UPB1;HGSNAT;CLDN1;CARD9;RNF213;TWNK;EHD4;DNM1L
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.44099729543415445,-0.8975643118185708,0.6,1.0,1.0,8/35,15.63%,MRPL23;MRPL16;MRPS18B;TWNK;IARS2;MRPS21;MRPL51;POLRMT
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.46225353375880357,-0.8973901084621727,0.5681818181818182,1.0,1.0,3/27,7.18%,NCKAP1L;IL4I1;HLA-DRA
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5341458358531288,-0.8972537284417256,0.5652173913043478,1.0,1.0,9/13,32.72%,RNF8;SUPT5H;NELFA;LARP7;NELFCD;NELFE;TCERG1;RECQL5;EAPP
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.421054489863905,0.8971826538117913,0.5526315789473685,1.0,1.0,11/61,11.39%,GALNT3;FLRT2;HNRNPH1;FGFR2;FLRT3;FGFR3;FGF5;FRS2;FGF17;FGF10;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.4460870977330484,0.8971486690011814,0.6274509803921569,1.0,1.0,5/22,11.23%,EGFR;HEY1;TSPAN15;DLL1;NOTCH3
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.481310184722943,0.8967958018582946,0.5094339622641509,1.0,1.0,2/12,5.73%,HMGB1;AGER
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.5171910915152034,-0.8960885298237871,0.5641025641025641,1.0,1.0,2/7,12.93%,DNM1;DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.5171910915152034,-0.8960885298237871,0.5641025641025641,1.0,1.0,2/7,12.93%,DNM1;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5578824266933045,0.8960289182864417,0.6122448979591837,1.0,1.0,2/8,14.42%,RAD18;SMC5
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.4329761767516969,0.8958672475759096,0.6078431372549019,1.0,1.0,6/28,20.74%,PRELP;GLB1;MPST;HEXB;GNS;VCAN
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.5259867692728052,0.8957597719616596,0.6274509803921569,1.0,1.0,3/11,14.11%,DYRK3;CRHBP;SLC38A2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.4092561436743012,-0.8957421865817387,0.6481481481481481,1.0,1.0,6/61,11.95%,TRMO;AARS2;TARBP1;METTL6;PUSL1;TRMT112
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.4579633692741921,0.8956455281863758,0.5925925925925926,1.0,1.0,1/22,2.25%,NEDD4
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.5298981140592247,0.8953275411297097,0.6140350877192983,1.0,1.0,6/10,23.16%,CRB2;SCX;CLASP1;CLASP2;PHLDB1;DAG1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.5759852404114789,-0.8953051956688628,0.6346153846153846,1.0,1.0,1/6,13.55%,ITM2C
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.35725752252949894,-0.894927660568257,0.5641025641025641,1.0,1.0,10/118,7.26%,ARHGAP15;OBSCN;ARHGAP22;RAC1;RASGRF2;ARAP3;VAV3;FOXM1;GMIP;FGD3
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.5533233531861583,-0.8944484553863057,0.6111111111111112,1.0,1.0,1/6,5.03%,DCTN1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.5594572928596236,-0.8943974630200887,0.6595744680851063,1.0,1.0,2/7,20.64%,EIF4G1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.5594572928596236,-0.8943974630200887,0.6595744680851063,1.0,1.0,2/7,20.64%,EIF4G1;STAT3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.45326548596959476,0.8943704671053142,0.5576923076923077,1.0,1.0,15/30,22.64%,IRS1;IRS2;RORA;SDHAF3;ADIPOR1;SIRT1;FBP1;OGT;AKT2;ZNF692;PDK4;PDK2;PDK1;GNMT;KHK
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.46623533674838297,-0.8943260319919688,0.6363636363636364,1.0,1.0,4/15,17.54%,DHX58;UFD1;C1QBP;DDX60
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.37141498609124407,-0.8942015382277404,0.6666666666666666,1.0,1.0,27/144,14.60%,SELP;GBP6;CD74;OAS3;DHX58;EPSTI1;B2M;UBE2L6;WARS1;LATS2;IFI44;CMTR1;IFIT1;PARP14;BTG1;RNF213;IFI27;RBCK1;OAS2;STAT2;PSME1;PSMB2;ISG15;RSAD2;PSMB8;NFKBIA;IL18BP
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.4495518058664871,-0.8941972209056026,0.6,1.0,1.0,2/18,8.14%,CACNB1;CACNG1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.353045569543014,-0.894122228769424,0.6521739130434783,1.0,1.0,18/151,11.06%,SPDEF;TAGLN;CLU;APOD;ADAM12;COL6A2;AGRN;ACTC1;RYR1;CRYAB;CRAT;CACNG1;COX7A1;MYL7;IGFBP3;SPARC;CFD;HDAC5
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.495415519660109,0.8940842900445306,0.6530612244897959,1.0,1.0,3/17,11.37%,ADGRB3;C3;EPHA8
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.5168947005902176,0.8940613623954391,0.5869565217391305,1.0,1.0,2/8,9.66%,FGFR2;COBL
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.5396862230629456,0.8939807915505045,0.6481481481481481,1.0,1.0,1/9,4.17%,BAG2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.45991503450032867,0.8936742564177617,0.5208333333333334,1.0,1.0,4/19,16.07%,SLIT2;TGFBR1;SMAD2;TGFBR3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.48388615005107066,-0.8934843813363312,0.6,1.0,1.0,2/14,6.95%,B3GALT4;ST8SIA2
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.41548673988284446,0.893465126568343,0.5686274509803921,1.0,1.0,16/58,17.91%,NRG1;ERBB4;EGFR;FAM83A;GAB1;SLC30A10;PLCE1;PRKCA;BCAR1;PIK3CA;ERBIN;NRG2;PIK3R1;BRAF;TGFA;PTPN12
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.393334181682243,-0.8933605176988912,0.6739130434782609,1.0,1.0,12/88,10.50%,FGL1;KLRB1;HLA-C;DHX58;B2M;IL4I1;MADCAM1;HLA-DRA;FOXP1;AMBP;COLEC12;LRP8
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.4788043213919967,0.8932085969533974,0.5769230769230769,1.0,1.0,3/18,11.87%,HS3ST5;TRIM22;TRIML2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.43000028263789325,-0.8930921425819798,0.5384615384615384,1.0,1.0,2/25,1.74%,DYSF;CLU
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.35014807542518084,-0.8929338860897924,0.6595744680851063,1.0,1.0,30/181,16.54%,CD9;NUPR1;SLA;HK2;AURKA;TOMM40;EIF2S2;NFKBIB;M6PR;WARS1;SORD;PRDX1;NMT1;PDAP1;PPP1R15A;ATP6V1D;PPA1;TM7SF2;YKT6;NIBAN1;MCM2;ENO1;LDHA;PSMC4;PSAT1;PNO1;PSMB5;SDF2L1;TUBG1;RPN1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.43755296118725384,-0.8928459814819332,0.7021276595744681,1.0,1.0,7/38,12.83%,CD9;ARR3;GTF2H2;RAB31;DRD3;DNM1;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.49171935345859197,0.8924620723217531,0.5932203389830508,1.0,1.0,4/18,9.64%,NEDD4;SNCA;PXK;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3871119555519674,0.8924000377405501,0.5636363636363636,1.0,1.0,18/124,12.28%,LTK;DCUN1D1;ERBB4;FGFR2;ROR1;EGFR;EPHA3;CSF1R;ARRDC3;RYK;FGFR3;EPHA7;PDGFRB;IGF1R;EPHA8;FGFR1;PLK1;CTNNB1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.45244889120443355,0.8922841475131758,0.6,1.0,1.0,3/21,4.04%,HPGDS;AKR1C1;PTGES
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.5481663879056002,-0.8920127216712451,0.5666666666666667,1.0,1.0,4/6,26.07%,TMEM9;PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5083900929719305,0.8915989633746724,0.5961538461538461,1.0,1.0,5/9,33.26%,SIRT1;MYOCD;KLF15;PRKAA2;DIP2A
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.5407229530308278,-0.8915846801976722,0.6,1.0,1.0,2/9,12.82%,GINS3;MCM2
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.45282810296541576,-0.8914410452747146,0.5769230769230769,1.0,1.0,4/13,20.07%,MYH14;PVALEF;CCDC78;STAC
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4730184097521513,-0.8913706721210987,0.72,1.0,1.0,10/22,24.25%,UBE3A;PRKACA;PINK1;PSME1;EFNA1;GPX1;ATP5IF1;PSME2;NUDT15;UBB
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.4473413219892428,-0.8909081336076613,0.6285714285714286,1.0,1.0,7/26,23.31%,SIGLEC1;GAK;CLTB;CLTA;CANX;AP2A1;AP2S1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5433656927505912,0.8908700701865445,0.6521739130434783,1.0,1.0,2/8,11.71%,ATP2B4;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5433656927505912,0.8908700701865445,0.6521739130434783,1.0,1.0,2/8,11.71%,ATP2B4;DYRK2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3633033463296826,0.89074910360739,0.6666666666666666,1.0,1.0,19/97,13.64%,EFNA5;SEMA5A;DSCAM;FRMD5;PKHD1;PPP3CA;CCL5;EPHA7;ABL2;ZDHHC2;ADAM8;PRKCA;DLL1;ITGAV;CDH13;EPHA8;CXCL12;KNG1;MDK
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.47757332469846236,-0.8906778091565188,0.4883720930232558,1.0,1.0,1/18,1.18%,OSTN
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.4256752377027636,-0.890438833969371,0.6590909090909091,1.0,1.0,4/37,7.42%,FBLN2;RAC1;BST1;MYADM
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.5603752533875341,-0.8901153261204446,0.7083333333333334,1.0,1.0,1/6,1.05%,CCN3
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.5459373517537078,-0.8900831003242703,0.6363636363636364,1.0,1.0,5/6,30.22%,BAK1;DAB2IP;BCL2L11;BAX;PTPN1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.5564258494596884,0.8900603870474998,0.5882352941176471,1.0,1.0,1/8,3.79%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.377401316034863,-0.8899309553923682,0.66,1.0,1.0,20/86,18.39%,RPS27L;UPF3B;RBM3;UPF3A;EIF5A;RCC1L;CIRBP;NIBAN1;YBX3;C1QBP;METTL3;UQCC2;TRMT10C;BOLL;EIF6;POLR2G;NAT10;RPL5;THBS1;PIWIL2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.4836519512210129,0.8899287145468029,0.5208333333333334,1.0,1.0,5/18,13.98%,CALCR;SNCA;P2RX7;AKAP6;NPSR1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3991427598318603,-0.8899160321781158,0.6382978723404256,1.0,1.0,4/48,6.01%,ABRAXAS1;SPRED3;SPRED2;RNF8
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.5552222756025416,-0.8898914995300775,0.6415094339622641,1.0,1.0,4/7,15.66%,RAB3B;DRD1;DRD3;DRD4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.501915609522378,-0.8898329568736313,0.6111111111111112,1.0,1.0,5/11,29.31%,WRAP53;CCT2;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.5447434468127754,0.889641858253095,0.6,1.0,1.0,2/5,15.04%,SIRT1;MEF2C
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.43147371247415395,0.8895526616728006,0.6041666666666666,1.0,1.0,5/31,17.81%,GLRA2;GLRB;SH3BP4;CPEB4;CPEB3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.539648027216854,0.8895111141735971,0.6222222222222222,1.0,1.0,4/8,25.33%,ABHD17B;LYPLAL1;LYPLA1;ABHD17C
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.539648027216854,0.8895111141735971,0.6222222222222222,1.0,1.0,4/8,25.33%,ABHD17B;LYPLAL1;LYPLA1;ABHD17C
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.5744348016768478,0.8893184555986099,0.6226415094339622,1.0,1.0,2/5,15.04%,DLL1;MEF2C
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.5643578140860411,0.8890201668576858,0.6226415094339622,1.0,1.0,1/5,8.80%,COL4A6
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.41759064006140273,0.8890063187944461,0.6181818181818182,1.0,1.0,13/56,15.04%,NFKBIZ;PLA2G7;WNT5A;SNCA;CCL5;LPL;ADAM8;PDE2A;NAPEPLD;IL16;IFI35;MDK;MEF2C
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.593142786793127,0.8887092267985208,0.6938775510204082,1.0,1.0,1/5,9.90%,PRIMPOL
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.41787822471226627,0.8886949468078502,0.625,1.0,1.0,10/31,19.36%,SLC26A3;SLC4A4;SLC26A6;SLC9A1;SLC4A7;CLN3;GPR89A;SLC9A2;CA2;GPR89B
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.3933664118250525,0.8885925386463793,0.5918367346938775,1.0,1.0,6/72,4.58%,MYRFL;KLKB1;KEL;HJV;RCE1;HGFAC
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.47716650082458023,-0.8885862758442332,0.5333333333333333,1.0,1.0,1/10,3.07%,ADRM1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.5275834211652234,-0.888556543503244,0.6545454545454545,1.0,1.0,1/7,6.38%,PAX8
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.36142977030038026,0.8884371310876055,0.6041666666666666,1.0,1.0,25/158,16.83%,PIK3R5;PLA2G10;PLD6;ABHD4;PIP4K2A;CHPT1;SYNJ2;PTPN13;LIPH;PIK3C2G;PIK3C2B;SLC44A5;INPP4B;LCAT;LPCAT3;PIK3CA;AGPAT5;SELENOI;PLA2G4C;ABHD5;PCYT1B;MTMR12;PIK3R1;CLN3;DGKB
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.5659365656354519,0.8884137063319391,0.6415094339622641,1.0,1.0,3/9,22.15%,GNAI1;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.5659365656354519,0.8884137063319391,0.6415094339622641,1.0,1.0,3/9,22.15%,GNAI1;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.5537221147499495,0.8883063675964661,0.6666666666666666,1.0,1.0,3/9,17.48%,FUT9;MDK;ADTRP
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4593896436681974,-0.8880874927161393,0.5882352941176471,1.0,1.0,3/21,12.93%,SLC14A1;SLC14A2;CPTP
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.4825645803902636,0.8877844299780769,0.6078431372549019,1.0,1.0,7/15,35.15%,SOX11;PROX1;PKD2;PKD1;ALDH1A2;ZNF358;GRHL2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.5042271861957024,0.8877710414150332,0.62,1.0,1.0,2/15,2.31%,NDNF;SEMA5A
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.47555230481040867,-0.8877097775662324,0.576271186440678,1.0,1.0,4/21,19.93%,TSPYL5;CRYAB;XRCC6;TMEM109
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.5599139962703555,0.8876894888841262,0.673469387755102,1.0,1.0,2/5,14.77%,BMPR1A;ACVR1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.5321191227255084,0.8873949358961428,0.5961538461538461,1.0,1.0,3/9,12.80%,ERRFI1;PDGFRB;PIK3CA
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.5608156692972774,-0.8873769889546258,0.6666666666666666,1.0,1.0,3/9,7.45%,CCN3;VIP;SCN11A
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.45100846258954724,0.8871802809178915,0.7,1.0,1.0,8/26,22.07%,SLC1A2;PRAF2;SLC7A2;SLC38A2;SLC25A12;SLC7A9;SLC38A3;SLC1A3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4656333957009689,-0.8867454785456288,0.5555555555555556,1.0,1.0,5/19,18.70%,ATXN7L3;USP51;USP22;TAF10;USP21
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.4719298786085543,0.8866887121495579,0.7021276595744681,1.0,1.0,6/20,15.57%,DNAH5;DLL1;CFAP53;DNAI2;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.41412223257604586,0.8866308642699305,0.5686274509803921,1.0,1.0,14/46,13.88%,PBX1;HEY1;DTX4;MAML2;GMDS;MAML3;JAG1;DLL1;NOTCH3;WWC1;NLE1;SUSD5;MDK;EP300
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.5745053004354879,-0.8864766436217328,0.660377358490566,1.0,1.0,1/7,4.07%,DECR2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.42173125322459437,-0.8863232200630798,0.6046511627906976,1.0,1.0,5/41,6.74%,NCKAP1L;CLU;SERPINE1;B2M;GPC3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.5556413742380353,-0.8856554526744451,0.6551724137931034,1.0,1.0,1/7,9.61%,ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.5596534469116679,0.8854338531629316,0.6792452830188679,1.0,1.0,1/9,3.54%,FGFR2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.4026727679996134,0.8849309134574096,0.5925925925925926,1.0,1.0,4/56,5.99%,CHIT1;ITGAX;ITGAM;CSF1R
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.44805802825273927,0.8848809951053765,0.7105263157894737,1.0,1.0,10/38,18.20%,PTCHD1;GRM5;SOBP;LINS1;SHROOM4;CHD7;TUSC3;MGAT3;C5AR1;BBS4
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5789062857924321,-0.8848148015648866,0.6363636363636364,1.0,1.0,1/5,17.06%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5789062857924321,-0.8848148015648866,0.6363636363636364,1.0,1.0,1/5,17.06%,NRDE2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.43752775644311565,0.8847386844616953,0.6470588235294118,1.0,1.0,3/22,10.96%,ITGAX;IZUMO1;ITGAV
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.5815993782510019,0.8846428940208928,0.7073170731707317,1.0,1.0,1/6,5.92%,MLLT3
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.488235642250496,-0.884567952350096,0.6086956521739131,1.0,1.0,4/14,22.56%,RPF2;DDX18;FTSJ3;NIFK
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.48601659514649054,-0.8843069007646538,0.6363636363636364,1.0,1.0,2/8,19.55%,EXOSC10;ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.48601659514649054,-0.8843069007646538,0.6363636363636364,1.0,1.0,2/8,19.55%,EXOSC10;ERI2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5633507626027455,0.8840244342371805,0.6,1.0,1.0,2/6,23.20%,MOCS3;GPHN
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.554538930654797,0.8838278604765997,0.6607142857142857,1.0,1.0,3/8,21.93%,RAB34;CLN3;PIKFYVE
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.586736690193549,-0.8837374576424155,0.6666666666666666,1.0,1.0,1/5,14.91%,DERA
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.4959463508229843,-0.8835585876653919,0.6666666666666666,1.0,1.0,2/14,6.95%,B3GALT4;ST8SIA2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.35301723904520493,-0.8835421211688291,0.6415094339622641,1.0,1.0,33/159,16.75%,HK2;HSD17B10;TOMM40;PTCD2;TIMM17B;SPG7;DNAJA3;MYH14;MTX1;TOMM20;CHCHD10;COX7A1;TWNK;ATP5F1B;PINK1;ADCK1;DNM1;DNM1L;FANCG;FIS1;CHCHD2;ATP5F1D;TIMM17A;SUPV3L1;TOMM7;BIK;PRDX3;TMEM11;PARP1;POLRMT;TIMM50;AFG3L2;IFIT2
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5167748641695482,0.8834688356401293,0.6545454545454545,1.0,1.0,1/11,3.15%,CYP4Z1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.3916450611853681,-0.88325926610705,0.6964285714285714,1.0,1.0,10/64,15.27%,TXK;TEC;HCK;MADCAM1;PRAM1;CDH17;CEACAM1;ISG15;APOA1;CCM2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3515772492057973,0.8830978085544805,0.6363636363636364,1.0,1.0,19/148,13.02%,SGK3;SGK2;NLK;TGFBR1;RPS6KA4;CLSPN;LATS1;ERN1;PRKD1;DYRK3;EIF2AK3;SGK1;PRKCA;DYRK1A;PLK1;DYRK2;RPS6KA6;CAMK4;DCLK3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.3833535189622932,-0.8829296241495267,0.6981132075471698,1.0,1.0,15/88,18.12%,TMEM179;KIF1A;CELF3;ST8SIA2;STMN1;KIF5A;RND2;VGF;CCDC177;MAGEL2;PCDH8;TUBB2B;RGS8;CACNG4;STMN2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.5704916274352074,-0.8828865799297326,0.6122448979591837,1.0,1.0,1/5,8.36%,PNPO
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.5148194722899857,0.8826754797978197,0.6379310344827587,1.0,1.0,2/9,10.86%,NXF5;RBFOX1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.5157788557552564,0.8825045805673579,0.6730769230769231,1.0,1.0,1/12,0.98%,HORMAD1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.5157788557552564,0.8825045805673579,0.6730769230769231,1.0,1.0,1/12,0.98%,HORMAD1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.4296814206185447,0.8824796447571159,0.55,1.0,1.0,1/26,1.70%,HSPB1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.4909131794395902,-0.8822607755906943,0.6530612244897959,1.0,1.0,3/17,13.98%,RAC1;DBNL;GARRE1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.48361631694139906,0.882161423827738,0.6410256410256411,1.0,1.0,4/18,15.10%,ATP2B4;DYRK2;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.5180250282179618,-0.8820614175098397,0.6222222222222222,1.0,1.0,2/6,25.78%,FBL;NOP58
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.38741693446123343,-0.8819162190165875,0.6530612244897959,1.0,1.0,7/66,7.78%,PLEKHH2;CLU;KANK3;SHANK3;STMN1;MYADM;CRYAB
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.379556960268683,-0.881869158620402,0.6727272727272727,1.0,1.0,3/87,3.41%,GSTM5;GSTM3;PAPSS2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.501911958624063,-0.8810537760598917,0.5531914893617021,1.0,1.0,5/12,20.35%,CALM1;PRKG2;PTS;GCHFR;NOS3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.40890587178084015,0.8810297468171683,0.6346153846153846,1.0,1.0,12/70,12.65%,CALCR;CNR2;RXFP2;ADGRB3;FSHR;LGR5;ADGRL3;TBXA2R;PTGFR;GNAQ;ADGRL2;GNA13
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3560709956143299,0.8810035113321306,0.6363636363636364,1.0,1.0,39/220,12.75%,IL1RAPL2;CX3CR1;PBX1;SNTG2;KLHL17;ITGAM;SHROOM2;AFF2;DDIT4;CNTN4;THOC6;GLIS2;ROGDI;SYNJ2;MEIS1;SLC23A1;PBX3;CNTNAP2;ROBO2;POU6F2;SCTR;CA10;ADGRL3;ATXN1;SH3GL2;EPHA7;CDH2;MBP;C3;SHROOM4;DLL1;CHD7;ADGRL2;MEIS2;PSPN;GRIK1;ASIC2;NPAS1;RPS6KA6
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.587196179466197,0.8809257600857802,0.6538461538461539,1.0,1.0,1/5,8.00%,DYRK3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.44381591273301785,-0.8809122547443764,0.6363636363636364,1.0,1.0,3/22,8.80%,NCKAP1L;ITGA6;GLMN
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.5115688006704009,-0.8808795208853263,0.62,1.0,1.0,2/11,8.45%,METAP2;METAP1D
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.448778390074975,0.8807794111181201,0.6808510638297872,1.0,1.0,2/19,4.80%,MT1M;EGFR
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.42659527848626017,-0.8806608872590955,0.6071428571428571,1.0,1.0,5/37,9.23%,INHA;NOG;NODAL;RBPMS;BMP3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.48605133186516397,0.8805739570404357,0.6041666666666666,1.0,1.0,2/16,9.45%,ERN1;BMPR1A
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.5552871769538307,-0.8805337250487065,0.6727272727272727,1.0,1.0,3/7,33.17%,CTPS2;UMPS;CTPS1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4570978231772845,0.8804663574444503,0.5952380952380952,1.0,1.0,4/29,9.45%,PPARG;ERN1;PRKG1;BMPR1A
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.3974232054484155,0.8804265666676588,0.6382978723404256,1.0,1.0,2/37,4.84%,MYBPC3;SLC8A1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5416136989127093,-0.8803299812599397,0.6444444444444445,1.0,1.0,3/10,16.08%,SCARF1;CERS2;RTN4R
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.48951749688746293,-0.88028072548601,0.6222222222222222,1.0,1.0,1/15,0.56%,SFRP1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4409168499769969,-0.8802190564795884,0.574468085106383,1.0,1.0,6/20,19.76%,EXOSC10;NOP14;NOP9;KRI1;ERI2;FTSJ3
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.40032123959649013,0.8801613029092561,0.45652173913043476,1.0,1.0,6/51,8.72%,ENPEP;PLA2G10;PLA2G7;CYP3A4;RIDA;PLA2G15
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.4743948664586388,-0.8799916352358867,0.58,1.0,1.0,2/16,15.57%,SLX4;PARP1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5036266605281376,-0.8798552683359874,0.56,1.0,1.0,2/10,4.93%,TK2;PUDP
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.5493375901494872,-0.8797971835737043,0.7083333333333334,1.0,1.0,1/5,5.95%,SORD
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.47131472347421655,0.8797305415110118,0.6666666666666666,1.0,1.0,4/17,22.39%,PRSS3;CBLIF;TCN2;CUBN
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.47131472347421655,0.8797305415110118,0.6666666666666666,1.0,1.0,4/17,22.39%,PRSS3;CBLIF;TCN2;CUBN
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.45707574036751497,0.8796606420799069,0.6444444444444445,1.0,1.0,2/26,2.31%,NDNF;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3653889804035542,-0.8796555118267442,0.5957446808510638,1.0,1.0,13/116,9.46%,TERF2IP;TNFSF18;CLU;NTRK1;NLRP3;NFKBIB;PRKCH;UBC;RHEBL1;CARD9;DDRGK1;RBCK1;PIDD1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.48370214390676614,-0.8795242408320321,0.5660377358490566,1.0,1.0,3/13,12.83%,APOD;ADRA2A;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5479178687286387,-0.879364863546667,0.7142857142857143,1.0,1.0,2/8,11.37%,APOD;NDRG4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5010308244622714,0.8793245728864111,0.7169811320754716,1.0,1.0,5/16,15.04%,PPARG;HMGB1;FGFR1;MDK;MEF2C
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.3517758931834613,0.8792221800852756,0.7209302325581395,1.0,1.0,24/164,12.38%,RUNX1;PLCB1;KCTD8;SEMA5A;FGFR2;RFNG;SULF1;KIF26A;TCF7L1;RGS6;PRKD1;TULP3;RGS14;CDKN2AIP;RORA;NCK1;TSPAN15;SOCS2;PLCE1;TMEM108;DLL1;NCAM1;SIRT1;LIFR
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.37399935902657255,-0.8788433598525303,0.6829268292682927,1.0,1.0,4/89,3.79%,SELP;SERPINE1;NLRP3;NFKBIB
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5050527021986596,0.8787241651478396,0.6222222222222222,1.0,1.0,4/10,13.17%,PLA2G7;HMGB1;CCL5;CXCL12
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5793589386909697,0.8783289629329195,0.717391304347826,1.0,1.0,3/7,15.39%,ANK2;GJC1;KCNA5
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.5126375284563377,-0.8782421394989337,0.6304347826086957,1.0,1.0,2/9,6.56%,STX4;SPI1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.43137667547911446,-0.878238013584121,0.6346153846153846,1.0,1.0,5/32,13.09%,NUPR1;EIF5A;RACK1;DNM1L;FIS1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.43973754480147786,0.8782073401910916,0.6346153846153846,1.0,1.0,1/21,0.45%,NOX5
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.5471533930247153,-0.8781971609005316,0.6530612244897959,1.0,1.0,1/5,2.90%,RAC1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3390956038576879,-0.8779688817892387,0.6744186046511628,1.0,1.0,14/146,6.65%,SFRP1;ISM1;HK2;SARS1;FGF1;SERPINE1;ADAM12;COL4A3;ETS1;WARS1;NODAL;HTATIP2;NAXE;TSPAN12
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.5342830791603769,0.8777533636352092,0.6444444444444445,1.0,1.0,1/6,12.87%,ANK2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.515151696492236,0.8775240030613968,0.6363636363636364,1.0,1.0,3/8,19.78%,BMPR1A;ACVR1;DCHS1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.5793029316731282,-0.8773393038957069,0.6304347826086957,1.0,1.0,1/5,6.04%,XRCC1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.45276184892566984,-0.8770661164463773,0.5833333333333334,1.0,1.0,2/13,4.35%,RAC1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.509895036005525,-0.8770409975728553,0.5869565217391305,1.0,1.0,2/10,8.54%,ADRA2A;PACSIN3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.44625003314485845,-0.8770360119622926,0.56,1.0,1.0,7/30,18.17%,SEPTIN5;STX1B;HCRT;BAIAP3;PREPL;CAMK2A;PNKD
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.410037199391416,0.8766713009086533,0.66,1.0,1.0,3/34,7.20%,KCNE4;KCNJ3;CACNB2
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.4396306154213312,0.8766161410892596,0.6590909090909091,1.0,1.0,7/27,18.34%,SLIT2;NRP1;PKHD1;FGF10;CTNNB1;SALL1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.5048521276592938,0.8765853808523489,0.6612903225806451,1.0,1.0,5/10,15.91%,AGER;ADAM8;MDK;CD99;ICAM1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4591202297026098,0.8764825583972322,0.6491228070175439,1.0,1.0,8/21,22.47%,NAV3;FGF13;HDGFL3;CLASP1;TRIM54;CLASP2;ATXN7;APC2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.49159069134092137,0.8762311219894732,0.660377358490566,1.0,1.0,2/13,8.04%,NAV3;ZFP36
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.49909319748112013,-0.8762082989474258,0.56,1.0,1.0,4/11,24.37%,IFI27;NUCKS1;PPIB;EIF2AK4
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.4055361381254707,0.8757133540208129,0.6875,1.0,1.0,12/43,18.34%,FGFR2;SULF1;WNT5A;TGFBR1;MBNL1;HINFP;CHD7;FGFR1;LIG4;PROX1;FUT8;VEGFA
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.4305397642917883,-0.8756465881672999,0.6470588235294118,1.0,1.0,10/30,18.02%,CLU;HK2;IFI6;BAK1;DNM1L;FIS1;BIK;TIMM50;IFIT2;CAMK2A
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.35310060395348875,-0.875562105495777,0.7291666666666666,1.0,1.0,19/165,9.94%,INHA;LDHC;CSRP2;HK2;SERPINE1;CASP6;PLIN2;ETS1;SELENBP1;GPC1;MAFF;GPC3;PKP1;SDC2;PPP1R15A;BTG1;KIF5A;IGFBP3;ANKZF1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.49219119121032107,-0.8749632510481,0.6,1.0,1.0,4/14,19.48%,PPP1R15A;DDRGK1;SEC16A;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3953626680727083,-0.8747468894494496,0.6976744186046512,1.0,1.0,8/70,9.10%,ASB9;PLK3;RILP;GPC3;ADRA2A;VIP;PACSIN3;PLK2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.584003357292825,-0.8746563186270182,0.6041666666666666,1.0,1.0,2/6,20.53%,LIMD1;PTHLH
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.45974985840263083,0.8746292732403199,0.6153846153846154,1.0,1.0,5/18,13.64%,CSF1;CSF1R;CCL5;MSTN;MDK
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.39328799910489093,-0.8745255081436321,0.68,1.0,1.0,10/64,15.54%,SFRP1;RAC1;TPM1;STMN1;SYNPO2L;EPHA1;MET;SERPINF2;APOA1;ASAP3
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.4618749583160583,0.8742327111204699,0.6363636363636364,1.0,1.0,1/12,5.92%,MLLT3
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.501074947910946,-0.8741161954717167,0.6,1.0,1.0,4/12,17.77%,TAF11;TAF7;TAF1;POLR1E
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.43165906830871964,-0.8740731643616632,0.5769230769230769,1.0,1.0,11/22,32.26%,ISCU;NDOR1;ISCA2;NUBP1;NUBPL;HSPA9;NFS1;CIAO2B;HSCB;CIAO1;NFU1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3874372559470112,-0.873947188980958,0.660377358490566,1.0,1.0,10/68,11.90%,SH3RF2;CLU;TRIB2;ARIH2;DDA1;RBX1;DDRGK1;ELOB;RFPL1;RACK1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.44449579364134834,-0.8737594019168633,0.5813953488372093,1.0,1.0,7/26,25.05%,CELF3;SF3A2;SF3A1;SRSF10;SFSWAP;KHDC4;SF3A3
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.45896703076752954,0.8737024433805726,0.5531914893617021,1.0,1.0,10/36,14.13%,SPHK1;TRIP6;NR3C2;EGFR;AGER;LRRC19;IFI35;SASH1;EP300;RELA
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.4417662405825462,0.8736561196330536,0.7291666666666666,1.0,1.0,4/21,9.88%,LOXL2;TRPS1;TGFBR1;SOX5
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.35414800923047424,-0.873420778342381,0.5625,1.0,1.0,11/88,9.95%,TRIM55;LDB1;ADAM12;TPM1;ACTC1;MYH14;CRYAB;NPHS1;CACNG1;COX7A1;FHL2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.4994551148362726,-0.8733820405399365,0.6065573770491803,1.0,1.0,4/10,18.22%,ST6GAL1;GNPDA1;AMDHD2;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3343458725761645,0.8731442901538834,0.6363636363636364,1.0,1.0,57/206,19.38%,FAS;NTF3;IRS1;KANK1;KLF2;NLGN1;FGFR2;NRXN1;ROBO1;SULF1;TGFBR1;TP63;NRP1;ERN1;MAML2;SPIN1;CTBP2;MN1;CDKN2AIP;MAML3;HIF1A;MYORG;LMO3;C3;RSPO2;JAG1;PRKCA;STK36;TMEM108;DLL1;ITGAV;RIMS2;NPTN;ZBTB7B;SIRT1;CRLF2;SNX5;SASH1;EP300;SORBS1;VWF;PRKCB;RAB34;PIK3R1;SALL1;DISC1;ASXL1;CRADD;KAT2B;LIMS1;BMP6;LGR6;MBD5;KLK14;ARNT;CD80;DMTN
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.4785116867547422,0.8729883137720196,0.6041666666666666,1.0,1.0,4/12,13.82%,SYK;CCL5;PRKCA;ANK3
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.33870205186025093,-0.8723417928682105,0.6326530612244898,1.0,1.0,37/166,20.46%,TYMS;RPS27L;MIF4GD;NCL;RBM4;UPF3B;RBM3;UPF3A;ILF3;EIF1;CIRBP;ZNF540;NOLC1;PATL2;NIBAN1;EIF1B;RACK1;METTL3;EIF2B4;EIF4A2;EIF6;PUM3;RBM4B;NAT10;RPS6KA1;RPL5;TCOF1;THBS1;PIWIL2;EIF2B2;EPRS1;MTPN;GLE1;RPS3;EIF4G1;EIF4H;CNOT10
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),0.5315852167650266,0.8722914880304806,0.6428571428571429,1.0,1.0,1/5,17.74%,CD274
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4413866491335884,0.8721773590317983,0.6808510638297872,1.0,1.0,2/19,4.38%,MAN2A1;ST8SIA6
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.37461372907593293,0.8721649043886792,0.660377358490566,1.0,1.0,4/58,5.23%,ACE2;CASP12;PTGES;WNT5A
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.3643003536300834,0.8720777572350855,0.5581395348837209,1.0,1.0,17/93,13.61%,FLRT2;FIGN;GUCY1A2;SEMA6D;ADAMTS9;SLIT2;PTPRG;FBXL7;BMPR1A;PTPN14;IL17RD;ADGRL2;TENM3;LIFR;ANK2;GJC1;ENAH
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.3565414364413545,0.8717647146459266,0.6470588235294118,1.0,1.0,20/70,21.84%,FGFR2;CNTN4;BTBD3;PARD3;RYK;CTNNA2;LRP4;SLITRK5;MEF2A;ANK3;MEF2C;PARD6B;KLF7;MAP2;BAIAP2;ZDHHC17;RAB10;LLGL1;NTNG1;PAK3
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.48812144084808834,0.8717587357036936,0.6382978723404256,1.0,1.0,3/15,13.64%,RUNX1;NFATC2;MDK
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.5484671150258964,0.8715379959605383,0.6964285714285714,1.0,1.0,1/6,7.64%,IL21R
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.5484671150258964,0.8715379959605383,0.6964285714285714,1.0,1.0,1/6,7.64%,IL21R
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.48166299405369484,-0.8710562983250731,0.6222222222222222,1.0,1.0,3/17,16.28%,PLK3;TYRO3;KDR
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4073406388608327,-0.8707977133601126,0.6097560975609756,1.0,1.0,3/35,6.75%,NUPR1;RILP;ADRA2A
prerank,PanglaoDB_Augmented_2021__Neurons,0.33220463267338524,0.8706312794234391,0.7058823529411765,1.0,1.0,49/265,15.81%,SHISA2;CADM2;RIT2;PPP1R14C;LRRTM3;OLFM3;NRXN1;ADGRB3;NXPH1;GPR162;NCALD;ZCCHC7;GRM5;KCNK1;RNF220;CNTNAP2;GRIA4;AMER2;CA10;ELAVL4;RAB3C;RORA;CTNNA2;SH3GL2;LUZP2;SPOCK3;PCSK2;ACSL4;NOL4;LHFPL4;SYNPR;RBFOX1;PDE1A;NPY;GNAI1;UNC79;DLGAP1;GNL3L;PPFIA2;RGS7BP;ERC2;ZNF445;AIM2;GRIA2;CSRNP3;SACS;PCLO;PPP1R9A;CCDC28B
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.4374981609468492,0.8705652195956892,0.6363636363636364,1.0,1.0,7/24,13.17%,CACNB2;GRM6;CCL5;PDGFRB;P2RX7;ANK2;CXCL12
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.5775156840945054,-0.8704897808872982,0.6862745098039216,1.0,1.0,1/8,2.64%,CYP2E1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.39664477249939395,-0.8701525677628437,0.6875,1.0,1.0,4/36,11.79%,RILP;PLEKHF1;TMEM9;DNM1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.5242007680347248,0.8697872031069688,0.62,1.0,1.0,1/8,1.17%,KLKB1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.44916012903662356,-0.8695923733558926,0.6226415094339622,1.0,1.0,5/14,17.93%,ADAMTS12;EDEM2;FBXO6;CTSL;FBXO2
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6101827600691663,0.8695722077067282,0.7307692307692307,1.0,1.0,3/5,28.89%,RELA;NFKB1;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.4874540539356272,-0.869556949229595,0.6346153846153846,1.0,1.0,1/8,7.62%,VDAC2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.4495529755986258,-0.8694340461248369,0.64,1.0,1.0,5/16,18.85%,ASPG;FOLH1;NIT2;GOT2;ASS1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.492894793189399,-0.8694099726106282,0.7111111111111111,1.0,1.0,2/10,4.29%,REXO4;DNASE1L1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.37278664332210415,-0.8693937129643684,0.6875,1.0,1.0,28/105,22.50%,TSPYL2;DCTN1;WIPI1;EXOSC10;CHAC1;NFYB;NOP14;IFIT1;ATF4;NOP56;NOLC1;EIF4A2;EXOSC4;GEMIN4;TUBB2A;PSAT1;XPOT;SLC30A5;SRPRA;KHSRP;SPCS1;KDELR3;CKS1B;EIF4G1;SLC7A5;IARS1;MTHFD2;RPS14
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.5687581992970321,-0.8693900386608208,0.6363636363636364,1.0,1.0,5/6,40.74%,EIF2AK4;ULK2;ATG5;ULK1;PHB2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.39464934367694493,0.869337325529511,0.6923076923076923,1.0,1.0,10/61,10.45%,TYR;GNAT2;GUCY2F;ADGRV1;ABLIM1;MYO7A;POU6F2;GRM8;GRM6;ATF6
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.4360281278108299,0.8693247910168637,0.6,1.0,1.0,3/15,7.36%,SULF1;SLIT2;TWSG1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3509010215440345,0.8693034945927718,0.6875,1.0,1.0,26/126,14.19%,ACE2;SPHK1;NFKBIZ;PLA2G7;PPARG;CASP12;PTGES;WNT5A;SNCA;LRFN5;NR1D2;MFHAS1;CCL5;RORA;LPL;LRRC19;PDE2A;NLRC3;NR1H3;NAPEPLD;LPCAT3;IL16;IFI35;MDK;RELA;SETD6
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.4412376266781295,0.8691462839479327,0.6785714285714286,1.0,1.0,10/31,19.36%,CD8A;LEPR;GLI3;CHD7;ZFP36L2;LIG4;GPR89A;RAG2;RAG1;GPR89B
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.4292463559977265,0.8691237019944863,0.5294117647058824,1.0,1.0,4/28,14.60%,CENPI;KNL1;HELLS;CENPO
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4161013783781885,0.868861438260988,0.5813953488372093,1.0,1.0,11/31,18.38%,ADGRV1;SLC8A1;WNT5A;ACVR2A;BMPR1A;GPM6B;P2RX7;ACVR1;MEF2C;SOX11;BMP6
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5347016350977575,-0.8688344019061742,0.6086956521739131,1.0,1.0,2/10,3.19%,MYB;NLRP3
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3122023751048853,0.8686468054712058,0.7966101694915254,1.0,1.0,178/904,17.26%,MYRFL;FZD1;MED17;IFI16;ESRRG;ZFPM2;ZNF300;RUNX1;NFIL3;PLCB1;RGMA;ERBB4;KLF2;PPARG;RFPL2;ATOH8;LITAF;CREB5;HNF4G;HJV;FGFR2;PBX1;FANK1;LDB2;HMGB1;NRIP1;TFEB;SMAD7;PPARGC1A;NR5A2;TOX3;EGFR;ARID1A;ZNF827;IRF2BPL;WNT5A;ZEB2;GLIS2;WWOX;TGFBR1;RUNX2;TP63;ARID1B;RPS6KA4;RFX3;HEY1;MLLT3;FOXO3;NFIA;MEIS1;TEAD2;SP3;LMO7;ACVR2A;MRTFA;PPP3CA;NR3C1;PRKD1;SSBP4;NCOA2;MAML2;SMAD5;PSRC1;TBL1XR1;SPIN1;CTBP2;RFXANK;TCF4;SERTAD2;NR1D2;NPAS3;HDAC2;TWIST1;HINFP;ZNF516;SUPT3H;HDAC3;MAML3;RORA;GLI3;EPCAM;EIF2AK3;DVL2;UBP1;HIF1A;SMAD1;NFATC2;IER5;MSTN;BMPR1A;AUTS2;NCK1;SMARCD3;FOXO1;MITF;SSBP2;JAG1;ZGLP1;FLI1;ATF6;ASF1A;EDN1;DYRK1A;ASXL3;SMAD2;DLL1;MRTFB;CDH13;WNT8A;ACTA2;MEIS2;POU2F1;ST18;NR1H3;TP53INP1;SIRT1;RFXAP;CTNNB1;ING1;BTRC;RYBP;CSRNP2;CAMK4;SNX5;PPM1A;EPC1;PTOV1;ZNF175;FOSL2;HGF;ZBTB17;MEF2A;EP300;SMAD3;YAF2;GABPA;DPF3;RELA;PLAC8;CD38;E2F5;CREB1;ACVR1;SCX;MEIS3;CSRNP3;MEF2C;PID1;SLC9A1;OGT;TET2;PICALM;SCAF8;RARB;ACTR3;ELF1;NFATC3;HNRNPD;KLF7;ZXDC;PIK3R1;HIVEP3;TRERF1;DR1;SALL1;NANOG;RUVBL2;VEZF1;SOX11;HLF;ASXL1;NFIB;MAP3K5;PROX1;SATB2;ELF2;SMARCD2;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.42068426761192,-0.8686466363094468,0.64,1.0,1.0,3/26,8.72%,TXK;CD74;PARP14
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.5020859391271557,0.8686354501742056,0.5666666666666667,1.0,1.0,1/8,3.20%,LEPR
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.49278876669321403,0.868623320477249,0.6904761904761905,1.0,1.0,2/15,5.40%,SLC2A5;SLC2A14
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.4366821103679869,-0.8683018385922671,0.6382978723404256,1.0,1.0,2/21,4.39%,RAC1;VAV3
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.519181221572566,-0.8681699118540223,0.6888888888888889,1.0,1.0,2/9,5.47%,PLEKHH2;VIL1
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.5619442708060453,0.867761433264108,0.6666666666666666,1.0,1.0,3/5,38.70%,MECP2;GRHL2;KMT2A
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5269474740585225,0.8677225917643286,0.6590909090909091,1.0,1.0,3/11,4.39%,EFNA5;KANK1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5269474740585225,0.8677225917643286,0.6590909090909091,1.0,1.0,3/11,4.39%,EFNA5;KANK1;AP1AR
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.349828672158216,0.8674335095436849,0.673469387755102,1.0,1.0,42/227,15.41%,LTK;SLC26A3;KCNC2;IRS1;PTPRK;CX3CR1;HMGB1;NRIP1;HCN1;EGFR;EPHA3;WNT5A;SLIT2;GLRA2;ATP2B4;PDE4B;BRINP3;PRKD1;ZFP36;RORA;ABL2;LPL;FER;FOXO1;CRHBP;PDE2A;IP6K2;NR1H3;PDE3A;P2RX7;SLC26A6;SH3BP4;AKAP6;AGAP3;P2RY1;ADNP2;RELA;CREB1;INSIG1;MEF2C;PID1;CPEB4
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.48088487423221893,0.8674299757440461,0.6153846153846154,1.0,1.0,1/6,10.13%,SPTY2D1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.4067366947854509,0.8674270328526944,0.660377358490566,1.0,1.0,4/47,7.98%,VAPB;ERN1;EXTL1;DNAJC3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.326216284296127,-0.8673679693633592,0.7857142857142857,1.0,1.0,20/243,12.05%,TEKT3;PLK4;RAC1;RILP;TEKT5;RAB17;CFAP221;UBXN10;AHI1;TXNDC15;FGD3;PARVB;ATP6V1D;CFAP52;TRAPPC14;DZIP1L;TCTN1;TRAF3IP1;B9D1;EHD4
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.5487354267616753,-0.8670175106042597,0.7058823529411765,1.0,1.0,1/5,6.60%,SHANK3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5652339946818303,0.8670043138043062,0.6481481481481481,1.0,1.0,1/6,4.02%,EGLN3
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.4407575704683222,0.8669130810470778,0.5510204081632653,1.0,1.0,5/27,12.28%,CX3CR1;ELAPOR2;HEY1;DLL1;CTNNB1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.3982862188870898,-0.86657160986184,0.68,1.0,1.0,11/50,24.39%,ADAMTS12;CTSO;CTSH;CLTA;RAB12;CTSL;SPATA18;CTSB;AP2A1;AP2S1;DAB2IP
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.5242972644320264,0.8661701024380306,0.6956521739130435,1.0,1.0,2/7,17.73%,ATG9A;ATG2B
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.3968581489470807,0.8660155722071184,0.7142857142857143,1.0,1.0,14/33,23.86%,ATP2B4;GLA;EP300;ACADVL;CRY1;PROX1;ROCK2;NFKB1;FYN;ACADL;SIRPA;ERLIN1;RAPGEF2;FBXW7
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.46800131519279,0.8657257228316886,0.7115384615384616,1.0,1.0,7/20,18.82%,TP63;PPP1R13B;BCL2;TP53BP2;MAPK8;YWHAZ;BAD
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.46800131519279,0.8657257228316886,0.7115384615384616,1.0,1.0,7/20,18.82%,TP63;PPP1R13B;BCL2;TP53BP2;MAPK8;YWHAZ;BAD
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.48186715130954233,-0.8654654394504424,0.7,1.0,1.0,2/15,6.27%,TRPC3;P2RY11
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.5394074245051736,-0.86538853974835,0.6666666666666666,1.0,1.0,1/8,4.67%,KIF20B
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5376455965632216,0.8651779726771964,0.6470588235294118,1.0,1.0,2/6,11.50%,TOR1AIP2;PLK1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.5320205259369606,-0.865128806336064,0.6101694915254238,1.0,1.0,1/8,7.26%,CHAC1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4604220802110808,0.8642081962289196,0.6956521739130435,1.0,1.0,1/14,2.44%,KANK1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.4719316322424017,0.8641841240279877,0.7111111111111111,1.0,1.0,7/18,19.39%,RUNX1;CD22;PRKCB;ELF1;PAX5;ELF2;CBFB
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.38244002771549673,0.8641503249729183,0.6226415094339622,1.0,1.0,17/74,15.41%,NDNF;NTF3;EGLN3;PPARGC1A;TOX3;FOXO3;GRID2;SLC30A10;EPHA7;ADAM8;CTNNB1;LANCL1;LIG4;MDK;BCL2;MEF2C;CPEB4
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4599973290824722,-0.8639192260669452,0.6458333333333334,1.0,1.0,6/24,20.47%,RBM4;PDE6B;PER2;RBM4B;PPP1CA;FBXL12
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.3875732234893471,-0.8637283860016869,0.6666666666666666,1.0,1.0,10/91,8.54%,INHA;AMH;CYP19A1;RND3;SEZ6L2;ADAMTS15;GPC1;MCAM;FKBP10;PACSIN3
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.4867715053425383,0.8636411932132113,0.68,1.0,1.0,1/7,6.49%,CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.48693900335295126,0.8633323278104311,0.631578947368421,1.0,1.0,5/14,15.34%,SLC30A10;CDK6;TWIST1;SIRT1;MARCHF5
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.45198392492839023,-0.8632988744028754,0.7017543859649122,1.0,1.0,4/19,13.33%,SDHC;UQCRH;UQCRC1;ATP5F1D
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.5419155681802624,0.8632278392676092,0.6666666666666666,1.0,1.0,2/5,8.91%,FRMPD4;CTNNA2
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.3410767348703748,-0.8631385113026411,0.7407407407407407,1.0,1.0,17/131,10.41%,NMB;TAGLN;COL6A1;HSD11B1;AZGP1;PXMP2;ADAM12;EPAS1;COL6A2;EPSTI1;FGF7;BCAT2;CRYAB;COX7A1;CYP1B1;CFD;ADAM33
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.4563485019928129,-0.8629674353779517,0.6779661016949152,1.0,1.0,4/21,18.71%,KIF1A;KIF5A;TUBA1B;CCDC186
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.510973064689588,-0.862898473303671,0.6304347826086957,1.0,1.0,1/8,1.32%,NUPR1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.4895559168468529,0.862254441044556,0.6226415094339622,1.0,1.0,3/11,18.34%,NRP1;CTNNB1;VEGFA
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5718327035939035,-0.8622534560511025,0.7037037037037037,1.0,1.0,2/5,18.81%,NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5059833265571116,-0.8618718137940832,0.6481481481481481,1.0,1.0,2/10,18.26%,EDEM2;SEC16A
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.534867884053104,-0.8613823143953346,0.75,1.0,1.0,1/9,4.85%,ACTC1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.36949537071053923,0.8610903636662822,0.62,1.0,1.0,16/72,13.52%,HSPB1;SEMA5A;ATOH8;HMGB1;WNT5A;RHOB;NRP1;NUS1;PRKD1;HIF1A;EDN1;PRKCA;FGFR1;SIRT1;BCAR1;SASH1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.40122754422494517,-0.8610323143591722,0.6304347826086957,1.0,1.0,11/72,11.66%,AMDHD1;SARDH;HSD17B10;IL4I1;HMGCL;BCKDK;BCAT2;AASS;NOS2;SLC25A44;ABAT
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.49165183461933837,-0.8609808496521284,0.673469387755102,1.0,1.0,4/10,11.90%,ATF4;NONO;PINK1;RACK1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.4374632155615763,0.8609593263424016,0.5319148936170213,1.0,1.0,2/26,5.02%,CENPI;KNL1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.4374632155615763,0.8609593263424016,0.5319148936170213,1.0,1.0,2/26,5.02%,CENPI;KNL1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.34659740601281863,-0.8609031169021409,0.7636363636363637,1.0,1.0,9/94,11.33%,NCKAP1L;CD74;SPG7;VIL1;FANCC;CHCHD10;TUBGCP2;ELOB;NUP133
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.43881819688838447,-0.8601449426094024,0.6511627906976745,1.0,1.0,4/24,6.11%,NCKAP1L;TEC;VAV3;SH2B2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.38763095927924424,-0.859962715597982,0.7090909090909091,1.0,1.0,10/44,19.61%,H1-4;H1-0;DAXX;HMGB2;CHAF1A;CTCF;SMARCA5;MACROH2A1;H1-2;POLE3
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.4381612838994364,-0.8599610776810906,0.6153846153846154,1.0,1.0,4/23,9.57%,SARDH;HSD17B10;IL4I1;THNSL2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5745531883076637,0.8598979240479478,0.7454545454545455,1.0,1.0,1/8,2.78%,RSPH6A
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.5682659207330878,0.8598420939552203,0.6938775510204082,1.0,1.0,1/6,6.82%,SNCA
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.4498435375908503,0.8596152654711914,0.7391304347826086,1.0,1.0,2/18,4.80%,MT1M;EGFR
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.431674134428769,-0.8593582669273458,0.6346153846153846,1.0,1.0,11/21,32.26%,ISCU;NDOR1;ISCA2;NUBP1;NUBPL;HSPA9;NFS1;CIAO2B;HSCB;CIAO1;NFU1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.4383678935649024,0.8592914217354599,0.5957446808510638,1.0,1.0,2/15,7.43%,INTS6;INTS11
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.4346088030012307,-0.8591849433959299,0.6481481481481481,1.0,1.0,5/19,18.14%,GNB3;ABCB11;NR1H4;ASAH1;EPHX2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.4088707661762133,0.8591607889613457,0.6666666666666666,1.0,1.0,8/40,15.50%,NRXN1;SNCA;SYT1;RIMS2;PPFIA3;SYN3;LIN7A;PCLO
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4581922416890599,-0.8590372228868816,0.6888888888888889,1.0,1.0,6/25,20.47%,RBM4;PDE6B;PER2;RBM4B;PPP1CA;FBXL12
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.4953691674906239,-0.8588220580357504,0.625,1.0,1.0,4/8,27.50%,PER2;PIWIL2;CRY2;SUV39H1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.40491461263676065,0.8586641725498741,0.5777777777777777,1.0,1.0,3/25,5.20%,PPARG;ATOH8;SULF1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.47216143591074855,-0.8585966756991418,0.6140350877192983,1.0,1.0,2/13,6.63%,CASP6;RYR1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.49777031844256237,-0.8580842230464919,0.6415094339622641,1.0,1.0,3/11,9.63%,TMSB4X;ZNF593;PER2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.49481483572128476,-0.8580217624408042,0.6557377049180327,1.0,1.0,2/16,7.32%,APOD;LATS2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5427564914454758,0.8579437883418094,0.6904761904761905,1.0,1.0,1/6,3.01%,ZBTB1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.44311128935764377,0.8579249365680236,0.5714285714285714,1.0,1.0,3/22,7.39%,PNP;FHIT;REXO2
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3958525862343081,-0.8577709241950291,0.6666666666666666,1.0,1.0,8/34,14.29%,CLU;SERPINE1;B2M;AHI1;CD63;DGKD;PPT1;SFRP4
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.4246345205376827,-0.8575491416627025,0.6666666666666666,1.0,1.0,5/24,14.26%,EXOSC10;NUDT16;POP1;EXOSC4;DIS3L
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.48624443711164256,0.8572327209461698,0.6909090909090909,1.0,1.0,4/14,15.04%,MCTP1;CHRNB4;SNCAIP;MEF2C
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.5273373902082533,0.8570162398977098,0.6551724137931034,1.0,1.0,1/6,12.06%,P2RX7
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.3878230455487379,0.8569507195798103,0.5576923076923077,1.0,1.0,11/44,19.49%,RHOB;CNKSR1;CDH13;GNA13;ARHGAP5;ADGRG1;ROPN1B;PHACTR4;EPS8;ROCK2;ARHGEF3
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.5291501301332464,0.856917515063382,0.6981132075471698,1.0,1.0,2/7,7.52%,ERBB4;ZSWIM6
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.5467674619219844,0.8567867716925229,0.7021276595744681,1.0,1.0,2/6,12.11%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5027518751992286,0.8567243730602099,0.5217391304347826,1.0,1.0,2/9,12.87%,LRRC38;ANK2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.5146268311219687,0.8567102194511935,0.723404255319149,1.0,1.0,2/10,11.28%,CD59;C4BPB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.40360230754675364,0.856394815528139,0.64,1.0,1.0,6/33,11.03%,ERN1;CCL5;BMPR1A;PDGFRB;EDN1;CDH13
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.5129799174838477,-0.8561798776750711,0.660377358490566,1.0,1.0,2/6,7.60%,PAH;BCAT2
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.550027569778699,0.8561277899284513,0.7209302325581395,1.0,1.0,2/5,10.21%,FGFR2;FGF10
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.38003920549602077,-0.8560953595243334,0.6296296296296297,1.0,1.0,15/62,21.49%,DND1;WTIP;POLR2I;POLR2J;LIMD1;NUP133;NUP43;POLR2G;POLR2C;NUP155;POLR2L;EIF4G1;NUP85;STAT3;POLR2K
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3405560946643637,-0.8558826458119169,0.7,1.0,1.0,11/158,8.78%,DSC1;CLDN4;AMH;GTF2F1;STX4;COL9A1;ACTC1;MYL12B;MADCAM1;CRAT;DHX16
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.43723929588740423,0.8557632003977995,0.5714285714285714,1.0,1.0,9/17,33.94%,PID1;PICALM;BCL2L1;PKDCC;PPP2R5A;RHOQ;MRAP;TMBIM1;TMEM59
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4210993361667024,0.8557434471598979,0.65,1.0,1.0,2/25,1.75%,CA9;SLC26A7
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.4814284820915644,-0.8557194716639619,0.7213114754098361,1.0,1.0,2/18,7.45%,MYH14;SCN11A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.41914383748697936,0.855598908209777,0.6666666666666666,1.0,1.0,10/45,12.25%,HSPB1;PPARG;HMGB1;ATP2B4;NUS1;PRKD1;HIF1A;PRKCA;FGFR1;SIRT1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.45708851221672675,-0.8555071254926772,0.64,1.0,1.0,2/17,9.16%,MYO15A;MYO7B
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.40341337238704883,0.8554059710257171,0.6470588235294118,1.0,1.0,6/37,9.59%,B4GALNT2;ABO;ST8SIA6;B4GALT1;GLA;FUT9
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.37679545452255997,0.8549448499769032,0.7659574468085106,1.0,1.0,7/61,13.64%,B4GALNT2;SEMA5A;DSCAM;JAG1;CDH13;KNG1;MDK
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.5302109285296391,-0.854824010123519,0.6595744680851063,1.0,1.0,1/7,12.38%,NECAB2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5151994534828438,0.8542662264455935,0.6590909090909091,1.0,1.0,7/11,34.47%,CLN3;TMEM39A;PHF23;TBC1D25;UVRAG;RUBCN;CALCOCO2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.48186135991900725,-0.85417095598142,0.6730769230769231,1.0,1.0,1/10,0.49%,NCKAP1L
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.383518922506582,0.854103020906215,0.7222222222222222,1.0,1.0,8/56,6.75%,SULT2A1;SLC26A7;FRK;ACKR2;OIT3;SLC23A1;CYP3A4;C6
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.3808481281258449,0.8540381458639628,0.723404255319149,1.0,1.0,9/68,12.97%,SPHK1;DCUN1D1;SMAD7;ARRDC3;HDAC3;PLK1;PRICKLE1;MARCHF7;NDFIP2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.48319681971825373,-0.8539387281424231,0.6153846153846154,1.0,1.0,1/8,4.90%,KNSTRN
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.42022892128723344,-0.8537009581074267,0.6521739130434783,1.0,1.0,3/32,7.65%,SFRP1;MEOX1;ACE
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.48283065116688334,0.8536576136862941,0.5925925925925926,1.0,1.0,1/14,1.59%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.5180200109918558,-0.8535830996470849,0.6521739130434783,1.0,1.0,3/6,19.42%,RACK1;KDR;TRPM4
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5392173345530366,0.8535753131683024,0.6666666666666666,1.0,1.0,1/6,5.17%,BTLA
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.44356157547362307,-0.853317512003587,0.72,1.0,1.0,6/24,16.80%,FABP5;FABP6;LIPC;LIPI;PNPLA1;FABP7
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.35506070444566024,0.8531630133772994,0.75,1.0,1.0,34/114,23.38%,LRIG3;GPC6;EGFR;AIF1L;SNX7;ERRFI1;RORA;CDR2L;DDAH1;ADGRL2;CLDN12;SLC7A2;BCAR1;SH3BP4;BOK;AMOTL2;MAGI1;LGR4;TSPAN9;GNG12;FKBP5;PC;PKDCC;ALDH4A1;DHCR24;ZDHHC9;CPE;PLXNB1;GALNT18;ARHGEF17;BCAT1;LAMB2;DAG1;LRP5
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.45795093183956526,-0.8529519236469659,0.68,1.0,1.0,4/9,18.86%,ADAMTS12;PIK3CB;SPRY2;IL12A
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3592064186866919,-0.8524800125355618,0.7090909090909091,1.0,1.0,18/53,26.94%,COX7A1;PINK1;NUP133;NUP43;FIS1;UQCC2;EIF6;NUP155;GCKR;ATP5IF1;NUP85;ABCD1;NUP214;COX7A2;SEC13;BEND3;SLC2A6;NUP50
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.36921696171282054,0.8524154753378305,0.7619047619047619,1.0,1.0,6/50,9.71%,STK26;PTPRK;EGFR;CAT;HIF1A;FER
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.34302090231359256,-0.852383811505208,0.7884615384615384,1.0,1.0,16/125,9.90%,CCN3;MMP26;AOAH;HCK;CRH;NLRP3;GPR83;P2RY11;GPR39;VIP;CRHR2;DRD1;HRH2;PLK2;PRKACA;PTH2R
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.5019221683034105,-0.8523435309837256,0.6458333333333334,1.0,1.0,2/10,5.34%,LOXL4;LOXL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.44170723815349267,-0.8522608003980756,0.6304347826086957,1.0,1.0,7/28,17.26%,NCL;RBM3;CELF3;CIRBP;SNW1;RBM22;RBMX
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.5141045808729827,-0.851974811746132,0.7,1.0,1.0,1/8,4.70%,GNPTG
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4309003947129161,-0.8518730415763145,0.6938775510204082,1.0,1.0,8/26,15.99%,XPC;UBC;RBX1;GTF2H2;CETN2;DDB1;PARP1;ERCC2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5473445919336224,0.851776504104365,0.6956521739130435,1.0,1.0,2/7,19.98%,YWHAZ;ARHGAP21
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.41801879451548807,-0.8516245683103019,0.6595744680851063,1.0,1.0,3/28,1.59%,CLDN4;CBLC;TMEM184A
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.29271428345196304,0.8515393142919933,1.0,1.0,1.0,253/1686,15.11%,DACH1;MYRFL;LOXL2;FZD1;MED17;TSHZ2;IFI16;ESRRG;NRG1;ZFPM2;ZNF300;NAB1;CCNH;RUNX1;PKNOX1;TPRX1;TFCP2L1;NFIL3;ZBTB2;PLCB1;ERBB4;ZNF792;TGIF1;KLF2;PPARG;PTPRK;RFPL2;BNC2;ATOH8;ZBTB1;LITAF;ZNF600;CREB5;ZNF114;ZSCAN20;HNF4G;TSHZ1;ZBTB10;PBX1;BBX;FANK1;NR3C2;ZBTB9;HMGB1;BATF3;ZNF697;FOXD4L5;ZNF706;TFEB;PRRX1;SMAD7;PPARGC1A;NR5A2;MTERF3;ZEB1;BAHD1;TOX3;EGFR;TRPS1;MAGED1;ARID1A;NLK;IRF2BPL;NEUROD2;WNT5A;ZEB2;GLIS2;ZNF257;NR2E1;TSHZ3;TGFBR1;ZNF165;RUNX2;TP63;ARID1B;RPS6KA4;SRCAP;ZNF20;ZBTB5;RFX3;TCF7L1;HEY1;MLLT3;FOXO3;ELP4;HIVEP2;NFIA;MEIS1;ATP2B4;TEAD2;ZNF202;DACH2;IKZF2;ZNF408;LCORL;SP3;HDAC9;FOXP2;PBX3;KCTD1;DENND4A;NR3C1;NCOA2;POU6F2;MKX;TRIM22;SMAD5;TULP3;PSRC1;TBL1XR1;SPIN1;ZNF613;ZBTB20;ATXN1;MYPOP;CTBP2;JMJD1C;RFXANK;RGS14;TCF4;NR1D2;NPAS3;HDAC2;TWIST1;HINFP;TOX;ZNF518A;ZNF516;ZNF493;SUPT3H;HDAC3;ZNF205;ZNF433;RORA;GLI3;ZNF283;ZNF782;DVL2;ZNF211;UBP1;HIF1A;ZNF732;ZNF675;SMAD1;SOX7;NFATC2;FOXO6;PHC2;MSTN;ZBTB34;BCOR;SMARCD3;ZSCAN22;TLE1;DMTF1;SOX5;FOXO1;MITF;SSBP2;SPTY2D1;ZGLP1;SLC39A8;ZNF677;FLI1;SPINDOC;ATF6;TSFM;KLF12;DYRK1A;ZNF630;SMAD2;MXD4;ZNF526;CHD7;ZNF616;ZFHX4;SMAD9;ARID5B;ACTA2;GPBP1L1;WWC1;BAZ2B;MEIS2;POU2F1;ST18;NR1H3;ZNF582;BRDT;TP53INP1;SMURF2;ZBTB7B;ZSCAN25;SIRT1;RFXAP;CTNNB1;TBX19;MED13L;ING1;BTRC;PRICKLE1;NPAS1;RYBP;ACVR1B;CSRNP2;ZNF396;CAMK4;TENM1;MLF1;SNX5;ID3;PPM1A;ZNF536;ZNF273;EPC1;ZBTB40;ZNF175;HIC2;ZNF646;FOSL2;FOXN3;THAP11;ZBTB17;MEF2A;EP300;SMAD3;YAF2;ZNF212;GABPA;ZNF445;DPF3;RELA;TBX6;NACC2;ETV6;CD38;ZBTB26;MNAT1;E2F5;CREB1;ZNF189;ZNF850;ZNF142;ACVR1;SCX;ZBTB37;MEIS3;RUNX1T1;CSRNP3;NFYC;MEF2C;ZNF45;ZNF320;SP4
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.45918310122471173,-0.8513000727435586,0.5882352941176471,1.0,1.0,6/12,23.90%,MAGEL2;ARPC5;IQGAP2;ARPC2;ARPC3;WHAMM
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.39191310186624595,0.8512447232559605,0.7674418604651163,1.0,1.0,6/33,11.39%,NTF3;EGFR;ABL2;PDGFRB;GNAQ;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4581692497711685,-0.8511755969997296,0.7111111111111111,1.0,1.0,2/13,19.97%,ZRANB3;ZNF830
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.4477698990853458,0.8511703198701532,0.6530612244897959,1.0,1.0,5/17,18.00%,CRPPA;TMTC2;POMGNT2;TMTC3;DPM1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.500075840176422,0.8508623163488515,0.7291666666666666,1.0,1.0,4/11,15.73%,RP1;GNAQ;PDE6A;CNGB1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.48696524723259765,-0.8505938337800321,0.6551724137931034,1.0,1.0,5/11,14.12%,SERPINE1;TPM1;IGFBP3;NDRG4;CORO1B
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39523119135409157,0.8503711342163747,0.7272727272727273,1.0,1.0,5/43,5.96%,EFNA5;KANK1;CASS4;AP1AR;NRP1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.3515402638162996,-0.850341601365055,0.7307692307692307,1.0,1.0,27/149,16.88%,PARP2;RAD51AP1;ABRAXAS1;DTX3L;SLX4;ERCC1;RNF8;XRCC1;PRPF19;KPNA2;MDC1;MORF4L1;HMGB2;KDM4D;XRCC2;POLM;HUS1;POLL;NUCKS1;INO80;ZSWIM7;PARP1;AP5S1;XRCC3;CYREN;SMARCA5;RECQL
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.37767985986819014,-0.8502698994780278,0.7962962962962963,1.0,1.0,5/61,6.35%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.556117589299502,0.8502140492011117,0.7142857142857143,1.0,1.0,3/5,38.09%,MAPK14;ATP11A;PIEZO1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.4443240375246657,-0.8500218086716373,0.6595744680851063,1.0,1.0,3/24,5.87%,ATXN7L3;DTX3L;SKP1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.37879149823181,-0.850001597868335,0.6530612244897959,1.0,1.0,5/56,7.20%,PIGO;PORCN;PGAP2;WIPI1;SELENOK
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.4948326520235118,-0.8497751174950123,0.6379310344827587,1.0,1.0,5/9,36.57%,PIAS3;PIAS4;RASD2;MUL1;UBA2
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.5377161293312549,0.8496699227202469,0.6724137931034483,1.0,1.0,2/6,26.02%,MYO3B;MYO3A
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.537918020633172,0.8496571912115057,0.6428571428571429,1.0,1.0,4/7,32.95%,WASHC1;CDC42EP3;CDC42EP4;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.537918020633172,0.8496571912115057,0.6428571428571429,1.0,1.0,4/7,32.95%,WASHC1;CDC42EP3;CDC42EP4;F2RL1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.4234749708245076,0.8492793184277591,0.6296296296296297,1.0,1.0,8/25,18.98%,PDE4D;PDE2A;MARVELD2;ICAM1;TJP3;AFDN;RAPGEF6;RAP1A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.3731716093955626,-0.8492726736491837,0.7708333333333334,1.0,1.0,13/72,14.63%,TMIE;COL4A3;PDZD7;KCNE1;CEMIP;TBL1X;MYH14;MYO7B;NDUFB9;GRXCR2;KCNQ1;TSPEAR;SNAI2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5042930264848057,0.8488480942037727,0.6607142857142857,1.0,1.0,3/12,9.34%,PPARG;CIDEA;LPL
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4090779129592759,0.8485566751361363,0.6153846153846154,1.0,1.0,11/70,9.45%,HEMGN;PPARG;FGFR2;RUNX2;TP63;ACVR2A;PRKD1;CDK6;TWIST1;RANBP3L;BMPR1A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4778989217872699,0.8485229777494192,0.6136363636363636,1.0,1.0,3/15,5.48%,NLGN1;NRXN1;TSHZ3
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.3545058051416791,0.8485161386474721,0.723404255319149,1.0,1.0,21/102,13.63%,MXRA5;PPARG;LDB2;PRRX1;GFAP;POSTN;SLC8A1;SULF1;CCN2;PDZRN3;NID2;ADAMTSL1;FBXL7;COLEC11;PDGFRB;FGF10;ACTA2;TIMP3;COL5A2;CXCL12;HGF
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.41556374965894827,-0.8482561581094584,0.7346938775510204,1.0,1.0,6/24,20.87%,EIF5A;IFI6;ARF1;RRP1B;IL12A;VWCE
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3279643483296373,-0.8481390932875067,0.7021276595744681,1.0,1.0,17/190,9.46%,STING1;TERF2IP;TNFSF18;CLU;NTRK1;NLRP3;NFKBIB;BEX1;PRKCH;NODAL;UBC;MBTPS2;RHEBL1;CARD9;DDRGK1;RBCK1;PIDD1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5168567322274856,-0.848132977635207,0.6122448979591837,1.0,1.0,1/13,2.48%,APOD
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.5515789436840715,0.8480135055036394,0.6206896551724138,1.0,1.0,2/6,19.95%,PDGFB;PTPRO
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.4757975269507897,-0.8479943616646932,0.6428571428571429,1.0,1.0,3/17,7.65%,WTIP;NEK8;LIMD1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.47949814724119266,-0.8476807427431817,0.7115384615384616,1.0,1.0,3/18,8.60%,NUPR1;CDK5;ATF4
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.571533520890003,-0.8476169959293903,0.75,1.0,1.0,1/5,12.93%,DNM1L
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.43974364686645667,0.8475065761969145,0.6808510638297872,1.0,1.0,6/27,12.28%,CX3CR1;HEY1;HDAC9;FOXO1;DLL1;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.30733348064673127,0.8474518368001047,0.9107142857142857,1.0,1.0,139/684,17.26%,MED17;IFI16;ZFPM2;ZNF300;RUNX1;RGMA;KLF2;PPARG;ATOH8;LITAF;HNF4G;HJV;FGFR2;PBX1;LDB2;HMGB1;NRIP1;TFEB;SMAD7;PPARGC1A;NR5A2;TOX3;EGFR;ZNF827;IRF2BPL;WNT5A;ZEB2;GLIS2;WWOX;RUNX2;TP63;RPS6KA4;RFX3;HEY1;FOXO3;NFIA;MEIS1;SP3;LMO7;ACVR2A;MRTFA;PPP3CA;NR3C1;PRKD1;SSBP4;NCOA2;MAML2;SMAD5;TBL1XR1;CTBP2;RFXANK;TCF4;NR1D2;HDAC2;TWIST1;HINFP;HDAC3;MAML3;RORA;GLI3;EPCAM;DVL2;UBP1;HIF1A;SMAD1;IER5;BMPR1A;AUTS2;NCK1;SMARCD3;FOXO1;MITF;SSBP2;JAG1;ZGLP1;ATF6;EDN1;ASXL3;SMAD2;DLL1;MRTFB;CDH13;CDK12;WNT8A;NOTCH3;SMAD9;WWC1;MEIS2;POU2F1;ST18;NR1H3;SIRT1;RFXAP;CTNNB1;CSRNP2;EPC1;PTOV1;ZNF175;FOSL2;HGF;ZBTB17;MEF2A;EP300;SMAD3;GABPA;DPF3;RELA;PLAC8;E2F5;CREB1;ACVR1;SCX;MEIS3;CSRNP3;MEF2C;PID1;SLC9A1;OGT;TET2;RARB;ACTR3;ELF1;NFATC3;KLF7;PIK3R1;TRERF1;DR1;SALL1;NANOG;RUVBL2;VEZF1;SOX11;HLF;ASXL1;NFIB;PROX1;SATB2;SMARCD2;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4631024321804136,0.8474339151082707,0.62,1.0,1.0,2/19,3.59%,RUNX1;CSF1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.43086247169763303,-0.8471418037891544,0.6851851851851852,1.0,1.0,4/29,7.42%,PLEKHH2;KANK3;SHANK3;MYADM
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4416591830119854,0.8468304606886065,0.7,1.0,1.0,5/21,18.00%,CRPPA;TMTC2;POMGNT2;TMTC3;DPM1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.5500330648284066,0.8466770995396223,0.6862745098039216,1.0,1.0,1/5,9.80%,DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.5500330648284066,0.8466770995396223,0.6862745098039216,1.0,1.0,1/5,9.80%,DHRS7B
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.42028951627160044,-0.8466043821430659,0.723404255319149,1.0,1.0,4/26,6.74%,GPC2;CDK5;GPC1;GPC3
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3271977986026155,-0.8464264010111315,0.8181818181818182,1.0,1.0,19/184,9.46%,NLRP1;DDX41;HK2;PLK3;CASP6;NLRP3;IFI27L2;CDK5;CIDEB;GADD45A;MAL;TCHP;IFI27L1;IFI6;PAK6;PPP1R15A;TRAF7;IFI27;PIDD1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4193539572523495,0.8463708526314648,0.6444444444444445,1.0,1.0,10/29,18.25%,NEDD4;FGF12;FGF14;FGF13;ANK3;NETO1;DMD;NEDD4L;SLMAP;HECW2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.3217627406135956,-0.8459530198072861,0.7719298245614035,1.0,1.0,40/231,17.31%,USP27X;ADRM1;PSMA7;NLRP3;ABRAXAS1;UCHL1;USP40;MBD6;PSMD7;UBC;USP20;PSMB4;PSMC3;TAF9B;TOMM20;COPS6;USP11;UFD1;PSMD8;PSME1;ACTB;USP35;PSMB2;USP51;PSMC4;PSMB8;NFKBIA;COPS7A;PSMC1;PSMB5;PSMD2;INO80;PSMA1;USP1;USP48;PSMD10;USP22;USP4;TAF10;USP10
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.49665586509703774,-0.8459412842952122,0.6739130434782609,1.0,1.0,2/9,7.05%,ASCL1;PAX6
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.5172802162636448,0.8456011091858902,0.6744186046511628,1.0,1.0,2/5,12.46%,EDN1;BCAR1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.4854290511621526,0.8454789148951036,0.6744186046511628,1.0,1.0,3/11,9.57%,SLC22A2;SLC22A6;TPD52
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.4510346941795504,-0.8454761349657105,0.7358490566037735,1.0,1.0,1/17,2.17%,UPB1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.39985172225072213,0.8453861521724966,0.6346153846153846,1.0,1.0,14/41,20.90%,TM4SF20;SPOP;HDAC2;PLK1;BTRC;RNF139;KNG1;OGT;PLAT;DNAJC1;CLN3;BAD;TRIM32;SPOPL
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3739216359084182,-0.845143878471096,0.7083333333333334,1.0,1.0,13/69,14.63%,TMIE;COL4A3;PDZD7;KCNE1;CEMIP;TBL1X;MYH14;MYO7B;NDUFB9;GRXCR2;KCNQ1;TSPEAR;SNAI2
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.5195510252875613,-0.8450435115204799,0.66,1.0,1.0,1/5,16.72%,ABCC4
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.49842271224434315,0.8449638265905869,0.6666666666666666,1.0,1.0,1/11,2.08%,PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.49842271224434315,0.8449638265905869,0.6666666666666666,1.0,1.0,1/11,2.08%,PLCB1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5117811956132173,-0.8449070037344475,0.75,1.0,1.0,2/8,7.18%,NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.4895381783133245,-0.8449037072174526,0.6585365853658537,1.0,1.0,1/11,4.85%,ACTC1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.5555354346229926,0.8448226015299034,0.6607142857142857,1.0,1.0,2/5,22.74%,FBP1;PFKP
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.555022843989363,0.844773565454719,0.7555555555555555,1.0,1.0,3/6,32.48%,SLC25A12;SLC25A18;SLC25A13
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.44289062135958857,-0.8446379777265277,0.6792452830188679,1.0,1.0,4/16,13.71%,TYMS;APRT;GMPR;POLL
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.46110633942357987,0.8446111259824987,0.75,1.0,1.0,7/21,19.96%,EFNA5;EPHA3;GPM6B;SLC9A1;CLASP1;ROCK2;PTK2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4348833055545752,0.844522296051262,0.66,1.0,1.0,9/44,12.15%,ALDH1A1;CIDEA;ARRDC3;PLCL1;TLE3;IL18R1;NOVA1;NR1H3;MAP2K6
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.44561049425685095,0.844507665324226,0.6792452830188679,1.0,1.0,4/17,18.84%,EGFR;PSRC1;PROX1;PDGFB
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.5155448300085143,0.8442492105384775,0.717391304347826,1.0,1.0,2/6,14.51%,FNBP1L;SMURF1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.38349063082572016,-0.8438982449685217,0.6470588235294118,1.0,1.0,4/44,7.95%,RAC1;CATIP;VIL1;WASHC3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.38754871861966467,-0.8437086466226335,0.6923076923076923,1.0,1.0,4/57,5.50%,SFRP1;LDB1;BST1;PLET1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.50887215541802,-0.8436723154891629,0.7321428571428571,1.0,1.0,2/11,8.60%,MBTPS2;ATF4
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.43579546495280236,0.8435808807192513,0.6326530612244898,1.0,1.0,8/33,16.08%,UNC5C;HEY1;NRP1;TLE3;CDK6;TLE1;RTN1;ADGRG1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.38140319747682283,-0.8434217446386738,0.7045454545454546,1.0,1.0,3/54,4.04%,KIF25;NUPR1;GOLGA2
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.507075061500216,0.8431961825206534,0.6666666666666666,1.0,1.0,6/9,32.91%,MBNL1;MYH3;LRP6;FBXW4;TGFB2;SKI
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.40453207807160024,-0.8431825339655865,0.7307692307692307,1.0,1.0,3/29,5.47%,RAC1;ENPP2;VIL1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.48750202708305784,0.8429345088501695,0.6785714285714286,1.0,1.0,2/11,10.00%,ARG1;DDAH1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3895573276788137,-0.8429234629363029,0.6875,1.0,1.0,3/32,7.35%,SPRY4;SPRY1;STMN1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.41734566192834244,0.8427849939541779,0.6721311475409836,1.0,1.0,5/27,12.25%,PKHD1;TMEM67;PDCD6IP;CEP120;SIRT1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.36725603370401516,-0.8427829397352724,0.7678571428571429,1.0,1.0,5/70,6.35%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.46655350885953584,0.8426019516265372,0.6274509803921569,1.0,1.0,1/9,3.63%,IDO1
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.46655350885953584,0.8426019516265372,0.6274509803921569,1.0,1.0,1/9,3.63%,IDO1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.5033244783553947,-0.8425776870500368,0.7288135593220338,1.0,1.0,2/10,11.84%,CENPH;CENPE
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.5264609261132863,-0.8419374071442796,0.7333333333333333,1.0,1.0,1/6,5.03%,DCTN1
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.5639042379933078,-0.8417873025441176,0.6875,1.0,1.0,2/5,5.34%,LOXL4;LOXL1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.402689539586303,0.84174607438507,0.603448275862069,1.0,1.0,3/46,3.79%,SSC5D;SYK;HMGB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.5455976454401736,-0.8417135144715596,0.7073170731707317,1.0,1.0,2/5,18.47%,HTR2A;PDGFA
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5133258697573508,0.8416786977103198,0.6875,1.0,1.0,3/10,15.63%,PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.518289921860179,-0.8412738403918508,0.6363636363636364,1.0,1.0,1/9,6.75%,ADRA2A
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.35305725962393664,-0.8412158874190342,0.7931034482758621,1.0,1.0,10/107,6.65%,SFRP1;CLDN4;KIF1A;WTIP;ETS1;WARS1;CDK5;HTATIP2;SHANK3;TSPAN12
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.32830815188732715,0.8411069706837075,0.8222222222222222,1.0,1.0,24/94,22.11%,EFNA5;IQCJ-SCHIP1;EPHA3;RHOB;SORBS3;GPM6B;PDGFRB;BICD1;P2RX7;SPATA4;RHOBTB3;EPHA5;CLN3;CLASP1;ROCK2;DMTN;CDK10;BAIAP2;PTK2;PEAK3;TESK1;PAK3;PHLDB1;PLXNB1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.48704104586204244,0.8408714852766678,0.7142857142857143,1.0,1.0,1/9,14.78%,MPST
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3851431779450142,0.8408053823847982,0.6666666666666666,1.0,1.0,16/63,13.63%,PIK3R5;NTF3;NEDD4;ROR1;IRS2;FSHR;GAB1;CCL5;PDGFRB;IGF1R;PTPN6;FGFR1;SIRT1;PDGFD;PIK3CA;HGF
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.31953618359869096,-0.8405257805847552,0.8679245283018868,1.0,1.0,30/242,14.22%,SFRP1;INHA;NUPR1;CDKN3;PPP2R3B;CDK5;TSPYL2;FOXM1;KIF20B;BEX2;ANKK1;GADD45A;RRP8;PPP1R15A;PER2;PRKACA;CCND1;TAF6;STK11;DYNLT3;PTPRC;RACK1;CDKN2B;CHEK1;METTL3;HPGD;RPL23;USP51;CDK11B;TRNP1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.341988382747071,-0.8405081501814887,0.6938775510204082,1.0,1.0,48/160,22.77%,RBM8A;UPF3B;UPF3A;EXOSC10;RPLP1;RPL28;RPL37A;RPL34;RPS15;RPL4;RPS8;PATL2;RPL12;RPL31;RPL8;MRTO4;RPL19;RPS27;RPL23;EXOSC4;RPL7A;POLR2G;RPL29;RPS24;RPL5;RPL13;RPL6;RPL37;RPL24;RPL38;RPS25;RPLP2;RPS4Y1;RPS20;RPS3;RNPS1;EIF4G1;CNOT10;RPL35A;RPL11;RPL10A;CNOT3;MTPAP;MAGOHB;RPL18;RPS14;DCPS;RPS4X
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.44278788053543916,0.840440886600396,0.6818181818181818,1.0,1.0,5/24,16.09%,ECT2;UBR5;HDAC3;SMAD3;PIK3R1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.416303769935366,0.8403008150710254,0.68,1.0,1.0,5/32,9.24%,LTK;EPHA3;WNT5A;BRINP3;ABL2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.45262969743758497,0.8396931649627162,0.6190476190476191,1.0,1.0,2/21,2.24%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.5019807876959396,0.8396838865990296,0.6964285714285714,1.0,1.0,3/8,16.69%,PROM2;NR1H3;CLN3
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.41887251241751045,-0.8395061533761197,0.7288135593220338,1.0,1.0,4/28,19.48%,COPE;COPG2;NAPG;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.513073230878788,-0.839397127543172,0.6808510638297872,1.0,1.0,2/13,0.66%,SFRP1;INHA
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.5424624956499328,0.839326785526664,0.6904761904761905,1.0,1.0,2/5,11.62%,PTPRG;TENM3
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.5100557110347994,0.8390867040110757,0.62,1.0,1.0,2/5,12.25%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.3327206387174597,0.8390041499331362,0.6956521739130435,1.0,1.0,35/215,13.64%,CD151;SEMA3C;FAM83H;SPHK1;NTF3;SEMA5A;TRIP6;ITGAX;SEMA6D;CSF1;CASS4;ARHGEF39;EGFR;TGFBR1;NRP1;CSF1R;GAB1;PPP3CA;CCL5;HIF1A;FER;LAMC2;PDGFRB;FGF10;IGF1R;EDN1;PRKCA;CDH13;SMURF2;PDGFD;BCAR1;ACVR1B;CXCL12;HGF;MDK
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.4892787068534946,0.8388177568772707,0.6666666666666666,1.0,1.0,1/10,1.50%,NDNF
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.37476649150606633,-0.8384938190572276,0.7441860465116279,1.0,1.0,6/57,10.94%,AHNAK2;AKAP17A;OAS3;AHNAK;OAS2;CLK3
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3551886074865319,-0.8383606355537246,0.8070175438596491,1.0,1.0,14/115,12.40%,PLK4;BACH1;PLK3;AURKA;HAUS8;FOXM1;DCTN1;SKP1;SSNA1;CETN2;PRKACA;TUBB4B;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.5002460670254519,-0.8381763742510979,0.7142857142857143,1.0,1.0,3/11,25.27%,SRC;MAP2K1;DENND10
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.39804159058691363,0.837662731668658,0.6222222222222222,1.0,1.0,6/27,11.29%,NLGN1;NRXN1;CBLN1;NLGN4X;TMEM108;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.500371876693021,-0.837599351195788,0.723404255319149,1.0,1.0,8/12,32.72%,RNF8;NELFA;LARP7;NELFCD;NELFE;TCERG1;RECQL5;EAPP
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.42114767123672586,-0.8375962435767612,0.7142857142857143,1.0,1.0,1/24,0.84%,DYSF
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.30280660108738156,0.8375548243054781,0.8888888888888888,1.0,1.0,86/559,14.87%,ACE2;SGK3;SGK2;LTK;NRG1;RUNX1;NTF3;FRK;ERBB4;IRS1;ITGAX;PTPRK;VEGFC;CHRNA10;P3H2;FGFR2;CSF1;MAGI2;SULT2B1;EGLN3;S100A13;EGFR;TGFBR1;IRS2;PKHD1;CSF1R;MEIS1;MINAR1;CTBP2;FGFR3;FGF5;CDK6;PTGFR;HDAC2;FGF17;EPCAM;SGK1;SOX7;IER5;BMPR1A;FER;LAMC2;DDAH1;JAG1;PTPN14;PDGFRB;FGF10;IGF1R;PTPN6;EDN1;BRICD5;DLL1;ITGAV;CDH13;CDCA7L;FGFR1;DNAJB2;VEGFD;MEIS2;ST18;TP53INP1;SIRT1;PDGFD;CTNNB1;LIFR;MARCHF7;CRLF2;RNF139;TENM1;THPO;SH3BP4;IFI35;ARID2;BTG2;ZBTB17;HSPA1A;RELA;PLPP1;BCL2;GML;TBX6;NACC2;BOK;TIMP1;SCX;MEIS3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.43530020140824033,0.8374021581075876,0.6440677966101694,1.0,1.0,1/15,2.58%,KLF2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.47943631176096857,-0.8373038740013586,0.717391304347826,1.0,1.0,2/11,14.41%,RBM4;EIF6
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.47943631176096857,-0.8373038740013586,0.717391304347826,1.0,1.0,2/11,14.41%,RBM4;EIF6
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.5494140411684585,-0.8371506851416242,0.717391304347826,1.0,1.0,1/6,5.24%,XG
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3646691612589977,0.8370351716004905,0.717391304347826,1.0,1.0,14/64,11.93%,SHISA2;NEDD4;PPARG;VWC2L;SMAD7;SULF1;SLIT2;ATP2B4;ACVR2A;SMAD5;SMAD1;BMPR1A;SMAD9;SMURF2
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4040360770371788,0.8367831408220165,0.6724137931034483,1.0,1.0,9/42,12.25%,HSPB1;HMGB1;HDAC9;NUS1;PRKD1;HIF1A;PRKCA;FGFR1;SIRT1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.33521887293109437,0.8367559825725277,0.6829268292682927,1.0,1.0,25/127,16.11%,NTF3;NLGN1;FGFR2;FLRT3;CNTN4;BTBD3;PARD3;TNIK;GPM6A;NYAP2;CNTNAP2;RYK;CTNNA2;SGK1;DOCK10;LRP4;CTNNB1;SLITRK5;MEF2A;ANK3;CTNND2;PARD6B;ALCAM;KLF7;MAP2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.33784457524380296,0.8365054065243782,0.7586206896551724,1.0,1.0,36/217,12.25%,FAS;EFNA5;HSPB1;ERBB4;VEGFC;LEPR;EGFR;SLIT2;PPP1R15B;AGER;PELI2;TNIK;CSF1R;GRM5;ECT2;ACVR2A;PTPN13;LIMK2;FGF5;HDAC3;FGF17;EIF2AK3;DVL2;FKBP8;SH3GL2;EPHA7;FER;C3;PROM2;PLCE1;FGF10;MOB1B;VEGFD;RAP2A;NPTN;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5181258298100526,0.8364563766469167,0.6875,1.0,1.0,2/6,9.31%,CBLN1;NLGN4X
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5071886745945476,-0.8363737620161518,0.7142857142857143,1.0,1.0,1/8,6.01%,RNF8
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.44627821496737047,0.8363291555942073,0.6296296296296297,1.0,1.0,2/21,7.53%,MYBPC3;TMOD1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.44627821496737047,0.8363291555942073,0.6296296296296297,1.0,1.0,2/21,7.53%,MYBPC3;TMOD1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.4360762202002486,0.8361019138253414,0.7659574468085106,1.0,1.0,1/23,0.98%,HORMAD1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.403121253092117,-0.8360417442495437,0.6818181818181818,1.0,1.0,3/33,4.58%,STX1B;STX4;CDK5
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.40877885399238645,-0.8356089717664206,0.6666666666666666,1.0,1.0,8/38,18.18%,CLU;UBE3A;GLMN;RPL23;ARAF;TAF1;RPL5;DESI1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3018078931546197,0.835592504714786,0.9824561403508771,1.0,1.0,119/752,14.55%,DACH1;LOXL2;IFI16;NRG1;ZFPM2;NAB1;RUNX1;NFIL3;ZBTB2;PLCB1;FRK;TGIF1;KLF2;PPARG;PTPRK;ATOH8;ZBTB1;HJV;FGFR2;LDB2;HMGB1;BATF3;ZNF706;NRIP1;SMAD7;MTERF3;ZEB1;BAHD1;TRPS1;IRF2BPL;WNT5A;ZEB2;GLIS2;WWOX;NR2E1;TSHZ3;RUNX2;TP63;ZNF20;ZBTB5;RFX3;HEY1;TENM2;FOXO3;ZNF202;SNCA;SP3;HDAC9;FOXP2;KCTD1;NR3C1;TBL1XR1;ZFP36;ATXN1;MYPOP;CTBP2;NR1D2;HDAC2;JAZF1;TWIST1;HINFP;HDAC3;ZNF205;PHF21A;GLI3;ZNF675;SOX7;PHC2;MIER2;BCOR;TLE1;FOXO1;MITF;ZGLP1;TAF3;SPINDOC;EDN1;KLF12;SMAD2;NCOA5;MXD4;RNF2;PDE2A;ARID5B;PLK1;WWC1;PEX2;MEIS2;POU2F1;NR1H3;ZNF582;SMURF2;ZBTB7B;SIRT1;CTNNB1;BTRC;PRICKLE1;NPAS1;ID3;PPM1A;ZNF536;EPC1;ZNF175;HIC2;FOXN3;THAP11;MEF2A;EP300;SMAD3;FST;YAF2;DPF3;RELA;TBX6;NACC2;ETV6;CD38;FBP1;CREB1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.35749486178140344,-0.8355576998049055,0.72,1.0,1.0,13/87,12.28%,SH3RF2;CLU;TRIB2;ARIH2;DDA1;GIPC1;RBX1;GLMN;DDRGK1;ELOB;RFPL1;RACK1;CAMLG
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.5125856695086309,0.8355440293866486,0.6862745098039216,1.0,1.0,4/7,25.45%,ASIC2;CACNA1H;PKD2;ABCC8
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5126794758773615,0.8354274657508571,0.68,1.0,1.0,5/8,29.09%,HMGCR;MVD;PDSS2;MVK;IDI2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.5270820054093895,-0.8354195552217215,0.6481481481481481,1.0,1.0,2/5,13.01%,PDCD5;SGTB
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.48745850935704366,-0.8353048552881758,0.6888888888888889,1.0,1.0,3/10,7.84%,CD74;OAS3;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.35139217160805886,0.8352416117939655,0.7540983606557377,1.0,1.0,17/105,14.32%,NLRP2B;PLA2G10;SMAD7;GLIS2;PKHD1;HDAC2;ZNF675;TAF3;RNF2;NLRC3;SIRT1;BTRC;ID3;ERBIN;AIM2;SETD6;TBX6
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3367116290050292,0.8347108026887503,0.72,1.0,1.0,27/168,15.03%,PLA2G10;SPHK1;PLCB1;ENPP1;ITPKB;INPP1;PIP4K2A;NUDT10;PPP3CA;PTPRD;LIMK2;PLA2G15;EPHA7;LPL;PLCE1;DUSP18;PLCB4;INPP4B;IP6K2;LCAT;PIK3CA;PPM1A;PLBD1;PLPP1;PLA2G4C;FBP1;GPD2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.45179374731150435,-0.8347090922022216,0.6078431372549019,1.0,1.0,4/13,18.41%,ZWILCH;SPDL1;CTCF;IK
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.41725668323302895,-0.8347029160844833,0.6842105263157895,1.0,1.0,3/24,13.82%,CLU;RACK1;SELENOS
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.40795951306671974,0.8346886739433091,0.6808510638297872,1.0,1.0,5/24,15.17%,DOC2B;SYT1;RIMS2;SYT15;SYT2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.5332131960805694,-0.8346674834939368,0.6956521739130435,1.0,1.0,1/7,4.05%,OAS3
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.34913849532194385,0.8345739145933531,0.8695652173913043,1.0,1.0,19/101,15.50%,CADM2;LRRC4C;GALNT13;UNC5D;NR2E1;SLC35F1;LGR5;ADGRL3;MEGF10;NOL4;LHFPL4;LRP4;ANK2;ZNF536;ERC2;GRIA2;CSRNP3;CTNND2;PCLO
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4332481285473543,0.8344985661581903,0.6346153846153846,1.0,1.0,6/23,20.85%,KLHL15;UGGT1;FBXL17;DERL1;CUL3;RNF185
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.3951973698099329,-0.8344460918155704,0.7142857142857143,1.0,1.0,4/43,5.72%,ATP6V1E2;FTH1;ATP6V1E1;SCARA5
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.5167054701480152,-0.8342807251637496,0.6382978723404256,1.0,1.0,1/6,20.64%,STAT3
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.4378241059412374,0.8341495734207742,0.6666666666666666,1.0,1.0,2/15,7.43%,INTS6;INTS11
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.38249376161359466,0.834118579605235,0.7608695652173914,1.0,1.0,3/40,7.24%,ROBO1;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.37616379454912136,0.8339451149713795,0.62,1.0,1.0,2/35,5.12%,EFNA5;EPHA3
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.5207543912500481,-0.8337097910616915,0.75,1.0,1.0,4/12,28.71%,AASS;CRYM;ALDH7A1;AADAT
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.5207543912500481,-0.8337097910616915,0.75,1.0,1.0,4/12,28.71%,AASS;CRYM;ALDH7A1;AADAT
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.37750982845875614,0.8333506628200131,0.7142857142857143,1.0,1.0,10/67,10.82%,FAM216B;TFCP2L1;HYDIN;CAPN13;LRRIQ1;DNAH5;SLC5A8;EXPH5;MUC16;ATP12A
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.5470199469974177,0.8333071057004648,0.6666666666666666,1.0,1.0,1/6,2.45%,PNP
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.4508139017713114,-0.8330948608467028,0.6666666666666666,1.0,1.0,2/19,9.16%,MYO15A;MYO7B
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.39311810229355926,-0.8328424842742632,0.6808510638297872,1.0,1.0,19/51,22.53%,H1-4;POLR1G;H1-0;SMARCD1;ELOF1;ZMIZ2;TAF1D;CHEK1;ACTB;SMARCA5;MACROH2A1;POLR1E;H1-2;DDX21;POLR2L;POLR1B;POLR2K;DEK;POLR1A
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.5328276800170209,0.8328225613232518,0.7608695652173914,1.0,1.0,3/6,19.35%,SLC8A1;SMAD3;ATP1A2
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.5314286139127438,0.8326409599941259,0.8,1.0,1.0,4/5,18.38%,CDK6;CDH2;DLL1;BMP6
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.32304490777776435,-0.8324092492658821,0.8490566037735849,1.0,1.0,39/223,17.31%,USP27X;ADRM1;PSMA7;NLRP3;ABRAXAS1;ATXN7L3;UCHL1;USP40;MBD6;PSMD7;UBC;USP20;PSMB4;PSMC3;TAF9B;TOMM20;USP11;UFD1;PSMD8;PSME1;ACTB;USP35;PSMB2;USP51;PSMC4;PSMB8;NFKBIA;PSMC1;PSMB5;PSMD2;INO80;PSMA1;USP1;USP48;PSMD10;USP22;USP4;TAF10;USP10
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.4181476107131338,0.8319905045791074,0.64,1.0,1.0,6/15,30.22%,GPR137B;SIK3;GPR137;GPR137C;RRAGD;KLHL22
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.38810035000108273,-0.8316892285501285,0.6428571428571429,1.0,1.0,10/46,22.42%,ANKLE2;LEMD2;NUP133;NUP43;EMD;NUP155;CHMP2A;NUP85;VRK1;RAN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.38810035000108273,-0.8316892285501285,0.6428571428571429,1.0,1.0,10/46,22.42%,ANKLE2;LEMD2;NUP133;NUP43;EMD;NUP155;CHMP2A;NUP85;VRK1;RAN
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.4994756620190097,-0.8314493924269749,0.7049180327868853,1.0,1.0,1/9,2.04%,NOG
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4764489307372393,0.8314074671830418,0.68,1.0,1.0,1/9,5.58%,KIF2C
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.32818412504211264,-0.8308557326382118,0.875,1.0,1.0,19/219,10.70%,TLCD2;NCKAP1L;LCP1;RAC1;CD74;SPG7;REC8;SYCE2;VIL1;CALD1;FANCC;PKP1;PARVB;CHCHD10;TUBGCP2;MYO7B;RSPH4A;ELOB;CFAP46
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.46848598726964785,-0.8307982034971549,0.6792452830188679,1.0,1.0,5/21,11.37%,APOD;TPM1;VIP;IGFBP3;NDRG4
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.4221090498717349,0.830238167099588,0.7368421052631579,1.0,1.0,10/26,24.92%,PHACTR1;CTNNA2;MDK;ADGRG1;PLXNB2;ZNF609;NTNG1;NIPBL;RAPGEF2;SRGAP2C
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.38781012380057456,0.8300007311073685,0.6530612244897959,1.0,1.0,5/31,9.74%,SLC30A8;DOC2B;IRS2;MCU;ACSL4
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.35312502701008347,-0.8299093629779325,0.7678571428571429,1.0,1.0,9/93,10.53%,P2RY10;CXCR5;F2RL2;TRPC3;CHRNA9;DRD1;CD24;ADRA1D;DRD3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.38207167425750366,-0.8296685082928632,0.6744186046511628,1.0,1.0,9/79,9.29%,CBLC;SPRY4;FGF1;UCHL1;TRIB2;SPRY1;ADRA2A;CD24;RGS2
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.3458842522881856,0.8293767692597703,0.7017543859649122,1.0,1.0,13/85,10.67%,EFNA5;KCNC2;IRS1;KCNS3;SLC30A8;DOC2B;RFX3;IRS2;MCU;CCL5;ACSL4;ITPR1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.5407632624584656,-0.8293630741530809,0.6792452830188679,1.0,1.0,1/5,10.53%,DRD3
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.45007052658602476,-0.8290227174299487,0.7678571428571429,1.0,1.0,2/22,8.93%,KIF1A;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.5321516486618408,0.8289280283345776,0.7073170731707317,1.0,1.0,1/5,3.79%,HMGB1
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.5096336049063194,0.8289065416725954,0.6590909090909091,1.0,1.0,1/5,11.15%,CHD7
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.42200396792308387,-0.8288045368351971,0.7169811320754716,1.0,1.0,2/21,3.40%,DUOX1;STX4
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.47698697335872514,0.8287984508317792,0.6041666666666666,1.0,1.0,3/9,17.26%,SIRT1;EP300;KAT2B
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.45603527700262503,0.8286944302720962,0.75,1.0,1.0,3/13,15.04%,PPARG;PRKG1;MEF2C
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.34266479318271603,0.8284085707529173,0.72,1.0,1.0,17/106,14.97%,LRIG3;MXRA5;SERTAD4;EGFR;CCN2;AGER;FAM114A1;FBLIM1;SCNN1B;LAMC2;NOTCH3;RADIL;P2RX7;SH3BP4;MEX3B;AMOTL2;THSD4
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4232684202056573,-0.8282603678734859,0.6170212765957447,1.0,1.0,9/24,19.73%,RAC1;DCTN1;MET;ANKRD53;TRPV4;DRG1;STMN2;KATNB1;RPS3
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4093355852468833,-0.8281244135904554,0.58,1.0,1.0,3/35,11.95%,EEF1AKMT2;METTL22;TRMT112
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.4293538351089826,-0.8279948530908757,0.7317073170731707,1.0,1.0,3/32,10.89%,NUPR1;TCHP;PINK1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.4183913516606751,-0.8279500532710747,0.6222222222222222,1.0,1.0,4/25,7.73%,FGF1;WNT7B;FGF7;RBP4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.4136063364415782,0.8274928263480948,0.75,1.0,1.0,4/19,16.72%,MICU1;MCU;MAIP1;PDZD8
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.5443094616500183,0.8270535652772695,0.75,1.0,1.0,1/7,1.84%,SPX
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.5294770736810689,0.8268794701614289,0.7241379310344828,1.0,1.0,2/5,22.24%,LPL;SREBF2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4476245489443414,0.8266909036019193,0.72,1.0,1.0,1/15,0.87%,GLYAT
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.4019420539934144,0.8264852838430629,0.6923076923076923,1.0,1.0,12/42,14.84%,PPARG;VWC2L;SMAD7;ACVR2A;SMAD5;GREM2;SMAD1;BMPR1A;SMAD9;SMURF2;SMURF1;UBE2D3
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.4775343717289446,0.8264104566860684,0.7058823529411765,1.0,1.0,1/9,8.37%,ODC1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4264811366358181,0.8263347770717593,0.6875,1.0,1.0,4/23,13.92%,TAB3;TLR1;TAB2;MAP3K1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3801049078959459,-0.8263243560584693,0.8,1.0,1.0,3/56,2.90%,SFRP1;FBLN2;RAC1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3782551758962336,-0.8259752700246725,0.7446808510638298,1.0,1.0,14/43,19.58%,SPRED3;WARS1;ATG14;SPRED2;ASPSCR1;KDM4D;STAT2;PIN1;PUM3;SPRED1;ATG10;HPF1;ROPN1L;PPIB
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.37481728839168527,0.8255916384094788,0.6829268292682927,1.0,1.0,17/95,12.46%,LRIG3;CXXC4;HNF4G;FLRT3;TOX3;AIF1L;C1ORF226;JPH1;FGFR3;COBL;DDAH1;WWC1;LRP4;SLC7A2;CTNNB1;CKMT1A;BCAR1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.4443058951293492,0.8251182539558953,0.673469387755102,1.0,1.0,1/11,1.80%,KCNJ3
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.5432963999023781,0.8250314091732691,0.6607142857142857,1.0,1.0,2/5,26.92%,RPE;RPEL1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.45768101601683353,-0.8249833619556365,0.6538461538461539,1.0,1.0,2/12,7.28%,BST1;CD63
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.3804278539641383,0.8248573339931001,0.7959183673469388,1.0,1.0,13/48,16.01%,SLIT2;KIF26A;MCTP1;SLC30A10;CDK6;TWIST1;DDAH1;NR1H3;SIRT1;LPCAT3;PIM3;ACVR1;KLF7
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.5586548128312468,0.8247716954454962,0.6938775510204082,1.0,1.0,2/5,15.04%,MEGF10;MEF2C
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.3435200809167303,0.8245922213697702,0.7142857142857143,1.0,1.0,17/88,11.17%,PCDHB3;NLGN1;CDH8;FLRT3;NRXN1;DSCAM;CDH18;CDH20;RAB29;GPM6A;FBLIM1;ADGRL3;RYK;CDH10;CDH2;CDH6;FLNC
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.49114572819706637,0.8243665165407247,0.6666666666666666,1.0,1.0,3/12,15.63%,PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5506672528729717,0.8243624364855849,0.7291666666666666,1.0,1.0,1/5,17.48%,ADTRP
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3693864754558691,0.8241578283877613,0.7254901960784313,1.0,1.0,10/54,15.96%,NLK;TGFBR1;PRKD1;DYRK3;PRKCA;DYRK1A;DYRK2;ACVR1B;ACVR1;MAPK8
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.497116386205372,0.8240630523501453,0.6595744680851063,1.0,1.0,1/7,1.80%,KCNJ3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3502050347125709,0.8239884421747944,0.7755102040816326,1.0,1.0,18/103,10.39%,SGK3;NRG1;ERBB4;LDB2;CAVIN1;EGFR;FRMD5;RHOB;CSF1R;FGF5;CDK6;TWIST1;FGF17;ABL2;SGK1;SPOCK3;FGF10;DOCK10
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4573409295441684,-0.8237653538599526,0.7446808510638298,1.0,1.0,7/14,26.62%,SH2B2;FPR3;CR1;GPLD1;SLA2;SPG21;BAG6
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.37597411836873895,0.8237400164634399,0.7090909090909091,1.0,1.0,6/43,11.70%,C1GALT1;SULF1;TGFBR1;ROBO2;FGF10;LRP4
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.45654048975774714,0.8234704221207816,0.5918367346938775,1.0,1.0,1/10,3.63%,IDO1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.40300521049655424,0.8233676147266279,0.7407407407407407,1.0,1.0,3/34,4.39%,EFNA5;KANK1;AP1AR
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.41439935818397144,0.8233535692314206,0.7115384615384616,1.0,1.0,5/46,6.82%,NEDD4;SYK;REP15;ACKR3;SNCA
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.3923834163527966,0.8232870828592604,0.6101694915254238,1.0,1.0,8/26,13.89%,KLF2;CX3CR1;ATP2B4;GLA;DDAH1;EDN1;DDAH2;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.38229052502394567,0.8231957701814946,0.6730769230769231,1.0,1.0,2/39,3.79%,NLRP2B;HMGB1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.4123948122010423,-0.8229564775447591,0.7083333333333334,1.0,1.0,4/27,11.36%,ATP6V1E2;ATP6V1E1;ATP6V1D;TMEM9
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4809581915605281,-0.8229450236572489,0.717391304347826,1.0,1.0,3/13,5.52%,SPRY4;GPC1;SPRY1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.3693757747131868,-0.8227991081732704,0.7692307692307693,1.0,1.0,10/65,9.02%,CLDN4;CBLC;TPPP3;ENTPD2;AZGP1;SELENBP1;ADRA2A;MYH14;LLGL2;CD24
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.471779878270153,-0.8226881165742915,0.7586206896551724,1.0,1.0,1/12,2.04%,NOG
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.4559530074943304,-0.8226383767225178,0.6792452830188679,1.0,1.0,7/17,28.76%,VPS11;SRC;MAP2K1;PTPN23;DENND10;MSN;EZR
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.4191956168823494,-0.8222532025519058,0.8076923076923077,1.0,1.0,5/36,8.60%,NUPR1;CLU;CDK5;DAXX;ATF4
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3077897837680072,0.8222273632757567,0.9272727272727272,1.0,1.0,90/539,14.45%,DACH1;LOXL2;IFI16;ZFPM2;RUNX1;NFIL3;ZBTB2;FRK;NEDD4;TGIF1;KLF2;PPARG;ZBTB1;HJV;FGFR2;LDB2;HMGB1;BATF3;NRIP1;SMAD7;ZEB1;TRPS1;IRF2BPL;ZEB2;GLIS2;WWOX;NR2E1;ZNF20;ZBTB5;HEY1;TENM2;FOXO3;ZNF202;SNCA;HDAC9;FOXP2;KCTD1;NR3C1;TBL1XR1;ZFP36;ATXN1;MYPOP;CTBP2;NR1D2;HDAC2;JAZF1;TWIST1;HDAC3;ZNF205;PHF21A;GLI3;ZNF675;MIER2;BCOR;MITF;ZGLP1;TAF3;EDN1;KLF12;SMAD2;NCOA5;MXD4;RNF2;PDE2A;ARID5B;PLK1;WWC1;PEX2;MEIS2;NR1H3;ZNF582;SMURF2;ZBTB7B;SIRT1;ID3;PPM1A;ZNF536;EPC1;ZNF175;THAP11;MEF2A;HSPA1A;EP300;SMAD3;FST;RELA;TBX6;NACC2;ETV6;FBP1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.5145318176517549,0.8222199847026829,0.7551020408163265,1.0,1.0,3/6,31.75%,ACVR1;TGFB2;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.3191418920805749,-0.822218991131667,0.8695652173913043,1.0,1.0,26/170,13.51%,TERF2IP;TRABD2A;FGF1;NTRK1;RAC1;CD74;GOLGA2;ATG14;CD4;ANKLE2;DAXX;FGF7;FGF20;ACE;PTPA;CALM1;ASPSCR1;CCND1;PINK1;TXN;FGF18;NIBAN1;RACK1;PDE8A;SVIP;PIN1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.43654236188615175,-0.8218044381105248,0.625,1.0,1.0,4/12,19.42%,TPM1;ADRA1D;KCNQ1;TRPM4
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.32217447128353477,0.8216179174010334,0.8235294117647058,1.0,1.0,37/166,20.49%,TYR;DCUN1D1;KEL;MARCHF8;TENT5C;FOXO3;CAT;SNCA;SLC30A10;NR3C1;MFHAS1;FBXO7;C3;ADIPOR1;BTRC;ABCG2;BTG2;PIGQ;SLC25A38;PICALM;GMPS;RBM5;VEZF1;KAT2B;CDR2;ENDOD1;LAMP2;CA2;SLC11A2;BNIP3L;DMTN;FECH;ARHGEF12;BSG;PC;SLC2A1;ACKR1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.4635691168814862,0.8215488389658926,0.6530612244897959,1.0,1.0,4/13,17.83%,CHRNB4;ERC2;DTNA;ERC1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5289527146398456,-0.8213930735372585,0.7608695652173914,1.0,1.0,2/7,4.95%,CD74;CD4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5293711245524133,-0.8212933575848033,0.6862745098039216,1.0,1.0,2/6,23.02%,PRKCZ;IL18
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.46043775714610513,-0.8210178988282559,0.6666666666666666,1.0,1.0,3/13,26.15%,DNM1L;ALKBH7;CD14
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4961629259071667,-0.8208889477516589,0.6938775510204082,1.0,1.0,3/9,22.61%,HM13;SPCS1;SEC11C
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.39051729996859263,0.8207455299101581,0.7755102040816326,1.0,1.0,9/54,16.52%,NEDD4;PTPRK;ZBTB1;CASP9;PDE6A;EP300;CNGB1;EIF2S1;RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.39646556571304553,0.820742384651608,0.6956521739130435,1.0,1.0,9/39,12.97%,NRG1;EPHA3;SNCA;MCTP1;PRKD1;PXK;ITGAV;NR1H3;NDFIP2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.40313811335382904,-0.8206074157335034,0.7543859649122807,1.0,1.0,7/30,19.52%,STX4;APOA1;CHTOP;YWHAB;AZIN2;CIB1;SOD1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.37103951166223315,0.8205885437834003,0.75,1.0,1.0,11/49,22.28%,MAN2A1;ST8SIA6;ADAMTS9;HIF1A;ST8SIA4;ADAMTS13;FUT8;HPSE;ST8SIA3;ST8SIA1;ST3GAL4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.41733431603902194,-0.8205863585702604,0.6333333333333333,1.0,1.0,8/21,19.42%,CALM1;RANGRF;DSC2;CTNNA3;CALM3;PKP2;JUP;TRPM4
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.38241224882188374,-0.8205461491406849,0.7608695652173914,1.0,1.0,11/51,21.49%,POLR2I;POLR2J;NUP133;NUP43;POLR2G;POLR2C;NUP155;POLR2L;EIF4G1;NUP85;POLR2K
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.38241224882188374,-0.8205461491406849,0.7608695652173914,1.0,1.0,11/51,21.49%,POLR2I;POLR2J;NUP133;NUP43;POLR2G;POLR2C;NUP155;POLR2L;EIF4G1;NUP85;POLR2K
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.4787548940229988,-0.8204245938616163,0.7222222222222222,1.0,1.0,3/13,9.49%,IGFBP2;IGFBP4;IGFBP3
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.5272029699756144,0.8198641564682491,0.6862745098039216,1.0,1.0,2/5,5.23%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.5272029699756144,0.8198641564682491,0.6862745098039216,1.0,1.0,2/5,5.23%,EGFR;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.43936490256440763,0.8197996247583291,0.7209302325581395,1.0,1.0,2/13,16.03%,ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.40616797993425496,-0.8196755296699948,0.7719298245614035,1.0,1.0,3/27,6.33%,LCP1;RFLNA;CALD1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.42246266225623064,-0.8194804106321008,0.7258064516129032,1.0,1.0,6/30,10.87%,KIF1A;CDK5;SHANK3;DBNL;LRP8;CUX2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.344986459093516,0.8193084647736139,0.8448275862068966,1.0,1.0,20/92,19.20%,ZBTB1;NPM3;BAHD1;ARID1A;ARID1B;SRCAP;HDAC2;SMARCD3;BAZ2B;BRDT;SIRT1;DR1;RUVBL2;SATB2;SMARCD2;KAT2B;ACTL6A;SMARCE1;GATAD2B;KDM6A
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.34109536349386194,-0.819096609627753,0.8125,1.0,1.0,24/108,17.88%,SFRP1;PSMA7;ADAMTS12;PSMD7;SKP1;UBC;PSMB4;RBX1;PSMC3;PSMD8;PSME1;PSMB2;IL1R1;PSMC4;PSMB8;NFKBIA;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;RBMX;USP10;IRAK1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.4871684682743903,0.819090324430357,0.7115384615384616,1.0,1.0,1/13,2.08%,PLCB1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.4442311126615478,-0.8189396839870314,0.7457627118644068,1.0,1.0,5/12,31.88%,MAP1LC3B;ACBD5;SQSTM1;PEX5;PIK3C3
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.4608026542330189,-0.818777614676747,0.64,1.0,1.0,3/17,6.83%,PDZD7;WNT7B;DACT2
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.48039889679437475,-0.8185222631625461,0.6792452830188679,1.0,1.0,1/10,3.20%,ATOX1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.5571422092605747,0.8183078974128973,0.7692307692307693,1.0,1.0,1/5,9.57%,NCK1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.3704691748629523,0.8177738382148466,0.7755102040816326,1.0,1.0,11/46,21.12%,RUNX1;H3-3A;CNOT4;RBBP5;THPO;EP300;MEF2C;KAT2B;CBFB;TESC;TNRC6C
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.28311394416540003,0.8176624206234048,1.0,1.0,1.0,112/864,14.84%,STK26;SGK3;SGK2;MAP3K11;LTK;LOXL2;NUAK2;DAPK2;DCUN1D1;CEL;PPEF2;FRK;CHRM3;ASB17;HS3ST5;SOCS6;TNC;KLHL21;PTPRK;SYK;PTAR1;MAN2A1;CSF1;PPM1L;RCE1;EGLN3;ST8SIA6;UBE2E2;AFP;NLK;EVA1A;TGFBR1;RPS6KA4;TNIK;CUL1;PPM1E;DUSP9;LMO7;ACVR2A;NUS1;PSMD13;LATS1;PPP3CA;PTPN13;PTPRD;ERN1;PRKD1;LIMK2;PARP8;DNAJC3;DYRK3;RYK;DCAF5;CDK6;PXK;PTPRG;MSRA;FBXO30;EIF2AK3;HIF1A;FBXO7;FBXL7;PRKG1;ABL2;SGK1;TIPARP;CDH2;BMPR1A;PRKACB;FUT9;FER;C3;SOCS2;FBXW9;PTPN14;RBBP5;PTPN6;PRKCA;DYRK1A;STK36;CDK12;FGFR1;FBXL3;PLK1;DYRK2;PTPRM;PGGT1B;SIRT1;BTRC;KCTD6;YES1;ACVR1B;NIM1K;CAMK4;CD247;PPM1A;PIM3;RCN1;SENP8;KNG1;FBXO11;MEX3B;MAP3K1;TF;UBE2E1;DUSP2;CREB1;TIMP1;PIGU;ACVR1;B3GNT2;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5257108470868901,0.8175666664436412,0.7358490566037735,1.0,1.0,1/8,5.80%,PELI1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.5075517627486568,-0.8174893682525057,0.7358490566037735,1.0,1.0,2/7,14.69%,RGS2;MLIP
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.4559796673364035,0.8174142041263562,0.7241379310344828,1.0,1.0,2/12,8.26%,ZFP36;ELAVL4
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.38631319706950495,0.8174067242636388,0.7090909090909091,1.0,1.0,14/59,19.56%,FAS;FGFR3;ITGAV;CASP9;P2RX7;ACVR1B;SMAD3;SORT1;BCL2;BOK;CRADD;CASP2;BAD;BCL2L1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.3651817636933681,-0.817298952841476,0.7872340425531915,1.0,1.0,7/66,6.33%,TAGLN;COL6A1;NOG;COL6A2;TPM1;LOXL1;CALD1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.4194654042049358,-0.8172151995958332,0.6938775510204082,1.0,1.0,2/16,14.14%,ADAM19;APH1B
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.5263625167393434,-0.8171495338110647,0.7446808510638298,1.0,1.0,2/6,12.36%,JADE2;MEAF6
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.36558445754857094,-0.8171037821087515,0.7777777777777778,1.0,1.0,4/53,6.57%,ISM1;SARS1;COL4A3;NAXE
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.4976315775061493,-0.8170986760098135,0.7346938775510204,1.0,1.0,2/6,30.22%,YBX1;DDX1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.4425925535172842,-0.8169782666888317,0.6226415094339622,1.0,1.0,1/17,1.86%,MYB
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.5549404449743065,0.8168761256124835,0.7777777777777778,1.0,1.0,3/5,9.55%,HMGB1;LPL;MBP
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.41747252941695256,-0.8166919672991229,0.7,1.0,1.0,8/41,8.37%,GPC2;AGRN;B3GNT9;B3GALT5;GPC1;XYLT2;GPC3;SDC2
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.4573386163531733,0.8163217632428711,0.6779661016949152,1.0,1.0,2/9,12.25%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5149560918485087,-0.8163018680710116,0.7678571428571429,1.0,1.0,1/6,6.01%,RNF8
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.3278564023038181,-0.8162411126343618,0.8125,1.0,1.0,23/108,15.98%,SFRP1;BACH1;PLK3;EPAS1;PSMA7;PSMD7;UBC;PSMB4;RBX1;LIMD1;PSMC3;ELOB;PINK1;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;BMP7;PSMA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.42955072691182167,-0.8160139375800568,0.7555555555555555,1.0,1.0,2/24,6.04%,UBC;XRCC1
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.5038357936401302,0.8155704116132402,0.7551020408163265,1.0,1.0,3/5,11.40%,ZFP36;NPR2;ZFP36L2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.5038357936401302,0.8155704116132402,0.7551020408163265,1.0,1.0,3/5,11.40%,ZFP36;NPR2;ZFP36L2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.3582316219874574,0.8153490033662286,0.7551020408163265,1.0,1.0,9/50,12.81%,ITGAX;ITGAM;LAIR1;CSF1R;TLR1;MITF;CSF2RA;PTAFR;DDX60L
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.4834870373009274,0.8151168627796204,0.7380952380952381,1.0,1.0,1/8,3.56%,MAN2A1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.5186462075657445,0.8148167049818845,0.7169811320754716,1.0,1.0,1/5,13.64%,MDK
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.45518519283636255,0.8148053133997467,0.6923076923076923,1.0,1.0,5/11,22.99%,KCNK1;KCNK9;KCNK12;KCNN4;KCNK2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.5730818100264252,0.8148024490210231,0.8,1.0,1.0,4/6,21.09%,SMAD1;SMAD2;SMAD3;SMAD4
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.4819164368490163,-0.814736984989946,0.6521739130434783,1.0,1.0,2/5,18.91%,NR1H4;KHSRP
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.5085435829793237,-0.8145115316210176,0.64,1.0,1.0,3/7,18.59%,FPR3;CR1;GPLD1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.40145999699250406,0.8143316747421063,0.7454545454545455,1.0,1.0,2/23,5.20%,CSGALNACT1;SULF1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.31249536051326215,0.8138871718007918,0.8727272727272727,1.0,1.0,62/332,15.18%,NRG1;ZFPM2;SPHK1;NTF3;ERBB4;IRS1;ITGAX;VEGFC;FGFR2;CSF1;S100A13;EGFR;WNT5A;TGFBR1;IRS2;PKHD1;CSF1R;MEIS1;MEGF10;FGFR3;FGF5;CDK6;PTGFR;HDAC2;TOX;CCL5;FGF17;EPCAM;BMPR1A;FER;LAMC2;DISP3;PDGFRB;FGF10;IGF1R;PTPN6;EDN1;DLL1;ITGAV;CDH13;CDCA7L;FGFR1;VEGFD;MEIS2;SIRT1;PDGFD;LIFR;MARCHF7;CRLF2;THPO;LIG4;MDK;RELA;BCL2;TBX6;TIMP1;SCX;MEIS3;MEF2C;AVPR1A;PID1;SAAL1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.43099485848593705,-0.8135489537007738,0.7735849056603774,1.0,1.0,5/26,13.48%,CDC37;OAS3;STAT2;METTL3;ISG15
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.3995022235598957,0.8135445164357291,0.6938775510204082,1.0,1.0,8/53,6.70%,ARHGAP25;PIK3R5;SELPLG;ITGAX;ITGAM;LAIR1;ARHGAP30;IKZF2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.42568520696519735,0.8134919559521271,0.7058823529411765,1.0,1.0,3/14,10.51%,ELAPOR2;ROBO2;PCM1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2927027130033891,0.8131184320220349,0.9512195121951219,1.0,1.0,38/272,16.81%,TBC1D3L;SNX31;ESAM;PTPRK;EGFR;WNT5A;RAB29;ARL5A;TBC1D12;MYO7A;GRID2;CNTNAP2;RABL2B;SEPTIN11;TBC1D8B;FGF10;REEP1;BICD1;RAP2A;CTNNB1;RABGAP1L;RUNDC1;ANK2;ARFIP1;ATG9A;TMED9;SMURF1;PIGU;TBC1D1;GRTP1;EVI5;CNTLN;KIF13A;DMD;TBC1D4;ARL5B;USP6NL;TBC1D5
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.501681938660001,0.8130731846962309,0.660377358490566,1.0,1.0,2/8,5.61%,CCNA2;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.49210220820375267,0.8130523079083747,0.7551020408163265,1.0,1.0,3/9,14.77%,MAGI2;FST;ACVR1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.43053014409905416,0.8128591696611499,0.6590909090909091,1.0,1.0,3/18,14.20%,SPHK1;ASAH2;PLPP1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.4773686600124356,-0.8124209937329996,0.8148148148148148,1.0,1.0,1/12,2.04%,NOG
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.4592480587847605,-0.8123514049319043,0.7209302325581395,1.0,1.0,2/9,19.55%,EXOSC10;ERI2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.42177887866056923,-0.8121825096175003,0.7258064516129032,1.0,1.0,2/22,7.65%,APOD;ACE
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.526856439502498,0.8120854387534258,0.7169811320754716,1.0,1.0,1/5,11.81%,NR1H3
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.3404190924112356,0.8119887871411617,0.8125,1.0,1.0,29/138,17.04%,KCNJ3;KCNS3;SLC22A2;SLC5A12;SLC12A3;SLC8A1;SLC23A1;KCNK1;SLC5A8;SCNN1B;SLC5A4;SGK1;KCNJ6;KCNB2;TRPM6;SLC4A4;NDFIP2;FGF13;SCNN1D;KCNN1;KCNV1;KCNG1;KCNJ2;KCNA5;KCNK9;CNGB1;SLC12A2;CLN3;NEDD4L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.5233311625363841,0.8119668007841925,0.8,1.0,1.0,4/8,23.28%,INSIG1;INSIG2;SREBF2;ERLIN1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5233311625363841,0.8119668007841925,0.8,1.0,1.0,4/8,23.28%,INSIG1;INSIG2;SREBF2;ERLIN1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.3583147579984558,-0.8119055928573288,0.8181818181818182,1.0,1.0,13/70,16.57%,TRABD2A;CLU;SLX4;WARS1;VIL1;ERCC1;SYNPO2L;BAK1;RACK1;BIK;HAS3;BMP7;CHMP2A
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.3902911674786734,-0.8118686286616751,0.7931034482758621,1.0,1.0,8/38,21.53%,LDB1;SPI1;JADE2;MEAF6;TAF10;POLE3;TADA3;TADA1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3480558826659296,0.8118686273076692,0.6666666666666666,1.0,1.0,17/87,12.37%,SHISA2;RUNX1;KANK1;CXXC4;FGFR2;NLK;SULF1;WWOX;TCF7L1;AMER2;SPIN1;SOX7;TLE1;RSPO2;GNAQ;CTNNB1;BTRC
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.39430714204313255,-0.8116898209400539,0.7380952380952381,1.0,1.0,8/23,22.03%,RPL23;LAMP3;EFNA1;TAF1;RPL5;GABARAPL2;RPL11;HSP90AB1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.5055584396983761,-0.8115988234983582,0.6739130434782609,1.0,1.0,2/5,21.04%,PPP1CA;PPP2CB
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.5068630282591067,-0.8115394680029416,0.6521739130434783,1.0,1.0,1/5,10.53%,DRD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4008907624545081,0.8114789581582768,0.6829268292682927,1.0,1.0,6/21,16.51%,JPH1;PDE4D;JSRP1;TRDN;AKAP6;DMD
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.39404174714808793,-0.8113213251575062,0.7333333333333333,1.0,1.0,1/28,0.56%,SFRP1
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.5359579210385739,0.8110804983413262,0.7708333333333334,1.0,1.0,2/5,18.34%,PROX1;VEGFA
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.39808047400245433,-0.8109297300783939,0.7115384615384616,1.0,1.0,5/34,15.78%,SEPTIN5;SYT6;RAB3A;PREPL;SYT12
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.5205475833530128,0.8109027317567417,0.7,1.0,1.0,1/7,7.63%,LDLR
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4673883161059085,0.8108049989470982,0.6923076923076923,1.0,1.0,5/13,19.96%,TLE1;PIK3CA;BCL2;PDK4;PTK2
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.45926547434800824,0.8106559836967776,0.7037037037037037,1.0,1.0,3/13,8.01%,TDG;DCTPP1;DUT
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.36411273637639624,-0.8102124515524053,0.7142857142857143,1.0,1.0,6/42,12.33%,PRPF6;CELF3;SF3A2;PRPF19;SF3A1;ZRSR2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4210062046898772,-0.8100468229949713,0.7547169811320755,1.0,1.0,4/29,9.23%,INHA;NODAL;RBPMS;BMP3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.331880250031401,-0.8100128895723278,0.82,1.0,1.0,11/139,5.52%,SFRP1;SINHCAF;WNT9A;MYB;NOG;ASCL1;SPRED3;ADAMTS12;SPRED2;TRIB2;SPRY1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.45319942133883573,0.8100025680128838,0.6964285714285714,1.0,1.0,1/7,5.82%,IRS2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.33691356067913475,-0.8098796246374331,0.8043478260869565,1.0,1.0,9/105,7.29%,CNGA3;LOXL4;NKX2-2;TMEM179;SST;CELF3;PCDHB4;PAX6;ID4
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.4801733716867561,0.8098495494260556,0.7857142857142857,1.0,1.0,3/7,17.08%,STARD4;SIRT1;PROX1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.3376807712662626,0.8098359513634998,0.8947368421052632,1.0,1.0,11/80,13.67%,TRPV2;SLC8A1;ATP2B4;MICU1;MCU;TRPC4;ITGAV;MAIP1;TRPM6;P2RX7;SLC24A2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.31967668242975117,-0.8097310984807989,0.8979591836734694,1.0,1.0,16/131,11.46%,LCP1;MYO15A;MARCKS;RAC1;RND3;TPM1;RFLNA;ACTC1;TPM4;VIL1;ERMN;MYO7B;RND2;RHOBTB1;RHOBTB2;MARCKSL1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3286505384539358,0.809562825688221,0.74,1.0,1.0,32/206,14.41%,IFI16;DAPK2;HSPB1;NEDD4;ATP6V0D2;LEPR;HMGB1;TFEB;TAB3;GFAP;PIP4K2A;FOXO3;ERN1;PRKD1;TRIM22;ABL2;FOXO1;TAB2;TRIM8;PRKAB2;ITPR1;ATF6;TP53INP1;TRIML2;SNX5;SH3BP4;DAPL1;GPR137B;HGF;EP300;BCL2;BOK
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.3931036290174357,-0.8093279287817162,0.6666666666666666,1.0,1.0,3/23,9.68%,NMB;NMU;HCRT
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.4569062542139103,0.8092856954168043,0.7,1.0,1.0,2/7,14.00%,SLC8A1;P2RY1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.3950621583873353,-0.8091263726852497,0.7222222222222222,1.0,1.0,1/33,0.65%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.3860382354171749,-0.8091187378413836,0.6923076923076923,1.0,1.0,4/25,14.13%,AURKA;BTC;DRD3;EREG
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.4750939496366591,-0.809015949985531,0.7083333333333334,1.0,1.0,4/8,26.55%,DRC1;HDAC6;HAP1;LAMP1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.4343489430926001,-0.8087024467733992,0.6590909090909091,1.0,1.0,1/14,2.04%,NOG
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4036085567217337,-0.8086977212515726,0.6190476190476191,1.0,1.0,4/21,10.60%,REXO4;DNASE1L1;H1-0;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.46109940609872735,0.8081895146259217,0.7222222222222222,1.0,1.0,3/14,15.64%,LDLR;NR1H3;ABHD5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.44867335790848833,0.8081605884739488,0.7,1.0,1.0,5/16,20.73%,PDCD6IP;PLK1;HSPA1A;CHMP1A;HNRNPU
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.42892680609515954,-0.8081280246548886,0.6818181818181818,1.0,1.0,1/14,2.81%,DND1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.5080070028204878,0.8081138044879022,0.6666666666666666,1.0,1.0,2/5,20.46%,MSRA;MSRB3
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.4923887071203974,0.8080659112762762,0.7021276595744681,1.0,1.0,3/8,17.55%,MAT2A;UGDH;SPAST
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.48397337716201067,0.8080587883478008,0.64,1.0,1.0,5/9,23.81%,SDS;SRR;SERINC5;PSPH;PHGDH
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.40221042024453674,0.8073294291075029,0.6111111111111112,1.0,1.0,9/22,19.35%,KCNE4;ATP2B4;ATP12A;SLC4A4;SLC40A1;SLC9A1;KCNA5;KCNT2;ATP1A2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.422575693941871,0.8071214883001541,0.7254901960784313,1.0,1.0,4/35,5.57%,PIK3R5;ITGAX;ITGAM;ARHGAP30
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.4980269714762029,-0.8070440046368883,0.78,1.0,1.0,1/11,4.87%,DCAKD
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.4980269714762029,-0.8070440046368883,0.78,1.0,1.0,1/11,4.87%,DCAKD
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.4980269714762029,-0.8070440046368883,0.78,1.0,1.0,1/11,4.87%,DCAKD
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.5045908401546534,-0.8069821806534206,0.6666666666666666,1.0,1.0,2/6,4.05%,APOD;OAS3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3905075085452541,-0.8068353397842322,0.74,1.0,1.0,1/37,0.65%,DDX11
prerank,PanglaoDB_Augmented_2021__Microglia,0.3602089233213634,0.8067603018445655,0.7966101694915254,1.0,1.0,11/79,5.99%,PIK3R5;SPHK1;HPGDS;ITGAX;CX3CR1;MRC2;SLC2A5;ITGAM;LAIR1;TGFBR1;CSF1R
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.3342202443230343,-0.8067590848280827,0.8297872340425532,1.0,1.0,18/103,18.70%,PARP2;SIN3B;INCENP;ATXN7L3;TBL1X;MORF4L1;TAF6;HDAC5;BRD8;USP51;MTA2;MAP3K12;HDAC6;USP22;TAF10;HDAC11;PRMT7;USP21
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.47309913704913403,0.8066374692319198,0.7142857142857143,1.0,1.0,1/7,9.94%,RP1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.3692538994631697,0.8066327920792064,0.8333333333333334,1.0,1.0,15/43,19.37%,ANLN;RHOB;CEP55;ECT2;PDCD6IP;SNX18;PLK1;ESPL1;ANK3;SPAST;CUL7;BBS4;ROCK2;CNTROB;SPTBN1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.4760918485959364,0.8065600438598162,0.7115384615384616,1.0,1.0,4/10,23.60%,TJP3;AFDN;RAPGEF6;RAPGEF2
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5001960917529878,0.8062508403606804,0.7307692307692307,1.0,1.0,2/7,19.20%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3648402908304448,0.8058403480297435,0.7115384615384616,1.0,1.0,15/88,12.84%,PIK3R5;ROBO1;EGFR;WNT5A;CSF1R;ATP2B4;SNCA;PSRC1;PDGFRB;ADAM8;EDN1;FGFR1;SIRT1;PDGFD;TENM1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3888701095946728,0.8057542502523579,0.7391304347826086,1.0,1.0,6/25,15.10%,SMAD7;SLC8A1;PDE4B;PDE4D;ANK2;SLC9A1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.3326424001511717,0.8057224499955804,0.7450980392156863,1.0,1.0,8/94,9.50%,NRG1;NTF3;WNT5A;TNIK;CLSPN;ECT2;BORA;PRKACB
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.4301030675401587,0.80562151387289,0.7058823529411765,1.0,1.0,2/25,6.82%,NLGN1;SNCA
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.39218958047426283,0.8054495400945596,0.8076923076923077,1.0,1.0,12/44,22.28%,ST8SIA6;GLA;GLB1;SMPD4;ESYT3;HEXB;ST6GALNAC4;PIGW;ESYT2;ST3GAL6;GALC;ST3GAL4
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.38247481740397754,-0.8053204985774886,0.7547169811320755,1.0,1.0,8/32,23.97%,EMC8;CAMLG;CYB5A;EMD;EMC4;SEC61G;EMC1;EMC3
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.47631411168929405,-0.8051721434493013,0.7358490566037735,1.0,1.0,4/9,26.88%,PINK1;BMP7;ABCD1;FBLN5
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5129142021624487,0.8048545121322014,0.7209302325581395,1.0,1.0,3/12,8.22%,MSH4;HFM1;EME2
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.5383591970872122,-0.8047960659632981,0.7307692307692307,1.0,1.0,1/5,6.56%,SPI1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.34392940290047047,0.8046541822864883,0.8297872340425532,1.0,1.0,28/89,19.12%,SEMA5A;VEGFC;FGFR2;EGFR;WNT5A;TGFBR1;NRP1;PKHD1;PRKD1;HIF1A;FGF10;PRKCA;CDH13;VEGFD;SIRT1;MDK;SOX11;PROX1;C5AR1;TGFA;THBS4;PDCL3;VEGFA;BMP6;ECM1;BAD;PDGFB;ARNT
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.43944720516998326,0.8044457503327528,0.7142857142857143,1.0,1.0,4/13,15.31%,KCNE4;AKAP6;ANK3;KCNG1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.5231222272649357,0.8042143524697309,0.7045454545454546,1.0,1.0,2/5,23.87%,MITF;ACTN4
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.4498246963050361,-0.8040372847708864,0.7446808510638298,1.0,1.0,3/20,9.34%,ATP6V1E2;ATP6V1E1;ATP6V1D
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.4911790558471888,0.804017441031027,0.6530612244897959,1.0,1.0,3/5,23.50%,ADTRP;ACADL;AIG1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.46937080205301257,-0.8039780235078621,0.7407407407407407,1.0,1.0,1/9,0.84%,DYSF
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.5086745885230742,0.803949808809392,0.7580645161290323,1.0,1.0,2/6,6.27%,LHFPL2;FSHR
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.35969943006655974,-0.8038987910327802,0.7962962962962963,1.0,1.0,12/65,13.66%,TAGLN;ASCL1;CASP6;DNPH1;UPK1B;VIL1;CDHR2;GSTK1;PTER;AKR1C2;KDM6B;TPP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3879765840924929,0.8036866742151813,0.7307692307692307,1.0,1.0,4/31,5.73%,IFI16;HSPB1;WNT5A;AGER
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.4019286788896149,-0.8035731787527175,0.6851851851851852,1.0,1.0,5/33,8.96%,LCP1;RBM4;GRIPAP1;CRYAB;REEP6
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.5197346168319888,-0.8034331799085177,0.6976744186046512,1.0,1.0,3/5,28.60%,RFTN1;FLOT1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.3798451622777499,0.8034137138192342,0.7037037037037037,1.0,1.0,7/57,11.70%,SPHK1;FGFR2;EGFR;PSRC1;ANKRD17;PRKCA;MEIS2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.3617264934960554,0.8033778977825,0.7555555555555555,1.0,1.0,3/40,8.28%,PLA2G10;CYP4Z1;SCD
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.4951427140180336,0.8032031046387089,0.7192982456140351,1.0,1.0,7/8,34.16%,CLASP1;CLASP2;PTEN;FERMT2;FERMT1;RREB1;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.4585470179030382,0.8031288906723629,0.7307692307692307,1.0,1.0,2/10,17.26%,TMEM67;KAT2B
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.4861608567690546,0.8029498883416264,0.6909090909090909,1.0,1.0,4/10,22.49%,LRWD1;RUVBL2;ACD;NIPBL
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.49939987789964213,0.8025800252503144,0.7735849056603774,1.0,1.0,2/8,19.20%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.2985979399748003,-0.8025415688895331,0.9629629629629629,1.0,1.0,15/181,10.89%,CBLC;AURKA;ADRM1;DTX3L;UBE2L6;ANAPC15;PCYOX1L;UBC;RNF8;ARIH2;RBX1;UBL7;RNF213;UFD1;PINK1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.38929839094125074,0.8024626971482249,0.7777777777777778,1.0,1.0,7/29,15.04%,NLGN1;GRIA4;DLG2;CRHBP;LRRC7;GRIA2;MEF2C
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.48180150616618495,0.8022100162945335,0.7906976744186046,1.0,1.0,2/8,24.85%,BARD1;RNF6
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.40247080832465193,0.8019359795058949,0.74,1.0,1.0,2/16,6.49%,RLBP1;CYP3A4
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.505206855080891,0.8015220336130853,0.717391304347826,1.0,1.0,1/5,3.79%,HMGB1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.3854474087056212,-0.8012309566486793,0.7115384615384616,1.0,1.0,10/52,13.69%,TOMM40;TIMM17B;SPG7;TOMM20;BAK1;KIFBP;SLC25A5;FIS1;TIMM17A;TOMM7
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.43559827796484857,0.8007228132374137,0.6486486486486487,1.0,1.0,4/10,23.28%,SIRT1;ACADVL;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.4942337865492018,-0.8006597933468195,0.6595744680851063,1.0,1.0,2/9,7.12%,ZWILCH;SPDL1
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.5566653122127287,-0.8006310356036762,0.7608695652173914,1.0,1.0,1/5,9.02%,CD24
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.5566653122127287,-0.8006310356036762,0.7608695652173914,1.0,1.0,1/5,9.02%,CD24
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.5266068259026633,-0.8004656416779873,0.7307692307692307,1.0,1.0,1/5,24.09%,UBE2S
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.4710166495681694,-0.8002773604137482,0.7142857142857143,1.0,1.0,2/9,23.19%,EHD2;RAB11B
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3854706476300872,0.8002232767244127,0.8085106382978723,1.0,1.0,7/35,12.25%,PPARGC1A;ERN1;ZBTB20;HIF1A;FOXO1;IGF1R;SIRT1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.515305650320671,0.8002041006760097,0.8,1.0,1.0,1/8,5.89%,AK3
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.3846841604081089,-0.8001189397724351,0.7358490566037735,1.0,1.0,9/30,15.99%,GTF2F1;POLR2I;POLR2J;GTF2H2;CMTR1;SUPT5H;POLR2G;POLR2C;ERCC2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.3846841604081089,-0.8001189397724351,0.7358490566037735,1.0,1.0,9/30,15.99%,GTF2F1;POLR2I;POLR2J;GTF2H2;CMTR1;SUPT5H;POLR2G;POLR2C;ERCC2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.46212804332729773,0.8000938121540779,0.7446808510638298,1.0,1.0,3/13,15.63%,PPAT;IMPDH1;GMPS
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.46121751848482895,0.8000202191565127,0.6904761904761905,1.0,1.0,3/8,24.72%,AKAP6;SLC9A1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.46121751848482895,0.8000202191565127,0.6904761904761905,1.0,1.0,3/8,24.72%,AKAP6;SLC9A1;SPPL3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.48674208622884574,-0.7996198891494992,0.7058823529411765,1.0,1.0,2/5,10.89%,NONO;PINK1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3836599993576537,0.7992964180314784,0.7254901960784313,1.0,1.0,2/26,6.27%,WNT5A;FSHR
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2703783976276912,0.7992447982792713,1.0,1.0,1.0,290/1645,17.33%,DACH1;LOXL2;MED17;TSHZ2;IFI16;ESRRG;ZFPM2;ZNF300;CCNH;RUNX1;PKNOX1;TPRX1;TFCP2L1;NFIL3;ZBTB2;FRK;RGMA;ZNF792;TGIF1;KLF2;PPARG;ATOH8;ZBTB1;LITAF;ZNF600;CREB5;ZSCAN20;HNF4G;HJV;TSHZ1;ZBTB10;FGFR2;PBX1;BBX;NR3C2;LDB2;ZBTB9;HMGB1;BATF3;ZNF697;FOXD4L5;NRIP1;TFEB;PRRX1;SMAD7;PPARGC1A;NR5A2;ZEB1;TOX3;EGFR;TRPS1;ARID1A;ZNF827;IRF2BPL;NEUROD2;WNT5A;ZEB2;GLIS2;WWOX;NR2E1;TSHZ3;ZNF165;RUNX2;TP63;ARID1B;RPS6KA4;SRCAP;ZNF20;ZBTB5;RFX3;TCF7L1;HEY1;TENM2;CSF1R;FOXO3;ELP4;HIVEP2;NFIA;MEIS1;ATP2B4;TEAD2;ZNF202;DACH2;IKZF2;ZNF408;LCORL;SNCA;SP3;HDAC9;LMO7;ACVR2A;MRTFA;FOXP2;PBX3;KCTD1;PPP3CA;NR3C1;PRKD1;SSBP4;NCOA2;POU6F2;MKX;MAML2;SMAD5;TBL1XR1;ZNF613;ZBTB20;ZFP36;ATXN1;MYPOP;CTBP2;JMJD1C;RFXANK;TCF4;NR1D2;NPAS3;HDAC2;JAZF1;TWIST1;HINFP;TOX;ZNF518A;ZNF493;SUPT3H;HDAC3;ZNF205;MAML3;ZNF433;RORA;PHF21A;GLI3;EPCAM;ZNF283;ZNF782;DVL2;ZNF211;UBP1;HIF1A;ZNF675;SMAD1;NFATC2;FOXO6;IER5;MIER2;BMPR1A;ZBTB34;AUTS2;NCK1;BCOR;SMARCD3;ZSCAN22;DMTF1;SOX5;FOXO1;MITF;SSBP2;JAG1;ZGLP1;TAF3;ZNF677;FLI1;ATF6;EDN1;KLF12;ASXL3;ZNF630;SMAD2;DLL1;MRTFB;NCOA5;CDH13;CDK12;WNT8A;MXD4;ZNF526;RNF2;ZNF616;ZFHX4;PDE2A;SMAD9;ARID5B;PLK1;WWC1;PEX2;BAZ2B;MEIS2;POU2F1;ST18;NR1H3;ZNF582;SMURF2;ZBTB7B;ZSCAN25;SIRT1;RFXAP;CTNNB1;TBX19;MED13L;NPAS1;CSRNP2;ZNF396;ID3;PPM1A;ZNF536;EPC1;PTOV1;ZBTB40;ZNF175;HIC2;FOSL2;HGF;THAP11;ZBTB17;MEF2A;EP300;SMAD3;FST;ZNF212;GABPA;ZNF445;DPF3;RELA;PLAC8;TBX6;NACC2;ETV6;FBP1;ZBTB26;MNAT1;E2F5;CREB1;ZNF189;ZNF850;ZNF142;ACVR1;SCX;ZBTB37;UBE2D3;MEIS3;CSRNP3;NFYC;MEF2C;ZNF45;ZNF320;PID1;SLC9A1;SP4;OGT;ZNF835;TET2;RARB;PRKCB;ACTR3;ZNF384;ELF1;NFATC3;KLF7;URI1;ZXDC;PIK3R1;HIVEP3;TRERF1;DR1;SALL1;ZFP62;ZNF367;NANOG;RUVBL2;CREM;PAX5;VEZF1;SOX11;HLF;ASXL1;NFIB;CRY1;HDGFL3;NEDD4L;OLIG1;PROX1;ZNF81;ZNF785;SATB2;ELF2;ZFX;SMARCD2;TGFA;KAT2B;ZNF30;ACTL6A
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.38239991222210734,-0.7989112825394853,0.8148148148148148,1.0,1.0,2/28,3.98%,NUPR1;TMSB4X
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.37841890057727223,0.7988023367030191,0.7627118644067796,1.0,1.0,8/51,11.15%,KCNC2;KCNS3;RFX3;CCL5;ITPR1;CRHBP;PRKCA;CHD7
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.4307186786655502,0.7986848962582402,0.7777777777777778,1.0,1.0,8/23,21.14%,SELPLG;FER;ST18;RELA;PID1;ST3GAL6;SMAD4;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.3644920875522546,0.7980284358942482,0.74,1.0,1.0,8/36,13.88%,ROBO1;TP63;ROBO2;MAML2;MAML3;JAG1;DLL1;EP300
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.4638335478694888,-0.7979302392641902,0.7450980392156863,1.0,1.0,2/11,10.86%,WIPI1;WIPI2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.38202127653227297,0.7978411534249115,0.7090909090909091,1.0,1.0,7/39,15.50%,NRXN1;SNCA;SYT1;PPFIA3;SYN3;LIN7A;PCLO
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.3419696923579052,0.7977183904468157,0.8113207547169812,1.0,1.0,6/92,5.67%,ACE2;CASP12;PTGES;GUCY2F;WNT5A;CAMKMT
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.40082028219121774,-0.7974515090010628,0.7346938775510204,1.0,1.0,8/26,24.25%,UBC;HDAC6;ACBD5;DYNLL1;CFTR;SQSTM1;PCNT;UBB
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.44090946924682906,-0.7972250116527462,0.7843137254901961,1.0,1.0,1/16,2.07%,LDB1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.5549196688039078,-0.7972207145388428,0.7551020408163265,1.0,1.0,2/5,16.48%,HLA-DRA;HLA-DMA
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.41510629217480344,0.7970870167667511,0.6909090909090909,1.0,1.0,11/31,22.47%,NAV3;SNCA;DYRK1A;FGF13;MAP2;HDGFL3;CLASP1;TRIM54;CLASP2;ATXN7;APC2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5089113287353779,-0.7970285836559731,0.7843137254901961,1.0,1.0,3/7,26.39%,APH1B;NCSTN;ADAM17
prerank,PanglaoDB_Augmented_2021__Platelets,-0.347492669022695,-0.7968238273198894,0.8367346938775511,1.0,1.0,9/110,6.56%,SELP;CD9;F5;AOAH;HCK;SERPINE1;OST4;LTBR;SPI1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.43525428911433606,0.7964812864438724,0.6862745098039216,1.0,1.0,1/21,1.32%,SPHK1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.40033961920362643,-0.7964629454238115,0.6486486486486487,1.0,1.0,7/25,24.28%,MMP21;AHI1;NDRG4;CCDC39;SHH;CCDC40;MICAL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.48786759401004354,0.7964037553648398,0.82,1.0,1.0,1/8,0.62%,LTK
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.48720426950263956,-0.7963777794246943,0.7368421052631579,1.0,1.0,1/6,6.26%,IL11
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3068489761890899,-0.7960771375670215,0.8958333333333334,1.0,1.0,15/129,9.58%,SLC29A3;GPR3;MYO15A;PLAG1;SCGB1A1;ACTC1;RYR1;PKP1;NPHS1;CACNG1;KCNE2;IGFBP2;PDE6B;THNSL2;ABCB11
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4557708285231145,-0.7958861031894771,0.6792452830188679,1.0,1.0,4/10,13.64%,TMSB4X;NOS2;PINK1;ENO1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.40469402480825384,0.7956674050653108,0.7884615384615384,1.0,1.0,12/28,23.57%,IRS1;PRKD1;FGFR3;PDGFRB;EPHA8;PIK3R1;PDGFB;PTK2;TNFAIP8L3;WDR81;AMBRA1;WASHC1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.4581253339853669,0.7956151025223748,0.7021276595744681,1.0,1.0,3/13,7.51%,HSPB1;SEMA5A;PRKD1
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.45021147721546273,-0.7956056388672096,0.72,1.0,1.0,1/7,3.46%,BST1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.3410139156053937,-0.7951034637243019,0.8333333333333334,1.0,1.0,14/72,16.23%,CLU;RPS27L;UPF3B;RBM3;UPF3A;CIRBP;NIBAN1;RACK1;METTL3;EIF6;EFNA1;TNFRSF1A;NAT10;RPL5
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.33733238756553624,0.7946745151561233,0.8958333333333334,1.0,1.0,17/86,15.27%,NEDD4;GFAP;EGFR;BANP;WNT5A;CHMP6;ODC1;TIPARP;FOXO1;HMGCR;ZDHHC2;C4BPB;SMURF2;SEC22B;SMURF1;BARD1;DTL
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3280692138283666,0.7942028723538627,0.8653846153846154,1.0,1.0,22/136,12.06%,FAS;RIT2;PPEF2;SYK;FGFR2;HMGB1;ROR1;EGFR;PELI2;TNIK;PKHD1;RYK;FGFR3;EPHA7;FGF10;IGF1R;PTPN6;PHLPP1;EPHA8;FGFR1;WWC1;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.46214969803580597,-0.7938821674887033,0.7391304347826086,1.0,1.0,1/13,4.67%,KIF20B
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3898345079493958,-0.7937160074252121,0.7608695652173914,1.0,1.0,10/33,28.51%,NUP133;NUP43;XPOT;NUP155;NUP85;RAN;NUP214;SEC13;NUP50;TPR
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3898345079493958,-0.7937160074252121,0.7608695652173914,1.0,1.0,10/33,28.51%,NUP133;NUP43;XPOT;NUP155;NUP85;RAN;NUP214;SEC13;NUP50;TPR
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.5223008170628136,0.7936307730239655,0.8260869565217391,1.0,1.0,1/7,10.19%,ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.4237069661545034,0.7931937114249685,0.7446808510638298,1.0,1.0,9/19,19.12%,SULF1;RORA;EIF2AK3;HIF1A;C3;C5;PTGS2;HPSE;ARNT
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.45477533668915815,0.7931348034886687,0.6666666666666666,1.0,1.0,10/14,40.28%,AIFM2;PDSS2;COQ8B;COQ7;UBIAD1;COQ3;COQ2;COQ10A;PDSS1;COQ9
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.32521186096906124,0.7930564121437921,0.9591836734693877,1.0,1.0,18/127,12.25%,ERBB4;TSHZ1;PBX1;UNC5D;EGFR;GRM5;SLC35F1;PPM1E;GRID2;POU6F2;ADGRL3;CBLN1;EPHA7;NOL4;NCAM1;PROKR2;B4GALNT4;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.41624912926404317,0.7929921553040873,0.6730769230769231,1.0,1.0,6/17,15.33%,EPHA3;MCTP1;PRKD1;PROM2;NR1H3;PICALM
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.3914361555649793,-0.7929687364186435,0.7619047619047619,1.0,1.0,1/24,1.32%,PLEKHH2
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.4704452788588131,-0.7929123015551878,0.6666666666666666,1.0,1.0,1/12,1.97%,NIPAL4
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.4486711012761567,0.7927556883440134,0.8297872340425532,1.0,1.0,2/13,5.89%,PNP;AK3
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.37405458190696494,0.7926574527344417,0.7674418604651163,1.0,1.0,15/47,16.07%,RGMA;HJV;SMAD7;RUNX2;ACVR2A;SMAD5;SMAD1;BMPR1A;SMAD2;SMAD9;SMAD3;SMURF1;ACVR1;SCX;TGFBR3
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.5089058281624682,0.7924546728480315,0.7708333333333334,1.0,1.0,2/6,19.03%,LDLR;ROCK2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.36250220637232766,-0.7922846571948543,0.8372093023255814,1.0,1.0,9/45,14.86%,FTH1;B2M;SCARA5;SKP1;ISCU;FRRS1;HEPH;ATP6V0A2;NUBP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.47596756971660004,0.7921469195622166,0.74,1.0,1.0,2/6,17.48%,SIRT1;DIPK2A
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.5501057141324016,-0.7919589073640555,0.78,1.0,1.0,1/5,4.05%,OAS3
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.4867329433595178,0.7915109716184106,0.6909090909090909,1.0,1.0,2/6,23.60%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.4504917216098343,0.7914809437819375,0.6808510638297872,1.0,1.0,4/10,27.48%,MID2;TRIM5;IFITM3;SNX3
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.42129428313779793,0.7913188393238998,0.7058823529411765,1.0,1.0,3/25,4.73%,CCDC63;DNAI4;DNAH5
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.33229264156024346,-0.7911675355799007,0.8813559322033898,1.0,1.0,14/116,12.40%,PLK4;PLK3;AURKA;HAUS8;FOXM1;DCTN1;SKP1;SSNA1;CETN2;PRKACA;TUBB4B;AKAP8L;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.5305783836842931,-0.7911115692812953,0.7647058823529411,1.0,1.0,2/6,17.17%,FOXM1;GSTP1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.3528777704410635,0.7910590132394204,0.8085106382978723,1.0,1.0,16/83,13.32%,MXRA5;SSC5D;TNC;PRRX1;POSTN;SULF1;CCN2;NID2;ADAMTSL1;FBXL7;PDGFRB;ACTA2;TIMP3;COL5A2;CXCL12;SPON2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.3597873808015805,-0.7910118773168503,0.92,1.0,1.0,20/107,19.81%,MAP1LC3B2;TOMM40;ATG14;VPS25;WIPI1;TOMM20;MAP1LC3A;WIPI2;PINK1;TOMM7;VPS28;VPS16;CHMP2A;SRC;MAP1LC3B;ATG10;VIPAS39;GABARAPL2;ACBD5;RUBCNL
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.45904046361487755,0.7908230767645232,0.75,1.0,1.0,6/12,22.38%,GLI3;ZFP36L2;LIG4;RAG2;RAG1;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.4482426857514813,0.7907135082918965,0.72,1.0,1.0,1/10,1.59%,RUNX1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.40771878196994393,0.7903032433522752,0.7446808510638298,1.0,1.0,8/23,17.26%,GLI3;RSPO2;FGF10;ZNRF3;CHD7;LRP4;SALL1;KAT2B
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.45255103409817354,-0.7900759848562906,0.7358490566037735,1.0,1.0,4/10,24.47%,LIPC;APOA1;ABCA5;PLTP
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.3916822568268796,-0.7900379933627031,0.7727272727272727,1.0,1.0,6/33,18.76%,PTCD2;CPSF4;SAFB;CDK11B;SRSF10;SUPT6H
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.5293022445724338,0.7900249045605408,0.7872340425531915,1.0,1.0,2/5,18.38%,VEGFA;BMP6
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.48672328636702644,-0.7899106506610853,0.6888888888888889,1.0,1.0,2/11,7.12%,ZWILCH;SPDL1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.32195631024077975,0.789723464780285,0.9090909090909091,1.0,1.0,18/114,11.07%,HMGCS1;PPARG;FDFT1;IRS2;ELOVL6;PSMD13;NCOA2;LDLR;TBL1XR1;SCD;ODC1;NR1D2;HDAC3;SMARCD3;HMGCR;PRKAB2;ACACA;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3625566313783218,0.7897065009428146,0.6888888888888889,1.0,1.0,11/51,13.64%,NFKBIZ;PLA2G7;WNT5A;SNCA;LPL;ADAM8;PDE2A;NAPEPLD;IL16;IFI35;MDK
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3281161945456051,0.7896106652520918,0.85,1.0,1.0,13/92,13.67%,TRPV2;SLC8A1;ATP2B4;CACNB2;MICU1;CCL5;ITPR1;TRPC4;ITGAV;TRPM6;P2RX7;ANK2;SLC24A2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.33269982117849245,0.7893513794668436,0.8518518518518519,1.0,1.0,8/76,11.78%,ZDHHC11;GDAP1;ZDHHC14;PARD3;ZDHHC11B;ZDHHC2;PEX2;VPS37D
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.44009759472506843,-0.7892829960687393,0.7884615384615384,1.0,1.0,5/17,23.51%,VIL1;SCIN;ADD2;TRIOBP;FLII
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.44009759472506843,-0.7892829960687393,0.7884615384615384,1.0,1.0,5/17,23.51%,VIL1;SCIN;ADD2;TRIOBP;FLII
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.4835086355683572,-0.7892731299177524,0.7727272727272727,1.0,1.0,3/9,7.84%,CD74;CD4;FOXP1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.3971314495497449,0.7891817455966745,0.75,1.0,1.0,1/24,4.38%,ST8SIA6
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.37322384331700936,-0.7888716560226953,0.7450980392156863,1.0,1.0,9/37,18.56%,SDHC;ETFB;UQCRH;UQCRC1;ATP5F1D;ETFDH;ETFRF1;NDUFA5;UQCR10
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.31928751711682285,-0.7888350920248268,0.8775510204081632,1.0,1.0,31/140,20.88%,PLK3;AURKA;CDK5;DAXX;RPF2;TAF9B;TAF6;STK11;RPS15;TAF11;TAF7;CHEK1;SUPT16H;MEAF6;HUS1;BRD7;PIN1;RPL23;TOP3A;MTA2;TAF1;RPL5;PAK1IP1;RPL37;TAF10;RPS20;TPX2;RBBP8;KAT5;RPL11;RMI1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.5274345901855154,0.7887313705517471,0.7636363636363637,1.0,1.0,1/5,9.71%,FER
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.413289700417945,-0.7886917814188065,0.7843137254901961,1.0,1.0,5/29,10.51%,TNFSF18;IL31RA;GHR;PARP14;STAP2
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.4896696058662469,0.7883311761284589,0.7021276595744681,1.0,1.0,1/10,2.31%,SEMA5A
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.39654765247354457,-0.7883018461281941,0.7321428571428571,1.0,1.0,3/35,9.16%,MYO15A;KIF1A;MYO7B
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.4230659338610536,-0.7882096911731672,0.7142857142857143,1.0,1.0,4/20,18.14%,GNB3;MBTPS2;NR1H4;EPHX2
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.4995056857619803,0.7878673623219424,0.717391304347826,1.0,1.0,2/7,10.00%,ARG1;DDAH1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.42912344741301883,0.7878162290425453,0.8571428571428571,1.0,1.0,3/17,18.34%,SHROOM2;TENM3;VEGFA
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.4187968439377606,0.7876923054900894,0.8666666666666667,1.0,1.0,6/29,13.77%,SLC26A3;HCN1;CRHBP;PDE2A;SLC26A6;AKAP6
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.42534727256915933,-0.7876529207646544,0.7636363636363637,1.0,1.0,5/20,15.66%,CACNB1;AHNAK;DRD3;GNB5;DRD4
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.34907169921153547,-0.7873373336281253,0.8974358974358975,1.0,1.0,13/90,14.43%,TMEM179;SARDH;KIF1A;ARVCF;CELF3;DACT2;CDHR2;REEP6;LRRTM1;CALY;TTBK1;RAP1GAP;APOA1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.41737127259638385,-0.7873365747475808,0.7647058823529411,1.0,1.0,1/27,1.18%,OSTN
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4815880368378219,-0.7870018656866219,0.7540983606557377,1.0,1.0,4/8,26.07%,TMEM9;PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.4636531124080804,-0.7866417322541696,0.7272727272727273,1.0,1.0,2/9,16.17%,PDHA1;MLYCD
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.4855465843321008,0.7864456504336599,0.6888888888888889,1.0,1.0,1/5,4.84%,SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.4855465843321008,0.7864456504336599,0.6888888888888889,1.0,1.0,1/5,4.84%,SLC8A1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.3049777426036446,-0.7863297896305759,0.8888888888888888,1.0,1.0,20/187,12.40%,PLK4;PLK3;AURKA;CDKN3;HAUS8;FOXM1;DCTN1;SKP1;ZNF324;SSNA1;LATS2;MAX;PLK2;CETN2;PRKACA;CCND1;CCNE1;TUBB4B;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.4555528707507575,-0.7862447615515863,0.7346938775510204,1.0,1.0,9/16,24.70%,KIF1A;KIF5A;NEFL;MAP1A;SOD1;PAFAH1B1;HAP1;MGARP;KIF1C
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.39037062927757754,-0.7862095239759097,0.7627118644067796,1.0,1.0,1/41,0.67%,BUD23
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.38525686813363624,0.786201255303609,0.7872340425531915,1.0,1.0,7/29,17.04%,KCNE4;FGF12;ANK2;GJC1;KCNJ2;KCNA5;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.37827770419903145,0.7860342344313623,0.7857142857142857,1.0,1.0,6/31,12.76%,KLHL15;NUDT16L1;UBR5;TWIST1;RADX;SHLD1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.41396795174221757,-0.7852959793329257,0.8076923076923077,1.0,1.0,5/24,9.72%,CACNB1;AHNAK;ADRA2A;CALM1;PRKACA
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.33300375507846314,-0.7852314284827648,0.7931034482758621,1.0,1.0,18/77,18.59%,FGF1;RAC1;ETS1;ENPP2;VIL1;FGF7;FOXP1;GFUS;SPARC;NRP2;PIK3CB;HDAC6;CTSH;KDR;THBS1;SRC;RAB11A;GPLD1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.5178609213613412,0.7851935682478599,0.7872340425531915,1.0,1.0,2/6,12.69%,PDE4D;CRLF2
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4544102594400953,0.7850382235889033,0.7254901960784313,1.0,1.0,2/13,5.59%,LEPROTL1;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.455824352316694,0.7847511547938151,0.7115384615384616,1.0,1.0,4/9,27.48%,MID2;TRIM5;IFITM3;SNX3
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4568489986268751,-0.7846693442448598,0.6486486486486487,1.0,1.0,2/16,6.38%,NOG;PAX8
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3025377768382254,-0.7844135251842737,0.9818181818181818,1.0,1.0,33/227,14.13%,STING1;HLA-DPB1;TXK;DDX41;CGAS;SERPINE1;NLRP3;CD74;DHX58;CD4;NODAL;BTN3A1;ADRA2A;FOXP1;LACC1;POLR3A;CARD9;ATF4;GLMN;POLR3E;NOS2;CYP1B1;POLR3D;PTPRC;NLRP9;POLR3H;ZP3;IL1R1;PRKCZ;ISG15;SERPINF2;NR1H4;EREG
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.40569713755843984,-0.7842271885096553,0.7254901960784313,1.0,1.0,6/22,14.19%,RNASE1;LACTB2;NUDT16;POP7;POP1;CPSF3
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.4734937120680218,0.7840601168008997,0.7407407407407407,1.0,1.0,1/8,5.23%,WNT5A
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.47153184817724336,-0.7838417065882541,0.7894736842105263,1.0,1.0,3/10,26.09%,METTL3;MACROH2A1;RBM15B
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.32053598364556,0.7838025901627736,0.8125,1.0,1.0,22/120,13.17%,MXRA5;FAT4;HMCN1;LDB2;PRRX1;POSTN;SULF1;CCN2;FAM114A1;NCOA2;NID2;ADAMTSL1;FBXL7;PDGFRB;DYRK1A;ARID5B;ACTA2;PDE3A;TIMP3;COL5A2;ABI3BP;CXCL12
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.36145638844680167,-0.7837925549803694,0.8301886792452831,1.0,1.0,7/41,17.93%,RNASET2;DNASE1L1;SUPV3L1;PABPC4;FBXO6;RAB12;FBXO2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.35448615369669534,0.7835799192774712,0.7777777777777778,1.0,1.0,9/27,23.02%,RHOB;ECT2;SIRT1;RELA;MAP3K5;PLEKHA1;NFE2L2;SIRPA;ABL1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.37112430447936096,-0.7833567828987013,0.7833333333333333,1.0,1.0,12/45,17.64%,SH3RF2;PRR7;SVBP;PER2;PIAS3;COPS9;CAMLG;ISG15;VPS28;RPL5;USP4;SPRY2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.3642947467471343,0.7831725566114195,0.7560975609756098,1.0,1.0,4/26,11.08%,ZSWIM6;ZSWIM5;PDGFRB;ZSWIM8
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.34094607386072107,-0.7830385417679872,0.8958333333333334,1.0,1.0,3/55,4.39%,NCKAP1L;RAC1;VAV3
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.4794563368801087,-0.7828014320575262,0.74,1.0,1.0,1/7,4.19%,DHX58
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.4469483234902367,-0.7827715118411025,0.717391304347826,1.0,1.0,1/12,6.15%,EPHB6
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.34739369280712756,0.782333582705821,0.7884615384615384,1.0,1.0,4/43,7.37%,IL1RAPL1;CASS4;NRP1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.47691432204373585,0.7821449521024436,0.7619047619047619,1.0,1.0,1/5,21.09%,SMAD4
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.37565374532669504,-0.7821101584324291,0.8627450980392157,1.0,1.0,11/46,17.64%,SH3RF2;DTX3L;PRR7;SVBP;PER2;CAMLG;ISG15;VPS28;TAF1;USP4;SPRY2
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.32080330873905627,0.7820203948203731,0.9245283018867925,1.0,1.0,17/142,12.46%,STK26;FAS;DAPK2;NTF3;FANK1;TOX3;MAGED1;TP63;CIDEA;SGK1;PTPN6;PHLPP1;TP53INP1;IFT57;PPP1R13B;SIRT1;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.3900665237469718,0.7813487134911073,0.7959183673469388,1.0,1.0,7/21,16.09%,MSTN;AUTS2;PLCE1;WASF2;PIK3CA;ACTR3;PIK3R1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.33591578949229145,-0.7807378984187476,0.7551020408163265,1.0,1.0,12/97,14.62%,TMEM179;KIF1A;GNG3;CELF3;SLC6A9;KIF5A;NDRG4;TAGLN3;CCDC177;TTBK1;PCDH8;TUBB2B
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),-0.4938627285745824,-0.7804913329252737,0.6938775510204082,1.0,1.0,1/5,5.74%,IL4I1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),-0.4938627285745824,-0.7804913329252737,0.6938775510204082,1.0,1.0,1/5,5.74%,IL4I1
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.46276392319055487,0.7802987988987531,0.75,1.0,1.0,2/9,14.76%,EGFR;TIMP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.38185375837635854,0.7802953906228872,0.711864406779661,1.0,1.0,14/41,27.53%,KCNJ3;KCNJ6;ANK2;AKAP6;KCNN1;KCNJ2;GNG2;KCNJ16;KCNN4;KCNMB3;KCNJ9;KCNN2;WNK1;GABBR1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.4935750646640198,0.7802395054755743,0.72,1.0,1.0,5/7,39.70%,GAL3ST1;B3GALT1;UGCG;UGT8;B4GALT3
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.5326388474912548,-0.7800947117578749,0.7674418604651163,1.0,1.0,1/5,4.53%,HPS4
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4319678436073931,0.7799970973518483,0.7307692307692307,1.0,1.0,5/18,13.78%,DCUN1D1;TGFBR1;HIF1A;DNAJB2;HSPA1A
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.4015354547774156,-0.7797274149413743,0.8363636363636363,1.0,1.0,4/26,6.60%,ARHGAP22;KIF1A;CDK5;SHANK3
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.4169118755085213,-0.7796721363222174,0.7555555555555555,1.0,1.0,7/17,23.90%,MAGEL2;ARPC5;IQGAP2;ARPC2;SCIN;ARPC3;WHAMM
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4881438841699883,0.7796089833241687,0.7659574468085106,1.0,1.0,3/11,22.38%,PAPOLA;BARD1;ZFP36L1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3496190514224713,0.7794933084557145,0.8043478260869565,1.0,1.0,21/108,17.26%,ATP6V0A4;IRS1;ENPP1;PPARG;ATP6V0D2;IRS2;GAB1;HDAC9;FER;FOXO1;IGF1R;BCAR1;INHBB;SORBS1;INSIG1;INSIG2;PIK3R1;AKT2;CPEB2;TBC1D4;KAT2B
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.4323384725005759,-0.779141936389256,0.7872340425531915,1.0,1.0,4/28,9.44%,ATP6V1E2;ATP6V1E1;ATP6V1D;RAB31
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.5085279341771063,0.779124609757959,0.6984126984126984,1.0,1.0,3/6,17.40%,DNAH11;ODAD2;CFAP43
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.3394655783029701,0.7787843524344887,0.8222222222222222,1.0,1.0,17/49,19.37%,TGIF1;SMAD7;TGFBR1;SMAD1;BMPR1A;SMURF2;CTNNB1;ID3;PPM1A;SMAD3;SMURF1;ACVR1;UBE2D3;SLC20A1;WWTR1;SKIL;SPTBN1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.49149315422991297,0.7786144848825511,0.7346938775510204,1.0,1.0,4/7,14.51%,ITGAM;AMER2;ZBTB7B;SMURF1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.47194349062876895,-0.7782638395891274,0.7169811320754716,1.0,1.0,1/7,7.28%,CD63
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.44664729725302826,0.7782527375969603,0.7592592592592593,1.0,1.0,5/13,19.06%,ARID1A;SMARCD3;ARID2;SMARCD2;SMARCE1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.44664729725302826,0.7782527375969603,0.7592592592592593,1.0,1.0,5/13,19.06%,ARID1A;SMARCD3;ARID2;SMARCD2;SMARCE1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.44256979432536936,0.778087574974176,0.6666666666666666,1.0,1.0,3/11,20.85%,RNFT1;USP13;RNF185
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.45298745483467595,-0.7780341063563483,0.711864406779661,1.0,1.0,3/12,12.22%,CCN3;CARD9;OCIAD2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.35638197382520576,0.778000693768607,0.7894736842105263,1.0,1.0,3/35,10.62%,SLC22A2;SLC6A13;SLC29A2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.40187648088060723,-0.777968883917716,0.7391304347826086,1.0,1.0,7/28,21.44%,APOD;CARD9;NOS2;LEP;STAT3;GBP5;ABCD1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.4404928012204793,-0.7776104144897106,0.7142857142857143,1.0,1.0,2/16,10.86%,WIPI1;WIPI2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4052469785343198,0.7775748561238331,0.7142857142857143,1.0,1.0,1/24,1.33%,FAS
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.5079140021042056,0.777397616160817,0.8163265306122449,1.0,1.0,1/5,15.02%,IDH1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.5346785701557006,0.7770694073941053,0.7755102040816326,1.0,1.0,2/5,18.93%,SLC39A8;SLC11A2
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.5346785701557006,0.7770694073941053,0.7755102040816326,1.0,1.0,2/5,18.93%,SLC39A8;SLC11A2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.40337407189266766,-0.7767487894931789,0.803921568627451,1.0,1.0,4/23,17.12%,SPI1;DAXX;TNFRSF1A;DELE1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3206107167625632,-0.7766832514225346,0.9454545454545454,1.0,1.0,6/121,6.27%,STING1;SFRP1;AQP8;CASP6;KCNE1;P2RY11
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.4444400453086723,0.776506585949727,0.8157894736842105,1.0,1.0,2/12,5.92%,TGFBR1;HEY1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.33476523587990065,-0.7762686907007714,0.8679245283018868,1.0,1.0,11/87,9.35%,COL6A1;ADAM12;RND3;ADAMTS12;TPM1;ACTC1;GPC1;CALD1;CRYAB;FKBP10;SYNC
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.342901410095688,-0.7762117557221241,0.7884615384615384,1.0,1.0,12/69,12.69%,SLC25A10;HMGB3;CCDC86;AGRN;EIF5A;GIPC1;KDELR1;PACSIN3;REEP6;LAS1L;RPL8;LMNB2
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5186263729469079,-0.7761140706483515,0.84,1.0,1.0,2/7,5.67%,MAFG;MAFF
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.36154976527637744,0.7759761276334436,0.7777777777777778,1.0,1.0,2/45,1.64%,FZD1;FRAT2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.4102161493811715,0.7759693512052266,0.7647058823529411,1.0,1.0,6/13,28.42%,APBA1;DYNC1I2;ARHGAP21;DYNC1I1;BORCS5;CAMSAP3
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.5030210810684942,0.7759375881554696,0.8163265306122449,1.0,1.0,2/8,17.75%,LIMK2;CLASP1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.49494703236979776,-0.7758732231733662,0.7435897435897436,1.0,1.0,2/7,12.87%,PPP1R3E;PPP1R3D
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.36311265648615615,0.7758182743758479,0.7708333333333334,1.0,1.0,9/36,16.51%,SNCA;JPH1;PDE4D;JSRP1;TRDN;ANK2;AKAP6;NPSR1;DMD
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.4433491524719381,0.7757444906021457,0.75,1.0,1.0,7/14,19.35%,SLC8A1;ATP12A;SLC9A1;KCNJ2;SLC12A2;NEDD4L;ATP1A2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.3812824970133139,0.7754119369318457,0.851063829787234,1.0,1.0,6/29,11.54%,LEPR;SLC30A8;NRP1;SNCA;DISP3;WWC1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.4773625217814733,0.7752759431043228,0.8604651162790697,1.0,1.0,2/11,9.36%,PARP8;TIPARP
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.49502142419024747,-0.7751398523844096,0.7551020408163265,1.0,1.0,4/6,28.61%,HDAC6;SAT2;SRM;SAT1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5039675287050647,-0.7751113499940068,0.7358490566037735,1.0,1.0,1/5,13.65%,EDEM2
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5039675287050647,-0.7751113499940068,0.7358490566037735,1.0,1.0,1/5,13.65%,EDEM2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5039675287050647,-0.7751113499940068,0.7358490566037735,1.0,1.0,1/5,13.65%,EDEM2
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.4707544617786936,0.7748507845773188,0.8421052631578947,1.0,1.0,5/12,33.45%,MDK;IL34;PTPRZ1;BIN1;DICER1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3853172761718843,-0.7747806941516459,0.7333333333333333,1.0,1.0,4/16,18.59%,ADRA2A;PACSIN3;TIMP4;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3493078183819035,-0.7745486539361759,0.8888888888888888,1.0,1.0,12/93,13.68%,SFRP1;CCN3;TSPYL2;TCHP;BTG1;STK11;MT1E;RACK1;PPT1;MT1G;ENO1;HNF4A
prerank,MSigDB_Hallmark_2020__Androgen Response,0.3169977214164164,0.7745192099877456,0.8571428571428571,1.0,1.0,21/95,14.98%,HERC3;HMGCS1;UBE2J1;ZBTB10;B4GALT1;STEAP4;UAP1;SCD;CDK6;SGK1;TPD52;HMGCR;KRT8;ITGAV;ARID5B;INPP4B;LIFR;SLC38A2;PLPP1;TSC22D1;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.4305830499682899,0.7744966864914271,0.7111111111111111,1.0,1.0,2/11,20.61%,CD160;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.47711703951904927,0.7742312114855083,0.7777777777777778,1.0,1.0,3/8,23.60%,SIRT1;MEF2C;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.34737971440459936,0.773960342488576,0.8666666666666667,1.0,1.0,12/53,18.30%,RAB9A;TRIM22;BORA;TRIML2;RABGAP1L;PICALM;MAPK8;MAP2;AFDN;TRIM5;OOEP;KIAA0586
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.4660505214786872,-0.7733337579634417,0.7391304347826086,1.0,1.0,3/8,24.81%,IFI27;PPIB;CFL1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.4610734144373132,-0.7733060276660634,0.7,1.0,1.0,2/9,15.78%,ETFB;ETFDH
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3452512651818784,0.7730637476979496,0.7857142857142857,1.0,1.0,17/62,18.82%,FAS;PPARG;SLC22A2;CASP12;EGLN3;ROBO1;SNCA;EIF2AK3;CASP9;IFT57;SMAD3;BOK;CASP10;CRADD;CASP2;SENP1;BAD
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.3380935096706417,0.7729027614574283,0.9166666666666666,1.0,1.0,13/57,13.89%,LOXL2;SMAD7;EPHA3;TGFBR1;TWIST1;CRB2;IL17RD;SMAD2;ADIPOR1;USF3;CTNNB1;MDK;SMAD3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3375141484195543,-0.7727287361922962,0.8727272727272727,1.0,1.0,23/76,16.79%,BACH1;EPAS1;PSMA7;PSMD7;UBC;PSMB4;RBX1;LIMD1;PSMC3;ATF4;ELOB;PSMD8;CHEK1;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;INO80;PSMA1;PSMD10
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3464783837536629,0.7725831634075634,0.7551020408163265,1.0,1.0,7/48,11.68%,GRM7;CHRM3;CHRM2;OPRK1;GRM8;PDE2A;GNAI1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3471396551220871,-0.7725146635424315,0.8653846153846154,1.0,1.0,4/92,5.34%,LOXL4;EEF1AKMT2;RNF113A;LOXL1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.42026599614918353,-0.7723433098706455,0.7959183673469388,1.0,1.0,4/26,10.80%,SLC9A8;LACC1;ATP5F1B;SLC9B1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.3233714133939511,-0.7722761805399733,1.0,1.0,1.0,2/61,4.20%,SFRP1;ADAMTS12
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3469522600652377,0.7722239707743545,0.76,1.0,1.0,4/39,10.00%,HMGB1;TAB3;TLR1;TAB2
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.3224798643376828,0.7721715691325636,0.8775510204081632,1.0,1.0,7/108,9.54%,LRP1B;SLC22A2;SLC19A2;SLC22A6;SLC23A1;ARRDC3;ABCC11
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.4320114653787402,0.7721467313201796,0.7058823529411765,1.0,1.0,2/14,5.79%,AP1AR;KIF26A
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.5013765615796526,-0.7721330919522862,0.7647058823529411,1.0,1.0,2/5,12.83%,CELA2A;CEACAM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.42477049792747495,-0.7719602368117698,0.8301886792452831,1.0,1.0,4/20,14.03%,RCC1L;C1QBP;UQCC2;TRMT10C
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.5033382953759774,0.7718278128214138,0.72,1.0,1.0,3/6,17.83%,ERC2;PCLO;ERC1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.33455964015867745,0.7717802090550231,0.8627450980392157,1.0,1.0,23/111,18.46%,PIK3R5;SOCS6;ITPKB;PIP4K2A;PIGP;SYNJ2;PTPN13;PIGA;SOCS2;PIK3C2G;PIK3C2B;INPP4B;IP6K2;PIK3CA;PIGV;PIGQ;PIGU;MTMR12;PIK3R1;PIGW;DPM1;SOCS4;SMG1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.47610077796867784,0.7711084975805974,0.7708333333333334,1.0,1.0,1/5,12.28%,CTNNB1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.47610077796867784,0.7711084975805974,0.7708333333333334,1.0,1.0,1/5,12.28%,CTNNB1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.40591038688834197,0.7709807961551979,0.8260869565217391,1.0,1.0,5/20,11.81%,HMGB1;XKR6;MEGF10;ITGAV;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.4742982736102267,-0.7709062919252961,0.7962962962962963,1.0,1.0,1/8,13.55%,ITM2C
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.49787654152734834,0.7705351494491406,0.8148148148148148,1.0,1.0,4/8,18.64%,PDCD6IP;CRB2;LIN7A;WDR1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.49787654152734834,0.7705351494491406,0.8148148148148148,1.0,1.0,4/8,18.64%,PDCD6IP;CRB2;LIN7A;WDR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.4932146628891635,0.7704973595638724,0.7692307692307693,1.0,1.0,4/8,27.60%,FRS2;MEF2C;MYOCD;SOX6
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.45141486340013365,-0.7702277490252755,0.7272727272727273,1.0,1.0,1/10,5.03%,DCTN1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.3522746713147448,-0.7701634973238646,0.7924528301886793,1.0,1.0,2/34,3.81%,PIGO;PGAP2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.3670075457090183,0.7700476043803152,0.8085106382978723,1.0,1.0,8/49,10.84%,ACE2;GOLT1A;CAPN13;SCTR;EPCAM;JAG1;ST14;KRT8
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.45371044779349146,-0.7699298231761683,0.7692307692307693,1.0,1.0,5/14,28.37%,EXOSC10;EXOSC4;MTPAP;DCP2;LSM1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4167109848633878,0.76973066870967,0.7735849056603774,1.0,1.0,6/17,19.96%,TLE1;PIK3CA;BCL2;BRMS1;PDK4;PTK2
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3302496572901201,-0.7695778762656366,0.8604651162790697,1.0,1.0,16/82,16.57%,KIF25;NCAPH;REC8;KNSTRN;SMC4;SPDL1;WRAP73;AKAP8L;CENPE;NCAPD3;ANKRD53;NCAPD2;INO80;KIF23;TUBG1;CHMP2A
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4499207279717315,-0.7694919061425126,0.7727272727272727,1.0,1.0,1/11,5.47%,VIL1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.502749071143052,0.7693476612056115,0.775,1.0,1.0,2/5,14.42%,NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.502749071143052,0.7693476612056115,0.775,1.0,1.0,2/5,14.42%,NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.502749071143052,0.7693476612056115,0.775,1.0,1.0,2/5,14.42%,NSMCE2;SMC5
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.44134717695180015,0.7692604017069414,0.7446808510638298,1.0,1.0,4/9,19.65%,DGAT2;FAAH;ABHD12B;ABHD12
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.37048370019987087,0.7691896610441552,0.8095238095238095,1.0,1.0,5/17,23.86%,ASXL3;ACADVL;ACADL;ERLIN1;FBXW7
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.4681379918654929,0.768926037568367,0.6964285714285714,1.0,1.0,2/6,17.65%,SLC26A6;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3045084599243808,0.7688724258223524,0.9285714285714286,1.0,1.0,29/163,14.23%,ARHGAP25;PPEF2;MAGI2;DDIT4;SLIT2;PKHD1;ATP2B4;CD22;MINAR1;TWIST1;RORA;PDE4D;MSTN;TLE1;ITPR1;PHLPP2;ADIPOR1;PDE2A;PHLPP1;WWC1;NLRC3;PDE3A;P2RX7;SIRT1;PPM1A;SH3BP4;IFI35;RELA;BCL2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.34470334896901883,0.7688389070645457,0.8214285714285714,1.0,1.0,2/31,4.70%,CCNH;CAVIN1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.4389321240771135,-0.7686997467471388,0.8181818181818182,1.0,1.0,3/12,11.73%,AHI1;PCARE;CDHR1
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.5027155597097351,0.7685691803847726,0.76,1.0,1.0,1/5,7.14%,ABCC2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4392516971270315,0.7685512511114618,0.8043478260869565,1.0,1.0,2/15,4.17%,SMAD7;BAG2
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.5071868635732749,0.7685384720857993,0.7857142857142857,1.0,1.0,1/5,4.40%,NRXN1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3947520056363979,0.7684894051504796,0.76,1.0,1.0,9/27,18.82%,TP63;ZNF205;PPP1R13B;BCL2;BOK;TP53BP2;MAPK8;YWHAZ;BAD
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.46682939558919834,-0.7684150738126782,0.8085106382978723,1.0,1.0,3/9,23.31%,CLTA;AP2A1;AP2S1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.46682939558919834,-0.7684150738126782,0.8085106382978723,1.0,1.0,3/9,23.31%,CLTA;AP2A1;AP2S1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.43814224190180967,0.7684052770453088,0.7241379310344828,1.0,1.0,2/8,12.25%,H3-3A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.5291195767909439,0.768222665870384,0.7692307692307693,1.0,1.0,3/5,18.34%,SMURF2;ACVR1B;VEGFA
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4025742261908941,0.7681968079007314,0.7446808510638298,1.0,1.0,1/13,2.72%,UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.40934100781476024,-0.768177213779696,0.8260869565217391,1.0,1.0,6/21,14.62%,DUOX1;ETS1;CCDC25;STK11;PHPT1;TUBB2B
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.39376727137955086,-0.767399117259613,0.7358490566037735,1.0,1.0,4/23,5.61%,CACNB1;AGRN;DCTN1;DNAJA3
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.4645235880408035,0.7672827353621112,0.711864406779661,1.0,1.0,3/9,9.04%,SYK;WNT5A;DVL2
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.3682194184373684,0.7668400496291482,0.7543859649122807,1.0,1.0,7/30,18.20%,RAB29;TULP3;BBS9;TUB;ROPN1B;TCTN2;BBS4
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.49446828485325467,-0.7667871984511131,0.7547169811320755,1.0,1.0,2/8,17.69%,FOXP1;SRC
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3609609029754211,0.7667643056154523,0.7551020408163265,1.0,1.0,6/65,12.97%,SPHK1;DCUN1D1;SMAD7;HDAC3;PRICKLE1;NDFIP2
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.48970492747658834,-0.7667230921474754,0.7884615384615384,1.0,1.0,1/7,11.86%,PDLIM4
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.4668528735763945,-0.7663124323018929,0.7708333333333334,1.0,1.0,3/7,19.59%,CEACAM1;KDR;TMEM100
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4528846648544939,0.7661749103308825,0.7758620689655172,1.0,1.0,5/11,22.66%,BBOX1;CPT1C;CPT2;ACADM;ACADL
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.3958586272447292,-0.7661481593995861,0.8163265306122449,1.0,1.0,1/23,1.86%,MYB
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.37901002143176055,0.7660953837824523,0.7727272727272727,1.0,1.0,4/30,10.18%,MAGI2;PPP1R15B;STYXL1;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4721969728451123,0.7660689238438757,0.8076923076923077,1.0,1.0,1/7,1.42%,KCNE4
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.4721969728451123,0.7660689238438757,0.8076923076923077,1.0,1.0,1/7,1.42%,KCNE4
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.39994991948394376,-0.7659269920364987,0.8125,1.0,1.0,1/17,7.05%,MYH14
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.5133963408658084,-0.765865393559097,0.7547169811320755,1.0,1.0,1/5,11.32%,PTPRC
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3378436332676936,-0.7657232484703226,0.7674418604651163,1.0,1.0,6/53,9.14%,DTX3L;RNF8;ARIH2;RBX1;UBE3A;IFI27
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.42928696794129206,-0.7656988762512967,0.7962962962962963,1.0,1.0,2/16,2.62%,CCN3;SERPINE1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.4560679314433993,0.7656873839015956,0.7884615384615384,1.0,1.0,2/8,25.30%,PLA2G4C;FITM2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.4608214350030263,0.7655149315487111,0.7142857142857143,1.0,1.0,1/11,3.01%,ZBTB1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3121681065006637,-0.7654744104098138,0.9333333333333333,1.0,1.0,5/89,6.35%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.35308199127891327,0.7650687690732234,0.8823529411764706,1.0,1.0,14/51,24.43%,PNLDC1;ZFP36;CNOT4;PATL1;DCP1B;DIS3;PAN3;CNOT2;PDE12;EXOSC8;CNOT6L;TUT7;CNOT8;CNOT7
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.4038670732942259,-0.7650176618453953,0.7619047619047619,1.0,1.0,1/15,1.74%,CLU
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.3791092352069812,0.7646753160918467,0.7708333333333334,1.0,1.0,3/14,14.42%,DMC1;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.3596735170466641,-0.7644162070484107,0.8536585365853658,1.0,1.0,2/35,3.00%,ATRAID;RILP
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.4761790355764532,0.7644071504209617,0.8,1.0,1.0,1/8,3.79%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.3890724021504238,0.7643455426271397,0.7209302325581395,1.0,1.0,7/23,21.42%,ITGAM;ANK3;MTCL1;AKT2;TCAF2;MIEF2;FYN
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.3606972926296452,-0.764275078568367,0.8260869565217391,1.0,1.0,8/32,13.87%,STARD5;SLC51A;RBP4;ABCB11;SLC10A6;CEACAM1;SLC16A8;NR1H4
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.364376961929606,0.7642691299889117,0.7413793103448276,1.0,1.0,9/40,19.08%,ARID1A;ARID1B;SRCAP;HDAC2;SPTY2D1;SMARCD2;ACTL6A;SMARCE1;GATAD2B
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.3334768879624178,-0.7642029923954002,0.84,1.0,1.0,13/65,17.82%,CLU;ITGA6;BCL2L2;TRIAP1;PRELID1;PINK1;SLC25A5;PSMD10;GPX1;GSTP1;THBS1;SRC;GHITM
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.4917826938256748,0.7641719727326729,0.8076923076923077,1.0,1.0,1/6,13.78%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),-0.49860426412049313,-0.7639760871355046,0.7872340425531915,1.0,1.0,2/5,13.87%,ABCB11;NR1H4
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.32413380791764,0.7639679043343587,0.8363636363636363,1.0,1.0,37/138,19.35%,LTK;IRS1;CX3CR1;HMGB1;NRIP1;EGFR;EPHA3;WNT5A;PDE4B;BRINP3;NR3C1;ZFP36;RORA;ABL2;LPL;TFPI;CRHBP;GNAI1;NR1H3;ADNP2;RELA;CREB1;INSIG1;MEF2C;PID1;MAPK8;URI1;RUVBL2;VIM;ADTRP;CD274;ADCY2;NLRP7;ROCK2;CD80;PDK4;ATP1A2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.33846572257893337,-0.7638691082521568,0.851063829787234,1.0,1.0,14/47,21.64%,PORCN;VIP;RAB3B;TANGO2;SVBP;COPG2;CAMK2G;RAB3A;PDIA4;WLS;RAB12;CANX;SCG2;STEAP3
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.42911703733000556,0.7634896744203583,0.717391304347826,1.0,1.0,3/14,11.29%,SLC30A8;EDN1;RIMS2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3898163936679089,0.7633688132287318,0.8035714285714286,1.0,1.0,4/34,15.83%,PLD6;TDRD9;TDRD1;FKBP6
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.38218867081990554,0.7630780291107354,0.8541666666666666,1.0,1.0,5/33,16.67%,ITPKB;IP6K2;AGPAT5;IPPK;MOCS3
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.29890801345976575,0.7627455568152192,0.9375,1.0,1.0,24/146,14.27%,EIF3E;IRS1;KLF2;PRR16;PPARGC1A;EGFR;ZEB2;IRS2;SNCA;LDLR;ZNF205;CCL5;HIF1A;DDAH1;PDGFRB;EDN1;STARD4;DDAH2;DYRK2;NR1H3;SIRT1;HGF;SMAD3;SORBS1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3474108511229937,0.7623503046836486,0.803921568627451,1.0,1.0,20/61,22.03%,ATP6V0A4;IRS1;ATP6V0D2;IRS2;GAB1;FER;FOXO1;IGF1R;BCAR1;PIK3CA;SORBS1;PIK3R1;AKT2;SOS1;PDK4;BAIAP2;PDK2;INSR;PHIP;IRS4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.41047137936844624,-0.7622660103936912,0.7843137254901961,1.0,1.0,4/29,16.08%,B2M;PAX6;GDI1;RTN4R
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.37284752252268955,-0.762139453388406,0.7954545454545454,1.0,1.0,2/34,2.62%,SERPINB8;SERPINE1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3921896827784084,0.762134803773141,0.782608695652174,1.0,1.0,5/26,14.76%,ERBB4;NLK;CCL5;ADIPOR1;PIGU
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.39166471537230213,0.761961097056451,0.825,1.0,1.0,9/28,20.51%,LEPROTL1;LATS1;MFHAS1;GPM6B;PICALM;COMMD1;NEDD4L;ROCK2;CAV3
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.47700853851617425,-0.7619467742054645,0.7586206896551724,1.0,1.0,1/6,5.94%,GHR
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3652357218467918,-0.7619258257982083,0.7966101694915254,1.0,1.0,7/46,8.37%,GPC2;HGSNAT;AGRN;GPC1;XYLT2;GPC3;SDC2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3117214238112765,-0.7618666525064614,0.9183673469387755,1.0,1.0,42/112,26.44%,PSMA7;PSMD7;UBC;PSMB4;PKP1;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;EXOSC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;YWHAB;PSMD10;APEX1;KHSRP;PSME2;PSMD12;CSDC2;SERBP1;EIF4G1;PSMC6;PSMB7;PSMB3;ZC3HAV1;GTPBP1;PRR5L;SET;PSMA5;NUP214;UBB;PCBP4;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4;SAMD4A
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.517390860207127,-0.761834734903405,0.7941176470588235,1.0,1.0,1/7,4.01%,ENPP2
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),0.5068971934045361,0.7617050528594497,0.7959183673469388,1.0,1.0,1/5,12.87%,ANK2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.3169775080838026,-0.7616141450500123,0.9347826086956522,1.0,1.0,5/118,3.21%,ETV5;SHC3;TMEM179;ASCL1;KIF1A
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.3211446620173178,0.7615076233292846,0.9019607843137255,1.0,1.0,19/80,15.31%,NLGN1;SHISA9;FGF12;FGF14;JPH1;CACNB2;GRIA4;DLG2;PDE4D;JSRP1;CRHBP;LRRC7;ANK2;FGF13;ANK3;GRIA2;NETO1;MEF2C;KCNG1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.3899390047207506,-0.760947474654823,0.7674418604651163,1.0,1.0,2/23,8.29%,RAC1;PARVB
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.45849308455410354,0.7607595857953489,0.7755102040816326,1.0,1.0,4/8,30.08%,YOD1;VCPIP1;OTUD7B;USP30
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.44270707276154814,-0.7605464876947449,0.7407407407407407,1.0,1.0,1/13,3.76%,PDZD7
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.3811041365273054,0.7604893057790664,0.7857142857142857,1.0,1.0,8/29,15.04%,ADGRV1;SLC8A1;ACVR2A;BMPR1A;GPM6B;P2RX7;ACVR1;MEF2C
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.4286673115991251,0.7604419032023773,0.7090909090909091,1.0,1.0,5/20,12.25%,DGAT2;RORA;LPL;NR1H3;SIRT1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.4565077178040814,-0.760264652558665,0.7058823529411765,1.0,1.0,4/6,30.05%,SAT2;SRM;SAT1;SMOX
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.33524435507454087,-0.7599840735523539,0.84,1.0,1.0,9/76,13.70%,STING1;PLK3;PLEKHF1;PLK2;STK11;PINK1;SUPT5H;SVIP;NPRL2
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.49803650742096095,-0.7594634912767079,0.7906976744186046,1.0,1.0,1/6,4.50%,PRKCH
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),0.498264168451164,0.7594479985024053,0.75,1.0,1.0,1/5,12.87%,ANK2
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.4529573114022938,0.7589506081972173,0.7254901960784313,1.0,1.0,1/7,1.50%,ALDH1A1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.3322938803061793,0.7588331057394321,0.9090909090909091,1.0,1.0,22/109,13.17%,MXRA5;SEMA5A;TNC;HMCN1;PRRX1;POSTN;SULF1;RUNX2;AGER;PDZRN3;PBX3;NID2;TCF4;ADAMTSL1;GLI3;FBXL7;PDGFRB;CRTAC1;CTNNB1;TIMP3;COL5A2;CXCL12
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.2778121052400018,-0.7587611371449394,0.9516129032258065,1.0,1.0,50/286,15.98%,ASB9;F5;EPAS1;PSMA7;DSCC1;CKAP4;PSMD7;SKP1;GPC3;DDA1;PSMB4;FBXO40;RBX1;PSMC3;MXRA8;NOTUM;SDC2;COPS6;IGFBP4;SCG3;IGFBP3;UBE2M;CHGB;VWA1;ELOB;NUCB1;SUMF2;PSMD8;PSME1;CALU;DDB1;VGF;PROC;PSMB2;RAB3A;PSMC4;PRSS23;SUMF1;PSMB8;APOA1;COPS7A;FBXO15;CUL9;PSMC1;PSMB5;PSMD2;FBXL13;LRR1;FBXW12;PSMA1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.3717497724112874,-0.7587516292687757,0.82,1.0,1.0,7/46,11.90%,SFRP1;TTC23;TXNDC15;GPC3;ZIC1;PDCL;RACK1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.3692385382872678,0.7587311853750959,0.8125,1.0,1.0,4/28,11.78%,CHMP6;PDCD6IP;RAB27A;VPS37D
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.37083636161586175,-0.7583251013251742,0.8775510204081632,1.0,1.0,4/37,4.39%,NCKAP1L;BST1;CD74;VAV3
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.31841221252996743,-0.7581352052640673,0.9375,1.0,1.0,9/89,9.10%,ASB9;CLU;LDB1;RILP;SLC6A9;GPC3;VIP;CARD9;PLK2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.5028352182557971,-0.7577043052257968,0.8085106382978723,1.0,1.0,3/7,13.08%,DCTN1;CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.509691076898426,0.7573871760994334,0.8070175438596491,1.0,1.0,1/5,7.77%,LIMK2
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.4438803318282707,0.7572265858291547,0.7368421052631579,1.0,1.0,1/8,10.01%,GGTA1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3472344332364179,0.7571482154701324,0.8604651162790697,1.0,1.0,10/45,18.45%,LAMB4;NRP1;USH2A;FER;ITGAV;RADIL;TMEFF2;PIK3R1;ATRNL1;MEGF9
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.31632890336981123,0.7569756270508178,0.8333333333333334,1.0,1.0,18/147,10.41%,ZDHHC11;IGLL1;FRK;PPARG;SYK;CX3CR1;KLRD1;HMGB1;AGER;SNCA;TRIM22;MFHAS1;COLEC11;ANKRD17;FER;C3;TRIM8;RNF135
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.35117170174157825,-0.7569649913569887,0.8823529411764706,1.0,1.0,12/58,20.22%,ABRAXAS1;ERCC1;RNF8;PRPF19;MDC1;HMGB2;POLM;POLL;CYREN;XRCC6;POLQ;KAT5
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.4908030494328455,-0.7566331580548808,0.7674418604651163,1.0,1.0,1/5,11.69%,TCTN1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.29224965409934744,0.7566198729694634,1.0,1.0,1.0,35/285,12.08%,MED17;ESRRG;CCNH;PKNOX1;PPARG;ZBTB1;HNF4G;NR3C2;PRRX1;PPARGC1A;NR5A2;CCN2;NR2E1;MLLT3;ELP4;TEAD2;INTS6;HDAC9;NR3C1;INTS11;MAML2;TBL1XR1;NR1D2;HDAC3;MAML3;RORA;SOX5;TAF3;CDK12;NOTCH3;POU2F1;NR1H3;TAF1A;PAPOLA;ZBTB7B
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.4222372076795372,-0.7566192275447472,0.7592592592592593,1.0,1.0,2/14,7.92%,GHR;PRLR
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.42527902022325537,-0.7566116372038217,0.7755102040816326,1.0,1.0,1/11,2.20%,WNT9B
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.507688139613307,-0.7565030700334618,0.8936170212765957,1.0,1.0,2/7,7.60%,HMGCL;BCAT2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.40945081398481076,0.7564342249888242,0.7906976744186046,1.0,1.0,3/13,8.55%,FGFR2;TGFBR1;TWIST1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.44226737033894303,-0.7563123643900574,0.8181818181818182,1.0,1.0,3/10,17.69%,CD4;MET;SRC
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.45798431463990663,-0.7562164757705886,0.8518518518518519,1.0,1.0,1/10,1.05%,CCN3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3432653406617162,-0.7561765259618645,0.8333333333333334,1.0,1.0,5/55,6.56%,TERF2IP;CCN3;NLRP3;TMSB4X;SPI1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3642613879715039,-0.7559138209295028,0.78,1.0,1.0,3/34,5.18%,DUOX1;AQP8;KCNE1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.35834145816135465,0.7555911874294033,0.8235294117647058,1.0,1.0,9/39,11.70%,PBX1;SHROOM2;MEIS1;MYO7A;PBX3;CPAMD8;ATF6;CHD7;MEIS2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.3349392370170948,0.7555321712613164,0.8604651162790697,1.0,1.0,14/70,22.11%,ZEB2;PDE2A;SPATA4;STX18;TMED9;EP300;CLN3;USP6NL;PDE4DIP;PTK2;MIEF2;RAB33B;TMEM33;PLXNB1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.31169834412504077,0.7555186432737567,0.8478260869565217,1.0,1.0,9/129,7.51%,STK26;IFI16;FAS;NUAK2;ATP6V0D2;TFEB;FOXO3;PRKD1;KPTN
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.521069988433692,0.755247385466678,0.8431372549019608,1.0,1.0,3/5,19.13%,TACR1;TACR3;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.521069988433692,0.755247385466678,0.8431372549019608,1.0,1.0,3/5,19.13%,TACR1;TACR3;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.521069988433692,0.755247385466678,0.8431372549019608,1.0,1.0,3/5,19.13%,TACR1;TACR3;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3999048865062363,-0.7552083657448164,0.8043478260869565,1.0,1.0,8/18,22.16%,GIPC1;STK11;CDKN2B;SNW1;THBS1;CDKN1C;HSP90AB1;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3999048865062363,-0.7552083657448164,0.8043478260869565,1.0,1.0,8/18,22.16%,GIPC1;STK11;CDKN2B;SNW1;THBS1;CDKN1C;HSP90AB1;SDCBP
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.37568702380952534,0.7548427986666398,0.8541666666666666,1.0,1.0,4/20,15.04%,SGCZ;PGM5;SGCG;MEF2C
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.30829356308692474,-0.7545741641795165,0.9285714285714286,1.0,1.0,5/92,6.35%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4724233019175159,0.7542654121609201,0.8070175438596491,1.0,1.0,4/9,20.61%,NFATC2;NFATC3;PDGFB;PDCD4
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.4437446992566682,0.7541009525552229,0.782608695652174,1.0,1.0,1/6,2.85%,SYK
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4072420141305294,-0.7539835781301002,0.7777777777777778,1.0,1.0,3/20,9.85%,DCTN1;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.2748426663079856,0.7539107727637893,1.0,1.0,1.0,117/800,14.13%,ACE2;IFI16;CALCR;ESRRG;NAB1;RUNX1;NFIL3;NFKBIZ;HNRNPH1;ITGAX;BNC2;ATOH8;SLC22A2;ZNF114;HMG20B;CSF1;TDG;TFEB;PPARGC1A;NR5A2;AFF2;ROBO1;SLC8A1;MAGED1;ZNF827;NLK;WNT5A;ZNF257;TGFBR1;RPS6KA4;ZNF804A;RFX3;TCF7L1;HEY1;NFIA;ATP2B4;TEAD2;SP3;ABCC2;DENND4A;NR3C1;NCOA2;POU6F2;TRIM22;TULP3;SPIN1;ATXN1;UBR5;JMJD1C;FGF5;CDK6;RFXANK;NR1D2;MBNL1;TWIST1;HINFP;ZNF516;SUPT3H;ZNF205;FGF17;FEZF2;RORA;EIF2AK3;DVL2;HIF1A;ZNF732;SH3GL2;ZNF675;SMAD1;SOX7;NFATC2;TIPARP;PCBP2;BMPR1A;TLE1;LRRC19;DMTF1;MITF;SSBP2;SPTY2D1;FGF10;RAB27A;NOVA1;SLC39A8;CHD7;PDE2A;RIMS2;ACTA2;GPBP1L1;WWC1;BRDT;TRIML2;P2RX7;ZBTB7B;SIRT1;ITGB8;RYBP;ACVR1B;ANK2;MBNL2;MLF1;NDFIP2;ZNF536;ZNF273;ZNF646;FOXN3;HSPA1A;ANK3;EP300;SMAD3;SORT1;YAF2;ADNP2;ZNF212;GABPA;SLC38A2;RELA
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2935142695899948,0.7538267648686332,0.9574468085106383,1.0,1.0,39/257,13.75%,NRG1;RIT2;ERBB4;GFRA1;IRS1;FGFR2;RCE1;ABHD17B;EGFR;IRS2;TNIK;CUL1;DUSP9;PSMD13;ZFP36;RASAL2;FGFR3;FGF5;FRS2;CCL5;FGF17;DLG2;MBP;PDGFRB;FGF10;IL17RD;ITGAV;NCAM1;FGFR1;ZFP36L2;LRRC7;CSF2RA;PSPN;BTRC;NRTN;PIK3CA;FGF13;HGF;MEF2A
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.34390015745943747,0.7538263973219382,0.8305084745762712,1.0,1.0,3/34,5.48%,C1GALT1;SULF1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4037906647541076,-0.7537199418123242,0.7959183673469388,1.0,1.0,5/35,10.51%,TNFSF18;IL31RA;GHR;PARP14;STAP2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.32986819989323357,0.7536505813159778,0.8490566037735849,1.0,1.0,7/66,14.84%,HMGB1;TAB3;ITGAM;TLR1;TAB2;MAP3K1;UBE2D3
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.42775351393522754,0.7535265863608256,0.7735849056603774,1.0,1.0,2/18,7.37%,IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.3131544284375817,0.753096795195391,0.8363636363636363,1.0,1.0,22/96,21.48%,KCNC2;KCNS3;RFX3;CCL5;EXPH5;HMGCR;ADAM8;ITPR1;PRKCA;ARFIP1;FRMD4A;KCNA5;DNAJC1;SLC12A2;ADTRP;BMP6;RAP1A;RAPGEF4;SLC2A1;STXBP5;LLGL1;DPH3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.34379543559517334,0.7528760195715154,0.8409090909090909,1.0,1.0,12/68,13.17%,MXRA5;SEMA5A;NYNRIN;POSTN;SULF1;FAM114A1;FBLIM1;SYNPO2;PDGFRB;ACTA2;TIMP3;CXCL12
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.3521332163678062,0.7527830191253988,0.9056603773584906,1.0,1.0,13/41,24.08%,SLC25A48;SLC38A11;SLC7A13;SLC7A2;SH3BP4;SLC38A2;SLC16A10;SLC43A1;SLC7A9;SLC7A14;SLC38A3;SLC38A8;SLC38A10
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.3485896070548686,0.7518934283136843,0.8363636363636363,1.0,1.0,2/39,2.24%,PLCB1;RALA
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3120616472076777,-0.7518448797090411,0.9,1.0,1.0,11/105,10.39%,INHA;CPXM2;CYP19A1;SLC9A8;EPAS1;ANO1;CALD1;CRYAB;PRLR;IGFBP3;CFD
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3614499607052814,-0.7512874924777125,0.8333333333333334,1.0,1.0,10/33,23.44%,XRCC1;NTHL1;SMUG1;POLL;PARP1;MBD4;APEX1;POLG;RPA3;PARG
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.48503290141263206,0.7509010070124055,0.8181818181818182,1.0,1.0,6/9,18.93%,SNCA;HIF1A;BCL2;TF;BMP6;SLC11A2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.46654246777007724,-0.7508431698984388,0.717391304347826,1.0,1.0,1/9,3.76%,PDZD7
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.38654719069351895,0.7508218132699283,0.7962962962962963,1.0,1.0,3/17,11.40%,FGF10;ITGAV;ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.4655045823273159,-0.7507149047423877,0.7317073170731707,1.0,1.0,1/7,3.02%,PLIN2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.42416603492266525,0.750707473915136,0.8113207547169812,1.0,1.0,4/10,25.28%,CCL5;PDGFB;PTPRO;FLT1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.4659230476461355,0.7506819782231763,0.7857142857142857,1.0,1.0,1/9,2.31%,SEMA5A
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.38711637099779916,0.7506280616250528,0.8409090909090909,1.0,1.0,7/26,18.26%,HJV;CYBRD1;SLC40A1;TF;PICALM;COMMD1;HMOX2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.4107709777883221,-0.7505467907603467,0.8571428571428571,1.0,1.0,4/12,17.00%,DEPDC5;STK11;ITFG2;SZT2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.3109372393469382,-0.7502946941585997,0.9622641509433962,1.0,1.0,38/147,21.32%,XPC;PSMA7;ANAPC15;KIF20B;PSMD7;SKP1;FBXO43;PSMB4;PSMC3;BTG1;RFPL1;DYNLT3;PSMD8;PSME1;DDB1;PSMB2;PIN1;PSMC4;CDK11B;PSMB8;ANAPC2;CUL9;PSMC1;PSMB5;PSMD2;PSMA1;ERCC2;PSMD10;USP22;CDKN1C;FZR1;PSME2;PSMD12;CKS1B;RNF20;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2968953330999189,0.7500959445898513,0.9545454545454546,1.0,1.0,63/381,14.13%,ESRRG;NAB1;NFIL3;CCNA2;BNC2;ZNF114;TFEB;PPARGC1A;NR5A2;MAGED1;NLK;ZNF257;TGFBR1;RPS6KA4;RFX3;TCF7L1;FOXO3;GRM5;NFIA;TEAD2;SP3;DENND4A;NR3C1;NCOA2;POU6F2;TRIM22;TULP3;SPIN1;ATXN1;JMJD1C;NR1D2;HINFP;ZNF516;SUPT3H;ZNF205;RORA;DVL2;HIF1A;ZNF732;ZNF675;SOX7;NFATC2;ANKRD17;DMTF1;MITF;SSBP2;SPTY2D1;SLC39A8;CHD7;GPBP1L1;WWC1;BRDT;RYBP;ACVR1B;MLF1;ZNF536;ZNF273;ZNF646;FOXN3;EP300;YAF2;ZNF212;RELA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.47836894335031765,0.750055271542416,0.7777777777777778,1.0,1.0,1/5,11.68%,GNAI1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3354956046954327,-0.7499047856129234,0.85,1.0,1.0,5/62,6.56%,SFRP1;SINHCAF;WNT9B;FOXM1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.4731458207731241,0.749314745732965,0.7307692307692307,1.0,1.0,3/5,33.10%,TMEM39A;PHF23;RUBCN
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3666131897798841,0.749256589455305,0.82,1.0,1.0,4/32,14.60%,CENPI;KNL1;HELLS;CENPO
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.3835871889046143,0.7491332761613716,0.8333333333333334,1.0,1.0,5/19,23.18%,BICD1;EIF2S1;LSM14A;G3BP1;YTHDF3
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.39112873208043986,-0.7487799054807525,0.7954545454545454,1.0,1.0,5/20,13.46%,SIGIRR;DHX58;TRAF3IP1;C1QBP;TYRO3
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5071895053582066,0.748720527807428,0.7758620689655172,1.0,1.0,3/6,17.16%,HDAC9;SORT1;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.41030211998456706,0.7487002954193217,0.7708333333333334,1.0,1.0,3/23,10.45%,KLF2;HIF1A;ATF6
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3562030352021276,-0.7486989017704652,0.8771929824561403,1.0,1.0,8/30,19.47%,RBM3;NOLC1;EIF2B4;NR1H4;PUM3;RBM4B;TCOF1;MTPN
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.36597187714498275,0.7486656667558402,0.8936170212765957,1.0,1.0,5/35,8.82%,GBP4;WNT5A;SNCA;SYNCRIP;CCL5
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.3291274020588063,0.7485841797166713,0.8852459016393442,1.0,1.0,7/49,13.37%,IFI16;CCL5;ADAM8;RNF135;PTPN6;NLRC3;IFI35
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4360134327602603,-0.7480700856927792,0.7254901960784313,1.0,1.0,1/10,4.19%,DHX58
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.39722731301986036,-0.748021486325448,0.8,1.0,1.0,5/28,16.23%,DTX3L;KDM4D;WRAP53;USP51;CYREN
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.43911007806832925,-0.7479149206793902,0.8666666666666667,1.0,1.0,1/14,4.87%,DCAKD
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.4871256420321457,0.7478310668710567,0.8,1.0,1.0,3/5,12.62%,ACVR2A;SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.39896616912521304,0.7478293023281583,0.8363636363636363,1.0,1.0,4/11,13.62%,HS3ST5;TFPI;EDN1;KNG1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.4739100022204081,-0.7475098569058698,0.7857142857142857,1.0,1.0,4/6,26.79%,NMD3;RAN;NPM1;SDAD1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.4118946703981792,-0.7470977661798819,0.8095238095238095,1.0,1.0,4/15,12.83%,AZGP1;HLA-DRA;PTPRC;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.42414655116884814,-0.7469808753304548,0.7735849056603774,1.0,1.0,3/11,11.87%,SPI1;THAP7;TAF7
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.42551194208364,0.7467850616849674,0.76,1.0,1.0,4/9,25.08%,PIK3R1;WDR81;PPP2R5A;RBL2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.2990800302297147,0.7466339315740574,0.9534883720930233,1.0,1.0,59/345,14.13%,ESRRG;NAB1;NFIL3;BNC2;ZNF114;TFEB;PPARGC1A;NR5A2;MAGED1;NLK;ZNF257;TGFBR1;RPS6KA4;RFX3;TCF7L1;NFIA;TEAD2;SP3;DENND4A;NR3C1;NCOA2;POU6F2;TRIM22;TULP3;SPIN1;ATXN1;JMJD1C;NR1D2;HINFP;ZNF516;SUPT3H;ZNF205;RORA;DVL2;HIF1A;ZNF732;ZNF675;SOX7;NFATC2;DMTF1;MITF;SSBP2;SPTY2D1;SLC39A8;CHD7;GPBP1L1;WWC1;BRDT;RYBP;ACVR1B;MLF1;ZNF536;ZNF273;ZNF646;FOXN3;EP300;YAF2;ZNF212;RELA
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.35843613616148484,0.7465560736230097,0.8431372549019608,1.0,1.0,2/37,2.24%,PLCB1;RALA
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.44713075094730415,0.7465303274161983,0.7833333333333333,1.0,1.0,5/13,17.16%,HDAC9;LPL;NR1H3;SORT1;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.3869638225396939,0.746512950712385,0.8,1.0,1.0,8/26,15.04%,ADGRV1;SLC8A1;ACVR2A;BMPR1A;GPM6B;P2RX7;ACVR1;MEF2C
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.38935356699585333,0.7463344137065278,0.8108108108108109,1.0,1.0,6/22,11.85%,PEX5L;SCTR;PDE4D;PDE2A;GNAI1;PDE3A
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3232023088775411,-0.7462083735545288,0.9423076923076923,1.0,1.0,9/89,7.29%,CCN3;SKOR1;NOG;SPRED3;PBLD;SPRED2;SPRY1;UBC;LEMD2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.41436702655148216,-0.7460422211460184,0.7924528301886793,1.0,1.0,4/11,20.35%,NOS2;DRD3;SCPEP1;NOS3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.3370053581703325,-0.7459851372463779,0.8571428571428571,1.0,1.0,6/65,9.01%,CSRP2;OBSCN;TPM1;ACTC1;MYH14;SYNPO2L
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.29777573634325216,-0.7459112990234145,0.9661016949152542,1.0,1.0,5/93,6.35%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.45852088343508185,-0.7458664236308266,0.8541666666666666,1.0,1.0,2/9,11.37%,APOD;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.44217494996982964,-0.7458466860523941,0.86,1.0,1.0,1/10,8.04%,AMBP
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.3804500663538602,-0.7457860223679035,0.7619047619047619,1.0,1.0,2/22,2.20%,GUCY2C;WNT9B
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4347979353493173,-0.745784717684352,0.7884615384615384,1.0,1.0,1/12,0.69%,CD9
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.4768803043320399,0.7456805185651696,0.7608695652173914,1.0,1.0,1/6,12.25%,SIRT1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.36025381491997654,0.7455821893527494,0.875,1.0,1.0,5/28,15.73%,CHPT1;SLC44A5;LCAT;LPCAT3;PCYT1B
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.35693517391394614,0.7455204399115116,0.7924528301886793,1.0,1.0,6/43,16.11%,EFNA5;FER;WWC1;EPHA5;PARD6B;MAP2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3966476941302459,0.7455099760855591,0.7692307692307693,1.0,1.0,3/13,12.82%,WNT5A;SIRT1;CAMK4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4124198563864898,-0.7453927190873049,0.8148148148148148,1.0,1.0,1/14,1.74%,CLU
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.32954682845244976,0.7453837726330815,0.8541666666666666,1.0,1.0,6/52,9.14%,RALA;PLD6;PPARGC1A;MCU;ZNF205;FBXO7
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.39262174220117146,-0.745313073036417,0.84,1.0,1.0,6/20,16.63%,WNT7B;GLMN;CCM2;SPRED1;KDR;EGFL7
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.4093827344387194,-0.745153724618151,0.8181818181818182,1.0,1.0,5/12,12.17%,SPI1;SMARCD1;ELOF1;ZMIZ2;CHEK1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.5112029312990687,0.744972785310631,0.7948717948717948,1.0,1.0,2/5,25.81%,FGF13;DCC
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.37560935735230677,0.7447635004580171,0.8461538461538461,1.0,1.0,4/25,8.67%,PPARG;CDK6;TWIST1;RANBP3L
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.2962088324268373,0.7441355670579095,0.9827586206896551,1.0,1.0,33/120,21.63%,NECTIN3;TNIK;KCNIP4;CACNB2;RAB3C;TSPAN15;ZDHHC2;TSPAN17;KCNB2;DPP10;RAP2A;PACS1;ANK2;FGF13;ANK3;P2RY1;SMURF1;RAB34;AFDN;MAP7;SLMAP;RAPGEF6;PIGW;TMED2;RAP1A;ROCK2;SPTBN1;BSG;CAV3;TESC;RAB10;ASB3;CLASP2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.30491905491802423,-0.7440981108839578,0.8979591836734694,1.0,1.0,7/81,8.60%,ETV5;TXNRD2;STX4;PRDX1;FANCC;RBM11;ATF4
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.34481913522129437,0.7440876453345977,0.8301886792452831,1.0,1.0,7/43,15.48%,ZBTB1;NSMCE1;PRIMPOL;RAD18;POLD3;DTL;RFC5
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.3376396917877732,-0.7440589126411392,0.8301886792452831,1.0,1.0,7/48,13.68%,APOBEC3H;OAS3;ILF3;IFIT1;OAS2;ISG15;RSAD2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.44310691190362084,-0.743999908504675,0.75,1.0,1.0,2/12,10.95%,LIMD1;PATL2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.33213484385252584,0.7439871983794474,0.9019607843137255,1.0,1.0,16/82,13.64%,NFKBIZ;PLA2G7;WNT5A;SNCA;CCL5;LPL;ANKRD17;PDGFRB;ADAM8;PRKCA;PDE2A;NAPEPLD;IL16;IFI35;SASH1;MDK
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3360502520959484,0.7438588786756999,0.8888888888888888,1.0,1.0,14/80,14.11%,SLC26A7;AKR1C1;SLC6A13;SLC25A48;SLC22A6;SLC23A1;ABCC2;NCOA2;ABCC11;SLC7A2;SLC26A6;SLC10A1;ABCG2;SLC38A2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3500508276072844,-0.743714071474882,0.8301886792452831,1.0,1.0,2/48,4.67%,NCKAP1L;KIF20B
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.3535732205619975,-0.7435792978583894,0.851063829787234,1.0,1.0,1/33,1.32%,NUPR1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.39145954850790865,0.743366833278971,0.8181818181818182,1.0,1.0,6/18,26.17%,SCO2;BCS1L;COX19;COX10;TIMM21;SCO1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.4832383734983849,0.7428714963040525,0.8,1.0,1.0,4/6,39.70%,GAL3ST1;B3GALT1;UGT8;B4GALT3
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.4832383734983849,0.7428714963040525,0.8,1.0,1.0,4/6,39.70%,GAL3ST1;B3GALT1;UGT8;B4GALT3
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.3769081791361948,0.7427986467972051,0.8444444444444444,1.0,1.0,5/35,12.77%,SLC26A7;ENPP1;ANO7;ANO5;SLC26A6
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.44685021712867556,0.742495386395771,0.8043478260869565,1.0,1.0,1/9,5.23%,WNT5A
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.4204972267948272,0.7422814100978649,0.7241379310344828,1.0,1.0,7/13,40.81%,TUT7;PRKRA;AGO3;DICER1;LIN28B;DROSHA;TARBP2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.37014736587222874,0.7421597185317432,0.88,1.0,1.0,7/27,16.64%,HDAC2;MBNL1;TWIST1;GLI3;CTNNB1;SALL1;AFF3
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.4696177567316214,0.7415732558357065,0.7818181818181819,1.0,1.0,3/6,22.39%,CBLIF;TCN2;CUBN
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.5001267329893941,-0.7412333786439605,0.8222222222222222,1.0,1.0,1/5,4.50%,PRKCH
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2809109936770231,0.741020176859716,0.975609756097561,1.0,1.0,15/298,8.84%,TBC1D3L;SNX31;ATP6V0A4;LRP1B;PPARG;ATP6V0D2;REP15;TVP23B;RAB29;ARL5A;TBC1D12;ARRDC3;RABL2B;RAB3C;TBC1D8B
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.43289852820789204,0.7405360337781409,0.7884615384615384,1.0,1.0,2/9,9.12%,DCUN1D1;HIF1A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.3185217533479142,0.7403759814775501,0.85,1.0,1.0,18/92,15.41%,SLC26A3;GABRB1;HCN1;SLIT2;GLRA2;GABRB2;CRHBP;PDE2A;PDE3A;P2RX7;CTNNB1;SLC26A6;SH3BP4;AKAP6;P2RY1;RELA;MEF2C;CPEB4
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.3383232252754037,-0.7403610340145099,0.9230769230769231,1.0,1.0,3/42,5.46%,MPZ;MAL;GPC1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.387803759560836,0.7403518969779315,0.76,1.0,1.0,6/15,20.73%,EPCAM;THPO;NANOG;SOX11;N4BP2L2;HNRNPU
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.428649810339703,0.740232480296278,0.8076923076923077,1.0,1.0,2/11,10.11%,MAGI2;JAG1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.4329814198597163,0.7400102979902711,0.7333333333333333,1.0,1.0,2/9,9.73%,ENPP1;BCOR
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4425765340713314,0.7398413416383999,0.7843137254901961,1.0,1.0,4/11,24.39%,C3;PRKCA;KLK14;PRMT5
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.45520249753192155,0.7390623836212327,0.7647058823529411,1.0,1.0,2/8,22.66%,ACADVL;ACADL
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.43452716195855273,-0.7386247338208671,0.7924528301886793,1.0,1.0,3/12,18.76%,AASS;MACROH2A1;SUPT6H
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.4441278712716844,-0.7380894048413466,0.75,1.0,1.0,2/6,7.43%,SKP1;RBX1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3259595191154605,-0.7380888160141357,0.9795918367346939,1.0,1.0,8/62,10.54%,INHA;NUPR1;TSPYL2;LATS2;INCA1;BTG1;TAF6;RFPL1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.466954217368725,-0.7376176758598555,0.7647058823529411,1.0,1.0,3/6,40.35%,MTHFR;MTHFD1;GOT1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.43568172875263966,-0.737606267924909,0.7755102040816326,1.0,1.0,2/9,5.74%,PAH;IL4I1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.2920916798162553,-0.7375251825801854,0.9433962264150944,1.0,1.0,23/168,12.12%,TCHH;NUPR1;RPS27L;PLK3;XPC;TSPYL2;GADD45A;RGS16;RRP8;TRIAP1;PPP1R15A;BTG1;PLK2;PIDD1;WRAP73;H2AJ;ISCU;DRAM1;BLCAP;BAK1;ABAT;RACK1;CDKN2B
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.31673464717750477,-0.7374419390076458,0.9259259259259259,1.0,1.0,14/107,11.98%,TAGLN;COL6A1;HSD11B1;FBLN2;COL6A2;MCAM;CRYAB;MXRA8;COX7A1;PDE5A;SPARC;ADAM33;ZIC1;ADAMTS5
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.4714481459083456,0.7373890716878745,0.8076923076923077,1.0,1.0,1/5,9.57%,NCK1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.3717147660028926,0.7372788794859474,0.7254901960784313,1.0,1.0,2/23,7.63%,PRELID2;LDLR
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.34036562983906676,-0.737216775036298,0.9555555555555556,1.0,1.0,18/65,21.49%,DDX24;GTF2F1;POLR2I;DNASE1L1;POLR2J;KPNA2;METTL3;POLR2G;HNRNPL;POLR2C;RBMX;HNRNPH2;HNRNPM;DDX54;POLR2L;POLG;PCBP1;POLR2K
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.4748510338083454,-0.7370294327025975,0.6851851851851852,1.0,1.0,2/6,16.08%,CERS2;RTN4R
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.35629028207686714,-0.7365125935054314,0.7555555555555555,1.0,1.0,10/39,18.28%,ZWILCH;BTG1;PLK2;WEE2;RFPL1;TOM1L1;CHEK1;BMP7;PRCC;CDKN1C
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.37431401152416877,-0.736269088383686,0.8070175438596491,1.0,1.0,7/22,19.29%,ARF1;PLK2;DRD3;TMEM25;PNKD;PRRT1;GRIK3
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.48757958130393786,-0.7362286938323981,0.8775510204081632,1.0,1.0,2/6,27.81%,TNFRSF1A;TRADD
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4415995408570663,0.7361148922831752,0.7735849056603774,1.0,1.0,1/7,8.00%,DYRK3
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),-0.47442935844119616,-0.7359437157950296,0.8076923076923077,1.0,1.0,1/6,2.04%,NOG
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.5124372187462999,0.7354854729125605,0.8490566037735849,1.0,1.0,4/6,27.19%,MYRF;PLP1;B4GALT6;B4GALT5
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.4838008410860436,-0.7353879248795205,0.8627450980392157,1.0,1.0,1/6,6.63%,RYR1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3579754241692415,0.7352329945105235,0.8095238095238095,1.0,1.0,10/47,14.08%,AKR1C1;SLC6A13;ABCC2;NCOA2;ABCC11;SLC16A7;SLC26A6;SLC10A1;ABCG2;SLC16A6
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.4166933344064036,0.7352247067780465,0.8043478260869565,1.0,1.0,5/10,16.93%,WNT5A;GABRB2;FGF13;GABRA2;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.3772637257626602,0.7352048907738863,0.7924528301886793,1.0,1.0,6/17,16.11%,KLF2;DDAH1;EDN1;DDAH2;SMAD3;PTGS2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.2866645691560445,0.7350584623940851,0.98,1.0,1.0,13/131,13.63%,MXRA5;FAS;ACKR3;POSTN;SULF1;STAB1;FAM114A1;TMTC2;PDE3A;TIMP3;COL5A2;CXCL12;PI16
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.4699370681775855,0.7350071410233718,0.7903225806451613,1.0,1.0,3/6,36.56%,TENT4B;SND1;LIN28B
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.3136527706618897,-0.7347947362733741,0.8867924528301887,1.0,1.0,21/94,13.09%,MYB;CFAP47;VWA3A;CATIP;TMEM212;CFAP61;PPP1R42;SCGB1A1;CFAP221;DNAH2;C11ORF97;SNTN;CFAP52;RSPH4A;LRRC23;DRC1;TEX26;CFAP99;AK8;CCDC60;CFAP77
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.35172069552175717,0.7347617956621887,0.8823529411764706,1.0,1.0,15/64,14.91%,ZFPM2;ENPP1;PPARG;WNT5A;ZFP36;RORA;LPL;LMO3;FOXO1;ZFP36L2;SIRT1;SMAD3;CREB1;FTO;RUNX1T1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.29662330479573684,-0.7343400090444352,0.94,1.0,1.0,19/109,15.98%,SFRP1;WNT9B;RAC1;PSMA7;PSMD7;PSMB4;PSMC3;PDE6B;CALM1;PSMD8;PSME1;PSMB2;PSMC4;SFRP4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.40207610021361334,0.7343269252357015,0.7647058823529411,1.0,1.0,2/13,10.22%,NLGN1;RAB27A
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.32033648107551693,0.734134240083126,0.9259259259259259,1.0,1.0,22/109,20.68%,HS6ST3;OLFM3;NRXN1;NXPH1;HMGCLL1;KCNJ6;NOL4;LHFPL4;KCNB2;TENM1;SMAD3;ERC2;GRIA2;CSRNP3;CTNND2;MAPK4;ATRNL1;DPYSL5;ST8SIA3;TMEM59L;ADGRA1;PAK5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.35904939290894855,0.7341223149303322,0.7884615384615384,1.0,1.0,4/25,12.37%,DCUN1D1;ARRDC3;PLK1;BTRC
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.42133132345708413,0.7337470989884766,0.7450980392156863,1.0,1.0,1/12,4.40%,SLC6A13
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.4428291360123803,0.7335569633051978,0.7636363636363637,1.0,1.0,6/11,33.82%,PKD2;GRIN2B;PKD1;CPSF6;CPSF7;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.33483885784633644,-0.7334741460727054,0.8913043478260869,1.0,1.0,5/50,9.10%,ASB9;RILP;GPC3;VIP;PLK2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.41031664140480634,0.7333591668624199,0.8421052631578947,1.0,1.0,4/12,18.30%,CEP120;CEP135;OOEP;KIAA0586
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.36293884494910855,0.7332779367909301,0.8823529411764706,1.0,1.0,3/24,5.73%,CALCR;IRS1;AGER
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.43704066905807426,0.7328985804935583,0.7959183673469388,1.0,1.0,3/8,24.31%,WASF2;WASF1;ABI2
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.3207226257126722,0.7327571899786399,0.9090909090909091,1.0,1.0,6/71,9.68%,SEM1;RFWD3;SWSAP1;TONSL;RAD51B;NSMCE1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.26168538841257405,0.7326128411417165,1.0,1.0,1.0,57/379,16.27%,ARHGAP25;DAPK2;HSPB1;RIT2;NLGN1;PEX5L;PIP4K2A;EGFR;DDIT4;BANP;WNT5A;TP63;ARHGAP30;AGER;RHOB;TNIK;PKHD1;SLC15A2;ARHGAP10;FSHR;ECT2;PTPN13;STYXL1;HDAC2;SGK1;PRKAB2;TAF3;ITGAV;PDE2A;PHLPP1;WWC1;GNAI1;DYRK2;TP53INP1;PPP1R13B;MAP2K6;GNA13;AKAP6;EP300;FGD4;RELA;TIAM2;ARAP2;TP53BP2;CCNG1;BARD1;VWF;ARHGAP24;RFC5;SYDE2;TAF2;PREX1;ARHGAP5;TAF4B;FBXL2;STARD8;SGMS1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.41076683114369794,-0.7324144749091713,0.7627118644067796,1.0,1.0,4/13,15.57%,TMSB4X;PINK1;ENO1;PARP1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.29772754177427974,-0.7323025214604999,0.96,1.0,1.0,22/118,16.39%,DDX11;MYB;SPI1;PWWP3A;DAXX;SMARCD1;HIRIP3;SAFB;HMGB2;KDM4D;HDAC5;GATAD1;SOX15;KDM6B;SUPV3L1;MTA2;NUCKS1;FAM50A;INO80;NPM2;MORC2;SMARCA5
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.46636145153251696,-0.7320972388881656,0.7755102040816326,1.0,1.0,1/7,6.63%,RYR1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.3123392929406391,0.7320424916440162,0.9090909090909091,1.0,1.0,5/52,8.50%,KANK1;NLGN1;RAB29;MINAR1;HDAC2
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4445001032916427,-0.7319034045153762,0.8703703703703703,1.0,1.0,3/6,20.95%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4445001032916427,-0.7319034045153762,0.8703703703703703,1.0,1.0,3/6,20.95%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.33089501329841864,0.7317546271179377,0.8723404255319149,1.0,1.0,9/42,13.49%,CX3CR1;HEY1;RGS14;PCM1;DLL1;FAIM;CTNNB1;SERPINF1;LIG4
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.4422432837470613,0.7317038208876301,0.7884615384615384,1.0,1.0,1/6,5.82%,IRS2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.39750228877295096,0.7315841611601827,0.8444444444444444,1.0,1.0,3/22,11.78%,NEDD4;UBAP1L;VPS37D
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.32865724028250265,0.7315350739269255,0.8333333333333334,1.0,1.0,3/32,10.57%,CLSPN;HINFP;SETMAR
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.36164539453187916,0.7311509338907015,0.8636363636363636,1.0,1.0,2/31,7.07%,ESAM;LATS1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.2976347995179889,-0.7307920989490665,0.9622641509433962,1.0,1.0,17/94,18.52%,FABP5;STARD5;SLC51A;TRIAP1;ABCB11;PRELID1;SLC10A6;CEACAM1;CPTP;NR1H4;NME4;APOA1;ABCC4;GOT2;PITPNA;ABCG4;ABCA5
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.4186588844869914,0.730710552118891,0.782608695652174,1.0,1.0,4/11,27.34%,CXCL12;SLC12A2;LRCH1;WNK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.33957968199455596,-0.7303173765728702,0.7777777777777778,1.0,1.0,6/58,7.92%,TXK;TEC;NTRK1;HCK;GHR;PRLR
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.4849992436208487,0.7301072276009628,0.8269230769230769,1.0,1.0,1/5,10.00%,DDAH1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.37677945164728144,0.7298816001046835,0.8958333333333334,1.0,1.0,4/17,16.07%,SLIT2;CATSPERB;NR1H3;TGFBR3
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.43774706916805806,0.72985715416161,0.765625,1.0,1.0,2/10,9.34%,SNCA;LPL
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.4308276754374471,0.7298047111303457,0.7666666666666667,1.0,1.0,1/8,2.71%,PPARG
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2996016216981187,-0.7296818948261754,0.9491525423728814,1.0,1.0,5/95,6.35%,FIP1L1;RBM8A;UPF3B;CPSF1;CPSF4
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.33687276318113696,-0.7295703083211483,0.8947368421052632,1.0,1.0,11/35,19.35%,APOD;VIP;FOXP1;IGFBP3;NDRG4;SERPINF2;EREG;THBS1;XRCC6;IL12A;STAT1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.4388514584419795,-0.7293242045044933,0.75,1.0,1.0,1/8,3.86%,IL31RA
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.41537881448639835,0.7291483191007745,0.7959183673469388,1.0,1.0,1/9,8.23%,NREP
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3155763818897994,0.7289143572683493,0.9245283018867925,1.0,1.0,15/91,12.25%,FAS;PPARG;SYK;SLC22A2;CASP12;HMGB1;EGLN3;ROBO1;SNCA;EIF2AK3;SOX7;CASP9;ST18;IFT57;SIRT1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4099177152931519,0.728825547438479,0.7540983606557377,1.0,1.0,2/11,14.20%,PARD3;PLPP1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.31162645214677526,0.7287912449613859,0.9069767441860465,1.0,1.0,26/97,16.06%,PTPN20;SPHK1;IL1RAPL1;SLIT2;TGFBR1;CSF1R;ACVR2A;ROBO2;PTPN13;NCOA2;IL18R1;CCL5;ASAH2;TIPARP;BMPR1A;SOCS2;PTPN14;PTPN6;CTNNB1;ACVR1B;AKAP6;SMAD3;ACVR1;PID1;MAPK8;URI1
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.4341022176056806,0.7283021125472326,0.8269230769230769,1.0,1.0,2/6,8.91%,GRID2;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.36185902583319474,0.7281414238650724,0.8852459016393442,1.0,1.0,3/24,11.81%,CIDEA;PTPN6;NLRC3
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.3063524699011206,0.7278765835631656,0.92,1.0,1.0,24/125,15.91%,FAS;CD8A;KLRD1;CSF1;EGFR;STAB1;HDAC9;ACVR2A;DYRK3;CCL5;HIF1A;TPD52;NCK1;TLR1;PTPN6;IL16;CD247;HLA-DMB;INHBB;TIMP1;IL4R;PRKCB;ST8SIA4;ICAM1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.354044138661752,-0.7278021622707976,0.8490566037735849,1.0,1.0,2/34,2.38%,DYSF;HCK
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.3137225100475494,0.7277411490428147,0.9807692307692307,1.0,1.0,7/60,10.56%,PLA2G10;RAB9A;SNCA;EXPH5;RAB27A;ADAM8;EDN1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3384972622155673,-0.7275302000638976,0.8723404255319149,1.0,1.0,4/47,7.16%,RBM4;RBM8A;CELF3;RBM11
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.2847681011299632,0.7272184787727026,1.0,1.0,1.0,3/154,2.99%,VAPB;BET1;GOLT1A
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.3451383907380713,-0.7272116142576871,0.8409090909090909,1.0,1.0,4/27,17.54%,SPI1;AEBP2;MORC2;MACROH2A1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.3693004157416433,0.727135349617882,0.9122807017543859,1.0,1.0,7/28,20.93%,DVL2;COBL;PRICKLE1;PHACTR4;BBS4;PLXNB2;VASP
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.3693004157416433,0.727135349617882,0.9122807017543859,1.0,1.0,7/28,20.93%,DVL2;COBL;PRICKLE1;PHACTR4;BBS4;PLXNB2;VASP
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.4404073313639792,-0.7270046572373257,0.7592592592592593,1.0,1.0,3/7,13.64%,TMSB4X;PINK1;ENO1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.450459936300078,0.7268551002147491,0.8333333333333334,1.0,1.0,2/5,33.95%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.3399062404085886,-0.7263374803766326,0.8541666666666666,1.0,1.0,8/35,16.97%,FABP5;FABP6;LIPC;LIPI;LMF1;PNPLA1;FABP7;GK5
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.45486717785131114,0.7262499772830342,0.8163265306122449,1.0,1.0,1/5,1.50%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.45486717785131114,0.7262499772830342,0.8163265306122449,1.0,1.0,1/5,1.50%,ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.42661524475294,-0.7261380426975387,0.7777777777777778,1.0,1.0,1/10,7.09%,VIP
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.4562832390317254,-0.7257937629454561,0.8363636363636363,1.0,1.0,1/9,6.19%,MBTPS2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.4405207400443075,0.7257602482138356,0.7735849056603774,1.0,1.0,3/10,20.61%,ZNF675;AIDA;PDCD4
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.4495157988866687,0.7255372497247172,0.8214285714285714,1.0,1.0,2/6,15.91%,AGER;ICAM1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.45861288458678634,0.7252760475957196,0.7796610169491526,1.0,1.0,1/5,21.07%,PDE12
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.39585992781803675,0.7250064527152538,0.8723404255319149,1.0,1.0,9/19,21.37%,SNCA;RGS14;CCL5;BICD1;CRY1;KLK14;ADA;RPGRIP1L;MGRN1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.30398818352727847,0.7249191099579393,0.9347826086956522,1.0,1.0,11/94,12.25%,CCNH;PPEF2;CCNA2;CCNB3;SLC8A1;CSF1R;SNCA;CCNP;CCNE2;CDK12;SIRT1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.46825556823233216,-0.7248412953533775,0.8,1.0,1.0,1/5,14.27%,TRPV4
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.4249571117245369,-0.7248185250753358,0.8863636363636364,1.0,1.0,2/9,12.87%,PPP1R3E;PPP1R3D
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.4981282085257659,0.7248072244445781,0.8571428571428571,1.0,1.0,1/5,8.75%,MFHAS1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.351853431814417,-0.7246355297791344,0.8301886792452831,1.0,1.0,2/24,5.46%,CDK5;GPC1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.412499471159055,-0.7246070064917514,0.7719298245614035,1.0,1.0,1/11,6.60%,SHANK3
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4242967969719307,-0.7245126638487495,0.7692307692307693,1.0,1.0,2/14,14.77%,EMD;RBM22
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.4802534988911377,-0.7244415809536409,0.8571428571428571,1.0,1.0,1/5,5.89%,GNB3
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.29461341038557204,0.7242889516500343,0.975609756097561,1.0,1.0,32/187,19.49%,MAP3K11;SHROOM1;SHROOM2;ANLN;KIF2C;ARHGAP10;ECT2;LATS1;KPTN;RASAL2;NCK1;ARHGAP27;PCM1;DOCK4;PLK1;WASF2;ESPL1;BCAR1;FGD4;PREX1;ARHGAP5;SSH2;ABR;MID1;RAPGEF6;CLASP1;SAC3D1;DST;CNTROB;SOS1;SPTBN1;ARHGEF3
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.32594468621164113,0.7239388521458143,0.92,1.0,1.0,11/70,11.81%,MARVELD3;FGFR2;EGFR;MAGED1;PKHD1;PRKD1;ZFP36;CDK6;FGF10;PEX2;NLRC3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.339989729991065,0.7238657195589954,0.8518518518518519,1.0,1.0,7/52,14.77%,FAS;WWOX;TGFBR1;ITGAV;FGFR1;RELA;ACVR1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.4623958048959852,-0.7237576334217344,0.8703703703703703,1.0,1.0,1/7,6.01%,RNF8
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.36516836868267233,-0.7236858203582484,0.8,1.0,1.0,1/26,2.15%,NTRK1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3598931432122373,-0.7235746627070687,0.85,1.0,1.0,6/33,15.26%,ATOX1;FTH1;TRPC3;ATP2C2;HEPH;SLC30A5
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.4731788376502718,0.723445513819251,0.8431372549019608,1.0,1.0,2/7,21.88%,C4BPB;CD55
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.4731788376502718,0.723445513819251,0.8431372549019608,1.0,1.0,2/7,21.88%,C4BPB;CD55
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.4731788376502718,0.723445513819251,0.8431372549019608,1.0,1.0,2/7,21.88%,C4BPB;CD55
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.27316259853812547,0.7234292362973954,1.0,1.0,1.0,76/441,15.07%,CALCR;NRG1;SPHK1;NTF3;ERBB4;IRS1;ITGAX;VEGFC;FGFR2;CSF1;S100A13;EGFR;WNT5A;CCN2;PARD3;TGFBR1;FRMD5;IRS2;PKHD1;CSF1R;MEIS1;H3-3A;PPP3CA;ZFP36;FGFR3;FGF5;CDKN2AIP;PTGFR;HDAC2;CCL5;FGF17;EPCAM;DVL2;IER5;ANKRD17;NSMCE1;FER;LAMC2;PDGFRB;FGF10;RAB27A;IGF1R;ADAM8;RAD18;PTPN6;EDN1;PRKCA;DLL1;ITGAV;ACACA;CDCA7L;FGFR1;VEGFD;MEIS2;P2RX7;SIRT1;PDGFD;LIFR;MARCHF7;CRLF2;CXCL12;THPO;MDK;AKAP6;ADNP2;IL15RA;RELA;BCL2;TBX6;SMC5;TUB;FASN;TIMP1;SCX;MEIS3;AVPR1A
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.43609033006034015,0.7233868408265571,0.8214285714285714,1.0,1.0,3/10,8.44%,ARID1A;ARID1B;SERTAD2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.426603294116192,-0.7231857426874128,0.75,1.0,1.0,1/7,4.45%,DUOXA1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.43156082170576193,-0.7230652606543412,0.75,1.0,1.0,2/9,9.46%,CD4;DCAF15
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.31432857488251154,-0.7230440432736225,0.9387755102040817,1.0,1.0,8/68,14.69%,FGF1;SEZ6L2;ARHGEF25;FKBP10;VAX2;VGF;TUBB2B;C1QL1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.39912904373390223,-0.7230204614445326,0.7857142857142857,1.0,1.0,2/11,16.57%,DDB1;CHMP2A
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.414140168898447,-0.7229587106421803,0.82,1.0,1.0,2/11,26.15%,DNM1L;CD14
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.36963491934991055,-0.7227869353253283,0.8367346938775511,1.0,1.0,3/19,11.10%,H1-0;HMGB2;BLCAP
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.3976825357791821,-0.7226256651007785,0.8695652173913043,1.0,1.0,1/11,3.89%,CD74
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.4168009419997126,-0.7225047440852316,0.7796610169491526,1.0,1.0,1/11,8.52%,TTLL2
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.465704249094116,0.7224723720117016,0.7708333333333334,1.0,1.0,2/5,29.60%,LEF1;STAT6
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.2891756063196667,0.7222535630476153,0.9591836734693877,1.0,1.0,43/171,21.99%,NLGN1;MAGI2;NRXN1;RAB29;TNIK;ARL5A;KCNIP4;CACNB2;RAB3C;DLG2;TSPAN15;ZDHHC2;TSPAN17;SAV1;KCNB2;DPP10;LRRC7;RAP2A;PACS1;ANK2;FGF13;ANK3;P2RY1;SMURF1;LIN7A;RAB34;ARL5B;MAP7;BRAF;SLMAP;RAPGEF6;PIGW;TMED2;RAP1A;ROCK2;SPTBN1;BSG;CAV3;TESC;RAB10;CPE;CLASP2;NUP54
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.4690368754004821,0.7221832287764188,0.7666666666666667,1.0,1.0,1/6,5.24%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.4690368754004821,0.7221832287764188,0.7666666666666667,1.0,1.0,1/6,5.24%,ZEB2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.382337332106111,0.7221831755808676,0.82,1.0,1.0,1/11,7.07%,LATS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.40333865642604866,-0.722093495495398,0.7857142857142857,1.0,1.0,1/14,8.98%,HMCES
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.4394184800485048,0.7218900127271778,0.8043478260869565,1.0,1.0,1/8,5.99%,CSF1R
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.4330750710990411,0.7216773658010858,0.8035714285714286,1.0,1.0,4/6,23.81%,SRR;SERINC5;PSPH;PHGDH
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.45198741517215346,0.721675243886214,0.7818181818181819,1.0,1.0,2/5,22.37%,PRIMPOL;DNA2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.31469974732079936,-0.7210744892317371,0.9152542372881356,1.0,1.0,17/59,13.09%,VWA3A;TMEM212;PPP1R42;SCGB1A1;CAPS;C11ORF97;SNTN;CFAP52;RSPH4A;LRRC23;DRC1;TUBB4B;ANKUB1;ATP5MK;TEX26;CCDC60;CFAP77
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.3100130717939824,0.720927670745127,0.9473684210526315,1.0,1.0,11/62,12.78%,SYK;HMGB1;WNT5A;AGER;TWIST1;LPL;MBP;TLR1;PTPN6;NLRC3;IL16
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4286339322655114,-0.7208535947681842,0.8269230769230769,1.0,1.0,1/14,4.36%,INTS5
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.41081673158425647,0.7206617718338763,0.8518518518518519,1.0,1.0,3/12,23.20%,MOCS3;NOXRED1;GPHN
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.369894830577722,-0.7205849810151025,0.8245614035087719,1.0,1.0,2/14,12.08%,HSD17B10;AKR1C2
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.36664194190388244,-0.7205429382686918,0.8409090909090909,1.0,1.0,6/19,20.59%,GOLGA2;SKP1;RPL23;RPL5;FZR1;RPL11
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3382033489777406,0.720276761704921,0.8461538461538461,1.0,1.0,3/48,3.79%,IFI16;SYK;HMGB1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.2583827936249764,-0.7201218614550507,1.0,1.0,1.0,37/319,15.98%,CBLC;AURKA;ADRM1;PSMA7;UCHL1;DTX3L;UBE2L6;ANAPC15;PSMD7;RNF8;ARIH2;PSMB4;TBL1X;RBX1;PSMC3;UBL7;RNF213;IFI27;RBCK1;RMND5B;NSFL1C;UFD1;PINK1;TOM1L1;PSMD8;PSME1;DDB1;PSMB2;PSMC4;PSMB8;ANAPC2;VPS28;PSMC1;PSMB5;PSMD2;TAF1;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2802992313466125,0.7198763330902299,0.9782608695652174,1.0,1.0,57/268,19.40%,CALCR;NTF3;KLF2;ITGAX;SLC22A2;CSF1;MAGI2;PPARGC1A;ROBO1;WNT5A;TGFBR1;ZNF804A;RAB29;HEY1;SNCA;UBR5;FGF5;TWIST1;HINFP;FGF17;EIF2AK3;HIF1A;SMAD1;TLE1;MITF;FGF10;RAB27A;PDE2A;RIMS2;ACTA2;P2RX7;ZBTB7B;ITGB8;ANK2;HSPA1A;ANK3;SMAD3;GABPA;SLC38A2;SCX;MEF2C;PID1;MAPK8;SOX11;TBC1D5;AFDN;BRAF;ADTRP;ATF7IP;PDCL3;VEGFA;LIMS1;BMP6;PDGFB;ROCK2;RBMS3;ATF2
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.46294222050169465,0.7198429183619708,0.8076923076923077,1.0,1.0,3/6,22.49%,LRWD1;RUVBL2;NIPBL
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.32951977454555453,0.7192552306938084,0.9433962264150944,1.0,1.0,3/62,2.85%,SPHK1;RUNX1;SYK
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.37393727479680866,0.719221607754195,0.8653846153846154,1.0,1.0,11/26,28.44%,RANBP3L;SMURF1;NUP42;ANKLE1;STRADA;XPO1;RANBP17;XPO7;STYX;PKD1;XPO4
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.36921871198991313,0.7191966302036512,0.8793103448275862,1.0,1.0,7/23,15.07%,SLC26A7;SLC22A6;ABCC2;SLC1A2;PRAF2;SLC26A6;SLC25A12
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.43301367868240676,-0.7187525451882482,0.76,1.0,1.0,4/7,41.79%,KYNU;MTHFD1;GOT1;HAAO
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.42078793335128506,-0.7187064178357185,0.8653846153846154,1.0,1.0,4/12,23.16%,KHSRP;ZC3HAV1;GTPBP1;PRR5L
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3094578914625319,0.7185895751923906,0.9090909090909091,1.0,1.0,4/94,4.12%,EIF3E;PLA2G10;CSF1;PRR16
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.4587857763540262,0.7184085928497653,0.8541666666666666,1.0,1.0,2/9,6.82%,MT1M;SNCA
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.3906743629085901,-0.7183641225510378,0.8235294117647058,1.0,1.0,9/21,26.22%,ACE;CALM1;TOM1L1;CALM3;PDGFA;GREM1;RAP2C;GPNMB;TAOK2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.3548256297664586,-0.7181405693415378,0.92,1.0,1.0,2/31,4.38%,CGAS;B2M
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.3611566763047415,0.7178140474188819,0.8636363636363636,1.0,1.0,4/34,10.13%,CENPI;KNL1;SRCAP;SPTY2D1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3159902284908164,-0.7176239372909988,0.9259259259259259,1.0,1.0,11/90,9.28%,DYSF;TPM1;ACTC1;TPM4;CALD1;MYL12B;RYR1;CRYAB;MYL5;CALM1;MYL7
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.4471021920649526,-0.7174209391781459,0.8461538461538461,1.0,1.0,2/8,12.96%,ASCL1;NRP2
prerank,MSigDB_Hallmark_2020__Complement,0.29555785667090767,0.7171998282434049,0.9534883720930233,1.0,1.0,27/147,16.03%,PIK3R5;KLKB1;ZFPM2;PLA2G7;RCE1;S100A13;ITGAM;ZEB1;CCL5;PRSS3;C3;DOCK10;CD59;CDH13;CASP9;C4BPB;DOCK4;DYRK2;CBLB;PIK3CA;HSPA1A;TIMP1;GPD2;PLAT;PCLO;CASP10;GNAI3
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.29428625851607937,0.7171898359480872,0.9523809523809523,1.0,1.0,33/212,13.03%,GPC5;SEMA5A;KANK1;FGFR2;EGFR;WNT5A;ZEB2;MLLT3;LGR5;RNF220;PSMD13;LATS1;TMEM198;AMER2;TLE3;TBL1XR1;SCEL;UBR5;GLI3;DVL2;BICC1;SOX7;TLE1;FGF10;ZNRF3;GNAQ;LRP4;SMURF2;TMEM170B;CTNNB1;BTRC;PRICKLE1;PPM1A
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.4724192870886398,0.7158564043660963,0.803921568627451,1.0,1.0,2/6,14.76%,TIMP3;TIMP1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.3848245904363724,0.7151155299249129,0.8235294117647058,1.0,1.0,1/12,11.41%,STARD4
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.3049414474618858,-0.7149280097698779,0.9333333333333333,1.0,1.0,10/111,8.60%,RTP5;TOMM40;TIMM17B;CDC37;HPS4;SRP54;GIPC1;TOMM20;SRP14;ZDHHC4
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.506609552091879,-0.7148293311645352,0.8888888888888888,1.0,1.0,1/5,8.50%,CARD9
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.506609552091879,-0.7148293311645352,0.8888888888888888,1.0,1.0,1/5,8.50%,CARD9
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.34163131494698096,-0.7147614388923341,0.9230769230769231,1.0,1.0,8/42,19.47%,ATG14;RBM3;NOLC1;EIF2B4;PUM3;RBM4B;TCOF1;MTPN
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3249432543024344,-0.7146454909154295,0.8888888888888888,1.0,1.0,14/64,18.55%,CLU;CRYAB;PACSIN3;TRAF3IP1;TMC8;SVIP;PRKCZ;NR1H4;APOA1;HDAC6;LRSAM1;SPRY2;SRC;CARMIL2
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.4374092398278184,-0.7145777769174866,0.8269230769230769,1.0,1.0,1/8,3.76%,PDZD7
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.36751878760806067,0.7145259270727691,0.8636363636363636,1.0,1.0,1/16,2.44%,KANK1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.2739100988399142,0.7144859067143812,1.0,1.0,1.0,48/352,14.11%,NOX5;EIF3E;IFI16;CALCR;ITGAX;SLC22A2;CSF1;SF3B1;PRR16;S100A13;PPARGC1A;ROBO1;EGFR;WNT5A;TGFBR1;ZNF804A;HEY1;ERN1;UBR5;ELAVL4;FGF5;TWIST1;HINFP;FGF17;EIF2AK3;HIF1A;SMAD1;TLE1;MITF;FGF10;RAB27A;DYRK1A;CADM1;CCDC88B;PDE2A;RIMS2;ACTA2;TAF1A;P2RX7;ZBTB7B;ITGB8;ANK2;HSPA1A;ANK3;EP300;SMAD3;GABPA;SLC38A2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.4688905408804168,-0.7144714204554112,0.8,1.0,1.0,1/6,16.39%,USP1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.45456035470002837,-0.7143789733927394,0.8085106382978723,1.0,1.0,1/8,2.18%,PLK3
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.40218941626485427,-0.7142410774949163,0.8125,1.0,1.0,7/17,26.60%,MBTPS2;APH1B;HM13;NCSTN;TGFB1;ADAM17;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.38851383419279695,-0.7141371339986449,0.8,1.0,1.0,1/12,8.98%,HMCES
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.38517969701215904,0.713935629845111,0.8695652173913043,1.0,1.0,5/21,20.73%,PDCD6IP;PLK1;HSPA1A;CHMP1A;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.33402701439410276,0.7133592450468812,0.9111111111111111,1.0,1.0,11/37,18.38%,RUNX2;TP63;ACVR2A;PRKD1;BMPR1A;HGF;ACVR1;MEF2C;SOX11;WWTR1;BMP6
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.42618649920068125,0.713140065528555,0.7804878048780488,1.0,1.0,2/5,14.73%,TDG;FTO
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.44301395860114057,0.7128493954451983,0.803921568627451,1.0,1.0,3/6,16.86%,CDH2;FER;AFDN
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.49014314803127457,-0.7128457233802713,0.8148148148148148,1.0,1.0,2/5,24.70%,APH1B;NCSTN
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.37369690975376224,0.7126730271607322,0.9069767441860465,1.0,1.0,3/17,9.19%,HEY1;TWIST1;ZNF675
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.36215767178941305,-0.7125516048402487,0.8636363636363636,1.0,1.0,2/26,8.29%,RAC1;PARVB
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.34034771383093876,-0.7123385148000447,0.8679245283018868,1.0,1.0,15/43,22.04%,HK2;TOMM40;TIMM17B;TOMM20;PINK1;FIS1;TIMM17A;TOMM7;TIMM50;TIMM44;TSPO;TOMM40L;TIMM13;SLC25A6;HSPD1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.4295160565395411,0.712252603266824,0.8076923076923077,1.0,1.0,1/10,1.42%,KCNE4
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.3548928009775064,-0.7121619706972242,0.9591836734693877,1.0,1.0,2/33,4.52%,SFRP1;PLK5
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.38752917628681105,0.7117191791491764,0.8409090909090909,1.0,1.0,5/16,22.66%,PPARGC1A;ACADVL;TYSND1;PDK4;ACADL
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.4148807978940591,-0.7115751720229521,0.8367346938775511,1.0,1.0,3/12,11.46%,RAC1;RHOBTB1;RHOBTB2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.3974003618265051,-0.7107847118419495,0.825,1.0,1.0,4/15,23.31%,CALY;CLTB;CLTA;AP2S1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.4165370056592014,0.7106261214485633,0.775,1.0,1.0,1/6,2.91%,NLGN1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.37084457824829464,0.7104759722628216,0.8333333333333334,1.0,1.0,5/28,13.88%,CX3CR1;CCL5;LRRC19;NAPEPLD;EP300
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.3518502037818981,-0.710405200055198,0.7291666666666666,1.0,1.0,4/12,24.60%,TOP3A;PARP1;MPV17;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.3310094586315646,0.7102176511382086,0.8235294117647058,1.0,1.0,4/29,16.52%,PPARGC1A;RPS6KA4;ZBTB7B;RUVBL2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.4003341281898581,-0.7099576637548586,0.8148148148148148,1.0,1.0,3/13,16.05%,TRAF3IP1;C1QBP;HERC5
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.3112079300002855,-0.7098395931426346,0.8666666666666667,1.0,1.0,21/76,25.39%,NDUFC1;NDUFS5;NDUFA1;NDUFB9;NDUFAF3;NDUFA3;NDUFS6;NDUFAB1;UQCC2;NDUFB10;TMEM126B;NDUFS2;NDUFA5;NDUFA10;NDUFAF5;NDUFA12;NDUFS8;NUBPL;COA5;TMEM126A;SDHAF4
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.36394460262559764,0.7097996974602577,0.7727272727272727,1.0,1.0,5/16,10.18%,SLIT2;NRP1;CCL5;BMPR1A;PDGFRB
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.38867588023415867,0.7092640289790614,0.803921568627451,1.0,1.0,1/14,11.93%,SEC23B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.3610328484348267,0.7091800267813059,0.8125,1.0,1.0,4/22,13.37%,PDE4B;PDE4D;ANK2;FGF13
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.37676084290164746,0.7090202355793874,0.8461538461538461,1.0,1.0,6/21,18.59%,ATP2B4;PDE4B;SNCA;GABPA;SLC9A1;GNG2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4016321369216449,0.7085339510596446,0.8301886792452831,1.0,1.0,1/13,6.37%,YAE1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.2802470227296702,0.7085023306970519,1.0,1.0,1.0,50/286,18.53%,MARCHF1;NEDD4;UBE2J1;RNF217;UBE2U;MARCHF8;UBE2E2;PELI1;PELI2;UBE3D;CUL1;SPOP;LMO7;PSMD13;TRIM22;UBR5;FBXO30;FBXO7;FBXL7;FBXW9;RNF135;UBE2E3;FBXL3;TRIML2;SMURF2;CTNNB1;BTRC;ARIH1;SHPRH;SASH1;FBXO11;RNF144A;BCL2;UBE2E1;SMURF1;UBE2D3;BARD1;SYVN1;DTL;MARCHF5;RNF19B;PSME4;FBXL17;NEDD4L;TRIM5;FBXO10;TRAF5;PSMF1;HECW2;KLHL3
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.44128169662651795,-0.7084314019679645,0.8333333333333334,1.0,1.0,1/7,3.76%,PDZD7
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.4481675066946964,-0.7081798411822486,0.7674418604651163,1.0,1.0,3/6,21.83%,MACROH2A1;SUPT6H;PHF19
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.43812048963556893,0.7080282074279552,0.7857142857142857,1.0,1.0,1/6,17.26%,KAT2B
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.4289441046746793,-0.7079410577175176,0.7692307692307693,1.0,1.0,1/10,6.80%,MEOX1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.4033359375931701,0.7079023582302503,0.8703703703703703,1.0,1.0,2/13,7.90%,CAVIN1;SPIN1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.35157492646181376,-0.7078585903459526,0.9090909090909091,1.0,1.0,2/26,6.33%,LCP1;CALD1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3046564842943809,0.7077925666984689,0.9259259259259259,1.0,1.0,25/114,17.97%,PTPN20;SPHK1;IL1RAPL1;CSF1R;XAF1;SNCA;PTPN13;IL18R1;ASAH2;PTPN14;PTPN6;PRKCA;TIMP3;LIFR;AKAP6;SMAD3;RELA;BCL2;TIMP1;PID1;MAPK8;AFF3;CD274;PTPN12;NFAT5
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.43585619320259805,0.7077406421668407,0.8490566037735849,1.0,1.0,2/7,26.55%,SASH1;BIRC2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.35397135153060644,-0.707731178939064,0.8679245283018868,1.0,1.0,4/18,22.24%,SUPT5H;CCNT1;RNF20;CTR9
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.4526554013251929,0.7075690154267511,0.8541666666666666,1.0,1.0,1/7,8.91%,CTNNA2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.3449691902724453,-0.707510706215294,0.9411764705882353,1.0,1.0,7/28,24.73%,POLR3H;SNAPC5;BRF1;GTF3C2;POLR2L;POLR2K;SNAPC4
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.32494323796200386,-0.7072774758780463,0.9615384615384616,1.0,1.0,13/49,16.05%,CDKN3;DIRAS3;CDC37;GADD45A;CCND1;CCNE1;CDKN2B;ACTB;CNPPD1;TTBK1;CCNT1;CAMK2N1;HERC5
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.3441500157210458,0.7072268670432154,0.9074074074074074,1.0,1.0,15/53,19.91%,KCND2;NDNF;EGLN3;TWIST1;RORA;HIF1A;ADAM8;SIRT1;CPEB4;PTGS2;CPEB2;VEGFA;BAD;BNIP3L;MDM2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.4631448327027736,-0.7070230527038189,0.875,1.0,1.0,1/6,6.81%,PGP
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.3329535487519073,0.7066488406349147,0.9285714285714286,1.0,1.0,5/32,16.41%,HSPB1;MEGF10;METAP1;CD99;MEGF11
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.41728304897388446,0.7062258774219171,0.84,1.0,1.0,4/8,19.35%,ATP12A;SLC4A4;SLC9A1;ATP1A2
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.39082091292302507,0.7061175424068948,0.8518518518518519,1.0,1.0,2/13,6.39%,PPARGC1A;CYB561
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.37799685941777705,0.7060097336036825,0.8,1.0,1.0,6/16,16.11%,KLF2;DDAH1;EDN1;DDAH2;SMAD3;PTGS2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3936746819232344,-0.705634840240641,0.9215686274509803,1.0,1.0,5/15,26.22%,CARD9;EIF2AK2;TAOK3;TAOK1;TAOK2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.3944422346904112,0.7056092626837712,0.8695652173913043,1.0,1.0,1/13,8.60%,PDCD6IP
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.40204410919804984,-0.7055883632826512,0.8181818181818182,1.0,1.0,3/13,14.57%,HMGB3;HMGB2;TOP3A
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.4620637487169068,0.7055796541135453,0.8666666666666667,1.0,1.0,2/7,10.99%,MEGF10;MRTFB
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.35334262580790227,-0.7055453585709708,0.8181818181818182,1.0,1.0,6/23,18.61%,VIL1;STMN1;STMN3;STMN2;KATNB1;CKAP5
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.3394306238366402,0.7054258586711911,0.8823529411764706,1.0,1.0,5/37,12.45%,CEL;AKR1C1;LDLR;STARD4;LCAT
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.29095182555561794,0.7049920791449169,0.9666666666666667,1.0,1.0,41/174,20.82%,HSPB1;LITAF;S100A13;TAB3;ROR1;WNT5A;PELI1;PELI2;ECT2;PRKD1;TRIM22;RORA;ANKRD17;TLE1;TAB2;TRIM8;NLRC3;TRIML2;SIRT1;NDFIP2;PPM1A;RELA;PRKCB;CASP10;C18ORF32;MID2;GPR89A;SLC20A1;TRIM5;TRAF5;ALPK1;TRIM59;ECM1;TFG;EEF1D;NOD1;ZFAND6;ZDHHC17;TRIM32;TSPAN6;LGALS1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.30111574936366226,0.7049786279332917,0.9555555555555556,1.0,1.0,12/66,13.52%,ATOH8;WNT5A;ADAMTS9;SLIT2;RHOB;NRP1;PRKD1;EDN1;PRKCA;PTPRM;BCAR1;SASH1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.3932399654256513,0.7048598878718605,0.8043478260869565,1.0,1.0,1/15,1.42%,KCNE4
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.4268653854162192,-0.7047775700430309,0.8823529411764706,1.0,1.0,1/12,2.04%,NOG
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.49086091269589016,0.7045588375814913,0.8222222222222222,1.0,1.0,2/5,31.88%,ABHD12;ABHD2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.42803857819946756,0.7043214972979522,0.8085106382978723,1.0,1.0,4/11,13.63%,MUC20;NRP1;BCAR1;HGF
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.44010873070503786,-0.7042357649390754,0.7954545454545454,1.0,1.0,3/7,24.49%,EIF6;RAN;NPM1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.47216295038629186,0.7041891894843532,0.8571428571428571,1.0,1.0,2/5,32.23%,HNRNPU;RCC2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.3514552821711311,0.7040724044022048,0.8518518518518519,1.0,1.0,6/31,13.78%,PSRC1;PDCD6IP;BORA;PLK1;GNAI1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3787894553721284,-0.7040452427079203,0.8448275862068966,1.0,1.0,3/13,11.78%,CHCHD10;BAK1;SLC25A5
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.34971746512408525,-0.7038052851521137,0.8571428571428571,1.0,1.0,6/26,15.88%,PLK5;DDRGK1;TCIM;PSME1;INO80;TAF1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3235836672499688,0.7037299538057791,0.94,1.0,1.0,12/72,14.55%,CALCR;RXFP2;SYK;CYSLTR2;GPR176;FSHR;SCTR;PRKACB;YES1;CD247;NPSR1;CREB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.3410862504065733,-0.7034518712552646,0.8653846153846154,1.0,1.0,5/19,16.28%,AURKA;PINK1;DNM1L;FIS1;KDR
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.27658634509300434,0.7033847820255115,0.975609756097561,1.0,1.0,34/282,17.68%,TBC1D3L;SNX31;SYK;NLGN1;RAB29;ARL5A;TBC1D12;RABL2B;RANBP3L;TBC1D8B;MAIP1;PRICKLE1;RABGAP1L;RUNDC1;ARFIP1;TMED9;AKAP6;AP1M2;SMURF1;TBC1D1;GRTP1;EVI5;KIF13A;AKT2;TBC1D4;ARL5B;USP6NL;TBC1D5;NUP42;PPP1R10;ARL17A;LAMP2;BCS1L;TMED2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.32455028063703006,-0.703362289225022,0.88,1.0,1.0,6/31,19.23%,CYP19A1;SOX15;BIK;LRP2;FGF9;MAMLD1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3777540817140385,-0.7032837230023564,0.8809523809523809,1.0,1.0,4/25,10.10%,AZGP1;SPI1;HLA-DRA;NOS2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.3865623795641485,0.7031341420511832,0.7959183673469388,1.0,1.0,2/12,12.56%,H6PD;LPCAT3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4229657660815168,-0.7026212186575073,0.8909090909090909,1.0,1.0,2/9,14.43%,PRKACA;APOA1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4226360587648236,0.7026013678945091,0.8125,1.0,1.0,1/8,5.53%,SLC25A48
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3664203577567728,-0.7025551036187864,0.825,1.0,1.0,2/16,14.27%,YBX3;TRPV4
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.39629679159355735,-0.7022395614994574,0.864406779661017,1.0,1.0,1/13,4.68%,RAB17
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.39629679159355735,-0.7022395614994574,0.864406779661017,1.0,1.0,1/13,4.68%,RAB17
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.30460317103047996,0.702087139234496,0.9565217391304348,1.0,1.0,13/114,8.19%,GPC5;SEMA5A;KANK1;FGFR2;EGFR;ZEB2;LGR5;RNF220;PSMD13;TMEM198;TBL1XR1;SCEL;UBR5
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.33292972497701756,0.702084527232946,0.9090909090909091,1.0,1.0,5/32,17.99%,NUS1;AGPAT5;SGMS1;CLN3;FDPS
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.30203109964058883,0.7019282880113572,0.9807692307692307,1.0,1.0,13/83,16.52%,NEDD4;PTPRK;ZBTB1;EGFR;CAT;PRIMPOL;CASP9;EP300;RELA;DTL;MAPK8;EIF2S1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.409230324900722,0.7016004858117321,0.7142857142857143,1.0,1.0,3/7,22.57%,FGF13;CAV3;CAMK2D
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.39733060972661827,-0.7014172319399056,0.8095238095238095,1.0,1.0,5/12,29.31%,WRAP53;CCT2;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.3853168532152492,-0.7014116491822624,0.8627450980392157,1.0,1.0,2/14,6.26%,RAC1;IL11
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.3607982906261797,-0.7013088206153609,0.8367346938775511,1.0,1.0,2/18,8.41%,SKP1;CHCHD10
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.349283599330239,0.70127722663873,0.9019607843137255,1.0,1.0,3/24,12.25%,HSPB1;FBXO7;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4016307046687179,0.7012695144742912,0.851063829787234,1.0,1.0,4/10,21.09%,ATP2B4;FOXO1;CAV3;SMAD4
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.3653956638093573,-0.7011868574087307,0.8333333333333334,1.0,1.0,3/22,7.84%,SIGIRR;CD74;FOXP1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.4258079326080923,-0.7008324697418551,0.8367346938775511,1.0,1.0,1/9,1.32%,NUPR1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.28644104790447994,0.7003531482691215,0.94,1.0,1.0,21/116,17.25%,GPC6;FIGN;GUCY1A2;GFRA1;SEMA6D;SLIT2;PDZRN3;FBXL7;ADGRL2;TENM3;LRP4;LIFR;BCAR1;ANK2;PRICKLE2;AMOTL2;MEIS3;KCNK9;VIM;DCLK1;MAGI1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.37451952981133757,-0.7002737780125127,0.8148148148148148,1.0,1.0,6/22,22.27%,AURKA;MET;CCDC39;LSR;E2F7;CCDC40
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.3580480264134178,0.7002094818914533,0.8771929824561403,1.0,1.0,7/31,20.93%,DVL2;COBL;PRICKLE1;PHACTR4;BBS4;PLXNB2;VASP
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.4569212013011734,0.7000507222844358,0.7906976744186046,1.0,1.0,2/5,38.60%,ITGB1;TNIP2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.4100527960919596,-0.6998447786129518,0.8936170212765957,1.0,1.0,2/14,9.02%,GNB3;CD24
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.3739238886644868,0.699794037197509,0.82,1.0,1.0,3/13,15.36%,AUTS2;OGT;ARHGAP24
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2995963364560285,0.6997268699879909,0.9111111111111111,1.0,1.0,13/85,14.13%,SYK;KLRD1;MUC20;TAB3;CUL1;PSMD13;MUC16;PRKACB;TAB2;MUC6;BTRC;EP300;RELA
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2995963364560285,0.6997268699879909,0.9111111111111111,1.0,1.0,13/85,14.13%,SYK;KLRD1;MUC20;TAB3;CUL1;PSMD13;MUC16;PRKACB;TAB2;MUC6;BTRC;EP300;RELA
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2995963364560285,0.6997268699879909,0.9111111111111111,1.0,1.0,13/85,14.13%,SYK;KLRD1;MUC20;TAB3;CUL1;PSMD13;MUC16;PRKACB;TAB2;MUC6;BTRC;EP300;RELA
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.42049286327048574,-0.6995710173983041,0.8367346938775511,1.0,1.0,3/13,16.27%,OPALIN;DRD3;SLC45A3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.45461046667825505,0.699453119729505,0.82,1.0,1.0,3/6,25.78%,ZFP36L2;ZFP36L1;PTEN
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.27756440849312664,-0.699386310433971,0.98,1.0,1.0,45/135,26.05%,DND1;PSMA7;PSMD7;UBC;PSMB4;VIP;PSMC3;CIRBP;PSMD8;PSME1;METTL3;PSMB2;PSMC4;EXOSC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;YWHAB;PSMD10;APEX1;KHSRP;SLC11A1;PSME2;PSMD12;CSDC2;SERBP1;EIF4G1;PSMC6;PSMB7;PSMB3;TBRG4;SET;PSMA5;NUP214;UBB;PCBP4;NPM1;PSMB1;PSMB6;PSMD3;YBX1;PSMD11;PSMA4
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.34448033287741014,0.6993062823539581,0.92,1.0,1.0,5/23,19.95%,ABHD17B;HDAC3;SIRT1;LYPLAL1;HDAC10
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3640922665662765,0.699182567006669,0.803921568627451,1.0,1.0,1/14,1.80%,KCNJ3
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.30898059928115845,-0.6991546129123394,0.9074074074074074,1.0,1.0,8/44,17.49%,SIN3B;TBL1X;PER2;MORF4L1;HDAC5;MTA2;HDAC6;HDAC11
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.2940549976806471,-0.6991533830966872,0.9387755102040817,1.0,1.0,4/63,3.79%,HCK;SERPINE1;NLRP3;NFKBIB
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.36076753343059365,0.6990650811464504,0.8444444444444444,1.0,1.0,6/27,17.04%,LEPROTL1;GPM6B;CTNNB1;PICALM;COMMD1;NEDD4L
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.28933951402151853,-0.6989628179198035,1.0,1.0,1.0,12/91,13.15%,COPE;STX16;M6PR;GNAS;CD63;ANP32E;ARF1;TOM1L1;YKT6;PPT1;DNM1L;ICA1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4149668257873159,-0.698649527450844,0.8148148148148148,1.0,1.0,2/14,6.57%,NUDT12;NAXE
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.32696413467282,-0.698377514157326,0.8636363636363636,1.0,1.0,8/42,14.86%,FTH1;SCARA5;SKP1;ISCU;FRRS1;HEPH;ATP6V0A2;NUBP1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.38868133090327384,-0.6982777431133677,0.8260869565217391,1.0,1.0,2/13,18.76%,HMCES;SUPT6H
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.352869544372605,-0.6982658422714609,0.8076923076923077,1.0,1.0,7/25,19.73%,RAC1;DCTN1;MET;ANKRD53;DRG1;CKAP5;RPS3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.27087489742227244,0.6978873451795865,1.0,1.0,1.0,13/162,11.06%,U2AF1;HNRNPH1;SF3B1;PPARGC1A;ADARB2;CELF2;SYNCRIP;ATXN1;ELAVL4;MBNL1;NOVA1;CDK12;BICD1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.36555128471889575,0.6978191015515619,0.8571428571428571,1.0,1.0,4/20,18.84%,EGFR;PSRC1;PROX1;PDGFB
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.3559920032037268,-0.6977681533567371,0.8653846153846154,1.0,1.0,2/21,9.58%,HSD17B10;ABCB11
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.36314606688528667,-0.6975984004919654,0.8979591836734694,1.0,1.0,5/30,14.68%,APOD;SORD;GALK1;AKR1A1;SLC35A2
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.40456949985642243,-0.697596917446201,0.8653846153846154,1.0,1.0,4/9,22.24%,SUPT5H;CCNT1;RNF20;CTR9
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.4277530182516937,-0.6970953742438775,0.8541666666666666,1.0,1.0,3/8,21.30%,STK11;IL12A;MME
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.39304185398561575,0.6970523675242708,0.8297872340425532,1.0,1.0,2/16,5.96%,NTF3;NRP1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.35269206711352535,-0.696288329097738,0.8867924528301887,1.0,1.0,5/20,26.84%,ZNF76;NAB2;BRF2;MTOR;AR
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.29500157184625125,-0.6960845276562644,0.9423076923076923,1.0,1.0,19/106,16.28%,RPS27L;LDB1;UPF3B;PPP1R3E;RBM3;UPF3A;SLC6A9;CIRBP;BCAR3;NIBAN1;AZU1;METTL3;STN1;EREG;EIF6;NPM2;NAT10;RPL5;KDR
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4294875786485997,0.6960395144113397,0.8571428571428571,1.0,1.0,4/9,28.49%,SLC30A10;FYN;ABCD2;ABCB7
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.4024587898688299,0.6957067852854435,0.7857142857142857,1.0,1.0,5/12,26.92%,H6PD;RPE;PGD;PGM2;RPEL1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.4043338953132284,0.6956885238236,0.8823529411764706,1.0,1.0,2/11,10.16%,NEDD4;PTPN14
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.30237326847720253,0.6954950726415083,0.9565217391304348,1.0,1.0,11/86,10.88%,FGFR2;PBX1;CAPN13;TOX3;PDZRN3;LGR5;LRRN1;AHCYL2;COBL;FREM1;ASXL3
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3246369251455655,0.6954858291488347,0.9423076923076923,1.0,1.0,2/29,4.70%,CCNH;CAVIN1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.42221347704138046,0.6953395589706208,0.8695652173913043,1.0,1.0,4/9,11.59%,ARG1;DDAH1;SLC39A8;DDAH2
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.3874093512170213,0.6951068216461422,0.94,1.0,1.0,2/13,10.88%,SLC30A10;ASXL3
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.41752985172775287,-0.6950813776231352,0.6896551724137931,1.0,1.0,1/5,10.53%,DRD3
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3293287001342051,-0.6949898284136324,0.8837209302325582,1.0,1.0,14/54,29.59%,CHTF18;DSCC1;WRAP53;NVL;CCT2;GREM1;HSP90AB1;CCT6A;RFC2;FBXO4;HSP90AA1;CCT8;DKC1;FGFR4
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.44412522664900056,0.6944943851112733,0.819672131147541,1.0,1.0,1/5,15.26%,OGT
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),0.4438819254595212,0.694302832244052,0.8571428571428571,1.0,1.0,2/5,19.82%,BAD;BMF
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.42181426421271967,-0.6940298043693741,0.8793103448275862,1.0,1.0,1/8,7.86%,KCNE3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.3624248714529107,0.6938027195347967,0.8085106382978723,1.0,1.0,7/21,17.81%,NLGN1;FOXO6;PPFIA2;MEF2C;LLPH;TANC2;CPEB3
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.44459707198080567,0.6936990607624068,0.9122807017543859,1.0,1.0,3/7,21.81%,CDH13;VEGFA;F3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.3508635934657369,0.6935202544176228,0.8490566037735849,1.0,1.0,5/22,15.91%,COL22A1;PDE4D;PDE2A;MARVELD2;ICAM1
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.45413783604613234,0.6934058411374808,0.8301886792452831,1.0,1.0,1/5,3.80%,HPD
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.410654327610994,-0.6933909631502915,0.8604651162790697,1.0,1.0,2/13,7.98%,ENTPD2;ITPA
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.42378698675386256,0.6933681487470117,0.8695652173913043,1.0,1.0,4/11,22.49%,PRKD1;ZBTB7B;VEGFA;NIPBL
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3297097706928728,0.6930573123412973,0.9387755102040817,1.0,1.0,4/29,16.69%,TFEB;MYO7A;CLVS1;CLN3
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.435119544317867,0.6929870093868838,0.8913043478260869,1.0,1.0,2/5,21.53%,MYORG;PHIP
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.40541871514979166,0.6929711254077741,0.8727272727272727,1.0,1.0,3/9,15.04%,ENPP1;MITF;MEF2C
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.3962048923553634,-0.6926909758333751,0.8958333333333334,1.0,1.0,1/12,1.72%,SLC25A10
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.39344607343718535,0.6925120382577102,0.84,1.0,1.0,4/12,24.68%,IKBIP;LIG4;NIPBL;MSH2
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.4094408084656061,-0.6923933128763596,0.875,1.0,1.0,1/9,2.62%,SERPINE1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3672675647644371,0.6922232152625919,0.8461538461538461,1.0,1.0,2/16,12.88%,NUS1;ALG13
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.4532139250754965,0.6921661280172986,0.8431372549019608,1.0,1.0,1/6,8.91%,CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.4319515257133442,-0.6918693514975864,0.8444444444444444,1.0,1.0,1/7,2.46%,CRH
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.39428711177370424,0.6918669862634775,0.86,1.0,1.0,1/15,1.42%,KCNE4
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.27417967026813694,0.6915538880516712,1.0,1.0,1.0,20/134,15.46%,ALDH1A1;CEL;HMGCS1;ADIPOR2;OSTC;CIDEA;ODC1;PTPRG;ACSL4;UGDH;PRDX6;XIST;FASN;ACADVL;IDH1;GPD2;ALDH3A2;METAP1;BCKDHB;CPT2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.42481377176695756,-0.6913387855541585,0.82,1.0,1.0,2/10,16.35%,CYP1B1;GSKIP
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.43622977617651126,-0.6912910214016984,0.8222222222222222,1.0,1.0,2/5,26.03%,FLOT1;PTPN22
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.34291538319474013,-0.6911715088658171,0.8627450980392157,1.0,1.0,3/35,4.98%,ADIRF;RAD51AP1;GADD45A
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.44768902427134016,-0.6910117942051974,0.85,1.0,1.0,1/5,18.26%,SEC16A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.2864838530247622,-0.6907766109087506,1.0,1.0,1.0,26/125,20.02%,CLU;INCENP;CD4;ADRA2A;DAXX;ACE;PAK6;CALM1;LRP8;STK11;TOM1L1;PTPRC;AZU1;CENPE;TTBK1;AGAP2;EREG;EFNA1;CALM3;SRC;SYAP1;XRCC6;CIB1;NAB2;SLC11A1;TPX2
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.44965100649435763,0.6905209437459706,0.8771929824561403,1.0,1.0,1/5,2.71%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.44965100649435763,0.6905209437459706,0.8771929824561403,1.0,1.0,1/5,2.71%,PPARG
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4065782930010613,-0.6903454634373833,0.9591836734693877,1.0,1.0,1/12,2.04%,NOG
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.41607567659117056,-0.6897953915902014,0.9130434782608695,1.0,1.0,1/7,3.89%,CD74
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.4594370546241176,-0.6895675745406993,0.8222222222222222,1.0,1.0,1/6,6.04%,XRCC1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.38819955411681006,0.6894347957804752,0.8297872340425532,1.0,1.0,3/12,16.30%,TGFBR1;MDK;SALL1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.38410575482364495,0.6893337009793605,0.8979591836734694,1.0,1.0,3/12,10.18%,MAGI2;PPP1R15B;PDGFRB
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.4160823494535659,0.6887898559149164,0.8695652173913043,1.0,1.0,3/9,12.28%,UNC5C;NRP1;CTNNB1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.44164627646176957,-0.6884835501659096,0.8913043478260869,1.0,1.0,1/6,13.84%,CNNM4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.4026678588111437,0.688417414631266,0.8653846153846154,1.0,1.0,5/15,11.44%,SPHK1;ACER1;GLA;ASAH2;SMPDL3A
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.34485293794369964,-0.6883958356974561,0.8461538461538461,1.0,1.0,4/20,16.57%,AURKA;NAT10;XRCC3;CHMP2A
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.37251187024320914,0.6882828828784316,0.86,1.0,1.0,2/16,12.45%,LDLR;LCAT
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.4594960351594133,0.6881957679720803,0.8235294117647058,1.0,1.0,2/5,23.02%,MAP2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.25710459029104993,-0.6881928351396365,1.0,1.0,1.0,19/261,10.95%,SFRP1;TYMS;AURKA;NCL;RBM4;NUDT12;ILF3;SPI1;MYADM;AEBP2;FOXP1;NUDT16;PARP14;DDRGK1;ZNF540;NOS2;BTN2A2;PINK1;PATL2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.38169687062216395,-0.68799329058381,0.8372093023255814,1.0,1.0,3/19,11.32%,PRKCH;FOXP1;PTPRC
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.3508838326703239,-0.6879786564715886,0.8703703703703703,1.0,1.0,3/23,10.53%,SYT6;FGF20;DRD3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.41591454229804636,0.6879617161182936,0.8727272727272727,1.0,1.0,3/10,11.78%,HDAC2;EDN1;TMEFF2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.31895156163999544,0.6873361097344652,0.94,1.0,1.0,12/71,14.55%,CALCR;RXFP2;SYK;CYSLTR2;GPR176;FSHR;SCTR;PRKACB;YES1;CD247;NPSR1;CREB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.37309959794940456,0.6871717540804232,0.8333333333333334,1.0,1.0,1/18,1.42%,KCNE4
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.39792578427849035,0.6870030350704991,0.86,1.0,1.0,3/13,33.27%,HNRNPD;TNKS;NEK7
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.4431340565236105,-0.6867406005780297,0.8363636363636363,1.0,1.0,2/5,22.12%,WRAP73;HAP1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.3714855680239571,0.6864251090033631,0.8297872340425532,1.0,1.0,3/30,3.50%,ATP6V0A4;ATP6V0D2;REP15
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.37315199270392485,0.6863970842500694,0.8409090909090909,1.0,1.0,3/20,8.75%,PPP1R8;STYXL1;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.3406278976361635,-0.6862974845560587,0.875,1.0,1.0,10/22,29.27%,IFIT1;PHPT1;HDAC6;CAMK2A;ATP5IF1;NOSIP;OXA1L;PARP9;MT3;NOS1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.2873233666160903,0.6862438168709234,0.9807692307692307,1.0,1.0,13/110,11.98%,NEDD4;LRP1B;SYK;ACKR3;ITGAM;STAB1;SNCA;LDLR;COLEC11;ARHGAP27;TMEM108;DLL1;DNAJC6
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.300394758692736,0.6861812391452828,0.9761904761904762,1.0,1.0,13/51,15.72%,CDH8;SMAD7;CDH18;CDH20;CDH10;CDH2;PRKCA;CDH6;CLDN12;CTNNB1;GJC1;CTNND2;PARD6B
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.32905505796469575,-0.6860924484821468,0.94,1.0,1.0,6/41,11.89%,CD4;ADRA2A;PACSIN3;CRACR2A;PLPP4;CAMK2G
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.31638113858216055,-0.6860177855640796,0.8823529411764706,1.0,1.0,8/45,17.71%,HPS4;ARIH2;NMT1;PINK1;TOMM7;YWHAB;VPS11;FZD5
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.2855412943935637,0.6859378787333246,1.0,1.0,1.0,23/180,15.82%,CD151;PPARG;ADIPOR2;CAVIN1;PPP1R15B;ELOVL6;CAT;CIDEA;LPL;DHRS7B;C3;DNAJC15;LIFR;LPCAT3;PIM3;QDPR;SORBS1;GBE1;IDH1;GPD2;CPT2;FAH;RAB34
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.33407869984398814,-0.6857206912988099,0.8545454545454545,1.0,1.0,3/28,10.53%,SYT6;FGF20;DRD3
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.3828902555963677,0.6857054187861168,0.8695652173913043,1.0,1.0,3/12,13.05%,CLSPN;SETMAR;STK33
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.38855689847646896,0.6856936734035604,0.8723404255319149,1.0,1.0,1/12,1.42%,KCNE4
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.40042642380990046,-0.6853692371841509,0.9111111111111111,1.0,1.0,1/8,4.49%,PIK3IP1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.4559863808745295,-0.6851887692168371,0.851063829787234,1.0,1.0,2/5,27.46%,TRPV4;SLC12A5
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.3142655429789568,-0.6849154921964133,0.9230769230769231,1.0,1.0,7/46,17.31%,GADD45A;TRIAP1;PRPF19;CHEK1;HUS1;FBXO6;USP10
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.43922410269842116,0.6847299544719905,0.8235294117647058,1.0,1.0,1/5,6.27%,FSHR
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.440807051924694,-0.6845565638337215,0.8913043478260869,1.0,1.0,1/6,14.43%,APOA1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.3664840490970317,0.6844943156484854,0.8888888888888888,1.0,1.0,9/34,18.82%,FAS;PDE2A;MAP3K1;TMEM150C;SLC9A1;MAPK8;CRADD;CASP2;BAD
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.28768299216864784,-0.6844033298425841,0.9821428571428571,1.0,1.0,12/82,16.19%,STX16;DCTN1;YKT6;CLTCL1;VPS52;BAIAP3;MAGEL2;VPS53;SNX6;PREPL;BET1L;RBSN
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.4131051798091501,-0.6842251414242697,0.8333333333333334,1.0,1.0,2/8,24.73%,SNAPC5;SNAPC4
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.3703497638288658,0.6839226727112826,0.8888888888888888,1.0,1.0,3/24,11.66%,P3H2;PPIL6;CWC27
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.36301276153785966,0.6834973352516831,0.84,1.0,1.0,4/11,27.26%,HIF1A;SPAST;TRAK2;SYBU
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.29635000592118743,-0.6827439115280278,1.0,1.0,1.0,8/103,8.60%,ETV5;TXNRD2;STX4;TPM1;PRDX1;FANCC;RBM11;ATF4
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.46037764350191657,0.6826321633112553,0.7777777777777778,1.0,1.0,3/6,12.37%,NLGN1;RORA;BTRC
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3671719147596428,0.6825469090853028,0.8292682926829268,1.0,1.0,3/15,12.69%,ERBB4;CCL5;CRLF2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.3442069364585759,0.6819546086238089,0.8490566037735849,1.0,1.0,5/19,20.37%,TRIM8;MID2;TRIM5;VPS37B;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.31215105777642027,-0.6819128385396246,0.9122807017543859,1.0,1.0,8/64,9.10%,STX1B;STX4;CACNG5;SHANK3;NMU;CRHR2;DRD1;PLK2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.4531926170595818,-0.6818661424328099,0.8653846153846154,1.0,1.0,3/7,22.53%,NVL;NMD3;POLR1A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.35056653405982874,-0.6818384190543294,0.9,1.0,1.0,10/22,32.72%,SUPT5H;SUPT16H;CCNT1;SUPT6H;ALYREF;THOC1;KAT7;LEO1;TCERG1;EAPP
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.43613103585163704,0.6817139714579846,0.78,1.0,1.0,1/5,15.82%,RAB34
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.4358151476251604,0.6814095173727353,0.8653846153846154,1.0,1.0,6/6,56.43%,TACC3;ANAPC1;CDC23;CDC27;ANAPC7;CDC16
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.4358151476251604,0.6814095173727353,0.8653846153846154,1.0,1.0,6/6,56.43%,TACC3;ANAPC1;CDC23;CDC27;ANAPC7;CDC16
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.3990229980429466,0.6813725717555411,0.8113207547169812,1.0,1.0,2/13,8.05%,PUS10;PUS7L
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.39647751356076144,0.681320844952449,0.82,1.0,1.0,2/12,10.62%,SLC22A2;SLC29A2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.37163661081598753,0.6812068848833817,0.8085106382978723,1.0,1.0,6/10,38.10%,SESN1;RRAGD;KLHL22;SESN2;UBR2;SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.37163661081598753,0.6812068848833817,0.8085106382978723,1.0,1.0,6/10,38.10%,SESN1;RRAGD;KLHL22;SESN2;UBR2;SESN3
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.4461254606421032,-0.6810408381632543,0.8461538461538461,1.0,1.0,4/5,41.18%,ATCAY;BNIP2;BNIPL;PRUNE2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.2603183692209272,-0.6808983976415708,1.0,1.0,1.0,23/191,13.75%,SPA17;CASP6;PDE4A;KLHDC9;SEZ6L2;WDR54;GPC1;ACBD7;EBF3;PCOLCE2;RAB3B;CFAP52;KCNC4;SCN4B;KIFBP;TMEM9;NDRG4;TRAF3IP1;B9D1;NRSN2;IFT22;SMIM10L2B;CNPPD1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.42017411595980303,-0.68088723882298,0.8571428571428571,1.0,1.0,3/7,31.88%,RPUSD2;DKC1;PUS1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.3162000776623038,0.6806249548433356,0.9565217391304348,1.0,1.0,3/28,13.05%,CLSPN;HINFP;STK33
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.427192665608381,-0.6805979558902087,0.8163265306122449,1.0,1.0,2/7,21.94%,PPT1;AXL
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.2722746441103554,0.6801708876628193,1.0,1.0,1.0,31/123,20.98%,RAB29;TNIK;KCNIP4;CACNB2;RAB3C;TSPAN15;ZDHHC2;TSPAN17;KCNB2;DPP10;RAP2A;PACS1;ANK2;FGF13;ANK3;P2RY1;SMURF1;LIN7A;RAB34;MAP7;SLMAP;RAPGEF6;PIGW;TMED2;RAP1A;ROCK2;SPTBN1;BSG;CAV3;TESC;RAB10
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.4021677613262862,-0.6801628697293078,0.8113207547169812,1.0,1.0,1/6,6.63%,RYR1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.28316430192288783,0.6801242568499942,1.0,1.0,1.0,13/96,13.78%,SPHK1;DCUN1D1;SMAD7;BAG2;TGFBR1;MINAR1;HDAC3;DNAJB2;PRICKLE1;NDFIP2;GNL3L;SASH1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.3646898754782886,0.6797814323113708,0.9038461538461539,1.0,1.0,3/23,5.98%,NDNF;SEMA5A;PKHD1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.30547061359907013,-0.6797797551736242,0.9607843137254902,1.0,1.0,10/61,17.64%,ADAMTS12;UBC;PRPF19;CTSO;DDB1;ISG15;HM13;HDAC6;CTSH;CTSL
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.3798381363130019,-0.6796959261095739,0.9056603773584906,1.0,1.0,3/12,22.26%,PROC;TNFRSF1A;S1PR3
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.3974340462537139,0.6795249443022765,0.9148936170212766,1.0,1.0,6/11,35.14%,YWHAZ;ARHGAP21;HOOK3;RIPOR1;UVRAG;PDCD10
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3065204310831349,-0.6793803445347101,0.9649122807017544,1.0,1.0,7/50,13.30%,RPS27L;ABRAXAS1;MDC1;CCND1;CHEK1;TICRR;HUS1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.32902179958274047,-0.6791554602013418,0.9285714285714286,1.0,1.0,1/25,5.93%,UBC
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.32902179958274047,-0.6791554602013418,0.9285714285714286,1.0,1.0,1/25,5.93%,UBC
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.31245647824759043,-0.6790919143123317,0.9272727272727272,1.0,1.0,10/50,17.93%,CELA2A;PRPF19;PPT1;DDB1;CEACAM1;TPP1;FBXO6;RAB12;LRSAM1;FBXO2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.3105170986548795,-0.6790400950720232,0.9807692307692307,1.0,1.0,9/37,19.73%,RAC1;DCTN1;STMN1;MET;ANKRD53;DRG1;STMN2;EML2;RPS3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.31342458709372095,0.6789216513834495,0.926829268292683,1.0,1.0,6/56,10.99%,HSPB1;IRS2;PPM1E;SNCA;CEP85;GNAQ
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3625174354304545,-0.6788843140241128,0.9166666666666666,1.0,1.0,2/22,4.50%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.3747268705476719,-0.6788690092024512,0.8333333333333334,1.0,1.0,2/10,4.95%,IL31RA;CD4
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.3922199410032905,0.6786098511123488,0.7962962962962963,1.0,1.0,5/14,19.06%,ARID1A;SMARCD3;ARID2;SMARCD2;SMARCE1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.3519239062690203,0.6781518751509885,0.9230769230769231,1.0,1.0,4/16,11.70%,MEIS1;ZFP36;CDK6;MEIS2
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.31206923070843295,0.6777309525305122,0.9215686274509803,1.0,1.0,5/31,12.80%,LOXL2;NRP1;PRSS3;CDH13;PIK3CA
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.375311392673759,-0.6777132512903561,0.9122807017543859,1.0,1.0,1/10,4.21%,SPG7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.42063260718327183,0.6774495055738001,0.9259259259259259,1.0,1.0,3/7,17.74%,AGER;DLL1;CD274
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.333928488682565,0.6772958646722288,0.9193548387096774,1.0,1.0,3/25,11.81%,CIDEA;PTPN6;NLRC3
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.3463899397035088,0.6772351460498518,0.8269230769230769,1.0,1.0,6/26,16.41%,KANK1;SLIT2;SNCA;DYRK1A;MAP2;SSH2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.3671622459324215,-0.6771502215452312,0.875,1.0,1.0,4/17,11.98%,ADAM12;ADAMTS15;ERVW-1;ADAMTS5
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.38860036792779207,-0.6768600295875028,0.8867924528301887,1.0,1.0,2/13,11.82%,DCTN1;TMEM201
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.407278115537435,0.6767466753381493,0.8541666666666666,1.0,1.0,1/7,10.73%,DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3789138855612988,0.6767347045307265,0.8214285714285714,1.0,1.0,4/13,21.23%,HDAC9;PTGS2;VEGFA;AKT3
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.27952043094260376,0.6766627007348726,0.9777777777777777,1.0,1.0,13/77,16.55%,RCVRN;GABRG3;HCN1;MGAT4C;GRM6;CHRNB4;KCNJ6;PDE6A;SLC24A2;SLC2A11;CNGB1;UNC13C;CREM
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3584060289700666,-0.6764235345067899,0.8958333333333334,1.0,1.0,8/16,24.39%,TSPAN12;CD63;PIK3CB;SPRY2;IL12A;ADAMTS3;CCBE1;DAB2IP
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.4444720680380926,0.6764232643586682,0.92,1.0,1.0,1/6,13.49%,LIG4
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.38896015728446104,-0.6762164169401937,0.9347826086956522,1.0,1.0,5/17,19.66%,NFE2L1;UROS;ATP5IF1;TSPO;PGRMC1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.28382064069701674,0.676163640652214,1.0,1.0,1.0,15/55,22.06%,HSPB1;ACKR3;SIRT1;CXCL12;HSPA1A;BCL2;SYVN1;URI1;BCL2L1;MDM2;ARMC10;TRIM32;TMEM161A;NFE2L2;CREB3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.40918142388365775,0.6761175715471547,0.86,1.0,1.0,3/9,11.85%,PDE4D;PDE2A;PDE3A
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.334621401244384,0.675876887251399,0.953125,1.0,1.0,4/25,13.37%,WNT5A;CCL5;ADAM8;IFI35
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.3966102270737967,-0.6757926060497548,0.875,1.0,1.0,4/14,16.09%,WNT7B;PAX8;BMP7;CTSH
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.31794231183293215,0.6755561637094032,0.9555555555555556,1.0,1.0,5/33,13.64%,NEDD4;RAB29;PCM1;TENM1;STX18
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.2827773710322165,0.6755095744800679,1.0,1.0,1.0,21/84,24.32%,UBE2J1;TMEM67;DNAJB2;RNF139;YOD1;UGGT1;SYVN1;FAM8A1;DERL1;SEL1L;USP13;RNF185;UBE4A;RNF103-CHMP3;RHBDD2;JKAMP;RHBDD1;ERLIN1;EDEM1;UBE2J2;DERL3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.30492228050691245,-0.6754298698940093,0.9183673469387755,1.0,1.0,4/62,6.75%,SFRP1;GHR;PAX8;ADRA2A
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.4155536345355277,0.6752774134218503,0.8333333333333334,1.0,1.0,2/7,17.26%,EP300;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.33303549540805794,0.6750916330694313,0.8333333333333334,1.0,1.0,6/37,15.38%,KCNJ3;KCNJ6;ANK2;AKAP6;KCNN1;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3125842964281839,-0.6750400703688575,1.0,1.0,1.0,3/39,7.78%,CLU;RILP;CRYAB
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.39681870400280916,0.6749834302418648,0.8461538461538461,1.0,1.0,3/9,33.45%,CLP1;AGO3;DICER1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.42160657953455677,-0.6747388739298165,0.7719298245614035,1.0,1.0,2/5,23.19%,RAB3A;RAB11B
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.3133163563351081,0.6745628770772572,0.9285714285714286,1.0,1.0,4/40,8.75%,IFI16;RUNX1;DYRK3;MFHAS1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.3218594828791147,0.6743615659108134,0.8913043478260869,1.0,1.0,3/19,11.29%,MICU1;MCU;MAIP1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.28713385120432966,-0.6742379742013285,1.0,1.0,1.0,8/65,18.06%,NUPR1;NUP133;NUP43;EIF6;NUP155;ENTPD5;GCKR;GAPDHS
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.2696915638676903,-0.674187675484745,1.0,1.0,1.0,15/140,13.51%,TXK;ATRAID;ASCL1;STX1B;RNF39;GNB3;FOXP1;ARF1;ATP1B1;PTPRC;TRIM58;HNRNPDL;YBX3;KDM6B;PIN1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3031322253341128,-0.6735082469212746,0.9375,1.0,1.0,8/63,9.05%,RNASE1;REXO4;DNASE1L1;ERCC1;UBC;RBX1;GTF2H2;IHO1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.43403797980484626,-0.6734805793725654,0.9038461538461539,1.0,1.0,1/6,7.84%,FOXP1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.39975778297001396,0.6732225929413174,0.8269230769230769,1.0,1.0,1/7,16.49%,IPPK
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.39985903672413925,-0.6731057298916051,0.8936170212765957,1.0,1.0,3/10,23.90%,PACSIN3;EHD2;WHAMM
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.4158963831097342,-0.6729993604799985,0.8679245283018868,1.0,1.0,3/9,15.77%,CHAC1;GSS;CNDP2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.31675373562772835,-0.6727706267969784,0.9166666666666666,1.0,1.0,5/37,13.30%,ABRAXAS1;CHEK1;ORC1;TICRR;HUS1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.3914518884603264,0.672678940031829,0.8260869565217391,1.0,1.0,2/9,15.24%,GALK2;GALT
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.42668562788912995,-0.67265846429802,0.9056603773584906,1.0,1.0,4/6,39.88%,RAB11B;RAB11FIP5;PTPRN2;PTPRN
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.32299041165426773,-0.6725930905819187,0.9491525423728814,1.0,1.0,8/39,18.15%,ADRA2A;RAB3B;DRD1;CRACR2A;SCN4B;DRD4;CAMK2A;PKP2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.4346931504131345,-0.6721483803034902,0.7959183673469388,1.0,1.0,2/7,16.08%,CERS2;RTN4R
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.33835158889220085,0.6721033776005347,0.8529411764705882,1.0,1.0,5/24,17.04%,NEDD4;ANK2;NETO1;KCNG1;NEDD4L
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.3702732568123678,-0.6720348973011746,0.92,1.0,1.0,3/28,4.58%,NTRK1;CACNB1;CDK5
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.3613669263953394,0.6720152232042046,0.9,1.0,1.0,5/25,16.69%,AKR1C1;CYP39A1;OSBPL6;CYP7B1;OSBPL3
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.3762845177241533,-0.671991325766863,0.8275862068965517,1.0,1.0,4/18,13.39%,STX4;CRHR2;PLK2;PRKCZ
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.350453154858817,0.6719786169381123,0.9166666666666666,1.0,1.0,3/33,6.00%,CASS4;CSF1R;GRM5
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.2714909118971071,-0.6716851074554633,1.0,1.0,1.0,18/135,15.34%,DUSP4;PPP2R3B;TPTE2;PGP;DUSP6;FAM220A;THNSL2;PPM1M;STK11;PLPP4;PPM1G;PTPRC;PTPN9;DUSP5;PHPT1;PTPRB;PLPPR3;UBLCP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.34846447731805885,-0.671671712370094,0.9322033898305084,1.0,1.0,1/21,1.69%,FXYD7
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.2846877289996555,-0.6715264599475393,0.96,1.0,1.0,2/70,1.67%,AHNAK2;AKAP17A
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.2948295435898794,-0.671525020035714,1.0,1.0,1.0,15/51,29.88%,HENMT1;AARS2;METTL3;NAT10;DTWD2;FTSJ3;URM1;QTRT1;THG1L;RBM15B;TSR3;LCMT2;QTRT2;TRMT6;NOP10
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.3504047831085332,-0.671462287554998,0.9230769230769231,1.0,1.0,2/23,4.01%,AOAH;ENPP2
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.41140641272228495,0.6711638623463327,0.8653846153846154,1.0,1.0,3/10,19.66%,FOXO3;TFB2M;MTERF1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.32910185220762334,0.6710378806181942,0.9016393442622951,1.0,1.0,8/25,22.47%,NAV3;FGF13;HDGFL3;CLASP1;TRIM54;CLASP2;ATXN7;APC2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.2808630583128328,-0.6710364585741762,0.9782608695652174,1.0,1.0,24/112,24.49%,NUPR1;MBTPS2;RSL1D1;CRYAB;ATF4;PINK1;NUP133;NUP43;CAMK2G;CHCHD2;USP51;BAG4;NUP155;CAMK2A;VASH1;EIF4G1;NUP85;ABCD1;RPA3;HSP90AB1;MTOR;NUP214;USP19;NPM1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.3892162903863017,0.6710202912470733,0.926829268292683,1.0,1.0,1/11,1.26%,APOLD1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.38671524746867286,-0.6710035199543947,0.8846153846153846,1.0,1.0,3/12,21.70%,EPHB6;SZT2;PAFAH1B1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.4229922181935525,-0.6709921177544197,0.803921568627451,1.0,1.0,1/8,4.62%,AGRN
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.4318405310620571,0.6709458555310516,0.8260869565217391,1.0,1.0,1/6,6.29%,DGAT2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.35759146655117224,-0.6706604676735793,0.9803921568627451,1.0,1.0,3/16,13.59%,MORF4L1;MEAF6;BRD8
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.4321351484254031,-0.6705325345269819,0.8301886792452831,1.0,1.0,1/5,8.64%,CRACR2A
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.4044662978130848,0.6705001140266023,0.8181818181818182,1.0,1.0,2/11,14.20%,ARID1A;PLPP1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.3717075041216813,-0.6704118540195318,0.9433962264150944,1.0,1.0,3/15,12.91%,NODAL;WEE2;ZP3
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.2833867315987959,-0.6703735972390379,1.0,1.0,1.0,5/78,7.78%,CCN3;CLU;CIDEB;PRR7;CRYAB
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.3160175944945478,-0.6703569408298155,0.96,1.0,1.0,6/61,9.83%,SH3RF2;DTX3L;RNF8;UBE3A;RNF213;NFX1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3037368248283403,0.6702280639035202,0.9523809523809523,1.0,1.0,8/61,14.19%,NLRP2B;PKHD1;ZNF675;NLRC3;SIRT1;ERBIN;AIM2;SETD6
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.4360375956178874,0.669968006153493,0.8444444444444444,1.0,1.0,1/5,21.31%,TRIP11
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),-0.40470951033192276,-0.6699212857889809,0.85,1.0,1.0,2/6,20.48%,STAT1;SHH
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.4166537453131702,-0.6693568930448714,0.8461538461538461,1.0,1.0,2/8,23.02%,PRKCZ;IL18
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.3238945468819905,0.6693302162108722,0.94,1.0,1.0,3/29,8.12%,NTF3;MAGI2;ANKRD13D
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.3557266741237026,0.6691293814735463,0.8936170212765957,1.0,1.0,5/20,15.99%,GDAP1;PEX2;PEX13;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3820039230160698,-0.669087062359541,0.9130434782608695,1.0,1.0,1/13,2.15%,NTRK1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.3133597399703669,0.6690315066138436,0.9473684210526315,1.0,1.0,11/51,16.69%,CYP39A1;ACSM1;SDS;LPL;LIPH;ACACA;SRR;OSBPL6;ABCD3;CYP7B1;OSBPL3
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.3374879037465847,0.668928315516882,0.8666666666666667,1.0,1.0,5/22,17.47%,HS3ST5;TRIM22;TRIML2;MID2;TRIM5
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.39826752450925773,0.6689016494333737,0.9019607843137255,1.0,1.0,2/12,8.00%,AFF2;DYRK3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.25094179070610273,-0.6688074291708619,1.0,1.0,1.0,28/347,11.90%,CBLC;RTF1;TRIM55;ASB9;UVSSA;EPAS1;DTX3L;RNF39;RNF113A;SKP1;UBC;RNF8;ARIH2;RBX1;TRAF7;DDRGK1;RNF213;DCAF15;UBE2M;ABCB11;NFX1;PIAS3;ELOB;PINK1;NUP133;TRIM58;NUP43;RACK1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.32156001359703323,0.6685726140477048,0.9130434782608695,1.0,1.0,1/30,1.16%,IFI16
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3651158147837268,0.6685483869325278,0.94,1.0,1.0,2/19,5.35%,ARHGAP25;SLIT2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.35616051147184313,0.6683845628826447,0.8541666666666666,1.0,1.0,3/21,12.15%,TAB3;TAB2;MAP2K6
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.3799865270667174,-0.6683373364069897,0.9285714285714286,1.0,1.0,1/12,3.89%,CD74
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.3982723888757053,-0.668303386839389,0.8863636363636364,1.0,1.0,3/7,17.60%,KDM6B;KDR;EDF1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.38985829826926466,0.6680434988940541,0.9347826086956522,1.0,1.0,2/9,8.09%,STEAP4;SLC1A2
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.38985829826926466,0.6680434988940541,0.9347826086956522,1.0,1.0,2/9,8.09%,STEAP4;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.3080824643220073,0.6677621877302468,0.9375,1.0,1.0,4/44,8.30%,FAS;WWOX;TGFBR1;STYXL1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.3612183767337714,-0.6677251349125062,0.8541666666666666,1.0,1.0,5/14,20.96%,NOS2;CYP1B1;GCHFR;NOS3;CYB5R3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.294825579584633,0.6673885829305466,1.0,1.0,1.0,9/75,11.50%,CCNH;CCNA2;CCNB3;EGFR;LATS1;PSRC1;CCNP;CCNE2;PLK1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.3969249772844181,0.6673176468976635,0.9333333333333333,1.0,1.0,4/10,15.95%,DUSP9;LATS1;WWC1;SLC6A4
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.2764162299117583,-0.6672347393688037,1.0,1.0,1.0,18/115,18.39%,B3GALT4;ST6GALNAC2;GOLGA2;B3GNT9;B3GALT5;ST8SIA2;ALG1L2;GALNT6;MPI;ALG8;EOGT;FUT2;RPN1;GALNT2;TMEM258;ENTPD5;ST3GAL1;ALG9
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.3957531897329249,-0.6671316064698629,0.8541666666666666,1.0,1.0,2/9,16.33%,IFIT1;CHTOP
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.36605547743234745,-0.6667661557751876,0.8367346938775511,1.0,1.0,1/15,2.48%,APOD
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.379131284640045,0.666466893739629,0.9333333333333333,1.0,1.0,4/14,15.04%,MAGI2;PPP1R15B;PDGFRB;MEF2C
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.4050176765448695,0.6664117734818165,0.9111111111111111,1.0,1.0,3/13,19.66%,FOXO3;TFB2M;MTERF1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.37805314718961947,-0.6660866104571401,0.9,1.0,1.0,2/16,4.38%,ASCL1;B2M
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.46941438518127476,0.6660481477013892,0.9622641509433962,1.0,1.0,1/5,13.89%,SMAD3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.2812621077663987,0.6660347480354816,0.9777777777777777,1.0,1.0,17/133,10.21%,GPC5;SEMA5A;KANK1;FGFR2;EGFR;SULF1;ZEB2;LGR5;RNF220;PSMD13;TMEM198;TBL1XR1;SPIN1;SCEL;UBR5;RSPO2;FGF10
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.3806291068176185,-0.66599582425585,0.9333333333333333,1.0,1.0,2/12,14.14%,ADAM19;APH1B
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.2956604140631227,0.6656300247657957,1.0,1.0,1.0,19/92,15.08%,PMP2;SLC39A12;NRXN1;GFAP;SLC8A1;CDH20;PLXDC2;CSF1R;GRM5;CA10;SLC1A2;SYNPR;P2RX7;RTN1;RGS7BP;LYVE1;GRIA2;VWF;PID1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.3477654408902612,-0.665574845920758,0.9111111111111111,1.0,1.0,7/29,13.48%,SPI1;GLYR1;THAP7;HDAC5;TAF7;CHEK1;BRD7
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.31247685943718917,-0.6653441724599882,0.9777777777777777,1.0,1.0,5/47,7.73%,WNT9A;WNT9B;ASCL1;WNT7B;RBP4
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.3622873686632451,-0.665336869182923,0.94,1.0,1.0,1/18,4.44%,SLX4
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.33121034277489136,0.6653260252911688,0.9056603773584906,1.0,1.0,5/23,19.94%,TAB3;TAB2;MAP2K6;ALPK1;NOD1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.3725814947173689,-0.6652896126362414,0.8703703703703703,1.0,1.0,5/12,28.51%,LAMP3;AXL;EIF2AK2;IFNAR1;TPR
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.3897538704725134,0.6649609776314629,0.8461538461538461,1.0,1.0,1/6,21.77%,VSTM5
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.2907852142340613,0.6649271665736036,1.0,1.0,1.0,7/91,11.04%,U2AF1;SF3B1;PPARGC1A;SYNCRIP;MBNL1;NOVA1;CDK12
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.4289406991627216,-0.664909409566076,0.8085106382978723,1.0,1.0,1/6,8.86%,CALM1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.33435306122124275,-0.6647155592160725,1.0,1.0,1.0,6/26,18.14%,GNB3;BCKDK;ABCB11;NR1H4;MLYCD;EPHX2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.24707781552828434,-0.664548882924883,1.0,1.0,1.0,62/454,17.15%,CBLC;RTF1;TRIM55;SH3RF2;ASB9;UVSSA;EPAS1;PSMA7;DTX3L;UBE2L6;RNF39;RNF113A;PSMD7;SKP1;UBC;RNF8;ARIH2;DDA1;PSMB4;FBXO40;RBX1;UNKL;UBE3A;PSMC3;TRAF7;RNF213;PRPF19;RBCK1;DCAF15;ABCB11;NFX1;ELOB;RUSC1;PINK1;TRIM58;RACK1;PSMD8;PSME1;DDB1;PSMB2;ISG15;SELENOS;PSMC4;PSMB8;FBXO15;CUL9;TRIM41;PSMC1;DTX1;PSMB5;PSMD2;FBXL13;FBXW12;TAF1;PSMA1;HERC5;MARCHF2;PSMD10;FBXO6;VPS11;USP22;TRPC4AP
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.3053665194113543,-0.6645168589544838,0.9583333333333334,1.0,1.0,12/37,25.41%,MAX;SOX15;CDKN2B;CHEK1;RING1;CBX5;CDC7;RBBP8;L3MBTL2;DAB2IP;TFDP1;UXT
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.30387642996941633,0.6642561540657054,0.9814814814814815,1.0,1.0,16/68,18.93%,HJV;SLC39A12;SLC30A8;MT1M;CUL1;SLC30A10;CYBRD1;SLC39A8;SLC40A1;ABCG2;TF;COX19;SLC31A1;HMOX2;BMP6;SLC11A2
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.45654079582780177,0.6641140450596976,0.8541666666666666,1.0,1.0,1/5,8.04%,ZFP36
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.3017531817989692,0.6640315755135828,0.9433962264150944,1.0,1.0,2/33,4.70%,CCNH;CAVIN1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.4269212705457725,-0.6638954238612231,0.8615384615384616,1.0,1.0,2/6,14.43%,STARD5;APOA1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.4269212705457725,-0.6638954238612231,0.8615384615384616,1.0,1.0,2/6,14.43%,STARD5;APOA1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.36061229628934255,-0.6636577359400117,0.8666666666666667,1.0,1.0,1/11,7.62%,VDAC2
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.4141882827557667,0.6635577999003424,0.8780487804878049,1.0,1.0,2/8,12.25%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3078216644181115,0.6635120901594632,0.9433962264150944,1.0,1.0,17/52,28.31%,TAB3;ZNF675;TAB2;FAIM;NLRC3;RELA;ERC1;ROCK2;RELB;RIPK2;IRAK1BP1;TAB1;BIRC2;TANK;TRAF6;REL;BCL3
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.32402148406694375,0.663292458762165,0.88,1.0,1.0,9/39,22.24%,GLA;GLB1;SMPD4;ESYT3;HEXB;ESYT2;ST8SIA3;ST8SIA1;GALC
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.359003143838489,-0.6628939417286681,0.88,1.0,1.0,1/19,2.31%,SEPTIN5
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.31731400279797584,0.6626777451689578,0.9818181818181818,1.0,1.0,6/55,8.43%,SPHK1;PLCB1;EGFR;TGFBR1;H3-3A;CDKN2AIP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.30224013650169657,0.662313457419341,1.0,1.0,1.0,10/56,15.04%,NLGN1;SHISA9;GRIA4;DLG2;CRHBP;LRRC7;DLGAP1;GRIA2;NETO1;MEF2C
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3323831822034249,0.6621026901958385,0.8974358974358975,1.0,1.0,4/28,12.87%,SLC8A1;SOCS2;TRDN;ANK2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.345336443831026,0.6619378887121873,0.9111111111111111,1.0,1.0,5/12,22.57%,SLC8A1;PIK3CA;KCNJ2;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.35845346392386823,0.6618493863194153,0.8269230769230769,1.0,1.0,2/23,3.31%,NLGN1;SHISA9
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.33623536335473264,0.6610100694695962,0.851063829787234,1.0,1.0,1/21,1.59%,RUNX1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.361642933746544,0.6602947694948921,0.8727272727272727,1.0,1.0,5/16,26.17%,SCO2;BCS1L;COX19;TIMM21;SCO1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.32514296834003314,-0.6602298019037622,0.8846153846153846,1.0,1.0,3/36,7.43%,ATXN7L3;DTX3L;RBX1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.32657371431853127,-0.6600804175692279,0.9230769230769231,1.0,1.0,2/22,9.61%,SLC6A9;ATP1B1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.342805002440669,0.6600182260490253,0.9130434782608695,1.0,1.0,8/22,22.57%,EDN1;PRKCA;MEF2A;SLC9A1;ROCK2;CAV3;SMAD4;CAMK2D
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.26900956042610186,-0.6599414997009829,0.9787234042553191,1.0,1.0,24/154,18.30%,USP27X;CLU;CDC37;HPS4;TBL1X;CRYAB;TAF9B;ATP1B1;PINK1;CAMLG;WIZ;A1CF;PIN1;RPL23;APOA1;EFNA1;BAG4;ZSWIM7;TAF1;RPL5;SAXO1;CCT2;SEC16A;NAPG
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.4121485735603627,0.6595461077668028,0.875,1.0,1.0,4/8,21.48%,CPEB2;DPH2;CPEB3;DPH3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.35973268551054716,-0.6595115567614328,0.8775510204081632,1.0,1.0,5/18,21.78%,EXOSC10;STN1;NAT10;SRC;PIF1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.26688074535422246,-0.6590943504485794,1.0,1.0,1.0,15/109,16.19%,RILP;STX16;DCTN1;GAK;YKT6;CLTCL1;VPS52;DOP1B;BAIAP3;MAGEL2;VPS53;SNX6;PREPL;BET1L;RBSN
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.29862169984360726,-0.6588911371813064,0.96,1.0,1.0,9/59,16.47%,CYP19A1;DHRS11;PRLR;LIPC;LIPI;CYP21A2;NDUFAB1;MLYCD;ACSF3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.3577904535409717,0.6586742078007914,0.9090909090909091,1.0,1.0,1/17,6.92%,RNF128
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.3233179146527778,0.6585866309142322,0.94,1.0,1.0,13/40,19.96%,EGFR;FAM83A;GAB1;SLC30A10;PLCE1;BCAR1;PIK3CA;ERBIN;PIK3R1;BRAF;TGFA;SOS1;PTK2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.32428577297351524,-0.658556192343829,0.9791666666666666,1.0,1.0,1/31,1.74%,CLU
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.3612815632560933,-0.6584405104114789,0.84,1.0,1.0,5/13,20.96%,NOS2;CYP1B1;GCHFR;NOS3;CYB5R3
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.3341366045749903,0.6583090761971478,0.875,1.0,1.0,4/27,11.12%,FGF12;ATP2B4;KCNIP4;DPP10
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.3861701933133066,0.6582379078489523,0.8490566037735849,1.0,1.0,4/9,19.35%,ATP12A;KCNJ2;SLC12A2;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.3594272581602321,-0.6578762727207184,0.8771929824561403,1.0,1.0,3/13,11.90%,PPP1R15A;DDRGK1;RACK1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.3651375418530112,-0.6573648332061814,0.8771929824561403,1.0,1.0,3/15,11.32%,ACE;HMGB2;PTPRC
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.3828250101355345,0.6571551610168093,0.8536585365853658,1.0,1.0,3/8,23.02%,MAP2K6;CRY1;ABL1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.31310852245688936,0.6569765272824832,0.9767441860465116,1.0,1.0,3/27,8.04%,SMAD7;IRS2;ZFP36
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.3756008742946094,-0.65689407608945,0.8846153846153846,1.0,1.0,4/14,17.03%,DNPH1;ITPA;DERA;GPX1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.35403958510618116,-0.6567129544236392,0.98,1.0,1.0,5/19,18.15%,KCNE1;KCNE2;SCN4B;ATP1A1;PKP2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.31241678670609385,0.6563505092499661,0.9411764705882353,1.0,1.0,6/41,15.48%,ZBTB1;POLE2;PRIMPOL;POLD3;DTL;RFC5
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.3735831564556237,-0.6560434706197807,0.8636363636363636,1.0,1.0,1/10,7.85%,PSMC3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.37179279117244557,0.6558023444648003,0.9,1.0,1.0,4/17,20.90%,STX18;USP6NL;PDE4DIP;RAB33B
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.38938618326953106,0.6557625319023223,0.9056603773584906,1.0,1.0,3/14,15.80%,CHST6;CHST7;MGAT3
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.3759183069402593,-0.6554434980186352,0.9555555555555556,1.0,1.0,2/9,12.37%,MAL;ACTB
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.4470266423854975,0.6551661839377712,0.9019607843137255,1.0,1.0,2/5,16.07%,HEY1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.29018142831939436,0.6547089954291526,0.95,1.0,1.0,20/86,20.23%,ITGAM;EGFR;EPHA3;TP63;ATP2B4;DPP10;PPP1R13B;ANK3;BCL2;SORBS1;TP53BP2;MTCL1;MAPK8;PIK3R1;AKT2;TCAF2;YWHAZ;BAD;SPTBN1;MIEF2
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),-0.40889592896518007,-0.6546784555665012,0.8771929824561403,1.0,1.0,1/5,12.14%,XYLB
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.28373894669033656,-0.6542228833924824,0.9803921568627451,1.0,1.0,19/98,15.98%,TEC;RAC1;PSMA7;VAV3;PSMD7;SKP1;PSMB4;PSMC3;CALM1;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PIK3CB;PSMA1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.3892170310070602,-0.6541809137524126,0.9019607843137255,1.0,1.0,2/10,16.06%,ERCC1;XRCC3
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.35295770055072334,-0.6540683769268038,0.8936170212765957,1.0,1.0,4/17,18.71%,CDK5;KIF5A;RAB11A;CCDC186
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.35051133330702267,-0.6539851679735927,0.9,1.0,1.0,4/26,12.70%,BDH1;HMGCL;PPT1;HPGD
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.372345457550615,0.6538725014123669,0.8936170212765957,1.0,1.0,1/14,1.42%,KCNE4
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.3499045626890324,0.6535982876116558,0.9,1.0,1.0,4/24,10.61%,RSPH6A;DNAI4;RP1;TOGARAM1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.3450861405458687,0.6534921587920028,0.84,1.0,1.0,3/17,11.68%,PSRC1;BORA;GNAI1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.4402715573826632,0.6528996520519332,0.9038461538461539,1.0,1.0,1/5,19.03%,NAA30
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.3640363266809071,0.6527884738858712,0.9056603773584906,1.0,1.0,8/17,25.97%,SLC8A1;PDGFRB;VEGFA;ALPK2;TCAP;SORBS2;FHOD3;CXADR
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.36236084291339415,-0.6520539346768152,0.8979591836734694,1.0,1.0,3/20,10.80%,IL4I1;GLMN;BTN2A2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.38200372067066213,-0.6517001478563084,0.86,1.0,1.0,1/8,10.80%,BTN2A2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.2809661627297644,-0.651674885617245,0.9803921568627451,1.0,1.0,8/83,12.57%,TYMS;NCL;RBM4;ILF3;ZNF540;PATL2;RACK1;METTL3
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.2939673249085152,-0.6516640403891975,0.9655172413793104,1.0,1.0,6/54,12.12%,SFRP1;ATG14;WIPI1;MAP1LC3A;WIPI2;CDKN2B
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.4030773960144012,-0.6516610814281704,0.9215686274509803,1.0,1.0,3/10,15.77%,CHAC1;GSS;CNDP2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.34275559260299066,-0.6516239533165137,0.8913043478260869,1.0,1.0,6/25,12.13%,SELENOK;CHAC1;PPP1R15A;ATF4;BAK1;ATP2A3
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3698290117236977,-0.6515545261664825,0.9259259259259259,1.0,1.0,5/17,12.22%,GHR;PRLR;IL10RB;CYP1B1;OCIAD2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.34471035958705276,0.6514657154113371,0.9038461538461539,1.0,1.0,2/18,4.40%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.28148194530143156,-0.6514190308030268,1.0,1.0,1.0,16/76,18.28%,WARS1;GADD45A;TRIB2;SH3BP5;EPHA1;PTPRC;TAF7;CEACAM1;PRKRIP1;PTPRB;CAMK2N1;SPRED1;GSKIP;GSTP1;MACROH2A1;CDKN1C
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3096923409768712,0.6508799933364069,0.8979591836734694,1.0,1.0,6/42,15.48%,ZBTB1;PRIMPOL;POLD3;SIRT1;DTL;RFC5
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.3377490004926146,0.65080991991934,0.92,1.0,1.0,6/21,22.49%,TDG;DUSP9;SCX;HPSE;INSR;NIPBL
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.41650344267564465,-0.6503747507331208,0.9090909090909091,1.0,1.0,2/8,22.82%,CENPE;CENPF
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.43841049790619824,0.6503256232590636,0.8928571428571429,1.0,1.0,3/6,21.41%,FGF13;PEX13;EFHC1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.3700707393166292,-0.6503189512158815,0.8775510204081632,1.0,1.0,2/13,4.04%,STX16;GOLGA2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),-0.4150057296237183,-0.6501207025126899,0.9074074074074074,1.0,1.0,2/8,18.17%,PLXND1;PLXNA1
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),-0.38099077259371844,-0.6497725705372244,0.8793103448275862,1.0,1.0,1/6,4.90%,DLX5
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.26702333965528485,0.6497384451119654,1.0,1.0,1.0,21/152,14.41%,KCTD8;YDJC;GALNTL6;OLFM3;ADGRB3;FGF12;NXPH1;GRIP1;SLC35F1;POU6F2;CA10;SH3GL2;SYT16;PRKCA;RBFOX1;DPP10;ASIC2;NKAIN3;BTBD10;ERC2;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.3273683821597164,0.6496892925103791,0.9090909090909091,1.0,1.0,7/30,11.29%,RAB29;SNCA;SYT1;GRIK2;CDKN2AIP;EDN1;RIMS2
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.3997624502157676,0.6495267531809056,0.8727272727272727,1.0,1.0,2/8,20.37%,SORT1;SLC2A1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.3878203520387028,-0.6495179425276797,0.8913043478260869,1.0,1.0,3/6,29.88%,NHP2;DKC1;NOP10
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.36314150000114953,0.6492683278659693,0.8958333333333334,1.0,1.0,4/10,23.81%,SRR;SERINC5;PSPH;PHGDH
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.35342406476398813,-0.6490751679821448,0.8461538461538461,1.0,1.0,1/11,5.37%,TCHP
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.4000157722209776,0.6483910432615738,0.8571428571428571,1.0,1.0,1/6,7.20%,CACNB2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.33612467059259077,0.6483161810996876,0.9130434782608695,1.0,1.0,5/25,16.09%,ECT2;UBR5;HDAC3;SMAD3;PIK3R1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.30539536874806783,-0.648136508488595,0.96,1.0,1.0,10/35,21.64%,RAB3B;TANGO2;SVBP;COPG2;RAB3A;PDIA4;RAB12;CANX;SCG2;STEAP3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.40002010810695526,-0.6479930250201823,0.8490566037735849,1.0,1.0,2/7,13.97%,GPC1;UQCC2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.31796369163110016,0.6477538609180226,0.9482758620689655,1.0,1.0,5/31,13.03%,RORA;TLE1;NLRC3;SIRT1;PPM1A
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.42402032699233605,0.6475045940464339,0.875,1.0,1.0,2/5,16.11%,MTCL1;MAP2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.37006690711465273,0.6473924364027555,0.9512195121951219,1.0,1.0,1/14,8.36%,RGS14
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3650873818076144,0.6473366571946826,0.8958333333333334,1.0,1.0,3/12,11.35%,NYNRIN;ZC3H12C;RPP40
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.27823485938665715,-0.6471522917581047,0.9836065573770492,1.0,1.0,24/89,20.88%,RAD51AP1;SLX4;REC8;XRCC1;MCM5;MORF4L1;KDM4D;XRCC2;MCM2;HUS1;POLL;NUCKS1;INO80;ZSWIM7;PARP1;AP5S1;MUS81;XRCC3;RECQL;FANCM;POLQ;CDC7;RBBP8;RMI1
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.37685977025626993,-0.6464067165198106,0.8979591836734694,1.0,1.0,4/10,20.48%,WLS;FZD5;RIPPLY2;SHH
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3729838065799646,-0.6462784909953698,0.8541666666666666,1.0,1.0,1/10,3.93%,ETS1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.3351148408937136,-0.645724716600391,0.8863636363636364,1.0,1.0,1/18,3.73%,GINS3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.3574116525177743,-0.6445780156942502,0.9298245614035088,1.0,1.0,1/12,5.03%,DCTN1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.4164218899001366,0.6442947066621599,0.9347826086956522,1.0,1.0,3/7,14.45%,SNCA;ANK3;FBP1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.3458496730176748,-0.6442944636329998,0.9629629629629629,1.0,1.0,4/18,17.71%,PINK1;DNM1L;HDAC6;FZD5
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.3819871563531824,-0.6442657738267519,0.9361702127659575,1.0,1.0,2/11,9.58%,ADRA2A;ABCB11
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.4502584650788476,-0.644261136459027,0.8837209302325582,1.0,1.0,2/6,11.28%,GFUS;MPI
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3710090319884422,-0.6439705883233308,0.8888888888888888,1.0,1.0,2/9,16.42%,CALM1;CALM3
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3710090319884422,-0.6439705883233308,0.8888888888888888,1.0,1.0,2/9,16.42%,CALM1;CALM3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.27527816659195486,0.6439209076189877,1.0,1.0,1.0,19/81,16.65%,SMAD7;ZEB2;TGFBR1;CIDEA;LATS1;ADAMTSL2;NREP;IL17RD;SMAD2;SMURF2;SIRT1;WFIKKN1;PPM1A;HSPA1A;EP300;SMAD3;SMURF1;TGFBR3;SOX11
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.33175870818668374,-0.6438404722756508,0.9615384615384616,1.0,1.0,3/24,9.85%,DCTN1;SPDL1;NSFL1C
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.4027326775676097,-0.6437059886697589,0.9193548387096774,1.0,1.0,2/7,18.59%,APOA1;GPLD1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.3739434049001113,-0.6435352772526569,0.8163265306122449,1.0,1.0,4/11,17.79%,DNPH1;ITPA;GPX1;HINT1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.30787252059867637,-0.6435177620413468,0.9818181818181818,1.0,1.0,7/57,14.74%,STX4;DTX3L;DDRGK1;NECAB2;MEAK7;VPS28;RANGRF
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.2998412015668413,0.6433813026305493,0.9787234042553191,1.0,1.0,5/49,11.75%,GDAP1;IMMP2L;PAM16;FBXO7;DNAJC15
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.35688284405243587,-0.6432591886226775,0.8909090909090909,1.0,1.0,2/18,13.88%,INTS5;EXOSC4
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.35224592513749214,-0.6430584772293745,0.9464285714285714,1.0,1.0,4/16,27.25%,IHO1;SGO2;PTTG1;ZCWPW1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.3630479563231439,-0.643046505781732,0.9622641509433962,1.0,1.0,4/20,10.34%,SARS1;NODAL;ATF4;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4193487648379994,-0.6427402362511697,0.8958333333333334,1.0,1.0,1/5,29.50%,GPS2
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.4070812415365693,0.6427053634173995,0.88,1.0,1.0,2/9,12.77%,SLC2A5;SLC26A6
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.41544042308229256,0.6426572902586072,0.8913043478260869,1.0,1.0,1/5,11.55%,NPY
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3067071951911184,0.6424858261107735,0.9807692307692307,1.0,1.0,9/59,15.91%,FAS;TGFBR1;ITGAV;FAIM;HSPA1A;RELA;BCL2;ACVR1;ICAM1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.3144636935447387,0.6424840787392575,0.9375,1.0,1.0,5/27,19.83%,CHMP6;PDCD6IP;VPS37D;CHMP1A;VPS37B
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.3145897461824876,0.6423760034463124,0.9433962264150944,1.0,1.0,4/29,10.96%,AP1AR;ANKRD13D;EDN1;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.35360523841479075,-0.6419322310224848,0.8983050847457628,1.0,1.0,2/10,18.15%,SCN4B;PKP2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.36624782251078225,0.6419208095255793,0.8936170212765957,1.0,1.0,1/10,4.61%,ABHD17B
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.3315301871736699,0.6417498270448403,0.9019607843137255,1.0,1.0,2/19,9.64%,LAMB4;GPM6B
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.24587233373311235,-0.6416653550597107,1.0,1.0,1.0,13/144,12.60%,SFRP1;AURKA;WDR54;SPI1;MYADM;FOXP1;PARP14;DDRGK1;NOS2;PINK1;LRPAP1;RACK1;RIN3
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.44707635407198804,0.6416442789487866,0.86,1.0,1.0,1/5,10.84%,CADM1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.27482713991102803,0.641267724296836,0.9830508474576272,1.0,1.0,10/75,14.54%,FZD1;MAGI2;WNT5A;PSMD13;RYK;DVL2;SMURF2;PRICKLE1;SMURF1;PRICKLE2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.27789787015828527,-0.6409202566482571,1.0,1.0,1.0,18/91,17.17%,WARS1;TSPYL2;CD4;TRIB2;DAXX;EPHA1;PTPRC;AZU1;CENPE;TAF7;CEACAM1;PRKRIP1;AGAP2;EREG;CAMK2N1;SPRED1;GSKIP;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.3285736158287778,-0.640600469449523,0.9818181818181818,1.0,1.0,2/23,7.65%,WTIP;LIMD1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.4089051267398685,-0.6404113847936377,0.9166666666666666,1.0,1.0,2/8,15.72%,ATP6V0A2;NDUFS2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2478889334956413,0.6400012601654818,1.0,1.0,1.0,35/189,21.16%,NEDD4;SOCS6;UBE2U;PELI1;UBE3D;SPOP;TRIM9;PSMD13;TBL1XR1;PCBP2;ZSWIM8;SMURF2;SIRT1;CTNNB1;BTRC;RNF139;AGAP3;SMURF1;UBE2D3;SYVN1;KCTD10;GID8;PSME4;FBXL17;NEDD4L;PSMF1;HECW2;MDM2;DERL1;SEL1L;CUL3;RNF185;SPOPL;KCTD5;WWP1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.29265581089473786,0.6399834051130465,1.0,1.0,1.0,11/43,22.18%,ANK3;BLZF1;RAB34;KIF13A;COMMD1;SPTBN1;EXOC8;RAB10;LLGL1;EXOC6B;GGA1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.3971662289053467,-0.639852895972112,0.94,1.0,1.0,1/7,13.92%,PTPRB
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3532637418063329,0.6396611434577868,0.9285714285714286,1.0,1.0,5/14,24.68%,HSPA1A;SYVN1;BCL2L1;CREB3;LRRK2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.282630475517923,0.639541541772111,0.9347826086956522,1.0,1.0,10/66,11.23%,RFNG;EGFR;TP63;HEY1;MAML2;MAML3;TSPAN15;JAG1;DLL1;NOTCH3
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.3292677511283204,0.6395042342859608,0.9545454545454546,1.0,1.0,5/13,22.57%,SLC8A1;PIK3CA;KCNJ2;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.42998729008123865,0.6393989484983307,0.8518518518518519,1.0,1.0,1/5,11.66%,TEX15
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.3764594047496619,0.6390767432571972,0.8235294117647058,1.0,1.0,1/8,3.93%,TDG
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.34338588629607786,0.6389843255040084,1.0,1.0,1.0,7/19,20.10%,LRRTM3;AGER;RELA;PICALM;SLC2A13;ROCK2;EPHA4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.3830347610696354,0.6384883528055887,0.82,1.0,1.0,1/7,6.29%,GRIP1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.4004652524894516,-0.6382659306962087,0.851063829787234,1.0,1.0,1/6,6.56%,SPI1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.4092999357844364,-0.6380680245546511,0.9137931034482759,1.0,1.0,1/7,7.86%,KCNE3
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.43812499287448536,-0.6379488668634532,0.8913043478260869,1.0,1.0,2/5,18.02%,SRC;CAMK2A
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.30637362393256695,0.6378802816206381,1.0,1.0,1.0,4/32,16.69%,TFEB;MYO7A;CLVS1;CLN3
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.2833524976436115,-0.6377360005512421,1.0,1.0,1.0,19/98,15.98%,TEC;RAC1;PSMA7;VAV3;PSMD7;SKP1;PSMB4;PSMC3;CALM1;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PIK3CB;PSMA1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.3888887206600911,0.6375970010114714,0.9433962264150944,1.0,1.0,1/9,5.24%,ZEB2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.36512654750236545,-0.6373420946628024,0.82,1.0,1.0,2/6,15.88%,RBX1;TAF1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.2882030636860361,0.6373352773486647,1.0,1.0,1.0,3/60,3.01%,NEDD4;PTPRK;ZBTB1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.40022191947726227,0.6372805205470831,0.8297872340425532,1.0,1.0,2/6,22.49%,HPSE;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3504091060125436,0.6371656942072907,0.9387755102040817,1.0,1.0,6/16,19.03%,EDN1;PRKCA;MEF2A;AKAP6;SLC9A1;ROCK2
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.3542677725750309,0.637115846578644,0.9444444444444444,1.0,1.0,2/11,10.26%,PNP;DPYD
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.2900413428859685,-0.6364913943989914,0.9661016949152542,1.0,1.0,6/55,15.12%,PLK3;KIF20B;RACK1;DNM1L;VPS28;MYO18A
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.32196129984859373,0.6362139231817175,0.9259259259259259,1.0,1.0,4/23,15.99%,PEX11A;TMEM135;PEX2;ABCD3
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.30182337438989054,-0.6362055028868739,0.9375,1.0,1.0,2/27,2.75%,SERPINE1;F8
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.2818250250337282,0.6361372414232435,0.9787234042553191,1.0,1.0,10/58,15.07%,SLC6A13;SLC23A1;SLC1A2;SLC39A8;SLC16A7;SLC25A41;PRAF2;SLC7A2;SLC25A38;SLC25A12
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.30100709081578203,0.6359720908052291,0.975609756097561,1.0,1.0,3/44,6.83%,IFI16;RHOB;ECT2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.28018501272188867,0.6358206795918863,1.0,1.0,1.0,13/66,18.45%,LAMB4;NRP1;PKHD1;USH2A;FER;ITGAV;RADIL;TMEFF2;MEF2C;PIK3R1;ATRNL1;PROX1;MEGF9
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.39794608472400517,0.6356652181309567,0.9302325581395349,1.0,1.0,6/6,60.22%,PIH1D1;SMARCB1;BRCA1;DNMT3B;DNMT1;KDM1A
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.3698432614150531,0.6356024464221193,0.875,1.0,1.0,2/8,11.00%,CAT;PXDNL
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.37655148742621425,-0.6351462114706562,0.9183673469387755,1.0,1.0,2/7,20.80%,KDM6B;ITGB4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.26159916963798646,0.6351115946735271,1.0,1.0,1.0,17/127,13.03%,PPEF2;PTPRK;PPM1L;PPP1R15B;PPM1E;DUSP9;PPP3CA;PTPN13;PTPRD;PTPRG;NCK1;PTPN14;PTPN6;DUSP18;PTPRM;BTRC;PPM1A
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.3952728133180426,-0.6350533448052698,0.8604651162790697,1.0,1.0,1/6,9.08%,PDZD11
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.3564271989000601,-0.6346872050067602,0.8666666666666667,1.0,1.0,4/12,33.27%,DYNC2I1;DYNC2LI1;TTC21A;WDR19
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.30322396769789484,0.6346035316431115,0.9523809523809523,1.0,1.0,9/57,18.21%,ECT2;LIMK2;UBR5;HDAC3;EIF2AK3;PLK1;SMAD3;PIK3R1;WWTR1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.40402661197213996,0.6339580181455937,0.819672131147541,1.0,1.0,1/6,21.42%,SLC38A3
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.3194578656107894,-0.6339542665247637,0.9444444444444444,1.0,1.0,1/41,1.30%,TAGLN
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.26832343052875124,-0.6335115186009113,1.0,1.0,1.0,25/82,21.32%,PSMA7;PSMD7;SKP1;UBC;PSMB4;RBX1;PSMC3;PSMD8;PSME1;PSMB2;IL1R1;PSMC4;PSMB8;NFKBIA;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;IRAK1;PSME2;PSMD12;PSMC6;PSMB7;PSMB3
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.3194877761916157,-0.6334554074887494,0.9807692307692307,1.0,1.0,2/27,5.93%,SKP1;UBC
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2932121186245525,0.6334542591083135,1.0,1.0,1.0,15/62,15.03%,ELAPOR2;SULF1;ZEB2;TGFBR1;ACVR2A;TWSG1;MSTN;BMPR1A;CRB2;SMAD2;ACVR1B;INHBB;EP300;ACVR1;GDF10
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3100125355736436,-0.6334276385774489,0.9795918367346939,1.0,1.0,6/40,13.09%,NUPR1;BCL2L2;PINK1;RACK1;DNM1L;FIS1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.32218659964065455,-0.6334262753610524,0.9791666666666666,1.0,1.0,10/23,22.68%,STX4;ANO1;ADRA2A;BAIAP3;NR1H4;BRSK2;GPLD1;TRPM4;NR1D1;CFTR
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.39486698207496507,-0.6331749839435419,0.8979591836734694,1.0,1.0,2/6,27.33%,RHOJ;NTN1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.37434108821544,-0.6331595004687882,0.9591836734693877,1.0,1.0,1/8,4.49%,PIK3IP1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.36554772434879745,0.6331288730708122,0.9183673469387755,1.0,1.0,5/11,29.18%,FER;CD55;CD47;RC3H1;ENPP3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.33574837118303286,0.6330576018548577,0.9122807017543859,1.0,1.0,2/21,5.59%,LEPROTL1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.34962022589787045,-0.6324362828831007,0.9130434782608695,1.0,1.0,2/23,8.24%,B2M;LACC1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.2753197288019264,-0.6324155662615489,1.0,1.0,1.0,28/94,24.84%,MCM5;ORC3;CHEK1;ORC1;MCM2;TICRR;HUS1;POLL;TOP3A;RPAIN;NT5M;KIN;POLE3;CDC7;RBBP8;KAT5;RMI1;POLG;RPA3;PIF1;MCM4;ORC2;IGHMBP2;PTMS;CDC6;SET;WDHD1;ORC6
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.3016087173370206,0.6321203392814913,0.9534883720930233,1.0,1.0,5/30,15.95%,TFEB;S100A13;PLEKHM1;RAB34;KLC2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.3444719185680534,0.6321090857093198,0.94,1.0,1.0,3/11,16.11%,PTGES;EDN1;PTGS2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.30549116126304704,-0.6320462332669176,0.9615384615384616,1.0,1.0,5/39,10.75%,HSD17B10;PNPO;ABCB11;PER2;TM7SF2
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.3782845449843579,-0.6318557653309365,0.8235294117647058,1.0,1.0,5/9,23.71%,HMGB2;SCIN;MTURN;PITHD1;RAB7B
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.38027060243270844,-0.6315996999838037,0.9019607843137255,1.0,1.0,3/5,20.64%,METTL3;GPR157;STAT3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.38245468952365447,-0.6312694376871978,0.9038461538461539,1.0,1.0,5/11,25.10%,P2RY11;TAF1;P2RX4;TRPV1;CIB2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.23332907998102181,-0.6310895445136245,1.0,1.0,1.0,35/296,15.98%,AURKA;PSMA7;UCHL1;ECRG4;ANAPC15;FBXO48;PSMD7;SKP1;UBC;PSMB4;TBL1X;RBX1;PSMC3;IFI27;RBCK1;RMND5B;UBXN8;NSFL1C;ANKZF1;UFD1;PSMD8;PSME1;DDB1;SGTB;PSMB2;SELENOS;PSMC4;PSMB8;ANAPC2;PSMC1;PSMB5;PSMD2;FBXL13;TAF1;PSMA1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.2938156772220931,0.6305924198733723,0.9583333333333334,1.0,1.0,6/65,9.01%,FAS;ATP6V0D2;TFEB;PRKD1;KPTN;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.4049439430877229,0.630482104320273,0.8541666666666666,1.0,1.0,1/6,7.63%,LDLR
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.3605188268708751,-0.6303594378135832,0.9583333333333334,1.0,1.0,3/11,18.76%,CLDN1;SUPV3L1;SUPT6H
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.41000017987425685,-0.6303081686239065,0.9074074074074074,1.0,1.0,2/6,22.12%,WRAP73;HAP1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.30565391221130894,-0.6302584545253264,0.9814814814814815,1.0,1.0,9/35,29.32%,DBNL;RTN4R;ISLR2;LIMK1;MAG;DNM2;NTN1;MT3;DBN1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.4094147607406422,0.6295731029901497,0.8863636363636364,1.0,1.0,1/5,8.03%,IL18R1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.3661411403213501,-0.6294681964037367,0.9272727272727272,1.0,1.0,1/13,8.86%,CALM1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.3687463880772982,-0.6290991800763666,0.9,1.0,1.0,2/12,9.49%,IL11;IGFBP3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.4026560251565859,-0.6286928374208934,0.9183673469387755,1.0,1.0,1/6,14.95%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.3969491280231253,-0.6285846087438636,0.9607843137254902,1.0,1.0,1/8,13.18%,SVIP
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.3914867295960538,0.6285686554783999,0.9166666666666666,1.0,1.0,2/6,26.15%,RELA;MAPK14
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.3914867295960538,0.6285686554783999,0.9166666666666666,1.0,1.0,2/6,26.15%,RELA;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.3083347068551199,0.6283624939185155,0.9666666666666667,1.0,1.0,10/29,23.17%,CCL5;ANKRD17;ADAM8;PRKCA;IFI35;SASH1;BMP6;AKIRIN2;PUM1;PLSCR1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.34938818179856107,0.6281099438467382,0.8909090909090909,1.0,1.0,1/14,5.00%,ARID1A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.3782223057118801,-0.6269793391534323,0.9090909090909091,1.0,1.0,3/11,13.39%,NLRP3;ZP3;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.31838739647655145,-0.6266056681603505,0.96875,1.0,1.0,3/28,8.86%,TMSB4X;SHANK3;CALM1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.3254313250463706,-0.6265793089297214,0.9259259259259259,1.0,1.0,1/19,2.62%,SERPINE1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.42354025444622445,0.6261753964731933,0.9387755102040817,1.0,1.0,2/6,18.84%,IL18R1;PDGFB
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.42354025444622445,0.6261753964731933,0.9387755102040817,1.0,1.0,2/6,18.84%,IL18R1;PDGFB
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.3601859882354547,-0.625861328210756,0.9473684210526315,1.0,1.0,5/13,18.61%,STMN1;STMN3;STMN2;KATNB1;CKAP5
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.3284819849227986,0.6258545685637263,0.9245283018867925,1.0,1.0,2/20,5.79%,SHROOM2;RAB29
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.3735607854717494,0.6254713439268375,0.851063829787234,1.0,1.0,1/6,18.41%,SENP1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.36098373818263696,0.6253302754177607,0.8979591836734694,1.0,1.0,3/7,27.97%,ABCD3;ABCD2;ACOX1
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),-0.3889890973871219,-0.6252184327667445,0.9038461538461539,1.0,1.0,2/6,21.70%,SHH;PAFAH1B1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.36787160226262183,0.6249884792273757,0.9152542372881356,1.0,1.0,3/11,16.11%,SNCA;DYRK1A;MAP2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.39619525163571584,0.6248758362600975,0.8627450980392157,1.0,1.0,3/8,15.95%,SLC22A2;SLC29A2;SLC6A4
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.36750936084035407,-0.6247763842038175,0.8958333333333334,1.0,1.0,3/7,17.17%,SELENOS;KDR;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.36853972393765916,-0.6244633792862228,0.8688524590163934,1.0,1.0,4/10,28.76%,VPS11;PTPN23;MSN;EZR
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.32227757014278563,0.6244158550569758,0.9523809523809523,1.0,1.0,11/36,19.54%,CERS3;ST8SIA6;TLCD3B;ASAH2;SMPD4;ST8SIA4;CERS5;SGMS1;ST6GALNAC4;CERS6;ST8SIA3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.2681787903835049,0.6242843961739478,1.0,1.0,1.0,17/71,24.32%,UBE2J1;TMEM67;DNAJB2;YOD1;SYVN1;FAM8A1;DERL1;SEL1L;RNF185;UBE4A;RNF103-CHMP3;RHBDD2;JKAMP;ERLIN1;EDEM1;UBE2J2;DERL3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.29876657077255175,0.6240298482871014,0.9655172413793104,1.0,1.0,5/50,5.33%,ATP6V0A4;KCNS3;SERTAD4;PTGES;SH2D4A
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.3267769288117571,0.6239226850741915,0.9111111111111111,1.0,1.0,5/21,17.81%,NLGN1;FOXO6;CAPRIN1;LLPH;CPEB3
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.3973552872348902,-0.623909112538911,0.8490566037735849,1.0,1.0,1/6,6.38%,PAX8
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.2940506366893197,0.6238638780994827,0.9795918367346939,1.0,1.0,13/54,14.51%,SMAD7;TGFBR1;CIDEA;ADAMTSL2;IL17RD;SMAD2;SMURF2;SIRT1;WFIKKN1;PPM1A;HSPA1A;SMAD3;SMURF1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.3423508607415936,-0.6237041280379533,0.9761904761904762,1.0,1.0,5/9,35.33%,CHMP2A;CHMP2B;IST1;VPS4B;CHMP5
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.3423508607415936,-0.6237041280379533,0.9761904761904762,1.0,1.0,5/9,35.33%,CHMP2A;CHMP2B;IST1;VPS4B;CHMP5
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.2985809188030278,-0.6236500285189225,0.9318181818181818,1.0,1.0,4/33,15.62%,ANAPC15;UBC;ANAPC2;NPM2
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.34602268014968185,0.6236038609240887,0.975609756097561,1.0,1.0,2/14,10.22%,SHROOM2;RAB27A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.34602268014968185,0.6236038609240887,0.975609756097561,1.0,1.0,2/14,10.22%,SHROOM2;RAB27A
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.2932554010813096,0.6230653958641785,0.9782608695652174,1.0,1.0,6/66,9.01%,FAS;ATP6V0D2;TFEB;PRKD1;KPTN;EIF2AK3
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.32815427096294203,0.6230230976342298,0.9166666666666666,1.0,1.0,3/20,16.65%,FGFR2;ACVR1;SOX11
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.3731612894265088,-0.6228066339255721,0.8604651162790697,1.0,1.0,2/8,21.44%,PEX1;ABCD1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.26401916974817236,0.6226576078671106,1.0,1.0,1.0,17/136,16.51%,NRG1;DNAI4;IMMP2L;ANLN;SNCA;PSMD13;TCF4;SMAD1;NCK1;SMAD2;SHQ1;HSPA1A;SMAD3;PICALM;VAMP8;PSMG2;DMD
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.4051327072705426,0.6225353031335896,0.8775510204081632,1.0,1.0,3/7,22.83%,DUSP22;FYN;NTRK2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.29157110785322027,0.6223334280766504,1.0,1.0,1.0,9/36,18.12%,PLA2G7;CYP2C8;CYP3A4;LPCAT3;PLPP1;DGKB;PLPPR5;DGKZ;PLPP6
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.3472376835368444,0.6222093794996663,0.92,1.0,1.0,5/14,18.88%,SLC30A10;IL16;ANK2;BCL2;STIM1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.39533293350995313,0.6222001709991853,0.8958333333333334,1.0,1.0,3/8,22.77%,DOCK4;PDGFB;DOCK5
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.35255904847590247,-0.6221333486593831,0.9215686274509803,1.0,1.0,2/12,11.27%,DCTN1;AKAP8L
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.3253215267856441,-0.622087903123632,0.9830508474576272,1.0,1.0,9/25,20.57%,SBDS;MBTPS2;GNAS;NOTUM;PTPRC;SFRP4;RPL13;PPIB;LRRC17
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.3714984521949163,0.6220871678816131,0.8867924528301887,1.0,1.0,1/9,7.63%,LDLR
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.30870939938132247,-0.6218592122787794,0.9473684210526315,1.0,1.0,6/40,16.21%,B2M;UBE2L6;UBC;APH1B;APOA1;CALB1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.3038327242770493,-0.6217190079349173,0.9298245614035088,1.0,1.0,6/27,16.42%,ANKLE2;PPP1R15A;PTPA;CALM1;PIN1;CALM3
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.35189253162964,-0.6216563278229604,0.8958333333333334,1.0,1.0,1/17,3.73%,GINS3
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.3509957426436412,-0.6215188686631248,0.875,1.0,1.0,3/11,24.81%,NUCKS1;PPIB;CFL1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.28296058437049404,-0.621417492387751,0.9444444444444444,1.0,1.0,7/43,17.49%,SIN3B;TBL1X;MORF4L1;HDAC5;MTA2;HDAC6;HDAC11
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.26218448035435704,-0.6213571437017261,1.0,1.0,1.0,5/65,9.99%,HSD17B10;MECR;PCCB;ECHDC2;HADHA
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.2669061937445369,0.6213543720411814,0.9811320754716981,1.0,1.0,4/44,8.50%,KANK1;RAB29;MINAR1;HDAC2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.41151334741985646,0.6211053988670494,0.9038461538461539,1.0,1.0,1/5,8.42%,TCF4
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.35756878360096367,0.6210669477095956,0.9272727272727272,1.0,1.0,4/15,20.80%,IGF1R;CLN3;MTRF1;INSR
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.3247084817025494,-0.6208763599534237,0.9230769230769231,1.0,1.0,7/16,29.31%,WRAP53;PTP4A3;CEP295;CCT2;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.3030593180294268,0.6200127585828805,0.96,1.0,1.0,11/48,15.75%,RALA;MCTP1;SYT1;RAB3C;CHRNB4;RIMS2;ARFIP1;SNCAIP;MEF2C;DNAJC1;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.35232481467931714,-0.6198918523137614,0.9655172413793104,1.0,1.0,1/13,6.60%,SHANK3
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.34826287302765363,-0.6197896764264665,0.8627450980392157,1.0,1.0,5/8,30.68%,BRF1;GTF3C2;POLR2L;GTF3C6;GTF3C3
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.38863810224832895,0.61965268382956,0.8888888888888888,1.0,1.0,1/7,9.71%,FER
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.3701360338770029,-0.6194746006585115,0.9183673469387755,1.0,1.0,2/9,12.01%,TRAF3IP1;C1QBP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3154701875210134,0.6190169040357661,0.9782608695652174,1.0,1.0,5/14,22.57%,SLC8A1;ANK2;DMD;ATP1A2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.3954153563578925,-0.6188289672764188,0.9090909090909091,1.0,1.0,4/7,28.76%,VPS11;PTPN23;MSN;EZR
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2924822341633992,-0.6185834640641924,0.9761904761904762,1.0,1.0,10/33,22.16%,GIPC1;DDRGK1;CAMLG;RPL23;TAF1;RPL5;MAP1A;RPL11;HSP90AB1;SDCBP
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.2677927136927707,-0.6185785866978797,1.0,1.0,1.0,4/88,4.39%,SLA;RAC1;NFKBIB;VAV3
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.3736647226952762,0.618562198088193,0.8958333333333334,1.0,1.0,4/8,18.99%,ABCC2;ABCG2;HMOX2;SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.3736647226952762,0.618562198088193,0.8958333333333334,1.0,1.0,4/8,18.99%,ABCC2;ABCG2;HMOX2;SLCO2B1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.3233357193566933,0.6185087446855353,0.9629629629629629,1.0,1.0,3/14,27.55%,SELENOI;CEPT1;ETNPPL
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.34880511239874856,0.618196068417033,0.9411764705882353,1.0,1.0,5/19,18.34%,UAP1;SLC35D1;UGDH;GNPNAT1;UGP2
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.42924808542109716,0.6176807275132158,0.8627450980392157,1.0,1.0,1/5,6.00%,GRM5
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.2931461924983375,-0.6173391770143772,0.9642857142857143,1.0,1.0,5/50,11.78%,AKAP17A;IL11;HDAC5;PTPRC;SLC25A5
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.35218562456275004,0.61728801514778,0.8679245283018868,1.0,1.0,4/11,18.20%,CTNNA2;SPEF2;SLC6A4;BBS4
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.24667589844647927,0.6172238085697008,1.0,1.0,1.0,15/121,18.20%,FAM83H;BANP;TULP3;TSPAN17;BICD1;BBS9;TRAM1L1;ANK2;TUB;ALDH3A2;MARCHF5;CNTLN;ROPN1B;LAMP2;BBS4
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.3780802029548964,0.616857988168563,0.8571428571428571,1.0,1.0,2/8,20.61%,STIM1;GRAMD2A
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.3527961020580632,-0.6166790497699015,0.8936170212765957,1.0,1.0,2/12,22.04%,STAT1;HSPD1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.30293489342973423,0.6166524504812327,1.0,1.0,1.0,12/36,23.80%,ZFP36;RIDA;ZFP36L2;FTO;CPEB3;MEX3D;ROCK2;PDE12;PUM1;ZFP36L1;YTHDF3;TUT7
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.32014194300563137,-0.6165225215579028,0.9215686274509803,1.0,1.0,7/25,24.00%,SHANK3;STMN1;MET;SHANK1;ARHGEF18;PFN1;CGNL1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.31028802369400865,0.6162652331795689,0.9230769230769231,1.0,1.0,6/25,21.23%,HDAC9;TBXA2R;PTGS2;VEGFA;MEOX2;AKT3
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3489044232296076,-0.6158895207304419,0.9166666666666666,1.0,1.0,6/18,17.02%,METAP2;NMT1;PDE6B;CALM1;FNTB;GUCA1B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.29705395281919494,0.6157377296407515,0.9636363636363636,1.0,1.0,5/35,14.13%,SYK;HMGB1;TLR1;HSPA1A;RELA
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.3404241620305338,0.615594280312752,0.8936170212765957,1.0,1.0,3/10,22.59%,ODC1;HDAC10;SMS
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2652500097564596,0.6154374912724888,1.0,1.0,1.0,33/133,20.82%,LITAF;S100A13;TAB3;ROR1;PELI1;PELI2;ECT2;PRKD1;TRIM22;ANKRD17;TAB2;TRIM8;TRIML2;NDFIP2;PPM1A;RELA;PRKCB;CASP10;C18ORF32;MID2;GPR89A;SLC20A1;TRIM5;TRAF5;ALPK1;ECM1;TFG;EEF1D;NOD1;ZDHHC17;TRIM32;TSPAN6;LGALS1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.28954859505182984,0.6153757808445923,1.0,1.0,1.0,5/34,10.76%,TENT5C;SYNCRIP;ZFP36;ELAVL4;TENT5A
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.2856882700056343,-0.6152377215335627,0.9791666666666666,1.0,1.0,5/35,19.16%,PHAX;HTATIP2;GEMIN4;SNRPD2;NXT1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.39014540817621585,0.6151083577480345,0.8666666666666667,1.0,1.0,1/5,9.51%,CEP120
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.36282369906334017,-0.6147356788925484,0.8837209302325582,1.0,1.0,3/8,25.83%,TNFRSF1A;CST3;TGFB1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.35282643095151395,0.6145294257599108,0.8909090909090909,1.0,1.0,9/13,40.28%,PDSS2;COQ8B;COQ7;UBIAD1;COQ3;COQ2;COQ10A;PDSS1;COQ9
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.35282643095151395,0.6145294257599108,0.8909090909090909,1.0,1.0,9/13,40.28%,PDSS2;COQ8B;COQ7;UBIAD1;COQ3;COQ2;COQ10A;PDSS1;COQ9
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.283014677852214,-0.6144271566501062,0.9791666666666666,1.0,1.0,2/36,8.43%,SLC25A10;SLC7A7
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.3478300440860731,0.6141346060396768,0.94,1.0,1.0,1/10,5.23%,WNT5A
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.3299302713085699,-0.6137533856996293,0.9074074074074074,1.0,1.0,2/19,15.57%,TTLL2;PARP1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.28513223081174816,0.6130954468203963,0.8823529411764706,1.0,1.0,4/25,23.30%,ARL5A;ARL5B;RAB33B;IFT20
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.30733708646464,0.6127211866844701,0.9545454545454546,1.0,1.0,10/29,20.10%,TM4SF20;TIMP3;KNG1;TIMP1;PLAT;DNAJC1;CLN3;ECM1;NLRP7;EPHA4
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.3838403000348066,-0.6125181324935766,0.8695652173913043,1.0,1.0,2/6,12.57%,NUDT16;METTL3
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.3579718234546502,0.6123404332758997,0.94,1.0,1.0,1/14,3.79%,HMGB1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.34680199745341306,-0.6121101116643762,0.8837209302325582,1.0,1.0,2/14,6.87%,GNB3;BCKDK
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.35281700810428196,0.6119889781451648,0.8888888888888888,1.0,1.0,8/13,29.81%,NPY;MAP2;NTRK2;RAPGEF2;B4GALT6;PTEN;B4GALT5;ARHGAP35
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.29171332748707945,-0.6108994962454503,0.9807692307692307,1.0,1.0,3/27,12.91%,ABRAXAS1;CHEK1;TICRR
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.3819878489899189,-0.610533285272619,0.9245283018867925,1.0,1.0,1/6,11.59%,GALK1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.3401739452307673,0.6104688044972293,0.9615384615384616,1.0,1.0,3/21,15.48%,POLE2;PRIMPOL;RFC5
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.31773912807814825,-0.6103393022057205,0.9795918367346939,1.0,1.0,7/22,16.72%,STARD5;SLC51A;ABCB11;SLC10A6;CEACAM1;NR1H4;ABCC4
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.34697175876433717,-0.6099617846548642,0.9347826086956522,1.0,1.0,2/11,12.01%,NODAL;C1QBP
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.29089566191408567,-0.6098251815156243,0.9807692307692307,1.0,1.0,9/40,24.97%,WRAP53;NVL;SRC;CCT2;GREM1;PIF1;HSP90AB1;PARP4;SMG6
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.3862049821939098,0.6091807914945843,0.9215686274509803,1.0,1.0,1/6,6.29%,GRIP1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.269355558155165,-0.6087274527903304,1.0,1.0,1.0,33/76,26.92%,RAC1;PSMA7;PSMD7;PSMB4;PSMC3;PSMD8;PSME1;PSMB2;PSMC4;PSMB8;PSMC1;PSMB5;PSMD2;PSMA1;PSMD10;FZD5;PSME2;PSMD12;PSMC6;PSMB7;PSMB3;AP2A1;PFN1;CELSR1;AP2S1;PSMA5;PSMB1;PSMB6;PSMD3;PSMD11;PSMA4;CELSR3;PSMA8
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3590924860673813,0.6085754251770378,0.9333333333333333,1.0,1.0,2/9,12.25%,SNCA;SIRT1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.35847984766954344,-0.607890476263173,0.9777777777777777,1.0,1.0,3/14,13.39%,NLRP3;ZP3;PRKCZ
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.3118098727378979,0.607755945897262,0.9375,1.0,1.0,5/25,15.99%,GDAP1;PEX2;PEX13;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.4010635711638624,-0.6077339245375788,0.9137931034482759,1.0,1.0,3/5,16.05%,UBE2L6;ISG15;HERC5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.38539679904022,-0.6076103727892085,0.9545454545454546,1.0,1.0,1/8,2.90%,RAC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.3977638566777127,0.6068851406013098,0.9347826086956522,1.0,1.0,2/5,9.92%,ATP2B4;FOXO1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.27172008952354876,0.6068682977435198,1.0,1.0,1.0,2/44,3.93%,APEX2;TDG
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.2954390286694601,0.6065298039949321,0.9787234042553191,1.0,1.0,7/25,22.18%,ANK3;BLZF1;RAB34;KIF13A;SPTBN1;RAB10;GGA1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.3054726144732305,0.6064988143533397,0.9607843137254902,1.0,1.0,7/41,13.78%,DXO;NUDT16L1;ERN1;ZFP36;RIDA;ZFP36L2;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3150869303889656,-0.6062101940958318,0.9836065573770492,1.0,1.0,3/22,8.86%,CEMIP;DRD1;CALM1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.3111431740864288,0.6053672481480983,0.9433962264150944,1.0,1.0,8/27,21.35%,PCM1;TOGARAM1;IFT57;GORAB;DISC1;BBS4;ARL13A;RPGRIP1L
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.42347267219497453,-0.6053592636825262,0.9230769230769231,1.0,1.0,2/5,10.89%,ATF4;PINK1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.32654779601367323,-0.6050582869934752,0.9,1.0,1.0,1/13,11.33%,NUP133
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.3665990722929311,0.6048804339604062,0.9444444444444444,1.0,1.0,2/10,18.84%,LDLR;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.4163420346925749,-0.6043893104820024,0.9767441860465116,1.0,1.0,1/5,5.24%,XG
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.4163420346925749,-0.6043893104820024,0.9767441860465116,1.0,1.0,1/5,5.24%,XG
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.37349648912268474,0.6041571833941521,0.84,1.0,1.0,2/7,15.82%,SNX5;RAB34
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.36826695888837424,-0.603864314114372,0.9387755102040817,1.0,1.0,1/6,11.55%,GART
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.3490010069751178,0.6036815303856621,0.92,1.0,1.0,2/10,12.87%,PATL1;DCP1B
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.31130412837147914,0.6029858847526025,1.0,1.0,1.0,8/29,20.65%,DDAH1;SLC39A8;RIMKLB;DDAH2;GLYATL1;MTHFS;RIMKLA;ALDH4A1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.2896899143268572,-0.6027942465394704,0.9811320754716981,1.0,1.0,9/53,19.15%,PLK3;TUBGCP5;DCTN1;TUBGCP2;TRPV4;STMN3;CLIP4;RAB11A;CIB1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.3595645508561204,0.6026685568277418,0.9215686274509803,1.0,1.0,1/6,17.83%,ERC1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.31212308128141897,-0.6026252726036199,0.9591836734693877,1.0,1.0,1/20,2.62%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.35169367437278815,-0.6016977603573191,0.8833333333333333,1.0,1.0,2/10,14.03%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.309680950925466,-0.601237943758443,0.9347826086956522,1.0,1.0,12/31,24.84%,MCM5;ORC3;ORC1;MCM2;POLE3;CDC7;RPA3;POLE4;MCM4;ORC2;CDC6;ORC6
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3130242758904773,0.6012376121725536,0.9454545454545454,1.0,1.0,4/23,16.52%,ATP10A;ATP8B3;ATP11C;ATP8A2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.3263045518544933,0.6008286636440002,0.9555555555555556,1.0,1.0,3/19,15.26%,MSL2;JADE3;OGT
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.37523988613535647,-0.6001767990833634,0.9387755102040817,1.0,1.0,1/9,5.72%,SCARA5
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.27206592169965316,-0.6001540483627412,0.9777777777777777,1.0,1.0,23/74,22.53%,DIRAS3;POLR1G;SPI1;AEBP2;GLMN;TAF1D;HDAC5;ACTB;CTCF;MORC2;HDAC6;SMARCA5;GPX1;MACROH2A1;POLR1E;DDX21;PRMT7;POLR2L;POLR1B;POLR2K;DEK;PHF19;POLR1A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.3294002506978384,-0.599201385984872,0.98,1.0,1.0,4/17,21.93%,UFD1;SELENOS;HM13;NPLOC4
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.35676759025099797,0.5986837133609361,0.9038461538461539,1.0,1.0,4/15,17.16%,RORA;LPL;NR1H3;ANGPTL4
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.2898670109654005,-0.5986625370343527,0.9433962264150944,1.0,1.0,8/43,15.62%,TSPYL2;DSCC1;ORC3;BCAR3;STN1;EREG;NUCKS1;NPM2
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.3592498621922518,0.5983493878097595,0.9791666666666666,1.0,1.0,1/8,3.33%,GBP4
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.31131107310512696,0.5982540119200427,0.9636363636363636,1.0,1.0,6/17,31.30%,MEF2A;LRRK2;TRAK2;ZBED3;MFN1;BRAT1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.2679554315759701,-0.5980143485906826,1.0,1.0,1.0,6/59,11.46%,RAC1;BST1;RND3;RND2;RHOBTB1;RHOBTB2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.34706357049296077,0.5978732782518665,0.9361702127659575,1.0,1.0,6/17,25.30%,P2RX7;AFDN;BAD;ADAM10;AHCTF1;TSPAN33
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.26720124012415636,-0.5975283311498572,1.0,1.0,1.0,15/64,20.29%,ARHGAP15;PPP1R17;VAV3;FGD3;EPHA1;PLXND1;RAP1GAP;STMN3;APOA1;ARHGAP12;CAMK2A;PLXNA1;ATP5IF1;SOD1;CFAP100
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3344686834022327,0.5969577126537656,0.9787234042553191,1.0,1.0,4/15,24.74%,SHQ1;RUVBL2;NAF1;RUVBL1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.3202955274363608,0.596898358610572,0.9130434782608695,1.0,1.0,3/15,11.03%,EGFR;FER;CDH13
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.3199678141351261,0.5967420778800943,0.9629629629629629,1.0,1.0,5/19,19.42%,RSAD1;ABCG2;SLC25A38;COX10;FECH
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3139312462966177,0.5966077736994626,1.0,1.0,1.0,6/23,19.94%,TAB3;TAB2;MAP2K6;RELA;OTULIN;NOD1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.4096737958504052,-0.5963880295884091,0.9302325581395349,1.0,1.0,2/5,22.42%,EIF6;RAN
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.37143060745284306,-0.5962126133693703,0.9803921568627451,1.0,1.0,1/7,14.95%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.30309164463067995,-0.5958300136882665,0.9347826086956522,1.0,1.0,2/24,11.84%,ANAPC15;CENPE
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),0.4009567115812831,0.595178219815572,0.9069767441860465,1.0,1.0,2/5,12.45%,LPL;LCAT
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.4009567115812831,0.595178219815572,0.9069767441860465,1.0,1.0,2/5,12.45%,LPL;LCAT
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.3752942295082476,0.5951440228803029,0.9347826086956522,1.0,1.0,3/9,22.75%,CRLF2;PIGU;MGAT5
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.26560640642331435,0.5949375410772025,1.0,1.0,1.0,7/24,27.03%,SLC8A1;KCNJ2;ATP1A2;CACNA1H;SCN2A;SCN3A;SCN8A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.33527882612914556,0.5945627941052838,0.9019607843137255,1.0,1.0,4/15,24.32%,PRKACB;ADCY2;ADCY3;ADCY9
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.25044780320102633,0.5944161765346446,1.0,1.0,1.0,14/105,13.71%,TMEM117;C1ORF226;RNF128;ENPP5;MYO1D;TSPAN15;COBL;ST14;ITGAV;SEC23B;CTNNB1;BCAR1;SH3BP4;MTUS1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3713319393279758,-0.5943592511309533,0.9047619047619048,1.0,1.0,2/7,18.86%,THBS1;IL12A
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.27426901379089375,0.5940524375161116,0.9814814814814815,1.0,1.0,5/32,18.60%,KPTN;DYRK3;GPR137B;SESN1;SIK3
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.3727284018725797,0.5937215738652156,0.9534883720930233,1.0,1.0,2/7,17.33%,SDS;GLDC
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.34443667747595585,-0.5932101571070157,0.95,1.0,1.0,1/10,6.74%,GPC3
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.3451578703489921,-0.5925419837599503,0.9230769230769231,1.0,1.0,3/12,13.48%,HK2;PINK1;ISG15
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.28718720051168856,0.5919545058134723,0.9795918367346939,1.0,1.0,4/31,21.56%,CTNNB1;NAF1;HNRNPA2B1;ACD
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.32338457688426153,0.5919039125521284,0.9622641509433962,1.0,1.0,3/22,9.95%,SOCS6;FER;SOCS2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.2773654947098189,0.5917690078447992,1.0,1.0,1.0,12/82,14.69%,IFI16;TMEM117;FHIT;CUL1;ZNF385B;ERN1;ITPR1;CASP9;PPP1R13B;BCL2;BOK;TP53BP2
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.349350199058331,-0.59175977502617,0.8863636363636364,1.0,1.0,4/7,32.66%,MEAF6;BRPF1;KAT7;BRD1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3473828611259365,0.5917072307900569,0.94,1.0,1.0,4/21,20.32%,DYRK3;RAD51B;DTL;MECP2
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.38903339022388916,0.5915150363970703,0.92,1.0,1.0,2/6,29.42%,NFE2L2;UBQLN1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.34524179360802676,-0.5913014361712732,0.9423076923076923,1.0,1.0,2/9,14.27%,DLX5;TRPV4
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.2915291946727788,-0.590913145733387,0.9821428571428571,1.0,1.0,4/27,13.50%,KCNE1;CEMIP;FIS1;GDI1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.27704619617821646,0.5908188128910636,1.0,1.0,1.0,7/45,16.09%,EGFR;EPHA3;ATP2B4;DPP10;GNAI1;SORBS1;PIK3R1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.3353331757696717,-0.5902711266978353,0.9607843137254902,1.0,1.0,6/13,26.37%,ATF4;MEAK7;EIF4G1;UCP1;MTOR;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.36049332074895324,-0.5892316620613184,0.9047619047619048,1.0,1.0,2/7,25.83%,STAT3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.3697423653926496,0.5888808644886305,0.9464285714285714,1.0,1.0,2/7,21.63%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.3812405446293494,-0.5888296412317028,0.8478260869565217,1.0,1.0,5/5,61.89%,DPM3;DPY19L4;DPY19L3;DPY19L2;DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.3812405446293494,-0.5888296412317028,0.8478260869565217,1.0,1.0,5/5,61.89%,DPM3;DPY19L4;DPY19L3;DPY19L2;DPY19L1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.2716324116989569,-0.588726099561937,1.0,1.0,1.0,1/37,1.14%,TPPP3
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.3164033157264848,0.5886563277659388,0.9,1.0,1.0,2/11,15.50%,SLC23A1;SLC2A11
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.27720121372941925,0.588217312025855,1.0,1.0,1.0,8/45,16.69%,EGFR;EPHA3;ATP2B4;ZDHHC2;DPP10;SORBS1;PIK3R1;CLN3
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.39684213094740317,-0.5882121410971155,0.9387755102040817,1.0,1.0,1/5,6.63%,HMGCL
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.28951986684792297,0.5880259421876444,0.9787234042553191,1.0,1.0,3/35,6.00%,CASS4;CSF1R;GRM5
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.3653092947796932,0.5878187571395055,0.9180327868852459,1.0,1.0,1/6,14.76%,TIMP1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.33742738609658124,-0.5874300645493928,0.9322033898305084,1.0,1.0,2/11,7.65%,ACTC1;ACE
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.3603326043408339,-0.5873787278403005,0.9107142857142857,1.0,1.0,1/9,9.85%,NSFL1C
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3203408886233536,0.5864484848779495,0.9433962264150944,1.0,1.0,6/19,20.47%,FGFR1;HSPA1A;BCL2;EYA2;BCL2L1;EYA3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.2851844092846385,0.5862012440760886,0.9803921568627451,1.0,1.0,9/27,31.85%,OGT;TET2;VCPKMT;ATPSCKMT;TET3;SETD3;SETD4;SETD1A;KMT5B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.3035007338807419,-0.5856076228339461,0.975609756097561,1.0,1.0,2/21,13.50%,KCNE1;GDI1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3369278516418722,0.584985372542517,0.8979591836734694,1.0,1.0,7/12,27.34%,ANK3;SLC9A1;DMD;TESC;ACTN4;GLRX;WNK1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.2803207049500004,0.5849127270599827,0.9523809523809523,1.0,1.0,5/36,11.50%,LATS1;LIMK2;MFHAS1;EIF2AK3;PLK1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.2956096091542254,0.5846630698220115,0.9607843137254902,1.0,1.0,5/27,15.99%,GDAP1;PEX2;PEX13;ALDH3A2;ABCD3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.34369698584669917,0.584592344314043,0.875,1.0,1.0,3/8,29.36%,TCAP;RYR2;INPP5F
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.30095832719572846,-0.5844235358408236,0.9795918367346939,1.0,1.0,2/28,11.95%,KMT2B;TRMT112
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.24923053236860043,-0.5841974760082476,1.0,1.0,1.0,13/71,20.08%,NIPAL4;TRPC3;RYR1;SELENOK;ATP2A3;CNNM4;TRPV4;SLC30A5;CACNG6;LRP2;CAMK2A;SLC11A1;NIPAL3
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.3486854157626855,-0.5837463756517957,0.8888888888888888,1.0,1.0,4/13,24.70%,ACE;APH1B;MME;NCSTN
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.3457211883710443,0.5833887884110976,0.9411764705882353,1.0,1.0,1/9,5.92%,HEY1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.3331768888861405,0.5829000665678007,0.9375,1.0,1.0,3/13,17.81%,CPEB4;CPEB2;CPEB3
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3013776433232344,-0.5824961189636676,0.9818181818181818,1.0,1.0,7/35,16.88%,HMGB3;ERCC1;XRCC2;SUPV3L1;RPAIN;XRCC3;RECQL
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.34727542163564284,-0.5814768348421959,0.9482758620689655,1.0,1.0,2/11,19.30%,IRAK1;CARD10
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.2836852826554014,0.5813872818160113,0.9777777777777777,1.0,1.0,5/17,19.35%,SLC8A1;ANK2;SLC9A1;DMD;ATP1A2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.28842441690472614,-0.5811165595912372,1.0,1.0,1.0,5/39,13.62%,RNASET2;NUDT12;NUDT16;METTL3;SUPV3L1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.31987241807330935,0.5810584180213029,0.9333333333333333,1.0,1.0,3/13,15.07%,PPARGC1A;GPD2;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.34808408089546283,0.5810054008631553,0.9038461538461539,1.0,1.0,3/10,11.81%,LDLR;LRFN5;NR1H3
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.3834250376652133,-0.5809473766398103,0.9454545454545454,1.0,1.0,1/6,7.65%,ACE
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.2837572801861633,-0.5807498768144006,1.0,1.0,1.0,5/29,22.03%,WRAP53;NVL;CCT2;GREM1;HSP90AB1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.3676977664618431,-0.5806012764269578,0.8627450980392157,1.0,1.0,1/7,5.94%,GHR
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.3640180158415645,0.5803877869412344,0.9090909090909091,1.0,1.0,1/5,12.56%,LPCAT3
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.38830216431679965,-0.580316583978835,0.9545454545454546,1.0,1.0,2/6,11.22%,ACE;TXN
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.24655095482502015,0.5801540926306105,1.0,1.0,1.0,14/67,20.64%,EGFR;EPHA3;ATP2B4;ZDHHC2;DPP10;SORBS1;PID1;PICALM;VAMP8;PIK3R1;CLN3;SPTBN1;BCL2L1;STX8
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.30849011588318304,0.5799379998842247,0.9795918367346939,1.0,1.0,4/17,15.74%,CAVIN1;SPIN1;GTF3C4;TAF1B
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.37558018434280227,0.5798104298195644,0.9302325581395349,1.0,1.0,1/6,13.49%,LIG4
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.38067486342044504,0.5797831894438598,0.9347826086956522,1.0,1.0,1/6,6.41%,CAT
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.33476313703354654,-0.5792559297517471,0.9148936170212766,1.0,1.0,2/18,7.38%,LATS2;INCA1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.40624773463708375,-0.5791472198923934,0.9,1.0,1.0,3/5,33.20%,RAB7B;SGSM2;GCC2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.31283269857958,-0.5788577391025101,0.9555555555555556,1.0,1.0,7/14,28.84%,CEACAM1;PHPT1;SLA2;PTPN22;PTPRJ;EZR;THY1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.36176233938068525,0.5787837129558744,0.9230769230769231,1.0,1.0,2/7,16.11%,BMPR1A;PTGS2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.37860519800208764,0.5785185920204851,0.9411764705882353,1.0,1.0,1/5,16.67%,MOCS3
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.35739365611954044,0.5782396457434784,0.9361702127659575,1.0,1.0,4/11,21.63%,SPAST;CLASP1;EPS8;CLASP2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.38577912254160385,0.5779259312534113,0.8823529411764706,1.0,1.0,5/5,61.43%,VPS13A;VPS13D;GOLPH3;SORL1;VPS13C
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.2840620832371691,-0.57766761905325,0.9411764705882353,1.0,1.0,4/30,14.43%,RAC1;MYADM;C1QBP;APOA1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.37840763357858614,0.5775120477632005,0.9024390243902439,1.0,1.0,2/6,11.83%,PDE4D;TRDN
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.24552364404472168,-0.5771560402648815,1.0,1.0,1.0,14/77,21.44%,CLU;PXMP2;NUP133;PEX11B;FIS1;RPAIN;NUP155;GCKR;NXT1;CSE1L;ACBD5;NUP85;STAT3;ABCD1
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.3896406650008257,-0.5770972167986628,0.9298245614035088,1.0,1.0,1/5,16.80%,GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.3896406650008257,-0.5770972167986628,0.9298245614035088,1.0,1.0,1/5,16.80%,GAS2L2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.2639282353602893,0.5769953559170701,1.0,1.0,1.0,10/42,22.60%,EGFR;UBR5;FGF10;RADX;SIRT1;EYA2;EYA3;BABAM2;TMEM161A;CEBPG
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.3661987753153222,-0.576681760758946,0.9782608695652174,1.0,1.0,1/5,17.54%,MACROH2A1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.263508861925362,0.5766373291939894,0.9811320754716981,1.0,1.0,15/59,21.14%,CX3CR1;HMGB1;WNT5A;PDE4B;ZFP36;NR1H3;RELA;MEF2C;MAPK8;VIM;CD274;NLRP7;CD80;PDCD4;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.37059852937137294,-0.5764960652198899,0.9333333333333333,1.0,1.0,1/5,9.29%,RGS2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.3636994352481454,-0.5761340636031216,0.9411764705882353,1.0,1.0,3/8,12.82%,MCM5;ORC3;MCM2
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.33553971488557693,0.5750589267352713,1.0,1.0,1.0,4/11,22.49%,DYRK1A;ZBTB7B;BRMS1;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.3584558600257005,-0.5749314987455524,0.9122807017543859,1.0,1.0,1/8,17.03%,VPS11
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.29232306628746435,-0.574650412713253,0.9818181818181818,1.0,1.0,5/23,21.93%,UFD1;SELENOS;RANGRF;SEC16A;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.3408830406675531,0.5746268643154627,0.975,1.0,1.0,7/7,65.92%,MYOCD;CTH;GPER1;KIT;ENG;EFEMP2;SOD2
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.3566879548630219,-0.5739350595366066,0.8958333333333334,1.0,1.0,1/7,8.57%,PDE6B
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.34184592285478343,-0.5739042498748254,0.9183673469387755,1.0,1.0,3/8,19.14%,SELENOS;TMCO1;ATG10
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.368495851097969,0.5734177029159097,0.8867924528301887,1.0,1.0,5/5,63.16%,RC3H1;TNFRSF21;ATM;BLK;LYN
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.2603507429837952,-0.5731759643333258,0.9591836734693877,1.0,1.0,13/41,29.54%,LACC1;NUP133;NUP43;EIF6;NUP155;GCKR;NUP85;NUP214;SEC13;SLC2A6;NUP50;TPR;ZBTB7A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.2888337621657432,-0.5725091992531969,0.9814814814814815,1.0,1.0,7/29,18.15%,KCNE1;KCNE2;ATP1B1;SCN4B;KCNQ1;ATP1A1;PKP2
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.31262829373864937,-0.5723730197207377,1.0,1.0,1.0,3/18,15.77%,CHAC1;GSS;CNDP2
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.3817266604971007,-0.5721917135893082,0.9122807017543859,1.0,1.0,1/5,23.38%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.2616334515972105,0.5717960693827084,1.0,1.0,1.0,13/86,15.17%,SPHK1;EGFR;TGFBR1;H3-3A;SYT1;CDKN2AIP;EDN1;RIMS2;AKAP6;ADNP2;BCL2;SMURF1;SYT2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.34001288749532493,-0.5717385690131676,0.9607843137254902,1.0,1.0,5/10,22.52%,MCM5;ORC3;MCM2;ZNF830;MCM4
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.33602195275301366,-0.5712985101622826,0.9166666666666666,1.0,1.0,3/10,16.16%,DCTN1;TPP1;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.29899330867478685,-0.5706017871088594,1.0,1.0,1.0,6/25,15.88%,SHANK3;ADRA2A;BTC;EREG;HDAC6;TAF1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.34713951682719313,-0.5700785230669718,0.9777777777777777,1.0,1.0,2/11,7.74%,NODAL;RBPMS
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.36009732042081155,0.5698588089928889,0.9534883720930233,1.0,1.0,1/5,14.73%,FTO
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.33094441559537413,-0.5695540165075996,0.9821428571428571,1.0,1.0,3/12,26.09%,METTL3;RLIM;RBM15B
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.3363934661463237,0.5695190782598549,1.0,1.0,1.0,3/14,15.04%,HELLS;BCL2;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3276510174152957,-0.5683561573607169,0.9574468085106383,1.0,1.0,4/19,18.28%,LATS2;INCA1;CAMK2N1;CDKN1C
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.34604810277628684,-0.5682682655601207,0.8979591836734694,1.0,1.0,2/9,13.88%,EXOSC10;EXOSC4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.2878746287944943,-0.5680631982338102,0.9347826086956522,1.0,1.0,10/25,28.37%,PRPF6;PRPF4;MPHOSPH10;SRSF10;KHSRP;SF3B3;SF3A3;SMNDC1;PRPF3;LSM1
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.3928849768486685,0.5678353649419251,0.9545454545454546,1.0,1.0,5/5,60.72%,WNT10A;TBX1;SIX4;INTU;WDPCP
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.269855252389547,-0.5677883360826067,1.0,1.0,1.0,7/65,17.16%,HCK;PLK2;TBC1D24;NPRL2;KIF9;VPS11;CEP295
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.24416785573363586,-0.5677828749480265,1.0,1.0,1.0,21/99,20.73%,RASGRF2;MBTPS2;SELENOK;CHAC1;PPP1R15A;ATF4;DDRGK1;BAK1;ERLEC1;NIBAN1;ATP2A3;UFC1;SELENOS;PDIA4;BRSK2;TMCO1;THBS1;SEC16A;ATG10;CREB3L1;FLOT1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.32314280210505963,-0.5677303676545982,0.9787234042553191,1.0,1.0,5/15,25.89%,EIF2B4;EIF2B3;EIF2B2;EIF2B1;SOX10
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.3364062384759764,0.5674772567246419,0.8974358974358975,1.0,1.0,1/6,9.12%,HIF1A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.23350624691704203,0.5674471200103067,1.0,1.0,1.0,16/106,16.30%,SHROOM2;GFAP;EGFR;FGFR3;DDAH1;ZNRF3;LRP4;FMNL2;LIFR;BCAR1;ABCG2;AMOTL2;MEIS3;ALCAM;MTCL1;SALL1
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.3197900035265028,-0.5672383022586571,0.9807692307692307,1.0,1.0,3/15,15.66%,DRD1;DRD3;DRD4
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.35634577818683444,-0.5668503298370567,1.0,1.0,1.0,2/7,17.69%,MET;SRC
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.32027506280684576,-0.5667079304735099,0.9583333333333334,1.0,1.0,3/10,21.44%,APOA1;SLC45A3;ABCD1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.3558053310080502,0.566596362914854,0.8913043478260869,1.0,1.0,2/7,12.87%,PATL1;DCP1B
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.2916643222286761,-0.5665286829451558,0.9622641509433962,1.0,1.0,2/23,9.63%,CALM1;PER2
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.35707734771001864,-0.5660858429000539,0.9411764705882353,1.0,1.0,1/6,11.77%,AZU1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.3503897970211489,0.566046747895357,0.8297872340425532,1.0,1.0,2/5,19.99%,LPL;PDK2
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.32175667597198615,0.5649621192118238,0.9787234042553191,1.0,1.0,1/12,6.02%,GLRA2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.3251778667147549,0.5649132445565984,0.98,1.0,1.0,1/12,5.96%,NRP1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.3586226240963422,0.5644959398031535,0.9333333333333333,1.0,1.0,1/7,8.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.2820876385416521,0.56445663637997,1.0,1.0,1.0,4/27,17.96%,RAB29;CD160;RELA;DGKZ
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.36713735558408234,0.5640802292870982,0.9272727272727272,1.0,1.0,6/6,63.30%,SLC12A6;RHD;SLC12A4;RHCG;RHCE;SLC12A7
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.3375040275666062,-0.5635732921249784,0.9019607843137255,1.0,1.0,2/6,28.51%,XRCC3;TPR
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.3375040275666062,-0.5635732921249784,0.9019607843137255,1.0,1.0,2/6,28.51%,XRCC3;TPR
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.33422895775325256,0.5634963523190034,0.9375,1.0,1.0,1/12,4.17%,SMAD7
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.28734079180007166,-0.5633262869224223,1.0,1.0,1.0,6/23,24.28%,AHI1;NDRG4;CCDC39;SHH;CCDC40;MICAL2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.2696448767099344,0.5631969163391728,0.9777777777777777,1.0,1.0,7/46,17.04%,PLCB1;SYT1;DLL1;RIMS2;SMURF1;SYT2;NEDD4L
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.25121480529081636,-0.5631459755989113,0.9787234042553191,1.0,1.0,22/66,29.56%,HTATIP2;NUP133;GEMIN4;RPAIN;NUP155;GCKR;SNRPD2;NXT1;CSE1L;NUP85;STAT3;RAN;SNRPD1;NUP214;IPO13;NUP62CL;SEC13;IPO7;NUP50;TPR;AKT1;SNRPB
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.38701019977416623,-0.5631123797195113,0.9285714285714286,1.0,1.0,3/5,19.20%,SNAI2;PKP2;JUP
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.3299226127828799,-0.56235744404839,0.9130434782608695,1.0,1.0,4/13,17.54%,AASS;THAP7;TAF7;MACROH2A1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.3442716304545971,-0.5622990008378115,0.9347826086956522,1.0,1.0,1/7,14.30%,PEX1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.3614084123442928,-0.5617002326087269,0.9545454545454546,1.0,1.0,2/5,25.45%,CTPS2;DCTD
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.33683974581078846,-0.5616159326650249,0.98,1.0,1.0,5/13,25.00%,GPLD1;MCOLN1;RAB11B;TRPV1;IMPACT
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.32832060739316576,-0.5610710663208375,0.9722222222222222,1.0,1.0,1/5,19.88%,GREM1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),0.38084058789398234,0.5604986903679101,0.9846153846153847,1.0,1.0,1/5,9.99%,HMGCR
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.2748223882194203,0.5600567200802542,1.0,1.0,1.0,7/29,20.51%,DGAT2;LPL;DGKB;DGKZ;ABHD12;SEL1L;CAV3
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.319715508830465,-0.5596399427360312,0.9622641509433962,1.0,1.0,3/12,19.42%,RGS2;KCNQ1;TRPM4
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.3314423767427571,0.559630002265418,0.9215686274509803,1.0,1.0,2/11,19.20%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.281915831394297,-0.5594912150417537,1.0,1.0,1.0,1/25,3.42%,KMT2B
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.32272392392302895,0.5594852315677298,0.9607843137254902,1.0,1.0,7/14,24.33%,SLC30A10;SLC39A8;TRPC4;SLC11A2;TRPC1;ATP2C1;TRPC7
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.3498240086693387,-0.5594447110730547,0.9285714285714286,1.0,1.0,3/9,20.91%,CARD9;STAT3;GBP5
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.3554894213942086,-0.558944646772789,1.0,1.0,1.0,1/7,11.37%,NDRG4
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.35075737658712713,0.5587450980143688,0.8888888888888888,1.0,1.0,1/10,3.79%,HMGB1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.3535693270226796,0.5585147374532856,0.9622641509433962,1.0,1.0,3/8,21.68%,EIF2AK3;EIF2S1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.32768822157784006,0.5583016003390523,0.9795918367346939,1.0,1.0,2/9,16.09%,ERN1;PIK3R1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3187485771579333,-0.5582304199584204,0.9811320754716981,1.0,1.0,3/11,19.80%,KDELR1;RER1;KDELR3
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.3247233898239953,-0.558035410335483,0.9473684210526315,1.0,1.0,2/10,17.64%,ERMN;SPRY2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.3011529801162761,-0.5578278171981886,1.0,1.0,1.0,2/26,10.60%,GBP6;HMGB2
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.3735433581593507,0.5575455899044635,0.9791666666666666,1.0,1.0,2/6,17.74%,TACR1;TACR3
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.33290091419682677,-0.5574887497307298,1.0,1.0,1.0,2/10,18.26%,BRSK2;SEC16A
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.3369996661455303,0.5571146901019927,0.9607843137254902,1.0,1.0,3/9,24.11%,SLC9A1;PKD1L3;LGMN
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.38367458418052364,-0.5568180715994935,0.9122807017543859,1.0,1.0,1/5,13.94%,SNX6
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.2992272290068816,0.5559950073041281,0.9473684210526315,1.0,1.0,6/16,20.64%,ZDHHC2;PLK1;VAMP8;CLN3;SPTBN1;STX8
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.3312159639290117,0.5557140914773162,0.9565217391304348,1.0,1.0,3/7,34.04%,ATG2B;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.3312159639290117,0.5557140914773162,0.9565217391304348,1.0,1.0,3/7,34.04%,ATG2B;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.337566490222153,0.5556717142651512,1.0,1.0,1.0,1/10,6.46%,CIDEA
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.3446411417603402,-0.5551231115033383,0.9444444444444444,1.0,1.0,2/9,5.73%,NODAL;ADAM19
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.34845907537022003,-0.555028517851248,0.94,1.0,1.0,1/7,12.14%,XYLB
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.3299859747602043,-0.554983494191831,0.9574468085106383,1.0,1.0,2/10,18.95%,TICRR;NUGGC
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.3200834223852586,-0.554535925509975,0.9545454545454546,1.0,1.0,7/15,25.55%,SPI1;SRC;STAT1;STAT3;IL6R;CTR9;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.27172010417860604,0.5534242912871394,1.0,1.0,1.0,6/44,15.26%,BAG2;HDAC2;ADAM8;PLK1;BTRC;OGT
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.3120562578578221,-0.5529623383884751,0.9607843137254902,1.0,1.0,3/22,14.77%,IFI27;EMD;RBM22
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.3397903571931072,0.5528462654597485,0.9347826086956522,1.0,1.0,1/5,18.61%,COX10
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.3333508633463179,0.5525134168287966,0.9555555555555556,1.0,1.0,1/9,9.14%,FBXO7
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.2808625594126804,0.5522083359260925,0.9767441860465116,1.0,1.0,6/29,19.91%,DOC2B;SYT1;SYT15;SYT2;SYT17;CACNA1H
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.3871975354611489,0.5516448530196598,0.9649122807017544,1.0,1.0,2/5,31.51%,SLC38A3;SLC38A5
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.32919169226537065,-0.5515953312332526,0.9347826086956522,1.0,1.0,7/7,67.10%,AGO1;ADAR;AGO2;AGO4;TARBP2;DICER1;AGO3
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.27946400250555664,-0.551475762022506,1.0,1.0,1.0,4/26,14.63%,KNSTRN;VIL1;PDE8A;SNAI2
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.31554450015416197,-0.5500755577383539,0.9,1.0,1.0,2/8,20.73%,AZU1;FLOT1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.38344984735543797,0.5498962049116253,0.9795918367346939,1.0,1.0,1/7,4.78%,PEX11A
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.3009027056850535,-0.5494444153512741,1.0,1.0,1.0,1/13,4.85%,ACTC1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2669285911665068,-0.5494045953939506,1.0,1.0,1.0,11/26,27.28%,GIPC1;DDRGK1;CAMLG;SVIP;MAP1A;RPL11;HSP90AB1;SDCBP;UBXN1;BAG6;PARK7
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.334633537247518,0.548829591488247,0.9791666666666666,1.0,1.0,4/7,25.93%,GALT;TKTL1;LRP5;PGM2
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.2655744243099628,0.5487285246169405,1.0,1.0,1.0,1/48,1.30%,TYR
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.29305247077054614,0.5485200374508558,1.0,1.0,1.0,3/19,13.24%,SOCS6;SOCS2;THPO
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.25826012061516507,0.5483652810144551,1.0,1.0,1.0,13/40,22.64%,IRS1;GNAI1;ZBTB7B;SIRT1;SORT1;CREB1;OGT;TGFBR3;CRY1;ROCK2;EPM2AIP1;ZFP36L1;KHK
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.25219546265381065,-0.5481045038872949,0.9795918367346939,1.0,1.0,6/38,18.34%,TPTE2;PLPP4;PLPPR3;INPP5B;EPHX2;PLPP2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.2489355217009469,0.5479231416678777,1.0,1.0,1.0,8/46,19.40%,MSL2;JADE3;EPC1;EP300;OGT;RUVBL2;ACTL6A;ATF2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.3015175513361223,-0.5455318721938158,0.9636363636363636,1.0,1.0,3/15,21.93%,UFD1;SELENOS;NPLOC4
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.3489539854700949,-0.5454232339812217,0.9215686274509803,1.0,1.0,3/8,16.03%,TCIM;INO80;RPS6KA1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.29870158760516324,-0.5452740679035851,1.0,1.0,1.0,8/18,29.88%,EXOSC10;CCT2;CCT6A;DCP2;NHP2;CCT8;DKC1;NOP10
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.2386801524742194,-0.5444692468160245,1.0,1.0,1.0,9/72,14.80%,RAC1;VAV3;EPHB6;SDC2;EPHA1;DNM1;ACTB;APH1B;EFNA1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.3166007758327625,0.5441465994778231,0.9791666666666666,1.0,1.0,5/8,38.21%,ABL1;NRCAM;APOE;GSK3B;SIN3A
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.2518192713265073,0.5440011834386335,1.0,1.0,1.0,18/56,28.44%,LIMK2;CEP120;TBC1D1;EVI5;USP6NL;TBC1D5;BBS4;CDK10;TESK1;TBC1D8;IFT20;TBC1D15;TBC1D2;ODAD3;CEP97;TAPT1;CYLD;CROCC
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.3065756997474385,0.5438450304705693,0.9777777777777777,1.0,1.0,3/7,21.36%,FGF10;MDK;STXBP4
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.3008972113962275,-0.5436499422640458,0.9821428571428571,1.0,1.0,5/13,27.85%,ACTB;LSR;ARHGEF18;CGNL1;ACTG1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.3021709568599318,0.5432438040952248,0.9285714285714286,1.0,1.0,2/14,13.09%,CTNNB1;GNL3L
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.2772261462450222,0.5432089733314681,0.9761904761904762,1.0,1.0,2/26,10.19%,AGER;ZDHHC2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.36108761303881054,-0.5423194417548216,0.9615384615384616,1.0,1.0,1/5,13.34%,KDM6B
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.33492370797239046,0.5421833067172775,0.92,1.0,1.0,3/6,32.81%,STIM1;CACNA1C;CACNA1D
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.28144204261337047,-0.5417696685647087,0.9777777777777777,1.0,1.0,2/18,13.65%,UBC;EDEM2
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.36576233067452346,-0.5413037978504746,0.9375,1.0,1.0,2/5,19.47%,CARMIL2;MTPN
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.24817388888774233,0.5399816424572462,1.0,1.0,1.0,2/66,2.85%,RALA;SYK
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.323911890301005,-0.5397946155066213,0.9574468085106383,1.0,1.0,2/10,13.88%,EXOSC10;EXOSC4
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.25464806949210084,0.5388556395598396,1.0,1.0,1.0,8/34,22.84%,GLRA2;GLRB;RNF139;SYVN1;DERL1;SEL1L;RNF185;RHBDD1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.26368913252844917,-0.5380946646215238,1.0,1.0,1.0,12/30,28.52%,LSM7;EXOSC4;POLR2G;DCPS;LSM4;LSM6;LSM5;LSM3;DCP2;LSM2;LSM1;EXOSC6
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.3194596623150774,-0.5380152858204685,0.9583333333333334,1.0,1.0,2/7,15.57%,ARHGAP12;BMP7
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.23475657235388736,0.5379747213373961,1.0,1.0,1.0,21/127,17.38%,ITGAM;TP63;RAB29;ECT2;UBR5;HDAC3;ZDHHC2;PCM1;PPP1R13B;TENM1;ANK3;SMAD3;BCL2;TP53BP2;UBE2D3;MTCL1;MAPK8;PIK3R1;AKT2;TCAF2;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.27407227147923907,0.5379289613556865,1.0,1.0,1.0,8/25,26.59%,LRP4;FGF13;MAP2;KIAA0319;RNF6;PTEN;DCC;RUFY3
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.35524974233917467,0.5373652095752641,0.96,1.0,1.0,2/6,27.82%,NOP53;TANK
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.26719155336520345,0.5367691339573684,1.0,1.0,1.0,5/23,19.58%,CDK6;DLL1;MDK;SOX11;MYRF
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.2807200768954161,-0.5366094629767613,0.9534883720930233,1.0,1.0,2/17,13.67%,ADAM19;SERPINF2
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.3508046881593186,0.5365703534513374,0.9491525423728814,1.0,1.0,2/6,21.14%,PDGFB;NFKB1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.2717994281801309,0.536408643070893,1.0,1.0,1.0,5/19,21.14%,NUS1;NR1H3;OSBPL6;YJEFN3;NFKB1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.29305287126296925,-0.5360988888786754,0.9583333333333334,1.0,1.0,2/12,18.39%,ALG8;ALG9
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.3108009417226919,-0.5360497467094576,0.9807692307692307,1.0,1.0,1/11,4.35%,TPM1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.34979140879292153,0.5355909745591859,0.953125,1.0,1.0,5/5,65.03%,AEBP1;RB1;COLGALT1;CHADL;EFEMP2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.26841039776193143,-0.5354787766523871,1.0,1.0,1.0,3/33,8.93%,KIF1A;KIF4A;KIF5A
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.3399297905436262,-0.5353904725003231,0.9629629629629629,1.0,1.0,5/9,23.70%,ORC1;TICRR;HUS1;ZNF830;CDC6
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.3034030483708676,-0.5350426210967905,0.9807692307692307,1.0,1.0,2/18,8.80%,IL4I1;GLMN
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.31734422055117595,-0.5349784408915471,0.9245283018867925,1.0,1.0,2/11,21.20%,MORC2;SETDB1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.3209008726798782,0.5342172073276796,0.9787234042553191,1.0,1.0,1/7,11.41%,STARD4
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.30040839990836116,-0.5332501121958222,0.9454545454545454,1.0,1.0,3/13,16.02%,MDC1;HUS1;MUS81
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.26851172663435957,0.5329044885348609,1.0,1.0,1.0,6/32,19.01%,HDAC9;BLNK;TPD52;SYVN1;RAG2;RAG1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.27416640270081205,0.531895906636049,1.0,1.0,1.0,7/23,21.42%,AGER;MBP;AIM2;PICALM;ROCK2;EPHA4;FYN
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.25836113664177723,-0.5314170144175087,0.9821428571428571,1.0,1.0,9/33,24.96%,DAXX;HMGB2;CHAF1A;SMARCA5;MACROH2A1;PADI4;HAT1;NPM1;CHAF1B
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.3023142225854994,-0.5309248061637926,1.0,1.0,1.0,2/14,16.16%,SHANK3;SHANK1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.2242262081955038,0.5302338114363169,1.0,1.0,1.0,13/75,23.87%,BAG2;IER5;SIRT1;HSPA1A;EP300;NUP42;RANBP2;DNAJB1;HSPA1L;NUP54;CAMK2D;HSPA8;BAG5
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.3339165298289072,-0.5287758342011116,0.9245283018867925,1.0,1.0,1/6,15.21%,BAG4
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.3037442180267184,0.5275487696157267,0.9259259259259259,1.0,1.0,1/10,8.20%,JMJD1C
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.2955553766839661,-0.5270629743619667,0.9782608695652174,1.0,1.0,4/15,15.62%,BCAR3;STN1;EREG;NPM2
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.3225614114147643,0.5265508416927115,0.9473684210526315,1.0,1.0,1/7,12.59%,MARCHF7
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.268328891080974,0.5253144111386063,0.9591836734693877,1.0,1.0,4/14,23.15%,DYRK3;CUL3;STXBP4;ZNF16
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.29734790705466774,0.5247892061987416,0.9803921568627451,1.0,1.0,3/17,13.04%,CTNNA2;WASF2;ARFIP1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.31054134991348403,-0.524708192463263,0.9636363636363636,1.0,1.0,1/11,8.72%,PARP14
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3094844982572005,-0.5241250658219914,1.0,1.0,1.0,14/14,69.08%,HNRNPM;SRSF9;RSRC1;DHX9;DDX17;SCNM1;SLU7;CELF4;SFPQ;RBM17;PQBP1;CDK13;PUF60;DDX5
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.3046125497117835,0.5238190823194215,0.9803921568627451,1.0,1.0,4/10,20.48%,PLA2G15;DGKB;DGKZ;GAL3ST1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.31860237955783904,-0.5214032251034115,1.0,1.0,1.0,2/6,21.65%,DPH6;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.31860237955783904,-0.5214032251034115,1.0,1.0,1.0,2/6,21.65%,DPH6;DPH7
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.259150395864669,-0.5202423537570016,1.0,1.0,1.0,10/47,27.26%,EXOSC10;STN1;NAT10;SRC;CCT2;PIF1;CCT6A;SMG6;FBXO4;DCP2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.31763481080764155,-0.5201080435321551,1.0,1.0,1.0,1/9,7.47%,FGF7
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.24964208504277535,0.5200249558631251,1.0,1.0,1.0,10/37,21.43%,GPT;DDAH1;RIMKLB;DDAH2;NAALAD2;SRR;SLC25A12;RIMKLA;KYAT3;GNMT
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2505605350556845,0.5196217286574549,1.0,1.0,1.0,5/19,17.27%,TRDN;ANK2;AKAP6;SLC9A1;VMP1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.2727010116042221,0.5194443398936923,0.9555555555555556,1.0,1.0,3/16,19.22%,MCM7;MCMDC2;MCM6
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.295272160315495,-0.5193902039098368,0.9795918367346939,1.0,1.0,11/11,70.49%,AP3S2;AP3D1;BLOC1S4;SNAPIN;BLOC1S2;AP3B2;AP3S1;DTNBP1;AP3M1;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.295272160315495,-0.5193902039098368,0.9795918367346939,1.0,1.0,11/11,70.49%,AP3S2;AP3D1;BLOC1S4;SNAPIN;BLOC1S2;AP3B2;AP3S1;DTNBP1;AP3M1;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.24528060075847846,0.5193571628303173,0.9818181818181818,1.0,1.0,6/32,18.08%,FHIT;EIF3H;RYBP;MARCHF7;OGT;PSMF1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.26830280824770775,0.5191418730151778,1.0,1.0,1.0,8/25,20.41%,NR3C1;TFPI;CATSPERB;NR1H3;URI1;ADTRP;ATP1A2;CATSPER2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.28340517674651844,0.518249138240451,0.9807692307692307,1.0,1.0,3/17,17.96%,CD22;CD160;DGKZ
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.23845725987304936,-0.5180735558238341,1.0,1.0,1.0,8/82,16.69%,STX4;FTH1;AP1S1;ARF1;DOP1B;CCDC93;CHMP2A;CLTA
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.24545503134322458,-0.5172068121275968,1.0,1.0,1.0,7/36,21.67%,SLC6A9;ATP1B1;SLC6A20;TRPM4;SLC29A4;SLC7A5;TRPM8
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.26742788547173996,0.5171473975737413,0.9655172413793104,1.0,1.0,7/19,38.11%,HNRNPD;TNKS;TERF2;NEK7;NBN;RAD50;MAP3K4
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.3467357417935081,0.517011556935857,0.9636363636363636,1.0,1.0,6/6,65.34%,TBCA;TCP1;TBCE;TBCC;VBP1;TBCD
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.33109024944856513,-0.516331056398304,0.9444444444444444,1.0,1.0,1/7,15.26%,SLC30A5
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.25632934001322705,0.5162646584238348,1.0,1.0,1.0,5/31,16.09%,ECT2;UBR5;HDAC3;SMAD3;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.3221014991060376,0.5158423336826157,0.9772727272727273,1.0,1.0,5/5,67.80%,BMPR2;PRCP;ADRB1;SOD2;GPR37L1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.318228261687252,0.5156312027783113,0.9814814814814815,1.0,1.0,3/7,23.31%,PLK1;HECW2;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.32444839787281693,0.515603305371221,1.0,1.0,1.0,1/5,11.41%,STARD4
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.32919169226537065,-0.5153895662776105,0.9807692307692307,1.0,1.0,7/7,67.10%,AGO1;DHX36;DHX9;AGO2;AGO4;DDX3X;AGO3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.32916150919176634,-0.5150475950297801,0.9411764705882353,1.0,1.0,5/5,67.10%,AGO1;AGO2;AGO4;MOV10;AGO3
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.35195657504766115,0.5133627797898996,0.9761904761904762,1.0,1.0,1/6,9.19%,ZNF675
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.2855308454563513,-0.5131415181398109,1.0,1.0,1.0,10/16,34.46%,ATF4;POLR2L;POLR2K;LYAR;WDR75;UTP15;UBTF;ERBB2;DHX33;HEATR1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.22819302831417576,-0.5129702567356473,1.0,1.0,1.0,13/66,22.67%,SPI1;JADE2;MORF4L1;TAF6;MEAF6;BRD8;TAF10;POLE3;KAT5;TADA3;YEATS4;TADA1;HAT1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.28148615771004726,0.5121519018955518,1.0,1.0,1.0,1/12,15.02%,IDH1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.2711500405892593,-0.5117432713281179,1.0,1.0,1.0,5/24,20.22%,MORF4L1;TAF6;BRD8;ATAT1;KAT5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.3052394318360769,-0.5113731768216349,0.9642857142857143,1.0,1.0,2/6,21.94%,SELENOS;AXL
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.2557904382693207,-0.5112762774386564,1.0,1.0,1.0,5/36,13.66%,KIF17;IFT27;TRAF3IP1;IFT22;DYNLRB1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.26544346933380697,0.5104988595665364,1.0,1.0,1.0,9/24,29.36%,SYNJ2;MTMR12;PIP4P2;MTMR11;PTEN;MTMR6;MTMR3;MTMR2;INPP5F
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.31820199534360827,0.5097565674623146,1.0,1.0,1.0,1/9,8.82%,CCL5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3152889070398332,-0.5096879040002497,1.0,1.0,1.0,4/7,35.06%,EXOSC4;EXOSC6;EXOSC7;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3152889070398332,-0.5096879040002497,1.0,1.0,1.0,4/7,35.06%,EXOSC4;EXOSC6;EXOSC7;EXOSC5
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.33228660109290553,0.5093498086937209,0.9574468085106383,1.0,1.0,2/6,30.72%,BMP6;WNT4
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.34056381858502716,0.508953564933669,0.9298245614035088,1.0,1.0,2/5,25.86%,ROCK2;NCOA4
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.34056381858502716,0.508953564933669,0.9298245614035088,1.0,1.0,2/5,25.86%,ROCK2;NCOA4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.27049215840799795,0.5089277816872264,0.9534883720930233,1.0,1.0,3/13,23.28%,ACADVL;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.2560336441424259,-0.5082671661822848,0.9791666666666666,1.0,1.0,2/24,8.68%,SHANK3;ARF1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.2816164804947021,-0.5072148834526095,1.0,1.0,1.0,4/13,24.60%,SLC25A5;ABCC4;ABCC6;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.31708117523011004,-0.5071099446815972,1.0,1.0,1.0,2/9,15.57%,LRP8;BMP7
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.34188645476029716,-0.506469534608386,0.9795918367346939,1.0,1.0,1/5,14.03%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.29272395555904707,-0.5060867347986592,0.9811320754716981,1.0,1.0,2/10,17.77%,NR1H4;ASAH1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.29795702170516497,-0.5056947339643985,0.9361702127659575,1.0,1.0,3/11,21.75%,PER2;GYS1;NR1D1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.29795702170516497,-0.5056947339643985,0.9361702127659575,1.0,1.0,3/11,21.75%,PER2;GYS1;NR1D1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.30806917683957974,-0.5050656102407112,0.9591836734693877,1.0,1.0,2/12,21.20%,MORC2;SETDB1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.29942278853096305,-0.5049594033256942,0.9722222222222222,1.0,1.0,1/6,11.79%,DNM1
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),0.33138380543313783,0.5047908793981967,1.0,1.0,1.0,2/5,25.70%,TCAP;RYR2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),-0.3056557153657161,-0.5046857696036162,0.9591836734693877,1.0,1.0,2/8,23.64%,CPNE7;CPNE6
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.31394166939024837,0.5046371922385899,0.9333333333333333,1.0,1.0,1/5,17.08%,PROX1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2939813072682714,-0.5043758167789685,0.9411764705882353,1.0,1.0,3/11,18.56%,UQCRH;UQCRC1;UQCR10
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.3100980225596921,-0.5033273157175644,0.9516129032258065,1.0,1.0,2/7,16.42%,CALM1;CALM3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.28338104564354627,-0.502799257472121,0.9591836734693877,1.0,1.0,2/9,26.84%,MTOR;AR
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.31731266894980437,-0.5011651717559996,0.9375,1.0,1.0,1/7,12.93%,DNM1L
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.2779525760690857,-0.5011519342921064,0.9818181818181818,1.0,1.0,3/12,19.30%,HDAC5;THBS1;CARD10
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.2851116511531934,0.5004216026424084,0.9636363636363636,1.0,1.0,9/9,71.50%,AHCTF1;NDC1;NUP153;NUP98;RTN4;NUP107;NUP205;NUP93;TPR
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.30416593711633,0.4997280198512954,0.9629629629629629,1.0,1.0,4/7,24.30%,CLN3;PKDCC;CNST;ATP2C1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.31109383853735806,-0.4986669938235997,0.9285714285714286,1.0,1.0,1/8,10.44%,HTR2A
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.29739166743777323,-0.49858367457276237,1.0,1.0,1.0,1/10,7.47%,FGF7
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.2856970343445683,-0.49821927645882935,0.9642857142857143,1.0,1.0,2/10,16.74%,AKAP8L;SAP30BP
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.27679959579475055,0.49780624871315055,1.0,1.0,1.0,2/12,13.31%,SLC8A1;GJC1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.3341997250183052,-0.49757841911415296,0.98,1.0,1.0,1/5,11.90%,RACK1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.3244889229175243,0.49746645353709773,1.0,1.0,1.0,3/7,17.40%,DNAH11;ODAD2;CFAP43
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.32201762298746717,-0.4959209642496672,1.0,1.0,1.0,3/6,24.96%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.32201762298746717,-0.4959209642496672,1.0,1.0,1.0,3/6,24.96%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.30964544909045577,-0.49547091299325463,0.9782608695652174,1.0,1.0,3/9,17.60%,KDM6B;KDR;EDF1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.3074420240881697,0.4954660305994759,0.9782608695652174,1.0,1.0,1/8,9.24%,ABL2
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.28753128741850476,-0.49531041079837856,0.9672131147540983,1.0,1.0,5/11,22.52%,MCM5;MCM2;MUS81;CDC7;MCM4
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.22979534961326462,0.49481535369627105,1.0,1.0,1.0,1/50,3.08%,KIAA1586
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.3302404325978473,0.4946482934230588,0.96,1.0,1.0,3/5,33.50%,ROCK2;TMBIM1;IL15
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.27065826674404814,0.4944616363384273,0.9818181818181818,1.0,1.0,3/17,12.57%,BCOR;RNF2;RYBP
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.24160841732381708,0.4943105394937339,1.0,1.0,1.0,3/29,21.56%,CTNNB1;NAF1;ACD
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.2210943356557823,-0.4942994979085582,1.0,1.0,1.0,12/46,26.94%,NOS2;NUP133;NUP43;EIF6;NUP155;GCKR;RUBCNL;NUP85;NUP214;SEC13;SLC2A6;NUP50
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.23054293645956137,-0.49317481045984474,0.9782608695652174,1.0,1.0,10/35,25.41%,MAX;CHEK1;RING1;CBX5;CDC7;RBBP8;L3MBTL2;DAB2IP;TFDP1;UXT
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.3297033394112895,-0.49293838937235945,0.9818181818181818,1.0,1.0,2/9,21.78%,SRC;PIF1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.23426227045853393,0.49256787073921676,1.0,1.0,1.0,6/25,22.92%,ERN1;PACRG;HSPA1A;HSPA1L;RHBDD1;HSPA8
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.268064967809202,0.49251249411003556,0.9795918367346939,1.0,1.0,4/12,26.94%,DESI2;SAE1;UBA5;UBA3
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.21253330414489435,0.4923322870519081,1.0,1.0,1.0,6/90,12.55%,SYK;BANP;TAF3;TOR1AIP2;PLK1;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.28639434501757316,-0.4918594664408008,1.0,1.0,1.0,2/8,20.73%,EHD2;FLOT1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.29457847186499203,0.4899301490580289,1.0,1.0,1.0,3/8,20.95%,PDK4;PDK2;PDK1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.29457847186499203,0.4899301490580289,1.0,1.0,1.0,3/8,20.95%,PDK4;PDK2;PDK1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.27425026420066995,-0.48909975016333174,1.0,1.0,1.0,6/20,24.60%,CDC37;YBX3;SPATA2;FLOT1;SDCBP;SLC25A4
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.24755384314228457,-0.4890251152380958,0.9772727272727273,1.0,1.0,2/23,13.65%,UBC;EDEM2
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.29215418111431757,0.48879679341314697,0.9787234042553191,1.0,1.0,3/8,23.72%,VIM;NOD1;RIPK2
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.29235356288939607,0.4882704336352903,0.94,1.0,1.0,2/8,22.44%,SLC9A1;PKD1L3
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.2351783231412103,-0.4875870636386245,1.0,1.0,1.0,6/26,24.28%,AHI1;NDRG4;CCDC39;SHH;CCDC40;MICAL2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.25051636247619496,-0.4874745274739265,1.0,1.0,1.0,3/19,22.42%,KHSRP;DGCR8;RAN
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.3172420116444322,-0.48735124824171033,0.9285714285714286,1.0,1.0,5/5,68.29%,TGFB1;IRAK3;CUEDC2;TGFB3;TGFB2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.28562531149368336,-0.48730725179559575,0.975,1.0,1.0,2/13,15.55%,DGKD;PIK3CB
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.27825726182510524,-0.48704572705157284,0.9183673469387755,1.0,1.0,2/11,16.19%,GAK;RBSN
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.2903953347752937,0.4852595341322494,0.9444444444444444,1.0,1.0,1/7,9.90%,PRIMPOL
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.2578834379766312,-0.4832104213421059,0.9824561403508771,1.0,1.0,5/18,22.28%,WRAP73;FUZ;SAXO1;HAP1;ENTR1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.2825972700417415,0.48076214100686826,1.0,1.0,1.0,2/13,16.50%,GSTO2;CPEB2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.3153583961719491,-0.47943556540462373,0.9787234042553191,1.0,1.0,1/5,12.91%,TICRR
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.2746330005105154,0.47871536796943476,1.0,1.0,1.0,5/14,20.47%,HSPA1A;BCL2;EYA2;BCL2L1;EYA3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.2746330005105154,0.47871536796943476,1.0,1.0,1.0,5/14,20.47%,HSPA1A;BCL2;EYA2;BCL2L1;EYA3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.2814835365421001,-0.4785989938525298,1.0,1.0,1.0,3/13,28.51%,MORC2;SETDB1;TPR
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.2738500028624291,0.47842761570990994,1.0,1.0,1.0,3/18,20.32%,RAD51B;DTL;MECP2
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.24881653706604887,-0.4774071711342414,1.0,1.0,1.0,6/28,24.48%,SCN11A;CACNG4;ATP5IF1;CACNA1A;P2RX4;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.2746898651548828,-0.4766481706838334,0.9795918367346939,1.0,1.0,2/11,18.76%,SUPT16H;SUPT6H
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.29538774073782814,-0.47631902495552286,0.9827586206896551,1.0,1.0,3/8,22.51%,PTPRC;HSPD1;CD70
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.29753993537808265,0.4754875434281067,1.0,1.0,1.0,1/6,13.54%,INSYN2A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.261616196492675,-0.4751310086208956,0.9807692307692307,1.0,1.0,2/15,17.66%,SFRP4;THBS1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.2366998380629639,0.47489548367088036,1.0,1.0,1.0,3/21,19.82%,MAIP1;BAD;BMF
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.2862051273835065,-0.47474166199792933,1.0,1.0,1.0,2/10,19.12%,DGKD;DGKG
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.27858198241329296,-0.47382806505384506,1.0,1.0,1.0,5/11,25.00%,ATF4;EIF2AK1;QRICH1;EIF2AK4;IMPACT
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.32425617750882507,0.47362331621371806,0.9787234042553191,1.0,1.0,5/5,67.58%,AXIN1;GSK3B;CSNK1A1;APC;AMER1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.2804291878321282,0.4734965603754094,0.98,1.0,1.0,4/12,23.33%,UAP1;GNPNAT1;NANP;GNPDA2
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.2765805806466923,-0.47343626567504077,0.9583333333333334,1.0,1.0,3/12,23.88%,NOS2;NOS3;ORAI1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.23631464600138608,-0.4733394874674313,1.0,1.0,1.0,10/27,31.68%,GAK;SDF2L1;ENTPD5;CCT2;ST13;HSPA2;HSPA9;DNAJB5;HSPA13;ERO1A
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.2670232977223731,0.4730994710116946,1.0,1.0,1.0,2/10,24.82%,TF;RPL39
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.2966715569411334,0.4723973052727273,0.9803921568627451,1.0,1.0,6/6,70.34%,MINPP1;PRUNE1;PRUNE2;BNIPL;BNIP2;ATCAY
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.24643189626530726,0.47089464046690643,1.0,1.0,1.0,4/20,23.30%,TBC1D12;ELAPOR1;PIKFYVE;IFT20
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.276343703296266,0.4695122923304613,0.9791666666666666,1.0,1.0,3/11,24.31%,WASF2;WASF1;ABI2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.30423745090430565,0.4691001887055481,0.9795918367346939,1.0,1.0,3/6,28.92%,ATF2;NAIF1;ACAA2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.24502133908023635,0.4688811815849595,1.0,1.0,1.0,1/17,7.37%,SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.2871361177040558,-0.46843907199169277,1.0,1.0,1.0,2/7,20.73%,EHD2;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.32090064199840806,0.46602201056502984,1.0,1.0,1.0,2/5,24.15%,MEF2C;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.30486389135297054,0.4655906575918759,0.98,1.0,1.0,2/5,21.14%,PROX1;NFKB1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.21580924261287554,0.4647001794038445,1.0,1.0,1.0,6/29,22.92%,ERN1;PACRG;HSPA1A;HSPA1L;RHBDD1;HSPA8
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2558717183096717,-0.4600489736114114,1.0,1.0,1.0,1/12,12.34%,CXCL14
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.27991870824085907,-0.4598764573618691,0.9565217391304348,1.0,1.0,1/7,8.60%,ATF4
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.25364476424102794,-0.4590403517210762,0.9833333333333333,1.0,1.0,5/16,28.71%,AASS;GOT2;CRYM;ALDH7A1;AADAT
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.2958193058987505,0.4585794656399991,0.9411764705882353,1.0,1.0,2/5,28.35%,MTMR3;MTMR2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.259466789269882,0.45774654456957553,0.9565217391304348,1.0,1.0,2/13,17.55%,HIF1A;SPAST
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.2875936309042226,-0.4571437494234371,0.96,1.0,1.0,2/7,23.93%,IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.24534744554100768,0.45685433247308826,1.0,1.0,1.0,5/18,24.68%,PLK1;LRWD1;RUVBL2;NIPBL;MSH2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.26894052281741043,0.4565769596669678,0.9807692307692307,1.0,1.0,3/8,26.64%,DMTN;PTK2;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.2580395958554919,0.45633134547587656,1.0,1.0,1.0,3/14,17.26%,SHQ1;PTBP2;KAT2B
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2311851966705428,-0.45606819993729986,1.0,1.0,1.0,11/28,28.52%,LSM7;EXOSC4;DCPS;LSM4;LSM6;LSM5;LSM3;DCP2;LSM2;LSM1;EXOSC6
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.2840933721560052,-0.4559185002764589,0.9791666666666666,1.0,1.0,3/6,33.77%,SPATA18;BNIP3;YME1L1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.22140789500476366,-0.45576924965260746,1.0,1.0,1.0,7/30,25.41%,COPG2;TMEM201;MAP1S;PAFAH1B1;HAP1;UBB;UXT
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.28243155548273063,0.45492831987852145,1.0,1.0,1.0,2/6,23.54%,SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.2743783770852355,0.4528327602235794,1.0,1.0,1.0,2/11,14.70%,UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.2504867236907043,0.45255763686800293,1.0,1.0,1.0,1/15,11.81%,NLRC3
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.20224282589997775,-0.4523420989013884,1.0,1.0,1.0,12/41,29.54%,NUP133;NUP43;EIF6;NUP155;GCKR;NUP85;NUP214;SEC13;SLC2A6;NUP50;TPR;ZBTB7A
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.2573603343448756,0.44977308425554463,1.0,1.0,1.0,4/10,25.70%,SYT1;STIM1;KCNMB3;RYR2
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.2425339429195776,-0.44975712532548234,0.9807692307692307,1.0,1.0,5/19,23.27%,PIN1;PPIC;PPIL3;PPIB;PPWD1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.21906972883930254,0.44946177854977365,1.0,1.0,1.0,5/20,21.48%,HMGCR;NDFIP2;ADTRP;PKDCC;DPH3
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.25755332710598017,-0.4465854507035052,0.9591836734693877,1.0,1.0,4/7,30.68%,GTF3C2;POLR2L;GTF3C6;GTF3C3
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.2837271294408214,-0.44576690598681723,0.975,1.0,1.0,1/5,20.31%,ABHD1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.28162957521833754,-0.44522182340532696,0.98,1.0,1.0,4/9,24.60%,SLC25A5;CR1;ABCC6;SLC25A4
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.302113418603585,0.4448765090268956,0.9411764705882353,1.0,1.0,5/5,69.80%,VCPIP1;SPRTN;TEX264;TRAIP;VCP
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.27617825050430955,-0.44394798214446546,0.9811320754716981,1.0,1.0,6/6,72.39%,PTPN22;EZR;DUSP1;DUSP10;DLG1;CYLD
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.21130785918955622,0.44368666068544366,1.0,1.0,1.0,10/22,33.11%,PIK3CA;MAP2;HSPA8;ABL1;CAMSAP3;AEBP1;CAMSAP2;CHRNA7;APOE;AKAP13
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.2814176333042961,0.44335437571887565,1.0,1.0,1.0,7/7,71.87%,LYST;UBXN6;MVB12A;CHMP3;VPS4B;VCP;CHMP2B
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.24974036057307036,-0.44324231274539366,1.0,1.0,1.0,4/15,18.87%,UBE3A;THBS1;SRC;CATSPERG
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.28565534314399665,-0.4428344887622969,1.0,1.0,1.0,5/5,71.45%,BEND3;KMT5C;SMYD5;KMT5B;SETD4
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.28565534314399665,-0.4428344887622969,1.0,1.0,1.0,5/5,71.45%,BEND3;KMT5C;SMYD5;KMT5B;SETD4
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.25347333669585953,0.4427383432153634,1.0,1.0,1.0,9/9,74.66%,PHF8;KDM4C;KDM7A;KDM2A;KDM8;KDM2B;RIOX2;RIOX1;KDM4B
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.26993412636897113,-0.4426845219086592,1.0,1.0,1.0,1/7,11.79%,DNM1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.2650146128597101,-0.44264130406639457,1.0,1.0,1.0,1/9,9.10%,PLK2
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.28396527708447095,0.4418918938527517,0.9767441860465116,1.0,1.0,2/9,24.58%,CACNA1H;FDX1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.28972682286715656,-0.4415987683407694,0.9836065573770492,1.0,1.0,1/5,19.52%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.28972682286715656,-0.4415987683407694,0.9836065573770492,1.0,1.0,1/5,19.52%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.28972682286715656,-0.4415987683407694,0.9836065573770492,1.0,1.0,1/5,19.52%,SOD1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.27815735244213885,0.4413910190267711,1.0,1.0,1.0,2/8,24.15%,MEF2C;MYOCD
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.25718893136193854,-0.44040238429075945,1.0,1.0,1.0,5/14,23.70%,ORC1;TICRR;HUS1;ZNF830;CDC6
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.28314689161929213,-0.4383934427405092,1.0,1.0,1.0,6/6,71.70%,IMPACT;WRN;YY1;POLH;MAP3K4;BCL3
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.30088921869475393,-0.43755134862980816,1.0,1.0,1.0,1/6,12.83%,CEACAM1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.25627034710440644,-0.4354439194500616,1.0,1.0,1.0,9/9,74.39%,IRAK1;EPG5;PIK3C3;PIK3R4;IRAK2;TNIP2;TRAF6;PIK3AP1;IRAK4
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.24511497295160117,0.43410795283120873,1.0,1.0,1.0,2/12,15.31%,OGT;TET2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.26847635520470214,0.43333540419054306,0.9629629629629629,1.0,1.0,1/8,9.90%,PRIMPOL
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.2752028606794115,0.4332779479110293,0.9811320754716981,1.0,1.0,5/5,72.49%,FBXW7;FBN1;NOTCH2;ATP6AP1;SIGLEC15
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.2503234175477416,-0.43254273689010425,1.0,1.0,1.0,2/17,16.40%,GMIP;RRP1B
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.24478962137542687,0.43223824670252303,1.0,1.0,1.0,3/14,23.31%,PLK1;HECW2;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.24145192821987774,-0.43210642689830064,1.0,1.0,1.0,4/17,23.69%,BOLL;POLR2G;CDC123;MTOR
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.20975453456680088,0.43101766142205467,1.0,1.0,1.0,7/39,22.79%,WASHC4;FNBP1L;SORT1;AKTIP;EXOC8;PI4K2B;ZFYVE16
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.2741382176842877,0.43063449850787183,0.9824561403508771,1.0,1.0,1/5,18.89%,CA2
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.2781866729720778,0.4306242247196139,0.9591836734693877,1.0,1.0,2/6,22.83%,FYN;NTRK2
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.2634450506625097,-0.4292966544060772,0.9523809523809523,1.0,1.0,7/7,73.67%,ALDH1A3;RARG;EFEMP1;KDM2B;FBN2;LRP6;FBN1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.2956653352025422,0.4289731385301829,1.0,1.0,1.0,1/6,10.95%,NPL
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2475482633216032,-0.42823865535537226,1.0,1.0,1.0,3/10,26.60%,EHD2;FLOT1;ADAM9
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.2459018998662037,0.4280941801389425,1.0,1.0,1.0,4/19,24.32%,PRKACB;ADCY2;ADCY3;ADCY9
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.23693140132061602,0.4277257789921347,1.0,1.0,1.0,10/10,76.32%,SESN1;RRAGD;SESN2;RRAGB;SESN3;GCN1;LARS1;IMPACT;EIF2AK4;MTOR
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.27075401563795026,0.4275374536206874,0.9791666666666666,1.0,1.0,2/8,20.84%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.27075401563795026,0.4275374536206874,0.9791666666666666,1.0,1.0,2/8,20.84%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.2727696034905934,0.42517117856865844,1.0,1.0,1.0,1/6,13.97%,GTF3C4
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.2799560671566046,-0.42473180316751824,1.0,1.0,1.0,1/6,16.09%,CTSH
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.2799560671566046,-0.42473180316751824,1.0,1.0,1.0,1/6,16.09%,CTSH
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.2476844304823201,-0.42427494809489524,1.0,1.0,1.0,1/7,15.75%,HDAC6
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.22152356848815774,0.42398854981501716,1.0,1.0,1.0,7/22,25.32%,WASF2;TMEFF2;PIK3R1;CLASP1;CLASP2;WAS;ARHGAP28
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.22328710450159767,-0.4229360350411549,1.0,1.0,1.0,8/22,31.68%,GAK;SDF2L1;ST13;HSPA2;HSPA9;DNAJB5;HSPA13;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.24194070433254292,0.4215482143912181,1.0,1.0,1.0,4/7,34.27%,RAP1A;FMR1;SLC30A1;RAP1B
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.2736970004605185,-0.42148792989269585,1.0,1.0,1.0,1/6,15.57%,BMP7
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),-0.2664466144042543,-0.42042347504809524,0.9565217391304348,1.0,1.0,5/5,73.37%,ADAM9;ITGA4;NPNT;PLPP3;ITGB1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.25617864184510986,0.41975813384324784,1.0,1.0,1.0,9/9,74.39%,VCAN;CHST12;DSE;NCAN;DCN;BCAN;CSPG5;UST;DSEL
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.28505936826662986,0.4161923249152725,0.975609756097561,1.0,1.0,5/5,71.50%,PLSCR1;CSNK2A1;CSNK2A2;NUMA1;TPR
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.26311761032078307,-0.4155649419287939,1.0,1.0,1.0,1/6,24.09%,UBE2S
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.24535251469923253,-0.41551298822189897,0.9791666666666666,1.0,1.0,1/10,9.61%,ATP1B1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.2561903888481292,0.41414811342380775,1.0,1.0,1.0,10/10,74.39%,VCAN;CHST12;DSE;NCAN;DCN;BCAN;IDUA;CSPG5;UST;DSEL
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.24079168348210114,0.41363649893218724,1.0,1.0,1.0,1/12,10.98%,SLC25A41
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.23016752298442686,-0.4119857019637146,1.0,1.0,1.0,7/15,34.57%,GOT2;OAT;DGLUCY;AADAT;GAD1;ALDH5A1;GCLM
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.2168958803781521,-0.4117067607957514,1.0,1.0,1.0,6/27,26.37%,CDKN2B;BRD7;E2F7;CDKN2D;GPNMB;FAM107A
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.24440827093861253,0.411260372564714,0.9821428571428571,1.0,1.0,3/11,20.85%,UGGT1;DERL1;RNF185
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.250256484019587,0.4070007048022395,0.9743589743589743,1.0,1.0,2/9,23.28%,NFKB1;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.24926587442433257,0.4069324046102101,1.0,1.0,1.0,2/6,27.04%,ADARB1;CORO1C
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.2425696078351594,0.40692173686699884,1.0,1.0,1.0,3/9,27.88%,GRAMD1C;GRAMD1A;LRP6
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.23237422411559622,-0.40610356015072463,1.0,1.0,1.0,2/9,18.43%,SHANK1;MAP1A
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.2625194913984129,-0.40444418181190694,0.9772727272727273,1.0,1.0,1/6,19.46%,SRGN
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.2584016886699017,-0.4031275567774891,1.0,1.0,1.0,3/7,28.51%,AXL;IFNAR1;TPR
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),-0.2745179001015093,-0.4027206270424852,1.0,1.0,1.0,1/5,20.48%,SHH
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.26116110751811256,-0.4026089589523619,1.0,1.0,1.0,1/6,18.79%,RFTN1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.2760865578580599,0.40177140229666025,1.0,1.0,1.0,6/6,72.40%,SLC16A10;SLC38A5;SLC7A8;SLC3A2;SLC36A4;SLC25A29
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.2741025993673497,-0.4002692241137018,1.0,1.0,1.0,5/5,72.60%,KIFC3;PLEKHA7;TJP1;CAMSAP3;FERMT2
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.2608838482381358,-0.396639263617715,1.0,1.0,1.0,2/6,22.83%,SLC29A4;SLC18A2
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.23323081150314187,0.39585538467885606,0.98,1.0,1.0,1/8,17.08%,PROX1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.2369096744612562,0.3918932281975343,1.0,1.0,1.0,8/8,76.32%,SMG1;NPRL3;LARP1;MLST8;RPTOR;CARD11;CLEC16A;MTOR
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.26099249857895035,0.388874077994055,1.0,1.0,1.0,2/5,23.92%,MEF2C;PKD2
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.2521064862600394,-0.38829734364380386,1.0,1.0,1.0,1/6,20.91%,GBP5
prerank,GO_Biological_Process_2021__regulation of system process (GO:0044057),0.257109274798763,0.3827325755237054,0.9795918367346939,1.0,1.0,1/5,19.03%,ROCK2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.19168686754349956,-0.3780958253638049,1.0,1.0,1.0,2/24,13.34%,KDM4D;KDM6B
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.2240667706135926,-0.37690963984385056,1.0,1.0,1.0,12/12,77.61%,ABCD1;FADS1;ACOT8;SCP2;ACAA1;HSD17B4;FADS2;ELOVL1;ACSL1;ACOX1;ELOVL5;ELOVL2
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.23394306147710078,-0.3727098035586684,1.0,1.0,1.0,5/5,76.62%,ENTR1;CCDC66;CCDC88A;CROCC;LZTFL1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.2230832721936906,0.36899324412008166,1.0,1.0,1.0,10/10,77.70%,CPEB3;NCBP1;CPEB1;CDC73;NCBP2;NUDT21;DHX36;HSF1;LEO1;PAF1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.23212871363094242,-0.36207816885999655,1.0,1.0,1.0,2/6,26.66%,SQSTM1;HOOK2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.18417835011082023,-0.353839717655396,1.0,1.0,1.0,3/23,21.33%,TRMT112;PRMT7;FBL
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.21293346034829283,0.34831525793311685,1.0,1.0,1.0,2/8,23.54%,SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.20384818619049277,0.3447569108800489,1.0,1.0,1.0,1/12,13.76%,TMED9
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.1969706245980945,-0.3424599588627865,1.0,1.0,1.0,1/10,14.32%,NME4
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.22447388932190182,0.3410162820123859,1.0,1.0,1.0,7/7,77.56%,GMPS;SHMT2;PAICS;CTPS1;SHMT1;UMPS;CTPS2
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.20726172465960685,0.3298696891034119,1.0,1.0,1.0,5/5,79.28%,CAV3;PACSIN2;CAV2;EMP2;FLOT1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.20326045109478474,-0.3249966307225751,1.0,1.0,1.0,4/12,31.10%,DNM1L;HAP1;ATCAY;MSTO1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.18551641900568713,0.3249328288445436,1.0,0.9999374579220579,1.0,14/14,81.46%,CLASP1;CLASP2;DPP4;DDR1;DDR2;FAP;FSCN1;PDPN;LRP1;MELTF;FGFR4;TGFB1;CST3;CARMIL2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.2046767537826685,-0.3225220126299123,1.0,1.0,1.0,8/8,79.54%,GLE1;SHFL;JMJD4;OGFOD1;UPF1;GSPT1;ETF1;MTRF1
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.21878168855165714,-0.3211209992672426,1.0,0.9999601280252861,1.0,1/5,20.31%,ABHD1
